<?xml version="1.0" encoding="UTF-8"?>
<dataset part="devel">
<document id="DDI-MedLine.d48">
    <sentence id="DDI-MedLine.d48.s0" text="Modification of surface histidine residues abolishes the cytotoxic activity of Clostridium difficile toxin A.">
        <entity id="DDI-MedLine.d48.s0.e0" charOffset="79-107"
            type="drug_n" text="Clostridium difficile toxin A"/>
    </sentence>
    <sentence id="DDI-MedLine.d48.s1" text="Clostridium difficile toxin A displays both cytotoxic and enterotoxic activities. ">
        <entity id="DDI-MedLine.d48.s1.e0" charOffset="0-28"
            type="drug_n" text="Clostridium difficile toxin A"/>
    </sentence>
    <sentence id="DDI-MedLine.d48.s2" text="It has recently been demonstrated that toxin A exerts its cytotoxic effect by the glucosylation of the small GTP-binding proteins of the Rho family. ">
        <entity id="DDI-MedLine.d48.s2.e0" charOffset="39-45"
            type="drug_n" text="toxin A"/>
    </sentence>
    <sentence id="DDI-MedLine.d48.s3" text="Diethyl pyrocarbonate, at pH 7.0, was used to chemically modify exposed histidine residues on toxin A. ">
        <entity id="DDI-MedLine.d48.s3.e0" charOffset="0-20"
            type="drug_n" text="Diethyl pyrocarbonate"/>
        <entity id="DDI-MedLine.d48.s3.e1" charOffset="94-100"
            type="drug_n" text="toxin A"/>
        <pair id="DDI-MedLine.d48.s3.p0" e1="DDI-MedLine.d48.s3.e0"
            e2="DDI-MedLine.d48.s3.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d48.s4" text="Modification of toxin A with diethyl pyrocarbonate abolished both its cytotoxic activity and the ability of the toxin to bind Zn-Sepharose gel. ">
        <entity id="DDI-MedLine.d48.s4.e0" charOffset="16-22"
            type="drug_n" text="toxin A"/>
        <entity id="DDI-MedLine.d48.s4.e1" charOffset="29-49"
            type="drug_n" text="diethyl pyrocarbonate"/>
        <pair id="DDI-MedLine.d48.s4.p0" e1="DDI-MedLine.d48.s4.e0"
            e2="DDI-MedLine.d48.s4.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d48.s5" text="Treatment of toxin A with [(14)C]-diethyl pyrocarbonate revealed concentration dependent labelling of histidine residues on the toxin molecules. ">
        <entity id="DDI-MedLine.d48.s5.e0" charOffset="13-19"
            type="drug_n" text="toxin A"/>
        <entity id="DDI-MedLine.d48.s5.e1" charOffset="34-54"
            type="drug_n" text="diethyl pyrocarbonate"/>
        <pair id="DDI-MedLine.d48.s5.p0" e1="DDI-MedLine.d48.s5.e0"
            e2="DDI-MedLine.d48.s5.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d48.s6" text="The effects of diethyl pyrocarbonate could be reversed by hydroxylamine treatment. ">
        <entity id="DDI-MedLine.d48.s6.e0" charOffset="15-35"
            type="drug_n" text="diethyl pyrocarbonate"/>
        <entity id="DDI-MedLine.d48.s6.e1" charOffset="58-70"
            type="drug_n" text="hydroxylamine"/>
        <pair id="DDI-MedLine.d48.s6.p0" e1="DDI-MedLine.d48.s6.e0"
            e2="DDI-MedLine.d48.s6.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d48.s7" text="These data suggest the modified histidine residues on toxin A are critical to its cytotoxic activity. ">
        <entity id="DDI-MedLine.d48.s7.e0" charOffset="54-60"
            type="drug_n" text="toxin A"/>
    </sentence>
    <sentence id="DDI-MedLine.d48.s8" text="Histidine modification had no effect on the glucosyl transferase enzyme activity of toxin A. ">
        <entity id="DDI-MedLine.d48.s8.e0" charOffset="84-90"
            type="drug_n" text="toxin A"/>
    </sentence>
    <sentence id="DDI-MedLine.d48.s9" text="However, modification abolished the 'cold' binding of toxin to bovine thyroglobulin in an ELISA and reduced ligand binding activity in a rabbit erythrocyte haemagglutination assay. "/>
    <sentence id="DDI-MedLine.d48.s10" text="The data suggest that the histidine residues may be crucial to the receptor-binding activity of toxin A. ">
        <entity id="DDI-MedLine.d48.s10.e0" charOffset="96-102"
            type="drug_n" text="toxin A"/>
    </sentence>
    <sentence id="DDI-MedLine.d48.s11" text="Exposed histidines on toxin A are available for zinc chelation, and these have been exploited in the development of a novel purification protocol for toxin A using zinc-chelating chromatography.">
        <entity id="DDI-MedLine.d48.s11.e0" charOffset="22-28"
            type="drug_n" text="toxin A"/>
        <entity id="DDI-MedLine.d48.s11.e1" charOffset="48-51"
            type="drug" text="zinc"/>
        <entity id="DDI-MedLine.d48.s11.e2" charOffset="150-156"
            type="drug_n" text="toxin A"/>
        <entity id="DDI-MedLine.d48.s11.e3" charOffset="164-167"
            type="drug" text="zinc"/>
        <pair id="DDI-MedLine.d48.s11.p0" e1="DDI-MedLine.d48.s11.e0"
            e2="DDI-MedLine.d48.s11.e1" ddi="false"/>
        <pair id="DDI-MedLine.d48.s11.p1" e1="DDI-MedLine.d48.s11.e0"
            e2="DDI-MedLine.d48.s11.e2" ddi="false"/>
        <pair id="DDI-MedLine.d48.s11.p2" e1="DDI-MedLine.d48.s11.e0"
            e2="DDI-MedLine.d48.s11.e3" ddi="false"/>
        <pair id="DDI-MedLine.d48.s11.p3" e1="DDI-MedLine.d48.s11.e1"
            e2="DDI-MedLine.d48.s11.e2" ddi="false"/>
        <pair id="DDI-MedLine.d48.s11.p4" e1="DDI-MedLine.d48.s11.e1"
            e2="DDI-MedLine.d48.s11.e3" ddi="false"/>
        <pair id="DDI-MedLine.d48.s11.p5" e1="DDI-MedLine.d48.s11.e2"
            e2="DDI-MedLine.d48.s11.e3" ddi="false"/>
    </sentence>
</document>
<document id="DDI-MedLine.d62">
    <sentence id="DDI-MedLine.d62.s0" text="Activation of an effector immediate-early gene arc by methamphetamine.">
        <entity id="DDI-MedLine.d62.s0.e0" charOffset="54-68"
            type="drug" text="methamphetamine"/>
    </sentence>
    <sentence id="DDI-MedLine.d62.s1" text="As immediate-early genes (IEGs) are thought to play a critical role in mediating stimulus-induced neural plasticity, IEG response induced by methamphetamine (METH) has been characterized to define the changes in gene expression that may underlie its long-lasting behavioral effects. ">
        <entity id="DDI-MedLine.d62.s1.e0" charOffset="141-155"
            type="drug" text="methamphetamine"/>
        <entity id="DDI-MedLine.d62.s1.e1" charOffset="158-161"
            type="drug" text="METH"/>
        <pair id="DDI-MedLine.d62.s1.p0" e1="DDI-MedLine.d62.s1.e0"
            e2="DDI-MedLine.d62.s1.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d62.s2" text="Although activation of several transcription factor IEGs has been described, little is known about effector IEGs. "/>
    <sentence id="DDI-MedLine.d62.s3" text="Here, we have examined whether METH administration affects expression of an effector IEG arc (activity-regulated, cytoskeleton-associated) that encodes a protein with homology to spectrin. ">
        <entity id="DDI-MedLine.d62.s3.e0" charOffset="31-34"
            type="drug" text="METH"/>
    </sentence>
    <sentence id="DDI-MedLine.d62.s4" text="Using in situ hybridization, we observed that METH caused a rapid and transient dose-dependent increase in arc mRNA level in the striatum and cortex that was abolished by pretreatment with the specific dopamine D1 receptor antagonist SCH-23390 but not by an atypical neuroleptic clozapine. ">
        <entity id="DDI-MedLine.d62.s4.e0" charOffset="46-49"
            type="drug" text="METH"/>
        <entity id="DDI-MedLine.d62.s4.e1" charOffset="234-242"
            type="drug_n" text="SCH-23390"/>
        <entity id="DDI-MedLine.d62.s4.e2" charOffset="258-277"
            type="group" text="atypical neuroleptic"/>
        <entity id="DDI-MedLine.d62.s4.e3" charOffset="279-287"
            type="drug" text="clozapine"/>
        <pair id="DDI-MedLine.d62.s4.p0" e1="DDI-MedLine.d62.s4.e0"
            e2="DDI-MedLine.d62.s4.e1" ddi="true" type="effect"/>
        <pair id="DDI-MedLine.d62.s4.p1" e1="DDI-MedLine.d62.s4.e0"
            e2="DDI-MedLine.d62.s4.e2" ddi="false"/>
        <pair id="DDI-MedLine.d62.s4.p2" e1="DDI-MedLine.d62.s4.e0"
            e2="DDI-MedLine.d62.s4.e3" ddi="false"/>
        <pair id="DDI-MedLine.d62.s4.p3" e1="DDI-MedLine.d62.s4.e1"
            e2="DDI-MedLine.d62.s4.e2" ddi="false"/>
        <pair id="DDI-MedLine.d62.s4.p4" e1="DDI-MedLine.d62.s4.e1"
            e2="DDI-MedLine.d62.s4.e3" ddi="false"/>
        <pair id="DDI-MedLine.d62.s4.p5" e1="DDI-MedLine.d62.s4.e2"
            e2="DDI-MedLine.d62.s4.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d62.s5" text="METH induced arc mRNA in layers IV and VI of the cortex which dopamine receptor are localized to. ">
        <entity id="DDI-MedLine.d62.s5.e0" charOffset="0-3" type="drug" text="METH"/>
    </sentence>
    <sentence id="DDI-MedLine.d62.s6" text="These results suggest that D1 receptors are coupled to activation of arc gene, which may be involved in functional or structural alterations underlying neural plasticity triggered by METH.">
        <entity id="DDI-MedLine.d62.s6.e0" charOffset="183-186"
            type="drug" text="METH"/>
    </sentence>
</document>
<document id="DDI-MedLine.d106">
    <sentence id="DDI-MedLine.d106.s0" text="Clinical implications of warfarin interactions with five sedatives.">
        <entity id="DDI-MedLine.d106.s0.e0" charOffset="25-32"
            type="drug" text="warfarin"/>
        <entity id="DDI-MedLine.d106.s0.e1" charOffset="57-65"
            type="group" text="sedatives"/>
        <pair id="DDI-MedLine.d106.s0.p0" e1="DDI-MedLine.d106.s0.e0"
            e2="DDI-MedLine.d106.s0.e1" ddi="true" type="int"/>
    </sentence>
    <sentence id="DDI-MedLine.d106.s1" text="The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy. ">
        <entity id="DDI-MedLine.d106.s1.e0" charOffset="45-57"
            type="group" text="anticoagulant"/>
        <entity id="DDI-MedLine.d106.s1.e1" charOffset="75-87"
            type="drug" text="phenobarbital"/>
        <entity id="DDI-MedLine.d106.s1.e2" charOffset="90-101"
            type="drug" text="secobarbital"/>
        <entity id="DDI-MedLine.d106.s1.e3" charOffset="104-115"
            type="drug" text="glutethimide"/>
        <entity id="DDI-MedLine.d106.s1.e4" charOffset="118-132"
            type="drug" text="chloral hydrate"/>
        <entity id="DDI-MedLine.d106.s1.e5" charOffset="138-149"
            type="drug" text="methaqualone"/>
        <entity id="DDI-MedLine.d106.s1.e6" charOffset="209-216"
            type="group" text="coumarin"/>
        <pair id="DDI-MedLine.d106.s1.p0" e1="DDI-MedLine.d106.s1.e0"
            e2="DDI-MedLine.d106.s1.e1" ddi="false"/>
        <pair id="DDI-MedLine.d106.s1.p1" e1="DDI-MedLine.d106.s1.e0"
            e2="DDI-MedLine.d106.s1.e2" ddi="false"/>
        <pair id="DDI-MedLine.d106.s1.p2" e1="DDI-MedLine.d106.s1.e0"
            e2="DDI-MedLine.d106.s1.e3" ddi="false"/>
        <pair id="DDI-MedLine.d106.s1.p3" e1="DDI-MedLine.d106.s1.e0"
            e2="DDI-MedLine.d106.s1.e4" ddi="false"/>
        <pair id="DDI-MedLine.d106.s1.p4" e1="DDI-MedLine.d106.s1.e0"
            e2="DDI-MedLine.d106.s1.e5" ddi="false"/>
        <pair id="DDI-MedLine.d106.s1.p5" e1="DDI-MedLine.d106.s1.e0"
            e2="DDI-MedLine.d106.s1.e6" ddi="false"/>
        <pair id="DDI-MedLine.d106.s1.p6" e1="DDI-MedLine.d106.s1.e1"
            e2="DDI-MedLine.d106.s1.e2" ddi="false"/>
        <pair id="DDI-MedLine.d106.s1.p7" e1="DDI-MedLine.d106.s1.e1"
            e2="DDI-MedLine.d106.s1.e3" ddi="false"/>
        <pair id="DDI-MedLine.d106.s1.p8" e1="DDI-MedLine.d106.s1.e1"
            e2="DDI-MedLine.d106.s1.e4" ddi="false"/>
        <pair id="DDI-MedLine.d106.s1.p9" e1="DDI-MedLine.d106.s1.e1"
            e2="DDI-MedLine.d106.s1.e5" ddi="false"/>
        <pair id="DDI-MedLine.d106.s1.p10" e1="DDI-MedLine.d106.s1.e1"
            e2="DDI-MedLine.d106.s1.e6" ddi="false"/>
        <pair id="DDI-MedLine.d106.s1.p11" e1="DDI-MedLine.d106.s1.e2"
            e2="DDI-MedLine.d106.s1.e3" ddi="false"/>
        <pair id="DDI-MedLine.d106.s1.p12" e1="DDI-MedLine.d106.s1.e2"
            e2="DDI-MedLine.d106.s1.e4" ddi="false"/>
        <pair id="DDI-MedLine.d106.s1.p13" e1="DDI-MedLine.d106.s1.e2"
            e2="DDI-MedLine.d106.s1.e5" ddi="false"/>
        <pair id="DDI-MedLine.d106.s1.p14" e1="DDI-MedLine.d106.s1.e2"
            e2="DDI-MedLine.d106.s1.e6" ddi="false"/>
        <pair id="DDI-MedLine.d106.s1.p15" e1="DDI-MedLine.d106.s1.e3"
            e2="DDI-MedLine.d106.s1.e4" ddi="false"/>
        <pair id="DDI-MedLine.d106.s1.p16" e1="DDI-MedLine.d106.s1.e3"
            e2="DDI-MedLine.d106.s1.e5" ddi="false"/>
        <pair id="DDI-MedLine.d106.s1.p17" e1="DDI-MedLine.d106.s1.e3"
            e2="DDI-MedLine.d106.s1.e6" ddi="false"/>
        <pair id="DDI-MedLine.d106.s1.p18" e1="DDI-MedLine.d106.s1.e4"
            e2="DDI-MedLine.d106.s1.e5" ddi="false"/>
        <pair id="DDI-MedLine.d106.s1.p19" e1="DDI-MedLine.d106.s1.e4"
            e2="DDI-MedLine.d106.s1.e6" ddi="false"/>
        <pair id="DDI-MedLine.d106.s1.p20" e1="DDI-MedLine.d106.s1.e5"
            e2="DDI-MedLine.d106.s1.e6" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d106.s2" text="Each subject received an individualized fixed daily dose of warfarin and served as his own pre- and postsedative treatment control. ">
        <entity id="DDI-MedLine.d106.s2.e0" charOffset="60-67"
            type="drug" text="warfarin"/>
    </sentence>
    <sentence id="DDI-MedLine.d106.s3" text="Prothrombin times were measured four times weekly during five long-term experiments. "/>
    <sentence id="DDI-MedLine.d106.s4" text="Anticoagulant inhibition was observed during the administration of phenobarbital, secobarbital and glutethimide; ">
        <entity id="DDI-MedLine.d106.s4.e0" charOffset="67-79"
            type="drug" text="phenobarbital"/>
        <entity id="DDI-MedLine.d106.s4.e1" charOffset="82-93"
            type="drug" text="secobarbital"/>
        <entity id="DDI-MedLine.d106.s4.e2" charOffset="99-110"
            type="drug" text="glutethimide"/>
        <pair id="DDI-MedLine.d106.s4.p0" e1="DDI-MedLine.d106.s4.e0"
            e2="DDI-MedLine.d106.s4.e1" ddi="false"/>
        <pair id="DDI-MedLine.d106.s4.p1" e1="DDI-MedLine.d106.s4.e0"
            e2="DDI-MedLine.d106.s4.e2" ddi="false"/>
        <pair id="DDI-MedLine.d106.s4.p2" e1="DDI-MedLine.d106.s4.e1"
            e2="DDI-MedLine.d106.s4.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d106.s5" text="there was no significant change in prothrombin test results during the trials of chloral hydrate and methaqualone. ">
        <entity id="DDI-MedLine.d106.s5.e0" charOffset="81-95"
            type="drug" text="chloral hydrate"/>
        <entity id="DDI-MedLine.d106.s5.e1" charOffset="101-112"
            type="drug" text="methaqualone"/>
        <pair id="DDI-MedLine.d106.s5.p0" e1="DDI-MedLine.d106.s5.e0"
            e2="DDI-MedLine.d106.s5.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d106.s6" text="Barbiturates and glutethimide should not be administered to patients receiving coumarin drugs. ">
        <entity id="DDI-MedLine.d106.s6.e0" charOffset="0-11"
            type="group" text="Barbiturates"/>
        <entity id="DDI-MedLine.d106.s6.e1" charOffset="17-28"
            type="drug" text="glutethimide"/>
        <entity id="DDI-MedLine.d106.s6.e2" charOffset="79-92"
            type="group" text="coumarin drugs"/>
        <pair id="DDI-MedLine.d106.s6.p0" e1="DDI-MedLine.d106.s6.e0"
            e2="DDI-MedLine.d106.s6.e1" ddi="false"/>
        <pair id="DDI-MedLine.d106.s6.p1" e1="DDI-MedLine.d106.s6.e0"
            e2="DDI-MedLine.d106.s6.e2" ddi="true" type="advise"/>
        <pair id="DDI-MedLine.d106.s6.p2" e1="DDI-MedLine.d106.s6.e1"
            e2="DDI-MedLine.d106.s6.e2" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-MedLine.d106.s7" text="The concurrent use of drugs from these groups is decreasing according to a survey of 200 hospital medical records. "/>
    <sentence id="DDI-MedLine.d106.s8" text="Chloral hydrate and methaqualone interact pharmacologically with orally administered anticoagulant agents, but the effect is not clinically significant. ">
        <entity id="DDI-MedLine.d106.s8.e0" charOffset="0-14"
            type="drug" text="Chloral hydrate"/>
        <entity id="DDI-MedLine.d106.s8.e1" charOffset="20-31"
            type="drug" text="methaqualone"/>
        <entity id="DDI-MedLine.d106.s8.e2" charOffset="85-104"
            type="group" text="anticoagulant agents"/>
        <pair id="DDI-MedLine.d106.s8.p0" e1="DDI-MedLine.d106.s8.e0"
            e2="DDI-MedLine.d106.s8.e1" ddi="false"/>
        <pair id="DDI-MedLine.d106.s8.p1" e1="DDI-MedLine.d106.s8.e0"
            e2="DDI-MedLine.d106.s8.e2" ddi="true" type="int"/>
        <pair id="DDI-MedLine.d106.s8.p2" e1="DDI-MedLine.d106.s8.e1"
            e2="DDI-MedLine.d106.s8.e2" ddi="true" type="int"/>
    </sentence>
    <sentence id="DDI-MedLine.d106.s9" text="It is concluded that chloral hydrate and methaqualone may be administered safely without additional caution in prothrombin test monitoring during oral anticoagulant therapy.">
        <entity id="DDI-MedLine.d106.s9.e0" charOffset="21-35"
            type="drug" text="chloral hydrate"/>
        <entity id="DDI-MedLine.d106.s9.e1" charOffset="41-52"
            type="drug" text="methaqualone"/>
        <entity id="DDI-MedLine.d106.s9.e2" charOffset="151-163"
            type="group" text="anticoagulant"/>
        <pair id="DDI-MedLine.d106.s9.p0" e1="DDI-MedLine.d106.s9.e0"
            e2="DDI-MedLine.d106.s9.e1" ddi="false"/>
        <pair id="DDI-MedLine.d106.s9.p1" e1="DDI-MedLine.d106.s9.e0"
            e2="DDI-MedLine.d106.s9.e2" ddi="false"/>
        <pair id="DDI-MedLine.d106.s9.p2" e1="DDI-MedLine.d106.s9.e1"
            e2="DDI-MedLine.d106.s9.e2" ddi="false"/>
    </sentence>
</document>
<document id="DDI-MedLine.d59">
    <sentence id="DDI-MedLine.d59.s0" text="A proposed mechanism for the potentiation of cAMP-mediated acid secretion by carbachol.">
        <entity id="DDI-MedLine.d59.s0.e0" charOffset="77-85"
            type="drug" text="carbachol"/>
    </sentence>
    <sentence id="DDI-MedLine.d59.s1" text="Acid secretion in isolated rabbit gastric glands was monitored by the accumulation of [(14)C]aminopyrine. ">
        <entity id="DDI-MedLine.d59.s1.e0" charOffset="93-103"
            type="drug" text="aminopyrine"/>
    </sentence>
    <sentence id="DDI-MedLine.d59.s2" text="Stimulation of the glands with carbachol synergistically augmented the response to dibutyryl cAMP. ">
        <entity id="DDI-MedLine.d59.s2.e0" charOffset="31-39"
            type="drug" text="carbachol"/>
    </sentence>
    <sentence id="DDI-MedLine.d59.s3" text="The augmentation persisted even after carbachol was washed out and was resistant to chelated extracellular Ca(2+) and to inhibitors of either protein kinase C or calmodulin kinase II. ">
        <entity id="DDI-MedLine.d59.s3.e0" charOffset="38-46"
            type="drug" text="carbachol"/>
    </sentence>
    <sentence id="DDI-MedLine.d59.s4" text="Cytochalasin D at 10 microM preferentially blocked the secretory effect of carbachol and its synergism with cAMP, whereas it had no effect on histamine- or cAMP-stimulated acid secretion within 15 min. ">
        <entity id="DDI-MedLine.d59.s4.e0" charOffset="0-13"
            type="drug_n" text="Cytochalasin D"/>
        <entity id="DDI-MedLine.d59.s4.e1" charOffset="75-83"
            type="drug" text="carbachol"/>
        <pair id="DDI-MedLine.d59.s4.p0" e1="DDI-MedLine.d59.s4.e0"
            e2="DDI-MedLine.d59.s4.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-MedLine.d59.s5" text="Cytochalasin D inhibited the carbachol-stimulated intracellular Ca(2+) concentration ([Ca(2+)](i)) increase due to release from the Ca(2+) store. ">
        <entity id="DDI-MedLine.d59.s5.e0" charOffset="0-13"
            type="drug_n" text="Cytochalasin D"/>
        <entity id="DDI-MedLine.d59.s5.e1" charOffset="29-37"
            type="drug" text="carbachol"/>
        <pair id="DDI-MedLine.d59.s5.p0" e1="DDI-MedLine.d59.s5.e0"
            e2="DDI-MedLine.d59.s5.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-MedLine.d59.s6" text="Treatment of the glands with cytochalasin D redistributed type 3 inositol 1,4,5-trisphosphate receptor (the major subtype in the parietal cell) from the fraction containing membranes of large size to the microsomal fraction, suggesting a dissociation of the store from the plasma membrane. ">
        <entity id="DDI-MedLine.d59.s6.e0" charOffset="29-42"
            type="drug_n" text="cytochalasin D"/>
    </sentence>
    <sentence id="DDI-MedLine.d59.s7" text="These findings suggest that intracellular Ca(2+) release by cholinergic stimulation is critical for determining synergism with cAMP in parietal cell activation and that functional coupling between the Ca(2+) store and the receptor is maintained by actin microfilaments."/>
</document>
<document id="DDI-MedLine.d58">
    <sentence id="DDI-MedLine.d58.s0" text="Effect of ginsenosides on voltage-dependent Ca(2+) channel subtypes in bovine chromaffin cells.">
        <entity id="DDI-MedLine.d58.s0.e0" charOffset="10-21"
            type="drug_n" text="ginsenosides"/>
    </sentence>
    <sentence id="DDI-MedLine.d58.s1" text="In previous reports we have shown that ginsenosides inhibit high threshold voltage-dependent Ca(2+) channels in neuronal cells. ">
        <entity id="DDI-MedLine.d58.s1.e0" charOffset="39-50"
            type="drug_n" text="ginsenosides"/>
    </sentence>
    <sentence id="DDI-MedLine.d58.s2" text="However, these studies did not show whether ginsenosides-induced inhibition of Ca(2+) currents discriminates among the various Ca(2+) channel subtypes, although it is known that there are at least five different Ca(2+) channel subtypes in neuronal cells. ">
        <entity id="DDI-MedLine.d58.s2.e0" charOffset="44-55"
            type="drug_n" text="ginsenosides"/>
    </sentence>
    <sentence id="DDI-MedLine.d58.s3" text="In this study we investigated the effect of ginsenosides on high threshold voltage-dependent Ca(2+) channel subtypes using their selective Ca(2+) channel blockers nimodipine (L-type), omega-conotoxin GVIA (N-type), or omega-agatoxin IVA (P-type) in bovine chromaffin cells. ">
        <entity id="DDI-MedLine.d58.s3.e0" charOffset="44-55"
            type="drug_n" text="ginsenosides"/>
        <entity id="DDI-MedLine.d58.s3.e1" charOffset="129-161"
            type="group" text="selective Ca(2+) channel blockers"/>
        <entity id="DDI-MedLine.d58.s3.e2" charOffset="163-172"
            type="drug" text="nimodipine"/>
        <entity id="DDI-MedLine.d58.s3.e3" charOffset="184-203"
            type="drug_n" text="omega-conotoxin GVIA"/>
        <entity id="DDI-MedLine.d58.s3.e4" charOffset="218-235"
            type="drug_n" text="omega-agatoxin IVA"/>
        <pair id="DDI-MedLine.d58.s3.p0" e1="DDI-MedLine.d58.s3.e0"
            e2="DDI-MedLine.d58.s3.e1" ddi="false"/>
        <pair id="DDI-MedLine.d58.s3.p1" e1="DDI-MedLine.d58.s3.e0"
            e2="DDI-MedLine.d58.s3.e2" ddi="false"/>
        <pair id="DDI-MedLine.d58.s3.p2" e1="DDI-MedLine.d58.s3.e0"
            e2="DDI-MedLine.d58.s3.e3" ddi="false"/>
        <pair id="DDI-MedLine.d58.s3.p3" e1="DDI-MedLine.d58.s3.e0"
            e2="DDI-MedLine.d58.s3.e4" ddi="false"/>
        <pair id="DDI-MedLine.d58.s3.p4" e1="DDI-MedLine.d58.s3.e1"
            e2="DDI-MedLine.d58.s3.e2" ddi="false"/>
        <pair id="DDI-MedLine.d58.s3.p5" e1="DDI-MedLine.d58.s3.e1"
            e2="DDI-MedLine.d58.s3.e3" ddi="false"/>
        <pair id="DDI-MedLine.d58.s3.p6" e1="DDI-MedLine.d58.s3.e1"
            e2="DDI-MedLine.d58.s3.e4" ddi="false"/>
        <pair id="DDI-MedLine.d58.s3.p7" e1="DDI-MedLine.d58.s3.e2"
            e2="DDI-MedLine.d58.s3.e3" ddi="false"/>
        <pair id="DDI-MedLine.d58.s3.p8" e1="DDI-MedLine.d58.s3.e2"
            e2="DDI-MedLine.d58.s3.e4" ddi="false"/>
        <pair id="DDI-MedLine.d58.s3.p9" e1="DDI-MedLine.d58.s3.e3"
            e2="DDI-MedLine.d58.s3.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d58.s4" text="We could observe that ginsenosides inhibited high threshold voltage-dependent Ca(2+) currents in a dose-dependent manner. ">
        <entity id="DDI-MedLine.d58.s4.e0" charOffset="22-33"
            type="drug_n" text="ginsenosides"/>
    </sentence>
    <sentence id="DDI-MedLine.d58.s5" text="The IC(50) was about 120 microgram/ml. "/>
    <sentence id="DDI-MedLine.d58.s6" text="Nimodipine had no effect on ginsenosides response. ">
        <entity id="DDI-MedLine.d58.s6.e0" charOffset="0-9" type="drug" text="Nimodipine"/>
        <entity id="DDI-MedLine.d58.s6.e1" charOffset="28-39"
            type="drug_n" text="ginsenosides"/>
        <pair id="DDI-MedLine.d58.s6.p0" e1="DDI-MedLine.d58.s6.e0"
            e2="DDI-MedLine.d58.s6.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d58.s7" text="These data suggest that ginsenosides are negatively coupled to three types of calcium channels in bovine chromaffin cell, including an omega-conotoxin GVIA-sensitive (N-type) channel, an omega-agatoxin IVA-sensitive (P-type) channel and nimodipine/omega-conotoxin GVIA/omega-agatoxin VIA-resistant (presumptive Q-type) channel. ">
        <entity id="DDI-MedLine.d58.s7.e0" charOffset="24-35"
            type="drug_n" text="ginsenosides"/>
        <entity id="DDI-MedLine.d58.s7.e1" charOffset="135-154"
            type="drug_n" text="omega-conotoxin GVIA"/>
        <entity id="DDI-MedLine.d58.s7.e2" charOffset="187-204"
            type="drug_n" text="omega-agatoxin IVA"/>
        <entity id="DDI-MedLine.d58.s7.e3" charOffset="237-246"
            type="drug" text="nimodipine"/>
        <entity id="DDI-MedLine.d58.s7.e4" charOffset="248-267"
            type="drug_n" text="omega-conotoxin GVIA"/>
        <entity id="DDI-MedLine.d58.s7.e5" charOffset="269-286"
            type="drug_n" text="omega-agatoxin VIA"/>
        <pair id="DDI-MedLine.d58.s7.p0" e1="DDI-MedLine.d58.s7.e0"
            e2="DDI-MedLine.d58.s7.e1" ddi="false"/>
        <pair id="DDI-MedLine.d58.s7.p1" e1="DDI-MedLine.d58.s7.e0"
            e2="DDI-MedLine.d58.s7.e2" ddi="false"/>
        <pair id="DDI-MedLine.d58.s7.p2" e1="DDI-MedLine.d58.s7.e0"
            e2="DDI-MedLine.d58.s7.e3" ddi="false"/>
        <pair id="DDI-MedLine.d58.s7.p3" e1="DDI-MedLine.d58.s7.e0"
            e2="DDI-MedLine.d58.s7.e4" ddi="false"/>
        <pair id="DDI-MedLine.d58.s7.p4" e1="DDI-MedLine.d58.s7.e0"
            e2="DDI-MedLine.d58.s7.e5" ddi="false"/>
        <pair id="DDI-MedLine.d58.s7.p5" e1="DDI-MedLine.d58.s7.e1"
            e2="DDI-MedLine.d58.s7.e2" ddi="false"/>
        <pair id="DDI-MedLine.d58.s7.p6" e1="DDI-MedLine.d58.s7.e1"
            e2="DDI-MedLine.d58.s7.e3" ddi="false"/>
        <pair id="DDI-MedLine.d58.s7.p7" e1="DDI-MedLine.d58.s7.e1"
            e2="DDI-MedLine.d58.s7.e4" ddi="false"/>
        <pair id="DDI-MedLine.d58.s7.p8" e1="DDI-MedLine.d58.s7.e1"
            e2="DDI-MedLine.d58.s7.e5" ddi="false"/>
        <pair id="DDI-MedLine.d58.s7.p9" e1="DDI-MedLine.d58.s7.e2"
            e2="DDI-MedLine.d58.s7.e3" ddi="false"/>
        <pair id="DDI-MedLine.d58.s7.p10" e1="DDI-MedLine.d58.s7.e2"
            e2="DDI-MedLine.d58.s7.e4" ddi="false"/>
        <pair id="DDI-MedLine.d58.s7.p11" e1="DDI-MedLine.d58.s7.e2"
            e2="DDI-MedLine.d58.s7.e5" ddi="false"/>
        <pair id="DDI-MedLine.d58.s7.p12" e1="DDI-MedLine.d58.s7.e3"
            e2="DDI-MedLine.d58.s7.e4" ddi="false"/>
        <pair id="DDI-MedLine.d58.s7.p13" e1="DDI-MedLine.d58.s7.e3"
            e2="DDI-MedLine.d58.s7.e5" ddi="false"/>
        <pair id="DDI-MedLine.d58.s7.p14" e1="DDI-MedLine.d58.s7.e4"
            e2="DDI-MedLine.d58.s7.e5" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d58.s8" text="Thus, the selective regulation of voltage-dependent Ca(2+) subtypes by ginsenosides in bovine chromaffin cell could be the cellular basis of antistress effects induced by ginseng.">
        <entity id="DDI-MedLine.d58.s8.e0" charOffset="71-82"
            type="drug_n" text="ginsenosides"/>
        <entity id="DDI-MedLine.d58.s8.e1" charOffset="171-177"
            type="drug" text="ginseng"/>
        <pair id="DDI-MedLine.d58.s8.p0" e1="DDI-MedLine.d58.s8.e0"
            e2="DDI-MedLine.d58.s8.e1" ddi="false"/>
    </sentence>
</document>
<document id="DDI-MedLine.d47">
    <sentence id="DDI-MedLine.d47.s0" text="Activity of buforin II alone and in combination with azithromycin and minocycline against Cryptosporidium parvum in cell culture.">
        <entity id="DDI-MedLine.d47.s0.e0" charOffset="12-21"
            type="drug_n" text="buforin II"/>
        <entity id="DDI-MedLine.d47.s0.e1" charOffset="53-64"
            type="drug" text="azithromycin"/>
        <entity id="DDI-MedLine.d47.s0.e2" charOffset="70-80"
            type="drug" text="minocycline"/>
        <pair id="DDI-MedLine.d47.s0.p0" e1="DDI-MedLine.d47.s0.e0"
            e2="DDI-MedLine.d47.s0.e1" ddi="false"/>
        <pair id="DDI-MedLine.d47.s0.p1" e1="DDI-MedLine.d47.s0.e0"
            e2="DDI-MedLine.d47.s0.e2" ddi="false"/>
        <pair id="DDI-MedLine.d47.s0.p2" e1="DDI-MedLine.d47.s0.e1"
            e2="DDI-MedLine.d47.s0.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d47.s1" text="The in vitro anti-cryptosporidial activity of buforin II alone and in combination with azithromycin and minocycline was investigated. ">
        <entity id="DDI-MedLine.d47.s1.e0" charOffset="46-55"
            type="drug_n" text="buforin II"/>
        <entity id="DDI-MedLine.d47.s1.e1" charOffset="87-98"
            type="drug" text="azithromycin"/>
        <entity id="DDI-MedLine.d47.s1.e2" charOffset="104-114"
            type="drug" text="minocycline"/>
        <pair id="DDI-MedLine.d47.s1.p0" e1="DDI-MedLine.d47.s1.e0"
            e2="DDI-MedLine.d47.s1.e1" ddi="false"/>
        <pair id="DDI-MedLine.d47.s1.p1" e1="DDI-MedLine.d47.s1.e0"
            e2="DDI-MedLine.d47.s1.e2" ddi="false"/>
        <pair id="DDI-MedLine.d47.s1.p2" e1="DDI-MedLine.d47.s1.e1"
            e2="DDI-MedLine.d47.s1.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d47.s2" text="Buforin II showed moderate activity, which increased with increasing concentration to 55.7% suppression of growth at 20 microM. ">
        <entity id="DDI-MedLine.d47.s2.e0" charOffset="0-9"
            type="drug_n" text="Buforin II"/>
    </sentence>
    <sentence id="DDI-MedLine.d47.s3" text="Moreover, its activity was enhanced when it was combined with either azithromycin or minocycline with 90% parasite reduction at the highest concentration tested. ">
        <entity id="DDI-MedLine.d47.s3.e0" charOffset="69-80"
            type="drug" text="azithromycin"/>
        <entity id="DDI-MedLine.d47.s3.e1" charOffset="85-95"
            type="drug" text="minocycline"/>
        <pair id="DDI-MedLine.d47.s3.p0" e1="DDI-MedLine.d47.s3.e0"
            e2="DDI-MedLine.d47.s3.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d47.s4" text="Buforin II may be active in inhibiting Cryptosporidium parvum growth in vitro upon combination with either azithromycin or minocycline.">
        <entity id="DDI-MedLine.d47.s4.e0" charOffset="0-9"
            type="drug_n" text="Buforin II"/>
        <entity id="DDI-MedLine.d47.s4.e1" charOffset="107-118"
            type="drug" text="azithromycin"/>
        <entity id="DDI-MedLine.d47.s4.e2" charOffset="123-133"
            type="drug" text="minocycline"/>
        <pair id="DDI-MedLine.d47.s4.p0" e1="DDI-MedLine.d47.s4.e0"
            e2="DDI-MedLine.d47.s4.e1" ddi="true" type="effect"/>
        <pair id="DDI-MedLine.d47.s4.p1" e1="DDI-MedLine.d47.s4.e0"
            e2="DDI-MedLine.d47.s4.e2" ddi="true" type="effect"/>
        <pair id="DDI-MedLine.d47.s4.p2" e1="DDI-MedLine.d47.s4.e1"
            e2="DDI-MedLine.d47.s4.e2" ddi="false"/>
    </sentence>
</document>
<document id="DDI-MedLine.d65">
    <sentence id="DDI-MedLine.d65.s0" text="Drug interactions: How to identify them."/>
    <sentence id="DDI-MedLine.d65.s1" text="Interactions between theraputic agents have been recognized as increasingly important causes of drug at their usual recommended dose may, under certain conditions, produce toxicity of life-endangering proportions. "/>
    <sentence id="DDI-MedLine.d65.s2" text="While the recognition of drug toxicity resulting from interactions is of importance to all physciains, it is especially so for the clinician responsible for the welfare of those in the aerospace environment. "/>
    <sentence id="DDI-MedLine.d65.s3" text="This paper attempts to provide a basis for the understanding and identifications of important drug interactions. "/>
    <sentence id="DDI-MedLine.d65.s4" text="Guidelines are provided to assist the clinician in his logical approach to the identification of drug interactions when serious drug toxicity is encountered in a pateint. "/>
    <sentence id="DDI-MedLine.d65.s5" text="Only with knowledge of the interaction can the therapeutic regimen be altered so as to provide therapeutic levels of necessary drugs while avoiding toxicity."/>
</document>
<document id="DDI-MedLine.d74">
    <sentence id="DDI-MedLine.d74.s0" text="Responses to arginine of the perfused pancreas of the genetically diabetic Chinese hamster.">
        <entity id="DDI-MedLine.d74.s0.e0" charOffset="13-20"
            type="drug" text="arginine"/>
    </sentence>
    <sentence id="DDI-MedLine.d74.s1" text="Nonketotic, genetically diabetic Cinese hamsters show subnormal pancreatic insulin release and impaired suppression of glucagon in response to glucose. "/>
    <sentence id="DDI-MedLine.d74.s2" text="To study the pancreatic effects of other agents, dynamic insulin and glucagon release was measured from the in vitro perfused pancreases of normal and diabetic Chinese hamsters in response to various combinations of arginine (20mM), glucose (100 or 150 mg. per 100 ml.), and theophylline (10 mM). ">
        <entity id="DDI-MedLine.d74.s2.e0" charOffset="216-223"
            type="drug" text="arginine"/>
        <entity id="DDI-MedLine.d74.s2.e1" charOffset="233-239"
            type="drug" text="glucose"/>
        <entity id="DDI-MedLine.d74.s2.e2" charOffset="275-286"
            type="drug" text="theophylline"/>
        <pair id="DDI-MedLine.d74.s2.p0" e1="DDI-MedLine.d74.s2.e0"
            e2="DDI-MedLine.d74.s2.e1" ddi="false"/>
        <pair id="DDI-MedLine.d74.s2.p1" e1="DDI-MedLine.d74.s2.e0"
            e2="DDI-MedLine.d74.s2.e2" ddi="false"/>
        <pair id="DDI-MedLine.d74.s2.p2" e1="DDI-MedLine.d74.s2.e1"
            e2="DDI-MedLine.d74.s2.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d74.s3" text="Theophylline alone caused identical insulin and glucagon release in diabetics and normals. ">
        <entity id="DDI-MedLine.d74.s3.e0" charOffset="0-11" type="drug" text="Theophylline"/>
    </sentence>
    <sentence id="DDI-MedLine.d74.s4" text="Glucose, alone and in the presence of theophylline, caused subnormal insulin release and less suppression of glucagon release in the diabectics than in the normals. ">
        <entity id="DDI-MedLine.d74.s4.e0" charOffset="0-6" type="drug" text="Glucose"/>
        <entity id="DDI-MedLine.d74.s4.e1" charOffset="38-49"
            type="drug" text="theophylline"/>
        <pair id="DDI-MedLine.d74.s4.p0" e1="DDI-MedLine.d74.s4.e0"
            e2="DDI-MedLine.d74.s4.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d74.s5" text="Arginine, in the presence of glucose and theophylline, caused excessive glucagon release but nearly normal insulin release in the diabetics. ">
        <entity id="DDI-MedLine.d74.s5.e0" charOffset="0-7" type="drug" text="Arginine"/>
        <entity id="DDI-MedLine.d74.s5.e1" charOffset="29-35"
            type="drug" text="glucose"/>
        <entity id="DDI-MedLine.d74.s5.e2" charOffset="41-52"
            type="drug" text="theophylline"/>
        <pair id="DDI-MedLine.d74.s5.p0" e1="DDI-MedLine.d74.s5.e0"
            e2="DDI-MedLine.d74.s5.e1" ddi="false"/>
        <pair id="DDI-MedLine.d74.s5.p1" e1="DDI-MedLine.d74.s5.e0"
            e2="DDI-MedLine.d74.s5.e2" ddi="false"/>
        <pair id="DDI-MedLine.d74.s5.p2" e1="DDI-MedLine.d74.s5.e1"
            e2="DDI-MedLine.d74.s5.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d74.s6" text="Arginine, in the absence of glucose or theophylline, caused excessive glucagon release in the diabetics and undetectable insulin release in either diabetics or normals. ">
        <entity id="DDI-MedLine.d74.s6.e0" charOffset="0-7" type="drug" text="Arginine"/>
        <entity id="DDI-MedLine.d74.s6.e1" charOffset="28-34"
            type="drug" text="glucose"/>
        <entity id="DDI-MedLine.d74.s6.e2" charOffset="39-50"
            type="drug" text="theophylline"/>
        <pair id="DDI-MedLine.d74.s6.p0" e1="DDI-MedLine.d74.s6.e0"
            e2="DDI-MedLine.d74.s6.e1" ddi="false"/>
        <pair id="DDI-MedLine.d74.s6.p1" e1="DDI-MedLine.d74.s6.e0"
            e2="DDI-MedLine.d74.s6.e2" ddi="false"/>
        <pair id="DDI-MedLine.d74.s6.p2" e1="DDI-MedLine.d74.s6.e1"
            e2="DDI-MedLine.d74.s6.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d74.s7" text="Pancreatic content after perfusion did not correlate with release during perfusion. "/>
    <sentence id="DDI-MedLine.d74.s8" text="Infusion of arginine alone markedly decreased the amount of extractable pancreatic insulin and glucagon. ">
        <entity id="DDI-MedLine.d74.s8.e0" charOffset="12-19"
            type="drug" text="arginine"/>
    </sentence>
    <sentence id="DDI-MedLine.d74.s9" text="These results indicate that the pancreatic alpha cell of the diabetic Chinese hamster responds excessively to arginine, as is seen in the human diabetic. ">
        <entity id="DDI-MedLine.d74.s9.e0" charOffset="110-117"
            type="drug" text="arginine"/>
    </sentence>
    <sentence id="DDI-MedLine.d74.s10" text="This defect is not related to acute insulin release or the presence of glucose. ">
        <entity id="DDI-MedLine.d74.s10.e0" charOffset="71-77"
            type="drug" text="glucose"/>
    </sentence>
    <sentence id="DDI-MedLine.d74.s11" text="Further, these results confirm that the diabetic Chinese hamster's alpha and beta cells respond normally to theophylline, but are relatively insensitive to glucose.">
        <entity id="DDI-MedLine.d74.s11.e0" charOffset="108-119"
            type="drug" text="theophylline"/>
        <entity id="DDI-MedLine.d74.s11.e1" charOffset="156-162"
            type="drug" text="glucose"/>
        <pair id="DDI-MedLine.d74.s11.p0" e1="DDI-MedLine.d74.s11.e0"
            e2="DDI-MedLine.d74.s11.e1" ddi="false"/>
    </sentence>
</document>
<document id="DDI-MedLine.d44">
    <sentence id="DDI-MedLine.d44.s0" text="Effects of etofibrate upon the metabolism of chylomicron-like emulsions in patients with coronary artery disease.">
        <entity id="DDI-MedLine.d44.s0.e0" charOffset="11-20"
            type="drug" text="etofibrate"/>
    </sentence>
    <sentence id="DDI-MedLine.d44.s1" text="Slow chylomicron intravascular catabolism has been associated with coronary artery disease and screening for drugs that can speed-up this process can be important. "/>
    <sentence id="DDI-MedLine.d44.s2" text="In this study, the effects of etofibrate upon chylomicron metabolism was tested by determination of the plasma kinetics of a chylomicron-like emulsion model in 12 patients with coronary artery disease, aged 59+/-11 years, (total cholesterol: 240+/-41 mg/dl; triglycerides: 188+/-42 mg/dl) submitted to a randomized, crossover, double-blind, placebo-controlled study with administration of 1 g per day etofibrate or placebo for 1-month. ">
        <entity id="DDI-MedLine.d44.s2.e0" charOffset="30-39"
            type="drug" text="etofibrate"/>
        <entity id="DDI-MedLine.d44.s2.e1" charOffset="401-410"
            type="drug" text="etofibrate"/>
        <pair id="DDI-MedLine.d44.s2.p0" e1="DDI-MedLine.d44.s2.e0"
            e2="DDI-MedLine.d44.s2.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d44.s3" text="A 1-month washout period was inserted between the treatment periods. "/>
    <sentence id="DDI-MedLine.d44.s4" text="Patients were intravenously injected a chylomicron-like emulsion doubly labeled with 14C-cholesteryl oleate and 3H-triolein at baseline and after treatments. "/>
    <sentence id="DDI-MedLine.d44.s5" text="After etofibrate treatment, there was decrease of total cholesterol and triglyceride plasma levels and a trend to increase high-density lipoprotein cholesterol plasma levels. ">
        <entity id="DDI-MedLine.d44.s5.e0" charOffset="6-15" type="drug" text="etofibrate"/>
    </sentence>
    <sentence id="DDI-MedLine.d44.s6" text="Etofibrate elicited 62% enhancement of post-heparin lipolytic activity and 100% increase of 3H-triglyceride fractional clearance rate compared with placebo treatment. ">
        <entity id="DDI-MedLine.d44.s6.e0" charOffset="0-9" type="drug" text="Etofibrate"/>
        <entity id="DDI-MedLine.d44.s6.e1" charOffset="44-50"
            type="drug" text="heparin"/>
        <pair id="DDI-MedLine.d44.s6.p0" e1="DDI-MedLine.d44.s6.e0"
            e2="DDI-MedLine.d44.s6.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-MedLine.d44.s7" text="14C-cholesterol ester fractional clearance rate was 260% greater after etofibrate than after placebo. ">
        <entity id="DDI-MedLine.d44.s7.e0" charOffset="71-80"
            type="drug" text="etofibrate"/>
    </sentence>
    <sentence id="DDI-MedLine.d44.s8" text="Therefore, a potent effect of etofibrate on both chylomicron lipolysis and remnant removal was achieved, indicating that this drug can be used to improve this metabolism in future prospective studies.">
        <entity id="DDI-MedLine.d44.s8.e0" charOffset="30-39"
            type="drug" text="etofibrate"/>
    </sentence>
</document>
<document id="DDI-MedLine.d125">
    <sentence id="DDI-MedLine.d125.s0" text="The mode of toxic action of the pesticide gliftor: the metabolism of 1,3-difluoroacetone to (-)-erythro-fluorocitrate.">
        <entity id="DDI-MedLine.d125.s0.e0" charOffset="42-48"
            type="drug_n" text="gliftor"/>
        <entity id="DDI-MedLine.d125.s0.e1" charOffset="69-87"
            type="drug_n" text="1,3-difluoroacetone"/>
        <entity id="DDI-MedLine.d125.s0.e2" charOffset="92-116"
            type="drug_n" text="(-)-erythro-fluorocitrate"/>
        <pair id="DDI-MedLine.d125.s0.p0" e1="DDI-MedLine.d125.s0.e0"
            e2="DDI-MedLine.d125.s0.e1" ddi="false"/>
        <pair id="DDI-MedLine.d125.s0.p1" e1="DDI-MedLine.d125.s0.e0"
            e2="DDI-MedLine.d125.s0.e2" ddi="false"/>
        <pair id="DDI-MedLine.d125.s0.p2" e1="DDI-MedLine.d125.s0.e1"
            e2="DDI-MedLine.d125.s0.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d125.s1" text="The biochemical toxicology of 1,3-difluoroacetone, a known metabolite of the major ingredient of the pesticide Gliftor (1,3-difluoro-2-propanol), was investigated in vivo and in vitro. ">
        <entity id="DDI-MedLine.d125.s1.e0" charOffset="30-48"
            type="drug_n" text="1,3-difluoroacetone"/>
        <entity id="DDI-MedLine.d125.s1.e1" charOffset="111-117"
            type="drug_n" text="Gliftor"/>
        <entity id="DDI-MedLine.d125.s1.e2" charOffset="120-142"
            type="drug_n" text="1,3-difluoro-2-propanol"/>
        <pair id="DDI-MedLine.d125.s1.p0" e1="DDI-MedLine.d125.s1.e0"
            e2="DDI-MedLine.d125.s1.e1" ddi="false"/>
        <pair id="DDI-MedLine.d125.s1.p1" e1="DDI-MedLine.d125.s1.e0"
            e2="DDI-MedLine.d125.s1.e2" ddi="false"/>
        <pair id="DDI-MedLine.d125.s1.p2" e1="DDI-MedLine.d125.s1.e1"
            e2="DDI-MedLine.d125.s1.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d125.s2" text="Rat kidney homogenates supplemented with coenzyme A, ATP, oxaloacetate, and Mg2+ converted 1,3-difluoroacetone to (-)-erythro-fluorocitrate in vitro. ">
        <entity id="DDI-MedLine.d125.s2.e0" charOffset="91-109"
            type="drug_n" text="1,3-difluoroacetone"/>
        <entity id="DDI-MedLine.d125.s2.e1" charOffset="114-138"
            type="drug_n" text="(-)-erythro-fluorocitrate"/>
        <pair id="DDI-MedLine.d125.s2.p0" e1="DDI-MedLine.d125.s2.e0"
            e2="DDI-MedLine.d125.s2.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d125.s3" text="Administration of 1,3-difluoroacetone (100 mg kg(-1) body weight) to rats in vivo resulted in (-)-erythro-fluorocitrate synthesis in the kidney, which was preceded by an elevation in fluoride levels and followed by citrate accumulation. ">
        <entity id="DDI-MedLine.d125.s3.e0" charOffset="18-36"
            type="drug_n" text="1,3-difluoroacetone"/>
        <entity id="DDI-MedLine.d125.s3.e1" charOffset="94-118"
            type="drug_n" text="(-)-erythro-fluorocitrate"/>
        <pair id="DDI-MedLine.d125.s3.p0" e1="DDI-MedLine.d125.s3.e0"
            e2="DDI-MedLine.d125.s3.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d125.s4" text="Animals dosed with 1,3-difluoroacetone did not display the 2-3 hour lag phase in either (-)-erythro-fluorocitrate synthesis or in citrate and fluoride accumulation characteristic of animals dosed with 1,3-difluoro-2-propanol. ">
        <entity id="DDI-MedLine.d125.s4.e0" charOffset="19-37"
            type="drug_n" text="1,3-difluoroacetone"/>
        <entity id="DDI-MedLine.d125.s4.e1" charOffset="88-112"
            type="drug_n" text="(-)-erythro-fluorocitrate"/>
        <entity id="DDI-MedLine.d125.s4.e2" charOffset="201-223"
            type="drug_n" text="1,3-difluoro-2-propanol"/>
        <pair id="DDI-MedLine.d125.s4.p0" e1="DDI-MedLine.d125.s4.e0"
            e2="DDI-MedLine.d125.s4.e1" ddi="false"/>
        <pair id="DDI-MedLine.d125.s4.p1" e1="DDI-MedLine.d125.s4.e0"
            e2="DDI-MedLine.d125.s4.e2" ddi="false"/>
        <pair id="DDI-MedLine.d125.s4.p2" e1="DDI-MedLine.d125.s4.e1"
            e2="DDI-MedLine.d125.s4.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d125.s5" text="We demonstrate that the conversion of 1,3-difluoro-2-propanol to 1,3-difluoroacetone by an NAD+-dependent oxidation is the rate-limiting step in the synthesis of the toxic product, (-)-erythro-fluorocitrate from 1,3-difluoro-2-propanol. ">
        <entity id="DDI-MedLine.d125.s5.e0" charOffset="38-60"
            type="drug_n" text="1,3-difluoro-2-propanol"/>
        <entity id="DDI-MedLine.d125.s5.e1" charOffset="65-83"
            type="drug_n" text="1,3-difluoroacetone"/>
        <entity id="DDI-MedLine.d125.s5.e2" charOffset="181-205"
            type="drug_n" text="(-)-erythro-fluorocitrate"/>
        <entity id="DDI-MedLine.d125.s5.e3" charOffset="212-234"
            type="drug_n" text="1,3-difluoro-2-propanol"/>
        <pair id="DDI-MedLine.d125.s5.p0" e1="DDI-MedLine.d125.s5.e0"
            e2="DDI-MedLine.d125.s5.e1" ddi="false"/>
        <pair id="DDI-MedLine.d125.s5.p1" e1="DDI-MedLine.d125.s5.e0"
            e2="DDI-MedLine.d125.s5.e2" ddi="false"/>
        <pair id="DDI-MedLine.d125.s5.p2" e1="DDI-MedLine.d125.s5.e0"
            e2="DDI-MedLine.d125.s5.e3" ddi="false"/>
        <pair id="DDI-MedLine.d125.s5.p3" e1="DDI-MedLine.d125.s5.e1"
            e2="DDI-MedLine.d125.s5.e2" ddi="false"/>
        <pair id="DDI-MedLine.d125.s5.p4" e1="DDI-MedLine.d125.s5.e1"
            e2="DDI-MedLine.d125.s5.e3" ddi="false"/>
        <pair id="DDI-MedLine.d125.s5.p5" e1="DDI-MedLine.d125.s5.e2"
            e2="DDI-MedLine.d125.s5.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d125.s6" text="Prior administration of 4-methylpyrazole (90 mg kg(-1) body weight) was shown to prevent the conversion of 1,3-difluoro-2-propanol (100 mg kg(-1) body weight) to (-)-erythro-fluorocitrate in vivo and to eliminate the fluoride and citrate elevations seen in 1,3-difluoro-2-propanol-intoxicated animals. ">
        <entity id="DDI-MedLine.d125.s6.e0" charOffset="24-39"
            type="drug" text="4-methylpyrazole"/>
        <entity id="DDI-MedLine.d125.s6.e1" charOffset="107-129"
            type="drug_n" text="1,3-difluoro-2-propanol"/>
        <entity id="DDI-MedLine.d125.s6.e2" charOffset="162-186"
            type="drug_n" text="(-)-erythro-fluorocitrate"/>
        <entity id="DDI-MedLine.d125.s6.e3" charOffset="257-279"
            type="drug_n" text="1,3-difluoro-2-propanol"/>
        <pair id="DDI-MedLine.d125.s6.p0" e1="DDI-MedLine.d125.s6.e0"
            e2="DDI-MedLine.d125.s6.e1" ddi="true" type="effect"/>
        <pair id="DDI-MedLine.d125.s6.p1" e1="DDI-MedLine.d125.s6.e0"
            e2="DDI-MedLine.d125.s6.e2" ddi="false"/>
        <pair id="DDI-MedLine.d125.s6.p2" e1="DDI-MedLine.d125.s6.e0"
            e2="DDI-MedLine.d125.s6.e3" ddi="false"/>
        <pair id="DDI-MedLine.d125.s6.p3" e1="DDI-MedLine.d125.s6.e1"
            e2="DDI-MedLine.d125.s6.e2" ddi="false"/>
        <pair id="DDI-MedLine.d125.s6.p4" e1="DDI-MedLine.d125.s6.e1"
            e2="DDI-MedLine.d125.s6.e3" ddi="false"/>
        <pair id="DDI-MedLine.d125.s6.p5" e1="DDI-MedLine.d125.s6.e2"
            e2="DDI-MedLine.d125.s6.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d125.s7" text="However, administration of 4-methylpyrazole (90 mg kg(-1) body weight) to rats 2 hours prior to 1,3-difluoroacetone (100 mg kg(-1) body weight) was ineffective in preventing (-)-erythro-fluorocitrate synthesis and did not diminish fluoride or citrate accumulation in vivo. ">
        <entity id="DDI-MedLine.d125.s7.e0" charOffset="27-42"
            type="drug" text="4-methylpyrazole"/>
        <entity id="DDI-MedLine.d125.s7.e1" charOffset="96-114"
            type="drug_n" text="1,3-difluoroacetone"/>
        <entity id="DDI-MedLine.d125.s7.e2" charOffset="174-198"
            type="drug_n" text="(-)-erythro-fluorocitrate"/>
        <pair id="DDI-MedLine.d125.s7.p0" e1="DDI-MedLine.d125.s7.e0"
            e2="DDI-MedLine.d125.s7.e1" ddi="false"/>
        <pair id="DDI-MedLine.d125.s7.p1" e1="DDI-MedLine.d125.s7.e0"
            e2="DDI-MedLine.d125.s7.e2" ddi="false"/>
        <pair id="DDI-MedLine.d125.s7.p2" e1="DDI-MedLine.d125.s7.e1"
            e2="DDI-MedLine.d125.s7.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d125.s8" text="We conclude that the prophylactic and antidotal properties of 4-methylpyrazole seen in animals treated with 1,3-difluoro-2-propanol derive from its capacity to inhibit the NAD+-dependent oxidation responsible for converting 1,3-difluoro-2-propanol to 1,3-difluoroacetone in the committed step of the toxic pathway.">
        <entity id="DDI-MedLine.d125.s8.e0" charOffset="62-77"
            type="drug" text="4-methylpyrazole"/>
        <entity id="DDI-MedLine.d125.s8.e1" charOffset="108-130"
            type="drug_n" text="1,3-difluoro-2-propanol"/>
        <entity id="DDI-MedLine.d125.s8.e2" charOffset="224-246"
            type="drug_n" text="1,3-difluoro-2-propanol"/>
        <entity id="DDI-MedLine.d125.s8.e3" charOffset="251-269"
            type="drug_n" text="1,3-difluoroacetone"/>
        <pair id="DDI-MedLine.d125.s8.p0" e1="DDI-MedLine.d125.s8.e0"
            e2="DDI-MedLine.d125.s8.e1" ddi="true" type="effect"/>
        <pair id="DDI-MedLine.d125.s8.p1" e1="DDI-MedLine.d125.s8.e0"
            e2="DDI-MedLine.d125.s8.e2" ddi="false"/>
        <pair id="DDI-MedLine.d125.s8.p2" e1="DDI-MedLine.d125.s8.e0"
            e2="DDI-MedLine.d125.s8.e3" ddi="false"/>
        <pair id="DDI-MedLine.d125.s8.p3" e1="DDI-MedLine.d125.s8.e1"
            e2="DDI-MedLine.d125.s8.e2" ddi="false"/>
        <pair id="DDI-MedLine.d125.s8.p4" e1="DDI-MedLine.d125.s8.e1"
            e2="DDI-MedLine.d125.s8.e3" ddi="false"/>
        <pair id="DDI-MedLine.d125.s8.p5" e1="DDI-MedLine.d125.s8.e2"
            e2="DDI-MedLine.d125.s8.e3" ddi="false"/>
    </sentence>
</document>
<document id="DDI-MedLine.d86">
    <sentence id="DDI-MedLine.d86.s0" text="Pharmacokinetic interaction between single oral doses of diltiazem and sirolimus in healthy volunteers.">
        <entity id="DDI-MedLine.d86.s0.e0" charOffset="57-65"
            type="drug" text="diltiazem"/>
        <entity id="DDI-MedLine.d86.s0.e1" charOffset="71-79"
            type="drug" text="sirolimus"/>
        <pair id="DDI-MedLine.d86.s0.p0" e1="DDI-MedLine.d86.s0.e0"
            e2="DDI-MedLine.d86.s0.e1" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-MedLine.d86.s1" text="AIM AND BACKGROUND: The pharmacokinetic interaction between sirolimus, a macrolide immunosuppressant metabolized by CYP3A4, and the calcium channel blocker diltiazem was studied in 18 healthy subjects. ">
        <entity id="DDI-MedLine.d86.s1.e0" charOffset="60-68"
            type="drug" text="sirolimus"/>
        <entity id="DDI-MedLine.d86.s1.e1" charOffset="73-99"
            type="group" text="macrolide immunosuppressant"/>
        <entity id="DDI-MedLine.d86.s1.e2" charOffset="132-154"
            type="group" text="calcium channel blocker"/>
        <entity id="DDI-MedLine.d86.s1.e3" charOffset="156-164"
            type="drug" text="diltiazem"/>
        <pair id="DDI-MedLine.d86.s1.p0" e1="DDI-MedLine.d86.s1.e0"
            e2="DDI-MedLine.d86.s1.e1" ddi="false"/>
        <pair id="DDI-MedLine.d86.s1.p1" e1="DDI-MedLine.d86.s1.e0"
            e2="DDI-MedLine.d86.s1.e2" ddi="false"/>
        <pair id="DDI-MedLine.d86.s1.p2" e1="DDI-MedLine.d86.s1.e0"
            e2="DDI-MedLine.d86.s1.e3" ddi="false"/>
        <pair id="DDI-MedLine.d86.s1.p3" e1="DDI-MedLine.d86.s1.e1"
            e2="DDI-MedLine.d86.s1.e2" ddi="false"/>
        <pair id="DDI-MedLine.d86.s1.p4" e1="DDI-MedLine.d86.s1.e1"
            e2="DDI-MedLine.d86.s1.e3" ddi="false"/>
        <pair id="DDI-MedLine.d86.s1.p5" e1="DDI-MedLine.d86.s1.e2"
            e2="DDI-MedLine.d86.s1.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d86.s2" text="Several clinically important interactions have previously been reported for other immunosuppressive drugs that are metabolized by the same enzyme and for calcium antagonists. ">
        <entity id="DDI-MedLine.d86.s2.e0" charOffset="82-104"
            type="group" text="immunosuppressive drugs"/>
        <entity id="DDI-MedLine.d86.s2.e1" charOffset="154-172"
            type="group" text="calcium antagonists"/>
        <pair id="DDI-MedLine.d86.s2.p0" e1="DDI-MedLine.d86.s2.e0"
            e2="DDI-MedLine.d86.s2.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d86.s3" text="METHODS: Healthy subjects who were 20 to 43 years old participated in an open, three-period, randomized, crossover study of the pharmacokinetics of a single 10-mg oral dose of sirolimus, a single oral 120-mg dose of diltiazem, and the two drugs given together. ">
        <entity id="DDI-MedLine.d86.s3.e0" charOffset="176-184"
            type="drug" text="sirolimus"/>
        <entity id="DDI-MedLine.d86.s3.e1" charOffset="216-224"
            type="drug" text="diltiazem"/>
        <pair id="DDI-MedLine.d86.s3.p0" e1="DDI-MedLine.d86.s3.e0"
            e2="DDI-MedLine.d86.s3.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d86.s4" text="The three study periods were separated by a 21-day washout phase. "/>
    <sentence id="DDI-MedLine.d86.s5" text="RESULTS: The geometric mean (90% confidence interval) whole blood sirolimus area under the plasma concentration time-curve increased 60% (35%-90%), from 736 to 1178 ng x h/mL, and maximum concentration increased 43% (14%-81%), from 67 to 96 ng/mL, with diltiazem coadministration, whereas the mean elimination half-life of sirolimus decreased slightly, from 79 to 67 hours. ">
        <entity id="DDI-MedLine.d86.s5.e0" charOffset="66-74"
            type="drug" text="sirolimus"/>
        <entity id="DDI-MedLine.d86.s5.e1" charOffset="253-261"
            type="drug" text="diltiazem"/>
        <entity id="DDI-MedLine.d86.s5.e2" charOffset="323-331"
            type="drug" text="sirolimus"/>
        <pair id="DDI-MedLine.d86.s5.p0" e1="DDI-MedLine.d86.s5.e0"
            e2="DDI-MedLine.d86.s5.e1" ddi="true" type="mechanism"/>
        <pair id="DDI-MedLine.d86.s5.p1" e1="DDI-MedLine.d86.s5.e0"
            e2="DDI-MedLine.d86.s5.e2" ddi="false"/>
        <pair id="DDI-MedLine.d86.s5.p2" e1="DDI-MedLine.d86.s5.e1"
            e2="DDI-MedLine.d86.s5.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d86.s6" text="Apparent oral clearance and volume of distribution of sirolimus decreased with 38% and 45%, respectively, when sirolimus was given with diltiazem. ">
        <entity id="DDI-MedLine.d86.s6.e0" charOffset="54-62"
            type="drug" text="sirolimus"/>
        <entity id="DDI-MedLine.d86.s6.e1" charOffset="111-119"
            type="drug" text="sirolimus"/>
        <entity id="DDI-MedLine.d86.s6.e2" charOffset="136-144"
            type="drug" text="diltiazem"/>
        <pair id="DDI-MedLine.d86.s6.p0" e1="DDI-MedLine.d86.s6.e0"
            e2="DDI-MedLine.d86.s6.e1" ddi="false"/>
        <pair id="DDI-MedLine.d86.s6.p1" e1="DDI-MedLine.d86.s6.e0"
            e2="DDI-MedLine.d86.s6.e2" ddi="false"/>
        <pair id="DDI-MedLine.d86.s6.p2" e1="DDI-MedLine.d86.s6.e1"
            e2="DDI-MedLine.d86.s6.e2" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-MedLine.d86.s7" text="The plasma maximum concentration and area under the plasma concentration-time curve of diltiazem, desacetyldiltiazem, and desmethyldiltiazem were unchanged after coadministration of sirolimus, and no potentiation of the effects of diltiazem on diastolic or systolic blood pressure or on the electrocardiographic parameters was seen. ">
        <entity id="DDI-MedLine.d86.s7.e0" charOffset="87-95"
            type="drug" text="diltiazem"/>
        <entity id="DDI-MedLine.d86.s7.e1" charOffset="98-115"
            type="drug_n" text="desacetyldiltiazem"/>
        <entity id="DDI-MedLine.d86.s7.e2" charOffset="122-139"
            type="drug_n" text="desmethyldiltiazem"/>
        <entity id="DDI-MedLine.d86.s7.e3" charOffset="182-190"
            type="drug" text="sirolimus"/>
        <entity id="DDI-MedLine.d86.s7.e4" charOffset="231-239"
            type="drug" text="diltiazem"/>
        <pair id="DDI-MedLine.d86.s7.p0" e1="DDI-MedLine.d86.s7.e0"
            e2="DDI-MedLine.d86.s7.e1" ddi="false"/>
        <pair id="DDI-MedLine.d86.s7.p1" e1="DDI-MedLine.d86.s7.e0"
            e2="DDI-MedLine.d86.s7.e2" ddi="false"/>
        <pair id="DDI-MedLine.d86.s7.p2" e1="DDI-MedLine.d86.s7.e0"
            e2="DDI-MedLine.d86.s7.e3" ddi="false"/>
        <pair id="DDI-MedLine.d86.s7.p3" e1="DDI-MedLine.d86.s7.e0"
            e2="DDI-MedLine.d86.s7.e4" ddi="false"/>
        <pair id="DDI-MedLine.d86.s7.p4" e1="DDI-MedLine.d86.s7.e1"
            e2="DDI-MedLine.d86.s7.e2" ddi="false"/>
        <pair id="DDI-MedLine.d86.s7.p5" e1="DDI-MedLine.d86.s7.e1"
            e2="DDI-MedLine.d86.s7.e3" ddi="false"/>
        <pair id="DDI-MedLine.d86.s7.p6" e1="DDI-MedLine.d86.s7.e1"
            e2="DDI-MedLine.d86.s7.e4" ddi="false"/>
        <pair id="DDI-MedLine.d86.s7.p7" e1="DDI-MedLine.d86.s7.e2"
            e2="DDI-MedLine.d86.s7.e3" ddi="false"/>
        <pair id="DDI-MedLine.d86.s7.p8" e1="DDI-MedLine.d86.s7.e2"
            e2="DDI-MedLine.d86.s7.e4" ddi="false"/>
        <pair id="DDI-MedLine.d86.s7.p9" e1="DDI-MedLine.d86.s7.e3"
            e2="DDI-MedLine.d86.s7.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d86.s8" text="CONCLUSIONS: Single-dose diltiazem coadministration leads to higher sirolimus exposure, presumably by inhibition of the first-pass metabolism of sirolimus. ">
        <entity id="DDI-MedLine.d86.s8.e0" charOffset="25-33"
            type="drug" text="diltiazem"/>
        <entity id="DDI-MedLine.d86.s8.e1" charOffset="68-76"
            type="drug" text="sirolimus"/>
        <entity id="DDI-MedLine.d86.s8.e2" charOffset="145-153"
            type="drug" text="sirolimus"/>
        <pair id="DDI-MedLine.d86.s8.p0" e1="DDI-MedLine.d86.s8.e0"
            e2="DDI-MedLine.d86.s8.e1" ddi="true" type="mechanism"/>
        <pair id="DDI-MedLine.d86.s8.p1" e1="DDI-MedLine.d86.s8.e0"
            e2="DDI-MedLine.d86.s8.e2" ddi="false"/>
        <pair id="DDI-MedLine.d86.s8.p2" e1="DDI-MedLine.d86.s8.e1"
            e2="DDI-MedLine.d86.s8.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d86.s9" text="Because of the pronounced intersubject variability in the extent of the sirolimus-diltiazem interaction, whole blood sirolimus concentrations should be monitored closely in patients treated with the two drugs.">
        <entity id="DDI-MedLine.d86.s9.e0" charOffset="72-80"
            type="drug" text="sirolimus"/>
        <entity id="DDI-MedLine.d86.s9.e1" charOffset="82-90"
            type="drug" text="diltiazem"/>
        <entity id="DDI-MedLine.d86.s9.e2" charOffset="117-125"
            type="drug" text="sirolimus"/>
        <pair id="DDI-MedLine.d86.s9.p0" e1="DDI-MedLine.d86.s9.e0"
            e2="DDI-MedLine.d86.s9.e1" ddi="true" type="advise"/>
        <pair id="DDI-MedLine.d86.s9.p1" e1="DDI-MedLine.d86.s9.e0"
            e2="DDI-MedLine.d86.s9.e2" ddi="false"/>
        <pair id="DDI-MedLine.d86.s9.p2" e1="DDI-MedLine.d86.s9.e1"
            e2="DDI-MedLine.d86.s9.e2" ddi="false"/>
    </sentence>
</document>
<document id="DDI-MedLine.d1">
    <sentence id="DDI-MedLine.d1.s0" text="[Drug treatment of erection disorders in patients with cardiovascular disease]Erectile dysfunction is a frequent condition in cardiovascular patients. "/>
    <sentence id="DDI-MedLine.d1.s1" text="Since the arrival of oral erection-supporting medication, patients want to know how safe sexual activity is in cardiovascular disease in general and during use of erection-supporting medication in particular. ">
        <entity id="DDI-MedLine.d1.s1.e0" charOffset="26-55"
            type="group" text="erection-supporting medication"/>
        <entity id="DDI-MedLine.d1.s1.e1" charOffset="163-192"
            type="group" text="erection-supporting medication"/>
        <pair id="DDI-MedLine.d1.s1.p0" e1="DDI-MedLine.d1.s1.e0"
            e2="DDI-MedLine.d1.s1.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d1.s2" text="Sexual intercourse with a steady partner causes no more cardiovascular risk than normal daily activities such as ironing, 2 kilometers of walking without climbing, paperhanging, playing golf or gardening. "/>
    <sentence id="DDI-MedLine.d1.s3" text="The relative risk of myocardial infarction during sexual activity is not significantly higher than for healthy persons. "/>
    <sentence id="DDI-MedLine.d1.s4" text="The incidence of cardiovascular morbidity and mortality is not higher among users of sildenafil. ">
        <entity id="DDI-MedLine.d1.s4.e0" charOffset="85-94" type="drug" text="sildenafil"/>
    </sentence>
    <sentence id="DDI-MedLine.d1.s5" text="Sildenafil is contraindicated in patients using long-acting nitrates or who may need to use short-acting nitrates, because the combination may cause a sharp fall of the blood pressure. ">
        <entity id="DDI-MedLine.d1.s5.e0" charOffset="0-9" type="drug" text="Sildenafil"/>
        <entity id="DDI-MedLine.d1.s5.e1" charOffset="48-67"
            type="group" text="long-acting nitrates"/>
        <entity id="DDI-MedLine.d1.s5.e2" charOffset="92-112"
            type="group" text="short-acting nitrates"/>
        <pair id="DDI-MedLine.d1.s5.p0" e1="DDI-MedLine.d1.s5.e0"
            e2="DDI-MedLine.d1.s5.e1" ddi="true" type="advise"/>
        <pair id="DDI-MedLine.d1.s5.p1" e1="DDI-MedLine.d1.s5.e0"
            e2="DDI-MedLine.d1.s5.e2" ddi="true" type="advise"/>
        <pair id="DDI-MedLine.d1.s5.p2" e1="DDI-MedLine.d1.s5.e1"
            e2="DDI-MedLine.d1.s5.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d1.s6" text="No interactions have been observed with beta-receptor blockers, calcium antagonists, thiazide and loop diuretics and ACE inhibitors. ">
        <entity id="DDI-MedLine.d1.s6.e0" charOffset="40-61"
            type="group" text="beta-receptor blockers"/>
        <entity id="DDI-MedLine.d1.s6.e1" charOffset="64-82"
            type="group" text="calcium antagonists"/>
        <entity id="DDI-MedLine.d1.s6.e2" charOffset="85-92;103-111"
            type="group" text="thiazide diuretics"/>
        <entity id="DDI-MedLine.d1.s6.e3" charOffset="98-111"
            type="group" text="loop diuretics"/>
        <entity id="DDI-MedLine.d1.s6.e4" charOffset="117-130"
            type="group" text="ACE inhibitors"/>
        <pair id="DDI-MedLine.d1.s6.p0" e1="DDI-MedLine.d1.s6.e0"
            e2="DDI-MedLine.d1.s6.e1" ddi="false"/>
        <pair id="DDI-MedLine.d1.s6.p1" e1="DDI-MedLine.d1.s6.e0"
            e2="DDI-MedLine.d1.s6.e2" ddi="false"/>
        <pair id="DDI-MedLine.d1.s6.p2" e1="DDI-MedLine.d1.s6.e0"
            e2="DDI-MedLine.d1.s6.e3" ddi="false"/>
        <pair id="DDI-MedLine.d1.s6.p3" e1="DDI-MedLine.d1.s6.e0"
            e2="DDI-MedLine.d1.s6.e4" ddi="false"/>
        <pair id="DDI-MedLine.d1.s6.p4" e1="DDI-MedLine.d1.s6.e1"
            e2="DDI-MedLine.d1.s6.e2" ddi="false"/>
        <pair id="DDI-MedLine.d1.s6.p5" e1="DDI-MedLine.d1.s6.e1"
            e2="DDI-MedLine.d1.s6.e3" ddi="false"/>
        <pair id="DDI-MedLine.d1.s6.p6" e1="DDI-MedLine.d1.s6.e1"
            e2="DDI-MedLine.d1.s6.e4" ddi="false"/>
        <pair id="DDI-MedLine.d1.s6.p7" e1="DDI-MedLine.d1.s6.e2"
            e2="DDI-MedLine.d1.s6.e3" ddi="false"/>
        <pair id="DDI-MedLine.d1.s6.p8" e1="DDI-MedLine.d1.s6.e2"
            e2="DDI-MedLine.d1.s6.e4" ddi="false"/>
        <pair id="DDI-MedLine.d1.s6.p9" e1="DDI-MedLine.d1.s6.e3"
            e2="DDI-MedLine.d1.s6.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d1.s7" text="Before prescribing a symptomatic (pharmaceutical) treatment for patients with an erection disorder, attention should be given tot the sexological, psychological and medical backgrounds of the disorder. "/>
    <sentence id="DDI-MedLine.d1.s8" text="Secondary prevention of atherosclerotic risk factors is also important: regulation of blood pressure and blood sugar level, hyperlipidaemia and obesity, as well as a change of lifestyle (giving up smoking, adapting of diet and more physical exertion). "/>
    <sentence id="DDI-MedLine.d1.s9" text="Patients with a very low cardiac capacity should be advised to refrain from treatment of the erection disorder."/>
</document>
<document id="DDI-MedLine.d132">
    <sentence id="DDI-MedLine.d132.s0" text="The emerging roles of non-nucleoside reverse transcriptase inhibitors in antiretroviral therapy.">
        <entity id="DDI-MedLine.d132.s0.e0" charOffset="22-68"
            type="group" text="non-nucleoside reverse transcriptase inhibitors"/>
        <entity id="DDI-MedLine.d132.s0.e1" charOffset="73-86"
            type="group" text="antiretroviral"/>
        <pair id="DDI-MedLine.d132.s0.p0" e1="DDI-MedLine.d132.s0.e0"
            e2="DDI-MedLine.d132.s0.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d132.s1" text="The availability of potent non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimens for antiretroviral therapy and concerns regarding protease inhibitor (PI)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection. ">
        <entity id="DDI-MedLine.d132.s1.e0" charOffset="27-72"
            type="group" text="non-nucleoside reverse transcriptase inhibitor"/>
        <entity id="DDI-MedLine.d132.s1.e1" charOffset="75-79"
            type="group" text="NNRTI"/>
        <entity id="DDI-MedLine.d132.s1.e2" charOffset="101-114"
            type="group" text="antiretroviral"/>
        <entity id="DDI-MedLine.d132.s1.e3" charOffset="147-164"
            type="group" text="protease inhibitor"/>
        <entity id="DDI-MedLine.d132.s1.e4" charOffset="167-168"
            type="group" text="PI"/>
        <pair id="DDI-MedLine.d132.s1.p0" e1="DDI-MedLine.d132.s1.e0"
            e2="DDI-MedLine.d132.s1.e1" ddi="false"/>
        <pair id="DDI-MedLine.d132.s1.p1" e1="DDI-MedLine.d132.s1.e0"
            e2="DDI-MedLine.d132.s1.e2" ddi="false"/>
        <pair id="DDI-MedLine.d132.s1.p2" e1="DDI-MedLine.d132.s1.e0"
            e2="DDI-MedLine.d132.s1.e3" ddi="false"/>
        <pair id="DDI-MedLine.d132.s1.p3" e1="DDI-MedLine.d132.s1.e0"
            e2="DDI-MedLine.d132.s1.e4" ddi="false"/>
        <pair id="DDI-MedLine.d132.s1.p4" e1="DDI-MedLine.d132.s1.e1"
            e2="DDI-MedLine.d132.s1.e2" ddi="false"/>
        <pair id="DDI-MedLine.d132.s1.p5" e1="DDI-MedLine.d132.s1.e1"
            e2="DDI-MedLine.d132.s1.e3" ddi="false"/>
        <pair id="DDI-MedLine.d132.s1.p6" e1="DDI-MedLine.d132.s1.e1"
            e2="DDI-MedLine.d132.s1.e4" ddi="false"/>
        <pair id="DDI-MedLine.d132.s1.p7" e1="DDI-MedLine.d132.s1.e2"
            e2="DDI-MedLine.d132.s1.e3" ddi="false"/>
        <pair id="DDI-MedLine.d132.s1.p8" e1="DDI-MedLine.d132.s1.e2"
            e2="DDI-MedLine.d132.s1.e4" ddi="false"/>
        <pair id="DDI-MedLine.d132.s1.p9" e1="DDI-MedLine.d132.s1.e3"
            e2="DDI-MedLine.d132.s1.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d132.s2" text="NNRTI-based regimens may have several advantages over PI-based therapy for initial or prolonged therapy, including more convenient administration regimens, lower tablet volume, fewer drug interactions, and central nervous system penetration. ">
        <entity id="DDI-MedLine.d132.s2.e0" charOffset="0-4"
            type="group" text="NNRTI"/>
        <entity id="DDI-MedLine.d132.s2.e1" charOffset="54-55"
            type="group" text="PI"/>
        <pair id="DDI-MedLine.d132.s2.p0" e1="DDI-MedLine.d132.s2.e0"
            e2="DDI-MedLine.d132.s2.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d132.s3" text="No data from prospective clinical trials currently exist comparing the 3 approved agents (efavirenz, nevirapine or delavirdine). ">
        <entity id="DDI-MedLine.d132.s3.e0" charOffset="90-98"
            type="drug" text="efavirenz"/>
        <entity id="DDI-MedLine.d132.s3.e1" charOffset="101-110"
            type="drug" text="nevirapine"/>
        <entity id="DDI-MedLine.d132.s3.e2" charOffset="115-125"
            type="drug" text="delavirdine"/>
        <pair id="DDI-MedLine.d132.s3.p0" e1="DDI-MedLine.d132.s3.e0"
            e2="DDI-MedLine.d132.s3.e1" ddi="false"/>
        <pair id="DDI-MedLine.d132.s3.p1" e1="DDI-MedLine.d132.s3.e0"
            e2="DDI-MedLine.d132.s3.e2" ddi="false"/>
        <pair id="DDI-MedLine.d132.s3.p2" e1="DDI-MedLine.d132.s3.e1"
            e2="DDI-MedLine.d132.s3.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d132.s4" text="Both efavirenz and nevirapine have been compared to triple therapy with the PI indinavir over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with efavirenz. ">
        <entity id="DDI-MedLine.d132.s4.e0" charOffset="5-13"
            type="drug" text="efavirenz"/>
        <entity id="DDI-MedLine.d132.s4.e1" charOffset="19-28"
            type="drug" text="nevirapine"/>
        <entity id="DDI-MedLine.d132.s4.e2" charOffset="76-77"
            type="group" text="PI"/>
        <entity id="DDI-MedLine.d132.s4.e3" charOffset="79-87"
            type="drug" text="indinavir"/>
        <entity id="DDI-MedLine.d132.s4.e4" charOffset="166-175"
            type="drug" text="nevirapine"/>
        <entity id="DDI-MedLine.d132.s4.e5" charOffset="216-224"
            type="drug" text="efavirenz"/>
        <pair id="DDI-MedLine.d132.s4.p0" e1="DDI-MedLine.d132.s4.e0"
            e2="DDI-MedLine.d132.s4.e1" ddi="false"/>
        <pair id="DDI-MedLine.d132.s4.p1" e1="DDI-MedLine.d132.s4.e0"
            e2="DDI-MedLine.d132.s4.e2" ddi="false"/>
        <pair id="DDI-MedLine.d132.s4.p2" e1="DDI-MedLine.d132.s4.e0"
            e2="DDI-MedLine.d132.s4.e3" ddi="false"/>
        <pair id="DDI-MedLine.d132.s4.p3" e1="DDI-MedLine.d132.s4.e0"
            e2="DDI-MedLine.d132.s4.e4" ddi="false"/>
        <pair id="DDI-MedLine.d132.s4.p4" e1="DDI-MedLine.d132.s4.e0"
            e2="DDI-MedLine.d132.s4.e5" ddi="false"/>
        <pair id="DDI-MedLine.d132.s4.p5" e1="DDI-MedLine.d132.s4.e1"
            e2="DDI-MedLine.d132.s4.e2" ddi="false"/>
        <pair id="DDI-MedLine.d132.s4.p6" e1="DDI-MedLine.d132.s4.e1"
            e2="DDI-MedLine.d132.s4.e3" ddi="false"/>
        <pair id="DDI-MedLine.d132.s4.p7" e1="DDI-MedLine.d132.s4.e1"
            e2="DDI-MedLine.d132.s4.e4" ddi="false"/>
        <pair id="DDI-MedLine.d132.s4.p8" e1="DDI-MedLine.d132.s4.e1"
            e2="DDI-MedLine.d132.s4.e5" ddi="false"/>
        <pair id="DDI-MedLine.d132.s4.p9" e1="DDI-MedLine.d132.s4.e2"
            e2="DDI-MedLine.d132.s4.e3" ddi="false"/>
        <pair id="DDI-MedLine.d132.s4.p10" e1="DDI-MedLine.d132.s4.e2"
            e2="DDI-MedLine.d132.s4.e4" ddi="false"/>
        <pair id="DDI-MedLine.d132.s4.p11" e1="DDI-MedLine.d132.s4.e2"
            e2="DDI-MedLine.d132.s4.e5" ddi="false"/>
        <pair id="DDI-MedLine.d132.s4.p12" e1="DDI-MedLine.d132.s4.e3"
            e2="DDI-MedLine.d132.s4.e4" ddi="false"/>
        <pair id="DDI-MedLine.d132.s4.p13" e1="DDI-MedLine.d132.s4.e3"
            e2="DDI-MedLine.d132.s4.e5" ddi="false"/>
        <pair id="DDI-MedLine.d132.s4.p14" e1="DDI-MedLine.d132.s4.e4"
            e2="DDI-MedLine.d132.s4.e5" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d132.s5" text="A smaller 24-week study has suggested nevirapine may be superior to the PI nelfinavir. ">
        <entity id="DDI-MedLine.d132.s5.e0" charOffset="38-47"
            type="drug" text="nevirapine"/>
        <entity id="DDI-MedLine.d132.s5.e1" charOffset="72-73"
            type="group" text="PI"/>
        <entity id="DDI-MedLine.d132.s5.e2" charOffset="75-84"
            type="drug" text="nelfinavir"/>
        <pair id="DDI-MedLine.d132.s5.p0" e1="DDI-MedLine.d132.s5.e0"
            e2="DDI-MedLine.d132.s5.e1" ddi="false"/>
        <pair id="DDI-MedLine.d132.s5.p1" e1="DDI-MedLine.d132.s5.e0"
            e2="DDI-MedLine.d132.s5.e2" ddi="false"/>
        <pair id="DDI-MedLine.d132.s5.p2" e1="DDI-MedLine.d132.s5.e1"
            e2="DDI-MedLine.d132.s5.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d132.s6" text="Limited comparative data in patients with high viral loads treated with nevirapine- or delavirdine-based regimens currently exist. ">
        <entity id="DDI-MedLine.d132.s6.e0" charOffset="72-81"
            type="drug" text="nevirapine"/>
        <entity id="DDI-MedLine.d132.s6.e1" charOffset="87-97"
            type="drug" text="delavirdine"/>
        <pair id="DDI-MedLine.d132.s6.p0" e1="DDI-MedLine.d132.s6.e0"
            e2="DDI-MedLine.d132.s6.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d132.s7" text="However, cohort data and selected patient data from clinical trials suggest comparable activity to PI-based regimens in these patients. ">
        <entity id="DDI-MedLine.d132.s7.e0" charOffset="99-100"
            type="group" text="PI"/>
    </sentence>
    <sentence id="DDI-MedLine.d132.s8" text="The superiority of efavirenz over indinavir-based regimens has been observed in comparative data in a subset of patients with high viral loads. ">
        <entity id="DDI-MedLine.d132.s8.e0" charOffset="19-27"
            type="drug" text="efavirenz"/>
        <entity id="DDI-MedLine.d132.s8.e1" charOffset="34-42"
            type="drug" text="indinavir"/>
        <pair id="DDI-MedLine.d132.s8.p0" e1="DDI-MedLine.d132.s8.e0"
            e2="DDI-MedLine.d132.s8.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d132.s9" text="In treatment-experienced patients, available uncontrolled data suggest these agents contribute to regimen efficacy in NNRTI-na  ve, treatment-experienced patients. ">
        <entity id="DDI-MedLine.d132.s9.e0" charOffset="118-122"
            type="group" text="NNRTI"/>
    </sentence>
    <sentence id="DDI-MedLine.d132.s10" text="Efavirenz has demonstrated superiority over nelfinavir in nucleoside-experienced patients, although combining these 2 agents may represent the best approach in these circumstances. ">
        <entity id="DDI-MedLine.d132.s10.e0" charOffset="0-8"
            type="drug" text="Efavirenz"/>
        <entity id="DDI-MedLine.d132.s10.e1" charOffset="44-53"
            type="drug" text="nelfinavir"/>
        <pair id="DDI-MedLine.d132.s10.p0" e1="DDI-MedLine.d132.s10.e0"
            e2="DDI-MedLine.d132.s10.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d132.s11" text="The tolerability of NNRTIs appears generally good with few individuals discontinuing in clinical studies as a result of adverse drug events. ">
        <entity id="DDI-MedLine.d132.s11.e0" charOffset="20-25"
            type="group" text="NNRTIs"/>
    </sentence>
    <sentence id="DDI-MedLine.d132.s12" text="The majority of adverse events with NNRTIs occur within the first month, and are predictable and manageable without therapy interruption.">
        <entity id="DDI-MedLine.d132.s12.e0" charOffset="36-41"
            type="group" text="NNRTIs"/>
    </sentence>
</document>
<document id="DDI-MedLine.d23">
    <sentence id="DDI-MedLine.d23.s0" text="The effects of ketamine and of Innovar anesthesia on digitalis tolerance in dogs.">
        <entity id="DDI-MedLine.d23.s0.e0" charOffset="15-22"
            type="drug" text="ketamine"/>
        <entity id="DDI-MedLine.d23.s0.e1" charOffset="31-37"
            type="brand" text="Innovar"/>
        <entity id="DDI-MedLine.d23.s0.e2" charOffset="53-61"
            type="group" text="digitalis"/>
        <pair id="DDI-MedLine.d23.s0.p0" e1="DDI-MedLine.d23.s0.e0"
            e2="DDI-MedLine.d23.s0.e1" ddi="false"/>
        <pair id="DDI-MedLine.d23.s0.p1" e1="DDI-MedLine.d23.s0.e0"
            e2="DDI-MedLine.d23.s0.e2" ddi="false"/>
        <pair id="DDI-MedLine.d23.s0.p2" e1="DDI-MedLine.d23.s0.e1"
            e2="DDI-MedLine.d23.s0.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d23.s1" text="In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with pentobarbital. ">
        <entity id="DDI-MedLine.d23.s1.e0" charOffset="19-27"
            type="group" text="digitalis"/>
        <entity id="DDI-MedLine.d23.s1.e1" charOffset="65-72"
            type="drug" text="ketamine"/>
        <entity id="DDI-MedLine.d23.s1.e2" charOffset="75-85"
            type="brand" text="Innovar Vet"/>
        <entity id="DDI-MedLine.d23.s1.e3" charOffset="91-103"
            type="drug" text="pentobarbital"/>
        <entity id="DDI-MedLine.d23.s1.e4" charOffset="120-126"
            type="drug" text="ouabain"/>
        <entity id="DDI-MedLine.d23.s1.e5" charOffset="213-219"
            type="drug" text="ouabain"/>
        <entity id="DDI-MedLine.d23.s1.e6" charOffset="227-234"
            type="drug" text="ketamine"/>
        <entity id="DDI-MedLine.d23.s1.e7" charOffset="239-245"
            type="brand" text="Innovar"/>
        <entity id="DDI-MedLine.d23.s1.e8" charOffset="257-269"
            type="drug" text="pentobarbital"/>
        <pair id="DDI-MedLine.d23.s1.p0" e1="DDI-MedLine.d23.s1.e0"
            e2="DDI-MedLine.d23.s1.e1" ddi="false"/>
        <pair id="DDI-MedLine.d23.s1.p1" e1="DDI-MedLine.d23.s1.e0"
            e2="DDI-MedLine.d23.s1.e2" ddi="false"/>
        <pair id="DDI-MedLine.d23.s1.p2" e1="DDI-MedLine.d23.s1.e0"
            e2="DDI-MedLine.d23.s1.e3" ddi="false"/>
        <pair id="DDI-MedLine.d23.s1.p3" e1="DDI-MedLine.d23.s1.e0"
            e2="DDI-MedLine.d23.s1.e4" ddi="false"/>
        <pair id="DDI-MedLine.d23.s1.p4" e1="DDI-MedLine.d23.s1.e0"
            e2="DDI-MedLine.d23.s1.e5" ddi="false"/>
        <pair id="DDI-MedLine.d23.s1.p5" e1="DDI-MedLine.d23.s1.e0"
            e2="DDI-MedLine.d23.s1.e6" ddi="false"/>
        <pair id="DDI-MedLine.d23.s1.p6" e1="DDI-MedLine.d23.s1.e0"
            e2="DDI-MedLine.d23.s1.e7" ddi="false"/>
        <pair id="DDI-MedLine.d23.s1.p7" e1="DDI-MedLine.d23.s1.e0"
            e2="DDI-MedLine.d23.s1.e8" ddi="false"/>
        <pair id="DDI-MedLine.d23.s1.p8" e1="DDI-MedLine.d23.s1.e1"
            e2="DDI-MedLine.d23.s1.e2" ddi="false"/>
        <pair id="DDI-MedLine.d23.s1.p9" e1="DDI-MedLine.d23.s1.e1"
            e2="DDI-MedLine.d23.s1.e3" ddi="false"/>
        <pair id="DDI-MedLine.d23.s1.p10" e1="DDI-MedLine.d23.s1.e1"
            e2="DDI-MedLine.d23.s1.e4" ddi="true" type="effect"/>
        <pair id="DDI-MedLine.d23.s1.p11" e1="DDI-MedLine.d23.s1.e1"
            e2="DDI-MedLine.d23.s1.e5" ddi="false"/>
        <pair id="DDI-MedLine.d23.s1.p12" e1="DDI-MedLine.d23.s1.e1"
            e2="DDI-MedLine.d23.s1.e6" ddi="false"/>
        <pair id="DDI-MedLine.d23.s1.p13" e1="DDI-MedLine.d23.s1.e1"
            e2="DDI-MedLine.d23.s1.e7" ddi="false"/>
        <pair id="DDI-MedLine.d23.s1.p14" e1="DDI-MedLine.d23.s1.e1"
            e2="DDI-MedLine.d23.s1.e8" ddi="false"/>
        <pair id="DDI-MedLine.d23.s1.p15" e1="DDI-MedLine.d23.s1.e2"
            e2="DDI-MedLine.d23.s1.e3" ddi="false"/>
        <pair id="DDI-MedLine.d23.s1.p16" e1="DDI-MedLine.d23.s1.e2"
            e2="DDI-MedLine.d23.s1.e4" ddi="true" type="effect"/>
        <pair id="DDI-MedLine.d23.s1.p17" e1="DDI-MedLine.d23.s1.e2"
            e2="DDI-MedLine.d23.s1.e5" ddi="false"/>
        <pair id="DDI-MedLine.d23.s1.p18" e1="DDI-MedLine.d23.s1.e2"
            e2="DDI-MedLine.d23.s1.e6" ddi="false"/>
        <pair id="DDI-MedLine.d23.s1.p19" e1="DDI-MedLine.d23.s1.e2"
            e2="DDI-MedLine.d23.s1.e7" ddi="false"/>
        <pair id="DDI-MedLine.d23.s1.p20" e1="DDI-MedLine.d23.s1.e2"
            e2="DDI-MedLine.d23.s1.e8" ddi="false"/>
        <pair id="DDI-MedLine.d23.s1.p21" e1="DDI-MedLine.d23.s1.e3"
            e2="DDI-MedLine.d23.s1.e4" ddi="true" type="effect"/>
        <pair id="DDI-MedLine.d23.s1.p22" e1="DDI-MedLine.d23.s1.e3"
            e2="DDI-MedLine.d23.s1.e5" ddi="false"/>
        <pair id="DDI-MedLine.d23.s1.p23" e1="DDI-MedLine.d23.s1.e3"
            e2="DDI-MedLine.d23.s1.e6" ddi="false"/>
        <pair id="DDI-MedLine.d23.s1.p24" e1="DDI-MedLine.d23.s1.e3"
            e2="DDI-MedLine.d23.s1.e7" ddi="false"/>
        <pair id="DDI-MedLine.d23.s1.p25" e1="DDI-MedLine.d23.s1.e3"
            e2="DDI-MedLine.d23.s1.e8" ddi="false"/>
        <pair id="DDI-MedLine.d23.s1.p26" e1="DDI-MedLine.d23.s1.e4"
            e2="DDI-MedLine.d23.s1.e5" ddi="false"/>
        <pair id="DDI-MedLine.d23.s1.p27" e1="DDI-MedLine.d23.s1.e4"
            e2="DDI-MedLine.d23.s1.e6" ddi="false"/>
        <pair id="DDI-MedLine.d23.s1.p28" e1="DDI-MedLine.d23.s1.e4"
            e2="DDI-MedLine.d23.s1.e7" ddi="false"/>
        <pair id="DDI-MedLine.d23.s1.p29" e1="DDI-MedLine.d23.s1.e4"
            e2="DDI-MedLine.d23.s1.e8" ddi="false"/>
        <pair id="DDI-MedLine.d23.s1.p30" e1="DDI-MedLine.d23.s1.e5"
            e2="DDI-MedLine.d23.s1.e6" ddi="false"/>
        <pair id="DDI-MedLine.d23.s1.p31" e1="DDI-MedLine.d23.s1.e5"
            e2="DDI-MedLine.d23.s1.e7" ddi="false"/>
        <pair id="DDI-MedLine.d23.s1.p32" e1="DDI-MedLine.d23.s1.e5"
            e2="DDI-MedLine.d23.s1.e8" ddi="false"/>
        <pair id="DDI-MedLine.d23.s1.p33" e1="DDI-MedLine.d23.s1.e6"
            e2="DDI-MedLine.d23.s1.e7" ddi="false"/>
        <pair id="DDI-MedLine.d23.s1.p34" e1="DDI-MedLine.d23.s1.e6"
            e2="DDI-MedLine.d23.s1.e8" ddi="false"/>
        <pair id="DDI-MedLine.d23.s1.p35" e1="DDI-MedLine.d23.s1.e7"
            e2="DDI-MedLine.d23.s1.e8" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d23.s2" text="Ventricular tachycardia induced by ouabain was generally converted to sinus rhythm following administration of Innovar, ketamine, or droperidol but not after administration of fentayl alone or after pentobarbital.">
        <entity id="DDI-MedLine.d23.s2.e0" charOffset="35-41"
            type="drug" text="ouabain"/>
        <entity id="DDI-MedLine.d23.s2.e1" charOffset="111-117"
            type="brand" text="Innovar"/>
        <entity id="DDI-MedLine.d23.s2.e2" charOffset="120-127"
            type="drug" text="ketamine"/>
        <entity id="DDI-MedLine.d23.s2.e3" charOffset="133-142"
            type="drug" text="droperidol"/>
        <entity id="DDI-MedLine.d23.s2.e4" charOffset="176-182"
            type="drug" text="fentayl"/>
        <entity id="DDI-MedLine.d23.s2.e5" charOffset="199-211"
            type="drug" text="pentobarbital"/>
        <pair id="DDI-MedLine.d23.s2.p0" e1="DDI-MedLine.d23.s2.e0"
            e2="DDI-MedLine.d23.s2.e1" ddi="true" type="effect"/>
        <pair id="DDI-MedLine.d23.s2.p1" e1="DDI-MedLine.d23.s2.e0"
            e2="DDI-MedLine.d23.s2.e2" ddi="true" type="effect"/>
        <pair id="DDI-MedLine.d23.s2.p2" e1="DDI-MedLine.d23.s2.e0"
            e2="DDI-MedLine.d23.s2.e3" ddi="true" type="effect"/>
        <pair id="DDI-MedLine.d23.s2.p3" e1="DDI-MedLine.d23.s2.e0"
            e2="DDI-MedLine.d23.s2.e4" ddi="false"/>
        <pair id="DDI-MedLine.d23.s2.p4" e1="DDI-MedLine.d23.s2.e0"
            e2="DDI-MedLine.d23.s2.e5" ddi="false"/>
        <pair id="DDI-MedLine.d23.s2.p5" e1="DDI-MedLine.d23.s2.e1"
            e2="DDI-MedLine.d23.s2.e2" ddi="false"/>
        <pair id="DDI-MedLine.d23.s2.p6" e1="DDI-MedLine.d23.s2.e1"
            e2="DDI-MedLine.d23.s2.e3" ddi="false"/>
        <pair id="DDI-MedLine.d23.s2.p7" e1="DDI-MedLine.d23.s2.e1"
            e2="DDI-MedLine.d23.s2.e4" ddi="false"/>
        <pair id="DDI-MedLine.d23.s2.p8" e1="DDI-MedLine.d23.s2.e1"
            e2="DDI-MedLine.d23.s2.e5" ddi="false"/>
        <pair id="DDI-MedLine.d23.s2.p9" e1="DDI-MedLine.d23.s2.e2"
            e2="DDI-MedLine.d23.s2.e3" ddi="false"/>
        <pair id="DDI-MedLine.d23.s2.p10" e1="DDI-MedLine.d23.s2.e2"
            e2="DDI-MedLine.d23.s2.e4" ddi="false"/>
        <pair id="DDI-MedLine.d23.s2.p11" e1="DDI-MedLine.d23.s2.e2"
            e2="DDI-MedLine.d23.s2.e5" ddi="false"/>
        <pair id="DDI-MedLine.d23.s2.p12" e1="DDI-MedLine.d23.s2.e3"
            e2="DDI-MedLine.d23.s2.e4" ddi="false"/>
        <pair id="DDI-MedLine.d23.s2.p13" e1="DDI-MedLine.d23.s2.e3"
            e2="DDI-MedLine.d23.s2.e5" ddi="false"/>
        <pair id="DDI-MedLine.d23.s2.p14" e1="DDI-MedLine.d23.s2.e4"
            e2="DDI-MedLine.d23.s2.e5" ddi="false"/>
    </sentence>
</document>
<document id="DDI-MedLine.d138">
    <sentence id="DDI-MedLine.d138.s0" text="Interaction between oxytocin and antidiuretic hormone and its effect on the milk secretion by alveoli of the mammary gland of lactating rats.">
        <entity id="DDI-MedLine.d138.s0.e0" charOffset="20-27"
            type="drug" text="oxytocin"/>
    </sentence>
    <sentence id="DDI-MedLine.d138.s1" text="Interaction between exogenous and endogenous oxytocin and vasopressin was found to affect the mechanism of milk ejection by the alveoli of the mammary gland in lactating rats. ">
        <entity id="DDI-MedLine.d138.s1.e0" charOffset="45-52"
            type="drug" text="oxytocin"/>
    </sentence>
    <sentence id="DDI-MedLine.d138.s2" text="Inhibition and stimulation of the effect of oxytocin on milk ejection by vasopressin was demonstrated. ">
        <entity id="DDI-MedLine.d138.s2.e0" charOffset="44-51"
            type="drug" text="oxytocin"/>
    </sentence>
    <sentence id="DDI-MedLine.d138.s3" text="On the basis of the principles observed the concentrations fo these hormones were investigated in the plasma of dogs deprived of water for 3 days and then allowed to drink."/>
</document>
<document id="DDI-MedLine.d29">
    <sentence id="DDI-MedLine.d29.s0" text="Effect of probenecid on the apparent volume of distribution and elimination of cloxacillin.">
        <entity id="DDI-MedLine.d29.s0.e0" charOffset="10-19"
            type="drug" text="probenecid"/>
        <entity id="DDI-MedLine.d29.s0.e1" charOffset="79-89"
            type="drug" text="cloxacillin"/>
        <pair id="DDI-MedLine.d29.s0.p0" e1="DDI-MedLine.d29.s0.e0"
            e2="DDI-MedLine.d29.s0.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d29.s1" text="According to Gibaldi et al. "/>
    <sentence id="DDI-MedLine.d29.s2" text="(1968, 1970), the higher serum concentrations of penicillins and cephaloridine reached after administration of probenecid are due not only to slower renal elimination but also to an altered distribution in the body. ">
        <entity id="DDI-MedLine.d29.s2.e0" charOffset="49-59"
            type="group" text="penicillins"/>
        <entity id="DDI-MedLine.d29.s2.e1" charOffset="65-77"
            type="drug" text="cephaloridine"/>
        <entity id="DDI-MedLine.d29.s2.e2" charOffset="111-120"
            type="drug" text="probenecid"/>
        <pair id="DDI-MedLine.d29.s2.p0" e1="DDI-MedLine.d29.s2.e0"
            e2="DDI-MedLine.d29.s2.e1" ddi="false"/>
        <pair id="DDI-MedLine.d29.s2.p1" e1="DDI-MedLine.d29.s2.e0"
            e2="DDI-MedLine.d29.s2.e2" ddi="true" type="mechanism"/>
        <pair id="DDI-MedLine.d29.s2.p2" e1="DDI-MedLine.d29.s2.e1"
            e2="DDI-MedLine.d29.s2.e2" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-MedLine.d29.s3" text="To determine whether probenecid has a direct effect on the distribution of cloxacillin, the elimination and distribution of cloxacillin was studied in six patients, five lacking kidney function and one with a partially impaired renal function, in the presence or absence of probenecid. ">
        <entity id="DDI-MedLine.d29.s3.e0" charOffset="21-30"
            type="drug" text="probenecid"/>
        <entity id="DDI-MedLine.d29.s3.e1" charOffset="75-85"
            type="drug" text="cloxacillin"/>
        <entity id="DDI-MedLine.d29.s3.e2" charOffset="124-134"
            type="drug" text="cloxacillin"/>
        <entity id="DDI-MedLine.d29.s3.e3" charOffset="274-283"
            type="drug" text="probenecid"/>
        <pair id="DDI-MedLine.d29.s3.p0" e1="DDI-MedLine.d29.s3.e0"
            e2="DDI-MedLine.d29.s3.e1" ddi="false"/>
        <pair id="DDI-MedLine.d29.s3.p1" e1="DDI-MedLine.d29.s3.e0"
            e2="DDI-MedLine.d29.s3.e2" ddi="false"/>
        <pair id="DDI-MedLine.d29.s3.p2" e1="DDI-MedLine.d29.s3.e0"
            e2="DDI-MedLine.d29.s3.e3" ddi="false"/>
        <pair id="DDI-MedLine.d29.s3.p3" e1="DDI-MedLine.d29.s3.e1"
            e2="DDI-MedLine.d29.s3.e2" ddi="false"/>
        <pair id="DDI-MedLine.d29.s3.p4" e1="DDI-MedLine.d29.s3.e1"
            e2="DDI-MedLine.d29.s3.e3" ddi="false"/>
        <pair id="DDI-MedLine.d29.s3.p5" e1="DDI-MedLine.d29.s3.e2"
            e2="DDI-MedLine.d29.s3.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d29.s4" text="No significant difference was found between the mean values of the volume of distribution of cloxacillin with and without probenecid (13.0 and 12.6 liters, respectively). ">
        <entity id="DDI-MedLine.d29.s4.e0" charOffset="93-103"
            type="drug" text="cloxacillin"/>
        <entity id="DDI-MedLine.d29.s4.e1" charOffset="122-131"
            type="drug" text="probenecid"/>
        <pair id="DDI-MedLine.d29.s4.p0" e1="DDI-MedLine.d29.s4.e0"
            e2="DDI-MedLine.d29.s4.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d29.s5" text="Thus, the hypothesis of Gibaldi et al. "/>
    <sentence id="DDI-MedLine.d29.s6" text="could not be confirmed for cloxacillin in patients lacking kidney function. ">
        <entity id="DDI-MedLine.d29.s6.e0" charOffset="27-37"
            type="drug" text="cloxacillin"/>
    </sentence>
    <sentence id="DDI-MedLine.d29.s7" text="In spite of the absence of kidney function, the value of the elimination rate constant was significantly decreased in the presence of probenecid (from 0.326 to 0.263/h). ">
        <entity id="DDI-MedLine.d29.s7.e0" charOffset="134-143"
            type="drug" text="probenecid"/>
    </sentence>
    <sentence id="DDI-MedLine.d29.s8" text="This might be explained by a blockade by probenecid of the elimination of cloxacillin by the liver.">
        <entity id="DDI-MedLine.d29.s8.e0" charOffset="41-50"
            type="drug" text="probenecid"/>
        <entity id="DDI-MedLine.d29.s8.e1" charOffset="74-84"
            type="drug" text="cloxacillin"/>
        <pair id="DDI-MedLine.d29.s8.p0" e1="DDI-MedLine.d29.s8.e0"
            e2="DDI-MedLine.d29.s8.e1" ddi="true" type="mechanism"/>
    </sentence>
</document>
<document id="DDI-MedLine.d118">
    <sentence id="DDI-MedLine.d118.s0" text="Sirolimus: mammalian target of rapamycin inhibitor to prevent kidney rejection.">
        <entity id="DDI-MedLine.d118.s0.e0" charOffset="0-8" type="drug" text="Sirolimus"/>
        <entity id="DDI-MedLine.d118.s0.e1" charOffset="31-39"
            type="drug" text="rapamycin"/>
        <pair id="DDI-MedLine.d118.s0.p0" e1="DDI-MedLine.d118.s0.e0"
            e2="DDI-MedLine.d118.s0.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d118.s1" text="Current immunosuppressive therapies are effective but can be associated with significant adverse reactions. "/>
    <sentence id="DDI-MedLine.d118.s2" text="Sirolimus works differently from the immunosuppressants currently available, and except for increased lipid levels, the adverse reaction profile of sirolimus does not appear to overlap to any great extent with that associated with cyclosporine or tacrolimus. ">
        <entity id="DDI-MedLine.d118.s2.e0" charOffset="0-8" type="drug" text="Sirolimus"/>
        <entity id="DDI-MedLine.d118.s2.e1" charOffset="37-54"
            type="group" text="immunosuppressants"/>
        <entity id="DDI-MedLine.d118.s2.e2" charOffset="148-156"
            type="drug" text="sirolimus"/>
        <entity id="DDI-MedLine.d118.s2.e3" charOffset="231-242"
            type="drug" text="cyclosporine"/>
        <entity id="DDI-MedLine.d118.s2.e4" charOffset="247-256"
            type="drug" text="tacrolimus"/>
        <pair id="DDI-MedLine.d118.s2.p0" e1="DDI-MedLine.d118.s2.e0"
            e2="DDI-MedLine.d118.s2.e1" ddi="false"/>
        <pair id="DDI-MedLine.d118.s2.p1" e1="DDI-MedLine.d118.s2.e0"
            e2="DDI-MedLine.d118.s2.e2" ddi="false"/>
        <pair id="DDI-MedLine.d118.s2.p2" e1="DDI-MedLine.d118.s2.e0"
            e2="DDI-MedLine.d118.s2.e3" ddi="false"/>
        <pair id="DDI-MedLine.d118.s2.p3" e1="DDI-MedLine.d118.s2.e0"
            e2="DDI-MedLine.d118.s2.e4" ddi="false"/>
        <pair id="DDI-MedLine.d118.s2.p4" e1="DDI-MedLine.d118.s2.e1"
            e2="DDI-MedLine.d118.s2.e2" ddi="false"/>
        <pair id="DDI-MedLine.d118.s2.p5" e1="DDI-MedLine.d118.s2.e1"
            e2="DDI-MedLine.d118.s2.e3" ddi="false"/>
        <pair id="DDI-MedLine.d118.s2.p6" e1="DDI-MedLine.d118.s2.e1"
            e2="DDI-MedLine.d118.s2.e4" ddi="false"/>
        <pair id="DDI-MedLine.d118.s2.p7" e1="DDI-MedLine.d118.s2.e2"
            e2="DDI-MedLine.d118.s2.e3" ddi="false"/>
        <pair id="DDI-MedLine.d118.s2.p8" e1="DDI-MedLine.d118.s2.e2"
            e2="DDI-MedLine.d118.s2.e4" ddi="false"/>
        <pair id="DDI-MedLine.d118.s2.p9" e1="DDI-MedLine.d118.s2.e3"
            e2="DDI-MedLine.d118.s2.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d118.s3" text="While additional research is needed, the initial clinical data in kidney recipients suggest that sirolimus, in combination with cyclosporine or tacrolimus, might have the potential to reduce the frequency of rejection episodes, permit reductions in cyclosporine or tacrolimus dosage, and permit steroid withdrawal (Kelly, 1999).">
        <entity id="DDI-MedLine.d118.s3.e0" charOffset="97-105"
            type="drug" text="sirolimus"/>
        <entity id="DDI-MedLine.d118.s3.e1" charOffset="128-139"
            type="drug" text="cyclosporine"/>
        <entity id="DDI-MedLine.d118.s3.e2" charOffset="144-153"
            type="drug" text="tacrolimus"/>
        <entity id="DDI-MedLine.d118.s3.e3" charOffset="249-260"
            type="drug" text="cyclosporine"/>
        <entity id="DDI-MedLine.d118.s3.e4" charOffset="265-274"
            type="drug" text="tacrolimus"/>
        <pair id="DDI-MedLine.d118.s3.p0" e1="DDI-MedLine.d118.s3.e0"
            e2="DDI-MedLine.d118.s3.e1" ddi="false"/>
        <pair id="DDI-MedLine.d118.s3.p1" e1="DDI-MedLine.d118.s3.e0"
            e2="DDI-MedLine.d118.s3.e2" ddi="false"/>
        <pair id="DDI-MedLine.d118.s3.p2" e1="DDI-MedLine.d118.s3.e0"
            e2="DDI-MedLine.d118.s3.e3" ddi="false"/>
        <pair id="DDI-MedLine.d118.s3.p3" e1="DDI-MedLine.d118.s3.e0"
            e2="DDI-MedLine.d118.s3.e4" ddi="false"/>
        <pair id="DDI-MedLine.d118.s3.p4" e1="DDI-MedLine.d118.s3.e1"
            e2="DDI-MedLine.d118.s3.e2" ddi="false"/>
        <pair id="DDI-MedLine.d118.s3.p5" e1="DDI-MedLine.d118.s3.e1"
            e2="DDI-MedLine.d118.s3.e3" ddi="false"/>
        <pair id="DDI-MedLine.d118.s3.p6" e1="DDI-MedLine.d118.s3.e1"
            e2="DDI-MedLine.d118.s3.e4" ddi="false"/>
        <pair id="DDI-MedLine.d118.s3.p7" e1="DDI-MedLine.d118.s3.e2"
            e2="DDI-MedLine.d118.s3.e3" ddi="false"/>
        <pair id="DDI-MedLine.d118.s3.p8" e1="DDI-MedLine.d118.s3.e2"
            e2="DDI-MedLine.d118.s3.e4" ddi="false"/>
        <pair id="DDI-MedLine.d118.s3.p9" e1="DDI-MedLine.d118.s3.e3"
            e2="DDI-MedLine.d118.s3.e4" ddi="false"/>
    </sentence>
</document>
<document id="DDI-MedLine.d185">
    <sentence id="DDI-MedLine.d185.s0" text="Effect of ketoconazole-mediated CYP3A4 inhibition on clinical pharmacokinetics of panobinostat (LBH589), an orally active histone deacetylase inhibitor.">
        <entity id="DDI-MedLine.d185.s0.e0" charOffset="10-21"
            type="drug" text="ketoconazole"/>
        <entity id="DDI-MedLine.d185.s0.e1" charOffset="82-93"
            type="drug" text="panobinostat"/>
        <entity id="DDI-MedLine.d185.s0.e2" charOffset="96-101"
            type="drug" text="LBH589"/>
        <entity id="DDI-MedLine.d185.s0.e3" charOffset="122-150"
            type="group" text="histone deacetylase inhibitor"/>
        <pair id="DDI-MedLine.d185.s0.p0" e1="DDI-MedLine.d185.s0.e0"
            e2="DDI-MedLine.d185.s0.e1" ddi="false"/>
        <pair id="DDI-MedLine.d185.s0.p1" e1="DDI-MedLine.d185.s0.e0"
            e2="DDI-MedLine.d185.s0.e2" ddi="false"/>
        <pair id="DDI-MedLine.d185.s0.p2" e1="DDI-MedLine.d185.s0.e0"
            e2="DDI-MedLine.d185.s0.e3" ddi="false"/>
        <pair id="DDI-MedLine.d185.s0.p3" e1="DDI-MedLine.d185.s0.e1"
            e2="DDI-MedLine.d185.s0.e2" ddi="false"/>
        <pair id="DDI-MedLine.d185.s0.p4" e1="DDI-MedLine.d185.s0.e1"
            e2="DDI-MedLine.d185.s0.e3" ddi="false"/>
        <pair id="DDI-MedLine.d185.s0.p5" e1="DDI-MedLine.d185.s0.e2"
            e2="DDI-MedLine.d185.s0.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d185.s1" text="Panobinostat is partly metabolized by CYP3A4 in vitro. ">
        <entity id="DDI-MedLine.d185.s1.e0" charOffset="0-11"
            type="drug" text="Panobinostat"/>
    </sentence>
    <sentence id="DDI-MedLine.d185.s2" text="This study evaluated the effect of a potent CYP3A inhibitor, ketoconazole, on the pharmacokinetics and safety of panobinostat.">
        <entity id="DDI-MedLine.d185.s2.e0" charOffset="61-72"
            type="drug" text="ketoconazole"/>
        <entity id="DDI-MedLine.d185.s2.e1" charOffset="113-124"
            type="drug" text="panobinostat"/>
        <pair id="DDI-MedLine.d185.s2.p0" e1="DDI-MedLine.d185.s2.e0"
            e2="DDI-MedLine.d185.s2.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d185.s3" text="Patients received a single panobinostat oral dose on day 1, followed by 4  days wash-out period. ">
        <entity id="DDI-MedLine.d185.s3.e0" charOffset="27-38"
            type="drug" text="panobinostat"/>
    </sentence>
    <sentence id="DDI-MedLine.d185.s4" text="On days 5-9, ketoconazole was administered. ">
        <entity id="DDI-MedLine.d185.s4.e0" charOffset="13-24"
            type="drug" text="ketoconazole"/>
    </sentence>
    <sentence id="DDI-MedLine.d185.s5" text="On day 8, a single panobinostat dose was co-administered with ketoconazole. ">
        <entity id="DDI-MedLine.d185.s5.e0" charOffset="19-30"
            type="drug" text="panobinostat"/>
        <entity id="DDI-MedLine.d185.s5.e1" charOffset="62-73"
            type="drug" text="ketoconazole"/>
        <pair id="DDI-MedLine.d185.s5.p0" e1="DDI-MedLine.d185.s5.e0"
            e2="DDI-MedLine.d185.s5.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d185.s6" text="Panobinostat was administered as single agent three times a week on day 15 and onward. ">
        <entity id="DDI-MedLine.d185.s6.e0" charOffset="0-11"
            type="drug" text="Panobinostat"/>
    </sentence>
    <sentence id="DDI-MedLine.d185.s7" text="In the presence of ketoconazole, there was 1.6- and 1.8-fold increase in C (max) and AUC of panobinostat, respectively. ">
        <entity id="DDI-MedLine.d185.s7.e0" charOffset="19-30"
            type="drug" text="ketoconazole"/>
        <entity id="DDI-MedLine.d185.s7.e1" charOffset="92-103"
            type="drug" text="panobinostat"/>
        <pair id="DDI-MedLine.d185.s7.p0" e1="DDI-MedLine.d185.s7.e0"
            e2="DDI-MedLine.d185.s7.e1" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-MedLine.d185.s8" text="No substantial change in T (max) or half-life was observed. "/>
    <sentence id="DDI-MedLine.d185.s9" text="No difference in panobinostat-pharmacokinetics between patients carrying CYP3A5*1/*3 and CYP3A5*3/*3 alleles was observed. ">
        <entity id="DDI-MedLine.d185.s9.e0" charOffset="17-28"
            type="drug" text="panobinostat"/>
    </sentence>
    <sentence id="DDI-MedLine.d185.s10" text="Most frequently reported adverse events were gastrointestinal related. "/>
    <sentence id="DDI-MedLine.d185.s11" text="Patients had asymptomatic hypophosphatemia (64%), and urine analysis suggested renal phosphate wasting. "/>
    <sentence id="DDI-MedLine.d185.s12" text="Co-administration of panobinostat with CYP3A inhibitors is feasible as the observed increase in panobinostat PK parameters was not considered clinically relevant. ">
        <entity id="DDI-MedLine.d185.s12.e0" charOffset="21-32"
            type="drug" text="panobinostat"/>
        <entity id="DDI-MedLine.d185.s12.e1" charOffset="96-107"
            type="drug" text="panobinostat"/>
        <pair id="DDI-MedLine.d185.s12.p0" e1="DDI-MedLine.d185.s12.e0"
            e2="DDI-MedLine.d185.s12.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d185.s13" text="Considering the variability in exposure following enzyme inhibition and the fact that chronic dosing of panobinostat was not studied with CYP3A inhibitors, close monitoring of panobinostat-related adverse events is necessary.">
        <entity id="DDI-MedLine.d185.s13.e0" charOffset="104-115"
            type="drug" text="panobinostat"/>
        <entity id="DDI-MedLine.d185.s13.e1" charOffset="176-187"
            type="drug" text="panobinostat"/>
        <pair id="DDI-MedLine.d185.s13.p0" e1="DDI-MedLine.d185.s13.e0"
            e2="DDI-MedLine.d185.s13.e1" ddi="false"/>
    </sentence>
</document>
<document id="DDI-MedLine.d180">
    <sentence id="DDI-MedLine.d180.s0" text="Determinants of sensitivity to DZNep induced apoptosis in multiple myeloma cells.">
        <entity id="DDI-MedLine.d180.s0.e0" charOffset="31-35"
            type="drug_n" text="DZNep"/>
    </sentence>
    <sentence id="DDI-MedLine.d180.s1" text="The 3-Deazaneplanocin A (DZNep), one of S-adenosylhomocysteine (AdoHcy) hydrolase inhibitors, has shown antitumor activities in a broad range of solid tumors and acute myeloid leukemia. ">
        <entity id="DDI-MedLine.d180.s1.e0" charOffset="4-22"
            type="drug_n" text="3-Deazaneplanocin A"/>
        <entity id="DDI-MedLine.d180.s1.e1" charOffset="25-29"
            type="drug_n" text="DZNep"/>
        <pair id="DDI-MedLine.d180.s1.p0" e1="DDI-MedLine.d180.s1.e0"
            e2="DDI-MedLine.d180.s1.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d180.s2" text="Here, we examined its effects on multiple myeloma (MM) cells and found that, at 500 nM, it potently inhibited growth and induced apoptosis in 2 of 8 MM cell lines. "/>
    <sentence id="DDI-MedLine.d180.s3" text="RNA from un-treated and DZNep treated cells was profiled by Affymetrix HG-U133 Plus 2.0 microarray and genes with a significant change in gene expression were determined by significance analysis of microarray (SAM) testing. ">
        <entity id="DDI-MedLine.d180.s3.e0" charOffset="24-28"
            type="drug_n" text="DZNep"/>
    </sentence>
    <sentence id="DDI-MedLine.d180.s4" text="ALOX5 was the most down-regulated gene (5.8-fold) in sensitive cells and was expressed at low level in resistant cells. "/>
    <sentence id="DDI-MedLine.d180.s5" text="The results were corroborated by quantitative RT-PCR. "/>
    <sentence id="DDI-MedLine.d180.s6" text="Western-blot analysis indicated ALOX5 was highly expressed only in sensitive cell line H929 and greatly decreased upon DZNep treatment. ">
        <entity id="DDI-MedLine.d180.s6.e0" charOffset="119-123"
            type="drug_n" text="DZNep"/>
    </sentence>
    <sentence id="DDI-MedLine.d180.s7" text="Ectopic expression of ALOX5 reduced sensitivity to DZNep in H929 cells. ">
        <entity id="DDI-MedLine.d180.s7.e0" charOffset="51-55"
            type="drug_n" text="DZNep"/>
    </sentence>
    <sentence id="DDI-MedLine.d180.s8" text="Furthermore, down-regulation of ALOX5 by RNA interference could also induce apoptosis in H929. "/>
    <sentence id="DDI-MedLine.d180.s9" text="Gene expression analysis on MM patient dataset indicated ALOX5 expression was significantly higher in MM patients compared to normal plasma cells. "/>
    <sentence id="DDI-MedLine.d180.s10" text="We also found that Bcl-2 was overexpressed in DZNep insensitive cells, and cotreatment with DZNep and ABT-737, a Bcl-2 family inhibitor, synergistically inhibited growth and induced apoptosis of DZNep insensitive MM cells. ">
        <entity id="DDI-MedLine.d180.s10.e0" charOffset="46-50"
            type="drug_n" text="DZNep"/>
        <entity id="DDI-MedLine.d180.s10.e1" charOffset="92-96"
            type="drug_n" text="DZNep"/>
        <entity id="DDI-MedLine.d180.s10.e2" charOffset="102-108"
            type="drug_n" text="ABT-737"/>
        <entity id="DDI-MedLine.d180.s10.e3" charOffset="195-199"
            type="drug_n" text="DZNep"/>
        <pair id="DDI-MedLine.d180.s10.p0" e1="DDI-MedLine.d180.s10.e0"
            e2="DDI-MedLine.d180.s10.e1" ddi="false"/>
        <pair id="DDI-MedLine.d180.s10.p1" e1="DDI-MedLine.d180.s10.e0"
            e2="DDI-MedLine.d180.s10.e2" ddi="false"/>
        <pair id="DDI-MedLine.d180.s10.p2" e1="DDI-MedLine.d180.s10.e0"
            e2="DDI-MedLine.d180.s10.e3" ddi="false"/>
        <pair id="DDI-MedLine.d180.s10.p3" e1="DDI-MedLine.d180.s10.e1"
            e2="DDI-MedLine.d180.s10.e2" ddi="true" type="effect"/>
        <pair id="DDI-MedLine.d180.s10.p4" e1="DDI-MedLine.d180.s10.e1"
            e2="DDI-MedLine.d180.s10.e3" ddi="false"/>
        <pair id="DDI-MedLine.d180.s10.p5" e1="DDI-MedLine.d180.s10.e2"
            e2="DDI-MedLine.d180.s10.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d180.s11" text="Taken together, this study shows one of mechanisms of the DZNep efficacy on MM correlates with its ability to down-regulate the ALOX5 levels. ">
        <entity id="DDI-MedLine.d180.s11.e0" charOffset="58-62"
            type="drug_n" text="DZNep"/>
    </sentence>
    <sentence id="DDI-MedLine.d180.s12" text="In addition, DZNep insensitivity might be associated with overexpression of Bcl-2, and the combination of ABT-737 and DZNep could synergistically induced apoptosis. ">
        <entity id="DDI-MedLine.d180.s12.e0" charOffset="13-17"
            type="drug_n" text="DZNep"/>
        <entity id="DDI-MedLine.d180.s12.e1" charOffset="106-112"
            type="drug_n" text="ABT-737"/>
        <entity id="DDI-MedLine.d180.s12.e2" charOffset="118-122"
            type="drug_n" text="DZNep"/>
        <pair id="DDI-MedLine.d180.s12.p0" e1="DDI-MedLine.d180.s12.e0"
            e2="DDI-MedLine.d180.s12.e1" ddi="false"/>
        <pair id="DDI-MedLine.d180.s12.p1" e1="DDI-MedLine.d180.s12.e0"
            e2="DDI-MedLine.d180.s12.e2" ddi="false"/>
        <pair id="DDI-MedLine.d180.s12.p2" e1="DDI-MedLine.d180.s12.e1"
            e2="DDI-MedLine.d180.s12.e2" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-MedLine.d180.s13" text="These results suggest that DZNep may be exploited therapeutically for a subset of MM.">
        <entity id="DDI-MedLine.d180.s13.e0" charOffset="27-31"
            type="drug_n" text="DZNep"/>
    </sentence>
</document>
<document id="DDI-MedLine.d181">
    <sentence id="DDI-MedLine.d181.s0" text="Drug interaction of levothyroxine with infant colic drops.">
        <entity id="DDI-MedLine.d181.s0.e0" charOffset="20-32"
            type="drug" text="levothyroxine"/>
    </sentence>
    <sentence id="DDI-MedLine.d181.s1" text="Infacol (Forest Laboratories UK, Kent, UK) is a widely available over-the-counter preparation used to relieve colic symptoms in neonates and infants. ">
        <entity id="DDI-MedLine.d181.s1.e0" charOffset="0-6"
            type="brand" text="Infacol"/>
    </sentence>
    <sentence id="DDI-MedLine.d181.s2" text="The active ingredient is simeticone. ">
        <entity id="DDI-MedLine.d181.s2.e0" charOffset="25-34"
            type="drug" text="simeticone"/>
    </sentence>
    <sentence id="DDI-MedLine.d181.s3" text="No drug interactions with simeticone are documented in the current summary of product characteristics. ">
        <entity id="DDI-MedLine.d181.s3.e0" charOffset="26-35"
            type="drug" text="simeticone"/>
    </sentence>
    <sentence id="DDI-MedLine.d181.s4" text="The authors report the case of an infant with confirmed congenital hypothyroidism on levothyroxine who experienced a possible drug interaction with simeticone. ">
        <entity id="DDI-MedLine.d181.s4.e0" charOffset="85-97"
            type="drug" text="levothyroxine"/>
        <entity id="DDI-MedLine.d181.s4.e1" charOffset="148-157"
            type="drug" text="simeticone"/>
        <pair id="DDI-MedLine.d181.s4.p0" e1="DDI-MedLine.d181.s4.e0"
            e2="DDI-MedLine.d181.s4.e1" ddi="true" type="int"/>
    </sentence>
    <sentence id="DDI-MedLine.d181.s5" text="Despite adequate levothyroxine dosage, thyroid stimulating hormone (TSH) was high, suggesting undertreatment. ">
        <entity id="DDI-MedLine.d181.s5.e0" charOffset="17-29"
            type="drug" text="levothyroxine"/>
    </sentence>
    <sentence id="DDI-MedLine.d181.s6" text="Questioning revealed the child was taking Infacol drops before feeds while on levothyroxine. ">
        <entity id="DDI-MedLine.d181.s6.e0" charOffset="42-48"
            type="brand" text="Infacol"/>
        <entity id="DDI-MedLine.d181.s6.e1" charOffset="78-90"
            type="drug" text="levothyroxine"/>
        <pair id="DDI-MedLine.d181.s6.p0" e1="DDI-MedLine.d181.s6.e0"
            e2="DDI-MedLine.d181.s6.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d181.s7" text="The colic drops were immediately discontinued and TSH promptly normalised with a reduction in thyroxine requirement to an age appropriate dosage. "/>
    <sentence id="DDI-MedLine.d181.s8" text="Drug interaction of thyroxine with simeticone has not been reported previously and is not listed in the British National Formulary for Children. ">
        <entity id="DDI-MedLine.d181.s8.e0" charOffset="20-28"
            type="drug" text="thyroxine"/>
        <entity id="DDI-MedLine.d181.s8.e1" charOffset="35-44"
            type="drug" text="simeticone"/>
        <pair id="DDI-MedLine.d181.s8.p0" e1="DDI-MedLine.d181.s8.e0"
            e2="DDI-MedLine.d181.s8.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d181.s9" text="Clinicians and parents need to be aware of this interaction to avoid unnecessary undertreatment and prevent potential long-term neurological sequelae."/>
</document>
<document id="DDI-MedLine.d169">
    <sentence id="DDI-MedLine.d169.s0" text="Calcium does not inhibit the absorption of 5 milligrams of nonheme or heme iron at doses less than 800 milligrams in nonpregnant women.">
        <entity id="DDI-MedLine.d169.s0.e0" charOffset="0-6" type="drug" text="Calcium"/>
        <entity id="DDI-MedLine.d169.s0.e1" charOffset="59-65;75-78"
            type="drug" text="nonheme iron"/>
        <entity id="DDI-MedLine.d169.s0.e2" charOffset="70-78"
            type="drug" text="heme iron"/>
        <pair id="DDI-MedLine.d169.s0.p0" e1="DDI-MedLine.d169.s0.e0"
            e2="DDI-MedLine.d169.s0.e1" ddi="false"/>
        <pair id="DDI-MedLine.d169.s0.p1" e1="DDI-MedLine.d169.s0.e0"
            e2="DDI-MedLine.d169.s0.e2" ddi="false"/>
        <pair id="DDI-MedLine.d169.s0.p2" e1="DDI-MedLine.d169.s0.e1"
            e2="DDI-MedLine.d169.s0.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d169.s1" text="Calcium is the only known component in the diet that may affect absorption of both nonheme and heme iron. ">
        <entity id="DDI-MedLine.d169.s1.e0" charOffset="0-6" type="drug" text="Calcium"/>
        <entity id="DDI-MedLine.d169.s1.e1" charOffset="83-89;100-103"
            type="drug" text="nonheme iron"/>
        <entity id="DDI-MedLine.d169.s1.e2" charOffset="95-103"
            type="drug" text="heme iron"/>
        <pair id="DDI-MedLine.d169.s1.p0" e1="DDI-MedLine.d169.s1.e0"
            e2="DDI-MedLine.d169.s1.e1" ddi="true" type="mechanism"/>
        <pair id="DDI-MedLine.d169.s1.p1" e1="DDI-MedLine.d169.s1.e0"
            e2="DDI-MedLine.d169.s1.e2" ddi="true" type="mechanism"/>
        <pair id="DDI-MedLine.d169.s1.p2" e1="DDI-MedLine.d169.s1.e1"
            e2="DDI-MedLine.d169.s1.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d169.s2" text="However, the evidence for a calcium effect on iron absorption mainly comes from studies that did not isolate the effect of calcium from that of other dietary components, because it was detected in single-meal studies. ">
        <entity id="DDI-MedLine.d169.s2.e0" charOffset="28-34"
            type="drug" text="calcium"/>
        <entity id="DDI-MedLine.d169.s2.e1" charOffset="46-49"
            type="drug" text="iron"/>
        <entity id="DDI-MedLine.d169.s2.e2" charOffset="123-129"
            type="drug" text="calcium"/>
        <pair id="DDI-MedLine.d169.s2.p0" e1="DDI-MedLine.d169.s2.e0"
            e2="DDI-MedLine.d169.s2.e1" ddi="true" type="mechanism"/>
        <pair id="DDI-MedLine.d169.s2.p1" e1="DDI-MedLine.d169.s2.e0"
            e2="DDI-MedLine.d169.s2.e2" ddi="false"/>
        <pair id="DDI-MedLine.d169.s2.p2" e1="DDI-MedLine.d169.s2.e1"
            e2="DDI-MedLine.d169.s2.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d169.s3" text="Our objective was to establish potential effects of calcium on absorption of nonheme and heme iron and the dose response for this effect in the absence of a meal. ">
        <entity id="DDI-MedLine.d169.s3.e0" charOffset="52-58"
            type="drug" text="calcium"/>
        <entity id="DDI-MedLine.d169.s3.e1" charOffset="77-83;94-97"
            type="drug" text="nonheme iron"/>
        <entity id="DDI-MedLine.d169.s3.e2" charOffset="89-97"
            type="drug" text="heme iron"/>
        <pair id="DDI-MedLine.d169.s3.p0" e1="DDI-MedLine.d169.s3.e0"
            e2="DDI-MedLine.d169.s3.e1" ddi="false"/>
        <pair id="DDI-MedLine.d169.s3.p1" e1="DDI-MedLine.d169.s3.e0"
            e2="DDI-MedLine.d169.s3.e2" ddi="false"/>
        <pair id="DDI-MedLine.d169.s3.p2" e1="DDI-MedLine.d169.s3.e1"
            e2="DDI-MedLine.d169.s3.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d169.s4" text="Fifty-four healthy, nonpregnant women were selected to participate in 4 iron absorption studies using iron radioactive tracers. ">
        <entity id="DDI-MedLine.d169.s4.e0" charOffset="72-75"
            type="drug" text="iron"/>
    </sentence>
    <sentence id="DDI-MedLine.d169.s5" text="We evaluated the effects of calcium doses between 200 and 1500 mg on absorption of 5 mg nonheme iron (as ferrous sulfate). ">
        <entity id="DDI-MedLine.d169.s5.e0" charOffset="28-34"
            type="drug" text="calcium"/>
        <entity id="DDI-MedLine.d169.s5.e1" charOffset="88-99"
            type="drug" text="nonheme iron"/>
        <entity id="DDI-MedLine.d169.s5.e2" charOffset="105-119"
            type="drug" text="ferrous sulfate"/>
        <pair id="DDI-MedLine.d169.s5.p0" e1="DDI-MedLine.d169.s5.e0"
            e2="DDI-MedLine.d169.s5.e1" ddi="false"/>
        <pair id="DDI-MedLine.d169.s5.p1" e1="DDI-MedLine.d169.s5.e0"
            e2="DDI-MedLine.d169.s5.e2" ddi="false"/>
        <pair id="DDI-MedLine.d169.s5.p2" e1="DDI-MedLine.d169.s5.e1"
            e2="DDI-MedLine.d169.s5.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d169.s6" text="We also evaluated the effects of calcium doses between 200 and 800 mg on absorption of 5 mg heme iron [as concentrated RBC (CRBC)]. ">
        <entity id="DDI-MedLine.d169.s6.e0" charOffset="33-39"
            type="drug" text="calcium"/>
        <entity id="DDI-MedLine.d169.s6.e1" charOffset="92-100"
            type="drug" text="heme iron"/>
        <pair id="DDI-MedLine.d169.s6.p0" e1="DDI-MedLine.d169.s6.e0"
            e2="DDI-MedLine.d169.s6.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d169.s7" text="Calcium was administered as calcium chloride in all studies and minerals were ingested on an empty stomach. ">
        <entity id="DDI-MedLine.d169.s7.e0" charOffset="0-6" type="drug" text="Calcium"/>
        <entity id="DDI-MedLine.d169.s7.e1" charOffset="28-43"
            type="drug" text="calcium chloride"/>
        <entity id="DDI-MedLine.d169.s7.e2" charOffset="64-71"
            type="group" text="minerals"/>
        <pair id="DDI-MedLine.d169.s7.p0" e1="DDI-MedLine.d169.s7.e0"
            e2="DDI-MedLine.d169.s7.e1" ddi="false"/>
        <pair id="DDI-MedLine.d169.s7.p1" e1="DDI-MedLine.d169.s7.e0"
            e2="DDI-MedLine.d169.s7.e2" ddi="false"/>
        <pair id="DDI-MedLine.d169.s7.p2" e1="DDI-MedLine.d169.s7.e1"
            e2="DDI-MedLine.d169.s7.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d169.s8" text="Calcium doses   1000 mg diminished nonheme iron absorption by an average of 49.6%.">
        <entity id="DDI-MedLine.d169.s8.e0" charOffset="0-6" type="drug" text="Calcium"/>
        <entity id="DDI-MedLine.d169.s8.e1" charOffset="35-46"
            type="drug" text="nonheme iron"/>
        <pair id="DDI-MedLine.d169.s8.p0" e1="DDI-MedLine.d169.s8.e0"
            e2="DDI-MedLine.d169.s8.e1" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-MedLine.d169.s9" text="A calcium dose of 800 mg diminished absorption of 5 mg heme iron by 37.7%. ">
        <entity id="DDI-MedLine.d169.s9.e0" charOffset="2-8" type="drug" text="calcium"/>
        <entity id="DDI-MedLine.d169.s9.e1" charOffset="55-63"
            type="drug" text="heme iron"/>
        <pair id="DDI-MedLine.d169.s9.p0" e1="DDI-MedLine.d169.s9.e0"
            e2="DDI-MedLine.d169.s9.e1" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-MedLine.d169.s10" text="In conclusion, we demonstrated an isolated effect of calcium (as chloride) on absorption of 5 mg of iron provided as nonheme (as sulfate) and heme (as CRBC) iron. ">
        <entity id="DDI-MedLine.d169.s10.e0" charOffset="53-59"
            type="drug" text="calcium"/>
        <entity id="DDI-MedLine.d169.s10.e1"
            charOffset="117-123;157-160" type="drug" text="nonheme iron"/>
        <entity id="DDI-MedLine.d169.s10.e2"
            charOffset="142-145;157-160" type="drug" text="heme iron"/>
        <pair id="DDI-MedLine.d169.s10.p0" e1="DDI-MedLine.d169.s10.e0"
            e2="DDI-MedLine.d169.s10.e1" ddi="true" type="mechanism"/>
        <pair id="DDI-MedLine.d169.s10.p1" e1="DDI-MedLine.d169.s10.e0"
            e2="DDI-MedLine.d169.s10.e2" ddi="true" type="mechanism"/>
        <pair id="DDI-MedLine.d169.s10.p2" e1="DDI-MedLine.d169.s10.e1"
            e2="DDI-MedLine.d169.s10.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d169.s11" text="This effect was observed at doses higher than previously reported from single-meal studies, starting at ~800 mg of calcium.">
        <entity id="DDI-MedLine.d169.s11.e0" charOffset="115-121"
            type="drug" text="calcium"/>
    </sentence>
</document>
<document id="DDI-MedLine.d179">
    <sentence id="DDI-MedLine.d179.s0" text="Synergistic interaction between sunitinib and docetaxel is sequence dependent in human non-small lung cancer with EGFR TKIs-resistant mutation.">
        <entity id="DDI-MedLine.d179.s0.e0" charOffset="32-40"
            type="drug" text="sunitinib"/>
        <entity id="DDI-MedLine.d179.s0.e1" charOffset="46-54"
            type="drug" text="docetaxel"/>
        <pair id="DDI-MedLine.d179.s0.p0" e1="DDI-MedLine.d179.s0.e0"
            e2="DDI-MedLine.d179.s0.e1" ddi="true" type="int"/>
    </sentence>
    <sentence id="DDI-MedLine.d179.s1" text="Previous studies have demonstrated that sunitinib has the anti-tumor activity in human non-small cell lung cancer (NSCLC). ">
        <entity id="DDI-MedLine.d179.s1.e0" charOffset="40-48"
            type="drug" text="sunitinib"/>
    </sentence>
    <sentence id="DDI-MedLine.d179.s2" text="This study was aimed to investigate the efficacy of single use of sunitinib and that of concurrent or sequential administration of sunitinib and docetaxel in NSCLC cell lines that are resistant to EGFR TKIs.">
        <entity id="DDI-MedLine.d179.s2.e0" charOffset="66-74"
            type="drug" text="sunitinib"/>
        <entity id="DDI-MedLine.d179.s2.e1" charOffset="131-139"
            type="drug" text="sunitinib"/>
        <entity id="DDI-MedLine.d179.s2.e2" charOffset="145-153"
            type="drug" text="docetaxel"/>
        <pair id="DDI-MedLine.d179.s2.p0" e1="DDI-MedLine.d179.s2.e0"
            e2="DDI-MedLine.d179.s2.e1" ddi="false"/>
        <pair id="DDI-MedLine.d179.s2.p1" e1="DDI-MedLine.d179.s2.e0"
            e2="DDI-MedLine.d179.s2.e2" ddi="false"/>
        <pair id="DDI-MedLine.d179.s2.p2" e1="DDI-MedLine.d179.s2.e1"
            e2="DDI-MedLine.d179.s2.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d179.s3" text="NSCLC cell lines with EGFR T790M mutation and K-ras mutation were exposed to either sunitinib or docetaxel or both based on various sequential administrations. ">
        <entity id="DDI-MedLine.d179.s3.e0" charOffset="84-92"
            type="drug" text="sunitinib"/>
        <entity id="DDI-MedLine.d179.s3.e1" charOffset="97-105"
            type="drug" text="docetaxel"/>
        <pair id="DDI-MedLine.d179.s3.p0" e1="DDI-MedLine.d179.s3.e0"
            e2="DDI-MedLine.d179.s3.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d179.s4" text="After exposure, the cell viability was measured by MTT assay, cell cycle distribution was analyzed by flow cytometry, and alterations in signaling pathway were determined by immunoblotting. "/>
    <sentence id="DDI-MedLine.d179.s5" text="Sunitinib exhibited dose-dependent growth inhibition in NSCLC cell lines and arrested cell cycle at G1 phase, whereas docetaxel arrested at S phase. ">
        <entity id="DDI-MedLine.d179.s5.e0" charOffset="0-8" type="drug" text="Sunitinib"/>
        <entity id="DDI-MedLine.d179.s5.e1" charOffset="118-126"
            type="drug" text="docetaxel"/>
        <pair id="DDI-MedLine.d179.s5.p0" e1="DDI-MedLine.d179.s5.e0"
            e2="DDI-MedLine.d179.s5.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d179.s6" text="Although single or concurrent use of sunitinib and docetaxel has some anti-proliferative effects, the sequential administrations of both drugs remarkably enhanced anti-tumor activity. ">
        <entity id="DDI-MedLine.d179.s6.e0" charOffset="37-45"
            type="drug" text="sunitinib"/>
        <entity id="DDI-MedLine.d179.s6.e1" charOffset="51-59"
            type="drug" text="docetaxel"/>
        <pair id="DDI-MedLine.d179.s6.p0" e1="DDI-MedLine.d179.s6.e0"
            e2="DDI-MedLine.d179.s6.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-MedLine.d179.s7" text="When cells were exposed to docetaxel followed by sunitinib, synergism was observed. ">
        <entity id="DDI-MedLine.d179.s7.e0" charOffset="27-35"
            type="drug" text="docetaxel"/>
        <entity id="DDI-MedLine.d179.s7.e1" charOffset="49-57"
            type="drug" text="sunitinib"/>
        <pair id="DDI-MedLine.d179.s7.p0" e1="DDI-MedLine.d179.s7.e0"
            e2="DDI-MedLine.d179.s7.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-MedLine.d179.s8" text="The molecular basis of this synergism is that the signaling pathways that were initially activated by docetaxel exposure were efficiently suppressed by the subsequent exposure to sunitinib. ">
        <entity id="DDI-MedLine.d179.s8.e0" charOffset="102-110"
            type="drug" text="docetaxel"/>
        <entity id="DDI-MedLine.d179.s8.e1" charOffset="179-187"
            type="drug" text="sunitinib"/>
        <pair id="DDI-MedLine.d179.s8.p0" e1="DDI-MedLine.d179.s8.e0"
            e2="DDI-MedLine.d179.s8.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-MedLine.d179.s9" text="In contrast, the reverse of this sequential administration resulted in antagonism, which may be due to differential effects on cell cycle arrest. "/>
    <sentence id="DDI-MedLine.d179.s10" text="Sunitinib as a single agent exhibits anti-proliferative effects in vitro in NSCLC cell lines with EGFR T790M and K-ras mutations but the sequential administration of docetaxel followed by sunitinib is superior to sunitinib followed by docetaxel and concurrent administration.">
        <entity id="DDI-MedLine.d179.s10.e0" charOffset="0-8"
            type="drug" text="Sunitinib"/>
        <entity id="DDI-MedLine.d179.s10.e1" charOffset="166-174"
            type="drug" text="docetaxel"/>
        <entity id="DDI-MedLine.d179.s10.e2" charOffset="188-196"
            type="drug" text="sunitinib"/>
        <entity id="DDI-MedLine.d179.s10.e3" charOffset="213-221"
            type="drug" text="sunitinib"/>
        <entity id="DDI-MedLine.d179.s10.e4" charOffset="235-243"
            type="drug" text="docetaxel"/>
        <pair id="DDI-MedLine.d179.s10.p0" e1="DDI-MedLine.d179.s10.e0"
            e2="DDI-MedLine.d179.s10.e1" ddi="false"/>
        <pair id="DDI-MedLine.d179.s10.p1" e1="DDI-MedLine.d179.s10.e0"
            e2="DDI-MedLine.d179.s10.e2" ddi="false"/>
        <pair id="DDI-MedLine.d179.s10.p2" e1="DDI-MedLine.d179.s10.e0"
            e2="DDI-MedLine.d179.s10.e3" ddi="false"/>
        <pair id="DDI-MedLine.d179.s10.p3" e1="DDI-MedLine.d179.s10.e0"
            e2="DDI-MedLine.d179.s10.e4" ddi="false"/>
        <pair id="DDI-MedLine.d179.s10.p4" e1="DDI-MedLine.d179.s10.e1"
            e2="DDI-MedLine.d179.s10.e2" ddi="true" type="effect"/>
        <pair id="DDI-MedLine.d179.s10.p5" e1="DDI-MedLine.d179.s10.e1"
            e2="DDI-MedLine.d179.s10.e3" ddi="false"/>
        <pair id="DDI-MedLine.d179.s10.p6" e1="DDI-MedLine.d179.s10.e1"
            e2="DDI-MedLine.d179.s10.e4" ddi="false"/>
        <pair id="DDI-MedLine.d179.s10.p7" e1="DDI-MedLine.d179.s10.e2"
            e2="DDI-MedLine.d179.s10.e3" ddi="false"/>
        <pair id="DDI-MedLine.d179.s10.p8" e1="DDI-MedLine.d179.s10.e2"
            e2="DDI-MedLine.d179.s10.e4" ddi="false"/>
        <pair id="DDI-MedLine.d179.s10.p9" e1="DDI-MedLine.d179.s10.e3"
            e2="DDI-MedLine.d179.s10.e4" ddi="false"/>
    </sentence>
</document>
<document id="DDI-MedLine.d159">
    <sentence id="DDI-MedLine.d159.s0" text="Protective effect of acetyl-l-carnitine and  alpha lipoic acid against the acute toxicity of diepoxybutane to human lymphocytes.">
        <entity id="DDI-MedLine.d159.s0.e0" charOffset="21-38"
            type="drug" text="acetyl-l-carnitine"/>
        <entity id="DDI-MedLine.d159.s0.e1" charOffset="45-61"
            type="drug_n" text="alpha lipoic acid"/>
        <pair id="DDI-MedLine.d159.s0.p0" e1="DDI-MedLine.d159.s0.e0"
            e2="DDI-MedLine.d159.s0.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d159.s1" text="The biotransformation and oxidative stress may contribute to 1,2:3,4-diepoxybutane (DEB)-induced toxicity to human lymphocytes of Fanconi Anemia (FA) patients. "/>
    <sentence id="DDI-MedLine.d159.s2" text="Thus, the identification of putative inhibitors of bioactivation, as well as the determination of the protective role of oxidant defenses, on DEB-induced toxicity, can help to understand what is failing in FA cells. "/>
    <sentence id="DDI-MedLine.d159.s3" text="In the present work we studied the contribution of several biochemical pathways for DEB-induced acute toxicity in human lymphocyte suspensions, by using inhibitors of epoxide hydrolases, inhibitors of protective enzymes as glutathione S-transferase and catalase, the depletion of glutathione (GSH), and the inhibition of protein synthesis; "/>
    <sentence id="DDI-MedLine.d159.s4" text="and a variety of putative protective compounds, including antioxidants, and mitochondrial protective agents. "/>
    <sentence id="DDI-MedLine.d159.s5" text="The present study reports two novel findings: (i) it was clearly evidenced, for the first time, that the acute exposure of freshly isolated human lymphocytes to DEB results in severe GSH depletion and loss of ATP, followed by cell death; "/>
    <sentence id="DDI-MedLine.d159.s6" text="(ii) acetyl-l-carnitine elicits a significant protective effect on DEB induced toxicity, which was potentiated by  alpha-lipoic acid.">
        <entity id="DDI-MedLine.d159.s6.e0" charOffset="5-22"
            type="drug" text="acetyl-l-carnitine"/>
        <entity id="DDI-MedLine.d159.s6.e1" charOffset="115-131"
            type="drug" text="alpha-lipoic acid"/>
        <pair id="DDI-MedLine.d159.s6.p0" e1="DDI-MedLine.d159.s6.e0"
            e2="DDI-MedLine.d159.s6.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-MedLine.d159.s7" text="Collectively, these findings contribute to increase our knowledge of DEB-induce toxicity and will be very useful when applied in studies with lymphocytes from FA patients, in order to find out a protective agent against spontaneous and DEB-induced chromosome instability."/>
</document>
<document id="DDI-MedLine.d164">
    <sentence id="DDI-MedLine.d164.s0" text="Lapatinib enhances herceptin-mediated antibody-dependent cellular cytotoxicity by up-regulation of cell surface HER2 expression.">
        <entity id="DDI-MedLine.d164.s0.e0" charOffset="0-8" type="drug" text="Lapatinib"/>
        <entity id="DDI-MedLine.d164.s0.e1" charOffset="19-27"
            type="brand" text="herceptin"/>
        <pair id="DDI-MedLine.d164.s0.p0" e1="DDI-MedLine.d164.s0.e0"
            e2="DDI-MedLine.d164.s0.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-MedLine.d164.s1" text="Although it was previously reported that lapatinib combined with Herceptin improved the progression-free survival rate compared with lapatinib alone for patients with Herceptin-refractory HER2-positive metastatic breast cancer, the mechanism is purported to be an antiproliferative effect relating to the synergism of these two agents.">
        <entity id="DDI-MedLine.d164.s1.e0" charOffset="41-49"
            type="drug" text="lapatinib"/>
        <entity id="DDI-MedLine.d164.s1.e1" charOffset="65-73"
            type="brand" text="Herceptin"/>
        <entity id="DDI-MedLine.d164.s1.e2" charOffset="133-141"
            type="drug" text="lapatinib"/>
        <entity id="DDI-MedLine.d164.s1.e3" charOffset="167-175"
            type="brand" text="Herceptin"/>
        <pair id="DDI-MedLine.d164.s1.p0" e1="DDI-MedLine.d164.s1.e0"
            e2="DDI-MedLine.d164.s1.e1" ddi="true" type="effect"/>
        <pair id="DDI-MedLine.d164.s1.p1" e1="DDI-MedLine.d164.s1.e0"
            e2="DDI-MedLine.d164.s1.e2" ddi="false"/>
        <pair id="DDI-MedLine.d164.s1.p2" e1="DDI-MedLine.d164.s1.e0"
            e2="DDI-MedLine.d164.s1.e3" ddi="false"/>
        <pair id="DDI-MedLine.d164.s1.p3" e1="DDI-MedLine.d164.s1.e1"
            e2="DDI-MedLine.d164.s1.e2" ddi="false"/>
        <pair id="DDI-MedLine.d164.s1.p4" e1="DDI-MedLine.d164.s1.e1"
            e2="DDI-MedLine.d164.s1.e3" ddi="false"/>
        <pair id="DDI-MedLine.d164.s1.p5" e1="DDI-MedLine.d164.s1.e2"
            e2="DDI-MedLine.d164.s1.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d164.s2" text="We evaluated how lapatinib interacts with Herceptin in HER2-positive breast cancer, with a particular focus on Herceptin-mediated antibody-dependent cellular cytotoxicity (ADCC). ">
        <entity id="DDI-MedLine.d164.s2.e0" charOffset="17-25"
            type="drug" text="lapatinib"/>
        <entity id="DDI-MedLine.d164.s2.e1" charOffset="42-50"
            type="brand" text="Herceptin"/>
        <entity id="DDI-MedLine.d164.s2.e2" charOffset="111-119"
            type="brand" text="Herceptin"/>
        <pair id="DDI-MedLine.d164.s2.p0" e1="DDI-MedLine.d164.s2.e0"
            e2="DDI-MedLine.d164.s2.e1" ddi="false"/>
        <pair id="DDI-MedLine.d164.s2.p1" e1="DDI-MedLine.d164.s2.e0"
            e2="DDI-MedLine.d164.s2.e2" ddi="false"/>
        <pair id="DDI-MedLine.d164.s2.p2" e1="DDI-MedLine.d164.s2.e1"
            e2="DDI-MedLine.d164.s2.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d164.s3" text="In an in vitro assay, lapatinib induced HER2 expression at the cell surface of HER2-positive breast cancer cell lines, leading to the enhancement of Herceptin-mediated ADCC. ">
        <entity id="DDI-MedLine.d164.s3.e0" charOffset="22-30"
            type="drug" text="lapatinib"/>
        <entity id="DDI-MedLine.d164.s3.e1" charOffset="149-157"
            type="brand" text="Herceptin"/>
        <pair id="DDI-MedLine.d164.s3.p0" e1="DDI-MedLine.d164.s3.e0"
            e2="DDI-MedLine.d164.s3.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-MedLine.d164.s4" text="Furthermore, we present a case report in which a second Herceptin treatment following lapatinib resulted in the marked shrinkage of multiple metastatic tumors in HER2-positive breast cancer. ">
        <entity id="DDI-MedLine.d164.s4.e0" charOffset="56-64"
            type="brand" text="Herceptin"/>
        <entity id="DDI-MedLine.d164.s4.e1" charOffset="86-94"
            type="drug" text="lapatinib"/>
        <pair id="DDI-MedLine.d164.s4.p0" e1="DDI-MedLine.d164.s4.e0"
            e2="DDI-MedLine.d164.s4.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-MedLine.d164.s5" text="Lapatinib may have the potential to convert Herceptin-refractory to Herceptin-sensitive tumors in HER2-positive breast cancer by up-regulation of the cell surface expression of HER2.">
        <entity id="DDI-MedLine.d164.s5.e0" charOffset="0-8" type="drug" text="Lapatinib"/>
        <entity id="DDI-MedLine.d164.s5.e1" charOffset="44-52"
            type="brand" text="Herceptin"/>
        <entity id="DDI-MedLine.d164.s5.e2" charOffset="68-76"
            type="brand" text="Herceptin"/>
        <pair id="DDI-MedLine.d164.s5.p0" e1="DDI-MedLine.d164.s5.e0"
            e2="DDI-MedLine.d164.s5.e1" ddi="false"/>
        <pair id="DDI-MedLine.d164.s5.p1" e1="DDI-MedLine.d164.s5.e0"
            e2="DDI-MedLine.d164.s5.e2" ddi="false"/>
        <pair id="DDI-MedLine.d164.s5.p2" e1="DDI-MedLine.d164.s5.e1"
            e2="DDI-MedLine.d164.s5.e2" ddi="false"/>
    </sentence>
</document>
<document id="DDI-MedLine.d193">
    <sentence id="DDI-MedLine.d193.s0" text="Ticagrelor (Brilinta)--better than clopidogrel (Plavix)">
        <entity id="DDI-MedLine.d193.s0.e0" charOffset="0-9" type="drug" text="Ticagrelor"/>
        <entity id="DDI-MedLine.d193.s0.e1" charOffset="12-19"
            type="brand" text="Brilinta"/>
        <entity id="DDI-MedLine.d193.s0.e2" charOffset="35-45"
            type="drug" text="clopidogrel"/>
        <entity id="DDI-MedLine.d193.s0.e3" charOffset="48-53"
            type="brand" text="Plavix"/>
        <pair id="DDI-MedLine.d193.s0.p0" e1="DDI-MedLine.d193.s0.e0"
            e2="DDI-MedLine.d193.s0.e1" ddi="false"/>
        <pair id="DDI-MedLine.d193.s0.p1" e1="DDI-MedLine.d193.s0.e0"
            e2="DDI-MedLine.d193.s0.e2" ddi="false"/>
        <pair id="DDI-MedLine.d193.s0.p2" e1="DDI-MedLine.d193.s0.e0"
            e2="DDI-MedLine.d193.s0.e3" ddi="false"/>
        <pair id="DDI-MedLine.d193.s0.p3" e1="DDI-MedLine.d193.s0.e1"
            e2="DDI-MedLine.d193.s0.e2" ddi="false"/>
        <pair id="DDI-MedLine.d193.s0.p4" e1="DDI-MedLine.d193.s0.e1"
            e2="DDI-MedLine.d193.s0.e3" ddi="false"/>
        <pair id="DDI-MedLine.d193.s0.p5" e1="DDI-MedLine.d193.s0.e2"
            e2="DDI-MedLine.d193.s0.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d193.s1" text="The FDA has approved ticagrelor (Brilinta-AstraZeneca), an oral antiplatelet drug, for use with low-dose aspirin to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS). ">
        <entity id="DDI-MedLine.d193.s1.e0" charOffset="21-30"
            type="drug" text="ticagrelor"/>
        <entity id="DDI-MedLine.d193.s1.e1" charOffset="33-40"
            type="brand" text="Brilinta"/>
        <entity id="DDI-MedLine.d193.s1.e2" charOffset="64-80"
            type="group" text="antiplatelet drug"/>
        <entity id="DDI-MedLine.d193.s1.e3" charOffset="105-111"
            type="brand" text="aspirin"/>
        <pair id="DDI-MedLine.d193.s1.p0" e1="DDI-MedLine.d193.s1.e0"
            e2="DDI-MedLine.d193.s1.e1" ddi="false"/>
        <pair id="DDI-MedLine.d193.s1.p1" e1="DDI-MedLine.d193.s1.e0"
            e2="DDI-MedLine.d193.s1.e2" ddi="false"/>
        <pair id="DDI-MedLine.d193.s1.p2" e1="DDI-MedLine.d193.s1.e0"
            e2="DDI-MedLine.d193.s1.e3" ddi="true" type="effect"/>
        <pair id="DDI-MedLine.d193.s1.p3" e1="DDI-MedLine.d193.s1.e1"
            e2="DDI-MedLine.d193.s1.e2" ddi="false"/>
        <pair id="DDI-MedLine.d193.s1.p4" e1="DDI-MedLine.d193.s1.e1"
            e2="DDI-MedLine.d193.s1.e3" ddi="true" type="effect"/>
        <pair id="DDI-MedLine.d193.s1.p5" e1="DDI-MedLine.d193.s1.e2"
            e2="DDI-MedLine.d193.s1.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d193.s2" text="It will compete with clopidogrel (Plavix) and prasugrel (Effient) for such use. ">
        <entity id="DDI-MedLine.d193.s2.e0" charOffset="21-31"
            type="drug" text="clopidogrel"/>
        <entity id="DDI-MedLine.d193.s2.e1" charOffset="34-39"
            type="brand" text="Plavix"/>
        <entity id="DDI-MedLine.d193.s2.e2" charOffset="46-54"
            type="drug" text="prasugrel"/>
        <entity id="DDI-MedLine.d193.s2.e3" charOffset="57-63"
            type="brand" text="Effient"/>
        <pair id="DDI-MedLine.d193.s2.p0" e1="DDI-MedLine.d193.s2.e0"
            e2="DDI-MedLine.d193.s2.e1" ddi="false"/>
        <pair id="DDI-MedLine.d193.s2.p1" e1="DDI-MedLine.d193.s2.e0"
            e2="DDI-MedLine.d193.s2.e2" ddi="false"/>
        <pair id="DDI-MedLine.d193.s2.p2" e1="DDI-MedLine.d193.s2.e0"
            e2="DDI-MedLine.d193.s2.e3" ddi="false"/>
        <pair id="DDI-MedLine.d193.s2.p3" e1="DDI-MedLine.d193.s2.e1"
            e2="DDI-MedLine.d193.s2.e2" ddi="false"/>
        <pair id="DDI-MedLine.d193.s2.p4" e1="DDI-MedLine.d193.s2.e1"
            e2="DDI-MedLine.d193.s2.e3" ddi="false"/>
        <pair id="DDI-MedLine.d193.s2.p5" e1="DDI-MedLine.d193.s2.e2"
            e2="DDI-MedLine.d193.s2.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d193.s3" text="Clopidogrel is expected to become available generically in the US within the next few months.">
        <entity id="DDI-MedLine.d193.s3.e0" charOffset="0-10"
            type="drug" text="Clopidogrel"/>
    </sentence>
</document>
<document id="DDI-MedLine.d43">
    <sentence id="DDI-MedLine.d43.s0" text="Tumor phenotype and susceptibility to progression as an expression of subpopulations of initiated murine cells."/>
    <sentence id="DDI-MedLine.d43.s1" text="Currently, it is conceived that a number of events, or hits, are required for the induction of tumors by chemical agents. "/>
    <sentence id="DDI-MedLine.d43.s2" text="The first phase of this sequence, initiation, is considered to result from at least one event in the genetic apparatus. "/>
    <sentence id="DDI-MedLine.d43.s3" text="Analyses of this sequence, however, usually give little consideration to the nature of the target cell or to the characteristics of the resultant tumors. "/>
    <sentence id="DDI-MedLine.d43.s4" text="Vesselinovitch et al. "/>
    <sentence id="DDI-MedLine.d43.s5" text="(Cancer Res., 38: 2003-2010, 1978) have reported that a single, small pulse of carcinogen can induce early and numerous liver tumors when administered neonatally to mice with a genetic predisposition to hepatotumorigenesis. "/>
    <sentence id="DDI-MedLine.d43.s6" text="In the current study, the nonpredisposed strain C57BL/6N was also shown to be highly susceptible to diethylnitrosamine during the neonatal period. "/>
    <sentence id="DDI-MedLine.d43.s7" text="C57BL/6N demonstrated large numbers of two of the three types of liver tumors seen in livers of genetically predisposed mice, one of which required the additional stimulus of dietary phenobarbital for growth. ">
        <entity id="DDI-MedLine.d43.s7.e0" charOffset="183-195"
            type="drug" text="phenobarbital"/>
    </sentence>
    <sentence id="DDI-MedLine.d43.s8" text="Tumors of more malignant phenotype were demonstrated only in genetically predisposed mice (C57BL/6N X C3H/HeN F1) that received one dose of carcinogen. "/>
    <sentence id="DDI-MedLine.d43.s9" text="These findings suggest that the phenotype of a tumor that results from a pulse of a chemical carcinogen may depend upon the target cell. "/>
    <sentence id="DDI-MedLine.d43.s10" text="The initiated cells that result from this hit may vary from those that demonstrate very little progression in cell type and may or may not require exogenous enhancement of growth to those that can progress very rapidly to fully malignant behavior. "/>
    <sentence id="DDI-MedLine.d43.s11" text="The latter might arise from a hit in a genetically initiated cell, the result of which is a more rapid progression in tumor type."/>
</document>
<document id="DDI-MedLine.d100">
    <sentence id="DDI-MedLine.d100.s0" text="Influence of calcium-channel blockers on platelet function and arachidonic acid metabolism.">
        <entity id="DDI-MedLine.d100.s0.e0" charOffset="13-36"
            type="group" text="calcium-channel blockers"/>
    </sentence>
    <sentence id="DDI-MedLine.d100.s1" text="Available data indicate that platelet function and arachidonic acid metabolism are important factors in hemostasis and regulation of vascular tone. "/>
    <sentence id="DDI-MedLine.d100.s2" text="Plasma membrane and intracellular mobilization of calcium ions are intimately related to platelet activation and release of platelet contents. "/>
    <sentence id="DDI-MedLine.d100.s3" text="Release of arachidonic acid from membrane phospholipids as well as subsequent synthesis and release of vasoconstrictor thromboxane A2 are also regulated by movement of calcium ions. "/>
    <sentence id="DDI-MedLine.d100.s4" text="Adenosine 3':5'-cyclic phosphate in turn controls levels of free calcium ions in platelets and regulates calcium-dependent reactions. "/>
    <sentence id="DDI-MedLine.d100.s5" text="Slow-channel calcium blockers, such as verapamil, diltiazem and nifedipine, inhibit platelet activation in vitro, and decrease platelet adhesion intravascularly. ">
        <entity id="DDI-MedLine.d100.s5.e0" charOffset="0-28"
            type="group" text="Slow-channel calcium blockers"/>
        <entity id="DDI-MedLine.d100.s5.e1" charOffset="39-47"
            type="drug" text="verapamil"/>
        <entity id="DDI-MedLine.d100.s5.e2" charOffset="50-58"
            type="drug" text="diltiazem"/>
        <entity id="DDI-MedLine.d100.s5.e3" charOffset="64-73"
            type="drug" text="nifedipine"/>
        <pair id="DDI-MedLine.d100.s5.p0" e1="DDI-MedLine.d100.s5.e0"
            e2="DDI-MedLine.d100.s5.e1" ddi="false"/>
        <pair id="DDI-MedLine.d100.s5.p1" e1="DDI-MedLine.d100.s5.e0"
            e2="DDI-MedLine.d100.s5.e2" ddi="false"/>
        <pair id="DDI-MedLine.d100.s5.p2" e1="DDI-MedLine.d100.s5.e0"
            e2="DDI-MedLine.d100.s5.e3" ddi="false"/>
        <pair id="DDI-MedLine.d100.s5.p3" e1="DDI-MedLine.d100.s5.e1"
            e2="DDI-MedLine.d100.s5.e2" ddi="false"/>
        <pair id="DDI-MedLine.d100.s5.p4" e1="DDI-MedLine.d100.s5.e1"
            e2="DDI-MedLine.d100.s5.e3" ddi="false"/>
        <pair id="DDI-MedLine.d100.s5.p5" e1="DDI-MedLine.d100.s5.e2"
            e2="DDI-MedLine.d100.s5.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d100.s6" text="These agents have also been shown to decrease platelet nucleotide release and thromboxane A2 generation. "/>
    <sentence id="DDI-MedLine.d100.s7" text="Some preliminary data suggest that calcium blockers also increase generation of vasodilator and platelet antiaggregant prostacyclin, which could contribute to decrease in platelet function. ">
        <entity id="DDI-MedLine.d100.s7.e0" charOffset="35-50"
            type="group" text="calcium blockers"/>
    </sentence>
    <sentence id="DDI-MedLine.d100.s8" text="These effects of calcium blockers on platelet function and arachidonic acid metabolism could contribute in part to their efficacy in patients with ischemic heart disease.">
        <entity id="DDI-MedLine.d100.s8.e0" charOffset="17-32"
            type="group" text="calcium blockers"/>
    </sentence>
</document>
<document id="DDI-MedLine.d73">
    <sentence id="DDI-MedLine.d73.s0" text="Neurochemical and functional consequences following 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) and methamphetamine.">
        <entity id="DDI-MedLine.d73.s0.e0" charOffset="52-95"
            type="drug_n" text="1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine"/>
        <entity id="DDI-MedLine.d73.s0.e1" charOffset="98-101"
            type="drug_n" text="MPTP"/>
        <entity id="DDI-MedLine.d73.s0.e2" charOffset="108-122"
            type="drug" text="methamphetamine"/>
        <pair id="DDI-MedLine.d73.s0.p0" e1="DDI-MedLine.d73.s0.e0"
            e2="DDI-MedLine.d73.s0.e1" ddi="false"/>
        <pair id="DDI-MedLine.d73.s0.p1" e1="DDI-MedLine.d73.s0.e0"
            e2="DDI-MedLine.d73.s0.e2" ddi="false"/>
        <pair id="DDI-MedLine.d73.s0.p2" e1="DDI-MedLine.d73.s0.e1"
            e2="DDI-MedLine.d73.s0.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d73.s1" text="The neurochemical and functional consequences following MPTP administration to the rat were evaluated and compared to similar effects following methamphetamine administration. ">
        <entity id="DDI-MedLine.d73.s1.e0" charOffset="56-59"
            type="drug_n" text="MPTP"/>
        <entity id="DDI-MedLine.d73.s1.e1" charOffset="144-158"
            type="drug" text="methamphetamine"/>
        <pair id="DDI-MedLine.d73.s1.p0" e1="DDI-MedLine.d73.s1.e0"
            e2="DDI-MedLine.d73.s1.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d73.s2" text="It was observed that MPTP induced long lasting depletions of striatal dopamine concentrations and this neurotoxic effect could be prevented by pargyline pretreatment. ">
        <entity id="DDI-MedLine.d73.s2.e0" charOffset="21-24"
            type="drug_n" text="MPTP"/>
        <entity id="DDI-MedLine.d73.s2.e1" charOffset="143-151"
            type="drug" text="pargyline"/>
        <pair id="DDI-MedLine.d73.s2.p0" e1="DDI-MedLine.d73.s2.e0"
            e2="DDI-MedLine.d73.s2.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-MedLine.d73.s3" text="The MPTP-induced neuronal damage produced a tolerance to the disruptive effects of amphetamine and a supersensitivity to the disruptive effects of apomorphine in rats responding in a schedule controlled paradigm. ">
        <entity id="DDI-MedLine.d73.s3.e0" charOffset="4-7" type="drug" text="MPTP"/>
        <entity id="DDI-MedLine.d73.s3.e1" charOffset="83-93"
            type="drug" text="amphetamine"/>
        <entity id="DDI-MedLine.d73.s3.e2" charOffset="147-157"
            type="drug" text="apomorphine"/>
        <pair id="DDI-MedLine.d73.s3.p0" e1="DDI-MedLine.d73.s3.e0"
            e2="DDI-MedLine.d73.s3.e1" ddi="true" type="effect"/>
        <pair id="DDI-MedLine.d73.s3.p1" e1="DDI-MedLine.d73.s3.e0"
            e2="DDI-MedLine.d73.s3.e2" ddi="true" type="effect"/>
        <pair id="DDI-MedLine.d73.s3.p2" e1="DDI-MedLine.d73.s3.e1"
            e2="DDI-MedLine.d73.s3.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d73.s4" text="Methamphetamine, like MPTP, produced depletions of striatal dopamine but these actions were potentiated by pargyline pretreatment. ">
        <entity id="DDI-MedLine.d73.s4.e0" charOffset="0-14" type="drug" text="Methamphetamine"/>
        <entity id="DDI-MedLine.d73.s4.e1" charOffset="22-25"
            type="drug_n" text="MPTP"/>
        <entity id="DDI-MedLine.d73.s4.e2" charOffset="107-115"
            type="drug" text="pargyline"/>
        <pair id="DDI-MedLine.d73.s4.p0" e1="DDI-MedLine.d73.s4.e0"
            e2="DDI-MedLine.d73.s4.e1" ddi="false"/>
        <pair id="DDI-MedLine.d73.s4.p1" e1="DDI-MedLine.d73.s4.e0"
            e2="DDI-MedLine.d73.s4.e2" ddi="true" type="effect"/>
        <pair id="DDI-MedLine.d73.s4.p2" e1="DDI-MedLine.d73.s4.e1"
            e2="DDI-MedLine.d73.s4.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d73.s5" text="These observations are discussed in reference to possible deleterious effects following the administration of pargyline to patients with Parkinson's Disease.">
        <entity id="DDI-MedLine.d73.s5.e0" charOffset="110-118"
            type="drug" text="pargyline"/>
    </sentence>
</document>
<document id="DDI-MedLine.d31">
    <sentence id="DDI-MedLine.d31.s0" text="Cancer in the elderly: basic science and clinical aspects."/>
    <sentence id="DDI-MedLine.d31.s1" text="The incidence of cancer increases progressively with age. "/>
    <sentence id="DDI-MedLine.d31.s2" text="Rearrangements of genomes have been found to accompany cellular aging. "/>
    <sentence id="DDI-MedLine.d31.s3" text="These factors, in concert with age-dependent alterations in immune function and host defense, may help to explain the increased risk of malignant disease in aged persons. "/>
    <sentence id="DDI-MedLine.d31.s4" text="The clinical presentation and natural history of neoplasia are also affected by aging. "/>
    <sentence id="DDI-MedLine.d31.s5" text="This conference reviews recent developments in these areas, examines the effects of drug use in the elderly and implications for management, and discusses current information on how age may influence the response of cancer to therapy."/>
</document>
<document id="DDI-DrugBank.d449">
    <sentence id="DDI-DrugBank.d449.s0" text="Co-administration with antifungal agents such as ketoconazole or itraconazole is not recommended.">
        <entity id="DDI-DrugBank.d449.s0.e0" charOffset="23-39"
            type="group" text="antifungal agents"/>
        <entity id="DDI-DrugBank.d449.s0.e1" charOffset="49-60"
            type="drug" text="ketoconazole"/>
        <entity id="DDI-DrugBank.d449.s0.e2" charOffset="65-76"
            type="drug" text="itraconazole"/>
        <pair id="DDI-DrugBank.d449.s0.p0" e1="DDI-DrugBank.d449.s0.e0"
            e2="DDI-DrugBank.d449.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d449.s0.p1" e1="DDI-DrugBank.d449.s0.e0"
            e2="DDI-DrugBank.d449.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d449.s0.p2" e1="DDI-DrugBank.d449.s0.e1"
            e2="DDI-DrugBank.d449.s0.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d449.s1" text="Nafazodone, fluvoxamine, cimetidine (consider Xanax dose reduction).">
        <entity id="DDI-DrugBank.d449.s1.e0" charOffset="0-9"
            type="drug" text="Nafazodone"/>
        <entity id="DDI-DrugBank.d449.s1.e1" charOffset="12-22"
            type="drug" text="fluvoxamine"/>
        <entity id="DDI-DrugBank.d449.s1.e2" charOffset="25-34"
            type="drug" text="cimetidine"/>
        <entity id="DDI-DrugBank.d449.s1.e3" charOffset="46-50"
            type="brand" text="Xanax"/>
        <pair id="DDI-DrugBank.d449.s1.p0" e1="DDI-DrugBank.d449.s1.e0"
            e2="DDI-DrugBank.d449.s1.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d449.s1.p1" e1="DDI-DrugBank.d449.s1.e0"
            e2="DDI-DrugBank.d449.s1.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d449.s1.p2" e1="DDI-DrugBank.d449.s1.e0"
            e2="DDI-DrugBank.d449.s1.e3" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d449.s1.p3" e1="DDI-DrugBank.d449.s1.e1"
            e2="DDI-DrugBank.d449.s1.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d449.s1.p4" e1="DDI-DrugBank.d449.s1.e1"
            e2="DDI-DrugBank.d449.s1.e3" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d449.s1.p5" e1="DDI-DrugBank.d449.s1.e2"
            e2="DDI-DrugBank.d449.s1.e3" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d449.s2" text="Fluoxetine, OCs, sertraline, diltiazem, macrolide antibiotics (exercise caution).">
        <entity id="DDI-DrugBank.d449.s2.e0" charOffset="0-9"
            type="drug" text="Fluoxetine"/>
        <entity id="DDI-DrugBank.d449.s2.e1" charOffset="12-14"
            type="group" text="OCs"/>
        <entity id="DDI-DrugBank.d449.s2.e2" charOffset="17-26"
            type="drug" text="sertraline"/>
        <entity id="DDI-DrugBank.d449.s2.e3" charOffset="29-37"
            type="drug" text="diltiazem"/>
        <entity id="DDI-DrugBank.d449.s2.e4" charOffset="40-60"
            type="group" text="macrolide antibiotics"/>
        <pair id="DDI-DrugBank.d449.s2.p0" e1="DDI-DrugBank.d449.s2.e0"
            e2="DDI-DrugBank.d449.s2.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d449.s2.p1" e1="DDI-DrugBank.d449.s2.e0"
            e2="DDI-DrugBank.d449.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d449.s2.p2" e1="DDI-DrugBank.d449.s2.e0"
            e2="DDI-DrugBank.d449.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d449.s2.p3" e1="DDI-DrugBank.d449.s2.e0"
            e2="DDI-DrugBank.d449.s2.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d449.s2.p4" e1="DDI-DrugBank.d449.s2.e1"
            e2="DDI-DrugBank.d449.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d449.s2.p5" e1="DDI-DrugBank.d449.s2.e1"
            e2="DDI-DrugBank.d449.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d449.s2.p6" e1="DDI-DrugBank.d449.s2.e1"
            e2="DDI-DrugBank.d449.s2.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d449.s2.p7" e1="DDI-DrugBank.d449.s2.e2"
            e2="DDI-DrugBank.d449.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d449.s2.p8" e1="DDI-DrugBank.d449.s2.e2"
            e2="DDI-DrugBank.d449.s2.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d449.s2.p9" e1="DDI-DrugBank.d449.s2.e3"
            e2="DDI-DrugBank.d449.s2.e4" ddi="false"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d8">
    <sentence id="DDI-DrugBank.d8.s0" text="Both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when ALFENTA is administered in combination with other CNS depressants such as barbiturates, tranquilizers, opioids, or inhalation general anesthetics.">
        <entity id="DDI-DrugBank.d8.s0.e0" charOffset="106-112"
            type="brand" text="ALFENTA"/>
        <entity id="DDI-DrugBank.d8.s0.e1" charOffset="156-170"
            type="group" text="CNS depressants"/>
        <entity id="DDI-DrugBank.d8.s0.e2" charOffset="180-191"
            type="group" text="barbiturates"/>
        <entity id="DDI-DrugBank.d8.s0.e3" charOffset="194-206"
            type="group" text="tranquilizers"/>
        <entity id="DDI-DrugBank.d8.s0.e4" charOffset="209-215"
            type="group" text="opioids"/>
        <entity id="DDI-DrugBank.d8.s0.e5" charOffset="240-250"
            type="group" text="anesthetics"/>
        <pair id="DDI-DrugBank.d8.s0.p0" e1="DDI-DrugBank.d8.s0.e0"
            e2="DDI-DrugBank.d8.s0.e1" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d8.s0.p1" e1="DDI-DrugBank.d8.s0.e0"
            e2="DDI-DrugBank.d8.s0.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d8.s0.p2" e1="DDI-DrugBank.d8.s0.e0"
            e2="DDI-DrugBank.d8.s0.e3" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d8.s0.p3" e1="DDI-DrugBank.d8.s0.e0"
            e2="DDI-DrugBank.d8.s0.e4" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d8.s0.p4" e1="DDI-DrugBank.d8.s0.e0"
            e2="DDI-DrugBank.d8.s0.e5" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d8.s0.p5" e1="DDI-DrugBank.d8.s0.e1"
            e2="DDI-DrugBank.d8.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d8.s0.p6" e1="DDI-DrugBank.d8.s0.e1"
            e2="DDI-DrugBank.d8.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d8.s0.p7" e1="DDI-DrugBank.d8.s0.e1"
            e2="DDI-DrugBank.d8.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d8.s0.p8" e1="DDI-DrugBank.d8.s0.e1"
            e2="DDI-DrugBank.d8.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d8.s0.p9" e1="DDI-DrugBank.d8.s0.e2"
            e2="DDI-DrugBank.d8.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d8.s0.p10" e1="DDI-DrugBank.d8.s0.e2"
            e2="DDI-DrugBank.d8.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d8.s0.p11" e1="DDI-DrugBank.d8.s0.e2"
            e2="DDI-DrugBank.d8.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d8.s0.p12" e1="DDI-DrugBank.d8.s0.e3"
            e2="DDI-DrugBank.d8.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d8.s0.p13" e1="DDI-DrugBank.d8.s0.e3"
            e2="DDI-DrugBank.d8.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d8.s0.p14" e1="DDI-DrugBank.d8.s0.e4"
            e2="DDI-DrugBank.d8.s0.e5" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d8.s1" text="Postoperative respiratory depression may be enhanced or prolonged by these agents."/>
    <sentence id="DDI-DrugBank.d8.s2" text="In such cases of combined treatment, the dose of one or both agents should be reduced."/>
    <sentence id="DDI-DrugBank.d8.s3" text="Limited clinical experience indicates that requirements for volatile inhalation anesthetics are reduced by 30 to 50% for the first sixty (60) minutes following ALFENTA induction The concomitant use of erythromycin with ALFENTA can significantly inhibit ALFENTA clearance and may increase the risk of prolonged or delayed respiratory depression.">
        <entity id="DDI-DrugBank.d8.s3.e0" charOffset="60-90"
            type="group" text="volatile inhalation anesthetics"/>
        <entity id="DDI-DrugBank.d8.s3.e1" charOffset="160-166"
            type="brand" text="ALFENTA"/>
        <entity id="DDI-DrugBank.d8.s3.e2" charOffset="201-212"
            type="drug" text="erythromycin"/>
        <entity id="DDI-DrugBank.d8.s3.e3" charOffset="219-225"
            type="brand" text="ALFENTA"/>
        <entity id="DDI-DrugBank.d8.s3.e4" charOffset="253-259"
            type="brand" text="ALFENTA"/>
        <pair id="DDI-DrugBank.d8.s3.p0" e1="DDI-DrugBank.d8.s3.e0"
            e2="DDI-DrugBank.d8.s3.e1" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d8.s3.p1" e1="DDI-DrugBank.d8.s3.e0"
            e2="DDI-DrugBank.d8.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d8.s3.p2" e1="DDI-DrugBank.d8.s3.e0"
            e2="DDI-DrugBank.d8.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d8.s3.p3" e1="DDI-DrugBank.d8.s3.e0"
            e2="DDI-DrugBank.d8.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d8.s3.p4" e1="DDI-DrugBank.d8.s3.e1"
            e2="DDI-DrugBank.d8.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d8.s3.p5" e1="DDI-DrugBank.d8.s3.e1"
            e2="DDI-DrugBank.d8.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d8.s3.p6" e1="DDI-DrugBank.d8.s3.e1"
            e2="DDI-DrugBank.d8.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d8.s3.p7" e1="DDI-DrugBank.d8.s3.e2"
            e2="DDI-DrugBank.d8.s3.e3" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d8.s3.p8" e1="DDI-DrugBank.d8.s3.e2"
            e2="DDI-DrugBank.d8.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d8.s3.p9" e1="DDI-DrugBank.d8.s3.e3"
            e2="DDI-DrugBank.d8.s3.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d8.s4" text="Cimetidine reduces the clearance of ALFENTA.">
        <entity id="DDI-DrugBank.d8.s4.e0" charOffset="0-9" type="drug" text="Cimetidine"/>
        <entity id="DDI-DrugBank.d8.s4.e1" charOffset="36-42"
            type="brand" text="ALFENTA"/>
        <pair id="DDI-DrugBank.d8.s4.p0" e1="DDI-DrugBank.d8.s4.e0"
            e2="DDI-DrugBank.d8.s4.e1" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d8.s5" text="Therefore smaller ALFENTA doses will be required with prolonged administration and the duration of action of ALFENTA my be extended.">
        <entity id="DDI-DrugBank.d8.s5.e0" charOffset="18-24"
            type="brand" text="ALFENTA"/>
        <entity id="DDI-DrugBank.d8.s5.e1" charOffset="109-115"
            type="brand" text="ALFENTA"/>
        <pair id="DDI-DrugBank.d8.s5.p0" e1="DDI-DrugBank.d8.s5.e0"
            e2="DDI-DrugBank.d8.s5.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d8.s6" text="Perioperative administration of drugs affecting hepatic blood flow or enzyme function may reduce plasma clearance and prolong recovery."/>
</document>
<document id="DDI-DrugBank.d416">
    <sentence id="DDI-DrugBank.d416.s0" text="Renal clearance measurements of PAH cannot be made with any significant accuracy in patients receiving sulfonamides, procaine, or thiazolesulfone.">
        <entity id="DDI-DrugBank.d416.s0.e0" charOffset="32-34"
            type="drug" text="PAH"/>
        <entity id="DDI-DrugBank.d416.s0.e1" charOffset="103-114"
            type="group" text="sulfonamides"/>
        <entity id="DDI-DrugBank.d416.s0.e2" charOffset="117-124"
            type="drug" text="procaine"/>
        <entity id="DDI-DrugBank.d416.s0.e3" charOffset="130-144"
            type="drug" text="thiazolesulfone"/>
        <pair id="DDI-DrugBank.d416.s0.p0" e1="DDI-DrugBank.d416.s0.e0"
            e2="DDI-DrugBank.d416.s0.e1" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d416.s0.p1" e1="DDI-DrugBank.d416.s0.e0"
            e2="DDI-DrugBank.d416.s0.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d416.s0.p2" e1="DDI-DrugBank.d416.s0.e0"
            e2="DDI-DrugBank.d416.s0.e3" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d416.s0.p3" e1="DDI-DrugBank.d416.s0.e1"
            e2="DDI-DrugBank.d416.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d416.s0.p4" e1="DDI-DrugBank.d416.s0.e1"
            e2="DDI-DrugBank.d416.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d416.s0.p5" e1="DDI-DrugBank.d416.s0.e2"
            e2="DDI-DrugBank.d416.s0.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d416.s1" text="These compounds interfere with chemical color development essential to the analytical procedures."/>
    <sentence id="DDI-DrugBank.d416.s2" text="Probenecid depresses tubular secretion of certain weak acids such as PAH.">
        <entity id="DDI-DrugBank.d416.s2.e0" charOffset="0-9"
            type="drug" text="Probenecid"/>
        <entity id="DDI-DrugBank.d416.s2.e1" charOffset="69-71"
            type="drug" text="PAH"/>
        <pair id="DDI-DrugBank.d416.s2.p0" e1="DDI-DrugBank.d416.s2.e0"
            e2="DDI-DrugBank.d416.s2.e1" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d416.s3" text="Therefore, patients receiving probenecid will have erroneously low ERPF and Tm PAH values.">
        <entity id="DDI-DrugBank.d416.s3.e0" charOffset="30-39"
            type="drug" text="probenecid"/>
        <entity id="DDI-DrugBank.d416.s3.e1" charOffset="79-81"
            type="drug" text="PAH"/>
        <pair id="DDI-DrugBank.d416.s3.p0" e1="DDI-DrugBank.d416.s3.e0"
            e2="DDI-DrugBank.d416.s3.e1" ddi="true" type="effect"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d22">
    <sentence id="DDI-DrugBank.d22.s0" text="Aminosalicylic acid may decrease the amount of digoxin (Lanoxin, Lanoxicaps) that gets absorbed into your body.">
        <entity id="DDI-DrugBank.d22.s0.e0" charOffset="0-18"
            type="drug" text="Aminosalicylic acid"/>
        <entity id="DDI-DrugBank.d22.s0.e1" charOffset="47-53"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d22.s0.e2" charOffset="56-62"
            type="brand" text="Lanoxin"/>
        <entity id="DDI-DrugBank.d22.s0.e3" charOffset="65-74"
            type="drug" text="Lanoxicaps"/>
        <pair id="DDI-DrugBank.d22.s0.p0" e1="DDI-DrugBank.d22.s0.e0"
            e2="DDI-DrugBank.d22.s0.e1" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d22.s0.p1" e1="DDI-DrugBank.d22.s0.e0"
            e2="DDI-DrugBank.d22.s0.e2" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d22.s0.p2" e1="DDI-DrugBank.d22.s0.e0"
            e2="DDI-DrugBank.d22.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d22.s0.p3" e1="DDI-DrugBank.d22.s0.e1"
            e2="DDI-DrugBank.d22.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d22.s0.p4" e1="DDI-DrugBank.d22.s0.e1"
            e2="DDI-DrugBank.d22.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d22.s0.p5" e1="DDI-DrugBank.d22.s0.e2"
            e2="DDI-DrugBank.d22.s0.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d22.s1" text="In the case that you are taking digoxin while taking aminosalicylic acid, higher doses of digoxin may be needed.">
        <entity id="DDI-DrugBank.d22.s1.e0" charOffset="32-38"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d22.s1.e1" charOffset="53-71"
            type="drug" text="aminosalicylic acid"/>
        <entity id="DDI-DrugBank.d22.s1.e2" charOffset="90-96"
            type="drug" text="digoxin"/>
        <pair id="DDI-DrugBank.d22.s1.p0" e1="DDI-DrugBank.d22.s1.e0"
            e2="DDI-DrugBank.d22.s1.e1" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d22.s1.p1" e1="DDI-DrugBank.d22.s1.e0"
            e2="DDI-DrugBank.d22.s1.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d22.s1.p2" e1="DDI-DrugBank.d22.s1.e1"
            e2="DDI-DrugBank.d22.s1.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d22.s2" text="Aminosalicylic acid may also decrease the absorption of vitamin B12, which can lead to a deficiency.">
        <entity id="DDI-DrugBank.d22.s2.e0" charOffset="0-18"
            type="drug" text="Aminosalicylic acid"/>
        <entity id="DDI-DrugBank.d22.s2.e1" charOffset="56-66"
            type="drug" text="vitamin B12"/>
        <pair id="DDI-DrugBank.d22.s2.p0" e1="DDI-DrugBank.d22.s2.e0"
            e2="DDI-DrugBank.d22.s2.e1" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d22.s3" text="Therefore you may need to take a vitamin B12 supplement while taking aminosalicylic acid.">
        <entity id="DDI-DrugBank.d22.s3.e0" charOffset="33-43"
            type="drug" text="vitamin B12"/>
        <entity id="DDI-DrugBank.d22.s3.e1" charOffset="69-87"
            type="drug" text="aminosalicylic acid"/>
        <pair id="DDI-DrugBank.d22.s3.p0" e1="DDI-DrugBank.d22.s3.e0"
            e2="DDI-DrugBank.d22.s3.e1" ddi="true" type="advise"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d318">
    <sentence id="DDI-DrugBank.d318.s0" text="When administered concurrently, the following drugs may interact with amphotericin B: Antineoplastic agents: may enhance the potential for renal toxicity, bronchospasm and hypotension.">
        <entity id="DDI-DrugBank.d318.s0.e0" charOffset="70-83"
            type="drug" text="amphotericin B"/>
        <entity id="DDI-DrugBank.d318.s0.e1" charOffset="86-106"
            type="group" text="Antineoplastic agents"/>
        <pair id="DDI-DrugBank.d318.s0.p0" e1="DDI-DrugBank.d318.s0.e0"
            e2="DDI-DrugBank.d318.s0.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d318.s1" text="Antineoplastic agents (e. g., nitrogen mustard, etc.) should be given concomitantly only with great caution.">
        <entity id="DDI-DrugBank.d318.s1.e0" charOffset="0-20"
            type="group" text="Antineoplastic agents"/>
        <entity id="DDI-DrugBank.d318.s1.e1" charOffset="30-45"
            type="drug" text="nitrogen mustard"/>
        <pair id="DDI-DrugBank.d318.s1.p0" e1="DDI-DrugBank.d318.s1.e0"
            e2="DDI-DrugBank.d318.s1.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d318.s2" text="Corticosteroids and Corticotropin (ACTH): may potentiate amphotericin B- induced hypokalemia which may predispose the patient to cardiac dysfunction.">
        <entity id="DDI-DrugBank.d318.s2.e0" charOffset="0-14"
            type="group" text="Corticosteroids"/>
        <entity id="DDI-DrugBank.d318.s2.e1" charOffset="20-32"
            type="drug" text="Corticotropin"/>
        <entity id="DDI-DrugBank.d318.s2.e2" charOffset="35-38"
            type="group" text="ACTH"/>
        <entity id="DDI-DrugBank.d318.s2.e3" charOffset="57-70"
            type="drug" text="amphotericin B"/>
        <pair id="DDI-DrugBank.d318.s2.p0" e1="DDI-DrugBank.d318.s2.e0"
            e2="DDI-DrugBank.d318.s2.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s2.p1" e1="DDI-DrugBank.d318.s2.e0"
            e2="DDI-DrugBank.d318.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s2.p2" e1="DDI-DrugBank.d318.s2.e0"
            e2="DDI-DrugBank.d318.s2.e3" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d318.s2.p3" e1="DDI-DrugBank.d318.s2.e1"
            e2="DDI-DrugBank.d318.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s2.p4" e1="DDI-DrugBank.d318.s2.e1"
            e2="DDI-DrugBank.d318.s2.e3" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d318.s2.p5" e1="DDI-DrugBank.d318.s2.e2"
            e2="DDI-DrugBank.d318.s2.e3" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d318.s3" text="Avoid concomitant use unless necessary to control side effects of amphotericin B.">
        <entity id="DDI-DrugBank.d318.s3.e0" charOffset="66-79"
            type="drug" text="amphotericin B"/>
    </sentence>
    <sentence id="DDI-DrugBank.d318.s4" text="If used concomitantly, closely monitor serum electrolytes and cardiac function."/>
    <sentence id="DDI-DrugBank.d318.s5" text="Digitalis glycosides: amphotericin B-induced hypokalemia may potentiate digitalis toxicity.">
        <entity id="DDI-DrugBank.d318.s5.e0" charOffset="0-19"
            type="group" text="Digitalis glycosides"/>
        <entity id="DDI-DrugBank.d318.s5.e1" charOffset="22-35"
            type="drug" text="amphotericin B"/>
        <entity id="DDI-DrugBank.d318.s5.e2" charOffset="72-80"
            type="group" text="digitalis"/>
        <pair id="DDI-DrugBank.d318.s5.p0" e1="DDI-DrugBank.d318.s5.e0"
            e2="DDI-DrugBank.d318.s5.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s5.p1" e1="DDI-DrugBank.d318.s5.e0"
            e2="DDI-DrugBank.d318.s5.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s5.p2" e1="DDI-DrugBank.d318.s5.e1"
            e2="DDI-DrugBank.d318.s5.e2" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d318.s6" text="Serum potassium levels and cardiac function should be closely monitored and any deficit promptly corrected."/>
    <sentence id="DDI-DrugBank.d318.s7" text="Flucytosine: while a synergistic relationship with amphotericin B has been reported, concomitant use may increase the toxicity of flucytosine by possibly increasing its cellular uptake and/or impairing its renal excretion.">
        <entity id="DDI-DrugBank.d318.s7.e0" charOffset="0-10"
            type="drug" text="Flucytosine"/>
        <entity id="DDI-DrugBank.d318.s7.e1" charOffset="51-64"
            type="drug" text="amphotericin B"/>
        <entity id="DDI-DrugBank.d318.s7.e2" charOffset="130-140"
            type="drug" text="flucytosine"/>
        <pair id="DDI-DrugBank.d318.s7.p0" e1="DDI-DrugBank.d318.s7.e0"
            e2="DDI-DrugBank.d318.s7.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s7.p1" e1="DDI-DrugBank.d318.s7.e0"
            e2="DDI-DrugBank.d318.s7.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s7.p2" e1="DDI-DrugBank.d318.s7.e1"
            e2="DDI-DrugBank.d318.s7.e2" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d318.s8" text="Imidazoles (e. g., ketoconazole, miconazole, clotrimazole, fluconazole, etc.): in vitro and animal studies with the combination of amphotericin B and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin B.">
        <entity id="DDI-DrugBank.d318.s8.e0" charOffset="0-9"
            type="group" text="Imidazoles"/>
        <entity id="DDI-DrugBank.d318.s8.e1" charOffset="19-30"
            type="drug" text="ketoconazole"/>
        <entity id="DDI-DrugBank.d318.s8.e2" charOffset="33-42"
            type="drug" text="miconazole"/>
        <entity id="DDI-DrugBank.d318.s8.e3" charOffset="45-56"
            type="drug" text="clotrimazole"/>
        <entity id="DDI-DrugBank.d318.s8.e4" charOffset="59-69"
            type="drug" text="fluconazole"/>
        <entity id="DDI-DrugBank.d318.s8.e5" charOffset="131-144"
            type="drug" text="amphotericin B"/>
        <entity id="DDI-DrugBank.d318.s8.e6" charOffset="150-159"
            type="group" text="imidazoles"/>
        <entity id="DDI-DrugBank.d318.s8.e7" charOffset="174-183"
            type="group" text="imidazoles"/>
        <entity id="DDI-DrugBank.d318.s8.e8" charOffset="217-230"
            type="drug" text="amphotericin B"/>
        <pair id="DDI-DrugBank.d318.s8.p0" e1="DDI-DrugBank.d318.s8.e0"
            e2="DDI-DrugBank.d318.s8.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s8.p1" e1="DDI-DrugBank.d318.s8.e0"
            e2="DDI-DrugBank.d318.s8.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s8.p2" e1="DDI-DrugBank.d318.s8.e0"
            e2="DDI-DrugBank.d318.s8.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s8.p3" e1="DDI-DrugBank.d318.s8.e0"
            e2="DDI-DrugBank.d318.s8.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s8.p4" e1="DDI-DrugBank.d318.s8.e0"
            e2="DDI-DrugBank.d318.s8.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s8.p5" e1="DDI-DrugBank.d318.s8.e0"
            e2="DDI-DrugBank.d318.s8.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s8.p6" e1="DDI-DrugBank.d318.s8.e0"
            e2="DDI-DrugBank.d318.s8.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s8.p7" e1="DDI-DrugBank.d318.s8.e0"
            e2="DDI-DrugBank.d318.s8.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s8.p8" e1="DDI-DrugBank.d318.s8.e1"
            e2="DDI-DrugBank.d318.s8.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s8.p9" e1="DDI-DrugBank.d318.s8.e1"
            e2="DDI-DrugBank.d318.s8.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s8.p10" e1="DDI-DrugBank.d318.s8.e1"
            e2="DDI-DrugBank.d318.s8.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s8.p11" e1="DDI-DrugBank.d318.s8.e1"
            e2="DDI-DrugBank.d318.s8.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s8.p12" e1="DDI-DrugBank.d318.s8.e1"
            e2="DDI-DrugBank.d318.s8.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s8.p13" e1="DDI-DrugBank.d318.s8.e1"
            e2="DDI-DrugBank.d318.s8.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s8.p14" e1="DDI-DrugBank.d318.s8.e1"
            e2="DDI-DrugBank.d318.s8.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s8.p15" e1="DDI-DrugBank.d318.s8.e2"
            e2="DDI-DrugBank.d318.s8.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s8.p16" e1="DDI-DrugBank.d318.s8.e2"
            e2="DDI-DrugBank.d318.s8.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s8.p17" e1="DDI-DrugBank.d318.s8.e2"
            e2="DDI-DrugBank.d318.s8.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s8.p18" e1="DDI-DrugBank.d318.s8.e2"
            e2="DDI-DrugBank.d318.s8.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s8.p19" e1="DDI-DrugBank.d318.s8.e2"
            e2="DDI-DrugBank.d318.s8.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s8.p20" e1="DDI-DrugBank.d318.s8.e2"
            e2="DDI-DrugBank.d318.s8.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s8.p21" e1="DDI-DrugBank.d318.s8.e3"
            e2="DDI-DrugBank.d318.s8.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s8.p22" e1="DDI-DrugBank.d318.s8.e3"
            e2="DDI-DrugBank.d318.s8.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s8.p23" e1="DDI-DrugBank.d318.s8.e3"
            e2="DDI-DrugBank.d318.s8.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s8.p24" e1="DDI-DrugBank.d318.s8.e3"
            e2="DDI-DrugBank.d318.s8.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s8.p25" e1="DDI-DrugBank.d318.s8.e3"
            e2="DDI-DrugBank.d318.s8.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s8.p26" e1="DDI-DrugBank.d318.s8.e4"
            e2="DDI-DrugBank.d318.s8.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s8.p27" e1="DDI-DrugBank.d318.s8.e4"
            e2="DDI-DrugBank.d318.s8.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s8.p28" e1="DDI-DrugBank.d318.s8.e4"
            e2="DDI-DrugBank.d318.s8.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s8.p29" e1="DDI-DrugBank.d318.s8.e4"
            e2="DDI-DrugBank.d318.s8.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s8.p30" e1="DDI-DrugBank.d318.s8.e5"
            e2="DDI-DrugBank.d318.s8.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s8.p31" e1="DDI-DrugBank.d318.s8.e5"
            e2="DDI-DrugBank.d318.s8.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s8.p32" e1="DDI-DrugBank.d318.s8.e5"
            e2="DDI-DrugBank.d318.s8.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s8.p33" e1="DDI-DrugBank.d318.s8.e6"
            e2="DDI-DrugBank.d318.s8.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s8.p34" e1="DDI-DrugBank.d318.s8.e6"
            e2="DDI-DrugBank.d318.s8.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s8.p35" e1="DDI-DrugBank.d318.s8.e7"
            e2="DDI-DrugBank.d318.s8.e8" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d318.s9" text="Combination therapy should be administered with caution, especially in immunocompromised patients."/>
    <sentence id="DDI-DrugBank.d318.s10" text="Other nephrotoxic medications: agents such as aminoglycosides, cyclosporine, and pentamidine may enhance the potential for drug-induced renal toxicity, and should be used concomitantly only with great caution.">
        <entity id="DDI-DrugBank.d318.s10.e0" charOffset="46-60"
            type="group" text="aminoglycosides"/>
        <entity id="DDI-DrugBank.d318.s10.e1" charOffset="63-74"
            type="drug" text="cyclosporine"/>
        <entity id="DDI-DrugBank.d318.s10.e2" charOffset="81-91"
            type="drug" text="pentamidine"/>
        <pair id="DDI-DrugBank.d318.s10.p0"
            e1="DDI-DrugBank.d318.s10.e0" e2="DDI-DrugBank.d318.s10.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s10.p1"
            e1="DDI-DrugBank.d318.s10.e0" e2="DDI-DrugBank.d318.s10.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s10.p2"
            e1="DDI-DrugBank.d318.s10.e1" e2="DDI-DrugBank.d318.s10.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d318.s11" text="Intensive monitoring of renal function is recommended in patients requiring any combination of nephrotoxic medications ."/>
    <sentence id="DDI-DrugBank.d318.s12" text="Skeletal muscle relaxants: amphotericin B-induced hypokalemia may enhance the curariform effect of skeletal muscle relaxants (e.g., tubocurarine).">
        <entity id="DDI-DrugBank.d318.s12.e0" charOffset="0-24"
            type="group" text="Skeletal muscle relaxants"/>
        <entity id="DDI-DrugBank.d318.s12.e1" charOffset="27-40"
            type="drug" text="amphotericin B"/>
        <entity id="DDI-DrugBank.d318.s12.e2" charOffset="99-123"
            type="group" text="skeletal muscle relaxants"/>
        <entity id="DDI-DrugBank.d318.s12.e3" charOffset="132-143"
            type="drug" text="tubocurarine"/>
        <pair id="DDI-DrugBank.d318.s12.p0"
            e1="DDI-DrugBank.d318.s12.e0" e2="DDI-DrugBank.d318.s12.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s12.p1"
            e1="DDI-DrugBank.d318.s12.e0" e2="DDI-DrugBank.d318.s12.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s12.p2"
            e1="DDI-DrugBank.d318.s12.e0" e2="DDI-DrugBank.d318.s12.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s12.p3"
            e1="DDI-DrugBank.d318.s12.e1" e2="DDI-DrugBank.d318.s12.e2"
            ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d318.s12.p4"
            e1="DDI-DrugBank.d318.s12.e1" e2="DDI-DrugBank.d318.s12.e3"
            ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d318.s12.p5"
            e1="DDI-DrugBank.d318.s12.e2" e2="DDI-DrugBank.d318.s12.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d318.s13" text="Serum potassium levels should be monitored and deficiencies corrected."/>
    <sentence id="DDI-DrugBank.d318.s14" text="Leukocyte transfusions: acute pulmonary toxicity has been reported in patients receiving intravenous amphotericin B and leukocyte transfusions.">
        <entity id="DDI-DrugBank.d318.s14.e0" charOffset="0-21"
            type="drug_n" text="Leukocyte transfusions"/>
        <entity id="DDI-DrugBank.d318.s14.e1" charOffset="101-114"
            type="drug" text="amphotericin B"/>
        <entity id="DDI-DrugBank.d318.s14.e2" charOffset="120-141"
            type="drug_n" text="leukocyte transfusions"/>
        <pair id="DDI-DrugBank.d318.s14.p0"
            e1="DDI-DrugBank.d318.s14.e0" e2="DDI-DrugBank.d318.s14.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s14.p1"
            e1="DDI-DrugBank.d318.s14.e0" e2="DDI-DrugBank.d318.s14.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d318.s14.p2"
            e1="DDI-DrugBank.d318.s14.e1" e2="DDI-DrugBank.d318.s14.e2"
            ddi="true" type="effect"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d357">
    <sentence id="DDI-DrugBank.d357.s0" text="5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron, the concomitant use of apomorphine with drugs of the 5HT3 antagonist class (including, for example, ondansetron, granisetron, dolasetron, palonosetron, and alosetron) is contraindicated .">
        <entity id="DDI-DrugBank.d357.s0.e0" charOffset="0-15"
            type="group" text="5HT3 Antagonists"/>
        <entity id="DDI-DrugBank.d357.s0.e1" charOffset="90-100"
            type="drug" text="apomorphine"/>
        <entity id="DDI-DrugBank.d357.s0.e2" charOffset="124-134"
            type="drug" text="ondansetron"/>
        <entity id="DDI-DrugBank.d357.s0.e3" charOffset="160-170"
            type="drug" text="apomorphine"/>
        <entity id="DDI-DrugBank.d357.s0.e4" charOffset="190-210"
            type="group" text="5HT3 antagonist class"/>
        <entity id="DDI-DrugBank.d357.s0.e5" charOffset="237-247"
            type="drug" text="ondansetron"/>
        <entity id="DDI-DrugBank.d357.s0.e6" charOffset="250-260"
            type="drug" text="granisetron"/>
        <entity id="DDI-DrugBank.d357.s0.e7" charOffset="263-272"
            type="drug" text="dolasetron"/>
        <entity id="DDI-DrugBank.d357.s0.e8" charOffset="275-286"
            type="drug" text="palonosetron"/>
        <entity id="DDI-DrugBank.d357.s0.e9" charOffset="293-301"
            type="drug" text="alosetron"/>
        <pair id="DDI-DrugBank.d357.s0.p0" e1="DDI-DrugBank.d357.s0.e0"
            e2="DDI-DrugBank.d357.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p1" e1="DDI-DrugBank.d357.s0.e0"
            e2="DDI-DrugBank.d357.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p2" e1="DDI-DrugBank.d357.s0.e0"
            e2="DDI-DrugBank.d357.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p3" e1="DDI-DrugBank.d357.s0.e0"
            e2="DDI-DrugBank.d357.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p4" e1="DDI-DrugBank.d357.s0.e0"
            e2="DDI-DrugBank.d357.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p5" e1="DDI-DrugBank.d357.s0.e0"
            e2="DDI-DrugBank.d357.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p6" e1="DDI-DrugBank.d357.s0.e0"
            e2="DDI-DrugBank.d357.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p7" e1="DDI-DrugBank.d357.s0.e0"
            e2="DDI-DrugBank.d357.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p8" e1="DDI-DrugBank.d357.s0.e0"
            e2="DDI-DrugBank.d357.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p9" e1="DDI-DrugBank.d357.s0.e1"
            e2="DDI-DrugBank.d357.s0.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d357.s0.p10" e1="DDI-DrugBank.d357.s0.e1"
            e2="DDI-DrugBank.d357.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p11" e1="DDI-DrugBank.d357.s0.e1"
            e2="DDI-DrugBank.d357.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p12" e1="DDI-DrugBank.d357.s0.e1"
            e2="DDI-DrugBank.d357.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p13" e1="DDI-DrugBank.d357.s0.e1"
            e2="DDI-DrugBank.d357.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p14" e1="DDI-DrugBank.d357.s0.e1"
            e2="DDI-DrugBank.d357.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p15" e1="DDI-DrugBank.d357.s0.e1"
            e2="DDI-DrugBank.d357.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p16" e1="DDI-DrugBank.d357.s0.e1"
            e2="DDI-DrugBank.d357.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p17" e1="DDI-DrugBank.d357.s0.e2"
            e2="DDI-DrugBank.d357.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p18" e1="DDI-DrugBank.d357.s0.e2"
            e2="DDI-DrugBank.d357.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p19" e1="DDI-DrugBank.d357.s0.e2"
            e2="DDI-DrugBank.d357.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p20" e1="DDI-DrugBank.d357.s0.e2"
            e2="DDI-DrugBank.d357.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p21" e1="DDI-DrugBank.d357.s0.e2"
            e2="DDI-DrugBank.d357.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p22" e1="DDI-DrugBank.d357.s0.e2"
            e2="DDI-DrugBank.d357.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p23" e1="DDI-DrugBank.d357.s0.e2"
            e2="DDI-DrugBank.d357.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p24" e1="DDI-DrugBank.d357.s0.e3"
            e2="DDI-DrugBank.d357.s0.e4" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d357.s0.p25" e1="DDI-DrugBank.d357.s0.e3"
            e2="DDI-DrugBank.d357.s0.e5" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d357.s0.p26" e1="DDI-DrugBank.d357.s0.e3"
            e2="DDI-DrugBank.d357.s0.e6" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d357.s0.p27" e1="DDI-DrugBank.d357.s0.e3"
            e2="DDI-DrugBank.d357.s0.e7" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d357.s0.p28" e1="DDI-DrugBank.d357.s0.e3"
            e2="DDI-DrugBank.d357.s0.e8" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d357.s0.p29" e1="DDI-DrugBank.d357.s0.e3"
            e2="DDI-DrugBank.d357.s0.e9" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d357.s0.p30" e1="DDI-DrugBank.d357.s0.e4"
            e2="DDI-DrugBank.d357.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p31" e1="DDI-DrugBank.d357.s0.e4"
            e2="DDI-DrugBank.d357.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p32" e1="DDI-DrugBank.d357.s0.e4"
            e2="DDI-DrugBank.d357.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p33" e1="DDI-DrugBank.d357.s0.e4"
            e2="DDI-DrugBank.d357.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p34" e1="DDI-DrugBank.d357.s0.e4"
            e2="DDI-DrugBank.d357.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p35" e1="DDI-DrugBank.d357.s0.e5"
            e2="DDI-DrugBank.d357.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p36" e1="DDI-DrugBank.d357.s0.e5"
            e2="DDI-DrugBank.d357.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p37" e1="DDI-DrugBank.d357.s0.e5"
            e2="DDI-DrugBank.d357.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p38" e1="DDI-DrugBank.d357.s0.e5"
            e2="DDI-DrugBank.d357.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p39" e1="DDI-DrugBank.d357.s0.e6"
            e2="DDI-DrugBank.d357.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p40" e1="DDI-DrugBank.d357.s0.e6"
            e2="DDI-DrugBank.d357.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p41" e1="DDI-DrugBank.d357.s0.e6"
            e2="DDI-DrugBank.d357.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p42" e1="DDI-DrugBank.d357.s0.e7"
            e2="DDI-DrugBank.d357.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p43" e1="DDI-DrugBank.d357.s0.e7"
            e2="DDI-DrugBank.d357.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s0.p44" e1="DDI-DrugBank.d357.s0.e8"
            e2="DDI-DrugBank.d357.s0.e9" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d357.s1" text="Antihypertensive Medications and Vasodilators: The following adverse events were experienced more commonly in patients receiving concomitant antihypertensive medications or vasodilators (n = 94) compared to patients not receiving these concomitant drugs (n = 456): hypotension 10% vs 4%, myocardial infarction 3% vs 1%, serious pneumonia 5% vs 3%, serious falls 9% vs 3%, and bone and joint injuries 6% vs 2%.">
        <entity id="DDI-DrugBank.d357.s1.e0" charOffset="0-27"
            type="group" text="Antihypertensive Medications"/>
        <entity id="DDI-DrugBank.d357.s1.e1" charOffset="33-44"
            type="group" text="Vasodilators"/>
        <entity id="DDI-DrugBank.d357.s1.e2" charOffset="141-168"
            type="group" text="antihypertensive medications"/>
        <entity id="DDI-DrugBank.d357.s1.e3" charOffset="173-184"
            type="group" text="vasodilators"/>
        <pair id="DDI-DrugBank.d357.s1.p0" e1="DDI-DrugBank.d357.s1.e0"
            e2="DDI-DrugBank.d357.s1.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s1.p1" e1="DDI-DrugBank.d357.s1.e0"
            e2="DDI-DrugBank.d357.s1.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s1.p2" e1="DDI-DrugBank.d357.s1.e0"
            e2="DDI-DrugBank.d357.s1.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s1.p3" e1="DDI-DrugBank.d357.s1.e1"
            e2="DDI-DrugBank.d357.s1.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s1.p4" e1="DDI-DrugBank.d357.s1.e1"
            e2="DDI-DrugBank.d357.s1.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s1.p5" e1="DDI-DrugBank.d357.s1.e2"
            e2="DDI-DrugBank.d357.s1.e3" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d357.s2" text="The mechanism underlying many of these events is unknown, but may represent increased hypotension ."/>
    <sentence id="DDI-DrugBank.d357.s3" text="Dopamine Antagonists: Since apomorphine is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of APOKYN.">
        <entity id="DDI-DrugBank.d357.s3.e0" charOffset="0-19"
            type="group" text="Dopamine Antagonists"/>
        <entity id="DDI-DrugBank.d357.s3.e1" charOffset="28-38"
            type="drug" text="apomorphine"/>
        <entity id="DDI-DrugBank.d357.s3.e2" charOffset="45-60"
            type="group" text="dopamine agonist"/>
        <entity id="DDI-DrugBank.d357.s3.e3" charOffset="83-102"
            type="group" text="dopamine antagonists"/>
        <entity id="DDI-DrugBank.d357.s3.e4" charOffset="117-128"
            type="group" text="neuroleptics"/>
        <entity id="DDI-DrugBank.d357.s3.e5" charOffset="131-144"
            type="group" text="phenothiazines"/>
        <entity id="DDI-DrugBank.d357.s3.e6" charOffset="147-160"
            type="group" text="butyrophenones"/>
        <entity id="DDI-DrugBank.d357.s3.e7" charOffset="163-175"
            type="group" text="thioxanthenes"/>
        <entity id="DDI-DrugBank.d357.s3.e8" charOffset="181-194"
            type="drug" text="metoclopramide"/>
        <entity id="DDI-DrugBank.d357.s3.e9" charOffset="231-236"
            type="brand" text="APOKYN"/>
        <pair id="DDI-DrugBank.d357.s3.p0" e1="DDI-DrugBank.d357.s3.e0"
            e2="DDI-DrugBank.d357.s3.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p1" e1="DDI-DrugBank.d357.s3.e0"
            e2="DDI-DrugBank.d357.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p2" e1="DDI-DrugBank.d357.s3.e0"
            e2="DDI-DrugBank.d357.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p3" e1="DDI-DrugBank.d357.s3.e0"
            e2="DDI-DrugBank.d357.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p4" e1="DDI-DrugBank.d357.s3.e0"
            e2="DDI-DrugBank.d357.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p5" e1="DDI-DrugBank.d357.s3.e0"
            e2="DDI-DrugBank.d357.s3.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p6" e1="DDI-DrugBank.d357.s3.e0"
            e2="DDI-DrugBank.d357.s3.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p7" e1="DDI-DrugBank.d357.s3.e0"
            e2="DDI-DrugBank.d357.s3.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p8" e1="DDI-DrugBank.d357.s3.e0"
            e2="DDI-DrugBank.d357.s3.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p9" e1="DDI-DrugBank.d357.s3.e1"
            e2="DDI-DrugBank.d357.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p10" e1="DDI-DrugBank.d357.s3.e1"
            e2="DDI-DrugBank.d357.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p11" e1="DDI-DrugBank.d357.s3.e1"
            e2="DDI-DrugBank.d357.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p12" e1="DDI-DrugBank.d357.s3.e1"
            e2="DDI-DrugBank.d357.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p13" e1="DDI-DrugBank.d357.s3.e1"
            e2="DDI-DrugBank.d357.s3.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p14" e1="DDI-DrugBank.d357.s3.e1"
            e2="DDI-DrugBank.d357.s3.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p15" e1="DDI-DrugBank.d357.s3.e1"
            e2="DDI-DrugBank.d357.s3.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p16" e1="DDI-DrugBank.d357.s3.e1"
            e2="DDI-DrugBank.d357.s3.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p17" e1="DDI-DrugBank.d357.s3.e2"
            e2="DDI-DrugBank.d357.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p18" e1="DDI-DrugBank.d357.s3.e2"
            e2="DDI-DrugBank.d357.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p19" e1="DDI-DrugBank.d357.s3.e2"
            e2="DDI-DrugBank.d357.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p20" e1="DDI-DrugBank.d357.s3.e2"
            e2="DDI-DrugBank.d357.s3.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p21" e1="DDI-DrugBank.d357.s3.e2"
            e2="DDI-DrugBank.d357.s3.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p22" e1="DDI-DrugBank.d357.s3.e2"
            e2="DDI-DrugBank.d357.s3.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p23" e1="DDI-DrugBank.d357.s3.e2"
            e2="DDI-DrugBank.d357.s3.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p24" e1="DDI-DrugBank.d357.s3.e3"
            e2="DDI-DrugBank.d357.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p25" e1="DDI-DrugBank.d357.s3.e3"
            e2="DDI-DrugBank.d357.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p26" e1="DDI-DrugBank.d357.s3.e3"
            e2="DDI-DrugBank.d357.s3.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p27" e1="DDI-DrugBank.d357.s3.e3"
            e2="DDI-DrugBank.d357.s3.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p28" e1="DDI-DrugBank.d357.s3.e3"
            e2="DDI-DrugBank.d357.s3.e8" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d357.s3.p29" e1="DDI-DrugBank.d357.s3.e3"
            e2="DDI-DrugBank.d357.s3.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p30" e1="DDI-DrugBank.d357.s3.e4"
            e2="DDI-DrugBank.d357.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p31" e1="DDI-DrugBank.d357.s3.e4"
            e2="DDI-DrugBank.d357.s3.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p32" e1="DDI-DrugBank.d357.s3.e4"
            e2="DDI-DrugBank.d357.s3.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p33" e1="DDI-DrugBank.d357.s3.e4"
            e2="DDI-DrugBank.d357.s3.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p34" e1="DDI-DrugBank.d357.s3.e4"
            e2="DDI-DrugBank.d357.s3.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p35" e1="DDI-DrugBank.d357.s3.e5"
            e2="DDI-DrugBank.d357.s3.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p36" e1="DDI-DrugBank.d357.s3.e5"
            e2="DDI-DrugBank.d357.s3.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p37" e1="DDI-DrugBank.d357.s3.e5"
            e2="DDI-DrugBank.d357.s3.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p38" e1="DDI-DrugBank.d357.s3.e5"
            e2="DDI-DrugBank.d357.s3.e9" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d357.s3.p39" e1="DDI-DrugBank.d357.s3.e6"
            e2="DDI-DrugBank.d357.s3.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p40" e1="DDI-DrugBank.d357.s3.e6"
            e2="DDI-DrugBank.d357.s3.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p41" e1="DDI-DrugBank.d357.s3.e6"
            e2="DDI-DrugBank.d357.s3.e9" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d357.s3.p42" e1="DDI-DrugBank.d357.s3.e7"
            e2="DDI-DrugBank.d357.s3.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d357.s3.p43" e1="DDI-DrugBank.d357.s3.e7"
            e2="DDI-DrugBank.d357.s3.e9" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d357.s3.p44" e1="DDI-DrugBank.d357.s3.e8"
            e2="DDI-DrugBank.d357.s3.e9" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d357.s4" text="Patients with major psychotic disorders, treated with neuroleptics, should be treated with dopamine agonists only if the potential benefits outweigh the risks.">
        <entity id="DDI-DrugBank.d357.s4.e0" charOffset="54-65"
            type="group" text="neuroleptics"/>
        <entity id="DDI-DrugBank.d357.s4.e1" charOffset="91-107"
            type="group" text="dopamine agonists"/>
        <pair id="DDI-DrugBank.d357.s4.p0" e1="DDI-DrugBank.d357.s4.e0"
            e2="DDI-DrugBank.d357.s4.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d357.s5" text="Drugs Prolonging the QT/QTc Interval Caution should be exercised when prescribing apomorphine concomitantly with drugs that prolong the QT/QTc interval.">
        <entity id="DDI-DrugBank.d357.s5.e0" charOffset="82-92"
            type="drug" text="apomorphine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d357.s6" text="Drug/Laboratory Test Interactions There are no known interactions between APOKYN and laboratory tests.">
        <entity id="DDI-DrugBank.d357.s6.e0" charOffset="74-79"
            type="brand" text="APOKYN"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d253">
    <sentence id="DDI-DrugBank.d253.s0" text="Beta-adrenergic blocking agents: concurrent use may blunt the response to arbutamine.">
        <entity id="DDI-DrugBank.d253.s0.e0" charOffset="0-30"
            type="group" text="Beta-adrenergic blocking agents"/>
        <entity id="DDI-DrugBank.d253.s0.e1" charOffset="74-83"
            type="drug" text="arbutamine"/>
        <pair id="DDI-DrugBank.d253.s0.p0" e1="DDI-DrugBank.d253.s0.e0"
            e2="DDI-DrugBank.d253.s0.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d253.s1" text="Beta-adrenergic blocking agents should be withdrawn at least 48 hours before conducting an arbutamine-mediated stress test.">
        <entity id="DDI-DrugBank.d253.s1.e0" charOffset="0-30"
            type="group" text="Beta-adrenergic blocking agents"/>
        <entity id="DDI-DrugBank.d253.s1.e1" charOffset="91-100"
            type="drug" text="arbutamine"/>
        <pair id="DDI-DrugBank.d253.s1.p0" e1="DDI-DrugBank.d253.s1.e0"
            e2="DDI-DrugBank.d253.s1.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d253.s2" text="Antiarrhythmic agents, class I (such as flecainide, lidocaine, or quinidine): concurrent use with arbutamine may have a proarrhythmic effect.">
        <entity id="DDI-DrugBank.d253.s2.e0" charOffset="0-29"
            type="drug" text="Antiarrhythmic agents, class I"/>
        <entity id="DDI-DrugBank.d253.s2.e1" charOffset="40-49"
            type="drug" text="flecainide"/>
        <entity id="DDI-DrugBank.d253.s2.e2" charOffset="52-60"
            type="drug" text="lidocaine"/>
        <entity id="DDI-DrugBank.d253.s2.e3" charOffset="66-74"
            type="drug" text="quinidine"/>
        <entity id="DDI-DrugBank.d253.s2.e4" charOffset="98-107"
            type="drug" text="arbutamine"/>
        <pair id="DDI-DrugBank.d253.s2.p0" e1="DDI-DrugBank.d253.s2.e0"
            e2="DDI-DrugBank.d253.s2.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d253.s2.p1" e1="DDI-DrugBank.d253.s2.e0"
            e2="DDI-DrugBank.d253.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d253.s2.p2" e1="DDI-DrugBank.d253.s2.e0"
            e2="DDI-DrugBank.d253.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d253.s2.p3" e1="DDI-DrugBank.d253.s2.e0"
            e2="DDI-DrugBank.d253.s2.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d253.s2.p4" e1="DDI-DrugBank.d253.s2.e1"
            e2="DDI-DrugBank.d253.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d253.s2.p5" e1="DDI-DrugBank.d253.s2.e1"
            e2="DDI-DrugBank.d253.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d253.s2.p6" e1="DDI-DrugBank.d253.s2.e1"
            e2="DDI-DrugBank.d253.s2.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d253.s2.p7" e1="DDI-DrugBank.d253.s2.e2"
            e2="DDI-DrugBank.d253.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d253.s2.p8" e1="DDI-DrugBank.d253.s2.e2"
            e2="DDI-DrugBank.d253.s2.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d253.s2.p9" e1="DDI-DrugBank.d253.s2.e3"
            e2="DDI-DrugBank.d253.s2.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d253.s3" text="Antidepressants (tricyclic), atropine or other anticholinergic agents, or digitalis glycosides: concurrent use with arbutamine may produce additive inotropic and/or chronotropic effects.">
        <entity id="DDI-DrugBank.d253.s3.e0" charOffset="0-14"
            type="group" text="Antidepressants"/>
        <entity id="DDI-DrugBank.d253.s3.e1" charOffset="17-25"
            type="group" text="tricyclic"/>
        <entity id="DDI-DrugBank.d253.s3.e2" charOffset="29-36"
            type="drug" text="atropine"/>
        <entity id="DDI-DrugBank.d253.s3.e3" charOffset="47-68"
            type="group" text="anticholinergic agents"/>
        <entity id="DDI-DrugBank.d253.s3.e4" charOffset="74-93"
            type="group" text="digitalis glycosides"/>
        <entity id="DDI-DrugBank.d253.s3.e5" charOffset="116-125"
            type="drug" text="arbutamine"/>
        <pair id="DDI-DrugBank.d253.s3.p0" e1="DDI-DrugBank.d253.s3.e0"
            e2="DDI-DrugBank.d253.s3.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d253.s3.p1" e1="DDI-DrugBank.d253.s3.e0"
            e2="DDI-DrugBank.d253.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d253.s3.p2" e1="DDI-DrugBank.d253.s3.e0"
            e2="DDI-DrugBank.d253.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d253.s3.p3" e1="DDI-DrugBank.d253.s3.e0"
            e2="DDI-DrugBank.d253.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d253.s3.p4" e1="DDI-DrugBank.d253.s3.e0"
            e2="DDI-DrugBank.d253.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d253.s3.p5" e1="DDI-DrugBank.d253.s3.e1"
            e2="DDI-DrugBank.d253.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d253.s3.p6" e1="DDI-DrugBank.d253.s3.e1"
            e2="DDI-DrugBank.d253.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d253.s3.p7" e1="DDI-DrugBank.d253.s3.e1"
            e2="DDI-DrugBank.d253.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d253.s3.p8" e1="DDI-DrugBank.d253.s3.e1"
            e2="DDI-DrugBank.d253.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d253.s3.p9" e1="DDI-DrugBank.d253.s3.e2"
            e2="DDI-DrugBank.d253.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d253.s3.p10" e1="DDI-DrugBank.d253.s3.e2"
            e2="DDI-DrugBank.d253.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d253.s3.p11" e1="DDI-DrugBank.d253.s3.e2"
            e2="DDI-DrugBank.d253.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d253.s3.p12" e1="DDI-DrugBank.d253.s3.e3"
            e2="DDI-DrugBank.d253.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d253.s3.p13" e1="DDI-DrugBank.d253.s3.e3"
            e2="DDI-DrugBank.d253.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d253.s3.p14" e1="DDI-DrugBank.d253.s3.e4"
            e2="DDI-DrugBank.d253.s3.e5" ddi="false"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d105">
    <sentence id="DDI-DrugBank.d105.s0" text="Anticoagulants including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs (NSAIDs), and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin.">
        <entity id="DDI-DrugBank.d105.s0.e0" charOffset="0-13"
            type="group" text="Anticoagulants"/>
        <entity id="DDI-DrugBank.d105.s0.e1" charOffset="75-105"
            type="group" text="platelet aggregation inhibitors"/>
        <entity id="DDI-DrugBank.d105.s0.e2" charOffset="115-150"
            type="group" text="nonsteroidal anti-inflammatory drugs"/>
        <entity id="DDI-DrugBank.d105.s0.e3" charOffset="153-158"
            type="group" text="NSAIDs"/>
        <entity id="DDI-DrugBank.d105.s0.e4" charOffset="166-172"
            type="brand" text="aspirin"/>
        <entity id="DDI-DrugBank.d105.s0.e5" charOffset="245-253"
            type="drug" text="ardeparin"/>
        <pair id="DDI-DrugBank.d105.s0.p0" e1="DDI-DrugBank.d105.s0.e0"
            e2="DDI-DrugBank.d105.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d105.s0.p1" e1="DDI-DrugBank.d105.s0.e0"
            e2="DDI-DrugBank.d105.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d105.s0.p2" e1="DDI-DrugBank.d105.s0.e0"
            e2="DDI-DrugBank.d105.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d105.s0.p3" e1="DDI-DrugBank.d105.s0.e0"
            e2="DDI-DrugBank.d105.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d105.s0.p4" e1="DDI-DrugBank.d105.s0.e0"
            e2="DDI-DrugBank.d105.s0.e5" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d105.s0.p5" e1="DDI-DrugBank.d105.s0.e1"
            e2="DDI-DrugBank.d105.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d105.s0.p6" e1="DDI-DrugBank.d105.s0.e1"
            e2="DDI-DrugBank.d105.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d105.s0.p7" e1="DDI-DrugBank.d105.s0.e1"
            e2="DDI-DrugBank.d105.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d105.s0.p8" e1="DDI-DrugBank.d105.s0.e1"
            e2="DDI-DrugBank.d105.s0.e5" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d105.s0.p9" e1="DDI-DrugBank.d105.s0.e2"
            e2="DDI-DrugBank.d105.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d105.s0.p10" e1="DDI-DrugBank.d105.s0.e2"
            e2="DDI-DrugBank.d105.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d105.s0.p11" e1="DDI-DrugBank.d105.s0.e2"
            e2="DDI-DrugBank.d105.s0.e5" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d105.s0.p12" e1="DDI-DrugBank.d105.s0.e3"
            e2="DDI-DrugBank.d105.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d105.s0.p13" e1="DDI-DrugBank.d105.s0.e3"
            e2="DDI-DrugBank.d105.s0.e5" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d105.s0.p14" e1="DDI-DrugBank.d105.s0.e4"
            e2="DDI-DrugBank.d105.s0.e5" ddi="true" type="effect"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d509">
    <sentence id="DDI-DrugBank.d509.s0" text="Drug-Drug Interactions Given the primary CNS effects of aripiprazole, caution should be used when ABILIFY is taken in combination with other centrally acting drugs and alcohol.">
        <entity id="DDI-DrugBank.d509.s0.e0" charOffset="56-67"
            type="drug" text="aripiprazole"/>
        <entity id="DDI-DrugBank.d509.s0.e1" charOffset="98-104"
            type="brand" text="ABILIFY"/>
        <entity id="DDI-DrugBank.d509.s0.e2" charOffset="141-162"
            type="group" text="centrally acting drugs"/>
        <entity id="DDI-DrugBank.d509.s0.e3" charOffset="168-174"
            type="drug" text="alcohol"/>
        <pair id="DDI-DrugBank.d509.s0.p0" e1="DDI-DrugBank.d509.s0.e0"
            e2="DDI-DrugBank.d509.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s0.p1" e1="DDI-DrugBank.d509.s0.e0"
            e2="DDI-DrugBank.d509.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s0.p2" e1="DDI-DrugBank.d509.s0.e0"
            e2="DDI-DrugBank.d509.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s0.p3" e1="DDI-DrugBank.d509.s0.e1"
            e2="DDI-DrugBank.d509.s0.e2" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d509.s0.p4" e1="DDI-DrugBank.d509.s0.e1"
            e2="DDI-DrugBank.d509.s0.e3" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d509.s0.p5" e1="DDI-DrugBank.d509.s0.e2"
            e2="DDI-DrugBank.d509.s0.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d509.s1" text="Due to its"/>
    <sentence id="DDI-DrugBank.d509.s2" text="1- adrenergic receptor antagonism, aripiprazole has the potential to enhance the effect of certain antihypertensive agents.">
        <entity id="DDI-DrugBank.d509.s2.e0" charOffset="35-46"
            type="drug" text="aripiprazole"/>
        <entity id="DDI-DrugBank.d509.s2.e1" charOffset="99-121"
            type="group" text="antihypertensive agents"/>
        <pair id="DDI-DrugBank.d509.s2.p0" e1="DDI-DrugBank.d509.s2.e0"
            e2="DDI-DrugBank.d509.s2.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d509.s3" text="Potential for Other Drugs to Affect ABILIFY Aripiprazole is not a substrate of CYP1A1, CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, or CYP2E1 enzymes.">
        <entity id="DDI-DrugBank.d509.s3.e0" charOffset="36-42"
            type="brand" text="ABILIFY"/>
        <entity id="DDI-DrugBank.d509.s3.e1" charOffset="44-55"
            type="brand" text="Aripiprazole"/>
        <pair id="DDI-DrugBank.d509.s3.p0" e1="DDI-DrugBank.d509.s3.e0"
            e2="DDI-DrugBank.d509.s3.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d509.s4" text="Aripiprazole also does not undergo direct glucuronidation.">
        <entity id="DDI-DrugBank.d509.s4.e0" charOffset="0-11"
            type="drug" text="Aripiprazole"/>
    </sentence>
    <sentence id="DDI-DrugBank.d509.s5" text="This suggests that an interaction of aripiprazole with inhibitors or inducers of these enzymes, or other factors, like smoking, is unlikely.">
        <entity id="DDI-DrugBank.d509.s5.e0" charOffset="37-48"
            type="drug" text="aripiprazole"/>
    </sentence>
    <sentence id="DDI-DrugBank.d509.s6" text="Both CYP3A4 and CYP2D6 are responsible for aripiprazole metabolism.">
        <entity id="DDI-DrugBank.d509.s6.e0" charOffset="43-54"
            type="drug" text="aripiprazole"/>
    </sentence>
    <sentence id="DDI-DrugBank.d509.s7" text="Agents that induce CYP3A4 (eg, carbamazepine) could cause an increase in aripiprazole clearance and lower blood levels.">
        <entity id="DDI-DrugBank.d509.s7.e0" charOffset="31-43"
            type="drug" text="carbamazepine"/>
        <entity id="DDI-DrugBank.d509.s7.e1" charOffset="73-84"
            type="drug" text="aripiprazole"/>
        <pair id="DDI-DrugBank.d509.s7.p0" e1="DDI-DrugBank.d509.s7.e0"
            e2="DDI-DrugBank.d509.s7.e1" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d509.s8" text="Inhibitors of CYP3A4 (eg, ketoconazole) or CYP2D6 (eg, quinidine, fluoxetine, or paroxetine) can inhibit aripiprazole elimination and cause increased blood levels.">
        <entity id="DDI-DrugBank.d509.s8.e0" charOffset="26-37"
            type="drug" text="ketoconazole"/>
        <entity id="DDI-DrugBank.d509.s8.e1" charOffset="55-63"
            type="drug" text="quinidine"/>
        <entity id="DDI-DrugBank.d509.s8.e2" charOffset="66-75"
            type="drug" text="fluoxetine"/>
        <entity id="DDI-DrugBank.d509.s8.e3" charOffset="81-90"
            type="drug" text="paroxetine"/>
        <entity id="DDI-DrugBank.d509.s8.e4" charOffset="105-116"
            type="drug" text="aripiprazole"/>
        <pair id="DDI-DrugBank.d509.s8.p0" e1="DDI-DrugBank.d509.s8.e0"
            e2="DDI-DrugBank.d509.s8.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s8.p1" e1="DDI-DrugBank.d509.s8.e0"
            e2="DDI-DrugBank.d509.s8.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s8.p2" e1="DDI-DrugBank.d509.s8.e0"
            e2="DDI-DrugBank.d509.s8.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s8.p3" e1="DDI-DrugBank.d509.s8.e0"
            e2="DDI-DrugBank.d509.s8.e4" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d509.s8.p4" e1="DDI-DrugBank.d509.s8.e1"
            e2="DDI-DrugBank.d509.s8.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s8.p5" e1="DDI-DrugBank.d509.s8.e1"
            e2="DDI-DrugBank.d509.s8.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s8.p6" e1="DDI-DrugBank.d509.s8.e1"
            e2="DDI-DrugBank.d509.s8.e4" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d509.s8.p7" e1="DDI-DrugBank.d509.s8.e2"
            e2="DDI-DrugBank.d509.s8.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s8.p8" e1="DDI-DrugBank.d509.s8.e2"
            e2="DDI-DrugBank.d509.s8.e4" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d509.s8.p9" e1="DDI-DrugBank.d509.s8.e3"
            e2="DDI-DrugBank.d509.s8.e4" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d509.s9" text="Ketoconazole: Coadministration of ketoconazole (200 mg/day for 14 days) with a 15-mg single dose of aripiprazole increased the AUC of aripiprazole and its active metabolite by 63% and 77%, respectively.">
        <entity id="DDI-DrugBank.d509.s9.e0" charOffset="0-11"
            type="drug" text="Ketoconazole"/>
        <entity id="DDI-DrugBank.d509.s9.e1" charOffset="34-45"
            type="drug" text="ketoconazole"/>
        <entity id="DDI-DrugBank.d509.s9.e2" charOffset="100-111"
            type="drug" text="aripiprazole"/>
        <entity id="DDI-DrugBank.d509.s9.e3" charOffset="134-145"
            type="drug" text="aripiprazole"/>
        <pair id="DDI-DrugBank.d509.s9.p0" e1="DDI-DrugBank.d509.s9.e0"
            e2="DDI-DrugBank.d509.s9.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s9.p1" e1="DDI-DrugBank.d509.s9.e0"
            e2="DDI-DrugBank.d509.s9.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s9.p2" e1="DDI-DrugBank.d509.s9.e0"
            e2="DDI-DrugBank.d509.s9.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s9.p3" e1="DDI-DrugBank.d509.s9.e1"
            e2="DDI-DrugBank.d509.s9.e2" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d509.s9.p4" e1="DDI-DrugBank.d509.s9.e1"
            e2="DDI-DrugBank.d509.s9.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s9.p5" e1="DDI-DrugBank.d509.s9.e2"
            e2="DDI-DrugBank.d509.s9.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d509.s10" text="The effect of a higher ketoconazole dose (400 mg/day) has not been studied.">
        <entity id="DDI-DrugBank.d509.s10.e0" charOffset="23-34"
            type="drug" text="ketoconazole"/>
    </sentence>
    <sentence id="DDI-DrugBank.d509.s11" text="When concomitant administration of ketoconazole with aripiprazole occurs, aripiprazole dose should be reduced to one-half of its normal dose.">
        <entity id="DDI-DrugBank.d509.s11.e0" charOffset="35-46"
            type="drug" text="ketoconazole"/>
        <entity id="DDI-DrugBank.d509.s11.e1" charOffset="53-64"
            type="drug" text="aripiprazole"/>
        <entity id="DDI-DrugBank.d509.s11.e2" charOffset="74-85"
            type="drug" text="aripiprazole"/>
        <pair id="DDI-DrugBank.d509.s11.p0"
            e1="DDI-DrugBank.d509.s11.e0" e2="DDI-DrugBank.d509.s11.e1"
            ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d509.s11.p1"
            e1="DDI-DrugBank.d509.s11.e0" e2="DDI-DrugBank.d509.s11.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s11.p2"
            e1="DDI-DrugBank.d509.s11.e1" e2="DDI-DrugBank.d509.s11.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d509.s12" text="Other strong inhibitors of CYP3A4 (itraconazole) would be expected to have similar effects and need similar dose reductions;">
        <entity id="DDI-DrugBank.d509.s12.e0" charOffset="35-46"
            type="drug" text="itraconazole"/>
    </sentence>
    <sentence id="DDI-DrugBank.d509.s13" text="weaker inhibitors (erythromycin, grapefruit juice) have not been studied.">
        <entity id="DDI-DrugBank.d509.s13.e0" charOffset="19-30"
            type="drug" text="erythromycin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d509.s14" text="When the CYP3A4 inhibitor is withdrawn from the combination therapy, aripiprazole dose should then be increased.">
        <entity id="DDI-DrugBank.d509.s14.e0" charOffset="69-80"
            type="drug" text="aripiprazole"/>
    </sentence>
    <sentence id="DDI-DrugBank.d509.s15" text="Quinidine: Coadministration of a 10-mg single dose of aripiprazole with quinidine (166 mg/day for 13 days), a potent inhibitor of CYP2D6, increased the AUC of aripiprazole by 112% but decreased the AUC of its active metabolite, dehydroaripiprazole, by 35%.">
        <entity id="DDI-DrugBank.d509.s15.e0" charOffset="0-8"
            type="drug" text="Quinidine"/>
        <entity id="DDI-DrugBank.d509.s15.e1" charOffset="54-65"
            type="drug" text="aripiprazole"/>
        <entity id="DDI-DrugBank.d509.s15.e2" charOffset="72-80"
            type="drug" text="quinidine"/>
        <entity id="DDI-DrugBank.d509.s15.e3" charOffset="159-170"
            type="drug" text="aripiprazole"/>
        <entity id="DDI-DrugBank.d509.s15.e4" charOffset="228-246"
            type="drug_n" text="dehydroaripiprazole"/>
        <pair id="DDI-DrugBank.d509.s15.p0"
            e1="DDI-DrugBank.d509.s15.e0" e2="DDI-DrugBank.d509.s15.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s15.p1"
            e1="DDI-DrugBank.d509.s15.e0" e2="DDI-DrugBank.d509.s15.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s15.p2"
            e1="DDI-DrugBank.d509.s15.e0" e2="DDI-DrugBank.d509.s15.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s15.p3"
            e1="DDI-DrugBank.d509.s15.e0" e2="DDI-DrugBank.d509.s15.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s15.p4"
            e1="DDI-DrugBank.d509.s15.e1" e2="DDI-DrugBank.d509.s15.e2"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d509.s15.p5"
            e1="DDI-DrugBank.d509.s15.e1" e2="DDI-DrugBank.d509.s15.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s15.p6"
            e1="DDI-DrugBank.d509.s15.e1" e2="DDI-DrugBank.d509.s15.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s15.p7"
            e1="DDI-DrugBank.d509.s15.e2" e2="DDI-DrugBank.d509.s15.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s15.p8"
            e1="DDI-DrugBank.d509.s15.e2" e2="DDI-DrugBank.d509.s15.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s15.p9"
            e1="DDI-DrugBank.d509.s15.e3" e2="DDI-DrugBank.d509.s15.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d509.s16" text="Aripiprazole dose should be reduced to one-half of its normal dose when concomitant administration of quinidine with aripiprazole occurs.">
        <entity id="DDI-DrugBank.d509.s16.e0" charOffset="0-11"
            type="drug" text="Aripiprazole"/>
        <entity id="DDI-DrugBank.d509.s16.e1" charOffset="102-110"
            type="drug" text="quinidine"/>
        <entity id="DDI-DrugBank.d509.s16.e2" charOffset="117-128"
            type="drug" text="aripiprazole"/>
        <pair id="DDI-DrugBank.d509.s16.p0"
            e1="DDI-DrugBank.d509.s16.e0" e2="DDI-DrugBank.d509.s16.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s16.p1"
            e1="DDI-DrugBank.d509.s16.e0" e2="DDI-DrugBank.d509.s16.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s16.p2"
            e1="DDI-DrugBank.d509.s16.e1" e2="DDI-DrugBank.d509.s16.e2"
            ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d509.s17" text="Other significant inhibitors of CYP2D6, such as fluoxetine or paroxetine, would be expected to have similar effects and, therefore, should be accompanied by similar dose reductions.">
        <entity id="DDI-DrugBank.d509.s17.e0" charOffset="48-57"
            type="drug" text="fluoxetine"/>
        <entity id="DDI-DrugBank.d509.s17.e1" charOffset="62-71"
            type="drug" text="paroxetine"/>
        <pair id="DDI-DrugBank.d509.s17.p0"
            e1="DDI-DrugBank.d509.s17.e0" e2="DDI-DrugBank.d509.s17.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d509.s18" text="When the CYP2D6 inhibitor is withdrawn from the combination therapy, aripiprazole dose should then be increased.">
        <entity id="DDI-DrugBank.d509.s18.e0" charOffset="69-80"
            type="drug" text="aripiprazole"/>
    </sentence>
    <sentence id="DDI-DrugBank.d509.s19" text="Carbamazepine: Coadministration of carbamazepine (200 mg BID), a potent CYP3A4 inducer, with aripiprazole (30 mg QD) resulted in an approximate 70% decrease in Cmax and AUC values of both aripiprazole and its active metabolite, dehydro-aripiprazole.">
        <entity id="DDI-DrugBank.d509.s19.e0" charOffset="0-12"
            type="drug" text="Carbamazepine"/>
        <entity id="DDI-DrugBank.d509.s19.e1" charOffset="35-47"
            type="drug" text="carbamazepine"/>
        <entity id="DDI-DrugBank.d509.s19.e2" charOffset="93-104"
            type="drug" text="aripiprazole"/>
        <entity id="DDI-DrugBank.d509.s19.e3" charOffset="188-199"
            type="drug" text="aripiprazole"/>
        <entity id="DDI-DrugBank.d509.s19.e4" charOffset="228-247"
            type="drug_n" text="dehydro-aripiprazole"/>
        <pair id="DDI-DrugBank.d509.s19.p0"
            e1="DDI-DrugBank.d509.s19.e0" e2="DDI-DrugBank.d509.s19.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s19.p1"
            e1="DDI-DrugBank.d509.s19.e0" e2="DDI-DrugBank.d509.s19.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s19.p2"
            e1="DDI-DrugBank.d509.s19.e0" e2="DDI-DrugBank.d509.s19.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s19.p3"
            e1="DDI-DrugBank.d509.s19.e0" e2="DDI-DrugBank.d509.s19.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s19.p4"
            e1="DDI-DrugBank.d509.s19.e1" e2="DDI-DrugBank.d509.s19.e2"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d509.s19.p5"
            e1="DDI-DrugBank.d509.s19.e1" e2="DDI-DrugBank.d509.s19.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s19.p6"
            e1="DDI-DrugBank.d509.s19.e1" e2="DDI-DrugBank.d509.s19.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s19.p7"
            e1="DDI-DrugBank.d509.s19.e2" e2="DDI-DrugBank.d509.s19.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s19.p8"
            e1="DDI-DrugBank.d509.s19.e2" e2="DDI-DrugBank.d509.s19.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s19.p9"
            e1="DDI-DrugBank.d509.s19.e3" e2="DDI-DrugBank.d509.s19.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d509.s20" text="When carbamazepine is added to aripiprazole therapy, aripiprazole dose should be doubled.">
        <entity id="DDI-DrugBank.d509.s20.e0" charOffset="5-17"
            type="drug" text="carbamazepine"/>
        <entity id="DDI-DrugBank.d509.s20.e1" charOffset="31-42"
            type="drug" text="aripiprazole"/>
        <entity id="DDI-DrugBank.d509.s20.e2" charOffset="53-64"
            type="drug" text="aripiprazole"/>
        <pair id="DDI-DrugBank.d509.s20.p0"
            e1="DDI-DrugBank.d509.s20.e0" e2="DDI-DrugBank.d509.s20.e1"
            ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d509.s20.p1"
            e1="DDI-DrugBank.d509.s20.e0" e2="DDI-DrugBank.d509.s20.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s20.p2"
            e1="DDI-DrugBank.d509.s20.e1" e2="DDI-DrugBank.d509.s20.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d509.s21" text="Additional dose increases should be based on clinical evaluation."/>
    <sentence id="DDI-DrugBank.d509.s22" text="When carbamazepine is withdrawn from the combination therapy, aripiprazole dose should then be reduced.">
        <entity id="DDI-DrugBank.d509.s22.e0" charOffset="5-17"
            type="drug" text="carbamazepine"/>
        <entity id="DDI-DrugBank.d509.s22.e1" charOffset="62-73"
            type="drug" text="aripiprazole"/>
        <pair id="DDI-DrugBank.d509.s22.p0"
            e1="DDI-DrugBank.d509.s22.e0" e2="DDI-DrugBank.d509.s22.e1"
            ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d509.s23" text="No clinically significant effect of famotidine, valproate, or lithium was seen on the pharmacokinetics of aripiprazole (see CLINICAL PHARMACOLOGY: Drug- Drug Interactions).">
        <entity id="DDI-DrugBank.d509.s23.e0" charOffset="36-45"
            type="drug" text="famotidine"/>
        <entity id="DDI-DrugBank.d509.s23.e1" charOffset="48-56"
            type="drug" text="valproate"/>
        <entity id="DDI-DrugBank.d509.s23.e2" charOffset="62-68"
            type="drug" text="lithium"/>
        <entity id="DDI-DrugBank.d509.s23.e3" charOffset="106-117"
            type="drug" text="aripiprazole"/>
        <pair id="DDI-DrugBank.d509.s23.p0"
            e1="DDI-DrugBank.d509.s23.e0" e2="DDI-DrugBank.d509.s23.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s23.p1"
            e1="DDI-DrugBank.d509.s23.e0" e2="DDI-DrugBank.d509.s23.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s23.p2"
            e1="DDI-DrugBank.d509.s23.e0" e2="DDI-DrugBank.d509.s23.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s23.p3"
            e1="DDI-DrugBank.d509.s23.e1" e2="DDI-DrugBank.d509.s23.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s23.p4"
            e1="DDI-DrugBank.d509.s23.e1" e2="DDI-DrugBank.d509.s23.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s23.p5"
            e1="DDI-DrugBank.d509.s23.e2" e2="DDI-DrugBank.d509.s23.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d509.s24" text="Potential for ABILIFY to Affect Other Drugs Aripiprazole is unlikely to cause clinically important pharmacokinetic interactions with drugs metabolized by cytochrome P450 enzymes.">
        <entity id="DDI-DrugBank.d509.s24.e0" charOffset="14-20"
            type="brand" text="ABILIFY"/>
        <entity id="DDI-DrugBank.d509.s24.e1" charOffset="44-55"
            type="drug" text="Aripiprazole"/>
        <pair id="DDI-DrugBank.d509.s24.p0"
            e1="DDI-DrugBank.d509.s24.e0" e2="DDI-DrugBank.d509.s24.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d509.s25" text="In in vivo studies, 10- to 30-mg/day doses of aripiprazole had no significant effect on metabolism by CYP2D6 (dextromethorphan), CYP2C9 (warfarin), CYP2C19 (omeprazole, warfarin), and CYP3A4 (dextromethorphan) substrates.">
        <entity id="DDI-DrugBank.d509.s25.e0" charOffset="46-57"
            type="drug" text="aripiprazole"/>
        <entity id="DDI-DrugBank.d509.s25.e1" charOffset="110-125"
            type="drug" text="dextromethorphan"/>
        <entity id="DDI-DrugBank.d509.s25.e2" charOffset="137-144"
            type="drug" text="warfarin"/>
        <entity id="DDI-DrugBank.d509.s25.e3" charOffset="157-166"
            type="drug" text="omeprazole"/>
        <entity id="DDI-DrugBank.d509.s25.e4" charOffset="169-176"
            type="drug" text="warfarin"/>
        <entity id="DDI-DrugBank.d509.s25.e5" charOffset="192-207"
            type="drug" text="dextromethorphan"/>
        <pair id="DDI-DrugBank.d509.s25.p0"
            e1="DDI-DrugBank.d509.s25.e0" e2="DDI-DrugBank.d509.s25.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s25.p1"
            e1="DDI-DrugBank.d509.s25.e0" e2="DDI-DrugBank.d509.s25.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s25.p2"
            e1="DDI-DrugBank.d509.s25.e0" e2="DDI-DrugBank.d509.s25.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s25.p3"
            e1="DDI-DrugBank.d509.s25.e0" e2="DDI-DrugBank.d509.s25.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s25.p4"
            e1="DDI-DrugBank.d509.s25.e0" e2="DDI-DrugBank.d509.s25.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s25.p5"
            e1="DDI-DrugBank.d509.s25.e1" e2="DDI-DrugBank.d509.s25.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s25.p6"
            e1="DDI-DrugBank.d509.s25.e1" e2="DDI-DrugBank.d509.s25.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s25.p7"
            e1="DDI-DrugBank.d509.s25.e1" e2="DDI-DrugBank.d509.s25.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s25.p8"
            e1="DDI-DrugBank.d509.s25.e1" e2="DDI-DrugBank.d509.s25.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s25.p9"
            e1="DDI-DrugBank.d509.s25.e2" e2="DDI-DrugBank.d509.s25.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s25.p10"
            e1="DDI-DrugBank.d509.s25.e2" e2="DDI-DrugBank.d509.s25.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s25.p11"
            e1="DDI-DrugBank.d509.s25.e2" e2="DDI-DrugBank.d509.s25.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s25.p12"
            e1="DDI-DrugBank.d509.s25.e3" e2="DDI-DrugBank.d509.s25.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s25.p13"
            e1="DDI-DrugBank.d509.s25.e3" e2="DDI-DrugBank.d509.s25.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s25.p14"
            e1="DDI-DrugBank.d509.s25.e4" e2="DDI-DrugBank.d509.s25.e5" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d509.s26" text="Additionally, aripiprazole and dehydroaripiprazole did not show potential for altering CYP1A2-mediated metabolism in vitro.">
        <entity id="DDI-DrugBank.d509.s26.e0" charOffset="14-25"
            type="drug" text="aripiprazole"/>
        <entity id="DDI-DrugBank.d509.s26.e1" charOffset="31-49"
            type="drug_n" text="dehydroaripiprazole"/>
        <pair id="DDI-DrugBank.d509.s26.p0"
            e1="DDI-DrugBank.d509.s26.e0" e2="DDI-DrugBank.d509.s26.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d509.s27" text="Alcohol: There was no significant difference between aripiprazole coadministered with ethanol and placebo coadministered with ethanol on performance of gross motor skills or stimulus response in healthy subjects.">
        <entity id="DDI-DrugBank.d509.s27.e0" charOffset="0-6"
            type="drug" text="Alcohol"/>
        <entity id="DDI-DrugBank.d509.s27.e1" charOffset="53-64"
            type="drug" text="aripiprazole"/>
        <entity id="DDI-DrugBank.d509.s27.e2" charOffset="86-92"
            type="drug" text="ethanol"/>
        <entity id="DDI-DrugBank.d509.s27.e3" charOffset="126-132"
            type="drug" text="ethanol"/>
        <pair id="DDI-DrugBank.d509.s27.p0"
            e1="DDI-DrugBank.d509.s27.e0" e2="DDI-DrugBank.d509.s27.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s27.p1"
            e1="DDI-DrugBank.d509.s27.e0" e2="DDI-DrugBank.d509.s27.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s27.p2"
            e1="DDI-DrugBank.d509.s27.e0" e2="DDI-DrugBank.d509.s27.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s27.p3"
            e1="DDI-DrugBank.d509.s27.e1" e2="DDI-DrugBank.d509.s27.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s27.p4"
            e1="DDI-DrugBank.d509.s27.e1" e2="DDI-DrugBank.d509.s27.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d509.s27.p5"
            e1="DDI-DrugBank.d509.s27.e2" e2="DDI-DrugBank.d509.s27.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d509.s28" text="As with most psychoactive medications, patients should be advised to avoid alcohol while taking ABILIFY">
        <entity id="DDI-DrugBank.d509.s28.e0" charOffset="75-81"
            type="drug" text="alcohol"/>
        <entity id="DDI-DrugBank.d509.s28.e1" charOffset="96-102"
            type="brand" text="ABILIFY"/>
        <pair id="DDI-DrugBank.d509.s28.p0"
            e1="DDI-DrugBank.d509.s28.e0" e2="DDI-DrugBank.d509.s28.e1"
            ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d509.s29" text="."/>
    <sentence id="DDI-DrugBank.d509.s30" text=""/>
</document>
<document id="DDI-DrugBank.d109">
    <sentence id="DDI-DrugBank.d109.s0" text="Ketoconazole/Itraconazole, Macrolides, Including Erythromycin">
        <entity id="DDI-DrugBank.d109.s0.e0" charOffset="0-11"
            type="drug" text="Ketoconazole"/>
        <entity id="DDI-DrugBank.d109.s0.e1" charOffset="13-24"
            type="drug" text="Itraconazole"/>
        <entity id="DDI-DrugBank.d109.s0.e2" charOffset="27-36"
            type="group" text="Macrolides"/>
        <entity id="DDI-DrugBank.d109.s0.e3" charOffset="49-60"
            type="drug" text="Erythromycin"/>
        <pair id="DDI-DrugBank.d109.s0.p0" e1="DDI-DrugBank.d109.s0.e0"
            e2="DDI-DrugBank.d109.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d109.s0.p1" e1="DDI-DrugBank.d109.s0.e0"
            e2="DDI-DrugBank.d109.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d109.s0.p2" e1="DDI-DrugBank.d109.s0.e0"
            e2="DDI-DrugBank.d109.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d109.s0.p3" e1="DDI-DrugBank.d109.s0.e1"
            e2="DDI-DrugBank.d109.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d109.s0.p4" e1="DDI-DrugBank.d109.s0.e1"
            e2="DDI-DrugBank.d109.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d109.s0.p5" e1="DDI-DrugBank.d109.s0.e2"
            e2="DDI-DrugBank.d109.s0.e3" ddi="false"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d73">
    <sentence id="DDI-DrugBank.d73.s0" text="Catecholamine-depleting drugs (eg, reserpine) may have an additive effect when given with beta-blocking agents.">
        <entity id="DDI-DrugBank.d73.s0.e0" charOffset="35-43"
            type="drug" text="reserpine"/>
        <entity id="DDI-DrugBank.d73.s0.e1" charOffset="90-109"
            type="group" text="beta-blocking agents"/>
        <pair id="DDI-DrugBank.d73.s0.p0" e1="DDI-DrugBank.d73.s0.e0"
            e2="DDI-DrugBank.d73.s0.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d73.s1" text="Patients treated with TENORMIN plus a catecholamine depletor should therefore be closely observed for evidence of hypotension and/or marked bradycardia which may produce vertigo, syncope, or postural hypotension.">
        <entity id="DDI-DrugBank.d73.s1.e0" charOffset="22-29"
            type="brand" text="TENORMIN"/>
    </sentence>
    <sentence id="DDI-DrugBank.d73.s2" text="Calcium channel blockers may also have an additive effect when given with TENORMIN .">
        <entity id="DDI-DrugBank.d73.s2.e0" charOffset="0-23"
            type="group" text="Calcium channel blockers"/>
        <entity id="DDI-DrugBank.d73.s2.e1" charOffset="74-81"
            type="brand" text="TENORMIN"/>
        <pair id="DDI-DrugBank.d73.s2.p0" e1="DDI-DrugBank.d73.s2.e0"
            e2="DDI-DrugBank.d73.s2.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d73.s3" text="Beta blockers may exacerbate the rebound hypertension which can follow the withdrawal of clonidine.">
        <entity id="DDI-DrugBank.d73.s3.e0" charOffset="0-12"
            type="group" text="Beta blockers"/>
        <entity id="DDI-DrugBank.d73.s3.e1" charOffset="89-97"
            type="drug" text="clonidine"/>
        <pair id="DDI-DrugBank.d73.s3.p0" e1="DDI-DrugBank.d73.s3.e0"
            e2="DDI-DrugBank.d73.s3.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d73.s4" text="If the two drugs are coadministered, the beta blocker should be withdrawn several days before the gradual withdrawal of clonidine.">
        <entity id="DDI-DrugBank.d73.s4.e0" charOffset="41-52"
            type="group" text="beta blocker"/>
        <entity id="DDI-DrugBank.d73.s4.e1" charOffset="120-128"
            type="drug" text="clonidine"/>
        <pair id="DDI-DrugBank.d73.s4.p0" e1="DDI-DrugBank.d73.s4.e0"
            e2="DDI-DrugBank.d73.s4.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d73.s5" text="If replacing clonidine by beta-blocker therapy, the introduction of beta blockers should be delayed for several days after clonidine administration has stopped.">
        <entity id="DDI-DrugBank.d73.s5.e0" charOffset="13-21"
            type="drug" text="clonidine"/>
        <entity id="DDI-DrugBank.d73.s5.e1" charOffset="26-37"
            type="group" text="beta-blocker"/>
        <entity id="DDI-DrugBank.d73.s5.e2" charOffset="68-80"
            type="group" text="beta blockers"/>
        <entity id="DDI-DrugBank.d73.s5.e3" charOffset="123-131"
            type="drug" text="clonidine"/>
        <pair id="DDI-DrugBank.d73.s5.p0" e1="DDI-DrugBank.d73.s5.e0"
            e2="DDI-DrugBank.d73.s5.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d73.s5.p1" e1="DDI-DrugBank.d73.s5.e0"
            e2="DDI-DrugBank.d73.s5.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d73.s5.p2" e1="DDI-DrugBank.d73.s5.e0"
            e2="DDI-DrugBank.d73.s5.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d73.s5.p3" e1="DDI-DrugBank.d73.s5.e1"
            e2="DDI-DrugBank.d73.s5.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d73.s5.p4" e1="DDI-DrugBank.d73.s5.e1"
            e2="DDI-DrugBank.d73.s5.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d73.s5.p5" e1="DDI-DrugBank.d73.s5.e2"
            e2="DDI-DrugBank.d73.s5.e3" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d73.s6" text="Concomitant use of prostaglandin synthase inhibiting drugs, eg, indomethacin, may decrease the hypotensive effects of beta blockers.">
        <entity id="DDI-DrugBank.d73.s6.e0" charOffset="64-75"
            type="drug" text="indomethacin"/>
        <entity id="DDI-DrugBank.d73.s6.e1" charOffset="118-130"
            type="group" text="beta blockers"/>
        <pair id="DDI-DrugBank.d73.s6.p0" e1="DDI-DrugBank.d73.s6.e0"
            e2="DDI-DrugBank.d73.s6.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d73.s7" text="Information on concurrent usage of atenolol and aspirin is limited.">
        <entity id="DDI-DrugBank.d73.s7.e0" charOffset="35-42"
            type="drug" text="atenolol"/>
        <entity id="DDI-DrugBank.d73.s7.e1" charOffset="48-54"
            type="brand" text="aspirin"/>
        <pair id="DDI-DrugBank.d73.s7.p0" e1="DDI-DrugBank.d73.s7.e0"
            e2="DDI-DrugBank.d73.s7.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d73.s8" text="Data from several studies, ie, TIMI-II, ISIS-2, currently do not suggest any clinical interaction between aspirin and beta blockers in the acute myocardial infarction setting.">
        <entity id="DDI-DrugBank.d73.s8.e0" charOffset="106-112"
            type="brand" text="aspirin"/>
        <entity id="DDI-DrugBank.d73.s8.e1" charOffset="118-130"
            type="group" text="beta blockers"/>
        <pair id="DDI-DrugBank.d73.s8.p0" e1="DDI-DrugBank.d73.s8.e0"
            e2="DDI-DrugBank.d73.s8.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d73.s9" text="While taking beta blockers, patients with a history of anaphylactic reaction to a variety of allergens may have a more severe reaction on repeated challenge, either accidental, diagnostic or therapeutic.">
        <entity id="DDI-DrugBank.d73.s9.e0" charOffset="13-25"
            type="group" text="beta blockers"/>
    </sentence>
    <sentence id="DDI-DrugBank.d73.s10" text="Such patients may be unresponsive to the usual doses of epinephrine used to treat the allergic reaction.">
        <entity id="DDI-DrugBank.d73.s10.e0" charOffset="56-66"
            type="drug" text="epinephrine"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d383">
    <sentence id="DDI-DrugBank.d383.s0" text="No information provided"/>
</document>
<document id="DDI-DrugBank.d489">
    <sentence id="DDI-DrugBank.d489.s0" text="The following drugs have been coadministered with Kerlone and have not altered its pharmacokinetics: cimetidine, nifedipine, chlorthalidone, and hydrochlorothiazide.">
        <entity id="DDI-DrugBank.d489.s0.e0" charOffset="50-56"
            type="brand" text="Kerlone"/>
        <entity id="DDI-DrugBank.d489.s0.e1" charOffset="101-110"
            type="drug" text="cimetidine"/>
        <entity id="DDI-DrugBank.d489.s0.e2" charOffset="113-122"
            type="drug" text="nifedipine"/>
        <entity id="DDI-DrugBank.d489.s0.e3" charOffset="125-138"
            type="drug" text="chlorthalidone"/>
        <entity id="DDI-DrugBank.d489.s0.e4" charOffset="145-163"
            type="drug" text="hydrochlorothiazide"/>
        <pair id="DDI-DrugBank.d489.s0.p0" e1="DDI-DrugBank.d489.s0.e0"
            e2="DDI-DrugBank.d489.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d489.s0.p1" e1="DDI-DrugBank.d489.s0.e0"
            e2="DDI-DrugBank.d489.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d489.s0.p2" e1="DDI-DrugBank.d489.s0.e0"
            e2="DDI-DrugBank.d489.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d489.s0.p3" e1="DDI-DrugBank.d489.s0.e0"
            e2="DDI-DrugBank.d489.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d489.s0.p4" e1="DDI-DrugBank.d489.s0.e1"
            e2="DDI-DrugBank.d489.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d489.s0.p5" e1="DDI-DrugBank.d489.s0.e1"
            e2="DDI-DrugBank.d489.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d489.s0.p6" e1="DDI-DrugBank.d489.s0.e1"
            e2="DDI-DrugBank.d489.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d489.s0.p7" e1="DDI-DrugBank.d489.s0.e2"
            e2="DDI-DrugBank.d489.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d489.s0.p8" e1="DDI-DrugBank.d489.s0.e2"
            e2="DDI-DrugBank.d489.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d489.s0.p9" e1="DDI-DrugBank.d489.s0.e3"
            e2="DDI-DrugBank.d489.s0.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d489.s1" text="Concomitant administration of Kerlone with the oral anticoagulant warfarin has been shown not to potentiate the anticoagulant effect of warfarin.">
        <entity id="DDI-DrugBank.d489.s1.e0" charOffset="30-36"
            type="brand" text="Kerlone"/>
        <entity id="DDI-DrugBank.d489.s1.e1" charOffset="52-64"
            type="group" text="anticoagulant"/>
        <entity id="DDI-DrugBank.d489.s1.e2" charOffset="66-73"
            type="drug" text="warfarin"/>
        <entity id="DDI-DrugBank.d489.s1.e3" charOffset="136-143"
            type="drug" text="warfarin"/>
        <pair id="DDI-DrugBank.d489.s1.p0" e1="DDI-DrugBank.d489.s1.e0"
            e2="DDI-DrugBank.d489.s1.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d489.s1.p1" e1="DDI-DrugBank.d489.s1.e0"
            e2="DDI-DrugBank.d489.s1.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d489.s1.p2" e1="DDI-DrugBank.d489.s1.e0"
            e2="DDI-DrugBank.d489.s1.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d489.s1.p3" e1="DDI-DrugBank.d489.s1.e1"
            e2="DDI-DrugBank.d489.s1.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d489.s1.p4" e1="DDI-DrugBank.d489.s1.e1"
            e2="DDI-DrugBank.d489.s1.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d489.s1.p5" e1="DDI-DrugBank.d489.s1.e2"
            e2="DDI-DrugBank.d489.s1.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d489.s2" text="Catecholamine-depleting drugs (e.g., reserpine) may have an additive effect when given with beta-blocking agents.">
        <entity id="DDI-DrugBank.d489.s2.e0" charOffset="37-45"
            type="drug" text="reserpine"/>
        <entity id="DDI-DrugBank.d489.s2.e1" charOffset="92-104"
            type="drug" text="beta-blocking"/>
        <pair id="DDI-DrugBank.d489.s2.p0" e1="DDI-DrugBank.d489.s2.e0"
            e2="DDI-DrugBank.d489.s2.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d489.s3" text="Patients treated with a beta-adrenergic receptor blocking agent plus a catecholamine depletor should therefore be closely observed for evidence of hypotension or marked bradycardia, which may produce vertigo, syncope, or postural hypotension.">
        <entity id="DDI-DrugBank.d489.s3.e0" charOffset="24-62"
            type="group" text="beta-adrenergic receptor blocking agent"/>
    </sentence>
    <sentence id="DDI-DrugBank.d489.s4" text="Should it be decided to discontinue therapy in patients receiving beta-blockers and clonidine concurrently, the beta-blocker should be discontinued slowly over several days before the gradual withdrawal of clonidine.">
        <entity id="DDI-DrugBank.d489.s4.e0" charOffset="66-78"
            type="group" text="beta-blockers"/>
        <entity id="DDI-DrugBank.d489.s4.e1" charOffset="84-92"
            type="drug" text="clonidine"/>
        <entity id="DDI-DrugBank.d489.s4.e2" charOffset="112-123"
            type="group" text="beta-blocker"/>
        <entity id="DDI-DrugBank.d489.s4.e3" charOffset="206-214"
            type="drug" text="clonidine"/>
        <pair id="DDI-DrugBank.d489.s4.p0" e1="DDI-DrugBank.d489.s4.e0"
            e2="DDI-DrugBank.d489.s4.e1" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d489.s4.p1" e1="DDI-DrugBank.d489.s4.e0"
            e2="DDI-DrugBank.d489.s4.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d489.s4.p2" e1="DDI-DrugBank.d489.s4.e0"
            e2="DDI-DrugBank.d489.s4.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d489.s4.p3" e1="DDI-DrugBank.d489.s4.e1"
            e2="DDI-DrugBank.d489.s4.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d489.s4.p4" e1="DDI-DrugBank.d489.s4.e1"
            e2="DDI-DrugBank.d489.s4.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d489.s4.p5" e1="DDI-DrugBank.d489.s4.e2"
            e2="DDI-DrugBank.d489.s4.e3" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d489.s5" text="Literature reports suggest that oral calcium antagonists may be used in combination with beta-adrenergic blocking agents when heart function is normal, but should be avoided in patients with impaired cardiac function.">
        <entity id="DDI-DrugBank.d489.s5.e0" charOffset="37-55"
            type="group" text="calcium antagonists"/>
        <entity id="DDI-DrugBank.d489.s5.e1" charOffset="89-119"
            type="group" text="beta-adrenergic blocking agents"/>
        <pair id="DDI-DrugBank.d489.s5.p0" e1="DDI-DrugBank.d489.s5.e0"
            e2="DDI-DrugBank.d489.s5.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d489.s6" text="Hypotension, AV conduction disturbances, and left ventricular failure have been reported in some patients receiving beta-adrenergic blocking agents when an oral calcium antagonist was added to the treatment regimen.">
        <entity id="DDI-DrugBank.d489.s6.e0" charOffset="116-146"
            type="group" text="beta-adrenergic blocking agents"/>
        <entity id="DDI-DrugBank.d489.s6.e1" charOffset="161-178"
            type="group" text="calcium antagonist"/>
        <pair id="DDI-DrugBank.d489.s6.p0" e1="DDI-DrugBank.d489.s6.e0"
            e2="DDI-DrugBank.d489.s6.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d489.s7" text="Hypotension was more likely to occur if the calcium antagonist were a dihydropyridine derivative, e.g., nifedipine, while left ventricular failure and AV conduction disturbances, including complete heart block, were more likely to occur with either verapamil or diltiazem.">
        <entity id="DDI-DrugBank.d489.s7.e0" charOffset="44-61"
            type="group" text="calcium antagonist"/>
        <entity id="DDI-DrugBank.d489.s7.e1" charOffset="70-95"
            type="group" text="dihydropyridine derivative"/>
        <entity id="DDI-DrugBank.d489.s7.e2" charOffset="104-113"
            type="drug" text="nifedipine"/>
        <entity id="DDI-DrugBank.d489.s7.e3" charOffset="249-257"
            type="drug" text="verapamil"/>
        <entity id="DDI-DrugBank.d489.s7.e4" charOffset="262-270"
            type="drug" text="diltiazem"/>
        <pair id="DDI-DrugBank.d489.s7.p0" e1="DDI-DrugBank.d489.s7.e0"
            e2="DDI-DrugBank.d489.s7.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d489.s7.p1" e1="DDI-DrugBank.d489.s7.e0"
            e2="DDI-DrugBank.d489.s7.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d489.s7.p2" e1="DDI-DrugBank.d489.s7.e0"
            e2="DDI-DrugBank.d489.s7.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d489.s7.p3" e1="DDI-DrugBank.d489.s7.e0"
            e2="DDI-DrugBank.d489.s7.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d489.s7.p4" e1="DDI-DrugBank.d489.s7.e1"
            e2="DDI-DrugBank.d489.s7.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d489.s7.p5" e1="DDI-DrugBank.d489.s7.e1"
            e2="DDI-DrugBank.d489.s7.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d489.s7.p6" e1="DDI-DrugBank.d489.s7.e1"
            e2="DDI-DrugBank.d489.s7.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d489.s7.p7" e1="DDI-DrugBank.d489.s7.e2"
            e2="DDI-DrugBank.d489.s7.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d489.s7.p8" e1="DDI-DrugBank.d489.s7.e2"
            e2="DDI-DrugBank.d489.s7.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d489.s7.p9" e1="DDI-DrugBank.d489.s7.e3"
            e2="DDI-DrugBank.d489.s7.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d489.s8" text="Risk of Anaphylactic Reaction: Although it is known that patients on beta-blockers may be refractory to epinephrine in the treatment of anaphylactic shock, beta-blockers can, in addition, interfere with the modulation of allergic reaction and lead to an increased severity and/or frequency of attacks.">
        <entity id="DDI-DrugBank.d489.s8.e0" charOffset="69-81"
            type="group" text="beta-blockers"/>
        <entity id="DDI-DrugBank.d489.s8.e1" charOffset="104-114"
            type="drug" text="epinephrine"/>
        <entity id="DDI-DrugBank.d489.s8.e2" charOffset="156-168"
            type="group" text="beta-blockers"/>
        <pair id="DDI-DrugBank.d489.s8.p0" e1="DDI-DrugBank.d489.s8.e0"
            e2="DDI-DrugBank.d489.s8.e1" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d489.s8.p1" e1="DDI-DrugBank.d489.s8.e0"
            e2="DDI-DrugBank.d489.s8.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d489.s8.p2" e1="DDI-DrugBank.d489.s8.e1"
            e2="DDI-DrugBank.d489.s8.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d489.s9" text="Severe allergic reactions including anaphylaxis have been reported in patients exposed to a variety of allergens either by repeated challenge, or accidental contact, and with diagnostic or therapeutic agents while receiving beta-blockers.">
        <entity id="DDI-DrugBank.d489.s9.e0" charOffset="224-236"
            type="group" text="beta-blockers"/>
    </sentence>
    <sentence id="DDI-DrugBank.d489.s10" text="Such patients may be unresponsive to the usual doses of epinephrine used to treat allergic reaction.">
        <entity id="DDI-DrugBank.d489.s10.e0" charOffset="56-66"
            type="drug" text="epinephrine"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d497">
    <sentence id="DDI-DrugBank.d497.s0" text="AZOPT (brinzolamide ophthalmic suspension) 1% contains a carbonic anhydrase inhibitor.">
        <entity id="DDI-DrugBank.d497.s0.e0" charOffset="0-4"
            type="brand" text="AZOPT"/>
        <entity id="DDI-DrugBank.d497.s0.e1" charOffset="7-18"
            type="drug" text="brinzolamide"/>
        <entity id="DDI-DrugBank.d497.s0.e2" charOffset="57-84"
            type="group" text="carbonic anhydrase inhibitor"/>
        <pair id="DDI-DrugBank.d497.s0.p0" e1="DDI-DrugBank.d497.s0.e0"
            e2="DDI-DrugBank.d497.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d497.s0.p1" e1="DDI-DrugBank.d497.s0.e0"
            e2="DDI-DrugBank.d497.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d497.s0.p2" e1="DDI-DrugBank.d497.s0.e1"
            e2="DDI-DrugBank.d497.s0.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d497.s1" text="Acid-base and electrolyte alterations were not reported in the clinical trials with brinzolamide.">
        <entity id="DDI-DrugBank.d497.s1.e0" charOffset="84-95"
            type="drug" text="brinzolamide"/>
    </sentence>
    <sentence id="DDI-DrugBank.d497.s2" text="However, in patients treated with oral carbonic anhydrase inhibitors, rare instances of drug interactions have occurred with high-dose salicylate therapy.">
        <entity id="DDI-DrugBank.d497.s2.e0" charOffset="39-67"
            type="group" text="carbonic anhydrase inhibitors"/>
        <entity id="DDI-DrugBank.d497.s2.e1" charOffset="135-144"
            type="drug" text="salicylate"/>
        <pair id="DDI-DrugBank.d497.s2.p0" e1="DDI-DrugBank.d497.s2.e0"
            e2="DDI-DrugBank.d497.s2.e1" ddi="true" type="int"/>
    </sentence>
    <sentence id="DDI-DrugBank.d497.s3" text="Therefore, the potential for such drug interaction should be considered in patients receiving AZOPT (brinzolamide ophthalmic suspension) 1%.">
        <entity id="DDI-DrugBank.d497.s3.e0" charOffset="94-98"
            type="brand" text="AZOPT"/>
        <entity id="DDI-DrugBank.d497.s3.e1" charOffset="101-112"
            type="drug" text="brinzolamide"/>
        <pair id="DDI-DrugBank.d497.s3.p0" e1="DDI-DrugBank.d497.s3.e0"
            e2="DDI-DrugBank.d497.s3.e1" ddi="false"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d153">
    <sentence id="DDI-DrugBank.d153.s0" text="The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.">
        <entity id="DDI-DrugBank.d153.s0.e0" charOffset="28-47"
            type="group" text="anesthetic solutions"/>
        <entity id="DDI-DrugBank.d153.s0.e1" charOffset="60-70"
            type="drug" text="epinephrine"/>
        <entity id="DDI-DrugBank.d153.s0.e2" charOffset="75-88"
            type="drug" text="norepinephrine"/>
        <entity id="DDI-DrugBank.d153.s0.e3" charOffset="112-139"
            type="group" text="monoamine oxidase inhibitors"/>
        <entity id="DDI-DrugBank.d153.s0.e4" charOffset="144-168"
            type="group" text="tricyclic antidepressants"/>
        <pair id="DDI-DrugBank.d153.s0.p0" e1="DDI-DrugBank.d153.s0.e0"
            e2="DDI-DrugBank.d153.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d153.s0.p1" e1="DDI-DrugBank.d153.s0.e0"
            e2="DDI-DrugBank.d153.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d153.s0.p2" e1="DDI-DrugBank.d153.s0.e0"
            e2="DDI-DrugBank.d153.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d153.s0.p3" e1="DDI-DrugBank.d153.s0.e0"
            e2="DDI-DrugBank.d153.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d153.s0.p4" e1="DDI-DrugBank.d153.s0.e1"
            e2="DDI-DrugBank.d153.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d153.s0.p5" e1="DDI-DrugBank.d153.s0.e1"
            e2="DDI-DrugBank.d153.s0.e3" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d153.s0.p6" e1="DDI-DrugBank.d153.s0.e1"
            e2="DDI-DrugBank.d153.s0.e4" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d153.s0.p7" e1="DDI-DrugBank.d153.s0.e2"
            e2="DDI-DrugBank.d153.s0.e3" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d153.s0.p8" e1="DDI-DrugBank.d153.s0.e2"
            e2="DDI-DrugBank.d153.s0.e4" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d153.s0.p9" e1="DDI-DrugBank.d153.s0.e3"
            e2="DDI-DrugBank.d153.s0.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d153.s1" text="Concurrent use of these agents should generally be avoided."/>
    <sentence id="DDI-DrugBank.d153.s2" text="In situations in which concurrent therapy is necessary, careful patient monitoring is essential."/>
    <sentence id="DDI-DrugBank.d153.s3" text="Concurrent administration of vasopressor drugs and of ergot-type oxytocic drugs may cause severe, persistent hypertension or cerebrovascular accidents.">
        <entity id="DDI-DrugBank.d153.s3.e0" charOffset="29-45"
            type="group" text="vasopressor drugs"/>
        <entity id="DDI-DrugBank.d153.s3.e1" charOffset="54-78"
            type="group" text="ergot-type oxytocic drugs"/>
        <pair id="DDI-DrugBank.d153.s3.p0" e1="DDI-DrugBank.d153.s3.e0"
            e2="DDI-DrugBank.d153.s3.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d153.s4" text="Phenothiazines and butyrophenones may reduce or reverse the pressor effect of epinephrine.">
        <entity id="DDI-DrugBank.d153.s4.e0" charOffset="0-13"
            type="group" text="Phenothiazines"/>
        <entity id="DDI-DrugBank.d153.s4.e1" charOffset="19-32"
            type="group" text="butyrophenones"/>
        <entity id="DDI-DrugBank.d153.s4.e2" charOffset="78-88"
            type="drug" text="epinephrine"/>
        <pair id="DDI-DrugBank.d153.s4.p0" e1="DDI-DrugBank.d153.s4.e0"
            e2="DDI-DrugBank.d153.s4.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d153.s4.p1" e1="DDI-DrugBank.d153.s4.e0"
            e2="DDI-DrugBank.d153.s4.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d153.s4.p2" e1="DDI-DrugBank.d153.s4.e1"
            e2="DDI-DrugBank.d153.s4.e2" ddi="true" type="effect"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d213">
    <sentence id="DDI-DrugBank.d213.s0" text="Iodine or iodine excess may decrease the effect of Carbimazole, and an iodine deficiency can increase the effect of Carbimazole.">
        <entity id="DDI-DrugBank.d213.s0.e0" charOffset="0-5"
            type="drug" text="Iodine"/>
        <entity id="DDI-DrugBank.d213.s0.e1" charOffset="10-15"
            type="drug" text="iodine"/>
        <entity id="DDI-DrugBank.d213.s0.e2" charOffset="51-61"
            type="drug" text="Carbimazole"/>
        <entity id="DDI-DrugBank.d213.s0.e3" charOffset="71-76"
            type="drug" text="iodine"/>
        <entity id="DDI-DrugBank.d213.s0.e4" charOffset="116-126"
            type="drug" text="Carbimazole"/>
        <pair id="DDI-DrugBank.d213.s0.p0" e1="DDI-DrugBank.d213.s0.e0"
            e2="DDI-DrugBank.d213.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d213.s0.p1" e1="DDI-DrugBank.d213.s0.e0"
            e2="DDI-DrugBank.d213.s0.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d213.s0.p2" e1="DDI-DrugBank.d213.s0.e0"
            e2="DDI-DrugBank.d213.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d213.s0.p3" e1="DDI-DrugBank.d213.s0.e0"
            e2="DDI-DrugBank.d213.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d213.s0.p4" e1="DDI-DrugBank.d213.s0.e1"
            e2="DDI-DrugBank.d213.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d213.s0.p5" e1="DDI-DrugBank.d213.s0.e1"
            e2="DDI-DrugBank.d213.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d213.s0.p6" e1="DDI-DrugBank.d213.s0.e1"
            e2="DDI-DrugBank.d213.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d213.s0.p7" e1="DDI-DrugBank.d213.s0.e2"
            e2="DDI-DrugBank.d213.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d213.s0.p8" e1="DDI-DrugBank.d213.s0.e2"
            e2="DDI-DrugBank.d213.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d213.s0.p9" e1="DDI-DrugBank.d213.s0.e3"
            e2="DDI-DrugBank.d213.s0.e4" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d213.s1" text="Serum concentration of digoxin and digitoxin may increase when patients take antithyroid agents.">
        <entity id="DDI-DrugBank.d213.s1.e0" charOffset="23-29"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d213.s1.e1" charOffset="35-43"
            type="drug" text="digitoxin"/>
        <entity id="DDI-DrugBank.d213.s1.e2" charOffset="77-94"
            type="group" text="antithyroid agents"/>
        <pair id="DDI-DrugBank.d213.s1.p0" e1="DDI-DrugBank.d213.s1.e0"
            e2="DDI-DrugBank.d213.s1.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d213.s1.p1" e1="DDI-DrugBank.d213.s1.e0"
            e2="DDI-DrugBank.d213.s1.e2" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d213.s1.p2" e1="DDI-DrugBank.d213.s1.e1"
            e2="DDI-DrugBank.d213.s1.e2" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d213.s2" text="A decrease of the dosage may be necessary when patient becomes euthyroid."/>
    <sentence id="DDI-DrugBank.d213.s3" text="Antithyroid agents may decrease thyroidal uptake of sodium iodide I131, a rebound in uptake may occur up to 5 days after sudden withdrawal of Carbimazole.">
        <entity id="DDI-DrugBank.d213.s3.e0" charOffset="0-17"
            type="group" text="Antithyroid agents"/>
        <entity id="DDI-DrugBank.d213.s3.e1" charOffset="52-69"
            type="drug" text="sodium iodide I131"/>
        <entity id="DDI-DrugBank.d213.s3.e2" charOffset="142-152"
            type="drug" text="Carbimazole"/>
        <pair id="DDI-DrugBank.d213.s3.p0" e1="DDI-DrugBank.d213.s3.e0"
            e2="DDI-DrugBank.d213.s3.e1" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d213.s3.p1" e1="DDI-DrugBank.d213.s3.e0"
            e2="DDI-DrugBank.d213.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d213.s3.p2" e1="DDI-DrugBank.d213.s3.e1"
            e2="DDI-DrugBank.d213.s3.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d213.s4" text="Patients response to oral anticoagulants may be affected by his/her thyroid and metabolic status.">
        <entity id="DDI-DrugBank.d213.s4.e0" charOffset="26-39"
            type="group" text="anticoagulants"/>
    </sentence>
    <sentence id="DDI-DrugBank.d213.s5" text="An evaluation of prothrombin time and an adjustment of anticoagulant dosage are recommended">
        <entity id="DDI-DrugBank.d213.s5.e0" charOffset="55-67"
            type="group" text="anticoagulant"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d520">
    <sentence id="DDI-DrugBank.d520.s0" text="The renal effects of nephrotoxic compounds may be potentiated by Carboplatin.">
        <entity id="DDI-DrugBank.d520.s0.e0" charOffset="65-75"
            type="drug" text="Carboplatin"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d269">
    <sentence id="DDI-DrugBank.d269.s0" text="Inhibitors of CYP2D6;"/>
    <sentence id="DDI-DrugBank.d269.s1" text="poor metabolizers of debrisoquin: Interactions of carvedilol with strong inhibitors of CYP2D6 (such as quinidine, fluoxetine, paroxetine, and propafenone) have not been studied, but these drugs would be expected to increase blood levels of the R(+) enantiomer of carvedilol .">
        <entity id="DDI-DrugBank.d269.s1.e0" charOffset="21-31"
            type="drug" text="debrisoquin"/>
        <entity id="DDI-DrugBank.d269.s1.e1" charOffset="50-59"
            type="drug" text="carvedilol"/>
        <entity id="DDI-DrugBank.d269.s1.e2" charOffset="103-111"
            type="drug" text="quinidine"/>
        <entity id="DDI-DrugBank.d269.s1.e3" charOffset="114-123"
            type="drug" text="fluoxetine"/>
        <entity id="DDI-DrugBank.d269.s1.e4" charOffset="126-135"
            type="drug" text="paroxetine"/>
        <entity id="DDI-DrugBank.d269.s1.e5" charOffset="142-152"
            type="drug" text="propafenone"/>
        <entity id="DDI-DrugBank.d269.s1.e6" charOffset="263-272"
            type="drug" text="carvedilol"/>
        <pair id="DDI-DrugBank.d269.s1.p0" e1="DDI-DrugBank.d269.s1.e0"
            e2="DDI-DrugBank.d269.s1.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s1.p1" e1="DDI-DrugBank.d269.s1.e0"
            e2="DDI-DrugBank.d269.s1.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s1.p2" e1="DDI-DrugBank.d269.s1.e0"
            e2="DDI-DrugBank.d269.s1.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s1.p3" e1="DDI-DrugBank.d269.s1.e0"
            e2="DDI-DrugBank.d269.s1.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s1.p4" e1="DDI-DrugBank.d269.s1.e0"
            e2="DDI-DrugBank.d269.s1.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s1.p5" e1="DDI-DrugBank.d269.s1.e0"
            e2="DDI-DrugBank.d269.s1.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s1.p6" e1="DDI-DrugBank.d269.s1.e1"
            e2="DDI-DrugBank.d269.s1.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s1.p7" e1="DDI-DrugBank.d269.s1.e1"
            e2="DDI-DrugBank.d269.s1.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s1.p8" e1="DDI-DrugBank.d269.s1.e1"
            e2="DDI-DrugBank.d269.s1.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s1.p9" e1="DDI-DrugBank.d269.s1.e1"
            e2="DDI-DrugBank.d269.s1.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s1.p10" e1="DDI-DrugBank.d269.s1.e1"
            e2="DDI-DrugBank.d269.s1.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s1.p11" e1="DDI-DrugBank.d269.s1.e2"
            e2="DDI-DrugBank.d269.s1.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s1.p12" e1="DDI-DrugBank.d269.s1.e2"
            e2="DDI-DrugBank.d269.s1.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s1.p13" e1="DDI-DrugBank.d269.s1.e2"
            e2="DDI-DrugBank.d269.s1.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s1.p14" e1="DDI-DrugBank.d269.s1.e2"
            e2="DDI-DrugBank.d269.s1.e6" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d269.s1.p15" e1="DDI-DrugBank.d269.s1.e3"
            e2="DDI-DrugBank.d269.s1.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s1.p16" e1="DDI-DrugBank.d269.s1.e3"
            e2="DDI-DrugBank.d269.s1.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s1.p17" e1="DDI-DrugBank.d269.s1.e3"
            e2="DDI-DrugBank.d269.s1.e6" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d269.s1.p18" e1="DDI-DrugBank.d269.s1.e4"
            e2="DDI-DrugBank.d269.s1.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s1.p19" e1="DDI-DrugBank.d269.s1.e4"
            e2="DDI-DrugBank.d269.s1.e6" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d269.s1.p20" e1="DDI-DrugBank.d269.s1.e5"
            e2="DDI-DrugBank.d269.s1.e6" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d269.s2" text="Retrospective analysis of side effects in clinical trials showed that poor 2D6 metabolizers had a higher rate of dizziness during up-titration, presumably resulting from vasodilating effects of the higher concentrations of the a-blocking R(+) enantiomer."/>
    <sentence id="DDI-DrugBank.d269.s3" text="Catecholamine-depleting Agents: Patients taking both agents with b-blocking properties and a drug that can deplete catecholamines (e.g., reserpine and monoamine oxidase inhibitors) should be observed closely for signs of hypotension and/or severe bradycardia.">
        <entity id="DDI-DrugBank.d269.s3.e0" charOffset="53-85"
            type="group" text="agents with b-blocking properties"/>
        <entity id="DDI-DrugBank.d269.s3.e1" charOffset="137-145"
            type="drug" text="reserpine"/>
        <entity id="DDI-DrugBank.d269.s3.e2" charOffset="151-178"
            type="group" text="monoamine oxidase inhibitors"/>
        <pair id="DDI-DrugBank.d269.s3.p0" e1="DDI-DrugBank.d269.s3.e0"
            e2="DDI-DrugBank.d269.s3.e1" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d269.s3.p1" e1="DDI-DrugBank.d269.s3.e0"
            e2="DDI-DrugBank.d269.s3.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d269.s3.p2" e1="DDI-DrugBank.d269.s3.e1"
            e2="DDI-DrugBank.d269.s3.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d269.s4" text="Clonidine: Concomitant administration of clonidine with agents with b-blocking properties may potentiate blood-pressure- and heart-rate-lowering effects.">
        <entity id="DDI-DrugBank.d269.s4.e0" charOffset="0-8"
            type="drug" text="Clonidine"/>
        <entity id="DDI-DrugBank.d269.s4.e1" charOffset="41-49"
            type="drug" text="clonidine"/>
        <entity id="DDI-DrugBank.d269.s4.e2" charOffset="56-88"
            type="group" text="agents with b-blocking properties"/>
        <pair id="DDI-DrugBank.d269.s4.p0" e1="DDI-DrugBank.d269.s4.e0"
            e2="DDI-DrugBank.d269.s4.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s4.p1" e1="DDI-DrugBank.d269.s4.e0"
            e2="DDI-DrugBank.d269.s4.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s4.p2" e1="DDI-DrugBank.d269.s4.e1"
            e2="DDI-DrugBank.d269.s4.e2" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d269.s5" text="When concomitant treatment with agents with b-blocking properties and clonidine is to be terminated, the b-blocking agent should be discontinued first.">
        <entity id="DDI-DrugBank.d269.s5.e0" charOffset="32-64"
            type="group" text="agents with b-blocking properties"/>
        <entity id="DDI-DrugBank.d269.s5.e1" charOffset="70-78"
            type="drug" text="clonidine"/>
        <entity id="DDI-DrugBank.d269.s5.e2" charOffset="105-120"
            type="group" text="b-blocking agent"/>
        <pair id="DDI-DrugBank.d269.s5.p0" e1="DDI-DrugBank.d269.s5.e0"
            e2="DDI-DrugBank.d269.s5.e1" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d269.s5.p1" e1="DDI-DrugBank.d269.s5.e0"
            e2="DDI-DrugBank.d269.s5.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s5.p2" e1="DDI-DrugBank.d269.s5.e1"
            e2="DDI-DrugBank.d269.s5.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d269.s6" text="Clonidine therapy can then be discontinued several days later by gradually decreasing the dosage.">
        <entity id="DDI-DrugBank.d269.s6.e0" charOffset="0-8"
            type="drug" text="Clonidine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d269.s7" text="Cyclosporine: Modest increases in mean trough cyclosporine concentrations were observed following initiation of carvedilol treatment in 21 renal transplant patients suffering from chronic vascular rejection.">
        <entity id="DDI-DrugBank.d269.s7.e0" charOffset="0-11"
            type="drug" text="Cyclosporine"/>
        <entity id="DDI-DrugBank.d269.s7.e1" charOffset="46-57"
            type="drug" text="cyclosporine"/>
        <entity id="DDI-DrugBank.d269.s7.e2" charOffset="112-121"
            type="drug" text="carvedilol"/>
        <pair id="DDI-DrugBank.d269.s7.p0" e1="DDI-DrugBank.d269.s7.e0"
            e2="DDI-DrugBank.d269.s7.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s7.p1" e1="DDI-DrugBank.d269.s7.e0"
            e2="DDI-DrugBank.d269.s7.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s7.p2" e1="DDI-DrugBank.d269.s7.e1"
            e2="DDI-DrugBank.d269.s7.e2" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d269.s8" text="In about 30% of patients, the dose of cyclosporine had to be reduced in order to maintain cyclosporine concentrations within the therapeutic range, while in the remainder no adjustment was needed.">
        <entity id="DDI-DrugBank.d269.s8.e0" charOffset="38-49"
            type="drug" text="cyclosporine"/>
        <entity id="DDI-DrugBank.d269.s8.e1" charOffset="90-101"
            type="drug" text="cyclosporine"/>
        <pair id="DDI-DrugBank.d269.s8.p0" e1="DDI-DrugBank.d269.s8.e0"
            e2="DDI-DrugBank.d269.s8.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d269.s9" text="On the average for the group, the dose of cyclosporine was reduced about 20% in these patients.">
        <entity id="DDI-DrugBank.d269.s9.e0" charOffset="42-53"
            type="drug" text="cyclosporine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d269.s10" text="Due to wide interindividual variability in the dose adjustment required, it is recommended that cyclosporine concentrations be monitored closely after initiation of carvedilol therapy and that the dose of cyclosporine be adjusted as appropriate.">
        <entity id="DDI-DrugBank.d269.s10.e0" charOffset="96-107"
            type="drug" text="cyclosporine"/>
        <entity id="DDI-DrugBank.d269.s10.e1" charOffset="165-174"
            type="drug" text="carvedilol"/>
        <entity id="DDI-DrugBank.d269.s10.e2" charOffset="205-216"
            type="drug" text="cyclosporine"/>
        <pair id="DDI-DrugBank.d269.s10.p0"
            e1="DDI-DrugBank.d269.s10.e0" e2="DDI-DrugBank.d269.s10.e1"
            ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d269.s10.p1"
            e1="DDI-DrugBank.d269.s10.e0" e2="DDI-DrugBank.d269.s10.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s10.p2"
            e1="DDI-DrugBank.d269.s10.e1" e2="DDI-DrugBank.d269.s10.e2"
            ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d269.s11" text="Digoxin: Digoxin concentrations are increased by about 15% when digoxin and carvedilol are administered concomitantly.">
        <entity id="DDI-DrugBank.d269.s11.e0" charOffset="0-6"
            type="drug" text="Digoxin"/>
        <entity id="DDI-DrugBank.d269.s11.e1" charOffset="9-15"
            type="drug" text="Digoxin"/>
        <entity id="DDI-DrugBank.d269.s11.e2" charOffset="64-70"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d269.s11.e3" charOffset="76-85"
            type="drug" text="carvedilol"/>
        <pair id="DDI-DrugBank.d269.s11.p0"
            e1="DDI-DrugBank.d269.s11.e0" e2="DDI-DrugBank.d269.s11.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s11.p1"
            e1="DDI-DrugBank.d269.s11.e0" e2="DDI-DrugBank.d269.s11.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s11.p2"
            e1="DDI-DrugBank.d269.s11.e0" e2="DDI-DrugBank.d269.s11.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s11.p3"
            e1="DDI-DrugBank.d269.s11.e1" e2="DDI-DrugBank.d269.s11.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s11.p4"
            e1="DDI-DrugBank.d269.s11.e1" e2="DDI-DrugBank.d269.s11.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s11.p5"
            e1="DDI-DrugBank.d269.s11.e2" e2="DDI-DrugBank.d269.s11.e3"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d269.s12" text="Both digoxin and COREG slow AV conduction.">
        <entity id="DDI-DrugBank.d269.s12.e0" charOffset="5-11"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d269.s12.e1" charOffset="17-21"
            type="brand" text="COREG"/>
        <pair id="DDI-DrugBank.d269.s12.p0"
            e1="DDI-DrugBank.d269.s12.e0" e2="DDI-DrugBank.d269.s12.e1"
            ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d269.s13" text="Therefore, increased monitoring of digoxin is recommended when initiating, adjusting, or discontinuing COREG.">
        <entity id="DDI-DrugBank.d269.s13.e0" charOffset="35-41"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d269.s13.e1" charOffset="103-107"
            type="brand" text="COREG"/>
        <pair id="DDI-DrugBank.d269.s13.p0"
            e1="DDI-DrugBank.d269.s13.e0" e2="DDI-DrugBank.d269.s13.e1"
            ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d269.s14" text="Inducers and Inhibitors of Hepatic Metabolism: Rifampin reduced plasma concentrations of carvedilol by about 70%.">
        <entity id="DDI-DrugBank.d269.s14.e0" charOffset="47-54"
            type="drug" text="Rifampin"/>
        <entity id="DDI-DrugBank.d269.s14.e1" charOffset="89-98"
            type="drug" text="carvedilol"/>
        <pair id="DDI-DrugBank.d269.s14.p0"
            e1="DDI-DrugBank.d269.s14.e0" e2="DDI-DrugBank.d269.s14.e1"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d269.s15" text="Cimetidine increased AUC by about 30% but caused no change in Cmax.">
        <entity id="DDI-DrugBank.d269.s15.e0" charOffset="0-9"
            type="drug" text="Cimetidine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d269.s16" text="Calcium Channel Blockers: Isolated cases of conduction disturbance (rarely with hemodynamic compromise) have been observed when COREG is co-administered with diltiazem.">
        <entity id="DDI-DrugBank.d269.s16.e0" charOffset="0-23"
            type="group" text="Calcium Channel Blockers"/>
        <entity id="DDI-DrugBank.d269.s16.e1" charOffset="128-132"
            type="brand" text="COREG"/>
        <entity id="DDI-DrugBank.d269.s16.e2" charOffset="158-166"
            type="drug" text="diltiazem"/>
        <pair id="DDI-DrugBank.d269.s16.p0"
            e1="DDI-DrugBank.d269.s16.e0" e2="DDI-DrugBank.d269.s16.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s16.p1"
            e1="DDI-DrugBank.d269.s16.e0" e2="DDI-DrugBank.d269.s16.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s16.p2"
            e1="DDI-DrugBank.d269.s16.e1" e2="DDI-DrugBank.d269.s16.e2"
            ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d269.s17" text="As with other agents with b-blocking properties, if COREG is to be administered orally with calcium channel blockers of the verapamil or diltiazem type, it is recommended that ECG and blood pressure be monitored.">
        <entity id="DDI-DrugBank.d269.s17.e0" charOffset="14-46"
            type="group" text="agents with b-blocking properties"/>
        <entity id="DDI-DrugBank.d269.s17.e1" charOffset="52-56"
            type="brand" text="COREG"/>
        <entity id="DDI-DrugBank.d269.s17.e2" charOffset="92-115"
            type="group" text="calcium channel blockers"/>
        <entity id="DDI-DrugBank.d269.s17.e3" charOffset="124-132"
            type="drug" text="verapamil"/>
        <entity id="DDI-DrugBank.d269.s17.e4" charOffset="137-145"
            type="drug" text="diltiazem"/>
        <pair id="DDI-DrugBank.d269.s17.p0"
            e1="DDI-DrugBank.d269.s17.e0" e2="DDI-DrugBank.d269.s17.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s17.p1"
            e1="DDI-DrugBank.d269.s17.e0" e2="DDI-DrugBank.d269.s17.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s17.p2"
            e1="DDI-DrugBank.d269.s17.e0" e2="DDI-DrugBank.d269.s17.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s17.p3"
            e1="DDI-DrugBank.d269.s17.e0" e2="DDI-DrugBank.d269.s17.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s17.p4"
            e1="DDI-DrugBank.d269.s17.e1" e2="DDI-DrugBank.d269.s17.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s17.p5"
            e1="DDI-DrugBank.d269.s17.e1" e2="DDI-DrugBank.d269.s17.e3"
            ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d269.s17.p6"
            e1="DDI-DrugBank.d269.s17.e1" e2="DDI-DrugBank.d269.s17.e4"
            ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d269.s17.p7"
            e1="DDI-DrugBank.d269.s17.e2" e2="DDI-DrugBank.d269.s17.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s17.p8"
            e1="DDI-DrugBank.d269.s17.e2" e2="DDI-DrugBank.d269.s17.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s17.p9"
            e1="DDI-DrugBank.d269.s17.e3" e2="DDI-DrugBank.d269.s17.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d269.s18" text="Insulin or Oral Hypoglycemics: Agents with b-blocking properties may enhance the blood-sugar-reducing effect of insulin and oral hypoglycemics.">
        <entity id="DDI-DrugBank.d269.s18.e0" charOffset="0-6"
            type="drug" text="Insulin"/>
        <entity id="DDI-DrugBank.d269.s18.e1" charOffset="16-28"
            type="group" text="Hypoglycemics"/>
        <entity id="DDI-DrugBank.d269.s18.e2" charOffset="31-63"
            type="group" text="Agents with b-blocking properties"/>
        <entity id="DDI-DrugBank.d269.s18.e3" charOffset="112-118"
            type="drug" text="insulin"/>
        <entity id="DDI-DrugBank.d269.s18.e4" charOffset="129-141"
            type="group" text="hypoglycemics"/>
        <pair id="DDI-DrugBank.d269.s18.p0"
            e1="DDI-DrugBank.d269.s18.e0" e2="DDI-DrugBank.d269.s18.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s18.p1"
            e1="DDI-DrugBank.d269.s18.e0" e2="DDI-DrugBank.d269.s18.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s18.p2"
            e1="DDI-DrugBank.d269.s18.e0" e2="DDI-DrugBank.d269.s18.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s18.p3"
            e1="DDI-DrugBank.d269.s18.e0" e2="DDI-DrugBank.d269.s18.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s18.p4"
            e1="DDI-DrugBank.d269.s18.e1" e2="DDI-DrugBank.d269.s18.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s18.p5"
            e1="DDI-DrugBank.d269.s18.e1" e2="DDI-DrugBank.d269.s18.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s18.p6"
            e1="DDI-DrugBank.d269.s18.e1" e2="DDI-DrugBank.d269.s18.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d269.s18.p7"
            e1="DDI-DrugBank.d269.s18.e2" e2="DDI-DrugBank.d269.s18.e3"
            ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d269.s18.p8"
            e1="DDI-DrugBank.d269.s18.e2" e2="DDI-DrugBank.d269.s18.e4"
            ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d269.s18.p9"
            e1="DDI-DrugBank.d269.s18.e3" e2="DDI-DrugBank.d269.s18.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d269.s19" text="Therefore, in patients taking insulin or oral hypoglycemics, regular monitoring of blood glucose is recommended.">
        <entity id="DDI-DrugBank.d269.s19.e0" charOffset="30-36"
            type="drug" text="insulin"/>
        <entity id="DDI-DrugBank.d269.s19.e1" charOffset="46-58"
            type="group" text="hypoglycemics"/>
        <pair id="DDI-DrugBank.d269.s19.p0"
            e1="DDI-DrugBank.d269.s19.e0" e2="DDI-DrugBank.d269.s19.e1" ddi="false"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d339">
    <sentence id="DDI-DrugBank.d339.s0" text="Carbamazepine: Elevated carbamazepine levels have been reported in postmarketing experience when SUPRAX is administered concomitantly.">
        <entity id="DDI-DrugBank.d339.s0.e0" charOffset="0-12"
            type="drug" text="Carbamazepine"/>
        <entity id="DDI-DrugBank.d339.s0.e1" charOffset="24-36"
            type="drug" text="carbamazepine"/>
        <entity id="DDI-DrugBank.d339.s0.e2" charOffset="97-102"
            type="brand" text="SUPRAX"/>
        <pair id="DDI-DrugBank.d339.s0.p0" e1="DDI-DrugBank.d339.s0.e0"
            e2="DDI-DrugBank.d339.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d339.s0.p1" e1="DDI-DrugBank.d339.s0.e0"
            e2="DDI-DrugBank.d339.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d339.s0.p2" e1="DDI-DrugBank.d339.s0.e1"
            e2="DDI-DrugBank.d339.s0.e2" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d339.s1" text="Drug monitoring may be of assistance in detecting alterations in carbamazepine plasma concentrations.">
        <entity id="DDI-DrugBank.d339.s1.e0" charOffset="65-77"
            type="drug" text="carbamazepine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d339.s2" text="Warfarin and Anticoagulants: Increased prothrombin time, with or without clinical bleeding, has been reported when cefixime is administered concomitantly.">
        <entity id="DDI-DrugBank.d339.s2.e0" charOffset="0-7"
            type="drug" text="Warfarin"/>
        <entity id="DDI-DrugBank.d339.s2.e1" charOffset="13-26"
            type="group" text="Anticoagulants"/>
        <entity id="DDI-DrugBank.d339.s2.e2" charOffset="115-122"
            type="drug" text="cefixime"/>
        <pair id="DDI-DrugBank.d339.s2.p0" e1="DDI-DrugBank.d339.s2.e0"
            e2="DDI-DrugBank.d339.s2.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d339.s2.p1" e1="DDI-DrugBank.d339.s2.e0"
            e2="DDI-DrugBank.d339.s2.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d339.s2.p2" e1="DDI-DrugBank.d339.s2.e1"
            e2="DDI-DrugBank.d339.s2.e2" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d339.s3" text="Drug/Laboratory Test Interactions A false-positive reaction for ketones in the urine may occur with tests using nitroprusside but not with those using nitroferricyanide.">
        <entity id="DDI-DrugBank.d339.s3.e0" charOffset="112-124"
            type="drug" text="nitroprusside"/>
        <entity id="DDI-DrugBank.d339.s3.e1" charOffset="151-167"
            type="drug" text="nitroferricyanide"/>
        <pair id="DDI-DrugBank.d339.s3.p0" e1="DDI-DrugBank.d339.s3.e0"
            e2="DDI-DrugBank.d339.s3.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d339.s4" text="The administration of SUPRAX may result in a false-positive reaction for glucose in the urine using Clinitest **, Benedict s solution, or Fehling s solution.">
        <entity id="DDI-DrugBank.d339.s4.e0" charOffset="22-27"
            type="brand" text="SUPRAX"/>
    </sentence>
    <sentence id="DDI-DrugBank.d339.s5" text="It is recommended that glucose tests based on enzymatic glucose oxidase reactions (such as Clinistix ** or Tes-Tape **) be used."/>
    <sentence id="DDI-DrugBank.d339.s6" text="A false-positive direct Coombs test has been reported during treatment with other cephalosporin antibiotics;">
        <entity id="DDI-DrugBank.d339.s6.e0" charOffset="82-106"
            type="group" text="cephalosporin antibiotics"/>
    </sentence>
    <sentence id="DDI-DrugBank.d339.s7" text="therefore, it should be recognized that a positive Coombs test may be due to the drug."/>
</document>
<document id="DDI-DrugBank.d172">
    <sentence id="DDI-DrugBank.d172.s0" text="General: Significant interactions may occur when celecoxib is administered together with drugs that inhibit P450 2C9.">
        <entity id="DDI-DrugBank.d172.s0.e0" charOffset="49-57"
            type="drug" text="celecoxib"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s1" text="Celecoxib metabolism is predominantly mediated via cytochrome P450 2C9 in the liver.">
        <entity id="DDI-DrugBank.d172.s1.e0" charOffset="0-8"
            type="drug" text="Celecoxib"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s2" text="Co-administration of celecoxib with drugs that are known to inhibit 2C9 should be done with caution.">
        <entity id="DDI-DrugBank.d172.s2.e0" charOffset="21-29"
            type="drug" text="celecoxib"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s3" text="In vitro studies indicate that celecoxib is not an inhibitor of cytochrome P450 2C9, 2C19 or 3A4.">
        <entity id="DDI-DrugBank.d172.s3.e0" charOffset="31-39"
            type="drug" text="celecoxib"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s4" text="In vitro studies also indicate that celecoxib, although not a substrate, is an inhibitor of cytochrome P450 2D6.">
        <entity id="DDI-DrugBank.d172.s4.e0" charOffset="36-44"
            type="drug" text="celecoxib"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s5" text="Therefore, there is a potential for an in vivo drug interaction with drugs that are metabolized by P450 2D6."/>
    <sentence id="DDI-DrugBank.d172.s6" text="Clinical studies with celecoxib have identified potentially significant interactions with fluconazole and lithium.">
        <entity id="DDI-DrugBank.d172.s6.e0" charOffset="22-30"
            type="drug" text="celecoxib"/>
        <entity id="DDI-DrugBank.d172.s6.e1" charOffset="90-100"
            type="drug" text="fluconazole"/>
        <entity id="DDI-DrugBank.d172.s6.e2" charOffset="106-112"
            type="drug" text="lithium"/>
        <pair id="DDI-DrugBank.d172.s6.p0" e1="DDI-DrugBank.d172.s6.e0"
            e2="DDI-DrugBank.d172.s6.e1" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d172.s6.p1" e1="DDI-DrugBank.d172.s6.e0"
            e2="DDI-DrugBank.d172.s6.e2" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d172.s6.p2" e1="DDI-DrugBank.d172.s6.e1"
            e2="DDI-DrugBank.d172.s6.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s7" text="Experience with nonsteroidal anti-inflammatory drugs (NSAIDs) suggests the potential for interactions with furosemide and ACE inhibitors.">
        <entity id="DDI-DrugBank.d172.s7.e0" charOffset="16-51"
            type="group" text="nonsteroidal anti-inflammatory drugs"/>
        <entity id="DDI-DrugBank.d172.s7.e1" charOffset="54-59"
            type="group" text="NSAIDs"/>
        <entity id="DDI-DrugBank.d172.s7.e2" charOffset="107-116"
            type="drug" text="furosemide"/>
        <entity id="DDI-DrugBank.d172.s7.e3" charOffset="122-135"
            type="group" text="ACE inhibitors"/>
        <pair id="DDI-DrugBank.d172.s7.p0" e1="DDI-DrugBank.d172.s7.e0"
            e2="DDI-DrugBank.d172.s7.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s7.p1" e1="DDI-DrugBank.d172.s7.e0"
            e2="DDI-DrugBank.d172.s7.e2" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d172.s7.p2" e1="DDI-DrugBank.d172.s7.e0"
            e2="DDI-DrugBank.d172.s7.e3" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d172.s7.p3" e1="DDI-DrugBank.d172.s7.e1"
            e2="DDI-DrugBank.d172.s7.e2" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d172.s7.p4" e1="DDI-DrugBank.d172.s7.e1"
            e2="DDI-DrugBank.d172.s7.e3" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d172.s7.p5" e1="DDI-DrugBank.d172.s7.e2"
            e2="DDI-DrugBank.d172.s7.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s8" text="The effects celecoxib on the pharmacokinetics and/or pharmacodynamics of glyburide, ketoconazole, methotrexate, phenytoin, tolbutamide, and warfarin have been studied in vivo and clinically important interactions have not been found.">
        <entity id="DDI-DrugBank.d172.s8.e0" charOffset="12-20"
            type="drug" text="celecoxib"/>
        <entity id="DDI-DrugBank.d172.s8.e1" charOffset="73-81"
            type="drug" text="glyburide"/>
        <entity id="DDI-DrugBank.d172.s8.e2" charOffset="84-95"
            type="drug" text="ketoconazole"/>
        <entity id="DDI-DrugBank.d172.s8.e3" charOffset="98-109"
            type="drug" text="methotrexate"/>
        <entity id="DDI-DrugBank.d172.s8.e4" charOffset="112-120"
            type="drug" text="phenytoin"/>
        <entity id="DDI-DrugBank.d172.s8.e5" charOffset="123-133"
            type="drug" text="tolbutamide"/>
        <entity id="DDI-DrugBank.d172.s8.e6" charOffset="140-147"
            type="drug" text="warfarin"/>
        <pair id="DDI-DrugBank.d172.s8.p0" e1="DDI-DrugBank.d172.s8.e0"
            e2="DDI-DrugBank.d172.s8.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s8.p1" e1="DDI-DrugBank.d172.s8.e0"
            e2="DDI-DrugBank.d172.s8.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s8.p2" e1="DDI-DrugBank.d172.s8.e0"
            e2="DDI-DrugBank.d172.s8.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s8.p3" e1="DDI-DrugBank.d172.s8.e0"
            e2="DDI-DrugBank.d172.s8.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s8.p4" e1="DDI-DrugBank.d172.s8.e0"
            e2="DDI-DrugBank.d172.s8.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s8.p5" e1="DDI-DrugBank.d172.s8.e0"
            e2="DDI-DrugBank.d172.s8.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s8.p6" e1="DDI-DrugBank.d172.s8.e1"
            e2="DDI-DrugBank.d172.s8.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s8.p7" e1="DDI-DrugBank.d172.s8.e1"
            e2="DDI-DrugBank.d172.s8.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s8.p8" e1="DDI-DrugBank.d172.s8.e1"
            e2="DDI-DrugBank.d172.s8.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s8.p9" e1="DDI-DrugBank.d172.s8.e1"
            e2="DDI-DrugBank.d172.s8.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s8.p10" e1="DDI-DrugBank.d172.s8.e1"
            e2="DDI-DrugBank.d172.s8.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s8.p11" e1="DDI-DrugBank.d172.s8.e2"
            e2="DDI-DrugBank.d172.s8.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s8.p12" e1="DDI-DrugBank.d172.s8.e2"
            e2="DDI-DrugBank.d172.s8.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s8.p13" e1="DDI-DrugBank.d172.s8.e2"
            e2="DDI-DrugBank.d172.s8.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s8.p14" e1="DDI-DrugBank.d172.s8.e2"
            e2="DDI-DrugBank.d172.s8.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s8.p15" e1="DDI-DrugBank.d172.s8.e3"
            e2="DDI-DrugBank.d172.s8.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s8.p16" e1="DDI-DrugBank.d172.s8.e3"
            e2="DDI-DrugBank.d172.s8.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s8.p17" e1="DDI-DrugBank.d172.s8.e3"
            e2="DDI-DrugBank.d172.s8.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s8.p18" e1="DDI-DrugBank.d172.s8.e4"
            e2="DDI-DrugBank.d172.s8.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s8.p19" e1="DDI-DrugBank.d172.s8.e4"
            e2="DDI-DrugBank.d172.s8.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s8.p20" e1="DDI-DrugBank.d172.s8.e5"
            e2="DDI-DrugBank.d172.s8.e6" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s9" text="ACE inhibitors: Reports suggest that NSAIDs may diminish the antihypertensive effect of Angiotensin Converting Enzyme (ACE) inhibitors.">
        <entity id="DDI-DrugBank.d172.s9.e0" charOffset="0-13"
            type="group" text="ACE inhibitors"/>
        <entity id="DDI-DrugBank.d172.s9.e1" charOffset="37-42"
            type="group" text="NSAIDs"/>
        <entity id="DDI-DrugBank.d172.s9.e2" charOffset="88-133"
            type="group" text="Angiotensin Converting Enzyme (ACE) inhibitors"/>
        <pair id="DDI-DrugBank.d172.s9.p0" e1="DDI-DrugBank.d172.s9.e0"
            e2="DDI-DrugBank.d172.s9.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s9.p1" e1="DDI-DrugBank.d172.s9.e0"
            e2="DDI-DrugBank.d172.s9.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s9.p2" e1="DDI-DrugBank.d172.s9.e1"
            e2="DDI-DrugBank.d172.s9.e2" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s10" text="This interaction should be given consideration in patients taking CELEBREX concomitantly with ACE-inhibitors.">
        <entity id="DDI-DrugBank.d172.s10.e0" charOffset="66-73"
            type="brand" text="CELEBREX"/>
        <entity id="DDI-DrugBank.d172.s10.e1" charOffset="94-107"
            type="group" text="ACE-inhibitors"/>
        <pair id="DDI-DrugBank.d172.s10.p0"
            e1="DDI-DrugBank.d172.s10.e0" e2="DDI-DrugBank.d172.s10.e1"
            ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s11" text="Furosemide: Clinical studies, as well as post marketing observations, have shown that NSAIDs can reduce the natriuretic effect of furosemide and thiazides in some patients.">
        <entity id="DDI-DrugBank.d172.s11.e0" charOffset="0-9"
            type="drug" text="Furosemide"/>
        <entity id="DDI-DrugBank.d172.s11.e1" charOffset="86-91"
            type="group" text="NSAIDs"/>
        <entity id="DDI-DrugBank.d172.s11.e2" charOffset="130-139"
            type="drug" text="furosemide"/>
        <entity id="DDI-DrugBank.d172.s11.e3" charOffset="145-153"
            type="group" text="thiazides"/>
        <pair id="DDI-DrugBank.d172.s11.p0"
            e1="DDI-DrugBank.d172.s11.e0" e2="DDI-DrugBank.d172.s11.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s11.p1"
            e1="DDI-DrugBank.d172.s11.e0" e2="DDI-DrugBank.d172.s11.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s11.p2"
            e1="DDI-DrugBank.d172.s11.e0" e2="DDI-DrugBank.d172.s11.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s11.p3"
            e1="DDI-DrugBank.d172.s11.e1" e2="DDI-DrugBank.d172.s11.e2"
            ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d172.s11.p4"
            e1="DDI-DrugBank.d172.s11.e1" e2="DDI-DrugBank.d172.s11.e3"
            ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d172.s11.p5"
            e1="DDI-DrugBank.d172.s11.e2" e2="DDI-DrugBank.d172.s11.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s12" text="This response has been attributed to inhibition of renal prostaglandin synthesis."/>
    <sentence id="DDI-DrugBank.d172.s13" text="Aspirin: CELEBREX can be used with low dose aspirin.">
        <entity id="DDI-DrugBank.d172.s13.e0" charOffset="0-6"
            type="brand" text="Aspirin"/>
        <entity id="DDI-DrugBank.d172.s13.e1" charOffset="9-16"
            type="brand" text="CELEBREX"/>
        <entity id="DDI-DrugBank.d172.s13.e2" charOffset="44-50"
            type="brand" text="aspirin"/>
        <pair id="DDI-DrugBank.d172.s13.p0"
            e1="DDI-DrugBank.d172.s13.e0" e2="DDI-DrugBank.d172.s13.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s13.p1"
            e1="DDI-DrugBank.d172.s13.e0" e2="DDI-DrugBank.d172.s13.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s13.p2"
            e1="DDI-DrugBank.d172.s13.e1" e2="DDI-DrugBank.d172.s13.e2"
            ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s14" text="However, concomitant administration of aspirin with CELEBREX may result in an increased rate of GI ulceration or other complications, compared to use of CELEBREX alone.">
        <entity id="DDI-DrugBank.d172.s14.e0" charOffset="39-45"
            type="brand" text="aspirin"/>
        <entity id="DDI-DrugBank.d172.s14.e1" charOffset="52-59"
            type="brand" text="CELEBREX"/>
        <entity id="DDI-DrugBank.d172.s14.e2" charOffset="153-160"
            type="brand" text="CELEBREX"/>
        <pair id="DDI-DrugBank.d172.s14.p0"
            e1="DDI-DrugBank.d172.s14.e0" e2="DDI-DrugBank.d172.s14.e1"
            ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d172.s14.p1"
            e1="DDI-DrugBank.d172.s14.e0" e2="DDI-DrugBank.d172.s14.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s14.p2"
            e1="DDI-DrugBank.d172.s14.e1" e2="DDI-DrugBank.d172.s14.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s15" text="Because of its lack of platelet effects, CELEBREX is not a substitute for aspirin for cardiovascular prophylaxis.">
        <entity id="DDI-DrugBank.d172.s15.e0" charOffset="41-48"
            type="brand" text="CELEBREX"/>
        <entity id="DDI-DrugBank.d172.s15.e1" charOffset="74-80"
            type="brand" text="aspirin"/>
        <pair id="DDI-DrugBank.d172.s15.p0"
            e1="DDI-DrugBank.d172.s15.e0" e2="DDI-DrugBank.d172.s15.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s16" text="Fluconazole: Concomitant administration of fluconazole at 200 mg QD resulted in a two-fold increase in celecoxib plasma concentration.">
        <entity id="DDI-DrugBank.d172.s16.e0" charOffset="0-10"
            type="drug" text="Fluconazole"/>
        <entity id="DDI-DrugBank.d172.s16.e1" charOffset="43-53"
            type="drug" text="fluconazole"/>
        <entity id="DDI-DrugBank.d172.s16.e2" charOffset="103-111"
            type="drug" text="celecoxib"/>
        <pair id="DDI-DrugBank.d172.s16.p0"
            e1="DDI-DrugBank.d172.s16.e0" e2="DDI-DrugBank.d172.s16.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s16.p1"
            e1="DDI-DrugBank.d172.s16.e0" e2="DDI-DrugBank.d172.s16.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s16.p2"
            e1="DDI-DrugBank.d172.s16.e1" e2="DDI-DrugBank.d172.s16.e2"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s17" text="This increase is due to the inhibition of celecoxib metabolism via P450 2C9 by fluconazole (see CLINICAL PHARMACOLOGY - Pharmacokinetics: Metabolism).">
        <entity id="DDI-DrugBank.d172.s17.e0" charOffset="42-50"
            type="drug" text="celecoxib"/>
        <entity id="DDI-DrugBank.d172.s17.e1" charOffset="79-89"
            type="drug" text="fluconazole"/>
        <pair id="DDI-DrugBank.d172.s17.p0"
            e1="DDI-DrugBank.d172.s17.e0" e2="DDI-DrugBank.d172.s17.e1"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s18" text="CELEBREX should be introduced at the lowest recommended dose in patients receiving fluconazole.">
        <entity id="DDI-DrugBank.d172.s18.e0" charOffset="0-7"
            type="brand" text="CELEBREX"/>
        <entity id="DDI-DrugBank.d172.s18.e1" charOffset="83-93"
            type="drug" text="fluconazole"/>
        <pair id="DDI-DrugBank.d172.s18.p0"
            e1="DDI-DrugBank.d172.s18.e0" e2="DDI-DrugBank.d172.s18.e1"
            ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s19" text="Lithium: In a study conducted in healthy subjects, mean steady-state lithium plasma levels increased approximately 17% in subjects receiving lithium 450 mg BID with CELEBREX 200 mg BID as compared to subjects receiving lithium alone.">
        <entity id="DDI-DrugBank.d172.s19.e0" charOffset="0-6"
            type="drug" text="Lithium"/>
        <entity id="DDI-DrugBank.d172.s19.e1" charOffset="69-75"
            type="drug" text="lithium"/>
        <entity id="DDI-DrugBank.d172.s19.e2" charOffset="141-147"
            type="drug" text="lithium"/>
        <entity id="DDI-DrugBank.d172.s19.e3" charOffset="165-172"
            type="brand" text="CELEBREX"/>
        <entity id="DDI-DrugBank.d172.s19.e4" charOffset="219-225"
            type="drug" text="lithium"/>
        <pair id="DDI-DrugBank.d172.s19.p0"
            e1="DDI-DrugBank.d172.s19.e0" e2="DDI-DrugBank.d172.s19.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s19.p1"
            e1="DDI-DrugBank.d172.s19.e0" e2="DDI-DrugBank.d172.s19.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s19.p2"
            e1="DDI-DrugBank.d172.s19.e0" e2="DDI-DrugBank.d172.s19.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s19.p3"
            e1="DDI-DrugBank.d172.s19.e0" e2="DDI-DrugBank.d172.s19.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s19.p4"
            e1="DDI-DrugBank.d172.s19.e1" e2="DDI-DrugBank.d172.s19.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s19.p5"
            e1="DDI-DrugBank.d172.s19.e1" e2="DDI-DrugBank.d172.s19.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s19.p6"
            e1="DDI-DrugBank.d172.s19.e1" e2="DDI-DrugBank.d172.s19.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s19.p7"
            e1="DDI-DrugBank.d172.s19.e2" e2="DDI-DrugBank.d172.s19.e3"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d172.s19.p8"
            e1="DDI-DrugBank.d172.s19.e2" e2="DDI-DrugBank.d172.s19.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s19.p9"
            e1="DDI-DrugBank.d172.s19.e3" e2="DDI-DrugBank.d172.s19.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s20" text="Patients on lithium treatment should be closely monitored when CELEBREX is introduced or withdrawn.">
        <entity id="DDI-DrugBank.d172.s20.e0" charOffset="12-18"
            type="drug" text="lithium"/>
        <entity id="DDI-DrugBank.d172.s20.e1" charOffset="63-70"
            type="brand" text="CELEBREX"/>
        <pair id="DDI-DrugBank.d172.s20.p0"
            e1="DDI-DrugBank.d172.s20.e0" e2="DDI-DrugBank.d172.s20.e1"
            ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s21" text="Methotrexate: In an interaction study of rheumatoid arthritis patients taking methotrexate, CELEBREX did not have a significant effect on the pharmacokinetics of methotrexate.">
        <entity id="DDI-DrugBank.d172.s21.e0" charOffset="0-11"
            type="drug" text="Methotrexate"/>
        <entity id="DDI-DrugBank.d172.s21.e1" charOffset="78-89"
            type="drug" text="methotrexate"/>
        <entity id="DDI-DrugBank.d172.s21.e2" charOffset="92-99"
            type="brand" text="CELEBREX"/>
        <entity id="DDI-DrugBank.d172.s21.e3" charOffset="162-173"
            type="drug" text="methotrexate"/>
        <pair id="DDI-DrugBank.d172.s21.p0"
            e1="DDI-DrugBank.d172.s21.e0" e2="DDI-DrugBank.d172.s21.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s21.p1"
            e1="DDI-DrugBank.d172.s21.e0" e2="DDI-DrugBank.d172.s21.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s21.p2"
            e1="DDI-DrugBank.d172.s21.e0" e2="DDI-DrugBank.d172.s21.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s21.p3"
            e1="DDI-DrugBank.d172.s21.e1" e2="DDI-DrugBank.d172.s21.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s21.p4"
            e1="DDI-DrugBank.d172.s21.e1" e2="DDI-DrugBank.d172.s21.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s21.p5"
            e1="DDI-DrugBank.d172.s21.e2" e2="DDI-DrugBank.d172.s21.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s22" text="Warfarin: The effect of celecoxib on the anti-coagulant effect of warfarin was studied in a group of healthy subjects receiving daily doses of 2-5 mg of warfarin.">
        <entity id="DDI-DrugBank.d172.s22.e0" charOffset="0-7"
            type="drug" text="Warfarin"/>
        <entity id="DDI-DrugBank.d172.s22.e1" charOffset="24-32"
            type="drug" text="celecoxib"/>
        <entity id="DDI-DrugBank.d172.s22.e2" charOffset="66-73"
            type="drug" text="warfarin"/>
        <entity id="DDI-DrugBank.d172.s22.e3" charOffset="153-160"
            type="drug" text="warfarin"/>
        <pair id="DDI-DrugBank.d172.s22.p0"
            e1="DDI-DrugBank.d172.s22.e0" e2="DDI-DrugBank.d172.s22.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s22.p1"
            e1="DDI-DrugBank.d172.s22.e0" e2="DDI-DrugBank.d172.s22.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s22.p2"
            e1="DDI-DrugBank.d172.s22.e0" e2="DDI-DrugBank.d172.s22.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s22.p3"
            e1="DDI-DrugBank.d172.s22.e1" e2="DDI-DrugBank.d172.s22.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s22.p4"
            e1="DDI-DrugBank.d172.s22.e1" e2="DDI-DrugBank.d172.s22.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d172.s22.p5"
            e1="DDI-DrugBank.d172.s22.e2" e2="DDI-DrugBank.d172.s22.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s23" text="In these subjects, celecoxib did not alter the anticoagulant effect of warfarin as determined by prothrombin time.">
        <entity id="DDI-DrugBank.d172.s23.e0" charOffset="19-27"
            type="drug" text="celecoxib"/>
        <entity id="DDI-DrugBank.d172.s23.e1" charOffset="71-78"
            type="drug" text="warfarin"/>
        <pair id="DDI-DrugBank.d172.s23.p0"
            e1="DDI-DrugBank.d172.s23.e0" e2="DDI-DrugBank.d172.s23.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s24" text="However, caution should be used when administering CELEBREX with warfarin since these patients are at increased risk of bleeding complications.">
        <entity id="DDI-DrugBank.d172.s24.e0" charOffset="51-58"
            type="brand" text="CELEBREX"/>
        <entity id="DDI-DrugBank.d172.s24.e1" charOffset="65-72"
            type="drug" text="warfarin"/>
        <pair id="DDI-DrugBank.d172.s24.p0"
            e1="DDI-DrugBank.d172.s24.e0" e2="DDI-DrugBank.d172.s24.e1"
            ddi="true" type="advise"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d141">
    <sentence id="DDI-DrugBank.d141.s0" text="Immunosuppressive Drugs, Fibric Acid Derivatives, Niacin (Nicotinic Acid, Erythromycin, Azole Antifungals: Skeletal Muscle.">
        <entity id="DDI-DrugBank.d141.s0.e0" charOffset="0-22"
            type="group" text="Immunosuppressive Drugs"/>
        <entity id="DDI-DrugBank.d141.s0.e1" charOffset="25-47"
            type="group" text="Fibric Acid Derivatives"/>
        <entity id="DDI-DrugBank.d141.s0.e2" charOffset="50-55"
            type="drug" text="Niacin"/>
        <entity id="DDI-DrugBank.d141.s0.e3" charOffset="58-71"
            type="drug" text="Nicotinic Acid"/>
        <entity id="DDI-DrugBank.d141.s0.e4" charOffset="74-85"
            type="drug" text="Erythromycin"/>
        <entity id="DDI-DrugBank.d141.s0.e5" charOffset="88-104"
            type="group" text="Azole Antifungals"/>
        <pair id="DDI-DrugBank.d141.s0.p0" e1="DDI-DrugBank.d141.s0.e0"
            e2="DDI-DrugBank.d141.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s0.p1" e1="DDI-DrugBank.d141.s0.e0"
            e2="DDI-DrugBank.d141.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s0.p2" e1="DDI-DrugBank.d141.s0.e0"
            e2="DDI-DrugBank.d141.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s0.p3" e1="DDI-DrugBank.d141.s0.e0"
            e2="DDI-DrugBank.d141.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s0.p4" e1="DDI-DrugBank.d141.s0.e0"
            e2="DDI-DrugBank.d141.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s0.p5" e1="DDI-DrugBank.d141.s0.e1"
            e2="DDI-DrugBank.d141.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s0.p6" e1="DDI-DrugBank.d141.s0.e1"
            e2="DDI-DrugBank.d141.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s0.p7" e1="DDI-DrugBank.d141.s0.e1"
            e2="DDI-DrugBank.d141.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s0.p8" e1="DDI-DrugBank.d141.s0.e1"
            e2="DDI-DrugBank.d141.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s0.p9" e1="DDI-DrugBank.d141.s0.e2"
            e2="DDI-DrugBank.d141.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s0.p10" e1="DDI-DrugBank.d141.s0.e2"
            e2="DDI-DrugBank.d141.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s0.p11" e1="DDI-DrugBank.d141.s0.e2"
            e2="DDI-DrugBank.d141.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s0.p12" e1="DDI-DrugBank.d141.s0.e3"
            e2="DDI-DrugBank.d141.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s0.p13" e1="DDI-DrugBank.d141.s0.e3"
            e2="DDI-DrugBank.d141.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s0.p14" e1="DDI-DrugBank.d141.s0.e4"
            e2="DDI-DrugBank.d141.s0.e5" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d141.s1" text="ANTACID (Magnesium-Aluminum Hydroxide): Cerivastatin plasma concentrations were not affected by co-administration of antacid.">
        <entity id="DDI-DrugBank.d141.s1.e0" charOffset="0-6"
            type="group" text="ANTACID"/>
        <entity id="DDI-DrugBank.d141.s1.e1" charOffset="9-36"
            type="drug" text="Magnesium-Aluminum Hydroxide"/>
        <entity id="DDI-DrugBank.d141.s1.e2" charOffset="40-51"
            type="drug" text="Cerivastatin"/>
        <entity id="DDI-DrugBank.d141.s1.e3" charOffset="117-123"
            type="group" text="antacid"/>
        <pair id="DDI-DrugBank.d141.s1.p0" e1="DDI-DrugBank.d141.s1.e0"
            e2="DDI-DrugBank.d141.s1.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s1.p1" e1="DDI-DrugBank.d141.s1.e0"
            e2="DDI-DrugBank.d141.s1.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s1.p2" e1="DDI-DrugBank.d141.s1.e0"
            e2="DDI-DrugBank.d141.s1.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s1.p3" e1="DDI-DrugBank.d141.s1.e1"
            e2="DDI-DrugBank.d141.s1.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s1.p4" e1="DDI-DrugBank.d141.s1.e1"
            e2="DDI-DrugBank.d141.s1.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s1.p5" e1="DDI-DrugBank.d141.s1.e2"
            e2="DDI-DrugBank.d141.s1.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d141.s2" text="CIMETlDINE: Cerivastatin plasma concentrations were not affected by co-administration of cimetidine.">
        <entity id="DDI-DrugBank.d141.s2.e0" charOffset="0-9"
            type="drug" text="CIMETlDINE"/>
        <entity id="DDI-DrugBank.d141.s2.e1" charOffset="12-23"
            type="drug" text="Cerivastatin"/>
        <entity id="DDI-DrugBank.d141.s2.e2" charOffset="89-98"
            type="drug" text="cimetidine"/>
        <pair id="DDI-DrugBank.d141.s2.p0" e1="DDI-DrugBank.d141.s2.e0"
            e2="DDI-DrugBank.d141.s2.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s2.p1" e1="DDI-DrugBank.d141.s2.e0"
            e2="DDI-DrugBank.d141.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s2.p2" e1="DDI-DrugBank.d141.s2.e1"
            e2="DDI-DrugBank.d141.s2.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d141.s3" text="CHOLESTYRAMINE: The influence of the bile-acidsequestering agent cholestyramine on the pharmacokinetits of cerivastatin sodium was evaluated in 12 healthy males in 2 separate randomized crossover studies.">
        <entity id="DDI-DrugBank.d141.s3.e0" charOffset="0-13"
            type="drug" text="CHOLESTYRAMINE"/>
        <entity id="DDI-DrugBank.d141.s3.e1" charOffset="65-78"
            type="drug" text="cholestyramine"/>
        <entity id="DDI-DrugBank.d141.s3.e2" charOffset="107-125"
            type="drug" text="cerivastatin sodium"/>
        <pair id="DDI-DrugBank.d141.s3.p0" e1="DDI-DrugBank.d141.s3.e0"
            e2="DDI-DrugBank.d141.s3.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s3.p1" e1="DDI-DrugBank.d141.s3.e0"
            e2="DDI-DrugBank.d141.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s3.p2" e1="DDI-DrugBank.d141.s3.e1"
            e2="DDI-DrugBank.d141.s3.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d141.s4" text="In the first study, concomitant administration of 0.2 mg cerivastatin sodium and 12 g cholestyramine resulted in decreases of more than 22% for AUC and 40% for Cmax when compared to dosing cerivastatin sodium alone.">
        <entity id="DDI-DrugBank.d141.s4.e0" charOffset="57-75"
            type="drug" text="cerivastatin sodium"/>
        <entity id="DDI-DrugBank.d141.s4.e1" charOffset="86-99"
            type="drug" text="cholestyramine"/>
        <entity id="DDI-DrugBank.d141.s4.e2" charOffset="189-207"
            type="drug" text="cerivastatin sodium"/>
        <pair id="DDI-DrugBank.d141.s4.p0" e1="DDI-DrugBank.d141.s4.e0"
            e2="DDI-DrugBank.d141.s4.e1" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d141.s4.p1" e1="DDI-DrugBank.d141.s4.e0"
            e2="DDI-DrugBank.d141.s4.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s4.p2" e1="DDI-DrugBank.d141.s4.e1"
            e2="DDI-DrugBank.d141.s4.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d141.s5" text="However, in the second study, administration of 12 g cholestyramine 1 hour before the evening meal and 0.3 mg cerivastatin sodium approximately 4 hours after the same evening meal resulted in a decrease in the cerivastatin AUC of less than 8%, and a decrease in Cmax of about 30% when compared to dosing cerivastatin sodium alone.">
        <entity id="DDI-DrugBank.d141.s5.e0" charOffset="53-66"
            type="drug" text="cholestyramine"/>
        <entity id="DDI-DrugBank.d141.s5.e1" charOffset="110-128"
            type="drug" text="cerivastatin sodium"/>
        <entity id="DDI-DrugBank.d141.s5.e2" charOffset="210-221"
            type="drug" text="cerivastatin"/>
        <entity id="DDI-DrugBank.d141.s5.e3" charOffset="304-322"
            type="drug" text="cerivastatin sodium"/>
        <pair id="DDI-DrugBank.d141.s5.p0" e1="DDI-DrugBank.d141.s5.e0"
            e2="DDI-DrugBank.d141.s5.e1" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d141.s5.p1" e1="DDI-DrugBank.d141.s5.e0"
            e2="DDI-DrugBank.d141.s5.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s5.p2" e1="DDI-DrugBank.d141.s5.e0"
            e2="DDI-DrugBank.d141.s5.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s5.p3" e1="DDI-DrugBank.d141.s5.e1"
            e2="DDI-DrugBank.d141.s5.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s5.p4" e1="DDI-DrugBank.d141.s5.e1"
            e2="DDI-DrugBank.d141.s5.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s5.p5" e1="DDI-DrugBank.d141.s5.e2"
            e2="DDI-DrugBank.d141.s5.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d141.s6" text="Therefore, it would be expected that a dosing schedule of cerivastatin sodium given at bedtime and cholestyramine given before the evening meal would not result in a significant decrease in the clinical effect of cerivastatin sodium.">
        <entity id="DDI-DrugBank.d141.s6.e0" charOffset="58-76"
            type="drug" text="cerivastatin sodium"/>
        <entity id="DDI-DrugBank.d141.s6.e1" charOffset="99-112"
            type="drug" text="cholestyramine"/>
        <entity id="DDI-DrugBank.d141.s6.e2" charOffset="213-231"
            type="drug" text="cerivastatin sodium"/>
        <pair id="DDI-DrugBank.d141.s6.p0" e1="DDI-DrugBank.d141.s6.e0"
            e2="DDI-DrugBank.d141.s6.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s6.p1" e1="DDI-DrugBank.d141.s6.e0"
            e2="DDI-DrugBank.d141.s6.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s6.p2" e1="DDI-DrugBank.d141.s6.e1"
            e2="DDI-DrugBank.d141.s6.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d141.s7" text="DIGOXIN: Plasma digoxin levels and digoxin clearance at steady-state were not affected by co-administration of 0.2 mg cerivastatin sodium.">
        <entity id="DDI-DrugBank.d141.s7.e0" charOffset="0-6"
            type="drug" text="DIGOXIN"/>
        <entity id="DDI-DrugBank.d141.s7.e1" charOffset="16-22"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d141.s7.e2" charOffset="35-41"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d141.s7.e3" charOffset="118-136"
            type="drug" text="cerivastatin sodium"/>
        <pair id="DDI-DrugBank.d141.s7.p0" e1="DDI-DrugBank.d141.s7.e0"
            e2="DDI-DrugBank.d141.s7.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s7.p1" e1="DDI-DrugBank.d141.s7.e0"
            e2="DDI-DrugBank.d141.s7.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s7.p2" e1="DDI-DrugBank.d141.s7.e0"
            e2="DDI-DrugBank.d141.s7.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s7.p3" e1="DDI-DrugBank.d141.s7.e1"
            e2="DDI-DrugBank.d141.s7.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s7.p4" e1="DDI-DrugBank.d141.s7.e1"
            e2="DDI-DrugBank.d141.s7.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s7.p5" e1="DDI-DrugBank.d141.s7.e2"
            e2="DDI-DrugBank.d141.s7.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d141.s8" text="Cerivastatin plasma concentrations were also not affected by co-administration of digoxin.">
        <entity id="DDI-DrugBank.d141.s8.e0" charOffset="0-11"
            type="drug" text="Cerivastatin"/>
        <entity id="DDI-DrugBank.d141.s8.e1" charOffset="82-88"
            type="drug" text="digoxin"/>
        <pair id="DDI-DrugBank.d141.s8.p0" e1="DDI-DrugBank.d141.s8.e0"
            e2="DDI-DrugBank.d141.s8.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d141.s9" text="WARFARIN: Co- administration of warfarin and cerivastatin to healthy volunteers did not result in any changes in prothrombin time or clotting factor VII when compared to co-administration of warfarin and placebo.">
        <entity id="DDI-DrugBank.d141.s9.e0" charOffset="0-7"
            type="drug" text="WARFARIN"/>
        <entity id="DDI-DrugBank.d141.s9.e1" charOffset="32-39"
            type="drug" text="warfarin"/>
        <entity id="DDI-DrugBank.d141.s9.e2" charOffset="45-56"
            type="drug" text="cerivastatin"/>
        <entity id="DDI-DrugBank.d141.s9.e3" charOffset="191-198"
            type="drug" text="warfarin"/>
        <pair id="DDI-DrugBank.d141.s9.p0" e1="DDI-DrugBank.d141.s9.e0"
            e2="DDI-DrugBank.d141.s9.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s9.p1" e1="DDI-DrugBank.d141.s9.e0"
            e2="DDI-DrugBank.d141.s9.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s9.p2" e1="DDI-DrugBank.d141.s9.e0"
            e2="DDI-DrugBank.d141.s9.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s9.p3" e1="DDI-DrugBank.d141.s9.e1"
            e2="DDI-DrugBank.d141.s9.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s9.p4" e1="DDI-DrugBank.d141.s9.e1"
            e2="DDI-DrugBank.d141.s9.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s9.p5" e1="DDI-DrugBank.d141.s9.e2"
            e2="DDI-DrugBank.d141.s9.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d141.s10" text="The AUC and Cmax of both the (R) and (S) isomers of warfarin were unaffected by concurrent dosing of 0.3 mg cerivastatin sodium.">
        <entity id="DDI-DrugBank.d141.s10.e0" charOffset="52-59"
            type="drug" text="warfarin"/>
        <entity id="DDI-DrugBank.d141.s10.e1" charOffset="108-126"
            type="drug" text="cerivastatin sodium"/>
        <pair id="DDI-DrugBank.d141.s10.p0"
            e1="DDI-DrugBank.d141.s10.e0" e2="DDI-DrugBank.d141.s10.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d141.s11" text="Co-administration of warfarin and cerivastatin did not alter the pharmacokinetics of cerivastatin sodium.">
        <entity id="DDI-DrugBank.d141.s11.e0" charOffset="21-28"
            type="drug" text="warfarin"/>
        <entity id="DDI-DrugBank.d141.s11.e1" charOffset="34-45"
            type="drug" text="cerivastatin"/>
        <entity id="DDI-DrugBank.d141.s11.e2" charOffset="85-103"
            type="drug" text="cerivastatin sodium"/>
        <pair id="DDI-DrugBank.d141.s11.p0"
            e1="DDI-DrugBank.d141.s11.e0" e2="DDI-DrugBank.d141.s11.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s11.p1"
            e1="DDI-DrugBank.d141.s11.e0" e2="DDI-DrugBank.d141.s11.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s11.p2"
            e1="DDI-DrugBank.d141.s11.e1" e2="DDI-DrugBank.d141.s11.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d141.s12" text="ERYTHROMYCIN: In hypercholesterolemic patients, steady-state cerivastatin AUC and Cmax increased approximately 50% and 24% respectively after 10 days with co-administration of erythromycin, a known inhibitor of cytochrome P450 3A4.">
        <entity id="DDI-DrugBank.d141.s12.e0" charOffset="0-11"
            type="drug" text="ERYTHROMYCIN"/>
        <entity id="DDI-DrugBank.d141.s12.e1" charOffset="61-72"
            type="drug" text="cerivastatin"/>
        <entity id="DDI-DrugBank.d141.s12.e2" charOffset="176-187"
            type="drug" text="erythromycin"/>
        <pair id="DDI-DrugBank.d141.s12.p0"
            e1="DDI-DrugBank.d141.s12.e0" e2="DDI-DrugBank.d141.s12.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s12.p1"
            e1="DDI-DrugBank.d141.s12.e0" e2="DDI-DrugBank.d141.s12.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s12.p2"
            e1="DDI-DrugBank.d141.s12.e1" e2="DDI-DrugBank.d141.s12.e2"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d141.s13" text="OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, calcium-channel blockers, diuretics, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.">
        <entity id="DDI-DrugBank.d141.s13.e0" charOffset="106-124"
            type="drug" text="cerivastatin sodium"/>
        <entity id="DDI-DrugBank.d141.s13.e1" charOffset="154-200"
            type="group" text="angiotensin- converting enzyme (ACE) inhibitors"/>
        <entity id="DDI-DrugBank.d141.s13.e2" charOffset="203-214"
            type="group" text="betablockers"/>
        <entity id="DDI-DrugBank.d141.s13.e3" charOffset="217-240"
            type="group" text="calcium-channel blockers"/>
        <entity id="DDI-DrugBank.d141.s13.e4" charOffset="243-251"
            type="group" text="diuretics"/>
        <entity id="DDI-DrugBank.d141.s13.e5" charOffset="258-293"
            type="group" text="nonsteroidal anti-inflammatory drugs"/>
        <entity id="DDI-DrugBank.d141.s13.e6" charOffset="296-301"
            type="group" text="NSAIDs"/>
        <pair id="DDI-DrugBank.d141.s13.p0"
            e1="DDI-DrugBank.d141.s13.e0" e2="DDI-DrugBank.d141.s13.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s13.p1"
            e1="DDI-DrugBank.d141.s13.e0" e2="DDI-DrugBank.d141.s13.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s13.p2"
            e1="DDI-DrugBank.d141.s13.e0" e2="DDI-DrugBank.d141.s13.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s13.p3"
            e1="DDI-DrugBank.d141.s13.e0" e2="DDI-DrugBank.d141.s13.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s13.p4"
            e1="DDI-DrugBank.d141.s13.e0" e2="DDI-DrugBank.d141.s13.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s13.p5"
            e1="DDI-DrugBank.d141.s13.e0" e2="DDI-DrugBank.d141.s13.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s13.p6"
            e1="DDI-DrugBank.d141.s13.e1" e2="DDI-DrugBank.d141.s13.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s13.p7"
            e1="DDI-DrugBank.d141.s13.e1" e2="DDI-DrugBank.d141.s13.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s13.p8"
            e1="DDI-DrugBank.d141.s13.e1" e2="DDI-DrugBank.d141.s13.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s13.p9"
            e1="DDI-DrugBank.d141.s13.e1" e2="DDI-DrugBank.d141.s13.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s13.p10"
            e1="DDI-DrugBank.d141.s13.e1" e2="DDI-DrugBank.d141.s13.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s13.p11"
            e1="DDI-DrugBank.d141.s13.e2" e2="DDI-DrugBank.d141.s13.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s13.p12"
            e1="DDI-DrugBank.d141.s13.e2" e2="DDI-DrugBank.d141.s13.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s13.p13"
            e1="DDI-DrugBank.d141.s13.e2" e2="DDI-DrugBank.d141.s13.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s13.p14"
            e1="DDI-DrugBank.d141.s13.e2" e2="DDI-DrugBank.d141.s13.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s13.p15"
            e1="DDI-DrugBank.d141.s13.e3" e2="DDI-DrugBank.d141.s13.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s13.p16"
            e1="DDI-DrugBank.d141.s13.e3" e2="DDI-DrugBank.d141.s13.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s13.p17"
            e1="DDI-DrugBank.d141.s13.e3" e2="DDI-DrugBank.d141.s13.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s13.p18"
            e1="DDI-DrugBank.d141.s13.e4" e2="DDI-DrugBank.d141.s13.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s13.p19"
            e1="DDI-DrugBank.d141.s13.e4" e2="DDI-DrugBank.d141.s13.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d141.s13.p20"
            e1="DDI-DrugBank.d141.s13.e5" e2="DDI-DrugBank.d141.s13.e6" ddi="false"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d287">
    <sentence id="DDI-DrugBank.d287.s0" text="Cevimeline should be administered with caution to patients taking beta adrenergic antagonists, because of the possibility of conduction disturbances.">
        <entity id="DDI-DrugBank.d287.s0.e0" charOffset="0-9"
            type="drug" text="Cevimeline"/>
        <entity id="DDI-DrugBank.d287.s0.e1" charOffset="66-92"
            type="group" text="beta adrenergic antagonists"/>
        <pair id="DDI-DrugBank.d287.s0.p0" e1="DDI-DrugBank.d287.s0.e0"
            e2="DDI-DrugBank.d287.s0.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d287.s1" text="Drugs with parasympathomimetic effects administered concurrently with cevimeline can be expected to have additive effects.">
        <entity id="DDI-DrugBank.d287.s1.e0" charOffset="70-79"
            type="drug" text="cevimeline"/>
    </sentence>
    <sentence id="DDI-DrugBank.d287.s2" text="Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly.">
        <entity id="DDI-DrugBank.d287.s2.e0" charOffset="0-9"
            type="drug" text="Cevimeline"/>
    </sentence>
    <sentence id="DDI-DrugBank.d287.s3" text="Drugs which inhibit CYP2D6 and CYP3A3/4 also inhibit the metabolism of cevimeline.">
        <entity id="DDI-DrugBank.d287.s3.e0" charOffset="71-80"
            type="drug" text="cevimeline"/>
    </sentence>
    <sentence id="DDI-DrugBank.d287.s4" text="Cevimeline should be used with caution in individuals known or suspected to be deficient in CYP2D6 activity, based on previous experience, as they may be at a higher risk of adverse events.">
        <entity id="DDI-DrugBank.d287.s4.e0" charOffset="0-9"
            type="drug" text="Cevimeline"/>
    </sentence>
    <sentence id="DDI-DrugBank.d287.s5" text="In an in vitro study, cytochrome P450 isozymes 1A2, 2A6, 2C9, 2C19, 2D6, 2E1, and 3A4 were not inhibited by exposure to cevimeline.">
        <entity id="DDI-DrugBank.d287.s5.e0" charOffset="120-129"
            type="drug" text="cevimeline"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d255">
    <sentence id="DDI-DrugBank.d255.s0" text="There are no known drug/drug interactions with chlorambucil.">
        <entity id="DDI-DrugBank.d255.s0.e0" charOffset="47-58"
            type="drug" text="chlorambucil"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d110">
    <sentence id="DDI-DrugBank.d110.s0" text="The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension.">
        <entity id="DDI-DrugBank.d110.s0.e0" charOffset="28-47"
            type="group" text="anesthetic solutions"/>
        <entity id="DDI-DrugBank.d110.s0.e1" charOffset="60-70"
            type="drug" text="epinephrine"/>
        <entity id="DDI-DrugBank.d110.s0.e2" charOffset="75-88"
            type="drug" text="norepinephrine"/>
        <entity id="DDI-DrugBank.d110.s0.e3" charOffset="112-139"
            type="group" text="monoamine oxidase inhibitors"/>
        <entity id="DDI-DrugBank.d110.s0.e4" charOffset="142-166"
            type="group" text="tricyclic antidepressants"/>
        <entity id="DDI-DrugBank.d110.s0.e5" charOffset="171-184"
            type="group" text="phenothiazines"/>
        <pair id="DDI-DrugBank.d110.s0.p0" e1="DDI-DrugBank.d110.s0.e0"
            e2="DDI-DrugBank.d110.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d110.s0.p1" e1="DDI-DrugBank.d110.s0.e0"
            e2="DDI-DrugBank.d110.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d110.s0.p2" e1="DDI-DrugBank.d110.s0.e0"
            e2="DDI-DrugBank.d110.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d110.s0.p3" e1="DDI-DrugBank.d110.s0.e0"
            e2="DDI-DrugBank.d110.s0.e4" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d110.s0.p4" e1="DDI-DrugBank.d110.s0.e0"
            e2="DDI-DrugBank.d110.s0.e5" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d110.s0.p5" e1="DDI-DrugBank.d110.s0.e1"
            e2="DDI-DrugBank.d110.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d110.s0.p6" e1="DDI-DrugBank.d110.s0.e1"
            e2="DDI-DrugBank.d110.s0.e3" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d110.s0.p7" e1="DDI-DrugBank.d110.s0.e1"
            e2="DDI-DrugBank.d110.s0.e4" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d110.s0.p8" e1="DDI-DrugBank.d110.s0.e1"
            e2="DDI-DrugBank.d110.s0.e5" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d110.s0.p9" e1="DDI-DrugBank.d110.s0.e2"
            e2="DDI-DrugBank.d110.s0.e3" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d110.s0.p10" e1="DDI-DrugBank.d110.s0.e2"
            e2="DDI-DrugBank.d110.s0.e4" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d110.s0.p11" e1="DDI-DrugBank.d110.s0.e2"
            e2="DDI-DrugBank.d110.s0.e5" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d110.s0.p12" e1="DDI-DrugBank.d110.s0.e3"
            e2="DDI-DrugBank.d110.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d110.s0.p13" e1="DDI-DrugBank.d110.s0.e3"
            e2="DDI-DrugBank.d110.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d110.s0.p14" e1="DDI-DrugBank.d110.s0.e4"
            e2="DDI-DrugBank.d110.s0.e5" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d110.s1" text="Concurrent use of these agents should generally be avoided."/>
    <sentence id="DDI-DrugBank.d110.s2" text="In situations when concurrent therapy is necessary, careful patient monitoring is essential."/>
    <sentence id="DDI-DrugBank.d110.s3" text="Concurrent administration of vasopressor drugs (for the treatment of hypotension related to obstetric blocks) and ergot-type oxytocic drugs may cause severe, persistent hypertension or cerebrovascular accidents.">
        <entity id="DDI-DrugBank.d110.s3.e0" charOffset="29-45"
            type="group" text="vasopressor drugs"/>
        <entity id="DDI-DrugBank.d110.s3.e1" charOffset="114-138"
            type="group" text="ergot-type oxytocic drugs"/>
        <pair id="DDI-DrugBank.d110.s3.p0" e1="DDI-DrugBank.d110.s3.e0"
            e2="DDI-DrugBank.d110.s3.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d110.s4" text="The para-aminobenzoic acid metabolite of chloroprocaine inhibits the action of sulfonamides.">
        <entity id="DDI-DrugBank.d110.s4.e0" charOffset="79-90"
            type="group" text="sulfonamides"/>
    </sentence>
    <sentence id="DDI-DrugBank.d110.s5" text="Therefore, chloroprocaine should not be used in any condition in which a sulfonamide drug is being employed.">
        <entity id="DDI-DrugBank.d110.s5.e0" charOffset="11-24"
            type="drug" text="chloroprocaine"/>
        <entity id="DDI-DrugBank.d110.s5.e1" charOffset="73-88"
            type="group" text="sulfonamide drug"/>
        <pair id="DDI-DrugBank.d110.s5.p0" e1="DDI-DrugBank.d110.s5.e0"
            e2="DDI-DrugBank.d110.s5.e1" ddi="true" type="advise"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d429">
    <sentence id="DDI-DrugBank.d429.s0" text="Antacids and kaolin: Antacids and kaolin can reduce absorption of chloroquine;">
        <entity id="DDI-DrugBank.d429.s0.e0" charOffset="0-7"
            type="group" text="Antacids"/>
        <entity id="DDI-DrugBank.d429.s0.e1" charOffset="13-18"
            type="drug" text="kaolin"/>
        <entity id="DDI-DrugBank.d429.s0.e2" charOffset="21-28"
            type="group" text="Antacids"/>
        <entity id="DDI-DrugBank.d429.s0.e3" charOffset="34-39"
            type="drug" text="kaolin"/>
        <entity id="DDI-DrugBank.d429.s0.e4" charOffset="66-76"
            type="drug" text="chloroquine"/>
        <pair id="DDI-DrugBank.d429.s0.p0" e1="DDI-DrugBank.d429.s0.e0"
            e2="DDI-DrugBank.d429.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d429.s0.p1" e1="DDI-DrugBank.d429.s0.e0"
            e2="DDI-DrugBank.d429.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d429.s0.p2" e1="DDI-DrugBank.d429.s0.e0"
            e2="DDI-DrugBank.d429.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d429.s0.p3" e1="DDI-DrugBank.d429.s0.e0"
            e2="DDI-DrugBank.d429.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d429.s0.p4" e1="DDI-DrugBank.d429.s0.e1"
            e2="DDI-DrugBank.d429.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d429.s0.p5" e1="DDI-DrugBank.d429.s0.e1"
            e2="DDI-DrugBank.d429.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d429.s0.p6" e1="DDI-DrugBank.d429.s0.e1"
            e2="DDI-DrugBank.d429.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d429.s0.p7" e1="DDI-DrugBank.d429.s0.e2"
            e2="DDI-DrugBank.d429.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d429.s0.p8" e1="DDI-DrugBank.d429.s0.e2"
            e2="DDI-DrugBank.d429.s0.e4" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d429.s0.p9" e1="DDI-DrugBank.d429.s0.e3"
            e2="DDI-DrugBank.d429.s0.e4" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d429.s1" text="an interval of at least 4 hours between intake of these agents and chloroquine should be observed.">
        <entity id="DDI-DrugBank.d429.s1.e0" charOffset="67-77"
            type="drug" text="chloroquine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d429.s2" text="Cimetidine: Cimetidine can inhibit the metabolism of chloroquine, increasing its plasma level.">
        <entity id="DDI-DrugBank.d429.s2.e0" charOffset="0-9"
            type="drug" text="Cimetidine"/>
        <entity id="DDI-DrugBank.d429.s2.e1" charOffset="12-21"
            type="drug" text="Cimetidine"/>
        <entity id="DDI-DrugBank.d429.s2.e2" charOffset="53-63"
            type="drug" text="chloroquine"/>
        <pair id="DDI-DrugBank.d429.s2.p0" e1="DDI-DrugBank.d429.s2.e0"
            e2="DDI-DrugBank.d429.s2.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d429.s2.p1" e1="DDI-DrugBank.d429.s2.e0"
            e2="DDI-DrugBank.d429.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d429.s2.p2" e1="DDI-DrugBank.d429.s2.e1"
            e2="DDI-DrugBank.d429.s2.e2" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d429.s3" text="Concomitant use of cimetidine should be avoided.">
        <entity id="DDI-DrugBank.d429.s3.e0" charOffset="19-28"
            type="drug" text="cimetidine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d429.s4" text="Ampicillin: In a study of healthy volunteers, chloroquine significantly reduced the bioavailability of ampicillin.">
        <entity id="DDI-DrugBank.d429.s4.e0" charOffset="0-9"
            type="drug" text="Ampicillin"/>
        <entity id="DDI-DrugBank.d429.s4.e1" charOffset="46-56"
            type="drug" text="chloroquine"/>
        <entity id="DDI-DrugBank.d429.s4.e2" charOffset="103-112"
            type="drug" text="ampicillin"/>
        <pair id="DDI-DrugBank.d429.s4.p0" e1="DDI-DrugBank.d429.s4.e0"
            e2="DDI-DrugBank.d429.s4.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d429.s4.p1" e1="DDI-DrugBank.d429.s4.e0"
            e2="DDI-DrugBank.d429.s4.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d429.s4.p2" e1="DDI-DrugBank.d429.s4.e1"
            e2="DDI-DrugBank.d429.s4.e2" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d429.s5" text="An interval of at least two hours between intake of this agent and chloroquine should be observed.">
        <entity id="DDI-DrugBank.d429.s5.e0" charOffset="67-77"
            type="drug" text="chloroquine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d429.s6" text="Cyclosporin: After introduction of chloroquine (oral form), a sudden increase in serum cyclosporin level has been reported.">
        <entity id="DDI-DrugBank.d429.s6.e0" charOffset="0-10"
            type="drug" text="Cyclosporin"/>
        <entity id="DDI-DrugBank.d429.s6.e1" charOffset="35-45"
            type="drug" text="chloroquine"/>
        <entity id="DDI-DrugBank.d429.s6.e2" charOffset="87-97"
            type="drug" text="cyclosporin"/>
        <pair id="DDI-DrugBank.d429.s6.p0" e1="DDI-DrugBank.d429.s6.e0"
            e2="DDI-DrugBank.d429.s6.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d429.s6.p1" e1="DDI-DrugBank.d429.s6.e0"
            e2="DDI-DrugBank.d429.s6.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d429.s6.p2" e1="DDI-DrugBank.d429.s6.e1"
            e2="DDI-DrugBank.d429.s6.e2" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d429.s7" text="Therefore, close monitoring of serum cyclosporin level is recommended and, if necessary, chloroquine should be discontinued.">
        <entity id="DDI-DrugBank.d429.s7.e0" charOffset="37-47"
            type="drug" text="cyclosporin"/>
        <entity id="DDI-DrugBank.d429.s7.e1" charOffset="89-99"
            type="drug" text="chloroquine"/>
        <pair id="DDI-DrugBank.d429.s7.p0" e1="DDI-DrugBank.d429.s7.e0"
            e2="DDI-DrugBank.d429.s7.e1" ddi="false"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d446">
    <sentence id="DDI-DrugBank.d446.s0" text="Chlorotrianisene may interact with antidepressants, aspirin, barbiturates, bromocriptine, calcium supplements, corticosteroids, corticotropin, cyclosporine, dantrolene, nicotine, somatropin, tamoxifen, and warfarin.">
        <entity id="DDI-DrugBank.d446.s0.e0" charOffset="0-15"
            type="drug" text="Chlorotrianisene"/>
        <entity id="DDI-DrugBank.d446.s0.e1" charOffset="35-49"
            type="group" text="antidepressants"/>
        <entity id="DDI-DrugBank.d446.s0.e2" charOffset="52-58"
            type="brand" text="aspirin"/>
        <entity id="DDI-DrugBank.d446.s0.e3" charOffset="61-72"
            type="group" text="barbiturates"/>
        <entity id="DDI-DrugBank.d446.s0.e4" charOffset="75-87"
            type="drug" text="bromocriptine"/>
        <entity id="DDI-DrugBank.d446.s0.e5" charOffset="90-96"
            type="drug" text="calcium"/>
        <entity id="DDI-DrugBank.d446.s0.e6" charOffset="111-125"
            type="group" text="corticosteroids"/>
        <entity id="DDI-DrugBank.d446.s0.e7" charOffset="128-140"
            type="drug" text="corticotropin"/>
        <entity id="DDI-DrugBank.d446.s0.e8" charOffset="143-154"
            type="drug" text="cyclosporine"/>
        <entity id="DDI-DrugBank.d446.s0.e9" charOffset="157-166"
            type="drug" text="dantrolene"/>
        <entity id="DDI-DrugBank.d446.s0.e10" charOffset="169-176"
            type="drug" text="nicotine"/>
        <entity id="DDI-DrugBank.d446.s0.e11" charOffset="179-188"
            type="drug" text="somatropin"/>
        <entity id="DDI-DrugBank.d446.s0.e12" charOffset="191-199"
            type="drug" text="tamoxifen"/>
        <entity id="DDI-DrugBank.d446.s0.e13" charOffset="206-213"
            type="drug" text="warfarin"/>
        <pair id="DDI-DrugBank.d446.s0.p0" e1="DDI-DrugBank.d446.s0.e0"
            e2="DDI-DrugBank.d446.s0.e1" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d446.s0.p1" e1="DDI-DrugBank.d446.s0.e0"
            e2="DDI-DrugBank.d446.s0.e2" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d446.s0.p2" e1="DDI-DrugBank.d446.s0.e0"
            e2="DDI-DrugBank.d446.s0.e3" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d446.s0.p3" e1="DDI-DrugBank.d446.s0.e0"
            e2="DDI-DrugBank.d446.s0.e4" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d446.s0.p4" e1="DDI-DrugBank.d446.s0.e0"
            e2="DDI-DrugBank.d446.s0.e5" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d446.s0.p5" e1="DDI-DrugBank.d446.s0.e0"
            e2="DDI-DrugBank.d446.s0.e6" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d446.s0.p6" e1="DDI-DrugBank.d446.s0.e0"
            e2="DDI-DrugBank.d446.s0.e7" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d446.s0.p7" e1="DDI-DrugBank.d446.s0.e0"
            e2="DDI-DrugBank.d446.s0.e8" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d446.s0.p8" e1="DDI-DrugBank.d446.s0.e0"
            e2="DDI-DrugBank.d446.s0.e9" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d446.s0.p9" e1="DDI-DrugBank.d446.s0.e0"
            e2="DDI-DrugBank.d446.s0.e10" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d446.s0.p10" e1="DDI-DrugBank.d446.s0.e0"
            e2="DDI-DrugBank.d446.s0.e11" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d446.s0.p11" e1="DDI-DrugBank.d446.s0.e0"
            e2="DDI-DrugBank.d446.s0.e12" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d446.s0.p12" e1="DDI-DrugBank.d446.s0.e0"
            e2="DDI-DrugBank.d446.s0.e13" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d446.s0.p13" e1="DDI-DrugBank.d446.s0.e1"
            e2="DDI-DrugBank.d446.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p14" e1="DDI-DrugBank.d446.s0.e1"
            e2="DDI-DrugBank.d446.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p15" e1="DDI-DrugBank.d446.s0.e1"
            e2="DDI-DrugBank.d446.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p16" e1="DDI-DrugBank.d446.s0.e1"
            e2="DDI-DrugBank.d446.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p17" e1="DDI-DrugBank.d446.s0.e1"
            e2="DDI-DrugBank.d446.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p18" e1="DDI-DrugBank.d446.s0.e1"
            e2="DDI-DrugBank.d446.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p19" e1="DDI-DrugBank.d446.s0.e1"
            e2="DDI-DrugBank.d446.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p20" e1="DDI-DrugBank.d446.s0.e1"
            e2="DDI-DrugBank.d446.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p21" e1="DDI-DrugBank.d446.s0.e1"
            e2="DDI-DrugBank.d446.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p22" e1="DDI-DrugBank.d446.s0.e1"
            e2="DDI-DrugBank.d446.s0.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p23" e1="DDI-DrugBank.d446.s0.e1"
            e2="DDI-DrugBank.d446.s0.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p24" e1="DDI-DrugBank.d446.s0.e1"
            e2="DDI-DrugBank.d446.s0.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p25" e1="DDI-DrugBank.d446.s0.e2"
            e2="DDI-DrugBank.d446.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p26" e1="DDI-DrugBank.d446.s0.e2"
            e2="DDI-DrugBank.d446.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p27" e1="DDI-DrugBank.d446.s0.e2"
            e2="DDI-DrugBank.d446.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p28" e1="DDI-DrugBank.d446.s0.e2"
            e2="DDI-DrugBank.d446.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p29" e1="DDI-DrugBank.d446.s0.e2"
            e2="DDI-DrugBank.d446.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p30" e1="DDI-DrugBank.d446.s0.e2"
            e2="DDI-DrugBank.d446.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p31" e1="DDI-DrugBank.d446.s0.e2"
            e2="DDI-DrugBank.d446.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p32" e1="DDI-DrugBank.d446.s0.e2"
            e2="DDI-DrugBank.d446.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p33" e1="DDI-DrugBank.d446.s0.e2"
            e2="DDI-DrugBank.d446.s0.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p34" e1="DDI-DrugBank.d446.s0.e2"
            e2="DDI-DrugBank.d446.s0.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p35" e1="DDI-DrugBank.d446.s0.e2"
            e2="DDI-DrugBank.d446.s0.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p36" e1="DDI-DrugBank.d446.s0.e3"
            e2="DDI-DrugBank.d446.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p37" e1="DDI-DrugBank.d446.s0.e3"
            e2="DDI-DrugBank.d446.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p38" e1="DDI-DrugBank.d446.s0.e3"
            e2="DDI-DrugBank.d446.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p39" e1="DDI-DrugBank.d446.s0.e3"
            e2="DDI-DrugBank.d446.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p40" e1="DDI-DrugBank.d446.s0.e3"
            e2="DDI-DrugBank.d446.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p41" e1="DDI-DrugBank.d446.s0.e3"
            e2="DDI-DrugBank.d446.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p42" e1="DDI-DrugBank.d446.s0.e3"
            e2="DDI-DrugBank.d446.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p43" e1="DDI-DrugBank.d446.s0.e3"
            e2="DDI-DrugBank.d446.s0.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p44" e1="DDI-DrugBank.d446.s0.e3"
            e2="DDI-DrugBank.d446.s0.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p45" e1="DDI-DrugBank.d446.s0.e3"
            e2="DDI-DrugBank.d446.s0.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p46" e1="DDI-DrugBank.d446.s0.e4"
            e2="DDI-DrugBank.d446.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p47" e1="DDI-DrugBank.d446.s0.e4"
            e2="DDI-DrugBank.d446.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p48" e1="DDI-DrugBank.d446.s0.e4"
            e2="DDI-DrugBank.d446.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p49" e1="DDI-DrugBank.d446.s0.e4"
            e2="DDI-DrugBank.d446.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p50" e1="DDI-DrugBank.d446.s0.e4"
            e2="DDI-DrugBank.d446.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p51" e1="DDI-DrugBank.d446.s0.e4"
            e2="DDI-DrugBank.d446.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p52" e1="DDI-DrugBank.d446.s0.e4"
            e2="DDI-DrugBank.d446.s0.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p53" e1="DDI-DrugBank.d446.s0.e4"
            e2="DDI-DrugBank.d446.s0.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p54" e1="DDI-DrugBank.d446.s0.e4"
            e2="DDI-DrugBank.d446.s0.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p55" e1="DDI-DrugBank.d446.s0.e5"
            e2="DDI-DrugBank.d446.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p56" e1="DDI-DrugBank.d446.s0.e5"
            e2="DDI-DrugBank.d446.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p57" e1="DDI-DrugBank.d446.s0.e5"
            e2="DDI-DrugBank.d446.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p58" e1="DDI-DrugBank.d446.s0.e5"
            e2="DDI-DrugBank.d446.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p59" e1="DDI-DrugBank.d446.s0.e5"
            e2="DDI-DrugBank.d446.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p60" e1="DDI-DrugBank.d446.s0.e5"
            e2="DDI-DrugBank.d446.s0.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p61" e1="DDI-DrugBank.d446.s0.e5"
            e2="DDI-DrugBank.d446.s0.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p62" e1="DDI-DrugBank.d446.s0.e5"
            e2="DDI-DrugBank.d446.s0.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p63" e1="DDI-DrugBank.d446.s0.e6"
            e2="DDI-DrugBank.d446.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p64" e1="DDI-DrugBank.d446.s0.e6"
            e2="DDI-DrugBank.d446.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p65" e1="DDI-DrugBank.d446.s0.e6"
            e2="DDI-DrugBank.d446.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p66" e1="DDI-DrugBank.d446.s0.e6"
            e2="DDI-DrugBank.d446.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p67" e1="DDI-DrugBank.d446.s0.e6"
            e2="DDI-DrugBank.d446.s0.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p68" e1="DDI-DrugBank.d446.s0.e6"
            e2="DDI-DrugBank.d446.s0.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p69" e1="DDI-DrugBank.d446.s0.e6"
            e2="DDI-DrugBank.d446.s0.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p70" e1="DDI-DrugBank.d446.s0.e7"
            e2="DDI-DrugBank.d446.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p71" e1="DDI-DrugBank.d446.s0.e7"
            e2="DDI-DrugBank.d446.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p72" e1="DDI-DrugBank.d446.s0.e7"
            e2="DDI-DrugBank.d446.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p73" e1="DDI-DrugBank.d446.s0.e7"
            e2="DDI-DrugBank.d446.s0.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p74" e1="DDI-DrugBank.d446.s0.e7"
            e2="DDI-DrugBank.d446.s0.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p75" e1="DDI-DrugBank.d446.s0.e7"
            e2="DDI-DrugBank.d446.s0.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p76" e1="DDI-DrugBank.d446.s0.e8"
            e2="DDI-DrugBank.d446.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p77" e1="DDI-DrugBank.d446.s0.e8"
            e2="DDI-DrugBank.d446.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p78" e1="DDI-DrugBank.d446.s0.e8"
            e2="DDI-DrugBank.d446.s0.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p79" e1="DDI-DrugBank.d446.s0.e8"
            e2="DDI-DrugBank.d446.s0.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p80" e1="DDI-DrugBank.d446.s0.e8"
            e2="DDI-DrugBank.d446.s0.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p81" e1="DDI-DrugBank.d446.s0.e9"
            e2="DDI-DrugBank.d446.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p82" e1="DDI-DrugBank.d446.s0.e9"
            e2="DDI-DrugBank.d446.s0.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p83" e1="DDI-DrugBank.d446.s0.e9"
            e2="DDI-DrugBank.d446.s0.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p84" e1="DDI-DrugBank.d446.s0.e9"
            e2="DDI-DrugBank.d446.s0.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p85"
            e1="DDI-DrugBank.d446.s0.e10" e2="DDI-DrugBank.d446.s0.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p86"
            e1="DDI-DrugBank.d446.s0.e10" e2="DDI-DrugBank.d446.s0.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p87"
            e1="DDI-DrugBank.d446.s0.e10" e2="DDI-DrugBank.d446.s0.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p88"
            e1="DDI-DrugBank.d446.s0.e11" e2="DDI-DrugBank.d446.s0.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p89"
            e1="DDI-DrugBank.d446.s0.e11" e2="DDI-DrugBank.d446.s0.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d446.s0.p90"
            e1="DDI-DrugBank.d446.s0.e12" e2="DDI-DrugBank.d446.s0.e13" ddi="false"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d245">
    <sentence id="DDI-DrugBank.d245.s0" text="The hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.">
        <entity id="DDI-DrugBank.d245.s0.e0" charOffset="27-38"
            type="group" text="sulfonylurea"/>
        <entity id="DDI-DrugBank.d245.s0.e1" charOffset="86-122"
            type="group" text="nonsteroidal anti-inflammatory agents"/>
        <entity id="DDI-DrugBank.d245.s0.e2" charOffset="171-181"
            type="group" text="salicylates"/>
        <entity id="DDI-DrugBank.d245.s0.e3" charOffset="184-195"
            type="group" text="sulfonamides"/>
        <entity id="DDI-DrugBank.d245.s0.e4" charOffset="198-212"
            type="drug" text="chloramphenicol"/>
        <entity id="DDI-DrugBank.d245.s0.e5" charOffset="215-224"
            type="drug" text="probenecid"/>
        <entity id="DDI-DrugBank.d245.s0.e6" charOffset="227-235"
            type="group" text="coumarins"/>
        <entity id="DDI-DrugBank.d245.s0.e7" charOffset="238-265"
            type="group" text="monoamine oxidase inhibitors"/>
        <entity id="DDI-DrugBank.d245.s0.e8" charOffset="272-302"
            type="group" text="beta adrenergic blocking agents"/>
        <pair id="DDI-DrugBank.d245.s0.p0" e1="DDI-DrugBank.d245.s0.e0"
            e2="DDI-DrugBank.d245.s0.e1" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d245.s0.p1" e1="DDI-DrugBank.d245.s0.e0"
            e2="DDI-DrugBank.d245.s0.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d245.s0.p2" e1="DDI-DrugBank.d245.s0.e0"
            e2="DDI-DrugBank.d245.s0.e3" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d245.s0.p3" e1="DDI-DrugBank.d245.s0.e0"
            e2="DDI-DrugBank.d245.s0.e4" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d245.s0.p4" e1="DDI-DrugBank.d245.s0.e0"
            e2="DDI-DrugBank.d245.s0.e5" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d245.s0.p5" e1="DDI-DrugBank.d245.s0.e0"
            e2="DDI-DrugBank.d245.s0.e6" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d245.s0.p6" e1="DDI-DrugBank.d245.s0.e0"
            e2="DDI-DrugBank.d245.s0.e7" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d245.s0.p7" e1="DDI-DrugBank.d245.s0.e0"
            e2="DDI-DrugBank.d245.s0.e8" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d245.s0.p8" e1="DDI-DrugBank.d245.s0.e1"
            e2="DDI-DrugBank.d245.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s0.p9" e1="DDI-DrugBank.d245.s0.e1"
            e2="DDI-DrugBank.d245.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s0.p10" e1="DDI-DrugBank.d245.s0.e1"
            e2="DDI-DrugBank.d245.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s0.p11" e1="DDI-DrugBank.d245.s0.e1"
            e2="DDI-DrugBank.d245.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s0.p12" e1="DDI-DrugBank.d245.s0.e1"
            e2="DDI-DrugBank.d245.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s0.p13" e1="DDI-DrugBank.d245.s0.e1"
            e2="DDI-DrugBank.d245.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s0.p14" e1="DDI-DrugBank.d245.s0.e1"
            e2="DDI-DrugBank.d245.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s0.p15" e1="DDI-DrugBank.d245.s0.e2"
            e2="DDI-DrugBank.d245.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s0.p16" e1="DDI-DrugBank.d245.s0.e2"
            e2="DDI-DrugBank.d245.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s0.p17" e1="DDI-DrugBank.d245.s0.e2"
            e2="DDI-DrugBank.d245.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s0.p18" e1="DDI-DrugBank.d245.s0.e2"
            e2="DDI-DrugBank.d245.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s0.p19" e1="DDI-DrugBank.d245.s0.e2"
            e2="DDI-DrugBank.d245.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s0.p20" e1="DDI-DrugBank.d245.s0.e2"
            e2="DDI-DrugBank.d245.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s0.p21" e1="DDI-DrugBank.d245.s0.e3"
            e2="DDI-DrugBank.d245.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s0.p22" e1="DDI-DrugBank.d245.s0.e3"
            e2="DDI-DrugBank.d245.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s0.p23" e1="DDI-DrugBank.d245.s0.e3"
            e2="DDI-DrugBank.d245.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s0.p24" e1="DDI-DrugBank.d245.s0.e3"
            e2="DDI-DrugBank.d245.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s0.p25" e1="DDI-DrugBank.d245.s0.e3"
            e2="DDI-DrugBank.d245.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s0.p26" e1="DDI-DrugBank.d245.s0.e4"
            e2="DDI-DrugBank.d245.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s0.p27" e1="DDI-DrugBank.d245.s0.e4"
            e2="DDI-DrugBank.d245.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s0.p28" e1="DDI-DrugBank.d245.s0.e4"
            e2="DDI-DrugBank.d245.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s0.p29" e1="DDI-DrugBank.d245.s0.e4"
            e2="DDI-DrugBank.d245.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s0.p30" e1="DDI-DrugBank.d245.s0.e5"
            e2="DDI-DrugBank.d245.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s0.p31" e1="DDI-DrugBank.d245.s0.e5"
            e2="DDI-DrugBank.d245.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s0.p32" e1="DDI-DrugBank.d245.s0.e5"
            e2="DDI-DrugBank.d245.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s0.p33" e1="DDI-DrugBank.d245.s0.e6"
            e2="DDI-DrugBank.d245.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s0.p34" e1="DDI-DrugBank.d245.s0.e6"
            e2="DDI-DrugBank.d245.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s0.p35" e1="DDI-DrugBank.d245.s0.e7"
            e2="DDI-DrugBank.d245.s0.e8" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d245.s1" text="When such drugs are administered to a patient receiving DIABINESE, the patient should be observed closely for hypoglycemia.">
        <entity id="DDI-DrugBank.d245.s1.e0" charOffset="56-64"
            type="brand" text="DIABINESE"/>
    </sentence>
    <sentence id="DDI-DrugBank.d245.s2" text="When such drugs are withdrawn from a patient receiving DIABINESE, the patient should be observed closely for loss of control.">
        <entity id="DDI-DrugBank.d245.s2.e0" charOffset="55-63"
            type="brand" text="DIABINESE"/>
    </sentence>
    <sentence id="DDI-DrugBank.d245.s3" text="Certain drugs tend to produce hyperglycemia and may lead to loss of control."/>
    <sentence id="DDI-DrugBank.d245.s4" text="These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.">
        <entity id="DDI-DrugBank.d245.s4.e0" charOffset="24-32"
            type="group" text="thiazides"/>
        <entity id="DDI-DrugBank.d245.s4.e1" charOffset="44-52"
            type="group" text="diuretics"/>
        <entity id="DDI-DrugBank.d245.s4.e2" charOffset="55-69"
            type="group" text="corticosteroids"/>
        <entity id="DDI-DrugBank.d245.s4.e3" charOffset="72-85"
            type="group" text="phenothiazines"/>
        <entity id="DDI-DrugBank.d245.s4.e4" charOffset="106-114"
            type="group" text="estrogens"/>
        <entity id="DDI-DrugBank.d245.s4.e5" charOffset="122-135"
            type="group" text="contraceptives"/>
        <entity id="DDI-DrugBank.d245.s4.e6" charOffset="138-146"
            type="drug" text="phenytoin"/>
        <entity id="DDI-DrugBank.d245.s4.e7" charOffset="149-162"
            type="drug" text="nicotinic acid"/>
        <entity id="DDI-DrugBank.d245.s4.e8" charOffset="165-180"
            type="group" text="sympathomimetics"/>
        <entity id="DDI-DrugBank.d245.s4.e9" charOffset="183-212"
            type="group" text="calcium channel blocking drugs"/>
        <entity id="DDI-DrugBank.d245.s4.e10" charOffset="219-227"
            type="drug" text="isoniazid"/>
        <pair id="DDI-DrugBank.d245.s4.p0" e1="DDI-DrugBank.d245.s4.e0"
            e2="DDI-DrugBank.d245.s4.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p1" e1="DDI-DrugBank.d245.s4.e0"
            e2="DDI-DrugBank.d245.s4.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p2" e1="DDI-DrugBank.d245.s4.e0"
            e2="DDI-DrugBank.d245.s4.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p3" e1="DDI-DrugBank.d245.s4.e0"
            e2="DDI-DrugBank.d245.s4.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p4" e1="DDI-DrugBank.d245.s4.e0"
            e2="DDI-DrugBank.d245.s4.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p5" e1="DDI-DrugBank.d245.s4.e0"
            e2="DDI-DrugBank.d245.s4.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p6" e1="DDI-DrugBank.d245.s4.e0"
            e2="DDI-DrugBank.d245.s4.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p7" e1="DDI-DrugBank.d245.s4.e0"
            e2="DDI-DrugBank.d245.s4.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p8" e1="DDI-DrugBank.d245.s4.e0"
            e2="DDI-DrugBank.d245.s4.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p9" e1="DDI-DrugBank.d245.s4.e0"
            e2="DDI-DrugBank.d245.s4.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p10" e1="DDI-DrugBank.d245.s4.e1"
            e2="DDI-DrugBank.d245.s4.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p11" e1="DDI-DrugBank.d245.s4.e1"
            e2="DDI-DrugBank.d245.s4.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p12" e1="DDI-DrugBank.d245.s4.e1"
            e2="DDI-DrugBank.d245.s4.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p13" e1="DDI-DrugBank.d245.s4.e1"
            e2="DDI-DrugBank.d245.s4.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p14" e1="DDI-DrugBank.d245.s4.e1"
            e2="DDI-DrugBank.d245.s4.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p15" e1="DDI-DrugBank.d245.s4.e1"
            e2="DDI-DrugBank.d245.s4.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p16" e1="DDI-DrugBank.d245.s4.e1"
            e2="DDI-DrugBank.d245.s4.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p17" e1="DDI-DrugBank.d245.s4.e1"
            e2="DDI-DrugBank.d245.s4.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p18" e1="DDI-DrugBank.d245.s4.e1"
            e2="DDI-DrugBank.d245.s4.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p19" e1="DDI-DrugBank.d245.s4.e2"
            e2="DDI-DrugBank.d245.s4.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p20" e1="DDI-DrugBank.d245.s4.e2"
            e2="DDI-DrugBank.d245.s4.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p21" e1="DDI-DrugBank.d245.s4.e2"
            e2="DDI-DrugBank.d245.s4.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p22" e1="DDI-DrugBank.d245.s4.e2"
            e2="DDI-DrugBank.d245.s4.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p23" e1="DDI-DrugBank.d245.s4.e2"
            e2="DDI-DrugBank.d245.s4.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p24" e1="DDI-DrugBank.d245.s4.e2"
            e2="DDI-DrugBank.d245.s4.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p25" e1="DDI-DrugBank.d245.s4.e2"
            e2="DDI-DrugBank.d245.s4.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p26" e1="DDI-DrugBank.d245.s4.e2"
            e2="DDI-DrugBank.d245.s4.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p27" e1="DDI-DrugBank.d245.s4.e3"
            e2="DDI-DrugBank.d245.s4.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p28" e1="DDI-DrugBank.d245.s4.e3"
            e2="DDI-DrugBank.d245.s4.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p29" e1="DDI-DrugBank.d245.s4.e3"
            e2="DDI-DrugBank.d245.s4.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p30" e1="DDI-DrugBank.d245.s4.e3"
            e2="DDI-DrugBank.d245.s4.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p31" e1="DDI-DrugBank.d245.s4.e3"
            e2="DDI-DrugBank.d245.s4.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p32" e1="DDI-DrugBank.d245.s4.e3"
            e2="DDI-DrugBank.d245.s4.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p33" e1="DDI-DrugBank.d245.s4.e3"
            e2="DDI-DrugBank.d245.s4.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p34" e1="DDI-DrugBank.d245.s4.e4"
            e2="DDI-DrugBank.d245.s4.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p35" e1="DDI-DrugBank.d245.s4.e4"
            e2="DDI-DrugBank.d245.s4.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p36" e1="DDI-DrugBank.d245.s4.e4"
            e2="DDI-DrugBank.d245.s4.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p37" e1="DDI-DrugBank.d245.s4.e4"
            e2="DDI-DrugBank.d245.s4.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p38" e1="DDI-DrugBank.d245.s4.e4"
            e2="DDI-DrugBank.d245.s4.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p39" e1="DDI-DrugBank.d245.s4.e4"
            e2="DDI-DrugBank.d245.s4.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p40" e1="DDI-DrugBank.d245.s4.e5"
            e2="DDI-DrugBank.d245.s4.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p41" e1="DDI-DrugBank.d245.s4.e5"
            e2="DDI-DrugBank.d245.s4.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p42" e1="DDI-DrugBank.d245.s4.e5"
            e2="DDI-DrugBank.d245.s4.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p43" e1="DDI-DrugBank.d245.s4.e5"
            e2="DDI-DrugBank.d245.s4.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p44" e1="DDI-DrugBank.d245.s4.e5"
            e2="DDI-DrugBank.d245.s4.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p45" e1="DDI-DrugBank.d245.s4.e6"
            e2="DDI-DrugBank.d245.s4.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p46" e1="DDI-DrugBank.d245.s4.e6"
            e2="DDI-DrugBank.d245.s4.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p47" e1="DDI-DrugBank.d245.s4.e6"
            e2="DDI-DrugBank.d245.s4.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p48" e1="DDI-DrugBank.d245.s4.e6"
            e2="DDI-DrugBank.d245.s4.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p49" e1="DDI-DrugBank.d245.s4.e7"
            e2="DDI-DrugBank.d245.s4.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p50" e1="DDI-DrugBank.d245.s4.e7"
            e2="DDI-DrugBank.d245.s4.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p51" e1="DDI-DrugBank.d245.s4.e7"
            e2="DDI-DrugBank.d245.s4.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p52" e1="DDI-DrugBank.d245.s4.e8"
            e2="DDI-DrugBank.d245.s4.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p53" e1="DDI-DrugBank.d245.s4.e8"
            e2="DDI-DrugBank.d245.s4.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s4.p54" e1="DDI-DrugBank.d245.s4.e9"
            e2="DDI-DrugBank.d245.s4.e10" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d245.s5" text="When such drugs are administered to a patient receiving DIABINESE, the patient should be closely observed for loss of control.">
        <entity id="DDI-DrugBank.d245.s5.e0" charOffset="56-64"
            type="brand" text="DIABINESE"/>
    </sentence>
    <sentence id="DDI-DrugBank.d245.s6" text="When such drugs are withdrawn from a patient receiving DIABINESE, the patient should be observed closely for hypoglycemia.">
        <entity id="DDI-DrugBank.d245.s6.e0" charOffset="55-63"
            type="brand" text="DIABINESE"/>
    </sentence>
    <sentence id="DDI-DrugBank.d245.s7" text="Since animal studies suggest that the action of barbiturates may be prolonged by therapy with chlorpropamide, barbiturates should be employed with caution.">
        <entity id="DDI-DrugBank.d245.s7.e0" charOffset="48-59"
            type="group" text="barbiturates"/>
        <entity id="DDI-DrugBank.d245.s7.e1" charOffset="94-107"
            type="drug" text="chlorpropamide"/>
        <entity id="DDI-DrugBank.d245.s7.e2" charOffset="110-121"
            type="group" text="barbiturates"/>
        <pair id="DDI-DrugBank.d245.s7.p0" e1="DDI-DrugBank.d245.s7.e0"
            e2="DDI-DrugBank.d245.s7.e1" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d245.s7.p1" e1="DDI-DrugBank.d245.s7.e0"
            e2="DDI-DrugBank.d245.s7.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d245.s7.p2" e1="DDI-DrugBank.d245.s7.e1"
            e2="DDI-DrugBank.d245.s7.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d245.s8" text="In some patients, a disulfiram-like reaction may be produced by the ingestion of alcohol.">
        <entity id="DDI-DrugBank.d245.s8.e0" charOffset="20-29"
            type="drug" text="disulfiram"/>
        <entity id="DDI-DrugBank.d245.s8.e1" charOffset="81-87"
            type="drug" text="alcohol"/>
        <pair id="DDI-DrugBank.d245.s8.p0" e1="DDI-DrugBank.d245.s8.e0"
            e2="DDI-DrugBank.d245.s8.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d245.s9" text="A potential interaction between oral miconazole and oral hypoglycemic agents leading to severe hypoglycemia has been reported.">
        <entity id="DDI-DrugBank.d245.s9.e0" charOffset="37-46"
            type="drug" text="miconazole"/>
        <entity id="DDI-DrugBank.d245.s9.e1" charOffset="57-75"
            type="group" text="hypoglycemic agents"/>
        <pair id="DDI-DrugBank.d245.s9.p0" e1="DDI-DrugBank.d245.s9.e0"
            e2="DDI-DrugBank.d245.s9.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d245.s10" text="Whether this interaction also occurs with the intravenous, topical, or vaginal preparations of miconazole is not known.">
        <entity id="DDI-DrugBank.d245.s10.e0" charOffset="95-104"
            type="drug" text="miconazole"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d171">
    <sentence id="DDI-DrugBank.d171.s0" text="Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.">
        <entity id="DDI-DrugBank.d171.s0.e0" charOffset="0-6"
            type="brand" text="Tagamet"/>
        <entity id="DDI-DrugBank.d171.s0.e1" charOffset="130-157"
            type="group" text="warfarin-type anticoagulants"/>
        <entity id="DDI-DrugBank.d171.s0.e2" charOffset="160-168"
            type="drug" text="phenytoin"/>
        <entity id="DDI-DrugBank.d171.s0.e3" charOffset="171-181"
            type="drug" text="propranolol"/>
        <entity id="DDI-DrugBank.d171.s0.e4" charOffset="184-193"
            type="drug" text="nifedipine"/>
        <entity id="DDI-DrugBank.d171.s0.e5" charOffset="196-211"
            type="drug" text="chlordiazepoxide"/>
        <entity id="DDI-DrugBank.d171.s0.e6" charOffset="214-221"
            type="drug" text="diazepam"/>
        <entity id="DDI-DrugBank.d171.s0.e7" charOffset="232-256"
            type="group" text="tricyclic antidepressants"/>
        <entity id="DDI-DrugBank.d171.s0.e8" charOffset="259-267"
            type="drug" text="lidocaine"/>
        <entity id="DDI-DrugBank.d171.s0.e9" charOffset="270-281"
            type="drug" text="theophylline"/>
        <entity id="DDI-DrugBank.d171.s0.e10" charOffset="287-299"
            type="drug" text="metronidazole"/>
        <pair id="DDI-DrugBank.d171.s0.p0" e1="DDI-DrugBank.d171.s0.e0"
            e2="DDI-DrugBank.d171.s0.e1" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d171.s0.p1" e1="DDI-DrugBank.d171.s0.e0"
            e2="DDI-DrugBank.d171.s0.e2" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d171.s0.p2" e1="DDI-DrugBank.d171.s0.e0"
            e2="DDI-DrugBank.d171.s0.e3" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d171.s0.p3" e1="DDI-DrugBank.d171.s0.e0"
            e2="DDI-DrugBank.d171.s0.e4" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d171.s0.p4" e1="DDI-DrugBank.d171.s0.e0"
            e2="DDI-DrugBank.d171.s0.e5" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d171.s0.p5" e1="DDI-DrugBank.d171.s0.e0"
            e2="DDI-DrugBank.d171.s0.e6" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d171.s0.p6" e1="DDI-DrugBank.d171.s0.e0"
            e2="DDI-DrugBank.d171.s0.e7" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d171.s0.p7" e1="DDI-DrugBank.d171.s0.e0"
            e2="DDI-DrugBank.d171.s0.e8" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d171.s0.p8" e1="DDI-DrugBank.d171.s0.e0"
            e2="DDI-DrugBank.d171.s0.e9" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d171.s0.p9" e1="DDI-DrugBank.d171.s0.e0"
            e2="DDI-DrugBank.d171.s0.e10" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d171.s0.p10" e1="DDI-DrugBank.d171.s0.e1"
            e2="DDI-DrugBank.d171.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p11" e1="DDI-DrugBank.d171.s0.e1"
            e2="DDI-DrugBank.d171.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p12" e1="DDI-DrugBank.d171.s0.e1"
            e2="DDI-DrugBank.d171.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p13" e1="DDI-DrugBank.d171.s0.e1"
            e2="DDI-DrugBank.d171.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p14" e1="DDI-DrugBank.d171.s0.e1"
            e2="DDI-DrugBank.d171.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p15" e1="DDI-DrugBank.d171.s0.e1"
            e2="DDI-DrugBank.d171.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p16" e1="DDI-DrugBank.d171.s0.e1"
            e2="DDI-DrugBank.d171.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p17" e1="DDI-DrugBank.d171.s0.e1"
            e2="DDI-DrugBank.d171.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p18" e1="DDI-DrugBank.d171.s0.e1"
            e2="DDI-DrugBank.d171.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p19" e1="DDI-DrugBank.d171.s0.e2"
            e2="DDI-DrugBank.d171.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p20" e1="DDI-DrugBank.d171.s0.e2"
            e2="DDI-DrugBank.d171.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p21" e1="DDI-DrugBank.d171.s0.e2"
            e2="DDI-DrugBank.d171.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p22" e1="DDI-DrugBank.d171.s0.e2"
            e2="DDI-DrugBank.d171.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p23" e1="DDI-DrugBank.d171.s0.e2"
            e2="DDI-DrugBank.d171.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p24" e1="DDI-DrugBank.d171.s0.e2"
            e2="DDI-DrugBank.d171.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p25" e1="DDI-DrugBank.d171.s0.e2"
            e2="DDI-DrugBank.d171.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p26" e1="DDI-DrugBank.d171.s0.e2"
            e2="DDI-DrugBank.d171.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p27" e1="DDI-DrugBank.d171.s0.e3"
            e2="DDI-DrugBank.d171.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p28" e1="DDI-DrugBank.d171.s0.e3"
            e2="DDI-DrugBank.d171.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p29" e1="DDI-DrugBank.d171.s0.e3"
            e2="DDI-DrugBank.d171.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p30" e1="DDI-DrugBank.d171.s0.e3"
            e2="DDI-DrugBank.d171.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p31" e1="DDI-DrugBank.d171.s0.e3"
            e2="DDI-DrugBank.d171.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p32" e1="DDI-DrugBank.d171.s0.e3"
            e2="DDI-DrugBank.d171.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p33" e1="DDI-DrugBank.d171.s0.e3"
            e2="DDI-DrugBank.d171.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p34" e1="DDI-DrugBank.d171.s0.e4"
            e2="DDI-DrugBank.d171.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p35" e1="DDI-DrugBank.d171.s0.e4"
            e2="DDI-DrugBank.d171.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p36" e1="DDI-DrugBank.d171.s0.e4"
            e2="DDI-DrugBank.d171.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p37" e1="DDI-DrugBank.d171.s0.e4"
            e2="DDI-DrugBank.d171.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p38" e1="DDI-DrugBank.d171.s0.e4"
            e2="DDI-DrugBank.d171.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p39" e1="DDI-DrugBank.d171.s0.e4"
            e2="DDI-DrugBank.d171.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p40" e1="DDI-DrugBank.d171.s0.e5"
            e2="DDI-DrugBank.d171.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p41" e1="DDI-DrugBank.d171.s0.e5"
            e2="DDI-DrugBank.d171.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p42" e1="DDI-DrugBank.d171.s0.e5"
            e2="DDI-DrugBank.d171.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p43" e1="DDI-DrugBank.d171.s0.e5"
            e2="DDI-DrugBank.d171.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p44" e1="DDI-DrugBank.d171.s0.e5"
            e2="DDI-DrugBank.d171.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p45" e1="DDI-DrugBank.d171.s0.e6"
            e2="DDI-DrugBank.d171.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p46" e1="DDI-DrugBank.d171.s0.e6"
            e2="DDI-DrugBank.d171.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p47" e1="DDI-DrugBank.d171.s0.e6"
            e2="DDI-DrugBank.d171.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p48" e1="DDI-DrugBank.d171.s0.e6"
            e2="DDI-DrugBank.d171.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p49" e1="DDI-DrugBank.d171.s0.e7"
            e2="DDI-DrugBank.d171.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p50" e1="DDI-DrugBank.d171.s0.e7"
            e2="DDI-DrugBank.d171.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p51" e1="DDI-DrugBank.d171.s0.e7"
            e2="DDI-DrugBank.d171.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p52" e1="DDI-DrugBank.d171.s0.e8"
            e2="DDI-DrugBank.d171.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p53" e1="DDI-DrugBank.d171.s0.e8"
            e2="DDI-DrugBank.d171.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s0.p54" e1="DDI-DrugBank.d171.s0.e9"
            e2="DDI-DrugBank.d171.s0.e10" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d171.s1" text="Clinically significant effects have been reported with the warfarin anticoagulants;">
        <entity id="DDI-DrugBank.d171.s1.e0" charOffset="59-81"
            type="group" text="warfarin anticoagulants"/>
    </sentence>
    <sentence id="DDI-DrugBank.d171.s2" text="therefore, close monitoring of prothrombin time is recommended, and adjustment of the anticoagulant dose may be necessary when Tagamet is administered concomitantly.">
        <entity id="DDI-DrugBank.d171.s2.e0" charOffset="86-98"
            type="group" text="anticoagulant"/>
        <entity id="DDI-DrugBank.d171.s2.e1" charOffset="127-133"
            type="brand" text="Tagamet"/>
        <pair id="DDI-DrugBank.d171.s2.p0" e1="DDI-DrugBank.d171.s2.e0"
            e2="DDI-DrugBank.d171.s2.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d171.s3" text="Interaction with phenytoin, lidocaine and theophylline has also been reported to produce adverse clinical effects.">
        <entity id="DDI-DrugBank.d171.s3.e0" charOffset="17-25"
            type="drug" text="phenytoin"/>
        <entity id="DDI-DrugBank.d171.s3.e1" charOffset="28-36"
            type="drug" text="lidocaine"/>
        <entity id="DDI-DrugBank.d171.s3.e2" charOffset="42-53"
            type="drug" text="theophylline"/>
        <pair id="DDI-DrugBank.d171.s3.p0" e1="DDI-DrugBank.d171.s3.e0"
            e2="DDI-DrugBank.d171.s3.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s3.p1" e1="DDI-DrugBank.d171.s3.e0"
            e2="DDI-DrugBank.d171.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s3.p2" e1="DDI-DrugBank.d171.s3.e1"
            e2="DDI-DrugBank.d171.s3.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d171.s4" text="However, a crossover study in healthy subjects receiving either Tagamet 300 mg q.i.d. or 800 mg h.s. concomitantly with a 300 mg b.i.d. dosage of theophylline (Theo-Dur , Key Pharmaceuticals, Inc.) demonstrated less alteration in steady-state theophylline peak serum levels with the 800 mg h.s. regimen, particularly in subjects aged 54 years and older.">
        <entity id="DDI-DrugBank.d171.s4.e0" charOffset="64-70"
            type="brand" text="Tagamet"/>
        <entity id="DDI-DrugBank.d171.s4.e1" charOffset="146-157"
            type="drug" text="theophylline"/>
        <entity id="DDI-DrugBank.d171.s4.e2" charOffset="160-167"
            type="brand" text="Theo-Dur"/>
        <entity id="DDI-DrugBank.d171.s4.e3" charOffset="243-254"
            type="drug" text="theophylline"/>
        <pair id="DDI-DrugBank.d171.s4.p0" e1="DDI-DrugBank.d171.s4.e0"
            e2="DDI-DrugBank.d171.s4.e1" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d171.s4.p1" e1="DDI-DrugBank.d171.s4.e0"
            e2="DDI-DrugBank.d171.s4.e2" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d171.s4.p2" e1="DDI-DrugBank.d171.s4.e0"
            e2="DDI-DrugBank.d171.s4.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s4.p3" e1="DDI-DrugBank.d171.s4.e1"
            e2="DDI-DrugBank.d171.s4.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s4.p4" e1="DDI-DrugBank.d171.s4.e1"
            e2="DDI-DrugBank.d171.s4.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d171.s4.p5" e1="DDI-DrugBank.d171.s4.e2"
            e2="DDI-DrugBank.d171.s4.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d171.s5" text="Data beyond 10 days are not available."/>
    <sentence id="DDI-DrugBank.d171.s6" text="(Note: All patients receiving theophylline should be monitored appropriately, regardless of concomitant drug therapy.)">
        <entity id="DDI-DrugBank.d171.s6.e0" charOffset="30-41"
            type="drug" text="theophylline"/>
    </sentence>
    <sentence id="DDI-DrugBank.d171.s7" text="Dosage of the drugs mentioned above and other similarly metabolized drugs, particularly those of low therapeutic ratio or in patients with renal and/or hepatic impairment, may require adjustment when starting or stopping concomitantly administered Tagamet to maintain optimum therapeutic blood levels.">
        <entity id="DDI-DrugBank.d171.s7.e0" charOffset="248-254"
            type="brand" text="Tagamet"/>
    </sentence>
    <sentence id="DDI-DrugBank.d171.s8" text="Alteration of pH may affect absorption of certain drugs (e.g., ketoconazole).">
        <entity id="DDI-DrugBank.d171.s8.e0" charOffset="63-74"
            type="drug" text="ketoconazole"/>
    </sentence>
    <sentence id="DDI-DrugBank.d171.s9" text="If these products are needed, they should be given at least 2 hours before cimetidine administration.">
        <entity id="DDI-DrugBank.d171.s9.e0" charOffset="75-84"
            type="drug" text="cimetidine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d171.s10" text="Additional clinical experience may reveal other drugs affected by the concomitant administration of Tagamet.">
        <entity id="DDI-DrugBank.d171.s10.e0" charOffset="100-106"
            type="brand" text="Tagamet"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d237">
    <sentence id="DDI-DrugBank.d237.s0" text="Cisapride is metabolized mainly via the cytochrome P450 3A4 enzyme.">
        <entity id="DDI-DrugBank.d237.s0.e0" charOffset="0-8"
            type="drug" text="Cisapride"/>
    </sentence>
    <sentence id="DDI-DrugBank.d237.s1" text="In some cases where serious ventricular arrhythmias, QT prolongation, and torsades de pointes have occurred when cisapride was taken in conjunction with one of the cytochrome P450 3A4 inhibitors, elevated blood cisapride levels were noted at the time of the QT prolongation.">
        <entity id="DDI-DrugBank.d237.s1.e0" charOffset="113-121"
            type="drug" text="cisapride"/>
        <entity id="DDI-DrugBank.d237.s1.e1" charOffset="211-219"
            type="drug" text="cisapride"/>
        <pair id="DDI-DrugBank.d237.s1.p0" e1="DDI-DrugBank.d237.s1.e0"
            e2="DDI-DrugBank.d237.s1.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d237.s2" text="Antibiotics: In vitro and/or in vivo data show that clarithromycin, erythromycin, and troleandomycin markedly inhibit the metabolism of cisapride, which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG.">
        <entity id="DDI-DrugBank.d237.s2.e0" charOffset="0-10"
            type="group" text="Antibiotics"/>
        <entity id="DDI-DrugBank.d237.s2.e1" charOffset="52-65"
            type="drug" text="clarithromycin"/>
        <entity id="DDI-DrugBank.d237.s2.e2" charOffset="68-79"
            type="drug" text="erythromycin"/>
        <entity id="DDI-DrugBank.d237.s2.e3" charOffset="86-99"
            type="drug" text="troleandomycin"/>
        <entity id="DDI-DrugBank.d237.s2.e4" charOffset="136-144"
            type="drug" text="cisapride"/>
        <entity id="DDI-DrugBank.d237.s2.e5" charOffset="189-197"
            type="drug" text="cisapride"/>
        <pair id="DDI-DrugBank.d237.s2.p0" e1="DDI-DrugBank.d237.s2.e0"
            e2="DDI-DrugBank.d237.s2.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s2.p1" e1="DDI-DrugBank.d237.s2.e0"
            e2="DDI-DrugBank.d237.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s2.p2" e1="DDI-DrugBank.d237.s2.e0"
            e2="DDI-DrugBank.d237.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s2.p3" e1="DDI-DrugBank.d237.s2.e0"
            e2="DDI-DrugBank.d237.s2.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s2.p4" e1="DDI-DrugBank.d237.s2.e0"
            e2="DDI-DrugBank.d237.s2.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s2.p5" e1="DDI-DrugBank.d237.s2.e1"
            e2="DDI-DrugBank.d237.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s2.p6" e1="DDI-DrugBank.d237.s2.e1"
            e2="DDI-DrugBank.d237.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s2.p7" e1="DDI-DrugBank.d237.s2.e1"
            e2="DDI-DrugBank.d237.s2.e4" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d237.s2.p8" e1="DDI-DrugBank.d237.s2.e1"
            e2="DDI-DrugBank.d237.s2.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s2.p9" e1="DDI-DrugBank.d237.s2.e2"
            e2="DDI-DrugBank.d237.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s2.p10" e1="DDI-DrugBank.d237.s2.e2"
            e2="DDI-DrugBank.d237.s2.e4" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d237.s2.p11" e1="DDI-DrugBank.d237.s2.e2"
            e2="DDI-DrugBank.d237.s2.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s2.p12" e1="DDI-DrugBank.d237.s2.e3"
            e2="DDI-DrugBank.d237.s2.e4" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d237.s2.p13" e1="DDI-DrugBank.d237.s2.e3"
            e2="DDI-DrugBank.d237.s2.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s2.p14" e1="DDI-DrugBank.d237.s2.e4"
            e2="DDI-DrugBank.d237.s2.e5" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d237.s3" text="Anticholinergics: Concurrent administration of certain anticholinergic compounds, such as belladonna alkaloids and dicyclomine, would be expected to compromise the beneficial effects of cisapride.">
        <entity id="DDI-DrugBank.d237.s3.e0" charOffset="0-15"
            type="group" text="Anticholinergics"/>
        <entity id="DDI-DrugBank.d237.s3.e1" charOffset="55-79"
            type="group" text="anticholinergic compounds"/>
        <entity id="DDI-DrugBank.d237.s3.e2" charOffset="90-109"
            type="group" text="belladonna alkaloids"/>
        <entity id="DDI-DrugBank.d237.s3.e3" charOffset="115-125"
            type="drug" text="dicyclomine"/>
        <entity id="DDI-DrugBank.d237.s3.e4" charOffset="186-194"
            type="drug" text="cisapride"/>
        <pair id="DDI-DrugBank.d237.s3.p0" e1="DDI-DrugBank.d237.s3.e0"
            e2="DDI-DrugBank.d237.s3.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s3.p1" e1="DDI-DrugBank.d237.s3.e0"
            e2="DDI-DrugBank.d237.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s3.p2" e1="DDI-DrugBank.d237.s3.e0"
            e2="DDI-DrugBank.d237.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s3.p3" e1="DDI-DrugBank.d237.s3.e0"
            e2="DDI-DrugBank.d237.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s3.p4" e1="DDI-DrugBank.d237.s3.e1"
            e2="DDI-DrugBank.d237.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s3.p5" e1="DDI-DrugBank.d237.s3.e1"
            e2="DDI-DrugBank.d237.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s3.p6" e1="DDI-DrugBank.d237.s3.e1"
            e2="DDI-DrugBank.d237.s3.e4" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d237.s3.p7" e1="DDI-DrugBank.d237.s3.e2"
            e2="DDI-DrugBank.d237.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s3.p8" e1="DDI-DrugBank.d237.s3.e2"
            e2="DDI-DrugBank.d237.s3.e4" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d237.s3.p9" e1="DDI-DrugBank.d237.s3.e3"
            e2="DDI-DrugBank.d237.s3.e4" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d237.s4" text="Anticoagulants (Oral): In patients receiving oral anticoagulants, the coagulation times were increased in some cases.">
        <entity id="DDI-DrugBank.d237.s4.e0" charOffset="0-13"
            type="group" text="Anticoagulants"/>
        <entity id="DDI-DrugBank.d237.s4.e1" charOffset="50-63"
            type="group" text="anticoagulants"/>
        <pair id="DDI-DrugBank.d237.s4.p0" e1="DDI-DrugBank.d237.s4.e0"
            e2="DDI-DrugBank.d237.s4.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d237.s5" text="It is advisable to check coagulation time within the first few days after the start and discontinuation of cisapride therapy, with an appropriate adjustment of the anticoagulant dose, if necessary.">
        <entity id="DDI-DrugBank.d237.s5.e0" charOffset="107-115"
            type="drug" text="cisapride"/>
        <entity id="DDI-DrugBank.d237.s5.e1" charOffset="164-176"
            type="group" text="anticoagulant"/>
        <pair id="DDI-DrugBank.d237.s5.p0" e1="DDI-DrugBank.d237.s5.e0"
            e2="DDI-DrugBank.d237.s5.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d237.s6" text="Antidepressants: In vitro data indicate that nefazodone inhibits the metabolism of cisapride, which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG.">
        <entity id="DDI-DrugBank.d237.s6.e0" charOffset="0-14"
            type="group" text="Antidepressants"/>
        <entity id="DDI-DrugBank.d237.s6.e1" charOffset="45-54"
            type="drug" text="nefazodone"/>
        <entity id="DDI-DrugBank.d237.s6.e2" charOffset="83-91"
            type="drug" text="cisapride"/>
        <entity id="DDI-DrugBank.d237.s6.e3" charOffset="136-144"
            type="drug" text="cisapride"/>
        <pair id="DDI-DrugBank.d237.s6.p0" e1="DDI-DrugBank.d237.s6.e0"
            e2="DDI-DrugBank.d237.s6.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s6.p1" e1="DDI-DrugBank.d237.s6.e0"
            e2="DDI-DrugBank.d237.s6.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s6.p2" e1="DDI-DrugBank.d237.s6.e0"
            e2="DDI-DrugBank.d237.s6.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s6.p3" e1="DDI-DrugBank.d237.s6.e1"
            e2="DDI-DrugBank.d237.s6.e2" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d237.s6.p4" e1="DDI-DrugBank.d237.s6.e1"
            e2="DDI-DrugBank.d237.s6.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s6.p5" e1="DDI-DrugBank.d237.s6.e2"
            e2="DDI-DrugBank.d237.s6.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d237.s7" text="Antifungals: In vitro and/or in vivo data indicate that fluconazole, itraconazole, and oral ketoconazole markedly inhibit the metabolism of cisapride, which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG.">
        <entity id="DDI-DrugBank.d237.s7.e0" charOffset="0-10"
            type="group" text="Antifungals"/>
        <entity id="DDI-DrugBank.d237.s7.e1" charOffset="56-66"
            type="drug" text="fluconazole"/>
        <entity id="DDI-DrugBank.d237.s7.e2" charOffset="69-80"
            type="drug" text="itraconazole"/>
        <entity id="DDI-DrugBank.d237.s7.e3" charOffset="92-103"
            type="drug" text="ketoconazole"/>
        <entity id="DDI-DrugBank.d237.s7.e4" charOffset="140-148"
            type="drug" text="cisapride"/>
        <entity id="DDI-DrugBank.d237.s7.e5" charOffset="193-201"
            type="drug" text="cisapride"/>
        <pair id="DDI-DrugBank.d237.s7.p0" e1="DDI-DrugBank.d237.s7.e0"
            e2="DDI-DrugBank.d237.s7.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s7.p1" e1="DDI-DrugBank.d237.s7.e0"
            e2="DDI-DrugBank.d237.s7.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s7.p2" e1="DDI-DrugBank.d237.s7.e0"
            e2="DDI-DrugBank.d237.s7.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s7.p3" e1="DDI-DrugBank.d237.s7.e0"
            e2="DDI-DrugBank.d237.s7.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s7.p4" e1="DDI-DrugBank.d237.s7.e0"
            e2="DDI-DrugBank.d237.s7.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s7.p5" e1="DDI-DrugBank.d237.s7.e1"
            e2="DDI-DrugBank.d237.s7.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s7.p6" e1="DDI-DrugBank.d237.s7.e1"
            e2="DDI-DrugBank.d237.s7.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s7.p7" e1="DDI-DrugBank.d237.s7.e1"
            e2="DDI-DrugBank.d237.s7.e4" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d237.s7.p8" e1="DDI-DrugBank.d237.s7.e1"
            e2="DDI-DrugBank.d237.s7.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s7.p9" e1="DDI-DrugBank.d237.s7.e2"
            e2="DDI-DrugBank.d237.s7.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s7.p10" e1="DDI-DrugBank.d237.s7.e2"
            e2="DDI-DrugBank.d237.s7.e4" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d237.s7.p11" e1="DDI-DrugBank.d237.s7.e2"
            e2="DDI-DrugBank.d237.s7.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s7.p12" e1="DDI-DrugBank.d237.s7.e3"
            e2="DDI-DrugBank.d237.s7.e4" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d237.s7.p13" e1="DDI-DrugBank.d237.s7.e3"
            e2="DDI-DrugBank.d237.s7.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s7.p14" e1="DDI-DrugBank.d237.s7.e4"
            e2="DDI-DrugBank.d237.s7.e5" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d237.s8" text="Human pharmacokinetic data indicate that oral ketoconazole markedly inhibits the metabolism of cisapride, resulting in a mean eight-fold increase in AUC of cisapride.">
        <entity id="DDI-DrugBank.d237.s8.e0" charOffset="46-57"
            type="drug" text="ketoconazole"/>
        <entity id="DDI-DrugBank.d237.s8.e1" charOffset="95-103"
            type="drug" text="cisapride"/>
        <entity id="DDI-DrugBank.d237.s8.e2" charOffset="156-164"
            type="drug" text="cisapride"/>
        <pair id="DDI-DrugBank.d237.s8.p0" e1="DDI-DrugBank.d237.s8.e0"
            e2="DDI-DrugBank.d237.s8.e1" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d237.s8.p1" e1="DDI-DrugBank.d237.s8.e0"
            e2="DDI-DrugBank.d237.s8.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s8.p2" e1="DDI-DrugBank.d237.s8.e1"
            e2="DDI-DrugBank.d237.s8.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d237.s9" text="A study in 14 normal male and female volunteers suggests that coadministration of cisapride and ketoconazole can result in prolongation of the QT interval on the ECG.">
        <entity id="DDI-DrugBank.d237.s9.e0" charOffset="82-90"
            type="drug" text="cisapride"/>
        <entity id="DDI-DrugBank.d237.s9.e1" charOffset="96-107"
            type="drug" text="ketoconazole"/>
        <pair id="DDI-DrugBank.d237.s9.p0" e1="DDI-DrugBank.d237.s9.e0"
            e2="DDI-DrugBank.d237.s9.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d237.s10" text="H2 Receptor Antagonists: Cimetidine coadministration leads to an increased peak plasma concentration and AUC of cisapride, there is no effect on cisapride absorption when it is coadministered with ranitidine.">
        <entity id="DDI-DrugBank.d237.s10.e0" charOffset="0-22"
            type="group" text="H2 Receptor Antagonists"/>
        <entity id="DDI-DrugBank.d237.s10.e1" charOffset="25-34"
            type="drug" text="Cimetidine"/>
        <entity id="DDI-DrugBank.d237.s10.e2" charOffset="112-120"
            type="drug" text="cisapride"/>
        <entity id="DDI-DrugBank.d237.s10.e3" charOffset="145-153"
            type="drug" text="cisapride"/>
        <entity id="DDI-DrugBank.d237.s10.e4" charOffset="197-206"
            type="drug" text="ranitidine"/>
        <pair id="DDI-DrugBank.d237.s10.p0"
            e1="DDI-DrugBank.d237.s10.e0" e2="DDI-DrugBank.d237.s10.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s10.p1"
            e1="DDI-DrugBank.d237.s10.e0" e2="DDI-DrugBank.d237.s10.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s10.p2"
            e1="DDI-DrugBank.d237.s10.e0" e2="DDI-DrugBank.d237.s10.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s10.p3"
            e1="DDI-DrugBank.d237.s10.e0" e2="DDI-DrugBank.d237.s10.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s10.p4"
            e1="DDI-DrugBank.d237.s10.e1" e2="DDI-DrugBank.d237.s10.e2"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d237.s10.p5"
            e1="DDI-DrugBank.d237.s10.e1" e2="DDI-DrugBank.d237.s10.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s10.p6"
            e1="DDI-DrugBank.d237.s10.e1" e2="DDI-DrugBank.d237.s10.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s10.p7"
            e1="DDI-DrugBank.d237.s10.e2" e2="DDI-DrugBank.d237.s10.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s10.p8"
            e1="DDI-DrugBank.d237.s10.e2" e2="DDI-DrugBank.d237.s10.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s10.p9"
            e1="DDI-DrugBank.d237.s10.e3" e2="DDI-DrugBank.d237.s10.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d237.s11" text="The gastrointestinal absorption of cimetidine and ranitidine is accelerated when they are coadministered with cisapride.">
        <entity id="DDI-DrugBank.d237.s11.e0" charOffset="35-44"
            type="drug" text="cimetidine"/>
        <entity id="DDI-DrugBank.d237.s11.e1" charOffset="50-59"
            type="drug" text="ranitidine"/>
        <entity id="DDI-DrugBank.d237.s11.e2" charOffset="110-118"
            type="drug" text="cisapride"/>
        <pair id="DDI-DrugBank.d237.s11.p0"
            e1="DDI-DrugBank.d237.s11.e0" e2="DDI-DrugBank.d237.s11.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s11.p1"
            e1="DDI-DrugBank.d237.s11.e0" e2="DDI-DrugBank.d237.s11.e2"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d237.s11.p2"
            e1="DDI-DrugBank.d237.s11.e1" e2="DDI-DrugBank.d237.s11.e2"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d237.s12" text="Protease Inhibitors: In vitro data indicate that indinavir and ritonavir markedly inhibit the metabolism of cisapride which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG.">
        <entity id="DDI-DrugBank.d237.s12.e0" charOffset="0-18"
            type="group" text="Protease Inhibitors"/>
        <entity id="DDI-DrugBank.d237.s12.e1" charOffset="49-57"
            type="drug" text="indinavir"/>
        <entity id="DDI-DrugBank.d237.s12.e2" charOffset="63-71"
            type="drug" text="ritonavir"/>
        <entity id="DDI-DrugBank.d237.s12.e3" charOffset="108-116"
            type="drug" text="cisapride"/>
        <entity id="DDI-DrugBank.d237.s12.e4" charOffset="160-168"
            type="drug" text="cisapride"/>
        <pair id="DDI-DrugBank.d237.s12.p0"
            e1="DDI-DrugBank.d237.s12.e0" e2="DDI-DrugBank.d237.s12.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s12.p1"
            e1="DDI-DrugBank.d237.s12.e0" e2="DDI-DrugBank.d237.s12.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s12.p2"
            e1="DDI-DrugBank.d237.s12.e0" e2="DDI-DrugBank.d237.s12.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s12.p3"
            e1="DDI-DrugBank.d237.s12.e0" e2="DDI-DrugBank.d237.s12.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s12.p4"
            e1="DDI-DrugBank.d237.s12.e1" e2="DDI-DrugBank.d237.s12.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s12.p5"
            e1="DDI-DrugBank.d237.s12.e1" e2="DDI-DrugBank.d237.s12.e3"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d237.s12.p6"
            e1="DDI-DrugBank.d237.s12.e1" e2="DDI-DrugBank.d237.s12.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s12.p7"
            e1="DDI-DrugBank.d237.s12.e2" e2="DDI-DrugBank.d237.s12.e3"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d237.s12.p8"
            e1="DDI-DrugBank.d237.s12.e2" e2="DDI-DrugBank.d237.s12.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s12.p9"
            e1="DDI-DrugBank.d237.s12.e3" e2="DDI-DrugBank.d237.s12.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d237.s13" text="Other: Coadministration of grapefruit juice with cisapride increases the bioavailability of cisapride and concomitant use should be avoided.">
        <entity id="DDI-DrugBank.d237.s13.e0" charOffset="49-57"
            type="drug" text="cisapride"/>
        <entity id="DDI-DrugBank.d237.s13.e1" charOffset="92-100"
            type="drug" text="cisapride"/>
        <pair id="DDI-DrugBank.d237.s13.p0"
            e1="DDI-DrugBank.d237.s13.e0" e2="DDI-DrugBank.d237.s13.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d237.s14" text="Cisapride should not be used concomitantly with other drugs known to prolong the QT interval: certain antiarrhythmics, including those of Class IA (such as quinidine and procainamide) and Class III (such as sotalol);">
        <entity id="DDI-DrugBank.d237.s14.e0" charOffset="0-8"
            type="drug" text="Cisapride"/>
        <entity id="DDI-DrugBank.d237.s14.e1" charOffset="102-116"
            type="group" text="antiarrhythmics"/>
        <entity id="DDI-DrugBank.d237.s14.e2" charOffset="156-164"
            type="drug" text="quinidine"/>
        <entity id="DDI-DrugBank.d237.s14.e3" charOffset="170-181"
            type="drug" text="procainamide"/>
        <entity id="DDI-DrugBank.d237.s14.e4" charOffset="207-213"
            type="drug" text="sotalol"/>
        <pair id="DDI-DrugBank.d237.s14.p0"
            e1="DDI-DrugBank.d237.s14.e0" e2="DDI-DrugBank.d237.s14.e1"
            ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d237.s14.p1"
            e1="DDI-DrugBank.d237.s14.e0" e2="DDI-DrugBank.d237.s14.e2"
            ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d237.s14.p2"
            e1="DDI-DrugBank.d237.s14.e0" e2="DDI-DrugBank.d237.s14.e3"
            ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d237.s14.p3"
            e1="DDI-DrugBank.d237.s14.e0" e2="DDI-DrugBank.d237.s14.e4"
            ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d237.s14.p4"
            e1="DDI-DrugBank.d237.s14.e1" e2="DDI-DrugBank.d237.s14.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s14.p5"
            e1="DDI-DrugBank.d237.s14.e1" e2="DDI-DrugBank.d237.s14.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s14.p6"
            e1="DDI-DrugBank.d237.s14.e1" e2="DDI-DrugBank.d237.s14.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s14.p7"
            e1="DDI-DrugBank.d237.s14.e2" e2="DDI-DrugBank.d237.s14.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s14.p8"
            e1="DDI-DrugBank.d237.s14.e2" e2="DDI-DrugBank.d237.s14.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s14.p9"
            e1="DDI-DrugBank.d237.s14.e3" e2="DDI-DrugBank.d237.s14.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d237.s15" text="tricyclic antidepressants (such as amitriptyline);">
        <entity id="DDI-DrugBank.d237.s15.e0" charOffset="0-24"
            type="group" text="tricyclic antidepressants"/>
        <entity id="DDI-DrugBank.d237.s15.e1" charOffset="35-47"
            type="drug" text="amitriptyline"/>
        <pair id="DDI-DrugBank.d237.s15.p0"
            e1="DDI-DrugBank.d237.s15.e0" e2="DDI-DrugBank.d237.s15.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d237.s16" text="certain tetracyclic antidepressants (such as maprotiline);">
        <entity id="DDI-DrugBank.d237.s16.e0" charOffset="8-34"
            type="group" text="tetracyclic antidepressants"/>
        <entity id="DDI-DrugBank.d237.s16.e1" charOffset="45-55"
            type="drug" text="maprotiline"/>
        <pair id="DDI-DrugBank.d237.s16.p0"
            e1="DDI-DrugBank.d237.s16.e0" e2="DDI-DrugBank.d237.s16.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d237.s17" text="certain antipsychotic medications (such as sertindole);">
        <entity id="DDI-DrugBank.d237.s17.e0" charOffset="8-32"
            type="group" text="antipsychotic medications"/>
        <entity id="DDI-DrugBank.d237.s17.e1" charOffset="43-52"
            type="drug" text="sertindole"/>
        <pair id="DDI-DrugBank.d237.s17.p0"
            e1="DDI-DrugBank.d237.s17.e0" e2="DDI-DrugBank.d237.s17.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d237.s18" text="astemizole, bepridil, sparfloxacin, and terodiline.">
        <entity id="DDI-DrugBank.d237.s18.e0" charOffset="0-9"
            type="drug" text="astemizole"/>
        <entity id="DDI-DrugBank.d237.s18.e1" charOffset="12-19"
            type="drug" text="bepridil"/>
        <entity id="DDI-DrugBank.d237.s18.e2" charOffset="22-33"
            type="drug" text="sparfloxacin"/>
        <entity id="DDI-DrugBank.d237.s18.e3" charOffset="40-49"
            type="drug" text="terodiline"/>
        <pair id="DDI-DrugBank.d237.s18.p0"
            e1="DDI-DrugBank.d237.s18.e0" e2="DDI-DrugBank.d237.s18.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s18.p1"
            e1="DDI-DrugBank.d237.s18.e0" e2="DDI-DrugBank.d237.s18.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s18.p2"
            e1="DDI-DrugBank.d237.s18.e0" e2="DDI-DrugBank.d237.s18.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s18.p3"
            e1="DDI-DrugBank.d237.s18.e1" e2="DDI-DrugBank.d237.s18.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s18.p4"
            e1="DDI-DrugBank.d237.s18.e1" e2="DDI-DrugBank.d237.s18.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d237.s18.p5"
            e1="DDI-DrugBank.d237.s18.e2" e2="DDI-DrugBank.d237.s18.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d237.s19" text="The preceding lists of drugs are not comprehensive."/>
    <sentence id="DDI-DrugBank.d237.s20" text="The acceleration of gastric emptying by cisapride could affect the rate of absorption of other drugs.">
        <entity id="DDI-DrugBank.d237.s20.e0" charOffset="40-48"
            type="drug" text="cisapride"/>
    </sentence>
    <sentence id="DDI-DrugBank.d237.s21" text="Patients receiving narrow therapeutic ratio drugs or other drugs that require careful titration should be followed closely;"/>
    <sentence id="DDI-DrugBank.d237.s22" text="if plasma levels are being monitored, they should be reassessed."/>
</document>
<document id="DDI-DrugBank.d464">
    <sentence id="DDI-DrugBank.d464.s0" text="Codeine in combination with other narcotic analgesics, general anesthetics, phenothiazines, tranquilizers, sedative-hypnotics, or other CNS depressants (including alcohol) has additive depressant effects.">
        <entity id="DDI-DrugBank.d464.s0.e0" charOffset="0-6"
            type="drug" text="Codeine"/>
        <entity id="DDI-DrugBank.d464.s0.e1" charOffset="34-52"
            type="group" text="narcotic analgesics"/>
        <entity id="DDI-DrugBank.d464.s0.e2" charOffset="63-73"
            type="group" text="anesthetics"/>
        <entity id="DDI-DrugBank.d464.s0.e3" charOffset="76-89"
            type="group" text="phenothiazines"/>
        <entity id="DDI-DrugBank.d464.s0.e4" charOffset="92-104"
            type="group" text="tranquilizers"/>
        <entity id="DDI-DrugBank.d464.s0.e5" charOffset="107-124"
            type="group" text="sedative-hypnotics"/>
        <entity id="DDI-DrugBank.d464.s0.e6" charOffset="136-150"
            type="group" text="CNS depressants"/>
        <entity id="DDI-DrugBank.d464.s0.e7" charOffset="163-169"
            type="drug" text="alcohol"/>
        <pair id="DDI-DrugBank.d464.s0.p0" e1="DDI-DrugBank.d464.s0.e0"
            e2="DDI-DrugBank.d464.s0.e1" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d464.s0.p1" e1="DDI-DrugBank.d464.s0.e0"
            e2="DDI-DrugBank.d464.s0.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d464.s0.p2" e1="DDI-DrugBank.d464.s0.e0"
            e2="DDI-DrugBank.d464.s0.e3" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d464.s0.p3" e1="DDI-DrugBank.d464.s0.e0"
            e2="DDI-DrugBank.d464.s0.e4" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d464.s0.p4" e1="DDI-DrugBank.d464.s0.e0"
            e2="DDI-DrugBank.d464.s0.e5" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d464.s0.p5" e1="DDI-DrugBank.d464.s0.e0"
            e2="DDI-DrugBank.d464.s0.e6" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d464.s0.p6" e1="DDI-DrugBank.d464.s0.e0"
            e2="DDI-DrugBank.d464.s0.e7" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d464.s0.p7" e1="DDI-DrugBank.d464.s0.e1"
            e2="DDI-DrugBank.d464.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d464.s0.p8" e1="DDI-DrugBank.d464.s0.e1"
            e2="DDI-DrugBank.d464.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d464.s0.p9" e1="DDI-DrugBank.d464.s0.e1"
            e2="DDI-DrugBank.d464.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d464.s0.p10" e1="DDI-DrugBank.d464.s0.e1"
            e2="DDI-DrugBank.d464.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d464.s0.p11" e1="DDI-DrugBank.d464.s0.e1"
            e2="DDI-DrugBank.d464.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d464.s0.p12" e1="DDI-DrugBank.d464.s0.e1"
            e2="DDI-DrugBank.d464.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d464.s0.p13" e1="DDI-DrugBank.d464.s0.e2"
            e2="DDI-DrugBank.d464.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d464.s0.p14" e1="DDI-DrugBank.d464.s0.e2"
            e2="DDI-DrugBank.d464.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d464.s0.p15" e1="DDI-DrugBank.d464.s0.e2"
            e2="DDI-DrugBank.d464.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d464.s0.p16" e1="DDI-DrugBank.d464.s0.e2"
            e2="DDI-DrugBank.d464.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d464.s0.p17" e1="DDI-DrugBank.d464.s0.e2"
            e2="DDI-DrugBank.d464.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d464.s0.p18" e1="DDI-DrugBank.d464.s0.e3"
            e2="DDI-DrugBank.d464.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d464.s0.p19" e1="DDI-DrugBank.d464.s0.e3"
            e2="DDI-DrugBank.d464.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d464.s0.p20" e1="DDI-DrugBank.d464.s0.e3"
            e2="DDI-DrugBank.d464.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d464.s0.p21" e1="DDI-DrugBank.d464.s0.e3"
            e2="DDI-DrugBank.d464.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d464.s0.p22" e1="DDI-DrugBank.d464.s0.e4"
            e2="DDI-DrugBank.d464.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d464.s0.p23" e1="DDI-DrugBank.d464.s0.e4"
            e2="DDI-DrugBank.d464.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d464.s0.p24" e1="DDI-DrugBank.d464.s0.e4"
            e2="DDI-DrugBank.d464.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d464.s0.p25" e1="DDI-DrugBank.d464.s0.e5"
            e2="DDI-DrugBank.d464.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d464.s0.p26" e1="DDI-DrugBank.d464.s0.e5"
            e2="DDI-DrugBank.d464.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d464.s0.p27" e1="DDI-DrugBank.d464.s0.e6"
            e2="DDI-DrugBank.d464.s0.e7" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d464.s1" text="When s.c."/>
    <sentence id="DDI-DrugBank.d464.s2" text="combination therapy is contemplated, the dosage of one or both agents should be reduced."/>
</document>
<document id="DDI-DrugBank.d250">
    <sentence id="DDI-DrugBank.d250.s0" text="Certain other antibiotics (aminoglycosides and polymyxin) have also been reported to interfere with the nerve transmission at the neuromuscular junction.">
        <entity id="DDI-DrugBank.d250.s0.e0" charOffset="14-24"
            type="group" text="antibiotics"/>
        <entity id="DDI-DrugBank.d250.s0.e1" charOffset="27-41"
            type="group" text="aminoglycosides"/>
        <entity id="DDI-DrugBank.d250.s0.e2" charOffset="47-55"
            type="group" text="polymyxin"/>
        <pair id="DDI-DrugBank.d250.s0.p0" e1="DDI-DrugBank.d250.s0.e0"
            e2="DDI-DrugBank.d250.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d250.s0.p1" e1="DDI-DrugBank.d250.s0.e0"
            e2="DDI-DrugBank.d250.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d250.s0.p2" e1="DDI-DrugBank.d250.s0.e1"
            e2="DDI-DrugBank.d250.s0.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d250.s1" text="Based on this reported activity, they should not be given concomitantly with Coly-Mycin M Parenteral except with the greatest caution.">
        <entity id="DDI-DrugBank.d250.s1.e0" charOffset="77-88"
            type="brand" text="Coly-Mycin M"/>
    </sentence>
    <sentence id="DDI-DrugBank.d250.s2" text="Curariform muscle relaxants (eg, tubocurarine) and other drugs, including ether, succinylcholine, gallamine, decamethonium and sodium citrate, potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with Coly-Mycin M Parenteral.">
        <entity id="DDI-DrugBank.d250.s2.e0" charOffset="0-26"
            type="brand" text="Curariform muscle relaxants"/>
        <entity id="DDI-DrugBank.d250.s2.e1" charOffset="33-44"
            type="drug" text="tubocurarine"/>
        <entity id="DDI-DrugBank.d250.s2.e2" charOffset="81-95"
            type="drug" text="succinylcholine"/>
        <entity id="DDI-DrugBank.d250.s2.e3" charOffset="98-106"
            type="drug" text="gallamine"/>
        <entity id="DDI-DrugBank.d250.s2.e4" charOffset="109-121"
            type="drug" text="decamethonium"/>
        <entity id="DDI-DrugBank.d250.s2.e5" charOffset="127-140"
            type="drug" text="sodium citrate"/>
        <entity id="DDI-DrugBank.d250.s2.e6" charOffset="259-270"
            type="brand" text="Coly-Mycin M"/>
        <pair id="DDI-DrugBank.d250.s2.p0" e1="DDI-DrugBank.d250.s2.e0"
            e2="DDI-DrugBank.d250.s2.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d250.s2.p1" e1="DDI-DrugBank.d250.s2.e0"
            e2="DDI-DrugBank.d250.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d250.s2.p2" e1="DDI-DrugBank.d250.s2.e0"
            e2="DDI-DrugBank.d250.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d250.s2.p3" e1="DDI-DrugBank.d250.s2.e0"
            e2="DDI-DrugBank.d250.s2.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d250.s2.p4" e1="DDI-DrugBank.d250.s2.e0"
            e2="DDI-DrugBank.d250.s2.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d250.s2.p5" e1="DDI-DrugBank.d250.s2.e0"
            e2="DDI-DrugBank.d250.s2.e6" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d250.s2.p6" e1="DDI-DrugBank.d250.s2.e1"
            e2="DDI-DrugBank.d250.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d250.s2.p7" e1="DDI-DrugBank.d250.s2.e1"
            e2="DDI-DrugBank.d250.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d250.s2.p8" e1="DDI-DrugBank.d250.s2.e1"
            e2="DDI-DrugBank.d250.s2.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d250.s2.p9" e1="DDI-DrugBank.d250.s2.e1"
            e2="DDI-DrugBank.d250.s2.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d250.s2.p10" e1="DDI-DrugBank.d250.s2.e1"
            e2="DDI-DrugBank.d250.s2.e6" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d250.s2.p11" e1="DDI-DrugBank.d250.s2.e2"
            e2="DDI-DrugBank.d250.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d250.s2.p12" e1="DDI-DrugBank.d250.s2.e2"
            e2="DDI-DrugBank.d250.s2.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d250.s2.p13" e1="DDI-DrugBank.d250.s2.e2"
            e2="DDI-DrugBank.d250.s2.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d250.s2.p14" e1="DDI-DrugBank.d250.s2.e2"
            e2="DDI-DrugBank.d250.s2.e6" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d250.s2.p15" e1="DDI-DrugBank.d250.s2.e3"
            e2="DDI-DrugBank.d250.s2.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d250.s2.p16" e1="DDI-DrugBank.d250.s2.e3"
            e2="DDI-DrugBank.d250.s2.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d250.s2.p17" e1="DDI-DrugBank.d250.s2.e3"
            e2="DDI-DrugBank.d250.s2.e6" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d250.s2.p18" e1="DDI-DrugBank.d250.s2.e4"
            e2="DDI-DrugBank.d250.s2.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d250.s2.p19" e1="DDI-DrugBank.d250.s2.e4"
            e2="DDI-DrugBank.d250.s2.e6" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d250.s2.p20" e1="DDI-DrugBank.d250.s2.e5"
            e2="DDI-DrugBank.d250.s2.e6" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d250.s3" text="Sodium cephalothin may enhance the nephrotoxicity of Coly-Mycin M Parenteral.">
        <entity id="DDI-DrugBank.d250.s3.e0" charOffset="0-17"
            type="drug" text="Sodium cephalothin"/>
        <entity id="DDI-DrugBank.d250.s3.e1" charOffset="53-64"
            type="brand" text="Coly-Mycin M"/>
        <pair id="DDI-DrugBank.d250.s3.p0" e1="DDI-DrugBank.d250.s3.e0"
            e2="DDI-DrugBank.d250.s3.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d250.s4" text="The concomitant use of sodium cephalothin and Coly-Mycin M Parenteral should be avoided.">
        <entity id="DDI-DrugBank.d250.s4.e0" charOffset="23-40"
            type="drug" text="sodium cephalothin"/>
        <entity id="DDI-DrugBank.d250.s4.e1" charOffset="46-57"
            type="brand" text="Coly-Mycin M"/>
        <pair id="DDI-DrugBank.d250.s4.p0" e1="DDI-DrugBank.d250.s4.e0"
            e2="DDI-DrugBank.d250.s4.e1" ddi="true" type="advise"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d317">
    <sentence id="DDI-DrugBank.d317.s0" text="DRUG/LABORATORY TEST INTERACTIONS 1."/>
    <sentence id="DDI-DrugBank.d317.s1" text="Accelerated prothrombin time, partial thromboplastin time, and platelet aggregation time;"/>
    <sentence id="DDI-DrugBank.d317.s2" text="increased platelet count;"/>
    <sentence id="DDI-DrugBank.d317.s3" text="increased factors II, VII antigen, VIII antigen, VIII coagulant activity, IX, X, XII, VII-X complex, II-VII-X complex, and beta-thromboglobulin;"/>
    <sentence id="DDI-DrugBank.d317.s4" text="decreased levels of anti-factor Xa and antithrombin III, decreased antithrombin III activity;">
        <entity id="DDI-DrugBank.d317.s4.e0" charOffset="39-54"
            type="drug" text="antithrombin III"/>
        <entity id="DDI-DrugBank.d317.s4.e1" charOffset="67-82"
            type="drug" text="antithrombin III"/>
        <pair id="DDI-DrugBank.d317.s4.p0" e1="DDI-DrugBank.d317.s4.e0"
            e2="DDI-DrugBank.d317.s4.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d317.s5" text="increased levels of fibrinogen and fibrinogen activity;">
        <entity id="DDI-DrugBank.d317.s5.e0" charOffset="20-29"
            type="drug" text="fibrinogen"/>
        <entity id="DDI-DrugBank.d317.s5.e1" charOffset="35-44"
            type="drug" text="fibrinogen"/>
        <pair id="DDI-DrugBank.d317.s5.p0" e1="DDI-DrugBank.d317.s5.e0"
            e2="DDI-DrugBank.d317.s5.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d317.s6" text="increased plasminogen antigen and activity."/>
    <sentence id="DDI-DrugBank.d317.s7" text="2."/>
    <sentence id="DDI-DrugBank.d317.s8" text="Increased thyroid-binding globulin (TBG) levels leading to increased circulating total thyroid hormone levels as measured by protein-bound iodine (PBI), T4 levels (by column or by radioimmunoassay) or T3 levels by radioimmunoassay.">
        <entity id="DDI-DrugBank.d317.s8.e0" charOffset="139-144"
            type="drug" text="iodine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d317.s9" text="T3 resin uptake is decreased, reflecting the elevated TBG."/>
    <sentence id="DDI-DrugBank.d317.s10" text="Free T4 and free T3 concentrations are unaltered."/>
    <sentence id="DDI-DrugBank.d317.s11" text="Patients on thyroid replacement therapy may require higher doses of thyroid hormone.">
        <entity id="DDI-DrugBank.d317.s11.e0" charOffset="68-82"
            type="group" text="thyroid hormone"/>
    </sentence>
    <sentence id="DDI-DrugBank.d317.s12" text="3."/>
    <sentence id="DDI-DrugBank.d317.s13" text="Other binding proteins may be elevated in serum, (i.e., corticosteroid binding globulin (CBG), sex hormone binding globulin (SHBG)) leading to increased total circulating corticosteroids and sex steroids, respectively.">
        <entity id="DDI-DrugBank.d317.s13.e0" charOffset="171-185"
            type="group" text="corticosteroids"/>
        <entity id="DDI-DrugBank.d317.s13.e1" charOffset="191-202"
            type="group" text="sex steroids"/>
        <pair id="DDI-DrugBank.d317.s13.p0"
            e1="DDI-DrugBank.d317.s13.e0" e2="DDI-DrugBank.d317.s13.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d317.s14" text="Free hormone concentrations may be decreased."/>
    <sentence id="DDI-DrugBank.d317.s15" text="Other plasma proteins may be increased (angiotensinogen/renin substrate, alpha-1-antitrypsin, ceruloplasmin)."/>
    <sentence id="DDI-DrugBank.d317.s16" text="4."/>
    <sentence id="DDI-DrugBank.d317.s17" text="Increased plasma HDL and HDL2 cholesterol subfraction concentrations, reduced LDL cholesterol concentration, increased triglyceride levels."/>
    <sentence id="DDI-DrugBank.d317.s18" text="5."/>
    <sentence id="DDI-DrugBank.d317.s19" text="Impaired glucose tolerance."/>
    <sentence id="DDI-DrugBank.d317.s20" text="6."/>
    <sentence id="DDI-DrugBank.d317.s21" text="Reduced response to metyrapone test."/>
</document>
<document id="DDI-DrugBank.d439">
    <sentence id="DDI-DrugBank.d439.s0" text="Corticotropin may accentuate the electrolyte loss associated with diuretic therapy.">
        <entity id="DDI-DrugBank.d439.s0.e0" charOffset="0-12"
            type="drug" text="Corticotropin"/>
        <entity id="DDI-DrugBank.d439.s0.e1" charOffset="66-73"
            type="group" text="diuretic"/>
        <pair id="DDI-DrugBank.d439.s0.p0" e1="DDI-DrugBank.d439.s0.e0"
            e2="DDI-DrugBank.d439.s0.e1" ddi="true" type="effect"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d101">
    <sentence id="DDI-DrugBank.d101.s0" text="Steady state plasma digitoxin concentrations did not appear to change.">
        <entity id="DDI-DrugBank.d101.s0.e0" charOffset="20-28"
            type="drug" text="digitoxin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d101.s1" text="Therefore, monitoring of plasma digoxin levels may be indicated in patients receiving similar combination chemotherapy regimens.">
        <entity id="DDI-DrugBank.d101.s1.e0" charOffset="32-38"
            type="drug" text="digoxin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d101.s2" text="The utilization of digitoxin for such patients may be considered as an alternative.">
        <entity id="DDI-DrugBank.d101.s2.e0" charOffset="19-27"
            type="drug" text="digitoxin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d101.s3" text="Also flucytosine.">
        <entity id="DDI-DrugBank.d101.s3.e0" charOffset="5-15"
            type="drug" text="flucytosine"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d185">
    <sentence id="DDI-DrugBank.d185.s0" text="A drug-drug interaction study evaluated the effect of the use of ACZONE Gel, 5%, in combination with double strength (160 mg/800 mg) trimethoprim/sulfamethoxazole (TMP/SMX).">
        <entity id="DDI-DrugBank.d185.s0.e0" charOffset="65-70"
            type="brand" text="ACZONE"/>
        <entity id="DDI-DrugBank.d185.s0.e1" charOffset="133-144"
            type="drug" text="trimethoprim"/>
        <entity id="DDI-DrugBank.d185.s0.e2" charOffset="146-161"
            type="drug" text="sulfamethoxazole"/>
        <entity id="DDI-DrugBank.d185.s0.e3" charOffset="164-166"
            type="drug" text="TMP"/>
        <entity id="DDI-DrugBank.d185.s0.e4" charOffset="168-170"
            type="drug" text="SMX"/>
        <pair id="DDI-DrugBank.d185.s0.p0" e1="DDI-DrugBank.d185.s0.e0"
            e2="DDI-DrugBank.d185.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d185.s0.p1" e1="DDI-DrugBank.d185.s0.e0"
            e2="DDI-DrugBank.d185.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d185.s0.p2" e1="DDI-DrugBank.d185.s0.e0"
            e2="DDI-DrugBank.d185.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d185.s0.p3" e1="DDI-DrugBank.d185.s0.e0"
            e2="DDI-DrugBank.d185.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d185.s0.p4" e1="DDI-DrugBank.d185.s0.e1"
            e2="DDI-DrugBank.d185.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d185.s0.p5" e1="DDI-DrugBank.d185.s0.e1"
            e2="DDI-DrugBank.d185.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d185.s0.p6" e1="DDI-DrugBank.d185.s0.e1"
            e2="DDI-DrugBank.d185.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d185.s0.p7" e1="DDI-DrugBank.d185.s0.e2"
            e2="DDI-DrugBank.d185.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d185.s0.p8" e1="DDI-DrugBank.d185.s0.e2"
            e2="DDI-DrugBank.d185.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d185.s0.p9" e1="DDI-DrugBank.d185.s0.e3"
            e2="DDI-DrugBank.d185.s0.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d185.s1" text="During co-administration, systemic levels of TMP and SMX were essentially unchanged.">
        <entity id="DDI-DrugBank.d185.s1.e0" charOffset="45-47"
            type="drug" text="TMP"/>
        <entity id="DDI-DrugBank.d185.s1.e1" charOffset="53-55"
            type="drug" text="SMX"/>
        <pair id="DDI-DrugBank.d185.s1.p0" e1="DDI-DrugBank.d185.s1.e0"
            e2="DDI-DrugBank.d185.s1.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d185.s2" text="Notably, systemic exposure (AUC0-12) of dapsone hydroxylamine (DHA) was more than doubled in the presence of TMP/SMX.">
        <entity id="DDI-DrugBank.d185.s2.e0" charOffset="40-60"
            type="drug_n" text="dapsone hydroxylamine"/>
        <entity id="DDI-DrugBank.d185.s2.e1" charOffset="63-65"
            type="drug_n" text="DHA"/>
        <entity id="DDI-DrugBank.d185.s2.e2" charOffset="109-111"
            type="drug" text="TMP"/>
        <entity id="DDI-DrugBank.d185.s2.e3" charOffset="113-115"
            type="drug" text="SMX"/>
        <pair id="DDI-DrugBank.d185.s2.p0" e1="DDI-DrugBank.d185.s2.e0"
            e2="DDI-DrugBank.d185.s2.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d185.s2.p1" e1="DDI-DrugBank.d185.s2.e0"
            e2="DDI-DrugBank.d185.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d185.s2.p2" e1="DDI-DrugBank.d185.s2.e0"
            e2="DDI-DrugBank.d185.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d185.s2.p3" e1="DDI-DrugBank.d185.s2.e1"
            e2="DDI-DrugBank.d185.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d185.s2.p4" e1="DDI-DrugBank.d185.s2.e1"
            e2="DDI-DrugBank.d185.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d185.s2.p5" e1="DDI-DrugBank.d185.s2.e2"
            e2="DDI-DrugBank.d185.s2.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d185.s3" text="Exposure from the proposed topical dose is about 1% of that from the 100 mg oral dose, even when co-administered with TMP/SMX.">
        <entity id="DDI-DrugBank.d185.s3.e0" charOffset="118-120"
            type="drug" text="TMP"/>
        <entity id="DDI-DrugBank.d185.s3.e1" charOffset="122-124"
            type="drug" text="SMX"/>
        <pair id="DDI-DrugBank.d185.s3.p0" e1="DDI-DrugBank.d185.s3.e0"
            e2="DDI-DrugBank.d185.s3.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d185.s4" text="Certain concomitant medications (such as rifampin, anticonvulsants, St.">
        <entity id="DDI-DrugBank.d185.s4.e0" charOffset="41-48"
            type="drug" text="rifampin"/>
        <entity id="DDI-DrugBank.d185.s4.e1" charOffset="51-65"
            type="group" text="anticonvulsants"/>
        <pair id="DDI-DrugBank.d185.s4.p0" e1="DDI-DrugBank.d185.s4.e0"
            e2="DDI-DrugBank.d185.s4.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d185.s5" text="John s wort) may increase the formation of dapsone hydroxylamine, a metabolite of dapsone associated with hemolysis.">
        <entity id="DDI-DrugBank.d185.s5.e0" charOffset="43-63"
            type="drug_n" text="dapsone hydroxylamine"/>
        <entity id="DDI-DrugBank.d185.s5.e1" charOffset="82-88"
            type="drug" text="dapsone"/>
        <pair id="DDI-DrugBank.d185.s5.p0" e1="DDI-DrugBank.d185.s5.e0"
            e2="DDI-DrugBank.d185.s5.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d185.s6" text="With oral dapsone treatment, folic acid antagonists such as pyrimethamine have been noted to possibly increase the likelihood of hematologic reactions">
        <entity id="DDI-DrugBank.d185.s6.e0" charOffset="10-16"
            type="drug" text="dapsone"/>
        <entity id="DDI-DrugBank.d185.s6.e1" charOffset="29-50"
            type="group" text="folic acid antagonists"/>
        <entity id="DDI-DrugBank.d185.s6.e2" charOffset="60-72"
            type="drug" text="pyrimethamine"/>
        <pair id="DDI-DrugBank.d185.s6.p0" e1="DDI-DrugBank.d185.s6.e0"
            e2="DDI-DrugBank.d185.s6.e1" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d185.s6.p1" e1="DDI-DrugBank.d185.s6.e0"
            e2="DDI-DrugBank.d185.s6.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d185.s6.p2" e1="DDI-DrugBank.d185.s6.e1"
            e2="DDI-DrugBank.d185.s6.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d185.s7" text="."/>
    <sentence id="DDI-DrugBank.d185.s8" text=""/>
</document>
<document id="DDI-DrugBank.d69">
    <sentence id="DDI-DrugBank.d69.s0" text="Use of Cerubidine in a patient who has previously received doxorubicin increases the risk of cardiotoxicity.">
        <entity id="DDI-DrugBank.d69.s0.e0" charOffset="7-16"
            type="brand" text="Cerubidine"/>
        <entity id="DDI-DrugBank.d69.s0.e1" charOffset="59-69"
            type="drug" text="doxorubicin"/>
        <pair id="DDI-DrugBank.d69.s0.p0" e1="DDI-DrugBank.d69.s0.e0"
            e2="DDI-DrugBank.d69.s0.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d69.s1" text="Cerubidine should not be used in patients who have previously received the recommended maximum cumulative doses of doxorubicin or Cerubidine.">
        <entity id="DDI-DrugBank.d69.s1.e0" charOffset="0-9"
            type="brand" text="Cerubidine"/>
        <entity id="DDI-DrugBank.d69.s1.e1" charOffset="115-125"
            type="drug" text="doxorubicin"/>
        <entity id="DDI-DrugBank.d69.s1.e2" charOffset="130-139"
            type="brand" text="Cerubidine"/>
        <pair id="DDI-DrugBank.d69.s1.p0" e1="DDI-DrugBank.d69.s1.e0"
            e2="DDI-DrugBank.d69.s1.e1" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d69.s1.p1" e1="DDI-DrugBank.d69.s1.e0"
            e2="DDI-DrugBank.d69.s1.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d69.s1.p2" e1="DDI-DrugBank.d69.s1.e1"
            e2="DDI-DrugBank.d69.s1.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d69.s2" text="Cyclophosphamide used concurrently with Cerubidine may also result in increased cardiotoxicity.">
        <entity id="DDI-DrugBank.d69.s2.e0" charOffset="0-15"
            type="drug" text="Cyclophosphamide"/>
        <entity id="DDI-DrugBank.d69.s2.e1" charOffset="40-49"
            type="brand" text="Cerubidine"/>
        <pair id="DDI-DrugBank.d69.s2.p0" e1="DDI-DrugBank.d69.s2.e0"
            e2="DDI-DrugBank.d69.s2.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d69.s3" text="Dosage reduction of Cerubidine may be required when used concurrently with other myelosuppressive agents.">
        <entity id="DDI-DrugBank.d69.s3.e0" charOffset="20-29"
            type="brand" text="Cerubidine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d69.s4" text="Hepatotoxic medications, such as high-dose methotrexate, may impair liver function and increase the risk of toxicity.">
        <entity id="DDI-DrugBank.d69.s4.e0" charOffset="43-54"
            type="drug" text="methotrexate"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d197">
    <sentence id="DDI-DrugBank.d197.s0" text="General In vitro studies in human liver microsomes demonstrated no evidence of cytochrome P450-mediated drug interactions that are likely to be of clinical relevance."/>
    <sentence id="DDI-DrugBank.d197.s1" text="Anesthetics/Sedatives/Hypnotics/Opioids: Co-administration of PRECEDEX with anesthetics, sedatives, hypnotics, and opioids is likely to lead to an enhancement of effects.">
        <entity id="DDI-DrugBank.d197.s1.e0" charOffset="0-10"
            type="group" text="Anesthetics"/>
        <entity id="DDI-DrugBank.d197.s1.e1" charOffset="12-20"
            type="group" text="Sedatives"/>
        <entity id="DDI-DrugBank.d197.s1.e2" charOffset="22-30"
            type="group" text="Hypnotics"/>
        <entity id="DDI-DrugBank.d197.s1.e3" charOffset="32-38"
            type="group" text="Opioids"/>
        <entity id="DDI-DrugBank.d197.s1.e4" charOffset="62-69"
            type="brand" text="PRECEDEX"/>
        <entity id="DDI-DrugBank.d197.s1.e5" charOffset="76-86"
            type="group" text="anesthetics"/>
        <entity id="DDI-DrugBank.d197.s1.e6" charOffset="89-97"
            type="group" text="sedatives"/>
        <entity id="DDI-DrugBank.d197.s1.e7" charOffset="100-108"
            type="group" text="hypnotics"/>
        <entity id="DDI-DrugBank.d197.s1.e8" charOffset="115-121"
            type="group" text="opioids"/>
        <pair id="DDI-DrugBank.d197.s1.p0" e1="DDI-DrugBank.d197.s1.e0"
            e2="DDI-DrugBank.d197.s1.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s1.p1" e1="DDI-DrugBank.d197.s1.e0"
            e2="DDI-DrugBank.d197.s1.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s1.p2" e1="DDI-DrugBank.d197.s1.e0"
            e2="DDI-DrugBank.d197.s1.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s1.p3" e1="DDI-DrugBank.d197.s1.e0"
            e2="DDI-DrugBank.d197.s1.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s1.p4" e1="DDI-DrugBank.d197.s1.e0"
            e2="DDI-DrugBank.d197.s1.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s1.p5" e1="DDI-DrugBank.d197.s1.e0"
            e2="DDI-DrugBank.d197.s1.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s1.p6" e1="DDI-DrugBank.d197.s1.e0"
            e2="DDI-DrugBank.d197.s1.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s1.p7" e1="DDI-DrugBank.d197.s1.e0"
            e2="DDI-DrugBank.d197.s1.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s1.p8" e1="DDI-DrugBank.d197.s1.e1"
            e2="DDI-DrugBank.d197.s1.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s1.p9" e1="DDI-DrugBank.d197.s1.e1"
            e2="DDI-DrugBank.d197.s1.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s1.p10" e1="DDI-DrugBank.d197.s1.e1"
            e2="DDI-DrugBank.d197.s1.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s1.p11" e1="DDI-DrugBank.d197.s1.e1"
            e2="DDI-DrugBank.d197.s1.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s1.p12" e1="DDI-DrugBank.d197.s1.e1"
            e2="DDI-DrugBank.d197.s1.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s1.p13" e1="DDI-DrugBank.d197.s1.e1"
            e2="DDI-DrugBank.d197.s1.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s1.p14" e1="DDI-DrugBank.d197.s1.e1"
            e2="DDI-DrugBank.d197.s1.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s1.p15" e1="DDI-DrugBank.d197.s1.e2"
            e2="DDI-DrugBank.d197.s1.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s1.p16" e1="DDI-DrugBank.d197.s1.e2"
            e2="DDI-DrugBank.d197.s1.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s1.p17" e1="DDI-DrugBank.d197.s1.e2"
            e2="DDI-DrugBank.d197.s1.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s1.p18" e1="DDI-DrugBank.d197.s1.e2"
            e2="DDI-DrugBank.d197.s1.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s1.p19" e1="DDI-DrugBank.d197.s1.e2"
            e2="DDI-DrugBank.d197.s1.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s1.p20" e1="DDI-DrugBank.d197.s1.e2"
            e2="DDI-DrugBank.d197.s1.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s1.p21" e1="DDI-DrugBank.d197.s1.e3"
            e2="DDI-DrugBank.d197.s1.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s1.p22" e1="DDI-DrugBank.d197.s1.e3"
            e2="DDI-DrugBank.d197.s1.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s1.p23" e1="DDI-DrugBank.d197.s1.e3"
            e2="DDI-DrugBank.d197.s1.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s1.p24" e1="DDI-DrugBank.d197.s1.e3"
            e2="DDI-DrugBank.d197.s1.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s1.p25" e1="DDI-DrugBank.d197.s1.e3"
            e2="DDI-DrugBank.d197.s1.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s1.p26" e1="DDI-DrugBank.d197.s1.e4"
            e2="DDI-DrugBank.d197.s1.e5" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d197.s1.p27" e1="DDI-DrugBank.d197.s1.e4"
            e2="DDI-DrugBank.d197.s1.e6" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d197.s1.p28" e1="DDI-DrugBank.d197.s1.e4"
            e2="DDI-DrugBank.d197.s1.e7" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d197.s1.p29" e1="DDI-DrugBank.d197.s1.e4"
            e2="DDI-DrugBank.d197.s1.e8" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d197.s1.p30" e1="DDI-DrugBank.d197.s1.e5"
            e2="DDI-DrugBank.d197.s1.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s1.p31" e1="DDI-DrugBank.d197.s1.e5"
            e2="DDI-DrugBank.d197.s1.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s1.p32" e1="DDI-DrugBank.d197.s1.e5"
            e2="DDI-DrugBank.d197.s1.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s1.p33" e1="DDI-DrugBank.d197.s1.e6"
            e2="DDI-DrugBank.d197.s1.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s1.p34" e1="DDI-DrugBank.d197.s1.e6"
            e2="DDI-DrugBank.d197.s1.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s1.p35" e1="DDI-DrugBank.d197.s1.e7"
            e2="DDI-DrugBank.d197.s1.e8" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d197.s2" text="Specific studies have confirmed these effects with sevoflurane, isoflurane, propofol, alfentanil, and midazolam.">
        <entity id="DDI-DrugBank.d197.s2.e0" charOffset="51-61"
            type="drug" text="sevoflurane"/>
        <entity id="DDI-DrugBank.d197.s2.e1" charOffset="64-73"
            type="drug" text="isoflurane"/>
        <entity id="DDI-DrugBank.d197.s2.e2" charOffset="76-83"
            type="drug" text="propofol"/>
        <entity id="DDI-DrugBank.d197.s2.e3" charOffset="86-95"
            type="drug" text="alfentanil"/>
        <entity id="DDI-DrugBank.d197.s2.e4" charOffset="102-110"
            type="drug" text="midazolam"/>
        <pair id="DDI-DrugBank.d197.s2.p0" e1="DDI-DrugBank.d197.s2.e0"
            e2="DDI-DrugBank.d197.s2.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s2.p1" e1="DDI-DrugBank.d197.s2.e0"
            e2="DDI-DrugBank.d197.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s2.p2" e1="DDI-DrugBank.d197.s2.e0"
            e2="DDI-DrugBank.d197.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s2.p3" e1="DDI-DrugBank.d197.s2.e0"
            e2="DDI-DrugBank.d197.s2.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s2.p4" e1="DDI-DrugBank.d197.s2.e1"
            e2="DDI-DrugBank.d197.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s2.p5" e1="DDI-DrugBank.d197.s2.e1"
            e2="DDI-DrugBank.d197.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s2.p6" e1="DDI-DrugBank.d197.s2.e1"
            e2="DDI-DrugBank.d197.s2.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s2.p7" e1="DDI-DrugBank.d197.s2.e2"
            e2="DDI-DrugBank.d197.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s2.p8" e1="DDI-DrugBank.d197.s2.e2"
            e2="DDI-DrugBank.d197.s2.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s2.p9" e1="DDI-DrugBank.d197.s2.e3"
            e2="DDI-DrugBank.d197.s2.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d197.s3" text="No pharmacokinetic interactions between dexmedetomidine and isoflurane, propofol, alfentanil, and midazolam have been demonstrated.">
        <entity id="DDI-DrugBank.d197.s3.e0" charOffset="40-54"
            type="drug" text="dexmedetomidine"/>
        <entity id="DDI-DrugBank.d197.s3.e1" charOffset="60-69"
            type="drug" text="isoflurane"/>
        <entity id="DDI-DrugBank.d197.s3.e2" charOffset="72-79"
            type="drug" text="propofol"/>
        <entity id="DDI-DrugBank.d197.s3.e3" charOffset="82-91"
            type="drug" text="alfentanil"/>
        <entity id="DDI-DrugBank.d197.s3.e4" charOffset="98-106"
            type="drug" text="midazolam"/>
        <pair id="DDI-DrugBank.d197.s3.p0" e1="DDI-DrugBank.d197.s3.e0"
            e2="DDI-DrugBank.d197.s3.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s3.p1" e1="DDI-DrugBank.d197.s3.e0"
            e2="DDI-DrugBank.d197.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s3.p2" e1="DDI-DrugBank.d197.s3.e0"
            e2="DDI-DrugBank.d197.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s3.p3" e1="DDI-DrugBank.d197.s3.e0"
            e2="DDI-DrugBank.d197.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s3.p4" e1="DDI-DrugBank.d197.s3.e1"
            e2="DDI-DrugBank.d197.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s3.p5" e1="DDI-DrugBank.d197.s3.e1"
            e2="DDI-DrugBank.d197.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s3.p6" e1="DDI-DrugBank.d197.s3.e1"
            e2="DDI-DrugBank.d197.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s3.p7" e1="DDI-DrugBank.d197.s3.e2"
            e2="DDI-DrugBank.d197.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s3.p8" e1="DDI-DrugBank.d197.s3.e2"
            e2="DDI-DrugBank.d197.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s3.p9" e1="DDI-DrugBank.d197.s3.e3"
            e2="DDI-DrugBank.d197.s3.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d197.s4" text="However, due to possible pharmacodynamic interactions, when co-administered with PRECEDEX, a reduction in dosage of PRECEDEX on the concomitant anesthetic, sedative, hypnotic or opioid may be required.">
        <entity id="DDI-DrugBank.d197.s4.e0" charOffset="81-88"
            type="brand" text="PRECEDEX"/>
        <entity id="DDI-DrugBank.d197.s4.e1" charOffset="116-123"
            type="brand" text="PRECEDEX"/>
        <entity id="DDI-DrugBank.d197.s4.e2" charOffset="144-153"
            type="group" text="anesthetic"/>
        <entity id="DDI-DrugBank.d197.s4.e3" charOffset="156-163"
            type="group" text="sedative"/>
        <entity id="DDI-DrugBank.d197.s4.e4" charOffset="166-173"
            type="group" text="hypnotic"/>
        <entity id="DDI-DrugBank.d197.s4.e5" charOffset="178-183"
            type="group" text="opioid"/>
        <pair id="DDI-DrugBank.d197.s4.p0" e1="DDI-DrugBank.d197.s4.e0"
            e2="DDI-DrugBank.d197.s4.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s4.p1" e1="DDI-DrugBank.d197.s4.e0"
            e2="DDI-DrugBank.d197.s4.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s4.p2" e1="DDI-DrugBank.d197.s4.e0"
            e2="DDI-DrugBank.d197.s4.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s4.p3" e1="DDI-DrugBank.d197.s4.e0"
            e2="DDI-DrugBank.d197.s4.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s4.p4" e1="DDI-DrugBank.d197.s4.e0"
            e2="DDI-DrugBank.d197.s4.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s4.p5" e1="DDI-DrugBank.d197.s4.e1"
            e2="DDI-DrugBank.d197.s4.e2" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d197.s4.p6" e1="DDI-DrugBank.d197.s4.e1"
            e2="DDI-DrugBank.d197.s4.e3" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d197.s4.p7" e1="DDI-DrugBank.d197.s4.e1"
            e2="DDI-DrugBank.d197.s4.e4" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d197.s4.p8" e1="DDI-DrugBank.d197.s4.e1"
            e2="DDI-DrugBank.d197.s4.e5" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d197.s4.p9" e1="DDI-DrugBank.d197.s4.e2"
            e2="DDI-DrugBank.d197.s4.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s4.p10" e1="DDI-DrugBank.d197.s4.e2"
            e2="DDI-DrugBank.d197.s4.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s4.p11" e1="DDI-DrugBank.d197.s4.e2"
            e2="DDI-DrugBank.d197.s4.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s4.p12" e1="DDI-DrugBank.d197.s4.e3"
            e2="DDI-DrugBank.d197.s4.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s4.p13" e1="DDI-DrugBank.d197.s4.e3"
            e2="DDI-DrugBank.d197.s4.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s4.p14" e1="DDI-DrugBank.d197.s4.e4"
            e2="DDI-DrugBank.d197.s4.e5" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d197.s5" text="Neuromuscular Blockers: In one study of 10 healthy volunteers, administration of PRECEDEX for 45 minutes at a plasma concentration of 1 (one) ng/mL resulted in no clinically meaningful increases in the magnitude or neuromuscular blockade associated with rocuronium administration.">
        <entity id="DDI-DrugBank.d197.s5.e0" charOffset="0-21"
            type="group" text="Neuromuscular Blockers"/>
        <entity id="DDI-DrugBank.d197.s5.e1" charOffset="81-88"
            type="brand" text="PRECEDEX"/>
        <entity id="DDI-DrugBank.d197.s5.e2" charOffset="254-263"
            type="drug" text="rocuronium"/>
        <pair id="DDI-DrugBank.d197.s5.p0" e1="DDI-DrugBank.d197.s5.e0"
            e2="DDI-DrugBank.d197.s5.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s5.p1" e1="DDI-DrugBank.d197.s5.e0"
            e2="DDI-DrugBank.d197.s5.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d197.s5.p2" e1="DDI-DrugBank.d197.s5.e1"
            e2="DDI-DrugBank.d197.s5.e2" ddi="false"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d181">
    <sentence id="DDI-DrugBank.d181.s0" text="Oxytocin or other oxytocics (concurrent use with dinoprost may result in uterine hypertonus, possibly causing uterine rupture or cervical laceration, especially in the absence of adequate cervical dilatation;">
        <entity id="DDI-DrugBank.d181.s0.e0" charOffset="0-7"
            type="drug" text="Oxytocin"/>
        <entity id="DDI-DrugBank.d181.s0.e1" charOffset="18-26"
            type="group" text="oxytocics"/>
        <entity id="DDI-DrugBank.d181.s0.e2" charOffset="49-57"
            type="drug" text="dinoprost"/>
        <pair id="DDI-DrugBank.d181.s0.p0" e1="DDI-DrugBank.d181.s0.e0"
            e2="DDI-DrugBank.d181.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d181.s0.p1" e1="DDI-DrugBank.d181.s0.e0"
            e2="DDI-DrugBank.d181.s0.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d181.s0.p2" e1="DDI-DrugBank.d181.s0.e1"
            e2="DDI-DrugBank.d181.s0.e2" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d181.s1" text="although combinations are sometimes used for therapeutic advantage, when used concurrently, patient should be closely monitored."/>
</document>
<document id="DDI-DrugBank.d168">
    <sentence id="DDI-DrugBank.d168.s0" text="This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).">
        <entity id="DDI-DrugBank.d168.s0.e0" charOffset="28-34"
            type="drug" text="alcohol"/>
        <entity id="DDI-DrugBank.d168.s0.e1" charOffset="45-59"
            type="group" text="CNS depressants"/>
        <entity id="DDI-DrugBank.d168.s0.e2" charOffset="135-148"
            type="group" text="antihistamines"/>
        <entity id="DDI-DrugBank.d168.s0.e3" charOffset="152-167"
            type="group" text="anticholinergics"/>
        <entity id="DDI-DrugBank.d168.s0.e4" charOffset="314-327"
            type="group" text="antihistamines"/>
        <entity id="DDI-DrugBank.d168.s0.e5" charOffset="335-368"
            type="group" text="monoamine oxidase (MAO) inhibitors"/>
        <entity id="DDI-DrugBank.d168.s0.e6" charOffset="391-404"
            type="drug" text="antihistamines"/>
        <entity id="DDI-DrugBank.d168.s0.e7" charOffset="482-495"
            type="drug" text="antihistamines"/>
        <pair id="DDI-DrugBank.d168.s0.p0" e1="DDI-DrugBank.d168.s0.e0"
            e2="DDI-DrugBank.d168.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d168.s0.p1" e1="DDI-DrugBank.d168.s0.e0"
            e2="DDI-DrugBank.d168.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d168.s0.p2" e1="DDI-DrugBank.d168.s0.e0"
            e2="DDI-DrugBank.d168.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d168.s0.p3" e1="DDI-DrugBank.d168.s0.e0"
            e2="DDI-DrugBank.d168.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d168.s0.p4" e1="DDI-DrugBank.d168.s0.e0"
            e2="DDI-DrugBank.d168.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d168.s0.p5" e1="DDI-DrugBank.d168.s0.e0"
            e2="DDI-DrugBank.d168.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d168.s0.p6" e1="DDI-DrugBank.d168.s0.e0"
            e2="DDI-DrugBank.d168.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d168.s0.p7" e1="DDI-DrugBank.d168.s0.e1"
            e2="DDI-DrugBank.d168.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d168.s0.p8" e1="DDI-DrugBank.d168.s0.e1"
            e2="DDI-DrugBank.d168.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d168.s0.p9" e1="DDI-DrugBank.d168.s0.e1"
            e2="DDI-DrugBank.d168.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d168.s0.p10" e1="DDI-DrugBank.d168.s0.e1"
            e2="DDI-DrugBank.d168.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d168.s0.p11" e1="DDI-DrugBank.d168.s0.e1"
            e2="DDI-DrugBank.d168.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d168.s0.p12" e1="DDI-DrugBank.d168.s0.e1"
            e2="DDI-DrugBank.d168.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d168.s0.p13" e1="DDI-DrugBank.d168.s0.e2"
            e2="DDI-DrugBank.d168.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d168.s0.p14" e1="DDI-DrugBank.d168.s0.e2"
            e2="DDI-DrugBank.d168.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d168.s0.p15" e1="DDI-DrugBank.d168.s0.e2"
            e2="DDI-DrugBank.d168.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d168.s0.p16" e1="DDI-DrugBank.d168.s0.e2"
            e2="DDI-DrugBank.d168.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d168.s0.p17" e1="DDI-DrugBank.d168.s0.e2"
            e2="DDI-DrugBank.d168.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d168.s0.p18" e1="DDI-DrugBank.d168.s0.e3"
            e2="DDI-DrugBank.d168.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d168.s0.p19" e1="DDI-DrugBank.d168.s0.e3"
            e2="DDI-DrugBank.d168.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d168.s0.p20" e1="DDI-DrugBank.d168.s0.e3"
            e2="DDI-DrugBank.d168.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d168.s0.p21" e1="DDI-DrugBank.d168.s0.e3"
            e2="DDI-DrugBank.d168.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d168.s0.p22" e1="DDI-DrugBank.d168.s0.e4"
            e2="DDI-DrugBank.d168.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d168.s0.p23" e1="DDI-DrugBank.d168.s0.e4"
            e2="DDI-DrugBank.d168.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d168.s0.p24" e1="DDI-DrugBank.d168.s0.e4"
            e2="DDI-DrugBank.d168.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d168.s0.p25" e1="DDI-DrugBank.d168.s0.e5"
            e2="DDI-DrugBank.d168.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d168.s0.p26" e1="DDI-DrugBank.d168.s0.e5"
            e2="DDI-DrugBank.d168.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d168.s0.p27" e1="DDI-DrugBank.d168.s0.e6"
            e2="DDI-DrugBank.d168.s0.e7" ddi="false"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d19">
    <sentence id="DDI-DrugBank.d19.s0" text="Disulfiram appears to decrease the rate at which certain drugs are metabolized and therefore may increase the blood levels and the possibility of clinical toxicity of drugs given concomitantly.">
        <entity id="DDI-DrugBank.d19.s0.e0" charOffset="0-9" type="drug" text="Disulfiram"/>
    </sentence>
    <sentence id="DDI-DrugBank.d19.s1" text="DISULFIRAM SHOULD BE USED WITH CAUTION IN THOSE PATIENTS REVEIVING PHENYTOIN AND ITS CONGENERS.">
        <entity id="DDI-DrugBank.d19.s1.e0" charOffset="0-9" type="drug" text="DISULFIRAM"/>
        <entity id="DDI-DrugBank.d19.s1.e1" charOffset="67-75"
            type="drug" text="PHENYTOIN"/>
        <pair id="DDI-DrugBank.d19.s1.p0" e1="DDI-DrugBank.d19.s1.e0"
            e2="DDI-DrugBank.d19.s1.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d19.s2" text="SINCE THE CONCOMITANT ADMINISTRATION OF THESE TWO DRUGS CAN LEAD TO PHENYTOIN INTOXICATION, PRIOR TO ADMINISTERING DISULFIRAM TO A PATIENT ON PHENYTOIN THERAPY, A BASELINE PHENYTOIN SERUM LEVEL SHOULD BE OBTAINED.">
        <entity id="DDI-DrugBank.d19.s2.e0" charOffset="68-76"
            type="drug" text="PHENYTOIN"/>
        <entity id="DDI-DrugBank.d19.s2.e1" charOffset="115-124"
            type="drug" text="DISULFIRAM"/>
        <entity id="DDI-DrugBank.d19.s2.e2" charOffset="142-150"
            type="drug" text="PHENYTOIN"/>
        <entity id="DDI-DrugBank.d19.s2.e3" charOffset="172-180"
            type="drug" text="PHENYTOIN"/>
        <pair id="DDI-DrugBank.d19.s2.p0" e1="DDI-DrugBank.d19.s2.e0"
            e2="DDI-DrugBank.d19.s2.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d19.s2.p1" e1="DDI-DrugBank.d19.s2.e0"
            e2="DDI-DrugBank.d19.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d19.s2.p2" e1="DDI-DrugBank.d19.s2.e0"
            e2="DDI-DrugBank.d19.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d19.s2.p3" e1="DDI-DrugBank.d19.s2.e1"
            e2="DDI-DrugBank.d19.s2.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d19.s2.p4" e1="DDI-DrugBank.d19.s2.e1"
            e2="DDI-DrugBank.d19.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d19.s2.p5" e1="DDI-DrugBank.d19.s2.e2"
            e2="DDI-DrugBank.d19.s2.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d19.s3" text="SUBSEQUENT TO INITIATION OF DISULFIRAM THERAPY.">
        <entity id="DDI-DrugBank.d19.s3.e0" charOffset="28-37"
            type="drug" text="DISULFIRAM"/>
    </sentence>
    <sentence id="DDI-DrugBank.d19.s4" text="SERUM LEVELS OF PHENYTOIN SHOULD BE DETERMINED ON DIFFERENT DAYS FOR EVIDENCE OF AN INCREASE OR FOR A CONTINUING RISE IN LEVELS.">
        <entity id="DDI-DrugBank.d19.s4.e0" charOffset="16-24"
            type="drug" text="PHENYTOIN"/>
    </sentence>
    <sentence id="DDI-DrugBank.d19.s5" text="INCREASED PHENYTOIN LEVELS SHOULD BE TREATED WITH APPROPRIATE DOSAGE ADJUSTMENT.">
        <entity id="DDI-DrugBank.d19.s5.e0" charOffset="10-18"
            type="drug" text="PHENYTOIN"/>
    </sentence>
    <sentence id="DDI-DrugBank.d19.s6" text="It may be necessary to adjust the dosage of oral anticoagulants upon beginning or stopping disulfiram. since disulfiram may prolong prothrombin time.">
        <entity id="DDI-DrugBank.d19.s6.e0" charOffset="49-62"
            type="group" text="anticoagulants"/>
        <entity id="DDI-DrugBank.d19.s6.e1" charOffset="91-100"
            type="drug" text="disulfiram"/>
        <entity id="DDI-DrugBank.d19.s6.e2" charOffset="109-118"
            type="drug" text="disulfiram"/>
        <pair id="DDI-DrugBank.d19.s6.p0" e1="DDI-DrugBank.d19.s6.e0"
            e2="DDI-DrugBank.d19.s6.e1" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d19.s6.p1" e1="DDI-DrugBank.d19.s6.e0"
            e2="DDI-DrugBank.d19.s6.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d19.s6.p2" e1="DDI-DrugBank.d19.s6.e1"
            e2="DDI-DrugBank.d19.s6.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d19.s7" text="Patients taking isoniazid when disulfiram is given should be observed for the appearance of unsteady gait or marked changes in mental status;">
        <entity id="DDI-DrugBank.d19.s7.e0" charOffset="16-24"
            type="drug" text="isoniazid"/>
        <entity id="DDI-DrugBank.d19.s7.e1" charOffset="31-40"
            type="drug" text="disulfiram"/>
        <pair id="DDI-DrugBank.d19.s7.p0" e1="DDI-DrugBank.d19.s7.e0"
            e2="DDI-DrugBank.d19.s7.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d19.s8" text="the disulfiram should be discontinued if such signs appear.">
        <entity id="DDI-DrugBank.d19.s8.e0" charOffset="4-13"
            type="drug" text="disulfiram"/>
    </sentence>
    <sentence id="DDI-DrugBank.d19.s9" text="In rats, simultaneous ingestion of disulfiram and nitrite in the diet for 78 weeks has been reported to cause tumors, and it has been suggested that disulfiram may react with nitrites in the rat stomach to form a nitrosamine, which is tumorigenic.">
        <entity id="DDI-DrugBank.d19.s9.e0" charOffset="35-44"
            type="drug" text="disulfiram"/>
        <entity id="DDI-DrugBank.d19.s9.e1" charOffset="50-56"
            type="drug" text="nitrite"/>
        <entity id="DDI-DrugBank.d19.s9.e2" charOffset="149-158"
            type="drug" text="disulfiram"/>
        <entity id="DDI-DrugBank.d19.s9.e3" charOffset="175-182"
            type="group" text="nitrites"/>
        <pair id="DDI-DrugBank.d19.s9.p0" e1="DDI-DrugBank.d19.s9.e0"
            e2="DDI-DrugBank.d19.s9.e1" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d19.s9.p1" e1="DDI-DrugBank.d19.s9.e0"
            e2="DDI-DrugBank.d19.s9.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d19.s9.p2" e1="DDI-DrugBank.d19.s9.e0"
            e2="DDI-DrugBank.d19.s9.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d19.s9.p3" e1="DDI-DrugBank.d19.s9.e1"
            e2="DDI-DrugBank.d19.s9.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d19.s9.p4" e1="DDI-DrugBank.d19.s9.e1"
            e2="DDI-DrugBank.d19.s9.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d19.s9.p5" e1="DDI-DrugBank.d19.s9.e2"
            e2="DDI-DrugBank.d19.s9.e3" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d19.s10" text="Disulfiram alone in the rat s diet did not lead to such tumors.">
        <entity id="DDI-DrugBank.d19.s10.e0" charOffset="0-9"
            type="drug" text="Disulfiram"/>
    </sentence>
    <sentence id="DDI-DrugBank.d19.s11" text="The relevance of this finding to humans is not known at this time."/>
</document>
<document id="DDI-DrugBank.d371">
    <sentence id="DDI-DrugBank.d371.s0" text="There have been no formal clinical studies to evaluate the drug interactions of TAXOTERE with other medications.">
        <entity id="DDI-DrugBank.d371.s0.e0" charOffset="80-87"
            type="brand" text="TAXOTERE"/>
    </sentence>
    <sentence id="DDI-DrugBank.d371.s1" text="In vitro studies have shown that the metabolism of docetaxel may be modified by the concomitant administration of compounds that induce, inhibit, or are metabolized by cytochrome P450 3A4, such as cyclosporine, terfenadine, ketoconazole, erythromycin, and troleandomycin.">
        <entity id="DDI-DrugBank.d371.s1.e0" charOffset="51-59"
            type="drug" text="docetaxel"/>
        <entity id="DDI-DrugBank.d371.s1.e1" charOffset="197-208"
            type="drug" text="cyclosporine"/>
        <entity id="DDI-DrugBank.d371.s1.e2" charOffset="211-221"
            type="drug" text="terfenadine"/>
        <entity id="DDI-DrugBank.d371.s1.e3" charOffset="224-235"
            type="drug" text="ketoconazole"/>
        <entity id="DDI-DrugBank.d371.s1.e4" charOffset="238-249"
            type="drug" text="erythromycin"/>
        <entity id="DDI-DrugBank.d371.s1.e5" charOffset="256-269"
            type="drug" text="troleandomycin"/>
        <pair id="DDI-DrugBank.d371.s1.p0" e1="DDI-DrugBank.d371.s1.e0"
            e2="DDI-DrugBank.d371.s1.e1" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d371.s1.p1" e1="DDI-DrugBank.d371.s1.e0"
            e2="DDI-DrugBank.d371.s1.e2" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d371.s1.p2" e1="DDI-DrugBank.d371.s1.e0"
            e2="DDI-DrugBank.d371.s1.e3" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d371.s1.p3" e1="DDI-DrugBank.d371.s1.e0"
            e2="DDI-DrugBank.d371.s1.e4" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d371.s1.p4" e1="DDI-DrugBank.d371.s1.e0"
            e2="DDI-DrugBank.d371.s1.e5" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d371.s1.p5" e1="DDI-DrugBank.d371.s1.e1"
            e2="DDI-DrugBank.d371.s1.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d371.s1.p6" e1="DDI-DrugBank.d371.s1.e1"
            e2="DDI-DrugBank.d371.s1.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d371.s1.p7" e1="DDI-DrugBank.d371.s1.e1"
            e2="DDI-DrugBank.d371.s1.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d371.s1.p8" e1="DDI-DrugBank.d371.s1.e1"
            e2="DDI-DrugBank.d371.s1.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d371.s1.p9" e1="DDI-DrugBank.d371.s1.e2"
            e2="DDI-DrugBank.d371.s1.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d371.s1.p10" e1="DDI-DrugBank.d371.s1.e2"
            e2="DDI-DrugBank.d371.s1.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d371.s1.p11" e1="DDI-DrugBank.d371.s1.e2"
            e2="DDI-DrugBank.d371.s1.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d371.s1.p12" e1="DDI-DrugBank.d371.s1.e3"
            e2="DDI-DrugBank.d371.s1.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d371.s1.p13" e1="DDI-DrugBank.d371.s1.e3"
            e2="DDI-DrugBank.d371.s1.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d371.s1.p14" e1="DDI-DrugBank.d371.s1.e4"
            e2="DDI-DrugBank.d371.s1.e5" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d371.s2" text="Caution should be exercised with these drugs when treating patients receiving TAXOTERE as there is a potential for a significant interaction.">
        <entity id="DDI-DrugBank.d371.s2.e0" charOffset="78-85"
            type="brand" text="TAXOTERE"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d367">
    <sentence id="DDI-DrugBank.d367.s0" text="Most (98%) of plasma doxazosin is protein bound.">
        <entity id="DDI-DrugBank.d367.s0.e0" charOffset="21-29"
            type="drug" text="doxazosin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d367.s1" text="In vitro data in human plasma indicate that doxazosin mesylate has no effect on protein binding of digoxin, warfarin, phenytoin or indomethacin.">
        <entity id="DDI-DrugBank.d367.s1.e0" charOffset="44-61"
            type="drug" text="doxazosin mesylate"/>
        <entity id="DDI-DrugBank.d367.s1.e1" charOffset="99-105"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d367.s1.e2" charOffset="108-115"
            type="drug" text="warfarin"/>
        <entity id="DDI-DrugBank.d367.s1.e3" charOffset="118-126"
            type="drug" text="phenytoin"/>
        <entity id="DDI-DrugBank.d367.s1.e4" charOffset="131-142"
            type="drug" text="indomethacin"/>
        <pair id="DDI-DrugBank.d367.s1.p0" e1="DDI-DrugBank.d367.s1.e0"
            e2="DDI-DrugBank.d367.s1.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s1.p1" e1="DDI-DrugBank.d367.s1.e0"
            e2="DDI-DrugBank.d367.s1.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s1.p2" e1="DDI-DrugBank.d367.s1.e0"
            e2="DDI-DrugBank.d367.s1.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s1.p3" e1="DDI-DrugBank.d367.s1.e0"
            e2="DDI-DrugBank.d367.s1.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s1.p4" e1="DDI-DrugBank.d367.s1.e1"
            e2="DDI-DrugBank.d367.s1.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s1.p5" e1="DDI-DrugBank.d367.s1.e1"
            e2="DDI-DrugBank.d367.s1.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s1.p6" e1="DDI-DrugBank.d367.s1.e1"
            e2="DDI-DrugBank.d367.s1.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s1.p7" e1="DDI-DrugBank.d367.s1.e2"
            e2="DDI-DrugBank.d367.s1.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s1.p8" e1="DDI-DrugBank.d367.s1.e2"
            e2="DDI-DrugBank.d367.s1.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s1.p9" e1="DDI-DrugBank.d367.s1.e3"
            e2="DDI-DrugBank.d367.s1.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d367.s2" text="There is no information on the effect of other highly plasma protein bound drugs on doxazosin binding.">
        <entity id="DDI-DrugBank.d367.s2.e0" charOffset="84-92"
            type="drug" text="doxazosin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d367.s3" text="Doxazosin mesylate has been administered without any evidence of an adverse drug interaction to patients receiving thiazide diuretics, beta-blocking agents, and nonsteroidal anti-inflammatory drugs.">
        <entity id="DDI-DrugBank.d367.s3.e0" charOffset="0-17"
            type="drug" text="Doxazosin mesylate"/>
        <entity id="DDI-DrugBank.d367.s3.e1" charOffset="115-132"
            type="group" text="thiazide diuretics"/>
        <entity id="DDI-DrugBank.d367.s3.e2" charOffset="135-154"
            type="group" text="beta-blocking agents"/>
        <entity id="DDI-DrugBank.d367.s3.e3" charOffset="161-196"
            type="group" text="nonsteroidal anti-inflammatory drugs"/>
        <pair id="DDI-DrugBank.d367.s3.p0" e1="DDI-DrugBank.d367.s3.e0"
            e2="DDI-DrugBank.d367.s3.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s3.p1" e1="DDI-DrugBank.d367.s3.e0"
            e2="DDI-DrugBank.d367.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s3.p2" e1="DDI-DrugBank.d367.s3.e0"
            e2="DDI-DrugBank.d367.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s3.p3" e1="DDI-DrugBank.d367.s3.e1"
            e2="DDI-DrugBank.d367.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s3.p4" e1="DDI-DrugBank.d367.s3.e1"
            e2="DDI-DrugBank.d367.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s3.p5" e1="DDI-DrugBank.d367.s3.e2"
            e2="DDI-DrugBank.d367.s3.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d367.s4" text="In a placebo-controlled trial in normal volunteers, the administration of a single 1 mg dose of doxazosin on day 1 of a four-day regimen of oral cimetidine (400 mg twice daily) resulted in a 10% increase in mean AUC of doxazosin (p=0.006), and a slight but not statistically significant increase in mean Cmax and mean half-life of doxazosin.">
        <entity id="DDI-DrugBank.d367.s4.e0" charOffset="96-104"
            type="drug" text="doxazosin"/>
        <entity id="DDI-DrugBank.d367.s4.e1" charOffset="145-154"
            type="drug" text="cimetidine"/>
        <entity id="DDI-DrugBank.d367.s4.e2" charOffset="219-227"
            type="drug" text="doxazosin"/>
        <entity id="DDI-DrugBank.d367.s4.e3" charOffset="331-339"
            type="drug" text="doxazosin"/>
        <pair id="DDI-DrugBank.d367.s4.p0" e1="DDI-DrugBank.d367.s4.e0"
            e2="DDI-DrugBank.d367.s4.e1" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d367.s4.p1" e1="DDI-DrugBank.d367.s4.e0"
            e2="DDI-DrugBank.d367.s4.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s4.p2" e1="DDI-DrugBank.d367.s4.e0"
            e2="DDI-DrugBank.d367.s4.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s4.p3" e1="DDI-DrugBank.d367.s4.e1"
            e2="DDI-DrugBank.d367.s4.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s4.p4" e1="DDI-DrugBank.d367.s4.e1"
            e2="DDI-DrugBank.d367.s4.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s4.p5" e1="DDI-DrugBank.d367.s4.e2"
            e2="DDI-DrugBank.d367.s4.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d367.s5" text="The clinical significance of this increase in doxazosin AUC is unknown.">
        <entity id="DDI-DrugBank.d367.s5.e0" charOffset="46-54"
            type="drug" text="doxazosin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d367.s6" text="In clinical trials, doxazosin mesylate tablets have been administered to patients on a variety of concomitant medications;">
        <entity id="DDI-DrugBank.d367.s6.e0" charOffset="20-37"
            type="drug" text="doxazosin mesylate"/>
    </sentence>
    <sentence id="DDI-DrugBank.d367.s7" text="while no formal interaction studies have been conducted, no interactions were observed."/>
    <sentence id="DDI-DrugBank.d367.s8" text="Doxazosin mesylate tablets have been used with the following drugs or drug classes: 1.">
        <entity id="DDI-DrugBank.d367.s8.e0" charOffset="0-17"
            type="drug" text="Doxazosin mesylate"/>
    </sentence>
    <sentence id="DDI-DrugBank.d367.s9" text="Analgesic/anti-inflammatory (e.g., acetaminophen, aspirin, codeine and codeine combinations, ibuprofen, indomethacin).">
        <entity id="DDI-DrugBank.d367.s9.e0" charOffset="0-8"
            type="group" text="Analgesic"/>
        <entity id="DDI-DrugBank.d367.s9.e1" charOffset="10-26"
            type="group" text="anti-inflammatory"/>
        <entity id="DDI-DrugBank.d367.s9.e2" charOffset="35-47"
            type="drug" text="acetaminophen"/>
        <entity id="DDI-DrugBank.d367.s9.e3" charOffset="50-56"
            type="brand" text="aspirin"/>
        <entity id="DDI-DrugBank.d367.s9.e4" charOffset="59-65"
            type="drug" text="codeine"/>
        <entity id="DDI-DrugBank.d367.s9.e5" charOffset="71-77"
            type="drug" text="codeine"/>
        <entity id="DDI-DrugBank.d367.s9.e6" charOffset="93-101"
            type="drug" text="ibuprofen"/>
        <entity id="DDI-DrugBank.d367.s9.e7" charOffset="104-115"
            type="drug" text="indomethacin"/>
        <pair id="DDI-DrugBank.d367.s9.p0" e1="DDI-DrugBank.d367.s9.e0"
            e2="DDI-DrugBank.d367.s9.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s9.p1" e1="DDI-DrugBank.d367.s9.e0"
            e2="DDI-DrugBank.d367.s9.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s9.p2" e1="DDI-DrugBank.d367.s9.e0"
            e2="DDI-DrugBank.d367.s9.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s9.p3" e1="DDI-DrugBank.d367.s9.e0"
            e2="DDI-DrugBank.d367.s9.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s9.p4" e1="DDI-DrugBank.d367.s9.e0"
            e2="DDI-DrugBank.d367.s9.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s9.p5" e1="DDI-DrugBank.d367.s9.e0"
            e2="DDI-DrugBank.d367.s9.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s9.p6" e1="DDI-DrugBank.d367.s9.e0"
            e2="DDI-DrugBank.d367.s9.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s9.p7" e1="DDI-DrugBank.d367.s9.e1"
            e2="DDI-DrugBank.d367.s9.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s9.p8" e1="DDI-DrugBank.d367.s9.e1"
            e2="DDI-DrugBank.d367.s9.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s9.p9" e1="DDI-DrugBank.d367.s9.e1"
            e2="DDI-DrugBank.d367.s9.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s9.p10" e1="DDI-DrugBank.d367.s9.e1"
            e2="DDI-DrugBank.d367.s9.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s9.p11" e1="DDI-DrugBank.d367.s9.e1"
            e2="DDI-DrugBank.d367.s9.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s9.p12" e1="DDI-DrugBank.d367.s9.e1"
            e2="DDI-DrugBank.d367.s9.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s9.p13" e1="DDI-DrugBank.d367.s9.e2"
            e2="DDI-DrugBank.d367.s9.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s9.p14" e1="DDI-DrugBank.d367.s9.e2"
            e2="DDI-DrugBank.d367.s9.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s9.p15" e1="DDI-DrugBank.d367.s9.e2"
            e2="DDI-DrugBank.d367.s9.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s9.p16" e1="DDI-DrugBank.d367.s9.e2"
            e2="DDI-DrugBank.d367.s9.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s9.p17" e1="DDI-DrugBank.d367.s9.e2"
            e2="DDI-DrugBank.d367.s9.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s9.p18" e1="DDI-DrugBank.d367.s9.e3"
            e2="DDI-DrugBank.d367.s9.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s9.p19" e1="DDI-DrugBank.d367.s9.e3"
            e2="DDI-DrugBank.d367.s9.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s9.p20" e1="DDI-DrugBank.d367.s9.e3"
            e2="DDI-DrugBank.d367.s9.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s9.p21" e1="DDI-DrugBank.d367.s9.e3"
            e2="DDI-DrugBank.d367.s9.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s9.p22" e1="DDI-DrugBank.d367.s9.e4"
            e2="DDI-DrugBank.d367.s9.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s9.p23" e1="DDI-DrugBank.d367.s9.e4"
            e2="DDI-DrugBank.d367.s9.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s9.p24" e1="DDI-DrugBank.d367.s9.e4"
            e2="DDI-DrugBank.d367.s9.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s9.p25" e1="DDI-DrugBank.d367.s9.e5"
            e2="DDI-DrugBank.d367.s9.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s9.p26" e1="DDI-DrugBank.d367.s9.e5"
            e2="DDI-DrugBank.d367.s9.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s9.p27" e1="DDI-DrugBank.d367.s9.e6"
            e2="DDI-DrugBank.d367.s9.e7" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d367.s10" text="2."/>
    <sentence id="DDI-DrugBank.d367.s11" text="Antibiotics (e.g., erythromycin, trimethoprim and sulfamethoxazole, amoxicillin).">
        <entity id="DDI-DrugBank.d367.s11.e0" charOffset="0-10"
            type="group" text="Antibiotics"/>
        <entity id="DDI-DrugBank.d367.s11.e1" charOffset="19-30"
            type="drug" text="erythromycin"/>
        <entity id="DDI-DrugBank.d367.s11.e2" charOffset="33-44"
            type="drug" text="trimethoprim"/>
        <entity id="DDI-DrugBank.d367.s11.e3" charOffset="50-65"
            type="drug" text="sulfamethoxazole"/>
        <entity id="DDI-DrugBank.d367.s11.e4" charOffset="68-78"
            type="drug" text="amoxicillin"/>
        <pair id="DDI-DrugBank.d367.s11.p0"
            e1="DDI-DrugBank.d367.s11.e0" e2="DDI-DrugBank.d367.s11.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s11.p1"
            e1="DDI-DrugBank.d367.s11.e0" e2="DDI-DrugBank.d367.s11.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s11.p2"
            e1="DDI-DrugBank.d367.s11.e0" e2="DDI-DrugBank.d367.s11.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s11.p3"
            e1="DDI-DrugBank.d367.s11.e0" e2="DDI-DrugBank.d367.s11.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s11.p4"
            e1="DDI-DrugBank.d367.s11.e1" e2="DDI-DrugBank.d367.s11.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s11.p5"
            e1="DDI-DrugBank.d367.s11.e1" e2="DDI-DrugBank.d367.s11.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s11.p6"
            e1="DDI-DrugBank.d367.s11.e1" e2="DDI-DrugBank.d367.s11.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s11.p7"
            e1="DDI-DrugBank.d367.s11.e2" e2="DDI-DrugBank.d367.s11.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s11.p8"
            e1="DDI-DrugBank.d367.s11.e2" e2="DDI-DrugBank.d367.s11.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s11.p9"
            e1="DDI-DrugBank.d367.s11.e3" e2="DDI-DrugBank.d367.s11.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d367.s12" text="3."/>
    <sentence id="DDI-DrugBank.d367.s13" text="Antihistamines (e.g., chlorpheniramine).">
        <entity id="DDI-DrugBank.d367.s13.e0" charOffset="0-13"
            type="group" text="Antihistamines"/>
        <entity id="DDI-DrugBank.d367.s13.e1" charOffset="22-37"
            type="group" text="chlorpheniramine"/>
        <pair id="DDI-DrugBank.d367.s13.p0"
            e1="DDI-DrugBank.d367.s13.e0" e2="DDI-DrugBank.d367.s13.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d367.s14" text="4."/>
    <sentence id="DDI-DrugBank.d367.s15" text="Cardiovascular agents (e.g., atenolol, hydrochlorothiazide, propranolol).">
        <entity id="DDI-DrugBank.d367.s15.e0" charOffset="29-36"
            type="drug" text="atenolol"/>
        <entity id="DDI-DrugBank.d367.s15.e1" charOffset="39-57"
            type="drug" text="hydrochlorothiazide"/>
        <entity id="DDI-DrugBank.d367.s15.e2" charOffset="60-70"
            type="drug" text="propranolol"/>
        <pair id="DDI-DrugBank.d367.s15.p0"
            e1="DDI-DrugBank.d367.s15.e0" e2="DDI-DrugBank.d367.s15.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s15.p1"
            e1="DDI-DrugBank.d367.s15.e0" e2="DDI-DrugBank.d367.s15.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s15.p2"
            e1="DDI-DrugBank.d367.s15.e1" e2="DDI-DrugBank.d367.s15.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d367.s16" text="5."/>
    <sentence id="DDI-DrugBank.d367.s17" text="Corticosteroids.">
        <entity id="DDI-DrugBank.d367.s17.e0" charOffset="0-14"
            type="group" text="Corticosteroids"/>
    </sentence>
    <sentence id="DDI-DrugBank.d367.s18" text="6."/>
    <sentence id="DDI-DrugBank.d367.s19" text="Gastrointestinal agents (e.g., antacids).">
        <entity id="DDI-DrugBank.d367.s19.e0" charOffset="31-38"
            type="group" text="antacids"/>
    </sentence>
    <sentence id="DDI-DrugBank.d367.s20" text="7."/>
    <sentence id="DDI-DrugBank.d367.s21" text="Hypoglycemics and endocrine drugs.">
        <entity id="DDI-DrugBank.d367.s21.e0" charOffset="0-12"
            type="group" text="Hypoglycemics"/>
    </sentence>
    <sentence id="DDI-DrugBank.d367.s22" text="8."/>
    <sentence id="DDI-DrugBank.d367.s23" text="Sedatives and tranquilizers (e.g., diazepam).">
        <entity id="DDI-DrugBank.d367.s23.e0" charOffset="0-8"
            type="group" text="Sedatives"/>
        <entity id="DDI-DrugBank.d367.s23.e1" charOffset="14-26"
            type="group" text="tranquilizers"/>
        <entity id="DDI-DrugBank.d367.s23.e2" charOffset="35-42"
            type="drug" text="diazepam"/>
        <pair id="DDI-DrugBank.d367.s23.p0"
            e1="DDI-DrugBank.d367.s23.e0" e2="DDI-DrugBank.d367.s23.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s23.p1"
            e1="DDI-DrugBank.d367.s23.e0" e2="DDI-DrugBank.d367.s23.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d367.s23.p2"
            e1="DDI-DrugBank.d367.s23.e1" e2="DDI-DrugBank.d367.s23.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d367.s24" text="9."/>
    <sentence id="DDI-DrugBank.d367.s25" text="Cold and flu remedies."/>
</document>
<document id="DDI-DrugBank.d223">
    <sentence id="DDI-DrugBank.d223.s0" text="Drugs Metabolized by P450 2D6: The biochemical activity of the drug metabolizing isozyme cytochrome P450 2D6 (debrisoquin hydroxylase) is reduced in a subset of the Caucasian population (about 7-10% of Caucasians are so-called poor metabolizers);"/>
    <sentence id="DDI-DrugBank.d223.s1" text="reliable estimates of the prevalence of reduced P450 2D6 isozyme activity among Asian, African and other populations are not yet available."/>
    <sentence id="DDI-DrugBank.d223.s2" text="Poor metabolizers have higher than expected plasma concentrations of tricyclic antidepressants (TCAs) when given usual doses.">
        <entity id="DDI-DrugBank.d223.s2.e0" charOffset="69-93"
            type="group" text="tricyclic antidepressants"/>
        <entity id="DDI-DrugBank.d223.s2.e1" charOffset="96-99"
            type="group" text="TCAs"/>
        <pair id="DDI-DrugBank.d223.s2.p0" e1="DDI-DrugBank.d223.s2.e0"
            e2="DDI-DrugBank.d223.s2.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s3" text="Depending on the fraction of drug metabolized by P450 2D6, the increase in plasma concentration may be small, or quite large (8-fold increase in plasma AUC of the TCA)."/>
    <sentence id="DDI-DrugBank.d223.s4" text="In addition, certain drugs inhibit the activity of this isozyme and make normal metabolizers resemble poor metabolizers."/>
    <sentence id="DDI-DrugBank.d223.s5" text="An individual who is stable on a given dose of TCA may become abruptly toxic when given one of these inhibiting drugs as concomitant therapy.">
        <entity id="DDI-DrugBank.d223.s5.e0" charOffset="47-49"
            type="group" text="TCA"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s6" text="The drugs that inhibit cytochrome P450 2D6 include some that are not metabolized by the enzyme (quinidine;">
        <entity id="DDI-DrugBank.d223.s6.e0" charOffset="96-104"
            type="drug" text="quinidine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s7" text="cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the Type 1C antiarrhythmics propafenone and flecainide).">
        <entity id="DDI-DrugBank.d223.s7.e0" charOffset="0-9"
            type="drug" text="cimetidine"/>
        <entity id="DDI-DrugBank.d223.s7.e1" charOffset="66-80"
            type="group" text="antidepressants"/>
        <entity id="DDI-DrugBank.d223.s7.e2" charOffset="83-96"
            type="group" text="phenothiazines"/>
        <entity id="DDI-DrugBank.d223.s7.e3" charOffset="107-129"
            type="group" text="Type 1C antiarrhythmics"/>
        <entity id="DDI-DrugBank.d223.s7.e4" charOffset="131-141"
            type="drug" text="propafenone"/>
        <entity id="DDI-DrugBank.d223.s7.e5" charOffset="147-156"
            type="drug" text="flecainide"/>
        <pair id="DDI-DrugBank.d223.s7.p0" e1="DDI-DrugBank.d223.s7.e0"
            e2="DDI-DrugBank.d223.s7.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s7.p1" e1="DDI-DrugBank.d223.s7.e0"
            e2="DDI-DrugBank.d223.s7.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s7.p2" e1="DDI-DrugBank.d223.s7.e0"
            e2="DDI-DrugBank.d223.s7.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s7.p3" e1="DDI-DrugBank.d223.s7.e0"
            e2="DDI-DrugBank.d223.s7.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s7.p4" e1="DDI-DrugBank.d223.s7.e0"
            e2="DDI-DrugBank.d223.s7.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s7.p5" e1="DDI-DrugBank.d223.s7.e1"
            e2="DDI-DrugBank.d223.s7.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s7.p6" e1="DDI-DrugBank.d223.s7.e1"
            e2="DDI-DrugBank.d223.s7.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s7.p7" e1="DDI-DrugBank.d223.s7.e1"
            e2="DDI-DrugBank.d223.s7.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s7.p8" e1="DDI-DrugBank.d223.s7.e1"
            e2="DDI-DrugBank.d223.s7.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s7.p9" e1="DDI-DrugBank.d223.s7.e2"
            e2="DDI-DrugBank.d223.s7.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s7.p10" e1="DDI-DrugBank.d223.s7.e2"
            e2="DDI-DrugBank.d223.s7.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s7.p11" e1="DDI-DrugBank.d223.s7.e2"
            e2="DDI-DrugBank.d223.s7.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s7.p12" e1="DDI-DrugBank.d223.s7.e3"
            e2="DDI-DrugBank.d223.s7.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s7.p13" e1="DDI-DrugBank.d223.s7.e3"
            e2="DDI-DrugBank.d223.s7.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s7.p14" e1="DDI-DrugBank.d223.s7.e4"
            e2="DDI-DrugBank.d223.s7.e5" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s8" text="While all the selective serotonin reuptake inhibitors (SSRIs), e.g., citalopram, escitalopram, fluoxetine, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.">
        <entity id="DDI-DrugBank.d223.s8.e0" charOffset="14-52"
            type="group" text="selective serotonin reuptake inhibitors"/>
        <entity id="DDI-DrugBank.d223.s8.e1" charOffset="55-59"
            type="group" text="SSRIs"/>
        <entity id="DDI-DrugBank.d223.s8.e2" charOffset="69-78"
            type="drug" text="citalopram"/>
        <entity id="DDI-DrugBank.d223.s8.e3" charOffset="81-92"
            type="drug" text="escitalopram"/>
        <entity id="DDI-DrugBank.d223.s8.e4" charOffset="95-104"
            type="drug" text="fluoxetine"/>
        <entity id="DDI-DrugBank.d223.s8.e5" charOffset="107-116"
            type="drug" text="sertraline"/>
        <entity id="DDI-DrugBank.d223.s8.e6" charOffset="123-132"
            type="drug" text="paroxetine"/>
        <pair id="DDI-DrugBank.d223.s8.p0" e1="DDI-DrugBank.d223.s8.e0"
            e2="DDI-DrugBank.d223.s8.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p1" e1="DDI-DrugBank.d223.s8.e0"
            e2="DDI-DrugBank.d223.s8.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p2" e1="DDI-DrugBank.d223.s8.e0"
            e2="DDI-DrugBank.d223.s8.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p3" e1="DDI-DrugBank.d223.s8.e0"
            e2="DDI-DrugBank.d223.s8.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p4" e1="DDI-DrugBank.d223.s8.e0"
            e2="DDI-DrugBank.d223.s8.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p5" e1="DDI-DrugBank.d223.s8.e0"
            e2="DDI-DrugBank.d223.s8.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p6" e1="DDI-DrugBank.d223.s8.e1"
            e2="DDI-DrugBank.d223.s8.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p7" e1="DDI-DrugBank.d223.s8.e1"
            e2="DDI-DrugBank.d223.s8.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p8" e1="DDI-DrugBank.d223.s8.e1"
            e2="DDI-DrugBank.d223.s8.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p9" e1="DDI-DrugBank.d223.s8.e1"
            e2="DDI-DrugBank.d223.s8.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p10" e1="DDI-DrugBank.d223.s8.e1"
            e2="DDI-DrugBank.d223.s8.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p11" e1="DDI-DrugBank.d223.s8.e2"
            e2="DDI-DrugBank.d223.s8.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p12" e1="DDI-DrugBank.d223.s8.e2"
            e2="DDI-DrugBank.d223.s8.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p13" e1="DDI-DrugBank.d223.s8.e2"
            e2="DDI-DrugBank.d223.s8.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p14" e1="DDI-DrugBank.d223.s8.e2"
            e2="DDI-DrugBank.d223.s8.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p15" e1="DDI-DrugBank.d223.s8.e3"
            e2="DDI-DrugBank.d223.s8.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p16" e1="DDI-DrugBank.d223.s8.e3"
            e2="DDI-DrugBank.d223.s8.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p17" e1="DDI-DrugBank.d223.s8.e3"
            e2="DDI-DrugBank.d223.s8.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p18" e1="DDI-DrugBank.d223.s8.e4"
            e2="DDI-DrugBank.d223.s8.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p19" e1="DDI-DrugBank.d223.s8.e4"
            e2="DDI-DrugBank.d223.s8.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p20" e1="DDI-DrugBank.d223.s8.e5"
            e2="DDI-DrugBank.d223.s8.e6" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s9" text="The extent to which SSRI-TCA interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the SSRI involved.">
        <entity id="DDI-DrugBank.d223.s9.e0" charOffset="20-23"
            type="group" text="SSRI"/>
        <entity id="DDI-DrugBank.d223.s9.e1" charOffset="25-27"
            type="group" text="TCA"/>
        <entity id="DDI-DrugBank.d223.s9.e2" charOffset="141-144"
            type="group" text="SSRI"/>
        <pair id="DDI-DrugBank.d223.s9.p0" e1="DDI-DrugBank.d223.s9.e0"
            e2="DDI-DrugBank.d223.s9.e1" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d223.s9.p1" e1="DDI-DrugBank.d223.s9.e0"
            e2="DDI-DrugBank.d223.s9.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s9.p2" e1="DDI-DrugBank.d223.s9.e1"
            e2="DDI-DrugBank.d223.s9.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s10" text="Nevertheless, caution is indicated in the co-administration of TCAs with any of the SSRIs and also in switching from one class to the other.">
        <entity id="DDI-DrugBank.d223.s10.e0" charOffset="63-66"
            type="group" text="TCAs"/>
        <entity id="DDI-DrugBank.d223.s10.e1" charOffset="84-88"
            type="group" text="SSRIs"/>
        <pair id="DDI-DrugBank.d223.s10.p0"
            e1="DDI-DrugBank.d223.s10.e0" e2="DDI-DrugBank.d223.s10.e1"
            ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s11" text="Of particular importance, sufficient time must elapse before initiating TCA treatment in a patient being withdrawn from fluoxetine, given the long half-life of the parent and active metabolite (at least 5 weeks may be necessary).">
        <entity id="DDI-DrugBank.d223.s11.e0" charOffset="120-129"
            type="drug" text="fluoxetine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s12" text="Concomitant use of tricyclic antidepressants with drugs that can inhibit cytochrome P450 2D6 may require lower doses than usually prescribed for either the tricyclic antidepressant or the other drug.">
        <entity id="DDI-DrugBank.d223.s12.e0" charOffset="19-43"
            type="group" text="tricyclic antidepressants"/>
        <entity id="DDI-DrugBank.d223.s12.e1" charOffset="156-179"
            type="group" text="tricyclic antidepressant"/>
        <pair id="DDI-DrugBank.d223.s12.p0"
            e1="DDI-DrugBank.d223.s12.e0" e2="DDI-DrugBank.d223.s12.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s13" text="Furthermore, whenever one of these other drugs is withdrawn from co-therapy, an increased dose of tricyclic antidepressant may be required.">
        <entity id="DDI-DrugBank.d223.s13.e0" charOffset="98-121"
            type="group" text="tricyclic antidepressant"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s14" text="It is desirable to monitor TCA plasma levels whenever a TCA is going to be co-administered with another drug known to be an inhibitor of P450 2D6.">
        <entity id="DDI-DrugBank.d223.s14.e0" charOffset="27-29"
            type="group" text="TCA"/>
        <entity id="DDI-DrugBank.d223.s14.e1" charOffset="56-58"
            type="group" text="TCA"/>
        <pair id="DDI-DrugBank.d223.s14.p0"
            e1="DDI-DrugBank.d223.s14.e0" e2="DDI-DrugBank.d223.s14.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s15" text="Doxepin is primarily metabolized by CYP2D6 (with CYP1A2  and  CYP3A4 as minor pathways).">
        <entity id="DDI-DrugBank.d223.s15.e0" charOffset="0-6"
            type="drug" text="Doxepin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s16" text="Inhibitors or substrates of CYP2D6 (i.e., quinidine, selective serotonin reuptake inhibitors [SSRIs]) may increase the plasma concentration of doxepin when administered concomitantly.">
        <entity id="DDI-DrugBank.d223.s16.e0" charOffset="42-50"
            type="drug" text="quinidine"/>
        <entity id="DDI-DrugBank.d223.s16.e1" charOffset="53-91"
            type="group" text="selective serotonin reuptake inhibitors"/>
        <entity id="DDI-DrugBank.d223.s16.e2" charOffset="94-98"
            type="group" text="SSRIs"/>
        <entity id="DDI-DrugBank.d223.s16.e3" charOffset="143-149"
            type="drug" text="doxepin"/>
        <pair id="DDI-DrugBank.d223.s16.p0"
            e1="DDI-DrugBank.d223.s16.e0" e2="DDI-DrugBank.d223.s16.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s16.p1"
            e1="DDI-DrugBank.d223.s16.e0" e2="DDI-DrugBank.d223.s16.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s16.p2"
            e1="DDI-DrugBank.d223.s16.e0" e2="DDI-DrugBank.d223.s16.e3"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d223.s16.p3"
            e1="DDI-DrugBank.d223.s16.e1" e2="DDI-DrugBank.d223.s16.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s16.p4"
            e1="DDI-DrugBank.d223.s16.e1" e2="DDI-DrugBank.d223.s16.e3"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d223.s16.p5"
            e1="DDI-DrugBank.d223.s16.e2" e2="DDI-DrugBank.d223.s16.e3"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s17" text="The extent of interaction depends on the variability of effect on CYP2D6."/>
    <sentence id="DDI-DrugBank.d223.s18" text="The clinical significance of this interaction with doxepin has not been systematically evaluated.">
        <entity id="DDI-DrugBank.d223.s18.e0" charOffset="51-57"
            type="drug" text="doxepin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s19" text="MAO Inhibitors: Serious side effects and even death have been reported following the concomitant use of certain drugs with MAO inhibitors.">
        <entity id="DDI-DrugBank.d223.s19.e0" charOffset="0-13"
            type="group" text="MAO Inhibitors"/>
        <entity id="DDI-DrugBank.d223.s19.e1" charOffset="123-136"
            type="group" text="MAO inhibitors"/>
        <pair id="DDI-DrugBank.d223.s19.p0"
            e1="DDI-DrugBank.d223.s19.e0" e2="DDI-DrugBank.d223.s19.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s20" text="Therefore, MAO inhibitors should be discontinued at least two weeks prior to the cautious initiation of therapy with SINEQUAN.">
        <entity id="DDI-DrugBank.d223.s20.e0" charOffset="11-24"
            type="group" text="MAO inhibitors"/>
        <entity id="DDI-DrugBank.d223.s20.e1" charOffset="117-124"
            type="brand" text="SINEQUAN"/>
        <pair id="DDI-DrugBank.d223.s20.p0"
            e1="DDI-DrugBank.d223.s20.e0" e2="DDI-DrugBank.d223.s20.e1"
            ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s21" text="The exact length of time may vary and is dependent upon the particular MAO inhibitor being used, the length of time it has been administered, and the dosage involved.">
        <entity id="DDI-DrugBank.d223.s21.e0" charOffset="71-83"
            type="group" text="MAO inhibitor"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s22" text="Cimetidine: Cimetidine has been reported to produce clinically significant fluctuations in steady-state serum concentrations of various tricyclic antidepressants.">
        <entity id="DDI-DrugBank.d223.s22.e0" charOffset="0-9"
            type="drug" text="Cimetidine"/>
        <entity id="DDI-DrugBank.d223.s22.e1" charOffset="12-21"
            type="drug" text="Cimetidine"/>
        <entity id="DDI-DrugBank.d223.s22.e2" charOffset="136-160"
            type="group" text="tricyclic antidepressants"/>
        <pair id="DDI-DrugBank.d223.s22.p0"
            e1="DDI-DrugBank.d223.s22.e0" e2="DDI-DrugBank.d223.s22.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s22.p1"
            e1="DDI-DrugBank.d223.s22.e0" e2="DDI-DrugBank.d223.s22.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s22.p2"
            e1="DDI-DrugBank.d223.s22.e1" e2="DDI-DrugBank.d223.s22.e2"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s23" text="Serious anticholinergic symptoms (i.e., severe dry mouth, urinary retention and blurred vision) have been associated with elevations in the serum levels of tricyclic antidepressant when cimetidine therapy is initiated.">
        <entity id="DDI-DrugBank.d223.s23.e0" charOffset="156-179"
            type="group" text="tricyclic antidepressant"/>
        <entity id="DDI-DrugBank.d223.s23.e1" charOffset="186-195"
            type="drug" text="cimetidine"/>
        <pair id="DDI-DrugBank.d223.s23.p0"
            e1="DDI-DrugBank.d223.s23.e0" e2="DDI-DrugBank.d223.s23.e1"
            ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s24" text="Additionally, higher than expected tricyclic antidepressant levels have been observed when they are begun in patients already taking cimetidine.">
        <entity id="DDI-DrugBank.d223.s24.e0" charOffset="35-58"
            type="group" text="tricyclic antidepressant"/>
        <entity id="DDI-DrugBank.d223.s24.e1" charOffset="133-142"
            type="drug" text="cimetidine"/>
        <pair id="DDI-DrugBank.d223.s24.p0"
            e1="DDI-DrugBank.d223.s24.e0" e2="DDI-DrugBank.d223.s24.e1"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s25" text="In patients who have been reported to be well controlled on tricyclic antidepressants receiving concurrent cimetidine therapy, discontinuation of cimetidine has been reported to decrease established steady-state serum tricyclic antidepressant levels and compromise their therapeutic effects.">
        <entity id="DDI-DrugBank.d223.s25.e0" charOffset="60-84"
            type="group" text="tricyclic antidepressants"/>
        <entity id="DDI-DrugBank.d223.s25.e1" charOffset="107-116"
            type="drug" text="cimetidine"/>
        <entity id="DDI-DrugBank.d223.s25.e2" charOffset="146-155"
            type="drug" text="cimetidine"/>
        <entity id="DDI-DrugBank.d223.s25.e3" charOffset="218-241"
            type="group" text="tricyclic antidepressant"/>
        <pair id="DDI-DrugBank.d223.s25.p0"
            e1="DDI-DrugBank.d223.s25.e0" e2="DDI-DrugBank.d223.s25.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s25.p1"
            e1="DDI-DrugBank.d223.s25.e0" e2="DDI-DrugBank.d223.s25.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s25.p2"
            e1="DDI-DrugBank.d223.s25.e0" e2="DDI-DrugBank.d223.s25.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s25.p3"
            e1="DDI-DrugBank.d223.s25.e1" e2="DDI-DrugBank.d223.s25.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s25.p4"
            e1="DDI-DrugBank.d223.s25.e1" e2="DDI-DrugBank.d223.s25.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s25.p5"
            e1="DDI-DrugBank.d223.s25.e2" e2="DDI-DrugBank.d223.s25.e3"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s26" text="Alcohol: It should be borne in mind that alcohol ingestion may increase the danger inherent in any intentional or unintentional SINEQUAN overdosage.">
        <entity id="DDI-DrugBank.d223.s26.e0" charOffset="0-6"
            type="drug" text="Alcohol"/>
        <entity id="DDI-DrugBank.d223.s26.e1" charOffset="41-47"
            type="drug" text="alcohol"/>
        <entity id="DDI-DrugBank.d223.s26.e2" charOffset="128-135"
            type="brand" text="SINEQUAN"/>
        <pair id="DDI-DrugBank.d223.s26.p0"
            e1="DDI-DrugBank.d223.s26.e0" e2="DDI-DrugBank.d223.s26.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s26.p1"
            e1="DDI-DrugBank.d223.s26.e0" e2="DDI-DrugBank.d223.s26.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s26.p2"
            e1="DDI-DrugBank.d223.s26.e1" e2="DDI-DrugBank.d223.s26.e2"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s27" text="This is especially important in patients who may use alcohol excessively.">
        <entity id="DDI-DrugBank.d223.s27.e0" charOffset="53-59"
            type="drug" text="alcohol"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s28" text="Tolazamide: A case of severe hypoglycemia has been reported in a type II diabetic patient maintained on tolazamide (1 gm/day) 11 days after the addition of doxepin (75 mg/day).">
        <entity id="DDI-DrugBank.d223.s28.e0" charOffset="0-9"
            type="drug" text="Tolazamide"/>
        <entity id="DDI-DrugBank.d223.s28.e1" charOffset="104-113"
            type="drug" text="tolazamide"/>
        <entity id="DDI-DrugBank.d223.s28.e2" charOffset="156-162"
            type="drug" text="doxepin"/>
        <pair id="DDI-DrugBank.d223.s28.p0"
            e1="DDI-DrugBank.d223.s28.e0" e2="DDI-DrugBank.d223.s28.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s28.p1"
            e1="DDI-DrugBank.d223.s28.e0" e2="DDI-DrugBank.d223.s28.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s28.p2"
            e1="DDI-DrugBank.d223.s28.e1" e2="DDI-DrugBank.d223.s28.e2"
            ddi="true" type="effect"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d44">
    <sentence id="DDI-DrugBank.d44.s0" text="No formal drug interaction studies have been performed with RAPTIVA.">
        <entity id="DDI-DrugBank.d44.s0.e0" charOffset="60-66"
            type="brand" text="RAPTIVA"/>
    </sentence>
    <sentence id="DDI-DrugBank.d44.s1" text="RAPTIVA should not be used with other immunosuppressive drugs.">
        <entity id="DDI-DrugBank.d44.s1.e0" charOffset="0-6"
            type="brand" text="RAPTIVA"/>
        <entity id="DDI-DrugBank.d44.s1.e1" charOffset="38-60"
            type="group" text="immunosuppressive drugs"/>
        <pair id="DDI-DrugBank.d44.s1.p0" e1="DDI-DrugBank.d44.s1.e0"
            e2="DDI-DrugBank.d44.s1.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d44.s2" text="Acellular, live and live-attenuated vaccines should not be administered during RAPTIVA treatment.">
        <entity id="DDI-DrugBank.d44.s2.e0" charOffset="0-8;36-43"
            type="group" text="Acellular vaccines"/>
        <entity id="DDI-DrugBank.d44.s2.e1" charOffset="11-14;36-43"
            type="group" text="live vaccines"/>
        <entity id="DDI-DrugBank.d44.s2.e2" charOffset="20-43"
            type="group" text="live-attenuated vaccines"/>
        <entity id="DDI-DrugBank.d44.s2.e3" charOffset="79-85"
            type="brand" text="RAPTIVA"/>
        <pair id="DDI-DrugBank.d44.s2.p0" e1="DDI-DrugBank.d44.s2.e0"
            e2="DDI-DrugBank.d44.s2.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d44.s2.p1" e1="DDI-DrugBank.d44.s2.e0"
            e2="DDI-DrugBank.d44.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d44.s2.p2" e1="DDI-DrugBank.d44.s2.e0"
            e2="DDI-DrugBank.d44.s2.e3" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d44.s2.p3" e1="DDI-DrugBank.d44.s2.e1"
            e2="DDI-DrugBank.d44.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d44.s2.p4" e1="DDI-DrugBank.d44.s2.e1"
            e2="DDI-DrugBank.d44.s2.e3" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d44.s2.p5" e1="DDI-DrugBank.d44.s2.e2"
            e2="DDI-DrugBank.d44.s2.e3" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d44.s3" text="Drug/Laboratory Test Interactions Increases in lymphocyte counts related to the pharmacologic mechanism of action are frequently observed during RAPTIVA treatment.">
        <entity id="DDI-DrugBank.d44.s3.e0" charOffset="145-151"
            type="brand" text="RAPTIVA"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d531">
    <sentence id="DDI-DrugBank.d531.s0" text="Efavirenz has been shown in vivo to induce CYP3A4.">
        <entity id="DDI-DrugBank.d531.s0.e0" charOffset="0-8"
            type="drug" text="Efavirenz"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s1" text="Other compounds that are substrates of CYP3A4 may have decreased plasma concentrations when coadministered with SUSTIVA (efavirenz).">
        <entity id="DDI-DrugBank.d531.s1.e0" charOffset="112-118"
            type="brand" text="SUSTIVA"/>
        <entity id="DDI-DrugBank.d531.s1.e1" charOffset="121-129"
            type="drug" text="efavirenz"/>
        <pair id="DDI-DrugBank.d531.s1.p0" e1="DDI-DrugBank.d531.s1.e0"
            e2="DDI-DrugBank.d531.s1.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s2" text="In vitro studies have demonstrated that efavirenz inhibits 2C9, 2C19, and 3A4 isozymes in the range of observed efavirenz plasma concentrations.">
        <entity id="DDI-DrugBank.d531.s2.e0" charOffset="40-48"
            type="drug" text="efavirenz"/>
        <entity id="DDI-DrugBank.d531.s2.e1" charOffset="112-120"
            type="drug" text="efavirenz"/>
        <pair id="DDI-DrugBank.d531.s2.p0" e1="DDI-DrugBank.d531.s2.e0"
            e2="DDI-DrugBank.d531.s2.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s3" text="Coadministration of efavirenz with drugs primarily metabolized by these isozymes may result in altered plasma concentrations of the coadministered drug.">
        <entity id="DDI-DrugBank.d531.s3.e0" charOffset="20-28"
            type="drug" text="efavirenz"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s4" text="Therefore, appropriate dose adjustments may be necessary for these drugs."/>
    <sentence id="DDI-DrugBank.d531.s5" text="Drugs which induce CYP3A4 activity (eg, phenobarbital, rifampin, rifabutin) would be expected to increase the clearance of efavirenz resulting in lowered plasma concentrations.">
        <entity id="DDI-DrugBank.d531.s5.e0" charOffset="40-52"
            type="drug" text="phenobarbital"/>
        <entity id="DDI-DrugBank.d531.s5.e1" charOffset="55-62"
            type="drug" text="rifampin"/>
        <entity id="DDI-DrugBank.d531.s5.e2" charOffset="65-73"
            type="drug" text="rifabutin"/>
        <entity id="DDI-DrugBank.d531.s5.e3" charOffset="123-131"
            type="drug" text="efavirenz"/>
        <pair id="DDI-DrugBank.d531.s5.p0" e1="DDI-DrugBank.d531.s5.e0"
            e2="DDI-DrugBank.d531.s5.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s5.p1" e1="DDI-DrugBank.d531.s5.e0"
            e2="DDI-DrugBank.d531.s5.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s5.p2" e1="DDI-DrugBank.d531.s5.e0"
            e2="DDI-DrugBank.d531.s5.e3" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d531.s5.p3" e1="DDI-DrugBank.d531.s5.e1"
            e2="DDI-DrugBank.d531.s5.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s5.p4" e1="DDI-DrugBank.d531.s5.e1"
            e2="DDI-DrugBank.d531.s5.e3" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d531.s5.p5" e1="DDI-DrugBank.d531.s5.e2"
            e2="DDI-DrugBank.d531.s5.e3" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s6" text="Drug interactions with SUSTIVA are summarized in Table 5.">
        <entity id="DDI-DrugBank.d531.s6.e0" charOffset="23-29"
            type="brand" text="SUSTIVA"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s7" text="Table 5a: Drugs That Should Not Be Coadministered With SUSTIVA">
        <entity id="DDI-DrugBank.d531.s7.e0" charOffset="55-61"
            type="brand" text="SUSTIVA"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s8" text="Drug Class"/>
    <sentence id="DDI-DrugBank.d531.s9" text="Drugs Within Class Not To Be Coadministered With SUSTIVA">
        <entity id="DDI-DrugBank.d531.s9.e0" charOffset="49-55"
            type="brand" text="SUSTIVA"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s10" text="Antihistamines: Benzodiazepines GI Motility Agents Anti-Migraine Antifungal">
        <entity id="DDI-DrugBank.d531.s10.e0" charOffset="0-13"
            type="group" text="Antihistamines"/>
        <entity id="DDI-DrugBank.d531.s10.e1" charOffset="16-30"
            type="group" text="Benzodiazepines"/>
        <entity id="DDI-DrugBank.d531.s10.e2" charOffset="51-63"
            type="group" text="Anti-Migraine"/>
        <entity id="DDI-DrugBank.d531.s10.e3" charOffset="65-74"
            type="group" text="Antifungal"/>
        <pair id="DDI-DrugBank.d531.s10.p0"
            e1="DDI-DrugBank.d531.s10.e0" e2="DDI-DrugBank.d531.s10.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s10.p1"
            e1="DDI-DrugBank.d531.s10.e0" e2="DDI-DrugBank.d531.s10.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s10.p2"
            e1="DDI-DrugBank.d531.s10.e0" e2="DDI-DrugBank.d531.s10.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s10.p3"
            e1="DDI-DrugBank.d531.s10.e1" e2="DDI-DrugBank.d531.s10.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s10.p4"
            e1="DDI-DrugBank.d531.s10.e1" e2="DDI-DrugBank.d531.s10.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s10.p5"
            e1="DDI-DrugBank.d531.s10.e2" e2="DDI-DrugBank.d531.s10.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s11" text="astemizole midazolam, triazolam cisapride ergot derivatives voriconazole">
        <entity id="DDI-DrugBank.d531.s11.e0" charOffset="0-9"
            type="drug" text="astemizole"/>
        <entity id="DDI-DrugBank.d531.s11.e1" charOffset="11-19"
            type="drug" text="midazolam"/>
        <entity id="DDI-DrugBank.d531.s11.e2" charOffset="22-30"
            type="drug" text="triazolam"/>
        <entity id="DDI-DrugBank.d531.s11.e3" charOffset="32-40"
            type="drug" text="cisapride"/>
        <entity id="DDI-DrugBank.d531.s11.e4" charOffset="60-71"
            type="drug" text="voriconazole"/>
        <pair id="DDI-DrugBank.d531.s11.p0"
            e1="DDI-DrugBank.d531.s11.e0" e2="DDI-DrugBank.d531.s11.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s11.p1"
            e1="DDI-DrugBank.d531.s11.e0" e2="DDI-DrugBank.d531.s11.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s11.p2"
            e1="DDI-DrugBank.d531.s11.e0" e2="DDI-DrugBank.d531.s11.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s11.p3"
            e1="DDI-DrugBank.d531.s11.e0" e2="DDI-DrugBank.d531.s11.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s11.p4"
            e1="DDI-DrugBank.d531.s11.e1" e2="DDI-DrugBank.d531.s11.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s11.p5"
            e1="DDI-DrugBank.d531.s11.e1" e2="DDI-DrugBank.d531.s11.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s11.p6"
            e1="DDI-DrugBank.d531.s11.e1" e2="DDI-DrugBank.d531.s11.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s11.p7"
            e1="DDI-DrugBank.d531.s11.e2" e2="DDI-DrugBank.d531.s11.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s11.p8"
            e1="DDI-DrugBank.d531.s11.e2" e2="DDI-DrugBank.d531.s11.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s11.p9"
            e1="DDI-DrugBank.d531.s11.e3" e2="DDI-DrugBank.d531.s11.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s12" text="Established Drug Interactions"/>
    <sentence id="DDI-DrugBank.d531.s13" text=""/>
    <sentence id="DDI-DrugBank.d531.s14" text="Drug Name"/>
    <sentence id="DDI-DrugBank.d531.s15" text="Effect"/>
    <sentence id="DDI-DrugBank.d531.s16" text="Clinical Comment"/>
    <sentence id="DDI-DrugBank.d531.s17" text="Atazanavir">
        <entity id="DDI-DrugBank.d531.s17.e0" charOffset="0-9"
            type="drug" text="Atazanavir"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s18" text="atazanavir">
        <entity id="DDI-DrugBank.d531.s18.e0" charOffset="0-9"
            type="drug" text="atazanavir"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s19" text="When coadministered with SUSTIVA in treatment-naive patients, the recommended dose of atazanavir is 300 mg with ritonavir 100 mg and SUSTIVA 600 mg (all once daily).">
        <entity id="DDI-DrugBank.d531.s19.e0" charOffset="25-31"
            type="brand" text="SUSTIVA"/>
        <entity id="DDI-DrugBank.d531.s19.e1" charOffset="86-95"
            type="drug" text="atazanavir"/>
        <entity id="DDI-DrugBank.d531.s19.e2" charOffset="112-120"
            type="drug" text="ritonavir"/>
        <entity id="DDI-DrugBank.d531.s19.e3" charOffset="133-139"
            type="brand" text="SUSTIVA"/>
        <pair id="DDI-DrugBank.d531.s19.p0"
            e1="DDI-DrugBank.d531.s19.e0" e2="DDI-DrugBank.d531.s19.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s19.p1"
            e1="DDI-DrugBank.d531.s19.e0" e2="DDI-DrugBank.d531.s19.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s19.p2"
            e1="DDI-DrugBank.d531.s19.e0" e2="DDI-DrugBank.d531.s19.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s19.p3"
            e1="DDI-DrugBank.d531.s19.e1" e2="DDI-DrugBank.d531.s19.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s19.p4"
            e1="DDI-DrugBank.d531.s19.e1" e2="DDI-DrugBank.d531.s19.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s19.p5"
            e1="DDI-DrugBank.d531.s19.e2" e2="DDI-DrugBank.d531.s19.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s20" text="Dosing recommendations for SUSTIVA and atazanavir in treatment-experienced patients have not been established.">
        <entity id="DDI-DrugBank.d531.s20.e0" charOffset="27-33"
            type="brand" text="SUSTIVA"/>
        <entity id="DDI-DrugBank.d531.s20.e1" charOffset="39-48"
            type="drug" text="atazanavir"/>
        <pair id="DDI-DrugBank.d531.s20.p0"
            e1="DDI-DrugBank.d531.s20.e0" e2="DDI-DrugBank.d531.s20.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s21" text="Established Drug Interactions (continued)"/>
    <sentence id="DDI-DrugBank.d531.s22" text="Drug Name"/>
    <sentence id="DDI-DrugBank.d531.s23" text="Effect"/>
    <sentence id="DDI-DrugBank.d531.s24" text="Clinical Comment"/>
    <sentence id="DDI-DrugBank.d531.s25" text="Clarithromycin">
        <entity id="DDI-DrugBank.d531.s25.e0" charOffset="0-13"
            type="drug" text="Clarithromycin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s26" text="clarithromycin concentration">
        <entity id="DDI-DrugBank.d531.s26.e0" charOffset="0-13"
            type="drug" text="clarithromycin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s27" text="Plasma concentrations decreased by SUSTIVA;">
        <entity id="DDI-DrugBank.d531.s27.e0" charOffset="35-41"
            type="brand" text="SUSTIVA"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s28" text="clinical significance unknown."/>
    <sentence id="DDI-DrugBank.d531.s29" text="In uninfected volunteers, 46% developed rash while receiving SUSTIVA and clarithromycin.">
        <entity id="DDI-DrugBank.d531.s29.e0" charOffset="61-67"
            type="brand" text="SUSTIVA"/>
        <entity id="DDI-DrugBank.d531.s29.e1" charOffset="73-86"
            type="drug" text="clarithromycin"/>
        <pair id="DDI-DrugBank.d531.s29.p0"
            e1="DDI-DrugBank.d531.s29.e0" e2="DDI-DrugBank.d531.s29.e1"
            ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s30" text="No dose adjustment of SUSTIVA is recommended when given with clarithromycin.">
        <entity id="DDI-DrugBank.d531.s30.e0" charOffset="22-28"
            type="brand" text="SUSTIVA"/>
        <entity id="DDI-DrugBank.d531.s30.e1" charOffset="61-74"
            type="drug" text="clarithromycin"/>
        <pair id="DDI-DrugBank.d531.s30.p0"
            e1="DDI-DrugBank.d531.s30.e0" e2="DDI-DrugBank.d531.s30.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s31" text="Alternatives to clarithromycin, such as azithromycin, should be considered.">
        <entity id="DDI-DrugBank.d531.s31.e0" charOffset="16-29"
            type="drug" text="clarithromycin"/>
        <entity id="DDI-DrugBank.d531.s31.e1" charOffset="40-51"
            type="drug" text="azithromycin"/>
        <pair id="DDI-DrugBank.d531.s31.p0"
            e1="DDI-DrugBank.d531.s31.e0" e2="DDI-DrugBank.d531.s31.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s32" text="Other macrolide antibiotics, such as erythromycin, have not been studied in combination with SUSTIVA.">
        <entity id="DDI-DrugBank.d531.s32.e0" charOffset="6-26"
            type="group" text="macrolide antibiotics"/>
        <entity id="DDI-DrugBank.d531.s32.e1" charOffset="37-48"
            type="drug" text="erythromycin"/>
        <entity id="DDI-DrugBank.d531.s32.e2" charOffset="93-99"
            type="brand" text="SUSTIVA"/>
        <pair id="DDI-DrugBank.d531.s32.p0"
            e1="DDI-DrugBank.d531.s32.e0" e2="DDI-DrugBank.d531.s32.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s32.p1"
            e1="DDI-DrugBank.d531.s32.e0" e2="DDI-DrugBank.d531.s32.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s32.p2"
            e1="DDI-DrugBank.d531.s32.e1" e2="DDI-DrugBank.d531.s32.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s33" text=""/>
    <sentence id="DDI-DrugBank.d531.s34" text="14-OH metabolite concentration"/>
    <sentence id="DDI-DrugBank.d531.s35" text="Indinavir">
        <entity id="DDI-DrugBank.d531.s35.e0" charOffset="0-8"
            type="drug" text="Indinavir"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s36" text="indinavir concentration">
        <entity id="DDI-DrugBank.d531.s36.e0" charOffset="0-8"
            type="drug" text="indinavir"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s37" text="The optimal dose of indinavir, when given in combination with SUSTIVA, is not known.">
        <entity id="DDI-DrugBank.d531.s37.e0" charOffset="20-28"
            type="drug" text="indinavir"/>
        <entity id="DDI-DrugBank.d531.s37.e1" charOffset="62-68"
            type="brand" text="SUSTIVA"/>
        <pair id="DDI-DrugBank.d531.s37.p0"
            e1="DDI-DrugBank.d531.s37.e0" e2="DDI-DrugBank.d531.s37.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s38" text="Increasing the indinavir dose to 1000 mg every 8 hours does not compensate for the increased indinavir metabolism due to SUSTIVA.">
        <entity id="DDI-DrugBank.d531.s38.e0" charOffset="15-23"
            type="drug" text="indinavir"/>
        <entity id="DDI-DrugBank.d531.s38.e1" charOffset="93-101"
            type="drug" text="indinavir"/>
        <entity id="DDI-DrugBank.d531.s38.e2" charOffset="121-127"
            type="brand" text="SUSTIVA"/>
        <pair id="DDI-DrugBank.d531.s38.p0"
            e1="DDI-DrugBank.d531.s38.e0" e2="DDI-DrugBank.d531.s38.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s38.p1"
            e1="DDI-DrugBank.d531.s38.e0" e2="DDI-DrugBank.d531.s38.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s38.p2"
            e1="DDI-DrugBank.d531.s38.e1" e2="DDI-DrugBank.d531.s38.e2"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s39" text="When indinavir at an increased dose (1000 mg every 8 hours) was given with SUSTIVA (600 mg once daily), the indinavir AUC and Cmin were decreased on average by 33-46% and 39-57%, respectively, compared to when indinavir (800 mg every 8 hours) was given alone.">
        <entity id="DDI-DrugBank.d531.s39.e0" charOffset="5-13"
            type="drug" text="indinavir"/>
        <entity id="DDI-DrugBank.d531.s39.e1" charOffset="75-81"
            type="brand" text="SUSTIVA"/>
        <entity id="DDI-DrugBank.d531.s39.e2" charOffset="108-116"
            type="drug" text="indinavir"/>
        <entity id="DDI-DrugBank.d531.s39.e3" charOffset="210-218"
            type="drug" text="indinavir"/>
        <pair id="DDI-DrugBank.d531.s39.p0"
            e1="DDI-DrugBank.d531.s39.e0" e2="DDI-DrugBank.d531.s39.e1"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d531.s39.p1"
            e1="DDI-DrugBank.d531.s39.e0" e2="DDI-DrugBank.d531.s39.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s39.p2"
            e1="DDI-DrugBank.d531.s39.e0" e2="DDI-DrugBank.d531.s39.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s39.p3"
            e1="DDI-DrugBank.d531.s39.e1" e2="DDI-DrugBank.d531.s39.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s39.p4"
            e1="DDI-DrugBank.d531.s39.e1" e2="DDI-DrugBank.d531.s39.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s39.p5"
            e1="DDI-DrugBank.d531.s39.e2" e2="DDI-DrugBank.d531.s39.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s40" text="Lopinavir/ritonavir">
        <entity id="DDI-DrugBank.d531.s40.e0" charOffset="0-8"
            type="drug" text="Lopinavir"/>
        <entity id="DDI-DrugBank.d531.s40.e1" charOffset="10-18"
            type="drug" text="ritonavir"/>
        <pair id="DDI-DrugBank.d531.s40.p0"
            e1="DDI-DrugBank.d531.s40.e0" e2="DDI-DrugBank.d531.s40.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s41" text="lopinavir concentration">
        <entity id="DDI-DrugBank.d531.s41.e0" charOffset="0-8"
            type="drug" text="lopinavir"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s42" text="A dose increase of lopinavir/ritonavir to 533/133 mg (4 capsules or 6.5 mL) twice daily taken with food is recommended when used in combination with SUSTIVA.">
        <entity id="DDI-DrugBank.d531.s42.e0" charOffset="19-27"
            type="drug" text="lopinavir"/>
        <entity id="DDI-DrugBank.d531.s42.e1" charOffset="29-37"
            type="drug" text="ritonavir"/>
        <entity id="DDI-DrugBank.d531.s42.e2" charOffset="149-155"
            type="brand" text="SUSTIVA"/>
        <pair id="DDI-DrugBank.d531.s42.p0"
            e1="DDI-DrugBank.d531.s42.e0" e2="DDI-DrugBank.d531.s42.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s42.p1"
            e1="DDI-DrugBank.d531.s42.e0" e2="DDI-DrugBank.d531.s42.e2"
            ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d531.s42.p2"
            e1="DDI-DrugBank.d531.s42.e1" e2="DDI-DrugBank.d531.s42.e2"
            ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s43" text="Methadone">
        <entity id="DDI-DrugBank.d531.s43.e0" charOffset="0-8"
            type="drug" text="Methadone"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s44" text="methadone concentration">
        <entity id="DDI-DrugBank.d531.s44.e0" charOffset="0-8"
            type="drug" text="methadone"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s45" text="Coadministration in HIV-infected individuals with a history of injection drug use resulted in decreased plasma levels of methadone and signs of opiate withdrawal.">
        <entity id="DDI-DrugBank.d531.s45.e0" charOffset="121-129"
            type="drug" text="methadone"/>
        <entity id="DDI-DrugBank.d531.s45.e1" charOffset="144-149"
            type="group" text="opiate"/>
        <pair id="DDI-DrugBank.d531.s45.p0"
            e1="DDI-DrugBank.d531.s45.e0" e2="DDI-DrugBank.d531.s45.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s46" text="Methadone dose was increased by a mean of 22% to alleviate withdrawal symptoms.">
        <entity id="DDI-DrugBank.d531.s46.e0" charOffset="0-8"
            type="drug" text="Methadone"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s47" text="Patients should be monitored for signs of withdrawal and their methadone dose increased as required to alleviate withdrawal symptoms.">
        <entity id="DDI-DrugBank.d531.s47.e0" charOffset="63-71"
            type="drug" text="methadone"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s48" text="Ethinyl estradiol">
        <entity id="DDI-DrugBank.d531.s48.e0" charOffset="0-16"
            type="drug" text="Ethinyl estradiol"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s49" text="ethinyl estradiol concentration">
        <entity id="DDI-DrugBank.d531.s49.e0" charOffset="0-16"
            type="drug" text="ethinyl estradiol"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s50" text="Plasma concentrations increased by SUSTIVA (efavirenz);">
        <entity id="DDI-DrugBank.d531.s50.e0" charOffset="35-41"
            type="brand" text="SUSTIVA"/>
        <entity id="DDI-DrugBank.d531.s50.e1" charOffset="44-52"
            type="drug" text="efavirenz"/>
        <pair id="DDI-DrugBank.d531.s50.p0"
            e1="DDI-DrugBank.d531.s50.e0" e2="DDI-DrugBank.d531.s50.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s51" text="clinical significance unknown."/>
    <sentence id="DDI-DrugBank.d531.s52" text="Because the potential interaction of efavirenz with oral contraceptives has not been fully characterized, a reliable method of barrier contraception should be used in addition to oral contraceptives.">
        <entity id="DDI-DrugBank.d531.s52.e0" charOffset="37-45"
            type="drug" text="efavirenz"/>
        <entity id="DDI-DrugBank.d531.s52.e1" charOffset="57-70"
            type="group" text="contraceptives"/>
        <entity id="DDI-DrugBank.d531.s52.e2" charOffset="184-197"
            type="group" text="contraceptives"/>
        <pair id="DDI-DrugBank.d531.s52.p0"
            e1="DDI-DrugBank.d531.s52.e0" e2="DDI-DrugBank.d531.s52.e1"
            ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d531.s52.p1"
            e1="DDI-DrugBank.d531.s52.e0" e2="DDI-DrugBank.d531.s52.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s52.p2"
            e1="DDI-DrugBank.d531.s52.e1" e2="DDI-DrugBank.d531.s52.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s53" text="Rifabutin">
        <entity id="DDI-DrugBank.d531.s53.e0" charOffset="0-8"
            type="drug" text="Rifabutin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s54" text="rifabutin concentration">
        <entity id="DDI-DrugBank.d531.s54.e0" charOffset="0-8"
            type="drug" text="rifabutin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s55" text="Increase daily dose of rifabutin by 50%.">
        <entity id="DDI-DrugBank.d531.s55.e0" charOffset="23-31"
            type="drug" text="rifabutin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s56" text="Consider doubling the rifabutin dose in regimens where rifabutin is given 2 or 3 times a week.">
        <entity id="DDI-DrugBank.d531.s56.e0" charOffset="22-30"
            type="drug" text="rifabutin"/>
        <entity id="DDI-DrugBank.d531.s56.e1" charOffset="55-63"
            type="drug" text="rifabutin"/>
        <pair id="DDI-DrugBank.d531.s56.p0"
            e1="DDI-DrugBank.d531.s56.e0" e2="DDI-DrugBank.d531.s56.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s57" text="Rifampin">
        <entity id="DDI-DrugBank.d531.s57.e0" charOffset="0-7"
            type="drug" text="Rifampin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s58" text="efavirenz concentration">
        <entity id="DDI-DrugBank.d531.s58.e0" charOffset="0-8"
            type="drug" text="efavirenz"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s59" text="Clinical significance of reduced efavirenz concentrations unknown.">
        <entity id="DDI-DrugBank.d531.s59.e0" charOffset="33-41"
            type="drug" text="efavirenz"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s60" text="Ritonavir">
        <entity id="DDI-DrugBank.d531.s60.e0" charOffset="0-8"
            type="drug" text="Ritonavir"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s61" text="ritonavir concentration">
        <entity id="DDI-DrugBank.d531.s61.e0" charOffset="0-8"
            type="drug" text="ritonavir"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s62" text="Combination was associated with a higher frequency of adverse clinical experiences (eg, dizziness, nausea, paresthesia) and laboratory abnormalities (elevated liver enzymes)."/>
    <sentence id="DDI-DrugBank.d531.s63" text="Monitoring of liver enzymes is recommended when SUSTIVA is used in combination with ritonavir.">
        <entity id="DDI-DrugBank.d531.s63.e0" charOffset="48-54"
            type="brand" text="SUSTIVA"/>
        <entity id="DDI-DrugBank.d531.s63.e1" charOffset="84-92"
            type="drug" text="ritonavir"/>
        <pair id="DDI-DrugBank.d531.s63.p0"
            e1="DDI-DrugBank.d531.s63.e0" e2="DDI-DrugBank.d531.s63.e1"
            ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s64" text="efavirenz concentration">
        <entity id="DDI-DrugBank.d531.s64.e0" charOffset="0-8"
            type="drug" text="efavirenz"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s65" text="Saquinavir">
        <entity id="DDI-DrugBank.d531.s65.e0" charOffset="0-9"
            type="drug" text="Saquinavir"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s66" text="saquinavir concentration">
        <entity id="DDI-DrugBank.d531.s66.e0" charOffset="0-9"
            type="drug" text="saquinavir"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s67" text="Should not be used as sole protease inhibitor in combination with SUSTIVA.">
        <entity id="DDI-DrugBank.d531.s67.e0" charOffset="27-44"
            type="group" text="protease inhibitor"/>
        <entity id="DDI-DrugBank.d531.s67.e1" charOffset="66-72"
            type="brand" text="SUSTIVA"/>
        <pair id="DDI-DrugBank.d531.s67.p0"
            e1="DDI-DrugBank.d531.s67.e0" e2="DDI-DrugBank.d531.s67.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s68" text="Sertraline">
        <entity id="DDI-DrugBank.d531.s68.e0" charOffset="0-9"
            type="drug" text="Sertraline"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s69" text="sertraline concentration">
        <entity id="DDI-DrugBank.d531.s69.e0" charOffset="0-9"
            type="drug" text="sertraline"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s70" text="Increases in sertraline dose should be guided by clinical response.">
        <entity id="DDI-DrugBank.d531.s70.e0" charOffset="13-22"
            type="drug" text="sertraline"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s71" text="Other Potentially Clinically Significant Drug or Herbal Product Interactions With SUSTIVAb"/>
    <sentence id="DDI-DrugBank.d531.s72" text="Anticoagulants: Warfarin">
        <entity id="DDI-DrugBank.d531.s72.e0" charOffset="0-13"
            type="group" text="Anticoagulants"/>
        <entity id="DDI-DrugBank.d531.s72.e1" charOffset="16-23"
            type="drug" text="Warfarin"/>
        <pair id="DDI-DrugBank.d531.s72.p0"
            e1="DDI-DrugBank.d531.s72.e0" e2="DDI-DrugBank.d531.s72.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s73" text="Plasma concentrations and effects potentially increased or decreased by SUSTIVA.">
        <entity id="DDI-DrugBank.d531.s73.e0" charOffset="72-78"
            type="brand" text="SUSTIVA"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s74" text="Anticonvulsants: Phenytoin Phenobarbital Carbamazepine">
        <entity id="DDI-DrugBank.d531.s74.e0" charOffset="0-14"
            type="group" text="Anticonvulsants"/>
        <entity id="DDI-DrugBank.d531.s74.e1" charOffset="17-25"
            type="drug" text="Phenytoin"/>
        <entity id="DDI-DrugBank.d531.s74.e2" charOffset="27-39"
            type="drug" text="Phenobarbital"/>
        <entity id="DDI-DrugBank.d531.s74.e3" charOffset="41-53"
            type="drug" text="Carbamazepine"/>
        <pair id="DDI-DrugBank.d531.s74.p0"
            e1="DDI-DrugBank.d531.s74.e0" e2="DDI-DrugBank.d531.s74.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s74.p1"
            e1="DDI-DrugBank.d531.s74.e0" e2="DDI-DrugBank.d531.s74.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s74.p2"
            e1="DDI-DrugBank.d531.s74.e0" e2="DDI-DrugBank.d531.s74.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s74.p3"
            e1="DDI-DrugBank.d531.s74.e1" e2="DDI-DrugBank.d531.s74.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s74.p4"
            e1="DDI-DrugBank.d531.s74.e1" e2="DDI-DrugBank.d531.s74.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s74.p5"
            e1="DDI-DrugBank.d531.s74.e2" e2="DDI-DrugBank.d531.s74.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s75" text="Potential for reduction in anticonvulsant and/or efavirenz plasma levels;">
        <entity id="DDI-DrugBank.d531.s75.e0" charOffset="27-40"
            type="group" text="anticonvulsant"/>
        <entity id="DDI-DrugBank.d531.s75.e1" charOffset="49-57"
            type="drug" text="efavirenz"/>
        <pair id="DDI-DrugBank.d531.s75.p0"
            e1="DDI-DrugBank.d531.s75.e0" e2="DDI-DrugBank.d531.s75.e1"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s76" text="periodic monitoring of anticonvulsant plasma levels should be conducted.">
        <entity id="DDI-DrugBank.d531.s76.e0" charOffset="23-36"
            type="group" text="anticonvulsant"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s77" text="Antifungals: Itraconazole Ketoconazole">
        <entity id="DDI-DrugBank.d531.s77.e0" charOffset="0-10"
            type="group" text="Antifungals"/>
        <entity id="DDI-DrugBank.d531.s77.e1" charOffset="13-24"
            type="drug" text="Itraconazole"/>
        <entity id="DDI-DrugBank.d531.s77.e2" charOffset="26-37"
            type="drug" text="Ketoconazole"/>
        <pair id="DDI-DrugBank.d531.s77.p0"
            e1="DDI-DrugBank.d531.s77.e0" e2="DDI-DrugBank.d531.s77.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s77.p1"
            e1="DDI-DrugBank.d531.s77.e0" e2="DDI-DrugBank.d531.s77.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s77.p2"
            e1="DDI-DrugBank.d531.s77.e1" e2="DDI-DrugBank.d531.s77.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s78" text="Drug interaction studies with SUSTIVA and these imidazole and triazole antifungals have not been conducted.">
        <entity id="DDI-DrugBank.d531.s78.e0" charOffset="30-36"
            type="brand" text="SUSTIVA"/>
        <entity id="DDI-DrugBank.d531.s78.e1" charOffset="48-56;71-81"
            type="group" text="imidazole antifungals"/>
        <entity id="DDI-DrugBank.d531.s78.e2" charOffset="62-81"
            type="group" text="triazole antifungals"/>
        <pair id="DDI-DrugBank.d531.s78.p0"
            e1="DDI-DrugBank.d531.s78.e0" e2="DDI-DrugBank.d531.s78.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s78.p1"
            e1="DDI-DrugBank.d531.s78.e0" e2="DDI-DrugBank.d531.s78.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s78.p2"
            e1="DDI-DrugBank.d531.s78.e1" e2="DDI-DrugBank.d531.s78.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s79" text="SUSTIVA has the potential to decrease plasma concentrations of itraconazole and ketoconazole.">
        <entity id="DDI-DrugBank.d531.s79.e0" charOffset="0-6"
            type="brand" text="SUSTIVA"/>
        <entity id="DDI-DrugBank.d531.s79.e1" charOffset="63-74"
            type="drug" text="itraconazole"/>
        <entity id="DDI-DrugBank.d531.s79.e2" charOffset="80-91"
            type="drug" text="ketoconazole"/>
        <pair id="DDI-DrugBank.d531.s79.p0"
            e1="DDI-DrugBank.d531.s79.e0" e2="DDI-DrugBank.d531.s79.e1"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d531.s79.p1"
            e1="DDI-DrugBank.d531.s79.e0" e2="DDI-DrugBank.d531.s79.e2"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d531.s79.p2"
            e1="DDI-DrugBank.d531.s79.e1" e2="DDI-DrugBank.d531.s79.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s80" text="Anti-HIV protease inhibitors: Saquinavir/ritonavir combination">
        <entity id="DDI-DrugBank.d531.s80.e0" charOffset="0-27"
            type="group" text="Anti-HIV protease inhibitors"/>
        <entity id="DDI-DrugBank.d531.s80.e1" charOffset="30-39"
            type="drug" text="Saquinavir"/>
        <entity id="DDI-DrugBank.d531.s80.e2" charOffset="41-49"
            type="drug" text="ritonavir"/>
        <pair id="DDI-DrugBank.d531.s80.p0"
            e1="DDI-DrugBank.d531.s80.e0" e2="DDI-DrugBank.d531.s80.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s80.p1"
            e1="DDI-DrugBank.d531.s80.e0" e2="DDI-DrugBank.d531.s80.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s80.p2"
            e1="DDI-DrugBank.d531.s80.e1" e2="DDI-DrugBank.d531.s80.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s81" text="No pharmacokinetic data are available."/>
    <sentence id="DDI-DrugBank.d531.s82" text="Amprenavir">
        <entity id="DDI-DrugBank.d531.s82.e0" charOffset="0-9"
            type="drug" text="Amprenavir"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s83" text="SUSTIVAhas the potential to decrease serum concentrations of amprenavir.">
        <entity id="DDI-DrugBank.d531.s83.e0" charOffset="61-70"
            type="drug" text="amprenavir"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s84" text="Non-nucleoside reverse transcriptase inhibitors">
        <entity id="DDI-DrugBank.d531.s84.e0" charOffset="0-46"
            type="group" text="Non-nucleoside reverse transcriptase inhibitors"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s85" text="No studies have been performed with other NNRTIs.">
        <entity id="DDI-DrugBank.d531.s85.e0" charOffset="42-47"
            type="group" text="NNRTIs"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s86" text="St. John s wort (Hypericum perforatum)"/>
    <sentence id="DDI-DrugBank.d531.s87" text="Expected to substantially decrease plasma levels of efavirenz;has not been studied in combination with SUSTIVA.">
        <entity id="DDI-DrugBank.d531.s87.e0" charOffset="52-60"
            type="drug" text="efavirenz"/>
        <entity id="DDI-DrugBank.d531.s87.e1" charOffset="103-109"
            type="brand" text="SUSTIVA"/>
        <pair id="DDI-DrugBank.d531.s87.p0"
            e1="DDI-DrugBank.d531.s87.e0" e2="DDI-DrugBank.d531.s87.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s88" text="a See Tables 1 and 2."/>
    <sentence id="DDI-DrugBank.d531.s89" text="b This table is not all-inclusive."/>
    <sentence id="DDI-DrugBank.d531.s90" text="Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, famotidine, fluconazole, lamivudine, lorazepam, nelfinavir, paroxetine, and zidovudine.">
        <entity id="DDI-DrugBank.d531.s90.e0" charOffset="104-110"
            type="brand" text="SUSTIVA"/>
        <entity id="DDI-DrugBank.d531.s90.e1" charOffset="113-121"
            type="drug" text="efavirenz"/>
        <entity id="DDI-DrugBank.d531.s90.e2" charOffset="153-189"
            type="group" text="aluminum/magnesium hydroxide antacids"/>
        <entity id="DDI-DrugBank.d531.s90.e3" charOffset="192-203"
            type="drug" text="azithromycin"/>
        <entity id="DDI-DrugBank.d531.s90.e4" charOffset="206-215"
            type="drug" text="cetirizine"/>
        <entity id="DDI-DrugBank.d531.s90.e5" charOffset="218-227"
            type="drug" text="famotidine"/>
        <entity id="DDI-DrugBank.d531.s90.e6" charOffset="230-240"
            type="drug" text="fluconazole"/>
        <entity id="DDI-DrugBank.d531.s90.e7" charOffset="243-252"
            type="drug" text="lamivudine"/>
        <entity id="DDI-DrugBank.d531.s90.e8" charOffset="255-263"
            type="drug" text="lorazepam"/>
        <entity id="DDI-DrugBank.d531.s90.e9" charOffset="266-275"
            type="drug" text="nelfinavir"/>
        <entity id="DDI-DrugBank.d531.s90.e10" charOffset="278-287"
            type="drug" text="paroxetine"/>
        <entity id="DDI-DrugBank.d531.s90.e11" charOffset="294-303"
            type="drug" text="zidovudine"/>
        <pair id="DDI-DrugBank.d531.s90.p0"
            e1="DDI-DrugBank.d531.s90.e0" e2="DDI-DrugBank.d531.s90.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p1"
            e1="DDI-DrugBank.d531.s90.e0" e2="DDI-DrugBank.d531.s90.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p2"
            e1="DDI-DrugBank.d531.s90.e0" e2="DDI-DrugBank.d531.s90.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p3"
            e1="DDI-DrugBank.d531.s90.e0" e2="DDI-DrugBank.d531.s90.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p4"
            e1="DDI-DrugBank.d531.s90.e0" e2="DDI-DrugBank.d531.s90.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p5"
            e1="DDI-DrugBank.d531.s90.e0" e2="DDI-DrugBank.d531.s90.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p6"
            e1="DDI-DrugBank.d531.s90.e0" e2="DDI-DrugBank.d531.s90.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p7"
            e1="DDI-DrugBank.d531.s90.e0" e2="DDI-DrugBank.d531.s90.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p8"
            e1="DDI-DrugBank.d531.s90.e0" e2="DDI-DrugBank.d531.s90.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p9"
            e1="DDI-DrugBank.d531.s90.e0" e2="DDI-DrugBank.d531.s90.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p10"
            e1="DDI-DrugBank.d531.s90.e0" e2="DDI-DrugBank.d531.s90.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p11"
            e1="DDI-DrugBank.d531.s90.e1" e2="DDI-DrugBank.d531.s90.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p12"
            e1="DDI-DrugBank.d531.s90.e1" e2="DDI-DrugBank.d531.s90.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p13"
            e1="DDI-DrugBank.d531.s90.e1" e2="DDI-DrugBank.d531.s90.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p14"
            e1="DDI-DrugBank.d531.s90.e1" e2="DDI-DrugBank.d531.s90.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p15"
            e1="DDI-DrugBank.d531.s90.e1" e2="DDI-DrugBank.d531.s90.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p16"
            e1="DDI-DrugBank.d531.s90.e1" e2="DDI-DrugBank.d531.s90.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p17"
            e1="DDI-DrugBank.d531.s90.e1" e2="DDI-DrugBank.d531.s90.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p18"
            e1="DDI-DrugBank.d531.s90.e1" e2="DDI-DrugBank.d531.s90.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p19"
            e1="DDI-DrugBank.d531.s90.e1" e2="DDI-DrugBank.d531.s90.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p20"
            e1="DDI-DrugBank.d531.s90.e1" e2="DDI-DrugBank.d531.s90.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p21"
            e1="DDI-DrugBank.d531.s90.e2" e2="DDI-DrugBank.d531.s90.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p22"
            e1="DDI-DrugBank.d531.s90.e2" e2="DDI-DrugBank.d531.s90.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p23"
            e1="DDI-DrugBank.d531.s90.e2" e2="DDI-DrugBank.d531.s90.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p24"
            e1="DDI-DrugBank.d531.s90.e2" e2="DDI-DrugBank.d531.s90.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p25"
            e1="DDI-DrugBank.d531.s90.e2" e2="DDI-DrugBank.d531.s90.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p26"
            e1="DDI-DrugBank.d531.s90.e2" e2="DDI-DrugBank.d531.s90.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p27"
            e1="DDI-DrugBank.d531.s90.e2" e2="DDI-DrugBank.d531.s90.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p28"
            e1="DDI-DrugBank.d531.s90.e2" e2="DDI-DrugBank.d531.s90.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p29"
            e1="DDI-DrugBank.d531.s90.e2" e2="DDI-DrugBank.d531.s90.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p30"
            e1="DDI-DrugBank.d531.s90.e3" e2="DDI-DrugBank.d531.s90.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p31"
            e1="DDI-DrugBank.d531.s90.e3" e2="DDI-DrugBank.d531.s90.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p32"
            e1="DDI-DrugBank.d531.s90.e3" e2="DDI-DrugBank.d531.s90.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p33"
            e1="DDI-DrugBank.d531.s90.e3" e2="DDI-DrugBank.d531.s90.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p34"
            e1="DDI-DrugBank.d531.s90.e3" e2="DDI-DrugBank.d531.s90.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p35"
            e1="DDI-DrugBank.d531.s90.e3" e2="DDI-DrugBank.d531.s90.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p36"
            e1="DDI-DrugBank.d531.s90.e3" e2="DDI-DrugBank.d531.s90.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p37"
            e1="DDI-DrugBank.d531.s90.e3" e2="DDI-DrugBank.d531.s90.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p38"
            e1="DDI-DrugBank.d531.s90.e4" e2="DDI-DrugBank.d531.s90.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p39"
            e1="DDI-DrugBank.d531.s90.e4" e2="DDI-DrugBank.d531.s90.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p40"
            e1="DDI-DrugBank.d531.s90.e4" e2="DDI-DrugBank.d531.s90.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p41"
            e1="DDI-DrugBank.d531.s90.e4" e2="DDI-DrugBank.d531.s90.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p42"
            e1="DDI-DrugBank.d531.s90.e4" e2="DDI-DrugBank.d531.s90.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p43"
            e1="DDI-DrugBank.d531.s90.e4" e2="DDI-DrugBank.d531.s90.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p44"
            e1="DDI-DrugBank.d531.s90.e4" e2="DDI-DrugBank.d531.s90.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p45"
            e1="DDI-DrugBank.d531.s90.e5" e2="DDI-DrugBank.d531.s90.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p46"
            e1="DDI-DrugBank.d531.s90.e5" e2="DDI-DrugBank.d531.s90.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p47"
            e1="DDI-DrugBank.d531.s90.e5" e2="DDI-DrugBank.d531.s90.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p48"
            e1="DDI-DrugBank.d531.s90.e5" e2="DDI-DrugBank.d531.s90.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p49"
            e1="DDI-DrugBank.d531.s90.e5" e2="DDI-DrugBank.d531.s90.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p50"
            e1="DDI-DrugBank.d531.s90.e5" e2="DDI-DrugBank.d531.s90.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p51"
            e1="DDI-DrugBank.d531.s90.e6" e2="DDI-DrugBank.d531.s90.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p52"
            e1="DDI-DrugBank.d531.s90.e6" e2="DDI-DrugBank.d531.s90.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p53"
            e1="DDI-DrugBank.d531.s90.e6" e2="DDI-DrugBank.d531.s90.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p54"
            e1="DDI-DrugBank.d531.s90.e6" e2="DDI-DrugBank.d531.s90.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p55"
            e1="DDI-DrugBank.d531.s90.e6" e2="DDI-DrugBank.d531.s90.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p56"
            e1="DDI-DrugBank.d531.s90.e7" e2="DDI-DrugBank.d531.s90.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p57"
            e1="DDI-DrugBank.d531.s90.e7" e2="DDI-DrugBank.d531.s90.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p58"
            e1="DDI-DrugBank.d531.s90.e7" e2="DDI-DrugBank.d531.s90.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p59"
            e1="DDI-DrugBank.d531.s90.e7" e2="DDI-DrugBank.d531.s90.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p60"
            e1="DDI-DrugBank.d531.s90.e8" e2="DDI-DrugBank.d531.s90.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p61"
            e1="DDI-DrugBank.d531.s90.e8" e2="DDI-DrugBank.d531.s90.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p62"
            e1="DDI-DrugBank.d531.s90.e8" e2="DDI-DrugBank.d531.s90.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p63"
            e1="DDI-DrugBank.d531.s90.e9" e2="DDI-DrugBank.d531.s90.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p64"
            e1="DDI-DrugBank.d531.s90.e9" e2="DDI-DrugBank.d531.s90.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s90.p65"
            e1="DDI-DrugBank.d531.s90.e10"
            e2="DDI-DrugBank.d531.s90.e11" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s91" text="Specific drug interaction studies have not been performed with SUSTIVA and NRTIs other than lamivudine and zidovudine.">
        <entity id="DDI-DrugBank.d531.s91.e0" charOffset="63-69"
            type="brand" text="SUSTIVA"/>
        <entity id="DDI-DrugBank.d531.s91.e1" charOffset="75-79"
            type="group" text="NRTIs"/>
        <entity id="DDI-DrugBank.d531.s91.e2" charOffset="92-101"
            type="drug" text="lamivudine"/>
        <entity id="DDI-DrugBank.d531.s91.e3" charOffset="107-116"
            type="drug" text="zidovudine"/>
        <pair id="DDI-DrugBank.d531.s91.p0"
            e1="DDI-DrugBank.d531.s91.e0" e2="DDI-DrugBank.d531.s91.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s91.p1"
            e1="DDI-DrugBank.d531.s91.e0" e2="DDI-DrugBank.d531.s91.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s91.p2"
            e1="DDI-DrugBank.d531.s91.e0" e2="DDI-DrugBank.d531.s91.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s91.p3"
            e1="DDI-DrugBank.d531.s91.e1" e2="DDI-DrugBank.d531.s91.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s91.p4"
            e1="DDI-DrugBank.d531.s91.e1" e2="DDI-DrugBank.d531.s91.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d531.s91.p5"
            e1="DDI-DrugBank.d531.s91.e2" e2="DDI-DrugBank.d531.s91.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d531.s92" text="Clinically significant interactions would not be expected since the NRTIs are metabolized via a different route than efavirenz and would be unlikely to compete for the same metabolic enzymes and elimination pathways.">
        <entity id="DDI-DrugBank.d531.s92.e0" charOffset="68-72"
            type="group" text="NRTIs"/>
        <entity id="DDI-DrugBank.d531.s92.e1" charOffset="117-125"
            type="drug" text="efavirenz"/>
        <pair id="DDI-DrugBank.d531.s92.p0"
            e1="DDI-DrugBank.d531.s92.e0" e2="DDI-DrugBank.d531.s92.e1" ddi="false"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d107">
    <sentence id="DDI-DrugBank.d107.s0" text="Hypotension: Patients on Diuretic Therapy: Patients on diuretics and especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with enalapril or enalaprilat.">
        <entity id="DDI-DrugBank.d107.s0.e0" charOffset="55-63"
            type="drug" text="diuretics"/>
        <entity id="DDI-DrugBank.d107.s0.e1" charOffset="238-246"
            type="drug" text="enalapril"/>
        <entity id="DDI-DrugBank.d107.s0.e2" charOffset="251-261"
            type="drug" text="enalaprilat"/>
        <pair id="DDI-DrugBank.d107.s0.p0" e1="DDI-DrugBank.d107.s0.e0"
            e2="DDI-DrugBank.d107.s0.e1" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d107.s0.p1" e1="DDI-DrugBank.d107.s0.e0"
            e2="DDI-DrugBank.d107.s0.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d107.s0.p2" e1="DDI-DrugBank.d107.s0.e1"
            e2="DDI-DrugBank.d107.s0.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d107.s1" text="The possibility of hypotensive effects with enalapril or enalaprilat can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with enalapril or enalaprilat.">
        <entity id="DDI-DrugBank.d107.s1.e0" charOffset="44-52"
            type="drug" text="enalapril"/>
        <entity id="DDI-DrugBank.d107.s1.e1" charOffset="57-67"
            type="drug" text="enalaprilat"/>
        <entity id="DDI-DrugBank.d107.s1.e2" charOffset="114-121"
            type="drug" text="diuretic"/>
        <entity id="DDI-DrugBank.d107.s1.e3" charOffset="191-199"
            type="drug" text="enalapril"/>
        <entity id="DDI-DrugBank.d107.s1.e4" charOffset="204-214"
            type="drug" text="enalaprilat"/>
        <pair id="DDI-DrugBank.d107.s1.p0" e1="DDI-DrugBank.d107.s1.e0"
            e2="DDI-DrugBank.d107.s1.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s1.p1" e1="DDI-DrugBank.d107.s1.e0"
            e2="DDI-DrugBank.d107.s1.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d107.s1.p2" e1="DDI-DrugBank.d107.s1.e0"
            e2="DDI-DrugBank.d107.s1.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s1.p3" e1="DDI-DrugBank.d107.s1.e0"
            e2="DDI-DrugBank.d107.s1.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s1.p4" e1="DDI-DrugBank.d107.s1.e1"
            e2="DDI-DrugBank.d107.s1.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d107.s1.p5" e1="DDI-DrugBank.d107.s1.e1"
            e2="DDI-DrugBank.d107.s1.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s1.p6" e1="DDI-DrugBank.d107.s1.e1"
            e2="DDI-DrugBank.d107.s1.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s1.p7" e1="DDI-DrugBank.d107.s1.e2"
            e2="DDI-DrugBank.d107.s1.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s1.p8" e1="DDI-DrugBank.d107.s1.e2"
            e2="DDI-DrugBank.d107.s1.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s1.p9" e1="DDI-DrugBank.d107.s1.e3"
            e2="DDI-DrugBank.d107.s1.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d107.s2" text="If it is necessary to continue the diuretic, provide close medical supervision after the initial dose for at least two hours and until blood pressure has stabilized for at least an additional hour..">
        <entity id="DDI-DrugBank.d107.s2.e0" charOffset="35-42"
            type="group" text="diuretic"/>
    </sentence>
    <sentence id="DDI-DrugBank.d107.s3" text="Agents Causing Renin Release: The antihypertensive effect of enalapril and enalapril IV is augmented by antihypertensive agents that cause renin release (e.g., diuretics).">
        <entity id="DDI-DrugBank.d107.s3.e0" charOffset="61-69"
            type="drug" text="enalapril"/>
        <entity id="DDI-DrugBank.d107.s3.e1" charOffset="75-83"
            type="drug" text="enalapril"/>
        <entity id="DDI-DrugBank.d107.s3.e2" charOffset="104-126"
            type="group" text="antihypertensive agents"/>
        <entity id="DDI-DrugBank.d107.s3.e3" charOffset="160-168"
            type="group" text="diuretics"/>
        <pair id="DDI-DrugBank.d107.s3.p0" e1="DDI-DrugBank.d107.s3.e0"
            e2="DDI-DrugBank.d107.s3.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s3.p1" e1="DDI-DrugBank.d107.s3.e0"
            e2="DDI-DrugBank.d107.s3.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d107.s3.p2" e1="DDI-DrugBank.d107.s3.e0"
            e2="DDI-DrugBank.d107.s3.e3" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d107.s3.p3" e1="DDI-DrugBank.d107.s3.e1"
            e2="DDI-DrugBank.d107.s3.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d107.s3.p4" e1="DDI-DrugBank.d107.s3.e1"
            e2="DDI-DrugBank.d107.s3.e3" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d107.s3.p5" e1="DDI-DrugBank.d107.s3.e2"
            e2="DDI-DrugBank.d107.s3.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d107.s4" text="Non-steroidal Anti-inflammatory Agents: In some patients with compromised renal function who are being treated with nonsteroidal anti-inflammatory drugs, the co-administration of enalapril may result in a further deterioration of renal function.">
        <entity id="DDI-DrugBank.d107.s4.e0" charOffset="0-37"
            type="group" text="Non-steroidal Anti-inflammatory Agents"/>
        <entity id="DDI-DrugBank.d107.s4.e1" charOffset="116-151"
            type="group" text="nonsteroidal anti-inflammatory drugs"/>
        <entity id="DDI-DrugBank.d107.s4.e2" charOffset="179-187"
            type="drug" text="enalapril"/>
        <pair id="DDI-DrugBank.d107.s4.p0" e1="DDI-DrugBank.d107.s4.e0"
            e2="DDI-DrugBank.d107.s4.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s4.p1" e1="DDI-DrugBank.d107.s4.e0"
            e2="DDI-DrugBank.d107.s4.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s4.p2" e1="DDI-DrugBank.d107.s4.e1"
            e2="DDI-DrugBank.d107.s4.e2" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d107.s5" text="These effects are usually reversible."/>
    <sentence id="DDI-DrugBank.d107.s6" text="In a clinical pharmacology study, indomethacin or sulindac was administered to hypertensive patients receiving VASOTEC.">
        <entity id="DDI-DrugBank.d107.s6.e0" charOffset="34-45"
            type="drug" text="indomethacin"/>
        <entity id="DDI-DrugBank.d107.s6.e1" charOffset="50-57"
            type="drug" text="sulindac"/>
        <entity id="DDI-DrugBank.d107.s6.e2" charOffset="111-117"
            type="brand" text="VASOTEC"/>
        <pair id="DDI-DrugBank.d107.s6.p0" e1="DDI-DrugBank.d107.s6.e0"
            e2="DDI-DrugBank.d107.s6.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s6.p1" e1="DDI-DrugBank.d107.s6.e0"
            e2="DDI-DrugBank.d107.s6.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s6.p2" e1="DDI-DrugBank.d107.s6.e1"
            e2="DDI-DrugBank.d107.s6.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d107.s7" text="In this study there was no evidence of a blunting of the antihypertensive action of VASOTEC.">
        <entity id="DDI-DrugBank.d107.s7.e0" charOffset="84-90"
            type="brand" text="VASOTEC"/>
    </sentence>
    <sentence id="DDI-DrugBank.d107.s8" text="However, reports suggest that NSAIDs may diminish the antihypertensive effect of ACE inhibitors.">
        <entity id="DDI-DrugBank.d107.s8.e0" charOffset="30-35"
            type="group" text="NSAIDs"/>
        <entity id="DDI-DrugBank.d107.s8.e1" charOffset="81-94"
            type="group" text="ACE inhibitors"/>
        <pair id="DDI-DrugBank.d107.s8.p0" e1="DDI-DrugBank.d107.s8.e0"
            e2="DDI-DrugBank.d107.s8.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d107.s9" text="This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE inhibitors.">
        <entity id="DDI-DrugBank.d107.s9.e0" charOffset="66-71"
            type="group" text="NSAIDs"/>
        <entity id="DDI-DrugBank.d107.s9.e1" charOffset="92-105"
            type="group" text="ACE inhibitors"/>
        <pair id="DDI-DrugBank.d107.s9.p0" e1="DDI-DrugBank.d107.s9.e0"
            e2="DDI-DrugBank.d107.s9.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d107.s10" text="Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.">
        <entity id="DDI-DrugBank.d107.s10.e0" charOffset="29-37"
            type="drug" text="Enalapril"/>
        <entity id="DDI-DrugBank.d107.s10.e1" charOffset="43-51"
            type="drug" text="enalapril"/>
        <entity id="DDI-DrugBank.d107.s10.e2" charOffset="90-120"
            type="group" text="beta adrenergic-blocking agents"/>
        <entity id="DDI-DrugBank.d107.s10.e3" charOffset="123-132"
            type="drug" text="methyldopa"/>
        <entity id="DDI-DrugBank.d107.s10.e4" charOffset="135-142"
            type="group" text="nitrates"/>
        <entity id="DDI-DrugBank.d107.s10.e5" charOffset="145-167"
            type="group" text="calcium-blocking agents"/>
        <entity id="DDI-DrugBank.d107.s10.e6" charOffset="170-180"
            type="drug" text="hydralazine"/>
        <entity id="DDI-DrugBank.d107.s10.e7" charOffset="183-190"
            type="drug" text="prazosin"/>
        <entity id="DDI-DrugBank.d107.s10.e8" charOffset="196-202"
            type="drug" text="digoxin"/>
        <pair id="DDI-DrugBank.d107.s10.p0"
            e1="DDI-DrugBank.d107.s10.e0" e2="DDI-DrugBank.d107.s10.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s10.p1"
            e1="DDI-DrugBank.d107.s10.e0" e2="DDI-DrugBank.d107.s10.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s10.p2"
            e1="DDI-DrugBank.d107.s10.e0" e2="DDI-DrugBank.d107.s10.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s10.p3"
            e1="DDI-DrugBank.d107.s10.e0" e2="DDI-DrugBank.d107.s10.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s10.p4"
            e1="DDI-DrugBank.d107.s10.e0" e2="DDI-DrugBank.d107.s10.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s10.p5"
            e1="DDI-DrugBank.d107.s10.e0" e2="DDI-DrugBank.d107.s10.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s10.p6"
            e1="DDI-DrugBank.d107.s10.e0" e2="DDI-DrugBank.d107.s10.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s10.p7"
            e1="DDI-DrugBank.d107.s10.e0" e2="DDI-DrugBank.d107.s10.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s10.p8"
            e1="DDI-DrugBank.d107.s10.e1" e2="DDI-DrugBank.d107.s10.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s10.p9"
            e1="DDI-DrugBank.d107.s10.e1" e2="DDI-DrugBank.d107.s10.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s10.p10"
            e1="DDI-DrugBank.d107.s10.e1" e2="DDI-DrugBank.d107.s10.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s10.p11"
            e1="DDI-DrugBank.d107.s10.e1" e2="DDI-DrugBank.d107.s10.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s10.p12"
            e1="DDI-DrugBank.d107.s10.e1" e2="DDI-DrugBank.d107.s10.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s10.p13"
            e1="DDI-DrugBank.d107.s10.e1" e2="DDI-DrugBank.d107.s10.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s10.p14"
            e1="DDI-DrugBank.d107.s10.e1" e2="DDI-DrugBank.d107.s10.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s10.p15"
            e1="DDI-DrugBank.d107.s10.e2" e2="DDI-DrugBank.d107.s10.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s10.p16"
            e1="DDI-DrugBank.d107.s10.e2" e2="DDI-DrugBank.d107.s10.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s10.p17"
            e1="DDI-DrugBank.d107.s10.e2" e2="DDI-DrugBank.d107.s10.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s10.p18"
            e1="DDI-DrugBank.d107.s10.e2" e2="DDI-DrugBank.d107.s10.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s10.p19"
            e1="DDI-DrugBank.d107.s10.e2" e2="DDI-DrugBank.d107.s10.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s10.p20"
            e1="DDI-DrugBank.d107.s10.e2" e2="DDI-DrugBank.d107.s10.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s10.p21"
            e1="DDI-DrugBank.d107.s10.e3" e2="DDI-DrugBank.d107.s10.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s10.p22"
            e1="DDI-DrugBank.d107.s10.e3" e2="DDI-DrugBank.d107.s10.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s10.p23"
            e1="DDI-DrugBank.d107.s10.e3" e2="DDI-DrugBank.d107.s10.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s10.p24"
            e1="DDI-DrugBank.d107.s10.e3" e2="DDI-DrugBank.d107.s10.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s10.p25"
            e1="DDI-DrugBank.d107.s10.e3" e2="DDI-DrugBank.d107.s10.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s10.p26"
            e1="DDI-DrugBank.d107.s10.e4" e2="DDI-DrugBank.d107.s10.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s10.p27"
            e1="DDI-DrugBank.d107.s10.e4" e2="DDI-DrugBank.d107.s10.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s10.p28"
            e1="DDI-DrugBank.d107.s10.e4" e2="DDI-DrugBank.d107.s10.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s10.p29"
            e1="DDI-DrugBank.d107.s10.e4" e2="DDI-DrugBank.d107.s10.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s10.p30"
            e1="DDI-DrugBank.d107.s10.e5" e2="DDI-DrugBank.d107.s10.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s10.p31"
            e1="DDI-DrugBank.d107.s10.e5" e2="DDI-DrugBank.d107.s10.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s10.p32"
            e1="DDI-DrugBank.d107.s10.e5" e2="DDI-DrugBank.d107.s10.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s10.p33"
            e1="DDI-DrugBank.d107.s10.e6" e2="DDI-DrugBank.d107.s10.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s10.p34"
            e1="DDI-DrugBank.d107.s10.e6" e2="DDI-DrugBank.d107.s10.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s10.p35"
            e1="DDI-DrugBank.d107.s10.e7" e2="DDI-DrugBank.d107.s10.e8" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d107.s11" text="Enalapril IV has been used concomitantly with digitalis without evidence of clinically significant adverse reactions.">
        <entity id="DDI-DrugBank.d107.s11.e0" charOffset="0-8"
            type="drug" text="Enalapril"/>
        <entity id="DDI-DrugBank.d107.s11.e1" charOffset="46-54"
            type="group" text="digitalis"/>
        <pair id="DDI-DrugBank.d107.s11.p0"
            e1="DDI-DrugBank.d107.s11.e0" e2="DDI-DrugBank.d107.s11.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d107.s12" text="Agents Increasing Serum Potassium: Enalapril and enalapril IV attenuate potassium loss caused by thiazide-type diuretics.">
        <entity id="DDI-DrugBank.d107.s12.e0" charOffset="35-43"
            type="drug" text="Enalapril"/>
        <entity id="DDI-DrugBank.d107.s12.e1" charOffset="49-57"
            type="drug" text="enalapril"/>
        <entity id="DDI-DrugBank.d107.s12.e2" charOffset="97-119"
            type="group" text="thiazide-type diuretics"/>
        <pair id="DDI-DrugBank.d107.s12.p0"
            e1="DDI-DrugBank.d107.s12.e0" e2="DDI-DrugBank.d107.s12.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s12.p1"
            e1="DDI-DrugBank.d107.s12.e0" e2="DDI-DrugBank.d107.s12.e2"
            ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d107.s12.p2"
            e1="DDI-DrugBank.d107.s12.e1" e2="DDI-DrugBank.d107.s12.e2"
            ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d107.s13" text="Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.">
        <entity id="DDI-DrugBank.d107.s13.e0" charOffset="0-26"
            type="group" text="Potassium-sparing diuretics"/>
        <entity id="DDI-DrugBank.d107.s13.e1" charOffset="35-48"
            type="drug" text="spironolactone"/>
        <entity id="DDI-DrugBank.d107.s13.e2" charOffset="51-61"
            type="drug" text="triamterene"/>
        <entity id="DDI-DrugBank.d107.s13.e3" charOffset="67-75"
            type="drug" text="amiloride"/>
        <entity id="DDI-DrugBank.d107.s13.e4" charOffset="79-87"
            type="drug" text="potassium"/>
        <entity id="DDI-DrugBank.d107.s13.e5" charOffset="105-113"
            type="drug" text="potassium"/>
        <pair id="DDI-DrugBank.d107.s13.p0"
            e1="DDI-DrugBank.d107.s13.e0" e2="DDI-DrugBank.d107.s13.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s13.p1"
            e1="DDI-DrugBank.d107.s13.e0" e2="DDI-DrugBank.d107.s13.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s13.p2"
            e1="DDI-DrugBank.d107.s13.e0" e2="DDI-DrugBank.d107.s13.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s13.p3"
            e1="DDI-DrugBank.d107.s13.e0" e2="DDI-DrugBank.d107.s13.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s13.p4"
            e1="DDI-DrugBank.d107.s13.e0" e2="DDI-DrugBank.d107.s13.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s13.p5"
            e1="DDI-DrugBank.d107.s13.e1" e2="DDI-DrugBank.d107.s13.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s13.p6"
            e1="DDI-DrugBank.d107.s13.e1" e2="DDI-DrugBank.d107.s13.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s13.p7"
            e1="DDI-DrugBank.d107.s13.e1" e2="DDI-DrugBank.d107.s13.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s13.p8"
            e1="DDI-DrugBank.d107.s13.e1" e2="DDI-DrugBank.d107.s13.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s13.p9"
            e1="DDI-DrugBank.d107.s13.e2" e2="DDI-DrugBank.d107.s13.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s13.p10"
            e1="DDI-DrugBank.d107.s13.e2" e2="DDI-DrugBank.d107.s13.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s13.p11"
            e1="DDI-DrugBank.d107.s13.e2" e2="DDI-DrugBank.d107.s13.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s13.p12"
            e1="DDI-DrugBank.d107.s13.e3" e2="DDI-DrugBank.d107.s13.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s13.p13"
            e1="DDI-DrugBank.d107.s13.e3" e2="DDI-DrugBank.d107.s13.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s13.p14"
            e1="DDI-DrugBank.d107.s13.e4" e2="DDI-DrugBank.d107.s13.e5" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d107.s14" text="Therefore, if concomitant use of these agents is indicated because of demonstrated hypokalemia, they should be used with caution and with frequent monitoring of serum potassium."/>
    <sentence id="DDI-DrugBank.d107.s15" text="Potassium sparing agents should generally not be used in patients with heart failure receiving enalapril.">
        <entity id="DDI-DrugBank.d107.s15.e0" charOffset="95-103"
            type="drug" text="enalapril"/>
    </sentence>
    <sentence id="DDI-DrugBank.d107.s16" text="Lithium: Lithium toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium, including ACE inhibitors.">
        <entity id="DDI-DrugBank.d107.s16.e0" charOffset="0-6"
            type="drug" text="Lithium"/>
        <entity id="DDI-DrugBank.d107.s16.e1" charOffset="9-15"
            type="drug" text="Lithium"/>
        <entity id="DDI-DrugBank.d107.s16.e2" charOffset="66-72"
            type="drug" text="lithium"/>
        <entity id="DDI-DrugBank.d107.s16.e3" charOffset="144-157"
            type="group" text="ACE inhibitors"/>
        <pair id="DDI-DrugBank.d107.s16.p0"
            e1="DDI-DrugBank.d107.s16.e0" e2="DDI-DrugBank.d107.s16.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s16.p1"
            e1="DDI-DrugBank.d107.s16.e0" e2="DDI-DrugBank.d107.s16.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s16.p2"
            e1="DDI-DrugBank.d107.s16.e0" e2="DDI-DrugBank.d107.s16.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s16.p3"
            e1="DDI-DrugBank.d107.s16.e1" e2="DDI-DrugBank.d107.s16.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s16.p4"
            e1="DDI-DrugBank.d107.s16.e1" e2="DDI-DrugBank.d107.s16.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s16.p5"
            e1="DDI-DrugBank.d107.s16.e2" e2="DDI-DrugBank.d107.s16.e3"
            ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d107.s17" text="It is recommended that serum lithium levels be monitored frequently if enalapril is administered concomitantly with lithium.">
        <entity id="DDI-DrugBank.d107.s17.e0" charOffset="29-35"
            type="drug" text="lithium"/>
        <entity id="DDI-DrugBank.d107.s17.e1" charOffset="71-79"
            type="drug" text="enalapril"/>
        <entity id="DDI-DrugBank.d107.s17.e2" charOffset="116-122"
            type="drug" text="lithium"/>
        <pair id="DDI-DrugBank.d107.s17.p0"
            e1="DDI-DrugBank.d107.s17.e0" e2="DDI-DrugBank.d107.s17.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s17.p1"
            e1="DDI-DrugBank.d107.s17.e0" e2="DDI-DrugBank.d107.s17.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d107.s17.p2"
            e1="DDI-DrugBank.d107.s17.e1" e2="DDI-DrugBank.d107.s17.e2"
            ddi="true" type="advise"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d395">
    <sentence id="DDI-DrugBank.d395.s0" text="Bismuth: Bismuth subsalicylate, given concomitantly with enoxacin or 60 minutes following enoxacin administration, decreased enoxacin bioavailability by approximately 25%.">
        <entity id="DDI-DrugBank.d395.s0.e0" charOffset="0-6"
            type="drug" text="Bismuth"/>
        <entity id="DDI-DrugBank.d395.s0.e1" charOffset="9-29"
            type="drug" text="Bismuth subsalicylate"/>
        <entity id="DDI-DrugBank.d395.s0.e2" charOffset="57-64"
            type="drug" text="enoxacin"/>
        <entity id="DDI-DrugBank.d395.s0.e3" charOffset="90-97"
            type="drug" text="enoxacin"/>
        <entity id="DDI-DrugBank.d395.s0.e4" charOffset="125-132"
            type="drug" text="enoxacin"/>
        <pair id="DDI-DrugBank.d395.s0.p0" e1="DDI-DrugBank.d395.s0.e0"
            e2="DDI-DrugBank.d395.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s0.p1" e1="DDI-DrugBank.d395.s0.e0"
            e2="DDI-DrugBank.d395.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s0.p2" e1="DDI-DrugBank.d395.s0.e0"
            e2="DDI-DrugBank.d395.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s0.p3" e1="DDI-DrugBank.d395.s0.e0"
            e2="DDI-DrugBank.d395.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s0.p4" e1="DDI-DrugBank.d395.s0.e1"
            e2="DDI-DrugBank.d395.s0.e2" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d395.s0.p5" e1="DDI-DrugBank.d395.s0.e1"
            e2="DDI-DrugBank.d395.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s0.p6" e1="DDI-DrugBank.d395.s0.e1"
            e2="DDI-DrugBank.d395.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s0.p7" e1="DDI-DrugBank.d395.s0.e2"
            e2="DDI-DrugBank.d395.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s0.p8" e1="DDI-DrugBank.d395.s0.e2"
            e2="DDI-DrugBank.d395.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s0.p9" e1="DDI-DrugBank.d395.s0.e3"
            e2="DDI-DrugBank.d395.s0.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d395.s1" text="Thus, concomitant administration of enoxacin and bismuth subsalicylate should be avoided.">
        <entity id="DDI-DrugBank.d395.s1.e0" charOffset="36-43"
            type="drug" text="enoxacin"/>
        <entity id="DDI-DrugBank.d395.s1.e1" charOffset="49-69"
            type="drug" text="bismuth subsalicylate"/>
        <pair id="DDI-DrugBank.d395.s1.p0" e1="DDI-DrugBank.d395.s1.e0"
            e2="DDI-DrugBank.d395.s1.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d395.s2" text="Caffeine: Enoxacin is a potent inhibitor of the cytochrome P-450 isozymes responsible for the metabolism of methylxanthines.">
        <entity id="DDI-DrugBank.d395.s2.e0" charOffset="0-7"
            type="drug" text="Caffeine"/>
        <entity id="DDI-DrugBank.d395.s2.e1" charOffset="10-17"
            type="drug" text="Enoxacin"/>
        <entity id="DDI-DrugBank.d395.s2.e2" charOffset="108-122"
            type="group" text="methylxanthines"/>
        <pair id="DDI-DrugBank.d395.s2.p0" e1="DDI-DrugBank.d395.s2.e0"
            e2="DDI-DrugBank.d395.s2.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s2.p1" e1="DDI-DrugBank.d395.s2.e0"
            e2="DDI-DrugBank.d395.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s2.p2" e1="DDI-DrugBank.d395.s2.e1"
            e2="DDI-DrugBank.d395.s2.e2" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d395.s3" text="In a multiple-dose study, enoxacin caused a dose-related increase in the mean elimination half-life of caffeine, thereby decreasing the clearance of caffeine by up to 80% and leading to a five-fold increase in the AUC and the half-life of caffeine.">
        <entity id="DDI-DrugBank.d395.s3.e0" charOffset="26-33"
            type="drug" text="enoxacin"/>
        <entity id="DDI-DrugBank.d395.s3.e1" charOffset="103-110"
            type="drug" text="caffeine"/>
        <entity id="DDI-DrugBank.d395.s3.e2" charOffset="149-156"
            type="drug" text="caffeine"/>
        <entity id="DDI-DrugBank.d395.s3.e3" charOffset="239-246"
            type="drug" text="caffeine"/>
        <pair id="DDI-DrugBank.d395.s3.p0" e1="DDI-DrugBank.d395.s3.e0"
            e2="DDI-DrugBank.d395.s3.e1" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d395.s3.p1" e1="DDI-DrugBank.d395.s3.e0"
            e2="DDI-DrugBank.d395.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s3.p2" e1="DDI-DrugBank.d395.s3.e0"
            e2="DDI-DrugBank.d395.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s3.p3" e1="DDI-DrugBank.d395.s3.e1"
            e2="DDI-DrugBank.d395.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s3.p4" e1="DDI-DrugBank.d395.s3.e1"
            e2="DDI-DrugBank.d395.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s3.p5" e1="DDI-DrugBank.d395.s3.e2"
            e2="DDI-DrugBank.d395.s3.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d395.s4" text="Trough plasma enoxacin levels were also 20% higher when caffeine and enoxacin were administered concomitantly.">
        <entity id="DDI-DrugBank.d395.s4.e0" charOffset="14-21"
            type="drug" text="enoxacin"/>
        <entity id="DDI-DrugBank.d395.s4.e1" charOffset="56-63"
            type="drug" text="caffeine"/>
        <entity id="DDI-DrugBank.d395.s4.e2" charOffset="69-76"
            type="drug" text="enoxacin"/>
        <pair id="DDI-DrugBank.d395.s4.p0" e1="DDI-DrugBank.d395.s4.e0"
            e2="DDI-DrugBank.d395.s4.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s4.p1" e1="DDI-DrugBank.d395.s4.e0"
            e2="DDI-DrugBank.d395.s4.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s4.p2" e1="DDI-DrugBank.d395.s4.e1"
            e2="DDI-DrugBank.d395.s4.e2" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d395.s5" text="Caffeine-related adverse effects have occurred in patients consuming caffeine while on therapy with enoxacin.">
        <entity id="DDI-DrugBank.d395.s5.e0" charOffset="0-7"
            type="drug" text="Caffeine"/>
        <entity id="DDI-DrugBank.d395.s5.e1" charOffset="69-76"
            type="drug" text="caffeine"/>
        <entity id="DDI-DrugBank.d395.s5.e2" charOffset="100-107"
            type="drug" text="enoxacin"/>
        <pair id="DDI-DrugBank.d395.s5.p0" e1="DDI-DrugBank.d395.s5.e0"
            e2="DDI-DrugBank.d395.s5.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s5.p1" e1="DDI-DrugBank.d395.s5.e0"
            e2="DDI-DrugBank.d395.s5.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s5.p2" e1="DDI-DrugBank.d395.s5.e1"
            e2="DDI-DrugBank.d395.s5.e2" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d395.s6" text="Cyclosporine: Elevated serum levels of cyclosporine have been reported with concomitant use of cyclosporine with other members of the quinolone class.">
        <entity id="DDI-DrugBank.d395.s6.e0" charOffset="0-11"
            type="drug" text="Cyclosporine"/>
        <entity id="DDI-DrugBank.d395.s6.e1" charOffset="39-50"
            type="drug" text="cyclosporine"/>
        <entity id="DDI-DrugBank.d395.s6.e2" charOffset="95-106"
            type="drug" text="cyclosporine"/>
        <entity id="DDI-DrugBank.d395.s6.e3" charOffset="134-148"
            type="group" text="quinolone class"/>
        <pair id="DDI-DrugBank.d395.s6.p0" e1="DDI-DrugBank.d395.s6.e0"
            e2="DDI-DrugBank.d395.s6.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s6.p1" e1="DDI-DrugBank.d395.s6.e0"
            e2="DDI-DrugBank.d395.s6.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s6.p2" e1="DDI-DrugBank.d395.s6.e0"
            e2="DDI-DrugBank.d395.s6.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s6.p3" e1="DDI-DrugBank.d395.s6.e1"
            e2="DDI-DrugBank.d395.s6.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s6.p4" e1="DDI-DrugBank.d395.s6.e1"
            e2="DDI-DrugBank.d395.s6.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s6.p5" e1="DDI-DrugBank.d395.s6.e2"
            e2="DDI-DrugBank.d395.s6.e3" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d395.s7" text="Digoxin: Enoxacin may raise serum digoxin levels in some individuals.">
        <entity id="DDI-DrugBank.d395.s7.e0" charOffset="0-6"
            type="drug" text="Digoxin"/>
        <entity id="DDI-DrugBank.d395.s7.e1" charOffset="9-16"
            type="drug" text="Enoxacin"/>
        <entity id="DDI-DrugBank.d395.s7.e2" charOffset="34-40"
            type="drug" text="digoxin"/>
        <pair id="DDI-DrugBank.d395.s7.p0" e1="DDI-DrugBank.d395.s7.e0"
            e2="DDI-DrugBank.d395.s7.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s7.p1" e1="DDI-DrugBank.d395.s7.e0"
            e2="DDI-DrugBank.d395.s7.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s7.p2" e1="DDI-DrugBank.d395.s7.e1"
            e2="DDI-DrugBank.d395.s7.e2" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d395.s8" text="If signs and symptoms suggestive of digoxin toxicity occur when enoxacin and digoxin are given concomitantly, physicians are advised to obtain serum digoxin levels and adjust digoxin doses appropriately.">
        <entity id="DDI-DrugBank.d395.s8.e0" charOffset="36-42"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d395.s8.e1" charOffset="64-71"
            type="drug" text="enoxacin"/>
        <entity id="DDI-DrugBank.d395.s8.e2" charOffset="77-83"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d395.s8.e3" charOffset="149-155"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d395.s8.e4" charOffset="175-181"
            type="drug" text="digoxin"/>
        <pair id="DDI-DrugBank.d395.s8.p0" e1="DDI-DrugBank.d395.s8.e0"
            e2="DDI-DrugBank.d395.s8.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s8.p1" e1="DDI-DrugBank.d395.s8.e0"
            e2="DDI-DrugBank.d395.s8.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s8.p2" e1="DDI-DrugBank.d395.s8.e0"
            e2="DDI-DrugBank.d395.s8.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s8.p3" e1="DDI-DrugBank.d395.s8.e0"
            e2="DDI-DrugBank.d395.s8.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s8.p4" e1="DDI-DrugBank.d395.s8.e1"
            e2="DDI-DrugBank.d395.s8.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d395.s8.p5" e1="DDI-DrugBank.d395.s8.e1"
            e2="DDI-DrugBank.d395.s8.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s8.p6" e1="DDI-DrugBank.d395.s8.e1"
            e2="DDI-DrugBank.d395.s8.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s8.p7" e1="DDI-DrugBank.d395.s8.e2"
            e2="DDI-DrugBank.d395.s8.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s8.p8" e1="DDI-DrugBank.d395.s8.e2"
            e2="DDI-DrugBank.d395.s8.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s8.p9" e1="DDI-DrugBank.d395.s8.e3"
            e2="DDI-DrugBank.d395.s8.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d395.s9" text="Non-steroidal anti-inflammatory agents: Seizures have been reported in patients taking enoxacin concomitantly with the nonsteroidal anti-inflammatory drug fenbufen.">
        <entity id="DDI-DrugBank.d395.s9.e0" charOffset="0-37"
            type="group" text="Non-steroidal anti-inflammatory agents"/>
        <entity id="DDI-DrugBank.d395.s9.e1" charOffset="87-94"
            type="drug" text="enoxacin"/>
        <entity id="DDI-DrugBank.d395.s9.e2" charOffset="119-153"
            type="group" text="nonsteroidal anti-inflammatory drug"/>
        <entity id="DDI-DrugBank.d395.s9.e3" charOffset="155-162"
            type="drug" text="fenbufen"/>
        <pair id="DDI-DrugBank.d395.s9.p0" e1="DDI-DrugBank.d395.s9.e0"
            e2="DDI-DrugBank.d395.s9.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s9.p1" e1="DDI-DrugBank.d395.s9.e0"
            e2="DDI-DrugBank.d395.s9.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s9.p2" e1="DDI-DrugBank.d395.s9.e0"
            e2="DDI-DrugBank.d395.s9.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s9.p3" e1="DDI-DrugBank.d395.s9.e1"
            e2="DDI-DrugBank.d395.s9.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s9.p4" e1="DDI-DrugBank.d395.s9.e1"
            e2="DDI-DrugBank.d395.s9.e3" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d395.s9.p5" e1="DDI-DrugBank.d395.s9.e2"
            e2="DDI-DrugBank.d395.s9.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d395.s10" text="Animal studies also suggest an increased potential for seizures when these two drugs are given concomitantly."/>
    <sentence id="DDI-DrugBank.d395.s11" text="Fenbufen is not approved in the United States at this time.">
        <entity id="DDI-DrugBank.d395.s11.e0" charOffset="0-7"
            type="drug" text="Fenbufen"/>
    </sentence>
    <sentence id="DDI-DrugBank.d395.s12" text="Sucralfate and antacids: Quinolones form chelates with metal cations.">
        <entity id="DDI-DrugBank.d395.s12.e0" charOffset="0-9"
            type="drug" text="Sucralfate"/>
        <entity id="DDI-DrugBank.d395.s12.e1" charOffset="15-22"
            type="group" text="antacids"/>
        <entity id="DDI-DrugBank.d395.s12.e2" charOffset="25-34"
            type="group" text="Quinolones"/>
        <pair id="DDI-DrugBank.d395.s12.p0"
            e1="DDI-DrugBank.d395.s12.e0" e2="DDI-DrugBank.d395.s12.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s12.p1"
            e1="DDI-DrugBank.d395.s12.e0" e2="DDI-DrugBank.d395.s12.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s12.p2"
            e1="DDI-DrugBank.d395.s12.e1" e2="DDI-DrugBank.d395.s12.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d395.s13" text="Therefore, administration of quinolones with antacids containing calcium, magnesium, or aluminum;">
        <entity id="DDI-DrugBank.d395.s13.e0" charOffset="29-38"
            type="group" text="quinolones"/>
        <entity id="DDI-DrugBank.d395.s13.e1" charOffset="45-52"
            type="group" text="antacids"/>
        <entity id="DDI-DrugBank.d395.s13.e2" charOffset="65-71"
            type="drug" text="calcium"/>
        <entity id="DDI-DrugBank.d395.s13.e3" charOffset="74-82"
            type="drug" text="magnesium"/>
        <entity id="DDI-DrugBank.d395.s13.e4" charOffset="88-95"
            type="drug" text="aluminum"/>
        <pair id="DDI-DrugBank.d395.s13.p0"
            e1="DDI-DrugBank.d395.s13.e0" e2="DDI-DrugBank.d395.s13.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s13.p1"
            e1="DDI-DrugBank.d395.s13.e0" e2="DDI-DrugBank.d395.s13.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s13.p2"
            e1="DDI-DrugBank.d395.s13.e0" e2="DDI-DrugBank.d395.s13.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s13.p3"
            e1="DDI-DrugBank.d395.s13.e0" e2="DDI-DrugBank.d395.s13.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s13.p4"
            e1="DDI-DrugBank.d395.s13.e1" e2="DDI-DrugBank.d395.s13.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s13.p5"
            e1="DDI-DrugBank.d395.s13.e1" e2="DDI-DrugBank.d395.s13.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s13.p6"
            e1="DDI-DrugBank.d395.s13.e1" e2="DDI-DrugBank.d395.s13.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s13.p7"
            e1="DDI-DrugBank.d395.s13.e2" e2="DDI-DrugBank.d395.s13.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s13.p8"
            e1="DDI-DrugBank.d395.s13.e2" e2="DDI-DrugBank.d395.s13.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s13.p9"
            e1="DDI-DrugBank.d395.s13.e3" e2="DDI-DrugBank.d395.s13.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d395.s14" text="with sucralfate;">
        <entity id="DDI-DrugBank.d395.s14.e0" charOffset="5-14"
            type="drug" text="sucralfate"/>
    </sentence>
    <sentence id="DDI-DrugBank.d395.s15" text="with divalent or trivalent cations such as iron;">
        <entity id="DDI-DrugBank.d395.s15.e0" charOffset="43-46"
            type="drug" text="iron"/>
    </sentence>
    <sentence id="DDI-DrugBank.d395.s16" text="or with multivitamins containing zinc may substantially interfere with drug absorption and result in insufficient plasma and tissue quinolone concentrations.">
        <entity id="DDI-DrugBank.d395.s16.e0" charOffset="8-20"
            type="group" text="multivitamins"/>
        <entity id="DDI-DrugBank.d395.s16.e1" charOffset="33-36"
            type="drug" text="zinc"/>
        <entity id="DDI-DrugBank.d395.s16.e2" charOffset="132-140"
            type="group" text="quinolone"/>
        <pair id="DDI-DrugBank.d395.s16.p0"
            e1="DDI-DrugBank.d395.s16.e0" e2="DDI-DrugBank.d395.s16.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s16.p1"
            e1="DDI-DrugBank.d395.s16.e0" e2="DDI-DrugBank.d395.s16.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s16.p2"
            e1="DDI-DrugBank.d395.s16.e1" e2="DDI-DrugBank.d395.s16.e2"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d395.s17" text="Antacids containing aluminum hydroxide and magnesium hydroxide reduce the oral absorption of enoxacin by 75%.">
        <entity id="DDI-DrugBank.d395.s17.e0" charOffset="0-7"
            type="group" text="Antacids"/>
        <entity id="DDI-DrugBank.d395.s17.e1" charOffset="20-37"
            type="drug" text="aluminum hydroxide"/>
        <entity id="DDI-DrugBank.d395.s17.e2" charOffset="43-61"
            type="drug" text="magnesium hydroxide"/>
        <entity id="DDI-DrugBank.d395.s17.e3" charOffset="93-100"
            type="drug" text="enoxacin"/>
        <pair id="DDI-DrugBank.d395.s17.p0"
            e1="DDI-DrugBank.d395.s17.e0" e2="DDI-DrugBank.d395.s17.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s17.p1"
            e1="DDI-DrugBank.d395.s17.e0" e2="DDI-DrugBank.d395.s17.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s17.p2"
            e1="DDI-DrugBank.d395.s17.e0" e2="DDI-DrugBank.d395.s17.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s17.p3"
            e1="DDI-DrugBank.d395.s17.e1" e2="DDI-DrugBank.d395.s17.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s17.p4"
            e1="DDI-DrugBank.d395.s17.e1" e2="DDI-DrugBank.d395.s17.e3"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d395.s17.p5"
            e1="DDI-DrugBank.d395.s17.e2" e2="DDI-DrugBank.d395.s17.e3"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d395.s18" text="The oral bioavailability of enoxacin is reduced by 60% with coadministration of ranitidine.">
        <entity id="DDI-DrugBank.d395.s18.e0" charOffset="28-35"
            type="drug" text="enoxacin"/>
        <entity id="DDI-DrugBank.d395.s18.e1" charOffset="80-89"
            type="drug" text="ranitidine"/>
        <pair id="DDI-DrugBank.d395.s18.p0"
            e1="DDI-DrugBank.d395.s18.e0" e2="DDI-DrugBank.d395.s18.e1"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d395.s19" text="These agents should not be taken for 8 hours before or for 2 hours after enoxacin administration.">
        <entity id="DDI-DrugBank.d395.s19.e0" charOffset="73-80"
            type="drug" text="enoxacin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d395.s20" text="Theophylline: Enoxacin is a potent inhibitor of the cytochrome P-450 isozymes responsible for the metabolism of methylxanthines.">
        <entity id="DDI-DrugBank.d395.s20.e0" charOffset="0-11"
            type="drug" text="Theophylline"/>
        <entity id="DDI-DrugBank.d395.s20.e1" charOffset="14-21"
            type="drug" text="Enoxacin"/>
        <entity id="DDI-DrugBank.d395.s20.e2" charOffset="112-126"
            type="group" text="methylxanthines"/>
        <pair id="DDI-DrugBank.d395.s20.p0"
            e1="DDI-DrugBank.d395.s20.e0" e2="DDI-DrugBank.d395.s20.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s20.p1"
            e1="DDI-DrugBank.d395.s20.e0" e2="DDI-DrugBank.d395.s20.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s20.p2"
            e1="DDI-DrugBank.d395.s20.e1" e2="DDI-DrugBank.d395.s20.e2"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d395.s21" text="Enoxacin interferes with the metabolism of theophylline resulting in a 42% to 74% dose-related decrease in theophylline clearance and a subsequent 260% to 350% increase in serum theophylline levels.">
        <entity id="DDI-DrugBank.d395.s21.e0" charOffset="0-7"
            type="drug" text="Enoxacin"/>
        <entity id="DDI-DrugBank.d395.s21.e1" charOffset="43-54"
            type="drug" text="theophylline"/>
        <entity id="DDI-DrugBank.d395.s21.e2" charOffset="107-118"
            type="drug" text="theophylline"/>
        <pair id="DDI-DrugBank.d395.s21.p0"
            e1="DDI-DrugBank.d395.s21.e0" e2="DDI-DrugBank.d395.s21.e1"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d395.s21.p1"
            e1="DDI-DrugBank.d395.s21.e0" e2="DDI-DrugBank.d395.s21.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s21.p2"
            e1="DDI-DrugBank.d395.s21.e1" e2="DDI-DrugBank.d395.s21.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d395.s22" text="Theophylline-related adverse effects have occurred in patients when theophylline and enoxacin were coadministered.">
        <entity id="DDI-DrugBank.d395.s22.e0" charOffset="0-11"
            type="drug" text="Theophylline"/>
        <entity id="DDI-DrugBank.d395.s22.e1" charOffset="68-79"
            type="drug" text="theophylline"/>
        <entity id="DDI-DrugBank.d395.s22.e2" charOffset="85-92"
            type="drug" text="enoxacin"/>
        <pair id="DDI-DrugBank.d395.s22.p0"
            e1="DDI-DrugBank.d395.s22.e0" e2="DDI-DrugBank.d395.s22.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s22.p1"
            e1="DDI-DrugBank.d395.s22.e0" e2="DDI-DrugBank.d395.s22.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s22.p2"
            e1="DDI-DrugBank.d395.s22.e1" e2="DDI-DrugBank.d395.s22.e2"
            ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d395.s23" text="Warfarin: Quinolones, including enoxacin, decrease the clearance of R-warfarin, the less active isomer of racemic warfarin.">
        <entity id="DDI-DrugBank.d395.s23.e0" charOffset="0-7"
            type="drug" text="Warfarin"/>
        <entity id="DDI-DrugBank.d395.s23.e1" charOffset="10-19"
            type="group" text="Quinolones"/>
        <entity id="DDI-DrugBank.d395.s23.e2" charOffset="32-39"
            type="drug" text="enoxacin"/>
        <entity id="DDI-DrugBank.d395.s23.e3" charOffset="68-77"
            type="drug" text="R-warfarin"/>
        <entity id="DDI-DrugBank.d395.s23.e4" charOffset="114-121"
            type="drug" text="warfarin"/>
        <pair id="DDI-DrugBank.d395.s23.p0"
            e1="DDI-DrugBank.d395.s23.e0" e2="DDI-DrugBank.d395.s23.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s23.p1"
            e1="DDI-DrugBank.d395.s23.e0" e2="DDI-DrugBank.d395.s23.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s23.p2"
            e1="DDI-DrugBank.d395.s23.e0" e2="DDI-DrugBank.d395.s23.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s23.p3"
            e1="DDI-DrugBank.d395.s23.e0" e2="DDI-DrugBank.d395.s23.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s23.p4"
            e1="DDI-DrugBank.d395.s23.e1" e2="DDI-DrugBank.d395.s23.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s23.p5"
            e1="DDI-DrugBank.d395.s23.e1" e2="DDI-DrugBank.d395.s23.e3"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d395.s23.p6"
            e1="DDI-DrugBank.d395.s23.e1" e2="DDI-DrugBank.d395.s23.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s23.p7"
            e1="DDI-DrugBank.d395.s23.e2" e2="DDI-DrugBank.d395.s23.e3"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d395.s23.p8"
            e1="DDI-DrugBank.d395.s23.e2" e2="DDI-DrugBank.d395.s23.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s23.p9"
            e1="DDI-DrugBank.d395.s23.e3" e2="DDI-DrugBank.d395.s23.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d395.s24" text="Enoxacin does not affect the clearance of the active S-isomer, and changes in clotting time have not been observed when enoxacin and warfarin were coadministered.">
        <entity id="DDI-DrugBank.d395.s24.e0" charOffset="0-7"
            type="drug" text="Enoxacin"/>
        <entity id="DDI-DrugBank.d395.s24.e1" charOffset="120-127"
            type="drug" text="enoxacin"/>
        <entity id="DDI-DrugBank.d395.s24.e2" charOffset="133-140"
            type="drug" text="warfarin"/>
        <pair id="DDI-DrugBank.d395.s24.p0"
            e1="DDI-DrugBank.d395.s24.e0" e2="DDI-DrugBank.d395.s24.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s24.p1"
            e1="DDI-DrugBank.d395.s24.e0" e2="DDI-DrugBank.d395.s24.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d395.s24.p2"
            e1="DDI-DrugBank.d395.s24.e1" e2="DDI-DrugBank.d395.s24.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d395.s25" text="Nevertheless, the prothrombin time or other suitable coagulation test should be monitored when warfarin or its derivatives and enoxacin are given concomitantly.">
        <entity id="DDI-DrugBank.d395.s25.e0" charOffset="95-102"
            type="drug" text="warfarin"/>
        <entity id="DDI-DrugBank.d395.s25.e1" charOffset="127-134"
            type="drug" text="enoxacin"/>
        <pair id="DDI-DrugBank.d395.s25.p0"
            e1="DDI-DrugBank.d395.s25.e0" e2="DDI-DrugBank.d395.s25.e1"
            ddi="true" type="advise"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d241">
    <sentence id="DDI-DrugBank.d241.s0" text="Additional reductions in blood pressure may occur when FLOLAN is administered with diuretics, antihypertensive agents, or other vasodilators.">
        <entity id="DDI-DrugBank.d241.s0.e0" charOffset="55-60"
            type="brand" text="FLOLAN"/>
        <entity id="DDI-DrugBank.d241.s0.e1" charOffset="83-91"
            type="group" text="diuretics"/>
        <entity id="DDI-DrugBank.d241.s0.e2" charOffset="94-116"
            type="group" text="antihypertensive agents"/>
        <entity id="DDI-DrugBank.d241.s0.e3" charOffset="128-139"
            type="group" text="vasodilators"/>
        <pair id="DDI-DrugBank.d241.s0.p0" e1="DDI-DrugBank.d241.s0.e0"
            e2="DDI-DrugBank.d241.s0.e1" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d241.s0.p1" e1="DDI-DrugBank.d241.s0.e0"
            e2="DDI-DrugBank.d241.s0.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d241.s0.p2" e1="DDI-DrugBank.d241.s0.e0"
            e2="DDI-DrugBank.d241.s0.e3" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d241.s0.p3" e1="DDI-DrugBank.d241.s0.e1"
            e2="DDI-DrugBank.d241.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s0.p4" e1="DDI-DrugBank.d241.s0.e1"
            e2="DDI-DrugBank.d241.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s0.p5" e1="DDI-DrugBank.d241.s0.e2"
            e2="DDI-DrugBank.d241.s0.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d241.s1" text="When other antiplatelet agents or anticoagulants are used concomitantly, there is the potential for FLOLAN to increase the risk of bleeding.">
        <entity id="DDI-DrugBank.d241.s1.e0" charOffset="11-29"
            type="group" text="antiplatelet agents"/>
        <entity id="DDI-DrugBank.d241.s1.e1" charOffset="34-47"
            type="group" text="anticoagulants"/>
        <entity id="DDI-DrugBank.d241.s1.e2" charOffset="100-105"
            type="brand" text="FLOLAN"/>
        <pair id="DDI-DrugBank.d241.s1.p0" e1="DDI-DrugBank.d241.s1.e0"
            e2="DDI-DrugBank.d241.s1.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s1.p1" e1="DDI-DrugBank.d241.s1.e0"
            e2="DDI-DrugBank.d241.s1.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d241.s1.p2" e1="DDI-DrugBank.d241.s1.e1"
            e2="DDI-DrugBank.d241.s1.e2" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d241.s2" text="However, patients receiving infusions of FLOLAN in clinical trials were maintained on anticoagulants without evidence of increased bleeding.">
        <entity id="DDI-DrugBank.d241.s2.e0" charOffset="41-46"
            type="brand" text="FLOLAN"/>
        <entity id="DDI-DrugBank.d241.s2.e1" charOffset="86-99"
            type="group" text="anticoagulants"/>
        <pair id="DDI-DrugBank.d241.s2.p0" e1="DDI-DrugBank.d241.s2.e0"
            e2="DDI-DrugBank.d241.s2.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d241.s3" text="In clinical trials, FLOLAN was used with digoxin, diuretics, anticoagulants, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.">
        <entity id="DDI-DrugBank.d241.s3.e0" charOffset="20-25"
            type="brand" text="FLOLAN"/>
        <entity id="DDI-DrugBank.d241.s3.e1" charOffset="41-47"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d241.s3.e2" charOffset="50-58"
            type="group" text="diuretics"/>
        <entity id="DDI-DrugBank.d241.s3.e3" charOffset="61-74"
            type="group" text="anticoagulants"/>
        <entity id="DDI-DrugBank.d241.s3.e4" charOffset="82-93"
            type="group" text="vasodilators"/>
        <entity id="DDI-DrugBank.d241.s3.e5" charOffset="113-118"
            type="drug" text="oxygen"/>
        <entity id="DDI-DrugBank.d241.s3.e6" charOffset="202-211"
            type="drug" text="furosemide"/>
        <entity id="DDI-DrugBank.d241.s3.e7" charOffset="216-222"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d241.s3.e8" charOffset="245-250"
            type="brand" text="FLOLAN"/>
        <entity id="DDI-DrugBank.d241.s3.e9" charOffset="302-311"
            type="drug" text="furosemide"/>
        <entity id="DDI-DrugBank.d241.s3.e10" charOffset="326-332"
            type="drug" text="digoxin"/>
        <pair id="DDI-DrugBank.d241.s3.p0" e1="DDI-DrugBank.d241.s3.e0"
            e2="DDI-DrugBank.d241.s3.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p1" e1="DDI-DrugBank.d241.s3.e0"
            e2="DDI-DrugBank.d241.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p2" e1="DDI-DrugBank.d241.s3.e0"
            e2="DDI-DrugBank.d241.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p3" e1="DDI-DrugBank.d241.s3.e0"
            e2="DDI-DrugBank.d241.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p4" e1="DDI-DrugBank.d241.s3.e0"
            e2="DDI-DrugBank.d241.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p5" e1="DDI-DrugBank.d241.s3.e0"
            e2="DDI-DrugBank.d241.s3.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p6" e1="DDI-DrugBank.d241.s3.e0"
            e2="DDI-DrugBank.d241.s3.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p7" e1="DDI-DrugBank.d241.s3.e0"
            e2="DDI-DrugBank.d241.s3.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p8" e1="DDI-DrugBank.d241.s3.e0"
            e2="DDI-DrugBank.d241.s3.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p9" e1="DDI-DrugBank.d241.s3.e0"
            e2="DDI-DrugBank.d241.s3.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p10" e1="DDI-DrugBank.d241.s3.e1"
            e2="DDI-DrugBank.d241.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p11" e1="DDI-DrugBank.d241.s3.e1"
            e2="DDI-DrugBank.d241.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p12" e1="DDI-DrugBank.d241.s3.e1"
            e2="DDI-DrugBank.d241.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p13" e1="DDI-DrugBank.d241.s3.e1"
            e2="DDI-DrugBank.d241.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p14" e1="DDI-DrugBank.d241.s3.e1"
            e2="DDI-DrugBank.d241.s3.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p15" e1="DDI-DrugBank.d241.s3.e1"
            e2="DDI-DrugBank.d241.s3.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p16" e1="DDI-DrugBank.d241.s3.e1"
            e2="DDI-DrugBank.d241.s3.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p17" e1="DDI-DrugBank.d241.s3.e1"
            e2="DDI-DrugBank.d241.s3.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p18" e1="DDI-DrugBank.d241.s3.e1"
            e2="DDI-DrugBank.d241.s3.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p19" e1="DDI-DrugBank.d241.s3.e2"
            e2="DDI-DrugBank.d241.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p20" e1="DDI-DrugBank.d241.s3.e2"
            e2="DDI-DrugBank.d241.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p21" e1="DDI-DrugBank.d241.s3.e2"
            e2="DDI-DrugBank.d241.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p22" e1="DDI-DrugBank.d241.s3.e2"
            e2="DDI-DrugBank.d241.s3.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p23" e1="DDI-DrugBank.d241.s3.e2"
            e2="DDI-DrugBank.d241.s3.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p24" e1="DDI-DrugBank.d241.s3.e2"
            e2="DDI-DrugBank.d241.s3.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p25" e1="DDI-DrugBank.d241.s3.e2"
            e2="DDI-DrugBank.d241.s3.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p26" e1="DDI-DrugBank.d241.s3.e2"
            e2="DDI-DrugBank.d241.s3.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p27" e1="DDI-DrugBank.d241.s3.e3"
            e2="DDI-DrugBank.d241.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p28" e1="DDI-DrugBank.d241.s3.e3"
            e2="DDI-DrugBank.d241.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p29" e1="DDI-DrugBank.d241.s3.e3"
            e2="DDI-DrugBank.d241.s3.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p30" e1="DDI-DrugBank.d241.s3.e3"
            e2="DDI-DrugBank.d241.s3.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p31" e1="DDI-DrugBank.d241.s3.e3"
            e2="DDI-DrugBank.d241.s3.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p32" e1="DDI-DrugBank.d241.s3.e3"
            e2="DDI-DrugBank.d241.s3.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p33" e1="DDI-DrugBank.d241.s3.e3"
            e2="DDI-DrugBank.d241.s3.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p34" e1="DDI-DrugBank.d241.s3.e4"
            e2="DDI-DrugBank.d241.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p35" e1="DDI-DrugBank.d241.s3.e4"
            e2="DDI-DrugBank.d241.s3.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p36" e1="DDI-DrugBank.d241.s3.e4"
            e2="DDI-DrugBank.d241.s3.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p37" e1="DDI-DrugBank.d241.s3.e4"
            e2="DDI-DrugBank.d241.s3.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p38" e1="DDI-DrugBank.d241.s3.e4"
            e2="DDI-DrugBank.d241.s3.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p39" e1="DDI-DrugBank.d241.s3.e4"
            e2="DDI-DrugBank.d241.s3.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p40" e1="DDI-DrugBank.d241.s3.e5"
            e2="DDI-DrugBank.d241.s3.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p41" e1="DDI-DrugBank.d241.s3.e5"
            e2="DDI-DrugBank.d241.s3.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p42" e1="DDI-DrugBank.d241.s3.e5"
            e2="DDI-DrugBank.d241.s3.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p43" e1="DDI-DrugBank.d241.s3.e5"
            e2="DDI-DrugBank.d241.s3.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p44" e1="DDI-DrugBank.d241.s3.e5"
            e2="DDI-DrugBank.d241.s3.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p45" e1="DDI-DrugBank.d241.s3.e6"
            e2="DDI-DrugBank.d241.s3.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p46" e1="DDI-DrugBank.d241.s3.e6"
            e2="DDI-DrugBank.d241.s3.e8" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d241.s3.p47" e1="DDI-DrugBank.d241.s3.e6"
            e2="DDI-DrugBank.d241.s3.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p48" e1="DDI-DrugBank.d241.s3.e6"
            e2="DDI-DrugBank.d241.s3.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p49" e1="DDI-DrugBank.d241.s3.e7"
            e2="DDI-DrugBank.d241.s3.e8" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d241.s3.p50" e1="DDI-DrugBank.d241.s3.e7"
            e2="DDI-DrugBank.d241.s3.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p51" e1="DDI-DrugBank.d241.s3.e7"
            e2="DDI-DrugBank.d241.s3.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p52" e1="DDI-DrugBank.d241.s3.e8"
            e2="DDI-DrugBank.d241.s3.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p53" e1="DDI-DrugBank.d241.s3.e8"
            e2="DDI-DrugBank.d241.s3.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s3.p54" e1="DDI-DrugBank.d241.s3.e9"
            e2="DDI-DrugBank.d241.s3.e10" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d241.s4" text="The change in furosemide clearance value is not likely to be clinically significant.">
        <entity id="DDI-DrugBank.d241.s4.e0" charOffset="14-23"
            type="drug" text="furosemide"/>
    </sentence>
    <sentence id="DDI-DrugBank.d241.s5" text="However, patients on digoxin may show elevations of digoxin concentrations after initiation of therapy with FLOLAN, which may be clinically significant in patients prone to digoxin toxicity.">
        <entity id="DDI-DrugBank.d241.s5.e0" charOffset="21-27"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d241.s5.e1" charOffset="52-58"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d241.s5.e2" charOffset="108-113"
            type="brand" text="FLOLAN"/>
        <entity id="DDI-DrugBank.d241.s5.e3" charOffset="173-179"
            type="drug" text="digoxin"/>
        <pair id="DDI-DrugBank.d241.s5.p0" e1="DDI-DrugBank.d241.s5.e0"
            e2="DDI-DrugBank.d241.s5.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s5.p1" e1="DDI-DrugBank.d241.s5.e0"
            e2="DDI-DrugBank.d241.s5.e2" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d241.s5.p2" e1="DDI-DrugBank.d241.s5.e0"
            e2="DDI-DrugBank.d241.s5.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s5.p3" e1="DDI-DrugBank.d241.s5.e1"
            e2="DDI-DrugBank.d241.s5.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s5.p4" e1="DDI-DrugBank.d241.s5.e1"
            e2="DDI-DrugBank.d241.s5.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d241.s5.p5" e1="DDI-DrugBank.d241.s5.e2"
            e2="DDI-DrugBank.d241.s5.e3" ddi="false"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d525">
    <sentence id="DDI-DrugBank.d525.s0" text="Eprosartan has been shown to have no effect on the pharmacokinetics of digoxin and the pharmacodynamics of warfarin and glyburide.">
        <entity id="DDI-DrugBank.d525.s0.e0" charOffset="0-9"
            type="drug" text="Eprosartan"/>
        <entity id="DDI-DrugBank.d525.s0.e1" charOffset="71-77"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d525.s0.e2" charOffset="107-114"
            type="drug" text="warfarin"/>
        <entity id="DDI-DrugBank.d525.s0.e3" charOffset="120-128"
            type="drug" text="glyburide"/>
        <pair id="DDI-DrugBank.d525.s0.p0" e1="DDI-DrugBank.d525.s0.e0"
            e2="DDI-DrugBank.d525.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d525.s0.p1" e1="DDI-DrugBank.d525.s0.e0"
            e2="DDI-DrugBank.d525.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d525.s0.p2" e1="DDI-DrugBank.d525.s0.e0"
            e2="DDI-DrugBank.d525.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d525.s0.p3" e1="DDI-DrugBank.d525.s0.e1"
            e2="DDI-DrugBank.d525.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d525.s0.p4" e1="DDI-DrugBank.d525.s0.e1"
            e2="DDI-DrugBank.d525.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d525.s0.p5" e1="DDI-DrugBank.d525.s0.e2"
            e2="DDI-DrugBank.d525.s0.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d525.s1" text="Thus no dosing adjustments are necessary during concomitant use with these agents."/>
    <sentence id="DDI-DrugBank.d525.s2" text="Because eprosartan is not metabolized by the cytochrome P450 system, inhibitors of CYP450 enzyme would not be expected to affect its metabolism, and ketoconazole and fluconazole, potent inhibitors of CYP3A and 2C9, respectively, have been shown to have no effect on eprosartan pharmacokinetics.">
        <entity id="DDI-DrugBank.d525.s2.e0" charOffset="8-17"
            type="drug" text="eprosartan"/>
        <entity id="DDI-DrugBank.d525.s2.e1" charOffset="149-160"
            type="drug" text="ketoconazole"/>
        <entity id="DDI-DrugBank.d525.s2.e2" charOffset="166-176"
            type="drug" text="fluconazole"/>
        <entity id="DDI-DrugBank.d525.s2.e3" charOffset="266-275"
            type="drug" text="eprosartan"/>
        <pair id="DDI-DrugBank.d525.s2.p0" e1="DDI-DrugBank.d525.s2.e0"
            e2="DDI-DrugBank.d525.s2.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d525.s2.p1" e1="DDI-DrugBank.d525.s2.e0"
            e2="DDI-DrugBank.d525.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d525.s2.p2" e1="DDI-DrugBank.d525.s2.e0"
            e2="DDI-DrugBank.d525.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d525.s2.p3" e1="DDI-DrugBank.d525.s2.e1"
            e2="DDI-DrugBank.d525.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d525.s2.p4" e1="DDI-DrugBank.d525.s2.e1"
            e2="DDI-DrugBank.d525.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d525.s2.p5" e1="DDI-DrugBank.d525.s2.e2"
            e2="DDI-DrugBank.d525.s2.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d525.s3" text="Ranitidine also has no effect on eprosartan pharmacokinetics.">
        <entity id="DDI-DrugBank.d525.s3.e0" charOffset="0-9"
            type="drug" text="Ranitidine"/>
        <entity id="DDI-DrugBank.d525.s3.e1" charOffset="33-42"
            type="drug" text="eprosartan"/>
        <pair id="DDI-DrugBank.d525.s3.p0" e1="DDI-DrugBank.d525.s3.e0"
            e2="DDI-DrugBank.d525.s3.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d525.s4" text="Eprosartan (up to 400 mg b.i.d. or 800 mg q.d.) doses have been safely used concomitantly with a thiazide diuretic (hydrochlorothiazide).">
        <entity id="DDI-DrugBank.d525.s4.e0" charOffset="0-9"
            type="drug" text="Eprosartan"/>
        <entity id="DDI-DrugBank.d525.s4.e1" charOffset="97-113"
            type="group" text="thiazide diuretic"/>
        <entity id="DDI-DrugBank.d525.s4.e2" charOffset="116-134"
            type="drug" text="hydrochlorothiazide"/>
        <pair id="DDI-DrugBank.d525.s4.p0" e1="DDI-DrugBank.d525.s4.e0"
            e2="DDI-DrugBank.d525.s4.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d525.s4.p1" e1="DDI-DrugBank.d525.s4.e0"
            e2="DDI-DrugBank.d525.s4.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d525.s4.p2" e1="DDI-DrugBank.d525.s4.e1"
            e2="DDI-DrugBank.d525.s4.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d525.s5" text="Eprosartan doses of up to 300 mg b.i.d. have been safely used concomitantly with sustained-release calcium channel blockers (sustained-release nifedipine) with no clinically significant adverse interactions.">
        <entity id="DDI-DrugBank.d525.s5.e0" charOffset="0-9"
            type="drug" text="Eprosartan"/>
        <entity id="DDI-DrugBank.d525.s5.e1" charOffset="99-122"
            type="group" text="calcium channel blockers"/>
        <entity id="DDI-DrugBank.d525.s5.e2" charOffset="143-152"
            type="drug" text="nifedipine"/>
        <pair id="DDI-DrugBank.d525.s5.p0" e1="DDI-DrugBank.d525.s5.e0"
            e2="DDI-DrugBank.d525.s5.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d525.s5.p1" e1="DDI-DrugBank.d525.s5.e0"
            e2="DDI-DrugBank.d525.s5.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d525.s5.p2" e1="DDI-DrugBank.d525.s5.e1"
            e2="DDI-DrugBank.d525.s5.e2" ddi="false"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d278">
    <sentence id="DDI-DrugBank.d278.s0" text="Enoxaparin dosed as a 1.0 mg/kg subcutaneous injection q12h for four doses did not alter the pharmacokinetics of eptifibatide or the level of platelet aggregation in healthy adults.">
        <entity id="DDI-DrugBank.d278.s0.e0" charOffset="0-9"
            type="drug" text="Enoxaparin"/>
        <entity id="DDI-DrugBank.d278.s0.e1" charOffset="113-124"
            type="drug" text="eptifibatide"/>
        <pair id="DDI-DrugBank.d278.s0.p0" e1="DDI-DrugBank.d278.s0.e0"
            e2="DDI-DrugBank.d278.s0.e1" ddi="false"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d152">
    <sentence id="DDI-DrugBank.d152.s0" text="Certain endocrine and liver function tests may be affected by estrogen-containing oral contraceptives.">
        <entity id="DDI-DrugBank.d152.s0.e0" charOffset="62-69"
            type="group" text="estrogen"/>
        <entity id="DDI-DrugBank.d152.s0.e1" charOffset="87-100"
            type="group" text="contraceptives"/>
        <pair id="DDI-DrugBank.d152.s0.p0" e1="DDI-DrugBank.d152.s0.e0"
            e2="DDI-DrugBank.d152.s0.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d152.s1" text="The following similar changes may be expected with larger doses of estrogen: Increased sulfobromophthalein retention;">
        <entity id="DDI-DrugBank.d152.s1.e0" charOffset="67-74"
            type="group" text="estrogen"/>
    </sentence>
    <sentence id="DDI-DrugBank.d152.s2" text="increased prothrombin and factors VII, VIII, IX, and X;"/>
    <sentence id="DDI-DrugBank.d152.s3" text="decreased antithrombin 3;"/>
    <sentence id="DDI-DrugBank.d152.s4" text="increased norepinephrine-induced platel et aggregation;"/>
    <sentence id="DDI-DrugBank.d152.s5" text="increased thyroid binding globulin (TBG) leading to increased circulating total thyroid hormone, as measured by PBI, T4 by column, or T4 by radioimmunoassay."/>
    <sentence id="DDI-DrugBank.d152.s6" text="Free T3 resin uptake is decreased, reflecting the elevated TBG;"/>
    <sentence id="DDI-DrugBank.d152.s7" text="free T4 concentration is unaltered: impaired glucose tolerance;"/>
    <sentence id="DDI-DrugBank.d152.s8" text="decreased pregnanediol excretion;"/>
    <sentence id="DDI-DrugBank.d152.s9" text="reduced response to metyrapone test;"/>
    <sentence id="DDI-DrugBank.d152.s10" text="reduced serum folate concentration;"/>
    <sentence id="DDI-DrugBank.d152.s11" text="increased serum triglyceride and phospholipid concentration."/>
</document>
<document id="DDI-DrugBank.d359">
    <sentence id="DDI-DrugBank.d359.s0" text="PEGANONE used in combination with other drugs known to adversely affect the hematopoietic system should be avoided if possible.">
        <entity id="DDI-DrugBank.d359.s0.e0" charOffset="0-7"
            type="brand" text="PEGANONE"/>
    </sentence>
    <sentence id="DDI-DrugBank.d359.s1" text="Considerable caution should be exercised if PEGANONE is administered concurrently with Phenurone (phenacemide) since paranoid symptoms have been reported during therapy with this combination.">
        <entity id="DDI-DrugBank.d359.s1.e0" charOffset="44-51"
            type="brand" text="PEGANONE"/>
        <entity id="DDI-DrugBank.d359.s1.e1" charOffset="87-95"
            type="brand" text="Phenurone"/>
        <entity id="DDI-DrugBank.d359.s1.e2" charOffset="98-108"
            type="drug" text="phenacemide"/>
        <pair id="DDI-DrugBank.d359.s1.p0" e1="DDI-DrugBank.d359.s1.e0"
            e2="DDI-DrugBank.d359.s1.e1" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d359.s1.p1" e1="DDI-DrugBank.d359.s1.e0"
            e2="DDI-DrugBank.d359.s1.e2" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d359.s1.p2" e1="DDI-DrugBank.d359.s1.e1"
            e2="DDI-DrugBank.d359.s1.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d359.s2" text="A two-way interaction between the hydantoin antiepileptic, phenytoin, and the coumarin anticoagulants has been suggested.">
        <entity id="DDI-DrugBank.d359.s2.e0" charOffset="34-56"
            type="group" text="hydantoin antiepileptic"/>
        <entity id="DDI-DrugBank.d359.s2.e1" charOffset="59-67"
            type="drug" text="phenytoin"/>
        <entity id="DDI-DrugBank.d359.s2.e2" charOffset="78-100"
            type="group" text="coumarin anticoagulants"/>
        <pair id="DDI-DrugBank.d359.s2.p0" e1="DDI-DrugBank.d359.s2.e0"
            e2="DDI-DrugBank.d359.s2.e1" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d359.s2.p1" e1="DDI-DrugBank.d359.s2.e0"
            e2="DDI-DrugBank.d359.s2.e2" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d359.s2.p2" e1="DDI-DrugBank.d359.s2.e1"
            e2="DDI-DrugBank.d359.s2.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d359.s3" text="Presumably, phenytoin acts as a stimulator of coumarin metabolism and has been reported to cause decreased serum levels of the coumarin anticoagulants and increased prothrombin-proconvertin concentrations.">
        <entity id="DDI-DrugBank.d359.s3.e0" charOffset="12-20"
            type="drug" text="phenytoin"/>
        <entity id="DDI-DrugBank.d359.s3.e1" charOffset="46-53"
            type="group" text="coumarin"/>
        <entity id="DDI-DrugBank.d359.s3.e2" charOffset="127-149"
            type="group" text="coumarin anticoagulants"/>
        <pair id="DDI-DrugBank.d359.s3.p0" e1="DDI-DrugBank.d359.s3.e0"
            e2="DDI-DrugBank.d359.s3.e1" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d359.s3.p1" e1="DDI-DrugBank.d359.s3.e0"
            e2="DDI-DrugBank.d359.s3.e2" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d359.s3.p2" e1="DDI-DrugBank.d359.s3.e1"
            e2="DDI-DrugBank.d359.s3.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d359.s4" text="Conversely, the coumarin anticoagulants have been reported to increase the serum levels and prolong the serum half-life of phenytoin by inhibiting its metabolism.">
        <entity id="DDI-DrugBank.d359.s4.e0" charOffset="16-38"
            type="group" text="coumarin anticoagulants"/>
        <entity id="DDI-DrugBank.d359.s4.e1" charOffset="123-131"
            type="drug" text="phenytoin"/>
        <pair id="DDI-DrugBank.d359.s4.p0" e1="DDI-DrugBank.d359.s4.e0"
            e2="DDI-DrugBank.d359.s4.e1" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d359.s5" text="Although there is no documentation of such, a similar interaction between ethotoin and the coumarin anticoagulants may occur.">
        <entity id="DDI-DrugBank.d359.s5.e0" charOffset="74-81"
            type="drug" text="ethotoin"/>
        <entity id="DDI-DrugBank.d359.s5.e1" charOffset="91-113"
            type="group" text="coumarin anticoagulants"/>
        <pair id="DDI-DrugBank.d359.s5.p0" e1="DDI-DrugBank.d359.s5.e0"
            e2="DDI-DrugBank.d359.s5.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d359.s6" text="Caution is therefore advised when administering PEGANONE to patients receiving coumarin anticoagulants.">
        <entity id="DDI-DrugBank.d359.s6.e0" charOffset="48-55"
            type="brand" text="PEGANONE"/>
        <entity id="DDI-DrugBank.d359.s6.e1" charOffset="79-101"
            type="group" text="coumarin anticoagulants"/>
        <pair id="DDI-DrugBank.d359.s6.p0" e1="DDI-DrugBank.d359.s6.e0"
            e2="DDI-DrugBank.d359.s6.e1" ddi="true" type="advise"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d219">
    <sentence id="DDI-DrugBank.d219.s0" text="ACE-inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors.">
        <entity id="DDI-DrugBank.d219.s0.e0" charOffset="0-13"
            type="group" text="ACE-inhibitors"/>
        <entity id="DDI-DrugBank.d219.s0.e1" charOffset="36-41"
            type="group" text="NSAIDs"/>
        <entity id="DDI-DrugBank.d219.s0.e2" charOffset="87-100"
            type="group" text="ACE-inhibitors"/>
        <pair id="DDI-DrugBank.d219.s0.p0" e1="DDI-DrugBank.d219.s0.e0"
            e2="DDI-DrugBank.d219.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s0.p1" e1="DDI-DrugBank.d219.s0.e0"
            e2="DDI-DrugBank.d219.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s0.p2" e1="DDI-DrugBank.d219.s0.e1"
            e2="DDI-DrugBank.d219.s0.e2" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d219.s1" text="This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors.">
        <entity id="DDI-DrugBank.d219.s1.e0" charOffset="66-71"
            type="group" text="NSAIDs"/>
        <entity id="DDI-DrugBank.d219.s1.e1" charOffset="92-105"
            type="group" text="ACE-inhibitors"/>
        <pair id="DDI-DrugBank.d219.s1.p0" e1="DDI-DrugBank.d219.s1.e0"
            e2="DDI-DrugBank.d219.s1.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d219.s2" text="Antacids: The concomitant administration of antacids has no apparent effect on the extent of absorption of Lodine.">
        <entity id="DDI-DrugBank.d219.s2.e0" charOffset="0-7"
            type="group" text="Antacids"/>
        <entity id="DDI-DrugBank.d219.s2.e1" charOffset="44-51"
            type="group" text="antacids"/>
        <entity id="DDI-DrugBank.d219.s2.e2" charOffset="107-112"
            type="brand" text="Lodine"/>
        <pair id="DDI-DrugBank.d219.s2.p0" e1="DDI-DrugBank.d219.s2.e0"
            e2="DDI-DrugBank.d219.s2.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s2.p1" e1="DDI-DrugBank.d219.s2.e0"
            e2="DDI-DrugBank.d219.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s2.p2" e1="DDI-DrugBank.d219.s2.e1"
            e2="DDI-DrugBank.d219.s2.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d219.s3" text="However, antacids can decrease the peak concentration reached by 15% to 20% but have no detectable effect on the time-to-peak.">
        <entity id="DDI-DrugBank.d219.s3.e0" charOffset="9-16"
            type="group" text="antacids"/>
    </sentence>
    <sentence id="DDI-DrugBank.d219.s4" text="Aspirin: When Lodine is administered with aspirin, its protein binding is reduced, although the clearance of free etodolac is not altered.">
        <entity id="DDI-DrugBank.d219.s4.e0" charOffset="0-6"
            type="brand" text="Aspirin"/>
        <entity id="DDI-DrugBank.d219.s4.e1" charOffset="14-19"
            type="brand" text="Lodine"/>
        <entity id="DDI-DrugBank.d219.s4.e2" charOffset="42-48"
            type="brand" text="aspirin"/>
        <entity id="DDI-DrugBank.d219.s4.e3" charOffset="114-121"
            type="drug" text="etodolac"/>
        <pair id="DDI-DrugBank.d219.s4.p0" e1="DDI-DrugBank.d219.s4.e0"
            e2="DDI-DrugBank.d219.s4.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s4.p1" e1="DDI-DrugBank.d219.s4.e0"
            e2="DDI-DrugBank.d219.s4.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s4.p2" e1="DDI-DrugBank.d219.s4.e0"
            e2="DDI-DrugBank.d219.s4.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s4.p3" e1="DDI-DrugBank.d219.s4.e1"
            e2="DDI-DrugBank.d219.s4.e2" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d219.s4.p4" e1="DDI-DrugBank.d219.s4.e1"
            e2="DDI-DrugBank.d219.s4.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s4.p5" e1="DDI-DrugBank.d219.s4.e2"
            e2="DDI-DrugBank.d219.s4.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d219.s5" text="The clinical significance of this interaction is not known;"/>
    <sentence id="DDI-DrugBank.d219.s6" text="however, as with other NSAIDs, concomitant administration of Lodine and aspirin is not generally recommended because of the potential of increased adverse effects.">
        <entity id="DDI-DrugBank.d219.s6.e0" charOffset="23-28"
            type="group" text="NSAIDs"/>
        <entity id="DDI-DrugBank.d219.s6.e1" charOffset="61-66"
            type="brand" text="Lodine"/>
        <entity id="DDI-DrugBank.d219.s6.e2" charOffset="72-78"
            type="brand" text="aspirin"/>
        <pair id="DDI-DrugBank.d219.s6.p0" e1="DDI-DrugBank.d219.s6.e0"
            e2="DDI-DrugBank.d219.s6.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s6.p1" e1="DDI-DrugBank.d219.s6.e0"
            e2="DDI-DrugBank.d219.s6.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s6.p2" e1="DDI-DrugBank.d219.s6.e1"
            e2="DDI-DrugBank.d219.s6.e2" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d219.s7" text="Cyclosporine, Digoxin, Methotrexate Lodine, like other NSAIDs, through effects on renal prostaglandins, may cause changes in the elimination of these drugs leading to elevated serum levels of cyclosporine, digoxin, methotrexate, and increased toxicity.">
        <entity id="DDI-DrugBank.d219.s7.e0" charOffset="36-41"
            type="brand" text="Lodine"/>
        <entity id="DDI-DrugBank.d219.s7.e1" charOffset="55-60"
            type="group" text="NSAIDs"/>
        <entity id="DDI-DrugBank.d219.s7.e2" charOffset="192-203"
            type="drug" text="cyclosporine"/>
        <entity id="DDI-DrugBank.d219.s7.e3" charOffset="206-212"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d219.s7.e4" charOffset="215-226"
            type="drug" text="methotrexate"/>
        <pair id="DDI-DrugBank.d219.s7.p0" e1="DDI-DrugBank.d219.s7.e0"
            e2="DDI-DrugBank.d219.s7.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s7.p1" e1="DDI-DrugBank.d219.s7.e0"
            e2="DDI-DrugBank.d219.s7.e2" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d219.s7.p2" e1="DDI-DrugBank.d219.s7.e0"
            e2="DDI-DrugBank.d219.s7.e3" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d219.s7.p3" e1="DDI-DrugBank.d219.s7.e0"
            e2="DDI-DrugBank.d219.s7.e4" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d219.s7.p4" e1="DDI-DrugBank.d219.s7.e1"
            e2="DDI-DrugBank.d219.s7.e2" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d219.s7.p5" e1="DDI-DrugBank.d219.s7.e1"
            e2="DDI-DrugBank.d219.s7.e3" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d219.s7.p6" e1="DDI-DrugBank.d219.s7.e1"
            e2="DDI-DrugBank.d219.s7.e4" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d219.s7.p7" e1="DDI-DrugBank.d219.s7.e2"
            e2="DDI-DrugBank.d219.s7.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s7.p8" e1="DDI-DrugBank.d219.s7.e2"
            e2="DDI-DrugBank.d219.s7.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s7.p9" e1="DDI-DrugBank.d219.s7.e3"
            e2="DDI-DrugBank.d219.s7.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d219.s8" text="Nephrotoxicity associated with cyclosporine may also be enhanced.">
        <entity id="DDI-DrugBank.d219.s8.e0" charOffset="31-42"
            type="drug" text="cyclosporine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d219.s9" text="Patients receiving these drugs who are given Lodine, or any other NSAID, and particularly those patients with altered renal function, should be observed for the development of the specific toxicities of these drugs.">
        <entity id="DDI-DrugBank.d219.s9.e0" charOffset="45-50"
            type="brand" text="Lodine"/>
        <entity id="DDI-DrugBank.d219.s9.e1" charOffset="66-70"
            type="group" text="NSAID"/>
        <pair id="DDI-DrugBank.d219.s9.p0" e1="DDI-DrugBank.d219.s9.e0"
            e2="DDI-DrugBank.d219.s9.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d219.s10" text="Diuretics: Etodolac has no apparent pharmacokinetic interaction when administered with furosemide or hydrochlorothiazide.">
        <entity id="DDI-DrugBank.d219.s10.e0" charOffset="0-8"
            type="group" text="Diuretics"/>
        <entity id="DDI-DrugBank.d219.s10.e1" charOffset="87-96"
            type="drug" text="furosemide"/>
        <entity id="DDI-DrugBank.d219.s10.e2" charOffset="101-119"
            type="drug" text="hydrochlorothiazide"/>
        <pair id="DDI-DrugBank.d219.s10.p0"
            e1="DDI-DrugBank.d219.s10.e0" e2="DDI-DrugBank.d219.s10.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s10.p1"
            e1="DDI-DrugBank.d219.s10.e0" e2="DDI-DrugBank.d219.s10.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s10.p2"
            e1="DDI-DrugBank.d219.s10.e1" e2="DDI-DrugBank.d219.s10.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d219.s11" text="Nevertheless, clinical studies, as well as postmarketing observations have shown that Lodine can reduce the natriuretic effect of furosemide and thiazides in some patients.">
        <entity id="DDI-DrugBank.d219.s11.e0" charOffset="86-91"
            type="brand" text="Lodine"/>
        <entity id="DDI-DrugBank.d219.s11.e1" charOffset="130-139"
            type="drug" text="furosemide"/>
        <entity id="DDI-DrugBank.d219.s11.e2" charOffset="145-153"
            type="group" text="thiazides"/>
        <pair id="DDI-DrugBank.d219.s11.p0"
            e1="DDI-DrugBank.d219.s11.e0" e2="DDI-DrugBank.d219.s11.e1"
            ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d219.s11.p1"
            e1="DDI-DrugBank.d219.s11.e0" e2="DDI-DrugBank.d219.s11.e2"
            ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d219.s11.p2"
            e1="DDI-DrugBank.d219.s11.e1" e2="DDI-DrugBank.d219.s11.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d219.s12" text="This response has been attributed to inhibition of renal prostaglandin synthesis."/>
    <sentence id="DDI-DrugBank.d219.s13" text="During concomitant therapy with NSAIDs, the patient should be observed closely for signs of renal failure, as well as to assure diuretic efficacy.">
        <entity id="DDI-DrugBank.d219.s13.e0" charOffset="32-37"
            type="group" text="NSAIDs"/>
    </sentence>
    <sentence id="DDI-DrugBank.d219.s14" text="Glyburide: Etodolac has no apparent pharmacokinetic interaction when administered with glyburide.">
        <entity id="DDI-DrugBank.d219.s14.e0" charOffset="0-8"
            type="drug" text="Glyburide"/>
        <entity id="DDI-DrugBank.d219.s14.e1" charOffset="11-18"
            type="drug" text="Etodolac"/>
        <entity id="DDI-DrugBank.d219.s14.e2" charOffset="87-95"
            type="drug" text="glyburide"/>
        <pair id="DDI-DrugBank.d219.s14.p0"
            e1="DDI-DrugBank.d219.s14.e0" e2="DDI-DrugBank.d219.s14.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s14.p1"
            e1="DDI-DrugBank.d219.s14.e0" e2="DDI-DrugBank.d219.s14.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s14.p2"
            e1="DDI-DrugBank.d219.s14.e1" e2="DDI-DrugBank.d219.s14.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d219.s15" text="Lithium: NSAIDs have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance.">
        <entity id="DDI-DrugBank.d219.s15.e0" charOffset="0-6"
            type="drug" text="Lithium"/>
        <entity id="DDI-DrugBank.d219.s15.e1" charOffset="9-14"
            type="group" text="NSAIDs"/>
        <entity id="DDI-DrugBank.d219.s15.e2" charOffset="53-59"
            type="drug" text="lithium"/>
        <entity id="DDI-DrugBank.d219.s15.e3" charOffset="93-99"
            type="drug" text="lithium"/>
        <pair id="DDI-DrugBank.d219.s15.p0"
            e1="DDI-DrugBank.d219.s15.e0" e2="DDI-DrugBank.d219.s15.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s15.p1"
            e1="DDI-DrugBank.d219.s15.e0" e2="DDI-DrugBank.d219.s15.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s15.p2"
            e1="DDI-DrugBank.d219.s15.e0" e2="DDI-DrugBank.d219.s15.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s15.p3"
            e1="DDI-DrugBank.d219.s15.e1" e2="DDI-DrugBank.d219.s15.e2"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d219.s15.p4"
            e1="DDI-DrugBank.d219.s15.e1" e2="DDI-DrugBank.d219.s15.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s15.p5"
            e1="DDI-DrugBank.d219.s15.e2" e2="DDI-DrugBank.d219.s15.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d219.s16" text="The mean minimum lithium concentration increased 15% and the renal clearance was decreased by approximately 20%.">
        <entity id="DDI-DrugBank.d219.s16.e0" charOffset="17-23"
            type="drug" text="lithium"/>
    </sentence>
    <sentence id="DDI-DrugBank.d219.s17" text="These effects have been attributed to inhibition of renal prostaglandin synthesis by the NSAID.">
        <entity id="DDI-DrugBank.d219.s17.e0" charOffset="89-93"
            type="group" text="NSAID"/>
    </sentence>
    <sentence id="DDI-DrugBank.d219.s18" text="Thus, when NSAIDs and lithium are administered concurrently, subjects should be observed carefully for signs of lithium toxicity.">
        <entity id="DDI-DrugBank.d219.s18.e0" charOffset="11-16"
            type="group" text="NSAIDs"/>
        <entity id="DDI-DrugBank.d219.s18.e1" charOffset="22-28"
            type="drug" text="lithium"/>
        <entity id="DDI-DrugBank.d219.s18.e2" charOffset="112-118"
            type="drug" text="lithium"/>
        <pair id="DDI-DrugBank.d219.s18.p0"
            e1="DDI-DrugBank.d219.s18.e0" e2="DDI-DrugBank.d219.s18.e1"
            ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d219.s18.p1"
            e1="DDI-DrugBank.d219.s18.e0" e2="DDI-DrugBank.d219.s18.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s18.p2"
            e1="DDI-DrugBank.d219.s18.e1" e2="DDI-DrugBank.d219.s18.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d219.s19" text="Phenylbutazone: Phenylbutazone causes increase (by about 80%) in the free fraction of etodolac.">
        <entity id="DDI-DrugBank.d219.s19.e0" charOffset="0-13"
            type="drug" text="Phenylbutazone"/>
        <entity id="DDI-DrugBank.d219.s19.e1" charOffset="16-29"
            type="drug" text="Phenylbutazone"/>
        <entity id="DDI-DrugBank.d219.s19.e2" charOffset="86-93"
            type="drug" text="etodolac"/>
        <pair id="DDI-DrugBank.d219.s19.p0"
            e1="DDI-DrugBank.d219.s19.e0" e2="DDI-DrugBank.d219.s19.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s19.p1"
            e1="DDI-DrugBank.d219.s19.e0" e2="DDI-DrugBank.d219.s19.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s19.p2"
            e1="DDI-DrugBank.d219.s19.e1" e2="DDI-DrugBank.d219.s19.e2"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d219.s20" text="Although in vivo studies have not been done to see if etodolac clearance is changed by coadministration of phenylbutazone, it is not recommended that they be coadministered.">
        <entity id="DDI-DrugBank.d219.s20.e0" charOffset="54-61"
            type="drug" text="etodolac"/>
        <entity id="DDI-DrugBank.d219.s20.e1" charOffset="107-120"
            type="drug" text="phenylbutazone"/>
        <pair id="DDI-DrugBank.d219.s20.p0"
            e1="DDI-DrugBank.d219.s20.e0" e2="DDI-DrugBank.d219.s20.e1"
            ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d219.s21" text="Phenytoin: Etodolac has no apparent pharmacokinetic interaction when administered with phenytoin.">
        <entity id="DDI-DrugBank.d219.s21.e0" charOffset="0-8"
            type="drug" text="Phenytoin"/>
        <entity id="DDI-DrugBank.d219.s21.e1" charOffset="11-18"
            type="drug" text="Etodolac"/>
        <entity id="DDI-DrugBank.d219.s21.e2" charOffset="87-95"
            type="drug" text="phenytoin"/>
        <pair id="DDI-DrugBank.d219.s21.p0"
            e1="DDI-DrugBank.d219.s21.e0" e2="DDI-DrugBank.d219.s21.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s21.p1"
            e1="DDI-DrugBank.d219.s21.e0" e2="DDI-DrugBank.d219.s21.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s21.p2"
            e1="DDI-DrugBank.d219.s21.e1" e2="DDI-DrugBank.d219.s21.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d219.s22" text="Warfarin: The effects of warfarin and NSAIDs on GI bleeding are synergistic, such that users of both drugs together have a risk of serious GI bleeding higher than that of users of either drug alone.">
        <entity id="DDI-DrugBank.d219.s22.e0" charOffset="0-7"
            type="drug" text="Warfarin"/>
        <entity id="DDI-DrugBank.d219.s22.e1" charOffset="25-32"
            type="drug" text="warfarin"/>
        <entity id="DDI-DrugBank.d219.s22.e2" charOffset="38-43"
            type="group" text="NSAIDs"/>
        <pair id="DDI-DrugBank.d219.s22.p0"
            e1="DDI-DrugBank.d219.s22.e0" e2="DDI-DrugBank.d219.s22.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s22.p1"
            e1="DDI-DrugBank.d219.s22.e0" e2="DDI-DrugBank.d219.s22.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s22.p2"
            e1="DDI-DrugBank.d219.s22.e1" e2="DDI-DrugBank.d219.s22.e2"
            ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d219.s23" text="Short-term pharmacokinetic studies have demonstrated that concomitant administration of warfarin and Lodine  (etodolac capsules and tablets) results in reduced protein binding of warfarin, but there was no change in the clearance of free warfarin.">
        <entity id="DDI-DrugBank.d219.s23.e0" charOffset="88-95"
            type="drug" text="warfarin"/>
        <entity id="DDI-DrugBank.d219.s23.e1" charOffset="101-106"
            type="brand" text="Lodine"/>
        <entity id="DDI-DrugBank.d219.s23.e2" charOffset="110-117"
            type="drug" text="etodolac"/>
        <entity id="DDI-DrugBank.d219.s23.e3" charOffset="179-186"
            type="drug" text="warfarin"/>
        <entity id="DDI-DrugBank.d219.s23.e4" charOffset="238-245"
            type="drug" text="warfarin"/>
        <pair id="DDI-DrugBank.d219.s23.p0"
            e1="DDI-DrugBank.d219.s23.e0" e2="DDI-DrugBank.d219.s23.e1"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d219.s23.p1"
            e1="DDI-DrugBank.d219.s23.e0" e2="DDI-DrugBank.d219.s23.e2"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d219.s23.p2"
            e1="DDI-DrugBank.d219.s23.e0" e2="DDI-DrugBank.d219.s23.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s23.p3"
            e1="DDI-DrugBank.d219.s23.e0" e2="DDI-DrugBank.d219.s23.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s23.p4"
            e1="DDI-DrugBank.d219.s23.e1" e2="DDI-DrugBank.d219.s23.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s23.p5"
            e1="DDI-DrugBank.d219.s23.e1" e2="DDI-DrugBank.d219.s23.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s23.p6"
            e1="DDI-DrugBank.d219.s23.e1" e2="DDI-DrugBank.d219.s23.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s23.p7"
            e1="DDI-DrugBank.d219.s23.e2" e2="DDI-DrugBank.d219.s23.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s23.p8"
            e1="DDI-DrugBank.d219.s23.e2" e2="DDI-DrugBank.d219.s23.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s23.p9"
            e1="DDI-DrugBank.d219.s23.e3" e2="DDI-DrugBank.d219.s23.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d219.s24" text="There was no significant difference in the pharmacodynamic effect of warfarin administered alone and warfarin administered with Lodine as measured by prothrombin time.">
        <entity id="DDI-DrugBank.d219.s24.e0" charOffset="69-76"
            type="drug" text="warfarin"/>
        <entity id="DDI-DrugBank.d219.s24.e1" charOffset="101-108"
            type="drug" text="warfarin"/>
        <entity id="DDI-DrugBank.d219.s24.e2" charOffset="128-133"
            type="brand" text="Lodine"/>
        <pair id="DDI-DrugBank.d219.s24.p0"
            e1="DDI-DrugBank.d219.s24.e0" e2="DDI-DrugBank.d219.s24.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s24.p1"
            e1="DDI-DrugBank.d219.s24.e0" e2="DDI-DrugBank.d219.s24.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d219.s24.p2"
            e1="DDI-DrugBank.d219.s24.e1" e2="DDI-DrugBank.d219.s24.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d219.s25" text="Thus, concomitant therapy with warfarin and Lodine should not require dosage adjustment of either drug.">
        <entity id="DDI-DrugBank.d219.s25.e0" charOffset="31-38"
            type="drug" text="warfarin"/>
        <entity id="DDI-DrugBank.d219.s25.e1" charOffset="44-49"
            type="brand" text="Lodine"/>
        <pair id="DDI-DrugBank.d219.s25.p0"
            e1="DDI-DrugBank.d219.s25.e0" e2="DDI-DrugBank.d219.s25.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d219.s26" text="However, caution should be exercised because there have been a few spontaneous reports of prolonged prothrombin times, with or without bleeding, in etodolac-treated patients receiving concomitant warfarin therapy.">
        <entity id="DDI-DrugBank.d219.s26.e0" charOffset="148-155"
            type="drug" text="etodolac"/>
        <entity id="DDI-DrugBank.d219.s26.e1" charOffset="196-203"
            type="drug" text="warfarin"/>
        <pair id="DDI-DrugBank.d219.s26.p0"
            e1="DDI-DrugBank.d219.s26.e0" e2="DDI-DrugBank.d219.s26.e1"
            ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d219.s27" text="Drug/Laboratory Test Interactions The urine of patients who take Lodine can give a false-positive reaction for urinary bilirubin (urobilin) due to the presence of phenolic metabolites of etodolac.">
        <entity id="DDI-DrugBank.d219.s27.e0" charOffset="65-70"
            type="brand" text="Lodine"/>
        <entity id="DDI-DrugBank.d219.s27.e1" charOffset="187-194"
            type="drug" text="etodolac"/>
        <pair id="DDI-DrugBank.d219.s27.p0"
            e1="DDI-DrugBank.d219.s27.e0" e2="DDI-DrugBank.d219.s27.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d219.s28" text="Diagnostic dip-stick methodology, used to detect ketone bodies in urine, has resulted in false-positive findings in some patients treated with Lodine.">
        <entity id="DDI-DrugBank.d219.s28.e0" charOffset="143-148"
            type="brand" text="Lodine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d219.s29" text="Generally, this phenomenon has not been associated with other clinically significant events."/>
    <sentence id="DDI-DrugBank.d219.s30" text="No dose relationship has been observed."/>
    <sentence id="DDI-DrugBank.d219.s31" text="Lodine treatment is associated with a small decrease in serum uric acid levels.">
        <entity id="DDI-DrugBank.d219.s31.e0" charOffset="0-5"
            type="brand" text="Lodine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d219.s32" text="In clinical trials, mean decreases of 1 to 2 mg/dL were observed in arthritic patients receiving etodolac (600 mg to 1000 mg/day) after 4 weeks of therapy.">
        <entity id="DDI-DrugBank.d219.s32.e0" charOffset="97-104"
            type="drug" text="etodolac"/>
    </sentence>
    <sentence id="DDI-DrugBank.d219.s33" text="These levels then remained stable for up to 1 year of therapy."/>
    <sentence id="DDI-DrugBank.d219.s34" text=""/>
</document>
<document id="DDI-DrugBank.d104">
    <sentence id="DDI-DrugBank.d104.s0" text="Fenfluramine may increase slightly the effect of antihypertensive drugs, e.g., guanethidine, methyldopa, reserpine.">
        <entity id="DDI-DrugBank.d104.s0.e0" charOffset="0-11"
            type="drug" text="Fenfluramine"/>
        <entity id="DDI-DrugBank.d104.s0.e1" charOffset="49-70"
            type="group" text="antihypertensive drugs"/>
        <entity id="DDI-DrugBank.d104.s0.e2" charOffset="79-90"
            type="drug" text="guanethidine"/>
        <entity id="DDI-DrugBank.d104.s0.e3" charOffset="93-102"
            type="drug" text="methyldopa"/>
        <entity id="DDI-DrugBank.d104.s0.e4" charOffset="105-113"
            type="drug" text="reserpine"/>
        <pair id="DDI-DrugBank.d104.s0.p0" e1="DDI-DrugBank.d104.s0.e0"
            e2="DDI-DrugBank.d104.s0.e1" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d104.s0.p1" e1="DDI-DrugBank.d104.s0.e0"
            e2="DDI-DrugBank.d104.s0.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d104.s0.p2" e1="DDI-DrugBank.d104.s0.e0"
            e2="DDI-DrugBank.d104.s0.e3" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d104.s0.p3" e1="DDI-DrugBank.d104.s0.e0"
            e2="DDI-DrugBank.d104.s0.e4" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d104.s0.p4" e1="DDI-DrugBank.d104.s0.e1"
            e2="DDI-DrugBank.d104.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d104.s0.p5" e1="DDI-DrugBank.d104.s0.e1"
            e2="DDI-DrugBank.d104.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d104.s0.p6" e1="DDI-DrugBank.d104.s0.e1"
            e2="DDI-DrugBank.d104.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d104.s0.p7" e1="DDI-DrugBank.d104.s0.e2"
            e2="DDI-DrugBank.d104.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d104.s0.p8" e1="DDI-DrugBank.d104.s0.e2"
            e2="DDI-DrugBank.d104.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d104.s0.p9" e1="DDI-DrugBank.d104.s0.e3"
            e2="DDI-DrugBank.d104.s0.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d104.s1" text="Other CNS depressant drugs should be used with caution in patients taking fenfluramine, since the effects may be additive.">
        <entity id="DDI-DrugBank.d104.s1.e0" charOffset="6-25"
            type="group" text="CNS depressant drugs"/>
        <entity id="DDI-DrugBank.d104.s1.e1" charOffset="74-85"
            type="drug" text="fenfluramine"/>
        <pair id="DDI-DrugBank.d104.s1.p0" e1="DDI-DrugBank.d104.s1.e0"
            e2="DDI-DrugBank.d104.s1.e1" ddi="true" type="advise"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d546">
    <sentence id="DDI-DrugBank.d546.s0" text="Drug Interactions with Beta-Blockers: Concomitant use of fenoldopam with beta-blockers should be avoided.">
        <entity id="DDI-DrugBank.d546.s0.e0" charOffset="23-35"
            type="group" text="Beta-Blockers"/>
        <entity id="DDI-DrugBank.d546.s0.e1" charOffset="57-66"
            type="drug" text="fenoldopam"/>
        <entity id="DDI-DrugBank.d546.s0.e2" charOffset="73-85"
            type="group" text="beta-blockers"/>
        <pair id="DDI-DrugBank.d546.s0.p0" e1="DDI-DrugBank.d546.s0.e0"
            e2="DDI-DrugBank.d546.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d546.s0.p1" e1="DDI-DrugBank.d546.s0.e0"
            e2="DDI-DrugBank.d546.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d546.s0.p2" e1="DDI-DrugBank.d546.s0.e1"
            e2="DDI-DrugBank.d546.s0.e2" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d546.s1" text="If the drugs are used together, caution should be exercised because unexpected hypotension could result from beta-blocker inhibition of the sympathetic reflex response to fenoldopam.">
        <entity id="DDI-DrugBank.d546.s1.e0" charOffset="171-180"
            type="drug" text="fenoldopam"/>
    </sentence>
    <sentence id="DDI-DrugBank.d546.s2" text="Drug Interactions, General: Although there have been no formal interaction studies, intravenous fenoldopam has been administered safely with drugs such as digitalis and sublingual nitroglycerin.">
        <entity id="DDI-DrugBank.d546.s2.e0" charOffset="96-105"
            type="drug" text="fenoldopam"/>
        <entity id="DDI-DrugBank.d546.s2.e1" charOffset="155-163"
            type="group" text="digitalis"/>
        <entity id="DDI-DrugBank.d546.s2.e2" charOffset="180-192"
            type="drug" text="nitroglycerin"/>
        <pair id="DDI-DrugBank.d546.s2.p0" e1="DDI-DrugBank.d546.s2.e0"
            e2="DDI-DrugBank.d546.s2.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d546.s2.p1" e1="DDI-DrugBank.d546.s2.e0"
            e2="DDI-DrugBank.d546.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d546.s2.p2" e1="DDI-DrugBank.d546.s2.e1"
            e2="DDI-DrugBank.d546.s2.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d546.s3" text="There is limited experience with concomitant antihypertensive agents such as alpha-blockers, calcium channel-blockers, ACE inhibitors, and diuretics (both thiazide-like and loop).">
        <entity id="DDI-DrugBank.d546.s3.e0" charOffset="45-67"
            type="group" text="antihypertensive agents"/>
        <entity id="DDI-DrugBank.d546.s3.e1" charOffset="77-90"
            type="group" text="alpha-blockers"/>
        <entity id="DDI-DrugBank.d546.s3.e2" charOffset="93-116"
            type="group" text="calcium channel-blockers"/>
        <entity id="DDI-DrugBank.d546.s3.e3" charOffset="119-132"
            type="group" text="ACE inhibitors"/>
        <entity id="DDI-DrugBank.d546.s3.e4" charOffset="139-147"
            type="group" text="diuretics"/>
        <entity id="DDI-DrugBank.d546.s3.e5" charOffset="155-162"
            type="group" text="thiazide"/>
        <pair id="DDI-DrugBank.d546.s3.p0" e1="DDI-DrugBank.d546.s3.e0"
            e2="DDI-DrugBank.d546.s3.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d546.s3.p1" e1="DDI-DrugBank.d546.s3.e0"
            e2="DDI-DrugBank.d546.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d546.s3.p2" e1="DDI-DrugBank.d546.s3.e0"
            e2="DDI-DrugBank.d546.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d546.s3.p3" e1="DDI-DrugBank.d546.s3.e0"
            e2="DDI-DrugBank.d546.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d546.s3.p4" e1="DDI-DrugBank.d546.s3.e0"
            e2="DDI-DrugBank.d546.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d546.s3.p5" e1="DDI-DrugBank.d546.s3.e1"
            e2="DDI-DrugBank.d546.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d546.s3.p6" e1="DDI-DrugBank.d546.s3.e1"
            e2="DDI-DrugBank.d546.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d546.s3.p7" e1="DDI-DrugBank.d546.s3.e1"
            e2="DDI-DrugBank.d546.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d546.s3.p8" e1="DDI-DrugBank.d546.s3.e1"
            e2="DDI-DrugBank.d546.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d546.s3.p9" e1="DDI-DrugBank.d546.s3.e2"
            e2="DDI-DrugBank.d546.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d546.s3.p10" e1="DDI-DrugBank.d546.s3.e2"
            e2="DDI-DrugBank.d546.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d546.s3.p11" e1="DDI-DrugBank.d546.s3.e2"
            e2="DDI-DrugBank.d546.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d546.s3.p12" e1="DDI-DrugBank.d546.s3.e3"
            e2="DDI-DrugBank.d546.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d546.s3.p13" e1="DDI-DrugBank.d546.s3.e3"
            e2="DDI-DrugBank.d546.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d546.s3.p14" e1="DDI-DrugBank.d546.s3.e4"
            e2="DDI-DrugBank.d546.s3.e5" ddi="false"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d776">
    <sentence id="DDI-DrugBank.d776.s0" text="Clinically or potentially significant drug interactions between DIFLUCAN and the following agents/classes have been observed. ">
        <entity id="DDI-DrugBank.d776.s0.e0" charOffset="64-71"
            type="brand" text="DIFLUCAN"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s1" text="These are described in greater detail below: DIFLUCAN and the following agents/classes have been observed. ">
        <entity id="DDI-DrugBank.d776.s1.e0" charOffset="45-52"
            type="brand" text="DIFLUCAN"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s2" text="These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; ">
        <entity id="DDI-DrugBank.d776.s2.e0" charOffset="51-63"
            type="group" text="hypoglycemics"/>
        <entity id="DDI-DrugBank.d776.s2.e1" charOffset="66-93"
            type="group" text="Coumarin-type anticoagulants"/>
        <entity id="DDI-DrugBank.d776.s2.e2" charOffset="96-104"
            type="drug" text="Phenytoin"/>
        <entity id="DDI-DrugBank.d776.s2.e3" charOffset="107-118"
            type="drug" text="Cyclosporine"/>
        <entity id="DDI-DrugBank.d776.s2.e4" charOffset="121-128"
            type="drug" text="Rifampin"/>
        <entity id="DDI-DrugBank.d776.s2.e5" charOffset="131-142"
            type="drug" text="Theophylline"/>
        <entity id="DDI-DrugBank.d776.s2.e6" charOffset="145-155"
            type="drug" text="Terfenadine"/>
        <entity id="DDI-DrugBank.d776.s2.e7" charOffset="158-166"
            type="drug" text="Cisapride"/>
        <entity id="DDI-DrugBank.d776.s2.e8" charOffset="169-178"
            type="drug" text="Astemizole"/>
        <entity id="DDI-DrugBank.d776.s2.e9" charOffset="181-189"
            type="drug" text="Rifabutin"/>
        <entity id="DDI-DrugBank.d776.s2.e10" charOffset="192-201"
            type="drug" text="Tacrolimus"/>
        <entity id="DDI-DrugBank.d776.s2.e11" charOffset="204-231"
            type="group" text="Short-acting benzodiazepines"/>
        <entity id="DDI-DrugBank.d776.s2.e12" charOffset="240-252"
            type="group" text="hypoglycemics"/>
        <entity id="DDI-DrugBank.d776.s2.e13" charOffset="325-332"
            type="brand" text="DIFLUCAN"/>
        <entity id="DDI-DrugBank.d776.s2.e14" charOffset="344-362"
            type="group" text="hypoglycemic agents"/>
        <pair id="DDI-DrugBank.d776.s2.p0" e1="DDI-DrugBank.d776.s2.e0"
            e2="DDI-DrugBank.d776.s2.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p1" e1="DDI-DrugBank.d776.s2.e0"
            e2="DDI-DrugBank.d776.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p2" e1="DDI-DrugBank.d776.s2.e0"
            e2="DDI-DrugBank.d776.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p3" e1="DDI-DrugBank.d776.s2.e0"
            e2="DDI-DrugBank.d776.s2.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p4" e1="DDI-DrugBank.d776.s2.e0"
            e2="DDI-DrugBank.d776.s2.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p5" e1="DDI-DrugBank.d776.s2.e0"
            e2="DDI-DrugBank.d776.s2.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p6" e1="DDI-DrugBank.d776.s2.e0"
            e2="DDI-DrugBank.d776.s2.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p7" e1="DDI-DrugBank.d776.s2.e0"
            e2="DDI-DrugBank.d776.s2.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p8" e1="DDI-DrugBank.d776.s2.e0"
            e2="DDI-DrugBank.d776.s2.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p9" e1="DDI-DrugBank.d776.s2.e0"
            e2="DDI-DrugBank.d776.s2.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p10" e1="DDI-DrugBank.d776.s2.e0"
            e2="DDI-DrugBank.d776.s2.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p11" e1="DDI-DrugBank.d776.s2.e0"
            e2="DDI-DrugBank.d776.s2.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p12" e1="DDI-DrugBank.d776.s2.e0"
            e2="DDI-DrugBank.d776.s2.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p13" e1="DDI-DrugBank.d776.s2.e0"
            e2="DDI-DrugBank.d776.s2.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p14" e1="DDI-DrugBank.d776.s2.e1"
            e2="DDI-DrugBank.d776.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p15" e1="DDI-DrugBank.d776.s2.e1"
            e2="DDI-DrugBank.d776.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p16" e1="DDI-DrugBank.d776.s2.e1"
            e2="DDI-DrugBank.d776.s2.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p17" e1="DDI-DrugBank.d776.s2.e1"
            e2="DDI-DrugBank.d776.s2.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p18" e1="DDI-DrugBank.d776.s2.e1"
            e2="DDI-DrugBank.d776.s2.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p19" e1="DDI-DrugBank.d776.s2.e1"
            e2="DDI-DrugBank.d776.s2.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p20" e1="DDI-DrugBank.d776.s2.e1"
            e2="DDI-DrugBank.d776.s2.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p21" e1="DDI-DrugBank.d776.s2.e1"
            e2="DDI-DrugBank.d776.s2.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p22" e1="DDI-DrugBank.d776.s2.e1"
            e2="DDI-DrugBank.d776.s2.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p23" e1="DDI-DrugBank.d776.s2.e1"
            e2="DDI-DrugBank.d776.s2.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p24" e1="DDI-DrugBank.d776.s2.e1"
            e2="DDI-DrugBank.d776.s2.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p25" e1="DDI-DrugBank.d776.s2.e1"
            e2="DDI-DrugBank.d776.s2.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p26" e1="DDI-DrugBank.d776.s2.e1"
            e2="DDI-DrugBank.d776.s2.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p27" e1="DDI-DrugBank.d776.s2.e2"
            e2="DDI-DrugBank.d776.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p28" e1="DDI-DrugBank.d776.s2.e2"
            e2="DDI-DrugBank.d776.s2.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p29" e1="DDI-DrugBank.d776.s2.e2"
            e2="DDI-DrugBank.d776.s2.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p30" e1="DDI-DrugBank.d776.s2.e2"
            e2="DDI-DrugBank.d776.s2.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p31" e1="DDI-DrugBank.d776.s2.e2"
            e2="DDI-DrugBank.d776.s2.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p32" e1="DDI-DrugBank.d776.s2.e2"
            e2="DDI-DrugBank.d776.s2.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p33" e1="DDI-DrugBank.d776.s2.e2"
            e2="DDI-DrugBank.d776.s2.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p34" e1="DDI-DrugBank.d776.s2.e2"
            e2="DDI-DrugBank.d776.s2.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p35" e1="DDI-DrugBank.d776.s2.e2"
            e2="DDI-DrugBank.d776.s2.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p36" e1="DDI-DrugBank.d776.s2.e2"
            e2="DDI-DrugBank.d776.s2.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p37" e1="DDI-DrugBank.d776.s2.e2"
            e2="DDI-DrugBank.d776.s2.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p38" e1="DDI-DrugBank.d776.s2.e2"
            e2="DDI-DrugBank.d776.s2.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p39" e1="DDI-DrugBank.d776.s2.e3"
            e2="DDI-DrugBank.d776.s2.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p40" e1="DDI-DrugBank.d776.s2.e3"
            e2="DDI-DrugBank.d776.s2.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p41" e1="DDI-DrugBank.d776.s2.e3"
            e2="DDI-DrugBank.d776.s2.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p42" e1="DDI-DrugBank.d776.s2.e3"
            e2="DDI-DrugBank.d776.s2.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p43" e1="DDI-DrugBank.d776.s2.e3"
            e2="DDI-DrugBank.d776.s2.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p44" e1="DDI-DrugBank.d776.s2.e3"
            e2="DDI-DrugBank.d776.s2.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p45" e1="DDI-DrugBank.d776.s2.e3"
            e2="DDI-DrugBank.d776.s2.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p46" e1="DDI-DrugBank.d776.s2.e3"
            e2="DDI-DrugBank.d776.s2.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p47" e1="DDI-DrugBank.d776.s2.e3"
            e2="DDI-DrugBank.d776.s2.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p48" e1="DDI-DrugBank.d776.s2.e3"
            e2="DDI-DrugBank.d776.s2.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p49" e1="DDI-DrugBank.d776.s2.e3"
            e2="DDI-DrugBank.d776.s2.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p50" e1="DDI-DrugBank.d776.s2.e4"
            e2="DDI-DrugBank.d776.s2.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p51" e1="DDI-DrugBank.d776.s2.e4"
            e2="DDI-DrugBank.d776.s2.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p52" e1="DDI-DrugBank.d776.s2.e4"
            e2="DDI-DrugBank.d776.s2.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p53" e1="DDI-DrugBank.d776.s2.e4"
            e2="DDI-DrugBank.d776.s2.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p54" e1="DDI-DrugBank.d776.s2.e4"
            e2="DDI-DrugBank.d776.s2.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p55" e1="DDI-DrugBank.d776.s2.e4"
            e2="DDI-DrugBank.d776.s2.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p56" e1="DDI-DrugBank.d776.s2.e4"
            e2="DDI-DrugBank.d776.s2.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p57" e1="DDI-DrugBank.d776.s2.e4"
            e2="DDI-DrugBank.d776.s2.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p58" e1="DDI-DrugBank.d776.s2.e4"
            e2="DDI-DrugBank.d776.s2.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p59" e1="DDI-DrugBank.d776.s2.e4"
            e2="DDI-DrugBank.d776.s2.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p60" e1="DDI-DrugBank.d776.s2.e5"
            e2="DDI-DrugBank.d776.s2.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p61" e1="DDI-DrugBank.d776.s2.e5"
            e2="DDI-DrugBank.d776.s2.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p62" e1="DDI-DrugBank.d776.s2.e5"
            e2="DDI-DrugBank.d776.s2.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p63" e1="DDI-DrugBank.d776.s2.e5"
            e2="DDI-DrugBank.d776.s2.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p64" e1="DDI-DrugBank.d776.s2.e5"
            e2="DDI-DrugBank.d776.s2.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p65" e1="DDI-DrugBank.d776.s2.e5"
            e2="DDI-DrugBank.d776.s2.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p66" e1="DDI-DrugBank.d776.s2.e5"
            e2="DDI-DrugBank.d776.s2.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p67" e1="DDI-DrugBank.d776.s2.e5"
            e2="DDI-DrugBank.d776.s2.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p68" e1="DDI-DrugBank.d776.s2.e5"
            e2="DDI-DrugBank.d776.s2.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p69" e1="DDI-DrugBank.d776.s2.e6"
            e2="DDI-DrugBank.d776.s2.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p70" e1="DDI-DrugBank.d776.s2.e6"
            e2="DDI-DrugBank.d776.s2.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p71" e1="DDI-DrugBank.d776.s2.e6"
            e2="DDI-DrugBank.d776.s2.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p72" e1="DDI-DrugBank.d776.s2.e6"
            e2="DDI-DrugBank.d776.s2.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p73" e1="DDI-DrugBank.d776.s2.e6"
            e2="DDI-DrugBank.d776.s2.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p74" e1="DDI-DrugBank.d776.s2.e6"
            e2="DDI-DrugBank.d776.s2.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p75" e1="DDI-DrugBank.d776.s2.e6"
            e2="DDI-DrugBank.d776.s2.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p76" e1="DDI-DrugBank.d776.s2.e6"
            e2="DDI-DrugBank.d776.s2.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p77" e1="DDI-DrugBank.d776.s2.e7"
            e2="DDI-DrugBank.d776.s2.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p78" e1="DDI-DrugBank.d776.s2.e7"
            e2="DDI-DrugBank.d776.s2.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p79" e1="DDI-DrugBank.d776.s2.e7"
            e2="DDI-DrugBank.d776.s2.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p80" e1="DDI-DrugBank.d776.s2.e7"
            e2="DDI-DrugBank.d776.s2.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p81" e1="DDI-DrugBank.d776.s2.e7"
            e2="DDI-DrugBank.d776.s2.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p82" e1="DDI-DrugBank.d776.s2.e7"
            e2="DDI-DrugBank.d776.s2.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p83" e1="DDI-DrugBank.d776.s2.e7"
            e2="DDI-DrugBank.d776.s2.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p84" e1="DDI-DrugBank.d776.s2.e8"
            e2="DDI-DrugBank.d776.s2.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p85" e1="DDI-DrugBank.d776.s2.e8"
            e2="DDI-DrugBank.d776.s2.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p86" e1="DDI-DrugBank.d776.s2.e8"
            e2="DDI-DrugBank.d776.s2.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p87" e1="DDI-DrugBank.d776.s2.e8"
            e2="DDI-DrugBank.d776.s2.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p88" e1="DDI-DrugBank.d776.s2.e8"
            e2="DDI-DrugBank.d776.s2.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p89" e1="DDI-DrugBank.d776.s2.e8"
            e2="DDI-DrugBank.d776.s2.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p90" e1="DDI-DrugBank.d776.s2.e9"
            e2="DDI-DrugBank.d776.s2.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p91" e1="DDI-DrugBank.d776.s2.e9"
            e2="DDI-DrugBank.d776.s2.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p92" e1="DDI-DrugBank.d776.s2.e9"
            e2="DDI-DrugBank.d776.s2.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p93" e1="DDI-DrugBank.d776.s2.e9"
            e2="DDI-DrugBank.d776.s2.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p94" e1="DDI-DrugBank.d776.s2.e9"
            e2="DDI-DrugBank.d776.s2.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p95"
            e1="DDI-DrugBank.d776.s2.e10" e2="DDI-DrugBank.d776.s2.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p96"
            e1="DDI-DrugBank.d776.s2.e10" e2="DDI-DrugBank.d776.s2.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p97"
            e1="DDI-DrugBank.d776.s2.e10" e2="DDI-DrugBank.d776.s2.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p98"
            e1="DDI-DrugBank.d776.s2.e10" e2="DDI-DrugBank.d776.s2.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p99"
            e1="DDI-DrugBank.d776.s2.e11" e2="DDI-DrugBank.d776.s2.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p100"
            e1="DDI-DrugBank.d776.s2.e11" e2="DDI-DrugBank.d776.s2.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p101"
            e1="DDI-DrugBank.d776.s2.e11" e2="DDI-DrugBank.d776.s2.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p102"
            e1="DDI-DrugBank.d776.s2.e12" e2="DDI-DrugBank.d776.s2.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p103"
            e1="DDI-DrugBank.d776.s2.e12" e2="DDI-DrugBank.d776.s2.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s2.p104"
            e1="DDI-DrugBank.d776.s2.e13" e2="DDI-DrugBank.d776.s2.e14"
            ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s3" text="one fatality has been reported from hypoglycemia in association with combined DIFLUCAN and glyburide use. ">
        <entity id="DDI-DrugBank.d776.s3.e0" charOffset="78-85"
            type="brand" text="DIFLUCAN"/>
        <entity id="DDI-DrugBank.d776.s3.e1" charOffset="91-99"
            type="drug" text="glyburide"/>
        <pair id="DDI-DrugBank.d776.s3.p0" e1="DDI-DrugBank.d776.s3.e0"
            e2="DDI-DrugBank.d776.s3.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s4" text="DIFLUCAN reduces the metabolism of tolbutamide, glyburide, and glipizide and increases the plasma concentration of these agents. ">
        <entity id="DDI-DrugBank.d776.s4.e0" charOffset="0-7"
            type="brand" text="DIFLUCAN"/>
        <entity id="DDI-DrugBank.d776.s4.e1" charOffset="35-45"
            type="drug" text="tolbutamide"/>
        <entity id="DDI-DrugBank.d776.s4.e2" charOffset="48-56"
            type="drug" text="glyburide"/>
        <entity id="DDI-DrugBank.d776.s4.e3" charOffset="63-71"
            type="drug" text="glipizide"/>
        <pair id="DDI-DrugBank.d776.s4.p0" e1="DDI-DrugBank.d776.s4.e0"
            e2="DDI-DrugBank.d776.s4.e1" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d776.s4.p1" e1="DDI-DrugBank.d776.s4.e0"
            e2="DDI-DrugBank.d776.s4.e2" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d776.s4.p2" e1="DDI-DrugBank.d776.s4.e0"
            e2="DDI-DrugBank.d776.s4.e3" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d776.s4.p3" e1="DDI-DrugBank.d776.s4.e1"
            e2="DDI-DrugBank.d776.s4.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s4.p4" e1="DDI-DrugBank.d776.s4.e1"
            e2="DDI-DrugBank.d776.s4.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s4.p5" e1="DDI-DrugBank.d776.s4.e2"
            e2="DDI-DrugBank.d776.s4.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s5" text="When DIFLUCAN is used concomitantly with these or other sulfonylurea oral hypoglycemic agents, blood glucose concentrations should be carefully monitored and the dose of the sulfonylurea should be adjusted as necessary. ">
        <entity id="DDI-DrugBank.d776.s5.e0" charOffset="5-12"
            type="brand" text="DIFLUCAN"/>
        <entity id="DDI-DrugBank.d776.s5.e1" charOffset="56-92"
            type="group" text="sulfonylurea oral hypoglycemic agents"/>
        <entity id="DDI-DrugBank.d776.s5.e2" charOffset="174-185"
            type="group" text="sulfonylurea"/>
        <pair id="DDI-DrugBank.d776.s5.p0" e1="DDI-DrugBank.d776.s5.e0"
            e2="DDI-DrugBank.d776.s5.e1" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d776.s5.p1" e1="DDI-DrugBank.d776.s5.e0"
            e2="DDI-DrugBank.d776.s5.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s5.p2" e1="DDI-DrugBank.d776.s5.e1"
            e2="DDI-DrugBank.d776.s5.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s6" text="Coumarin-type anticoagulants: Prothrombin time may be increased in patients receiving concomitant DIFLUCAN and coumarin-type anticoagulants. ">
        <entity id="DDI-DrugBank.d776.s6.e0" charOffset="0-27"
            type="group" text="Coumarin-type anticoagulants"/>
        <entity id="DDI-DrugBank.d776.s6.e1" charOffset="98-105"
            type="brand" text="DIFLUCAN"/>
        <entity id="DDI-DrugBank.d776.s6.e2" charOffset="111-138"
            type="group" text="coumarin-type anticoagulants"/>
        <pair id="DDI-DrugBank.d776.s6.p0" e1="DDI-DrugBank.d776.s6.e0"
            e2="DDI-DrugBank.d776.s6.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s6.p1" e1="DDI-DrugBank.d776.s6.e0"
            e2="DDI-DrugBank.d776.s6.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s6.p2" e1="DDI-DrugBank.d776.s6.e1"
            e2="DDI-DrugBank.d776.s6.e2" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s7" text="In post-marketing experience, as with other azole antifungals, bleeding events (bruising, epistaxis, gastrointestinal bleeding, hematuria, and melena) have been reported in association with increases in prothrombin time in patients receiving fluconazole concurrently with warfarin. ">
        <entity id="DDI-DrugBank.d776.s7.e0" charOffset="44-60"
            type="group" text="azole antifungals"/>
        <entity id="DDI-DrugBank.d776.s7.e1" charOffset="242-252"
            type="drug" text="fluconazole"/>
        <entity id="DDI-DrugBank.d776.s7.e2" charOffset="272-279"
            type="drug" text="warfarin"/>
        <pair id="DDI-DrugBank.d776.s7.p0" e1="DDI-DrugBank.d776.s7.e0"
            e2="DDI-DrugBank.d776.s7.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s7.p1" e1="DDI-DrugBank.d776.s7.e0"
            e2="DDI-DrugBank.d776.s7.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s7.p2" e1="DDI-DrugBank.d776.s7.e1"
            e2="DDI-DrugBank.d776.s7.e2" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s8" text="Careful monitoring of prothrombin time in patients receiving DIFLUCAN and coumarin-type anticoagulants is recommended. ">
        <entity id="DDI-DrugBank.d776.s8.e0" charOffset="61-68"
            type="brand" text="DIFLUCAN"/>
        <entity id="DDI-DrugBank.d776.s8.e1" charOffset="74-101"
            type="group" text="coumarin-type anticoagulants"/>
        <pair id="DDI-DrugBank.d776.s8.p0" e1="DDI-DrugBank.d776.s8.e0"
            e2="DDI-DrugBank.d776.s8.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s9" text="(See &lt;a href= &quot;flucon_cp.htm#CP&quot;>CLINICAL PHARMACOLOGY: Drug Interaction Studies.) "/>
    <sentence id="DDI-DrugBank.d776.s10" text="Phenytoin: DIFLUCAN increases the plasma concentrations of phenytoin. ">
        <entity id="DDI-DrugBank.d776.s10.e0" charOffset="0-8"
            type="drug" text="Phenytoin"/>
        <entity id="DDI-DrugBank.d776.s10.e1" charOffset="11-18"
            type="brand" text="DIFLUCAN"/>
        <entity id="DDI-DrugBank.d776.s10.e2" charOffset="59-67"
            type="drug" text="phenytoin"/>
        <pair id="DDI-DrugBank.d776.s10.p0"
            e1="DDI-DrugBank.d776.s10.e0" e2="DDI-DrugBank.d776.s10.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s10.p1"
            e1="DDI-DrugBank.d776.s10.e0" e2="DDI-DrugBank.d776.s10.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s10.p2"
            e1="DDI-DrugBank.d776.s10.e1" e2="DDI-DrugBank.d776.s10.e2"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s11" text="Careful monitoring of phenytoin concentrations in patients receiving DIFLUCAN and phenytoin is recommended. ">
        <entity id="DDI-DrugBank.d776.s11.e0" charOffset="22-30"
            type="drug" text="phenytoin"/>
        <entity id="DDI-DrugBank.d776.s11.e1" charOffset="69-76"
            type="brand" text="DIFLUCAN"/>
        <entity id="DDI-DrugBank.d776.s11.e2" charOffset="82-90"
            type="drug" text="phenytoin"/>
        <pair id="DDI-DrugBank.d776.s11.p0"
            e1="DDI-DrugBank.d776.s11.e0" e2="DDI-DrugBank.d776.s11.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s11.p1"
            e1="DDI-DrugBank.d776.s11.e0" e2="DDI-DrugBank.d776.s11.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s11.p2"
            e1="DDI-DrugBank.d776.s11.e1" e2="DDI-DrugBank.d776.s11.e2"
            ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s12" text="(See &lt;a href= &quot;flucon_cp.htm#CP&quot;>CLINICAL PHARMACOLOGY: Drug Interaction Studies.) "/>
    <sentence id="DDI-DrugBank.d776.s13" text="Cyclosporine: DIFLUCAN may significantly increase cyclosporine levels in renal transplant patients with or without renal impairment. ">
        <entity id="DDI-DrugBank.d776.s13.e0" charOffset="0-11"
            type="drug" text="Cyclosporine"/>
        <entity id="DDI-DrugBank.d776.s13.e1" charOffset="14-21"
            type="brand" text="DIFLUCAN"/>
        <entity id="DDI-DrugBank.d776.s13.e2" charOffset="50-61"
            type="drug" text="cyclosporine"/>
        <pair id="DDI-DrugBank.d776.s13.p0"
            e1="DDI-DrugBank.d776.s13.e0" e2="DDI-DrugBank.d776.s13.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s13.p1"
            e1="DDI-DrugBank.d776.s13.e0" e2="DDI-DrugBank.d776.s13.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s13.p2"
            e1="DDI-DrugBank.d776.s13.e1" e2="DDI-DrugBank.d776.s13.e2"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s14" text="Careful monitoring of cyclosporine concentrations and serum creatinine is recommended in patients receiving DIFLUCAN and cyclosporine. ">
        <entity id="DDI-DrugBank.d776.s14.e0" charOffset="22-33"
            type="drug" text="cyclosporine"/>
        <entity id="DDI-DrugBank.d776.s14.e1" charOffset="108-115"
            type="brand" text="DIFLUCAN"/>
        <entity id="DDI-DrugBank.d776.s14.e2" charOffset="121-132"
            type="drug" text="cyclosporine"/>
        <pair id="DDI-DrugBank.d776.s14.p0"
            e1="DDI-DrugBank.d776.s14.e0" e2="DDI-DrugBank.d776.s14.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s14.p1"
            e1="DDI-DrugBank.d776.s14.e0" e2="DDI-DrugBank.d776.s14.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s14.p2"
            e1="DDI-DrugBank.d776.s14.e1" e2="DDI-DrugBank.d776.s14.e2"
            ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s15" text="(See CLINICAL PHARMACOLOGY: Drug Interaction Studies.) "/>
    <sentence id="DDI-DrugBank.d776.s16" text="Rifampin: Rifampin enhances the metabolism of concurrently administered DIFLUCAN. ">
        <entity id="DDI-DrugBank.d776.s16.e0" charOffset="0-7"
            type="drug" text="Rifampin"/>
        <entity id="DDI-DrugBank.d776.s16.e1" charOffset="10-17"
            type="drug" text="Rifampin"/>
        <entity id="DDI-DrugBank.d776.s16.e2" charOffset="72-79"
            type="brand" text="DIFLUCAN"/>
        <pair id="DDI-DrugBank.d776.s16.p0"
            e1="DDI-DrugBank.d776.s16.e0" e2="DDI-DrugBank.d776.s16.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s16.p1"
            e1="DDI-DrugBank.d776.s16.e0" e2="DDI-DrugBank.d776.s16.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s16.p2"
            e1="DDI-DrugBank.d776.s16.e1" e2="DDI-DrugBank.d776.s16.e2"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s17" text="Depending on clinical circumstances, consideration should be given to increasing the dose of DIFLUCAN when it is administered with rifampin. ">
        <entity id="DDI-DrugBank.d776.s17.e0" charOffset="93-100"
            type="brand" text="DIFLUCAN"/>
        <entity id="DDI-DrugBank.d776.s17.e1" charOffset="131-138"
            type="drug" text="rifampin"/>
        <pair id="DDI-DrugBank.d776.s17.p0"
            e1="DDI-DrugBank.d776.s17.e0" e2="DDI-DrugBank.d776.s17.e1"
            ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s18" text="Theophylline: DIFLUCAN increases the serum concentrations of theophylline. ">
        <entity id="DDI-DrugBank.d776.s18.e0" charOffset="0-11"
            type="drug" text="Theophylline"/>
        <entity id="DDI-DrugBank.d776.s18.e1" charOffset="14-21"
            type="brand" text="DIFLUCAN"/>
        <entity id="DDI-DrugBank.d776.s18.e2" charOffset="61-72"
            type="drug" text="theophylline"/>
        <pair id="DDI-DrugBank.d776.s18.p0"
            e1="DDI-DrugBank.d776.s18.e0" e2="DDI-DrugBank.d776.s18.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s18.p1"
            e1="DDI-DrugBank.d776.s18.e0" e2="DDI-DrugBank.d776.s18.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s18.p2"
            e1="DDI-DrugBank.d776.s18.e1" e2="DDI-DrugBank.d776.s18.e2"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s19" text="Careful monitoring of serum theophylline concentrations in patients receiving DIFLUCAN and theophylline is recommended. ">
        <entity id="DDI-DrugBank.d776.s19.e0" charOffset="28-39"
            type="drug" text="theophylline"/>
        <entity id="DDI-DrugBank.d776.s19.e1" charOffset="78-85"
            type="brand" text="DIFLUCAN"/>
        <entity id="DDI-DrugBank.d776.s19.e2" charOffset="91-102"
            type="drug" text="theophylline"/>
        <pair id="DDI-DrugBank.d776.s19.p0"
            e1="DDI-DrugBank.d776.s19.e0" e2="DDI-DrugBank.d776.s19.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s19.p1"
            e1="DDI-DrugBank.d776.s19.e0" e2="DDI-DrugBank.d776.s19.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s19.p2"
            e1="DDI-DrugBank.d776.s19.e1" e2="DDI-DrugBank.d776.s19.e2"
            ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s20" text="Terfenadine: Because of the occurrence of serious cardiac dysrhythmias secondary to prolongation of the QTc interval in patients receiving azole antifungals in conjunction with terfenadine, interaction studies have been performed. ">
        <entity id="DDI-DrugBank.d776.s20.e0" charOffset="0-10"
            type="drug" text="Terfenadine"/>
        <entity id="DDI-DrugBank.d776.s20.e1" charOffset="139-155"
            type="group" text="azole antifungals"/>
        <entity id="DDI-DrugBank.d776.s20.e2" charOffset="177-187"
            type="drug" text="terfenadine"/>
        <pair id="DDI-DrugBank.d776.s20.p0"
            e1="DDI-DrugBank.d776.s20.e0" e2="DDI-DrugBank.d776.s20.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s20.p1"
            e1="DDI-DrugBank.d776.s20.e0" e2="DDI-DrugBank.d776.s20.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s20.p2"
            e1="DDI-DrugBank.d776.s20.e1" e2="DDI-DrugBank.d776.s20.e2"
            ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s21" text="One study at a 200-mg daily dose of fluconazole failed to demonstrate a prolongation in QTc interval. ">
        <entity id="DDI-DrugBank.d776.s21.e0" charOffset="36-46"
            type="drug" text="fluconazole"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s22" text="Another study at a 400-mg and 800-mg daily dose of fluconazole demonstrated that DIFLUCAN taken in doses of 400 mg per day or greater significantly increases plasma levels of terfenadine when taken concomitantly. ">
        <entity id="DDI-DrugBank.d776.s22.e0" charOffset="51-61"
            type="drug" text="fluconazole"/>
        <entity id="DDI-DrugBank.d776.s22.e1" charOffset="81-88"
            type="brand" text="DIFLUCAN"/>
        <entity id="DDI-DrugBank.d776.s22.e2" charOffset="175-185"
            type="drug" text="terfenadine"/>
        <pair id="DDI-DrugBank.d776.s22.p0"
            e1="DDI-DrugBank.d776.s22.e0" e2="DDI-DrugBank.d776.s22.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s22.p1"
            e1="DDI-DrugBank.d776.s22.e0" e2="DDI-DrugBank.d776.s22.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s22.p2"
            e1="DDI-DrugBank.d776.s22.e1" e2="DDI-DrugBank.d776.s22.e2"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s23" text="The combined use of fluconazole at doses of 400 mg or greater with terfenadine is contraindicated. ">
        <entity id="DDI-DrugBank.d776.s23.e0" charOffset="20-30"
            type="drug" text="fluconazole"/>
        <entity id="DDI-DrugBank.d776.s23.e1" charOffset="67-77"
            type="drug" text="terfenadine"/>
        <pair id="DDI-DrugBank.d776.s23.p0"
            e1="DDI-DrugBank.d776.s23.e0" e2="DDI-DrugBank.d776.s23.e1"
            ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s24" text="The coadministration of fluconazole at doses lower than 400 mg/day with terfenadine should be carefully monitored. ">
        <entity id="DDI-DrugBank.d776.s24.e0" charOffset="24-34"
            type="drug" text="fluconazole"/>
        <entity id="DDI-DrugBank.d776.s24.e1" charOffset="72-82"
            type="drug" text="terfenadine"/>
        <pair id="DDI-DrugBank.d776.s24.p0"
            e1="DDI-DrugBank.d776.s24.e0" e2="DDI-DrugBank.d776.s24.e1"
            ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s25" text="Cisapride: There have been reports of cardiac events, including torsade de pointes in patients to whom fluconazole and cisapride were coadministered. ">
        <entity id="DDI-DrugBank.d776.s25.e0" charOffset="0-8"
            type="drug" text="Cisapride"/>
        <entity id="DDI-DrugBank.d776.s25.e1" charOffset="103-113"
            type="drug" text="fluconazole"/>
        <entity id="DDI-DrugBank.d776.s25.e2" charOffset="119-127"
            type="drug" text="cisapride"/>
        <pair id="DDI-DrugBank.d776.s25.p0"
            e1="DDI-DrugBank.d776.s25.e0" e2="DDI-DrugBank.d776.s25.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s25.p1"
            e1="DDI-DrugBank.d776.s25.e0" e2="DDI-DrugBank.d776.s25.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s25.p2"
            e1="DDI-DrugBank.d776.s25.e1" e2="DDI-DrugBank.d776.s25.e2"
            ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s26" text="A controlled study found that concomitant fluconazole 200 mg once daily and cisapride 20 mg four times a day yielded a significant increase in cisapride plasma levels and prolongation of QTc interval.">
        <entity id="DDI-DrugBank.d776.s26.e0" charOffset="42-52"
            type="drug" text="fluconazole"/>
        <entity id="DDI-DrugBank.d776.s26.e1" charOffset="76-84"
            type="drug" text="cisapride"/>
        <entity id="DDI-DrugBank.d776.s26.e2" charOffset="143-151"
            type="drug" text="cisapride"/>
        <pair id="DDI-DrugBank.d776.s26.p0"
            e1="DDI-DrugBank.d776.s26.e0" e2="DDI-DrugBank.d776.s26.e1"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d776.s26.p1"
            e1="DDI-DrugBank.d776.s26.e0" e2="DDI-DrugBank.d776.s26.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s26.p2"
            e1="DDI-DrugBank.d776.s26.e1" e2="DDI-DrugBank.d776.s26.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s27" text="The combined use of fluconazole with cisapride is contraindicated. ">
        <entity id="DDI-DrugBank.d776.s27.e0" charOffset="20-30"
            type="drug" text="fluconazole"/>
        <entity id="DDI-DrugBank.d776.s27.e1" charOffset="37-45"
            type="drug" text="cisapride"/>
        <pair id="DDI-DrugBank.d776.s27.p0"
            e1="DDI-DrugBank.d776.s27.e0" e2="DDI-DrugBank.d776.s27.e1"
            ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s28" text="Astemizole: The use of fluconazole in patients concurrently taking astemizole or other drugs metabolized by the cytochrome P450 system may be associated with elevations in serum levels of these drugs. ">
        <entity id="DDI-DrugBank.d776.s28.e0" charOffset="0-9"
            type="drug" text="Astemizole"/>
        <entity id="DDI-DrugBank.d776.s28.e1" charOffset="23-33"
            type="drug" text="fluconazole"/>
        <entity id="DDI-DrugBank.d776.s28.e2" charOffset="67-76"
            type="drug" text="astemizole"/>
        <pair id="DDI-DrugBank.d776.s28.p0"
            e1="DDI-DrugBank.d776.s28.e0" e2="DDI-DrugBank.d776.s28.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s28.p1"
            e1="DDI-DrugBank.d776.s28.e0" e2="DDI-DrugBank.d776.s28.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s28.p2"
            e1="DDI-DrugBank.d776.s28.e1" e2="DDI-DrugBank.d776.s28.e2"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s29" text="In the absence of definitive information, caution should be used when coadministering fluconazole. ">
        <entity id="DDI-DrugBank.d776.s29.e0" charOffset="86-96"
            type="drug" text="fluconazole"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s30" text="Patients should be carefully monitored. "/>
    <sentence id="DDI-DrugBank.d776.s31" text="Rifabutin: There have been reports of uveitis in patients to whom fluconazole and rifabutin were coadministered. ">
        <entity id="DDI-DrugBank.d776.s31.e0" charOffset="0-8"
            type="drug" text="Rifabutin"/>
        <entity id="DDI-DrugBank.d776.s31.e1" charOffset="66-76"
            type="drug" text="fluconazole"/>
        <entity id="DDI-DrugBank.d776.s31.e2" charOffset="82-90"
            type="drug" text="rifabutin"/>
        <pair id="DDI-DrugBank.d776.s31.p0"
            e1="DDI-DrugBank.d776.s31.e0" e2="DDI-DrugBank.d776.s31.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s31.p1"
            e1="DDI-DrugBank.d776.s31.e0" e2="DDI-DrugBank.d776.s31.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s31.p2"
            e1="DDI-DrugBank.d776.s31.e1" e2="DDI-DrugBank.d776.s31.e2"
            ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s32" text="Patients receiving rifabutin and fluconazole concomitantly should be carefully monitored. ">
        <entity id="DDI-DrugBank.d776.s32.e0" charOffset="19-27"
            type="drug" text="rifabutin"/>
        <entity id="DDI-DrugBank.d776.s32.e1" charOffset="33-43"
            type="drug" text="fluconazole"/>
        <pair id="DDI-DrugBank.d776.s32.p0"
            e1="DDI-DrugBank.d776.s32.e0" e2="DDI-DrugBank.d776.s32.e1"
            ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s33" text="Tacrolimus: There have been reports of nephrotoxicity in patients to whom fluconazole and tacrolimus were coadministered. ">
        <entity id="DDI-DrugBank.d776.s33.e0" charOffset="0-9"
            type="drug" text="Tacrolimus"/>
        <entity id="DDI-DrugBank.d776.s33.e1" charOffset="74-84"
            type="drug" text="fluconazole"/>
        <entity id="DDI-DrugBank.d776.s33.e2" charOffset="90-99"
            type="drug" text="tacrolimus"/>
        <pair id="DDI-DrugBank.d776.s33.p0"
            e1="DDI-DrugBank.d776.s33.e0" e2="DDI-DrugBank.d776.s33.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s33.p1"
            e1="DDI-DrugBank.d776.s33.e0" e2="DDI-DrugBank.d776.s33.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s33.p2"
            e1="DDI-DrugBank.d776.s33.e1" e2="DDI-DrugBank.d776.s33.e2"
            ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s34" text="Patients receiving tacrolimus and fluconazole concomitantly should be carefully monitored. ">
        <entity id="DDI-DrugBank.d776.s34.e0" charOffset="19-28"
            type="drug" text="tacrolimus"/>
        <entity id="DDI-DrugBank.d776.s34.e1" charOffset="34-44"
            type="drug" text="fluconazole"/>
        <pair id="DDI-DrugBank.d776.s34.p0"
            e1="DDI-DrugBank.d776.s34.e0" e2="DDI-DrugBank.d776.s34.e1"
            ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s35" text="Short-acting Benzodiazepines: Following oral administration of midazolam, fluconazole resulted in substantial increases in midazolam concentrations and psychomotor effects. ">
        <entity id="DDI-DrugBank.d776.s35.e0" charOffset="0-27"
            type="group" text="Short-acting Benzodiazepines"/>
        <entity id="DDI-DrugBank.d776.s35.e1" charOffset="63-71"
            type="drug" text="midazolam"/>
        <entity id="DDI-DrugBank.d776.s35.e2" charOffset="74-84"
            type="drug" text="fluconazole"/>
        <entity id="DDI-DrugBank.d776.s35.e3" charOffset="123-131"
            type="drug" text="midazolam"/>
        <pair id="DDI-DrugBank.d776.s35.p0"
            e1="DDI-DrugBank.d776.s35.e0" e2="DDI-DrugBank.d776.s35.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s35.p1"
            e1="DDI-DrugBank.d776.s35.e0" e2="DDI-DrugBank.d776.s35.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s35.p2"
            e1="DDI-DrugBank.d776.s35.e0" e2="DDI-DrugBank.d776.s35.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s35.p3"
            e1="DDI-DrugBank.d776.s35.e1" e2="DDI-DrugBank.d776.s35.e2"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d776.s35.p4"
            e1="DDI-DrugBank.d776.s35.e1" e2="DDI-DrugBank.d776.s35.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s35.p5"
            e1="DDI-DrugBank.d776.s35.e2" e2="DDI-DrugBank.d776.s35.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s36" text="This effect on midazolam appears to be more pronounced following oral administration of fluconazole than with fluconazole administered intravenously. ">
        <entity id="DDI-DrugBank.d776.s36.e0" charOffset="15-23"
            type="drug" text="midazolam"/>
        <entity id="DDI-DrugBank.d776.s36.e1" charOffset="88-98"
            type="drug" text="fluconazole"/>
        <entity id="DDI-DrugBank.d776.s36.e2" charOffset="110-120"
            type="drug" text="fluconazole"/>
        <pair id="DDI-DrugBank.d776.s36.p0"
            e1="DDI-DrugBank.d776.s36.e0" e2="DDI-DrugBank.d776.s36.e1"
            ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d776.s36.p1"
            e1="DDI-DrugBank.d776.s36.e0" e2="DDI-DrugBank.d776.s36.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s36.p2"
            e1="DDI-DrugBank.d776.s36.e1" e2="DDI-DrugBank.d776.s36.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s37" text="If short-acting benzodiazepines, which are metabolized by the cytochrome P450 system, are concomitantly administered with fluconazole, consideration should be given to decreasing the benzodiazepine dosage, and the patients should be appropriately monitored. ">
        <entity id="DDI-DrugBank.d776.s37.e0" charOffset="3-30"
            type="group" text="short-acting benzodiazepines"/>
        <entity id="DDI-DrugBank.d776.s37.e1" charOffset="122-132"
            type="drug" text="fluconazole"/>
        <entity id="DDI-DrugBank.d776.s37.e2" charOffset="183-196"
            type="group" text="benzodiazepine"/>
        <pair id="DDI-DrugBank.d776.s37.p0"
            e1="DDI-DrugBank.d776.s37.e0" e2="DDI-DrugBank.d776.s37.e1"
            ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d776.s37.p1"
            e1="DDI-DrugBank.d776.s37.e0" e2="DDI-DrugBank.d776.s37.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s37.p2"
            e1="DDI-DrugBank.d776.s37.e1" e2="DDI-DrugBank.d776.s37.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s38" text="Fluconazole tablets coadministered with ethinyl estradiol- and levonorgestrel-containing oral contraceptives produced an overall mean increase in ethinyl estradiol and levonorgestrel levels; ">
        <entity id="DDI-DrugBank.d776.s38.e0" charOffset="0-10"
            type="drug" text="Fluconazole"/>
        <entity id="DDI-DrugBank.d776.s38.e1" charOffset="40-56"
            type="drug" text="ethinyl estradiol"/>
        <entity id="DDI-DrugBank.d776.s38.e2" charOffset="63-76"
            type="drug" text="levonorgestrel"/>
        <entity id="DDI-DrugBank.d776.s38.e3" charOffset="94-107"
            type="group" text="contraceptives"/>
        <entity id="DDI-DrugBank.d776.s38.e4" charOffset="146-162"
            type="drug" text="ethinyl estradiol"/>
        <entity id="DDI-DrugBank.d776.s38.e5" charOffset="168-181"
            type="drug" text="levonorgestrel"/>
        <pair id="DDI-DrugBank.d776.s38.p0"
            e1="DDI-DrugBank.d776.s38.e0" e2="DDI-DrugBank.d776.s38.e1"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d776.s38.p1"
            e1="DDI-DrugBank.d776.s38.e0" e2="DDI-DrugBank.d776.s38.e2"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d776.s38.p2"
            e1="DDI-DrugBank.d776.s38.e0" e2="DDI-DrugBank.d776.s38.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s38.p3"
            e1="DDI-DrugBank.d776.s38.e0" e2="DDI-DrugBank.d776.s38.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s38.p4"
            e1="DDI-DrugBank.d776.s38.e0" e2="DDI-DrugBank.d776.s38.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s38.p5"
            e1="DDI-DrugBank.d776.s38.e1" e2="DDI-DrugBank.d776.s38.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s38.p6"
            e1="DDI-DrugBank.d776.s38.e1" e2="DDI-DrugBank.d776.s38.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s38.p7"
            e1="DDI-DrugBank.d776.s38.e1" e2="DDI-DrugBank.d776.s38.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s38.p8"
            e1="DDI-DrugBank.d776.s38.e1" e2="DDI-DrugBank.d776.s38.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s38.p9"
            e1="DDI-DrugBank.d776.s38.e2" e2="DDI-DrugBank.d776.s38.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s38.p10"
            e1="DDI-DrugBank.d776.s38.e2" e2="DDI-DrugBank.d776.s38.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s38.p11"
            e1="DDI-DrugBank.d776.s38.e2" e2="DDI-DrugBank.d776.s38.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s38.p12"
            e1="DDI-DrugBank.d776.s38.e3" e2="DDI-DrugBank.d776.s38.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s38.p13"
            e1="DDI-DrugBank.d776.s38.e3" e2="DDI-DrugBank.d776.s38.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s38.p14"
            e1="DDI-DrugBank.d776.s38.e4" e2="DDI-DrugBank.d776.s38.e5" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s39" text="however, in some patients there were decreases up to 47% and 33% of ethinyl estradiol and levonorgestrel levels. ">
        <entity id="DDI-DrugBank.d776.s39.e0" charOffset="68-84"
            type="drug" text="ethinyl estradiol"/>
        <entity id="DDI-DrugBank.d776.s39.e1" charOffset="90-103"
            type="drug" text="levonorgestrel"/>
        <pair id="DDI-DrugBank.d776.s39.p0"
            e1="DDI-DrugBank.d776.s39.e0" e2="DDI-DrugBank.d776.s39.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s40" text="The data presently available indicate that the decreases in some individual ethinyl estradiol and levonorgestrel AUC values with fluconazole treatment are likely the result of random variation. ">
        <entity id="DDI-DrugBank.d776.s40.e0" charOffset="76-92"
            type="drug" text="ethinyl estradiol"/>
        <entity id="DDI-DrugBank.d776.s40.e1" charOffset="98-111"
            type="drug" text="levonorgestrel"/>
        <entity id="DDI-DrugBank.d776.s40.e2" charOffset="129-139"
            type="drug" text="fluconazole"/>
        <pair id="DDI-DrugBank.d776.s40.p0"
            e1="DDI-DrugBank.d776.s40.e0" e2="DDI-DrugBank.d776.s40.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s40.p1"
            e1="DDI-DrugBank.d776.s40.e0" e2="DDI-DrugBank.d776.s40.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s40.p2"
            e1="DDI-DrugBank.d776.s40.e1" e2="DDI-DrugBank.d776.s40.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s41" text="While there is evidence that fluconazole can inhibit the metabolism of ethinyl estradiol and levonorgestrel, there is no evidence that fluconazole is a net inducer of ethinyl estradiol or levonorgestrel metabolism. ">
        <entity id="DDI-DrugBank.d776.s41.e0" charOffset="29-39"
            type="drug" text="fluconazole"/>
        <entity id="DDI-DrugBank.d776.s41.e1" charOffset="71-87"
            type="drug" text="ethinyl estradiol"/>
        <entity id="DDI-DrugBank.d776.s41.e2" charOffset="93-106"
            type="drug" text="levonorgestrel"/>
        <entity id="DDI-DrugBank.d776.s41.e3" charOffset="135-145"
            type="drug" text="fluconazole"/>
        <entity id="DDI-DrugBank.d776.s41.e4" charOffset="167-183"
            type="drug" text="ethinyl estradiol"/>
        <entity id="DDI-DrugBank.d776.s41.e5" charOffset="188-201"
            type="drug" text="levonorgestrel"/>
        <pair id="DDI-DrugBank.d776.s41.p0"
            e1="DDI-DrugBank.d776.s41.e0" e2="DDI-DrugBank.d776.s41.e1"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d776.s41.p1"
            e1="DDI-DrugBank.d776.s41.e0" e2="DDI-DrugBank.d776.s41.e2"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d776.s41.p2"
            e1="DDI-DrugBank.d776.s41.e0" e2="DDI-DrugBank.d776.s41.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s41.p3"
            e1="DDI-DrugBank.d776.s41.e0" e2="DDI-DrugBank.d776.s41.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s41.p4"
            e1="DDI-DrugBank.d776.s41.e0" e2="DDI-DrugBank.d776.s41.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s41.p5"
            e1="DDI-DrugBank.d776.s41.e1" e2="DDI-DrugBank.d776.s41.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s41.p6"
            e1="DDI-DrugBank.d776.s41.e1" e2="DDI-DrugBank.d776.s41.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s41.p7"
            e1="DDI-DrugBank.d776.s41.e1" e2="DDI-DrugBank.d776.s41.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s41.p8"
            e1="DDI-DrugBank.d776.s41.e1" e2="DDI-DrugBank.d776.s41.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s41.p9"
            e1="DDI-DrugBank.d776.s41.e2" e2="DDI-DrugBank.d776.s41.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s41.p10"
            e1="DDI-DrugBank.d776.s41.e2" e2="DDI-DrugBank.d776.s41.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s41.p11"
            e1="DDI-DrugBank.d776.s41.e2" e2="DDI-DrugBank.d776.s41.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s41.p12"
            e1="DDI-DrugBank.d776.s41.e3" e2="DDI-DrugBank.d776.s41.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s41.p13"
            e1="DDI-DrugBank.d776.s41.e3" e2="DDI-DrugBank.d776.s41.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d776.s41.p14"
            e1="DDI-DrugBank.d776.s41.e4" e2="DDI-DrugBank.d776.s41.e5" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d776.s42" text="The clinical significance of these effects is presently unknown. "/>
    <sentence id="DDI-DrugBank.d776.s43" text="Physicians should be aware that interaction studies with medications other than those listed in the &lt;a href= &quot;flucon_cp.htm#CP&quot;>CLINICAL PHARMACOLOGY section have not been conducted, but such interactions may occur."/>
</document>
<document id="DDI-DrugBank.d78">
    <sentence id="DDI-DrugBank.d78.s0" text="Antacids, Sucralfate, Metal Cations, Multivitamins Quinolones form chelates with alkaline earth and transition metal cations.">
        <entity id="DDI-DrugBank.d78.s0.e0" charOffset="0-7"
            type="group" text="Antacids"/>
        <entity id="DDI-DrugBank.d78.s0.e1" charOffset="10-19"
            type="drug" text="Sucralfate"/>
        <entity id="DDI-DrugBank.d78.s0.e2" charOffset="37-49"
            type="group" text="Multivitamins"/>
        <entity id="DDI-DrugBank.d78.s0.e3" charOffset="51-60"
            type="group" text="Quinolones"/>
        <pair id="DDI-DrugBank.d78.s0.p0" e1="DDI-DrugBank.d78.s0.e0"
            e2="DDI-DrugBank.d78.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s0.p1" e1="DDI-DrugBank.d78.s0.e0"
            e2="DDI-DrugBank.d78.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s0.p2" e1="DDI-DrugBank.d78.s0.e0"
            e2="DDI-DrugBank.d78.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s0.p3" e1="DDI-DrugBank.d78.s0.e1"
            e2="DDI-DrugBank.d78.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s0.p4" e1="DDI-DrugBank.d78.s0.e1"
            e2="DDI-DrugBank.d78.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s0.p5" e1="DDI-DrugBank.d78.s0.e2"
            e2="DDI-DrugBank.d78.s0.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d78.s1" text="Administration of quinolones with antacids containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.">
        <entity id="DDI-DrugBank.d78.s1.e0" charOffset="18-27"
            type="group" text="quinolones"/>
        <entity id="DDI-DrugBank.d78.s1.e1" charOffset="34-41"
            type="group" text="antacids"/>
        <entity id="DDI-DrugBank.d78.s1.e2" charOffset="54-61"
            type="drug" text="aluminum"/>
        <entity id="DDI-DrugBank.d78.s1.e3" charOffset="64-72"
            type="drug" text="magnesium"/>
        <entity id="DDI-DrugBank.d78.s1.e4" charOffset="78-84"
            type="drug" text="calcium"/>
        <entity id="DDI-DrugBank.d78.s1.e5" charOffset="92-101"
            type="drug" text="sucralfate"/>
        <entity id="DDI-DrugBank.d78.s1.e6" charOffset="131-134"
            type="drug" text="iron"/>
        <entity id="DDI-DrugBank.d78.s1.e7" charOffset="145-157"
            type="group" text="multivitamins"/>
        <entity id="DDI-DrugBank.d78.s1.e8" charOffset="170-173"
            type="drug" text="iron"/>
        <entity id="DDI-DrugBank.d78.s1.e9" charOffset="178-181"
            type="drug" text="zinc"/>
        <entity id="DDI-DrugBank.d78.s1.e10" charOffset="255-259"
            type="brand" text="VIDEX"/>
        <entity id="DDI-DrugBank.d78.s1.e11" charOffset="262-271"
            type="drug" text="didanosine"/>
        <entity id="DDI-DrugBank.d78.s1.e12" charOffset="394-403"
            type="group" text="quinolones"/>
        <pair id="DDI-DrugBank.d78.s1.p0" e1="DDI-DrugBank.d78.s1.e0"
            e2="DDI-DrugBank.d78.s1.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p1" e1="DDI-DrugBank.d78.s1.e0"
            e2="DDI-DrugBank.d78.s1.e2" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d78.s1.p2" e1="DDI-DrugBank.d78.s1.e0"
            e2="DDI-DrugBank.d78.s1.e3" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d78.s1.p3" e1="DDI-DrugBank.d78.s1.e0"
            e2="DDI-DrugBank.d78.s1.e4" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d78.s1.p4" e1="DDI-DrugBank.d78.s1.e0"
            e2="DDI-DrugBank.d78.s1.e5" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d78.s1.p5" e1="DDI-DrugBank.d78.s1.e0"
            e2="DDI-DrugBank.d78.s1.e6" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d78.s1.p6" e1="DDI-DrugBank.d78.s1.e0"
            e2="DDI-DrugBank.d78.s1.e7" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d78.s1.p7" e1="DDI-DrugBank.d78.s1.e0"
            e2="DDI-DrugBank.d78.s1.e8" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d78.s1.p8" e1="DDI-DrugBank.d78.s1.e0"
            e2="DDI-DrugBank.d78.s1.e9" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d78.s1.p9" e1="DDI-DrugBank.d78.s1.e0"
            e2="DDI-DrugBank.d78.s1.e10" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d78.s1.p10" e1="DDI-DrugBank.d78.s1.e0"
            e2="DDI-DrugBank.d78.s1.e11" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d78.s1.p11" e1="DDI-DrugBank.d78.s1.e0"
            e2="DDI-DrugBank.d78.s1.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p12" e1="DDI-DrugBank.d78.s1.e1"
            e2="DDI-DrugBank.d78.s1.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p13" e1="DDI-DrugBank.d78.s1.e1"
            e2="DDI-DrugBank.d78.s1.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p14" e1="DDI-DrugBank.d78.s1.e1"
            e2="DDI-DrugBank.d78.s1.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p15" e1="DDI-DrugBank.d78.s1.e1"
            e2="DDI-DrugBank.d78.s1.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p16" e1="DDI-DrugBank.d78.s1.e1"
            e2="DDI-DrugBank.d78.s1.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p17" e1="DDI-DrugBank.d78.s1.e1"
            e2="DDI-DrugBank.d78.s1.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p18" e1="DDI-DrugBank.d78.s1.e1"
            e2="DDI-DrugBank.d78.s1.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p19" e1="DDI-DrugBank.d78.s1.e1"
            e2="DDI-DrugBank.d78.s1.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p20" e1="DDI-DrugBank.d78.s1.e1"
            e2="DDI-DrugBank.d78.s1.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p21" e1="DDI-DrugBank.d78.s1.e1"
            e2="DDI-DrugBank.d78.s1.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p22" e1="DDI-DrugBank.d78.s1.e1"
            e2="DDI-DrugBank.d78.s1.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p23" e1="DDI-DrugBank.d78.s1.e2"
            e2="DDI-DrugBank.d78.s1.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p24" e1="DDI-DrugBank.d78.s1.e2"
            e2="DDI-DrugBank.d78.s1.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p25" e1="DDI-DrugBank.d78.s1.e2"
            e2="DDI-DrugBank.d78.s1.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p26" e1="DDI-DrugBank.d78.s1.e2"
            e2="DDI-DrugBank.d78.s1.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p27" e1="DDI-DrugBank.d78.s1.e2"
            e2="DDI-DrugBank.d78.s1.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p28" e1="DDI-DrugBank.d78.s1.e2"
            e2="DDI-DrugBank.d78.s1.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p29" e1="DDI-DrugBank.d78.s1.e2"
            e2="DDI-DrugBank.d78.s1.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p30" e1="DDI-DrugBank.d78.s1.e2"
            e2="DDI-DrugBank.d78.s1.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p31" e1="DDI-DrugBank.d78.s1.e2"
            e2="DDI-DrugBank.d78.s1.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p32" e1="DDI-DrugBank.d78.s1.e2"
            e2="DDI-DrugBank.d78.s1.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p33" e1="DDI-DrugBank.d78.s1.e3"
            e2="DDI-DrugBank.d78.s1.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p34" e1="DDI-DrugBank.d78.s1.e3"
            e2="DDI-DrugBank.d78.s1.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p35" e1="DDI-DrugBank.d78.s1.e3"
            e2="DDI-DrugBank.d78.s1.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p36" e1="DDI-DrugBank.d78.s1.e3"
            e2="DDI-DrugBank.d78.s1.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p37" e1="DDI-DrugBank.d78.s1.e3"
            e2="DDI-DrugBank.d78.s1.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p38" e1="DDI-DrugBank.d78.s1.e3"
            e2="DDI-DrugBank.d78.s1.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p39" e1="DDI-DrugBank.d78.s1.e3"
            e2="DDI-DrugBank.d78.s1.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p40" e1="DDI-DrugBank.d78.s1.e3"
            e2="DDI-DrugBank.d78.s1.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p41" e1="DDI-DrugBank.d78.s1.e3"
            e2="DDI-DrugBank.d78.s1.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p42" e1="DDI-DrugBank.d78.s1.e4"
            e2="DDI-DrugBank.d78.s1.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p43" e1="DDI-DrugBank.d78.s1.e4"
            e2="DDI-DrugBank.d78.s1.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p44" e1="DDI-DrugBank.d78.s1.e4"
            e2="DDI-DrugBank.d78.s1.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p45" e1="DDI-DrugBank.d78.s1.e4"
            e2="DDI-DrugBank.d78.s1.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p46" e1="DDI-DrugBank.d78.s1.e4"
            e2="DDI-DrugBank.d78.s1.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p47" e1="DDI-DrugBank.d78.s1.e4"
            e2="DDI-DrugBank.d78.s1.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p48" e1="DDI-DrugBank.d78.s1.e4"
            e2="DDI-DrugBank.d78.s1.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p49" e1="DDI-DrugBank.d78.s1.e4"
            e2="DDI-DrugBank.d78.s1.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p50" e1="DDI-DrugBank.d78.s1.e5"
            e2="DDI-DrugBank.d78.s1.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p51" e1="DDI-DrugBank.d78.s1.e5"
            e2="DDI-DrugBank.d78.s1.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p52" e1="DDI-DrugBank.d78.s1.e5"
            e2="DDI-DrugBank.d78.s1.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p53" e1="DDI-DrugBank.d78.s1.e5"
            e2="DDI-DrugBank.d78.s1.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p54" e1="DDI-DrugBank.d78.s1.e5"
            e2="DDI-DrugBank.d78.s1.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p55" e1="DDI-DrugBank.d78.s1.e5"
            e2="DDI-DrugBank.d78.s1.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p56" e1="DDI-DrugBank.d78.s1.e5"
            e2="DDI-DrugBank.d78.s1.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p57" e1="DDI-DrugBank.d78.s1.e6"
            e2="DDI-DrugBank.d78.s1.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p58" e1="DDI-DrugBank.d78.s1.e6"
            e2="DDI-DrugBank.d78.s1.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p59" e1="DDI-DrugBank.d78.s1.e6"
            e2="DDI-DrugBank.d78.s1.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p60" e1="DDI-DrugBank.d78.s1.e6"
            e2="DDI-DrugBank.d78.s1.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p61" e1="DDI-DrugBank.d78.s1.e6"
            e2="DDI-DrugBank.d78.s1.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p62" e1="DDI-DrugBank.d78.s1.e6"
            e2="DDI-DrugBank.d78.s1.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p63" e1="DDI-DrugBank.d78.s1.e7"
            e2="DDI-DrugBank.d78.s1.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p64" e1="DDI-DrugBank.d78.s1.e7"
            e2="DDI-DrugBank.d78.s1.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p65" e1="DDI-DrugBank.d78.s1.e7"
            e2="DDI-DrugBank.d78.s1.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p66" e1="DDI-DrugBank.d78.s1.e7"
            e2="DDI-DrugBank.d78.s1.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p67" e1="DDI-DrugBank.d78.s1.e7"
            e2="DDI-DrugBank.d78.s1.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p68" e1="DDI-DrugBank.d78.s1.e8"
            e2="DDI-DrugBank.d78.s1.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p69" e1="DDI-DrugBank.d78.s1.e8"
            e2="DDI-DrugBank.d78.s1.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p70" e1="DDI-DrugBank.d78.s1.e8"
            e2="DDI-DrugBank.d78.s1.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p71" e1="DDI-DrugBank.d78.s1.e8"
            e2="DDI-DrugBank.d78.s1.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p72" e1="DDI-DrugBank.d78.s1.e9"
            e2="DDI-DrugBank.d78.s1.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p73" e1="DDI-DrugBank.d78.s1.e9"
            e2="DDI-DrugBank.d78.s1.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p74" e1="DDI-DrugBank.d78.s1.e9"
            e2="DDI-DrugBank.d78.s1.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p75" e1="DDI-DrugBank.d78.s1.e10"
            e2="DDI-DrugBank.d78.s1.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p76" e1="DDI-DrugBank.d78.s1.e10"
            e2="DDI-DrugBank.d78.s1.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s1.p77" e1="DDI-DrugBank.d78.s1.e11"
            e2="DDI-DrugBank.d78.s1.e12" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d78.s2" text="These agents should not be taken within 4 hours before or 4 hours after grepafloxacin administration.">
        <entity id="DDI-DrugBank.d78.s2.e0" charOffset="72-84"
            type="drug" text="grepafloxacin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d78.s3" text="Caffeine Theobromine Grepafloxacin, like other quinolones, may inhibit the metabolism of caffeine and theobromine.">
        <entity id="DDI-DrugBank.d78.s3.e0" charOffset="0-7" type="drug" text="Caffeine"/>
        <entity id="DDI-DrugBank.d78.s3.e1" charOffset="9-19"
            type="drug" text="Theobromine"/>
        <entity id="DDI-DrugBank.d78.s3.e2" charOffset="21-33"
            type="drug" text="Grepafloxacin"/>
        <entity id="DDI-DrugBank.d78.s3.e3" charOffset="47-56"
            type="group" text="quinolones"/>
        <entity id="DDI-DrugBank.d78.s3.e4" charOffset="89-96"
            type="drug" text="caffeine"/>
        <entity id="DDI-DrugBank.d78.s3.e5" charOffset="102-112"
            type="drug" text="theobromine"/>
        <pair id="DDI-DrugBank.d78.s3.p0" e1="DDI-DrugBank.d78.s3.e0"
            e2="DDI-DrugBank.d78.s3.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s3.p1" e1="DDI-DrugBank.d78.s3.e0"
            e2="DDI-DrugBank.d78.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s3.p2" e1="DDI-DrugBank.d78.s3.e0"
            e2="DDI-DrugBank.d78.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s3.p3" e1="DDI-DrugBank.d78.s3.e0"
            e2="DDI-DrugBank.d78.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s3.p4" e1="DDI-DrugBank.d78.s3.e0"
            e2="DDI-DrugBank.d78.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s3.p5" e1="DDI-DrugBank.d78.s3.e1"
            e2="DDI-DrugBank.d78.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s3.p6" e1="DDI-DrugBank.d78.s3.e1"
            e2="DDI-DrugBank.d78.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s3.p7" e1="DDI-DrugBank.d78.s3.e1"
            e2="DDI-DrugBank.d78.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s3.p8" e1="DDI-DrugBank.d78.s3.e1"
            e2="DDI-DrugBank.d78.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s3.p9" e1="DDI-DrugBank.d78.s3.e2"
            e2="DDI-DrugBank.d78.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s3.p10" e1="DDI-DrugBank.d78.s3.e2"
            e2="DDI-DrugBank.d78.s3.e4" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d78.s3.p11" e1="DDI-DrugBank.d78.s3.e2"
            e2="DDI-DrugBank.d78.s3.e5" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d78.s3.p12" e1="DDI-DrugBank.d78.s3.e3"
            e2="DDI-DrugBank.d78.s3.e4" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d78.s3.p13" e1="DDI-DrugBank.d78.s3.e3"
            e2="DDI-DrugBank.d78.s3.e5" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d78.s3.p14" e1="DDI-DrugBank.d78.s3.e4"
            e2="DDI-DrugBank.d78.s3.e5" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d78.s4" text="These stimulants are commonly found in coffee and tea, respectively."/>
    <sentence id="DDI-DrugBank.d78.s5" text="In some patients, this may lead to reduced clearance, prolongation of plasma half-life, and enhanced effects of caffeine and theobromine.">
        <entity id="DDI-DrugBank.d78.s5.e0" charOffset="112-119"
            type="drug" text="caffeine"/>
        <entity id="DDI-DrugBank.d78.s5.e1" charOffset="125-135"
            type="drug" text="theobromine"/>
        <pair id="DDI-DrugBank.d78.s5.p0" e1="DDI-DrugBank.d78.s5.e0"
            e2="DDI-DrugBank.d78.s5.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d78.s6" text="Theophylline: Grepafloxacin is a competitive inhibitor of the metabolism of theophylline.">
        <entity id="DDI-DrugBank.d78.s6.e0" charOffset="0-11"
            type="drug" text="Theophylline"/>
        <entity id="DDI-DrugBank.d78.s6.e1" charOffset="14-26"
            type="drug" text="Grepafloxacin"/>
        <entity id="DDI-DrugBank.d78.s6.e2" charOffset="76-87"
            type="drug" text="theophylline"/>
        <pair id="DDI-DrugBank.d78.s6.p0" e1="DDI-DrugBank.d78.s6.e0"
            e2="DDI-DrugBank.d78.s6.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s6.p1" e1="DDI-DrugBank.d78.s6.e0"
            e2="DDI-DrugBank.d78.s6.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s6.p2" e1="DDI-DrugBank.d78.s6.e1"
            e2="DDI-DrugBank.d78.s6.e2" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d78.s7" text="Serum theophylline concentrations increase when grepafloxacin is initiated in a patient maintained on theophylline.">
        <entity id="DDI-DrugBank.d78.s7.e0" charOffset="6-17"
            type="drug" text="theophylline"/>
        <entity id="DDI-DrugBank.d78.s7.e1" charOffset="48-60"
            type="drug" text="grepafloxacin"/>
        <entity id="DDI-DrugBank.d78.s7.e2" charOffset="102-113"
            type="drug" text="theophylline"/>
        <pair id="DDI-DrugBank.d78.s7.p0" e1="DDI-DrugBank.d78.s7.e0"
            e2="DDI-DrugBank.d78.s7.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s7.p1" e1="DDI-DrugBank.d78.s7.e0"
            e2="DDI-DrugBank.d78.s7.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s7.p2" e1="DDI-DrugBank.d78.s7.e1"
            e2="DDI-DrugBank.d78.s7.e2" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d78.s8" text="When initiating a multi-day course of grepafloxacin in a patient maintained on theophylline, the theophylline maintenance dose should be halved for the period of concurrent use of grepafloxacin and monitoring of serum theophylline concentrations should be initiated as a guide to further dosage adjustments.">
        <entity id="DDI-DrugBank.d78.s8.e0" charOffset="38-50"
            type="drug" text="grepafloxacin"/>
        <entity id="DDI-DrugBank.d78.s8.e1" charOffset="79-90"
            type="drug" text="theophylline"/>
        <entity id="DDI-DrugBank.d78.s8.e2" charOffset="97-108"
            type="drug" text="theophylline"/>
        <entity id="DDI-DrugBank.d78.s8.e3" charOffset="180-192"
            type="drug" text="grepafloxacin"/>
        <entity id="DDI-DrugBank.d78.s8.e4" charOffset="218-229"
            type="drug" text="theophylline"/>
        <pair id="DDI-DrugBank.d78.s8.p0" e1="DDI-DrugBank.d78.s8.e0"
            e2="DDI-DrugBank.d78.s8.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s8.p1" e1="DDI-DrugBank.d78.s8.e0"
            e2="DDI-DrugBank.d78.s8.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s8.p2" e1="DDI-DrugBank.d78.s8.e0"
            e2="DDI-DrugBank.d78.s8.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s8.p3" e1="DDI-DrugBank.d78.s8.e0"
            e2="DDI-DrugBank.d78.s8.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s8.p4" e1="DDI-DrugBank.d78.s8.e1"
            e2="DDI-DrugBank.d78.s8.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s8.p5" e1="DDI-DrugBank.d78.s8.e1"
            e2="DDI-DrugBank.d78.s8.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s8.p6" e1="DDI-DrugBank.d78.s8.e1"
            e2="DDI-DrugBank.d78.s8.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s8.p7" e1="DDI-DrugBank.d78.s8.e2"
            e2="DDI-DrugBank.d78.s8.e3" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d78.s8.p8" e1="DDI-DrugBank.d78.s8.e2"
            e2="DDI-DrugBank.d78.s8.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s8.p9" e1="DDI-DrugBank.d78.s8.e3"
            e2="DDI-DrugBank.d78.s8.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d78.s9" text="Warfarin: In subjects receiving warfarin, no significant change in clotting time was observed when grepafloxacin was coadministered.">
        <entity id="DDI-DrugBank.d78.s9.e0" charOffset="0-7" type="drug" text="Warfarin"/>
        <entity id="DDI-DrugBank.d78.s9.e1" charOffset="32-39"
            type="drug" text="warfarin"/>
        <entity id="DDI-DrugBank.d78.s9.e2" charOffset="99-111"
            type="drug" text="grepafloxacin"/>
        <pair id="DDI-DrugBank.d78.s9.p0" e1="DDI-DrugBank.d78.s9.e0"
            e2="DDI-DrugBank.d78.s9.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s9.p1" e1="DDI-DrugBank.d78.s9.e0"
            e2="DDI-DrugBank.d78.s9.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s9.p2" e1="DDI-DrugBank.d78.s9.e1"
            e2="DDI-DrugBank.d78.s9.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d78.s10" text="However, because some quinolones have been reported to enhance the effects of warfarin or its derivatives, prothrombin time or other suitable anticoagulation test should be monitored closely if a quinolone antimicrobial is administered with warfarin or its derivatives.">
        <entity id="DDI-DrugBank.d78.s10.e0" charOffset="22-31"
            type="group" text="quinolones"/>
        <entity id="DDI-DrugBank.d78.s10.e1" charOffset="78-85"
            type="drug" text="warfarin"/>
        <entity id="DDI-DrugBank.d78.s10.e2" charOffset="196-218"
            type="group" text="quinolone antimicrobial"/>
        <entity id="DDI-DrugBank.d78.s10.e3" charOffset="241-248"
            type="drug" text="warfarin"/>
        <pair id="DDI-DrugBank.d78.s10.p0" e1="DDI-DrugBank.d78.s10.e0"
            e2="DDI-DrugBank.d78.s10.e1" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d78.s10.p1" e1="DDI-DrugBank.d78.s10.e0"
            e2="DDI-DrugBank.d78.s10.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s10.p2" e1="DDI-DrugBank.d78.s10.e0"
            e2="DDI-DrugBank.d78.s10.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s10.p3" e1="DDI-DrugBank.d78.s10.e1"
            e2="DDI-DrugBank.d78.s10.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s10.p4" e1="DDI-DrugBank.d78.s10.e1"
            e2="DDI-DrugBank.d78.s10.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s10.p5" e1="DDI-DrugBank.d78.s10.e2"
            e2="DDI-DrugBank.d78.s10.e3" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d78.s11" text="Drugs Metabolized by Cytochrome P450 Enzymes The drug interaction study evaluating the effect of grepafloxacin on theophylline indicates that grepafloxacin inhibits theophylline metabolism, which is mediated by CYP1A2.">
        <entity id="DDI-DrugBank.d78.s11.e0" charOffset="97-109"
            type="drug" text="grepafloxacin"/>
        <entity id="DDI-DrugBank.d78.s11.e1" charOffset="114-125"
            type="drug" text="theophylline"/>
        <entity id="DDI-DrugBank.d78.s11.e2" charOffset="142-154"
            type="drug" text="grepafloxacin"/>
        <entity id="DDI-DrugBank.d78.s11.e3" charOffset="165-176"
            type="drug" text="theophylline"/>
        <pair id="DDI-DrugBank.d78.s11.p0" e1="DDI-DrugBank.d78.s11.e0"
            e2="DDI-DrugBank.d78.s11.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s11.p1" e1="DDI-DrugBank.d78.s11.e0"
            e2="DDI-DrugBank.d78.s11.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s11.p2" e1="DDI-DrugBank.d78.s11.e0"
            e2="DDI-DrugBank.d78.s11.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s11.p3" e1="DDI-DrugBank.d78.s11.e1"
            e2="DDI-DrugBank.d78.s11.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s11.p4" e1="DDI-DrugBank.d78.s11.e1"
            e2="DDI-DrugBank.d78.s11.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s11.p5" e1="DDI-DrugBank.d78.s11.e2"
            e2="DDI-DrugBank.d78.s11.e3" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d78.s12" text="While no clinical studies have been conducted to evaluate the effect of grepafloxacin on the metabolism of C.P.A.">
        <entity id="DDI-DrugBank.d78.s12.e0" charOffset="72-84"
            type="drug" text="grepafloxacin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d78.s13" text="substrates, in vitro data suggest similar effects of grepafloxacin in CYP3A4 mediated metabolism and theophylline metabolism.">
        <entity id="DDI-DrugBank.d78.s13.e0" charOffset="53-65"
            type="drug" text="grepafloxacin"/>
        <entity id="DDI-DrugBank.d78.s13.e1" charOffset="101-112"
            type="drug" text="theophylline"/>
        <pair id="DDI-DrugBank.d78.s13.p0" e1="DDI-DrugBank.d78.s13.e0"
            e2="DDI-DrugBank.d78.s13.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d78.s14" text="In addition, other quinolones have been reported to decrease the CYP3A4-mediated metabolism of cyclosporine.">
        <entity id="DDI-DrugBank.d78.s14.e0" charOffset="19-28"
            type="group" text="quinolones"/>
        <entity id="DDI-DrugBank.d78.s14.e1" charOffset="95-106"
            type="drug" text="cyclosporine"/>
        <pair id="DDI-DrugBank.d78.s14.p0" e1="DDI-DrugBank.d78.s14.e0"
            e2="DDI-DrugBank.d78.s14.e1" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d78.s15" text="Other drugs metabolized by C.P.A."/>
    <sentence id="DDI-DrugBank.d78.s16" text="include terfenadine, astemizole, cisapride, midazolam, and triazolam.">
        <entity id="DDI-DrugBank.d78.s16.e0" charOffset="8-18"
            type="drug" text="terfenadine"/>
        <entity id="DDI-DrugBank.d78.s16.e1" charOffset="21-30"
            type="drug" text="astemizole"/>
        <entity id="DDI-DrugBank.d78.s16.e2" charOffset="33-41"
            type="drug" text="cisapride"/>
        <entity id="DDI-DrugBank.d78.s16.e3" charOffset="44-52"
            type="drug" text="midazolam"/>
        <entity id="DDI-DrugBank.d78.s16.e4" charOffset="59-67"
            type="drug" text="triazolam"/>
        <pair id="DDI-DrugBank.d78.s16.p0" e1="DDI-DrugBank.d78.s16.e0"
            e2="DDI-DrugBank.d78.s16.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s16.p1" e1="DDI-DrugBank.d78.s16.e0"
            e2="DDI-DrugBank.d78.s16.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s16.p2" e1="DDI-DrugBank.d78.s16.e0"
            e2="DDI-DrugBank.d78.s16.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s16.p3" e1="DDI-DrugBank.d78.s16.e0"
            e2="DDI-DrugBank.d78.s16.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s16.p4" e1="DDI-DrugBank.d78.s16.e1"
            e2="DDI-DrugBank.d78.s16.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s16.p5" e1="DDI-DrugBank.d78.s16.e1"
            e2="DDI-DrugBank.d78.s16.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s16.p6" e1="DDI-DrugBank.d78.s16.e1"
            e2="DDI-DrugBank.d78.s16.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s16.p7" e1="DDI-DrugBank.d78.s16.e2"
            e2="DDI-DrugBank.d78.s16.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s16.p8" e1="DDI-DrugBank.d78.s16.e2"
            e2="DDI-DrugBank.d78.s16.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s16.p9" e1="DDI-DrugBank.d78.s16.e3"
            e2="DDI-DrugBank.d78.s16.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d78.s17" text="The clinical relevance of the potential effect of grepafloxacin on the metabolism of C.P.A. substrates is not known.">
        <entity id="DDI-DrugBank.d78.s17.e0" charOffset="50-62"
            type="drug" text="grepafloxacin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d78.s18" text="Patients receiving concurrent administration of substrates of C.P.A. were not excluded from clinical trials of grepafloxacin.">
        <entity id="DDI-DrugBank.d78.s18.e0" charOffset="111-123"
            type="drug" text="grepafloxacin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d78.s19" text="Nonsteroidal Anti-inflammatory Drugs (NSAIDs): The concomitant administration of a nonsteroidal anti inflammatory drug with a quinolone may increase the risks of CNS stimulation and convulsions.">
        <entity id="DDI-DrugBank.d78.s19.e0" charOffset="0-35"
            type="group" text="Nonsteroidal Anti-inflammatory Drugs"/>
        <entity id="DDI-DrugBank.d78.s19.e1" charOffset="38-43"
            type="group" text="NSAIDs"/>
        <entity id="DDI-DrugBank.d78.s19.e2" charOffset="83-117"
            type="group" text="nonsteroidal anti inflammatory drug"/>
        <entity id="DDI-DrugBank.d78.s19.e3" charOffset="126-134"
            type="group" text="quinolone"/>
        <pair id="DDI-DrugBank.d78.s19.p0" e1="DDI-DrugBank.d78.s19.e0"
            e2="DDI-DrugBank.d78.s19.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s19.p1" e1="DDI-DrugBank.d78.s19.e0"
            e2="DDI-DrugBank.d78.s19.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s19.p2" e1="DDI-DrugBank.d78.s19.e0"
            e2="DDI-DrugBank.d78.s19.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s19.p3" e1="DDI-DrugBank.d78.s19.e1"
            e2="DDI-DrugBank.d78.s19.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s19.p4" e1="DDI-DrugBank.d78.s19.e1"
            e2="DDI-DrugBank.d78.s19.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s19.p5" e1="DDI-DrugBank.d78.s19.e2"
            e2="DDI-DrugBank.d78.s19.e3" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d78.s20" text="Antidiabetic Agents: Disturbances of blood glucose, including hyperglycemia and hypoglycemia, have been reported in patients treated concomitantly with quinolones and an antidiabetic agent.">
        <entity id="DDI-DrugBank.d78.s20.e0" charOffset="0-18"
            type="group" text="Antidiabetic Agents"/>
        <entity id="DDI-DrugBank.d78.s20.e1" charOffset="152-161"
            type="group" text="quinolones"/>
        <entity id="DDI-DrugBank.d78.s20.e2" charOffset="170-187"
            type="group" text="antidiabetic agent"/>
        <pair id="DDI-DrugBank.d78.s20.p0" e1="DDI-DrugBank.d78.s20.e0"
            e2="DDI-DrugBank.d78.s20.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s20.p1" e1="DDI-DrugBank.d78.s20.e0"
            e2="DDI-DrugBank.d78.s20.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d78.s20.p2" e1="DDI-DrugBank.d78.s20.e1"
            e2="DDI-DrugBank.d78.s20.e2" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d78.s21" text="Therefore, careful monitoring of blood glucose is recommended when these agents are coadministered."/>
</document>
<document id="DDI-DrugBank.d302">
    <sentence id="DDI-DrugBank.d302.s0" text="http://www.rxlist.com/cgi/generic3/guanethidine_od.htm"/>
</document>
<document id="DDI-DrugBank.d186">
    <sentence id="DDI-DrugBank.d186.s0" text="An encephalopathic syndrome (characterized by weakness, lethargy, fever, tremulousness and confusion, extrapyramidal symptoms, leukocytosis, elevated serum enzymes, BUN, and FBS) followed by irreversible brain damage has occurred in a few patients treated with lithium plus HALDOL.">
        <entity id="DDI-DrugBank.d186.s0.e0" charOffset="261-267"
            type="drug" text="lithium"/>
        <entity id="DDI-DrugBank.d186.s0.e1" charOffset="274-279"
            type="brand" text="HALDOL"/>
        <pair id="DDI-DrugBank.d186.s0.p0" e1="DDI-DrugBank.d186.s0.e0"
            e2="DDI-DrugBank.d186.s0.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d186.s1" text="A causal relationship between these events and the concomitant administration of lithium and HALDOL has not been established;">
        <entity id="DDI-DrugBank.d186.s1.e0" charOffset="81-87"
            type="drug" text="lithium"/>
        <entity id="DDI-DrugBank.d186.s1.e1" charOffset="93-98"
            type="brand" text="HALDOL"/>
        <pair id="DDI-DrugBank.d186.s1.p0" e1="DDI-DrugBank.d186.s1.e0"
            e2="DDI-DrugBank.d186.s1.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d186.s2" text="however, patients receiving such combined therapy should be monitored closely for early evidence of neurological toxicity and treatment discontinued promptly if such signs appear."/>
    <sentence id="DDI-DrugBank.d186.s3" text="As with other antipsychotic agents, it should be noted that HALDOL may be capable of potentiating CNS depressants such as anesthetics, opiates, and alcohol.">
        <entity id="DDI-DrugBank.d186.s3.e0" charOffset="14-33"
            type="group" text="antipsychotic agents"/>
        <entity id="DDI-DrugBank.d186.s3.e1" charOffset="60-65"
            type="brand" text="HALDOL"/>
        <entity id="DDI-DrugBank.d186.s3.e2" charOffset="98-112"
            type="group" text="CNS depressants"/>
        <entity id="DDI-DrugBank.d186.s3.e3" charOffset="122-132"
            type="group" text="anesthetics"/>
        <entity id="DDI-DrugBank.d186.s3.e4" charOffset="135-141"
            type="group" text="opiates"/>
        <entity id="DDI-DrugBank.d186.s3.e5" charOffset="148-154"
            type="drug" text="alcohol"/>
        <pair id="DDI-DrugBank.d186.s3.p0" e1="DDI-DrugBank.d186.s3.e0"
            e2="DDI-DrugBank.d186.s3.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d186.s3.p1" e1="DDI-DrugBank.d186.s3.e0"
            e2="DDI-DrugBank.d186.s3.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d186.s3.p2" e1="DDI-DrugBank.d186.s3.e0"
            e2="DDI-DrugBank.d186.s3.e3" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d186.s3.p3" e1="DDI-DrugBank.d186.s3.e0"
            e2="DDI-DrugBank.d186.s3.e4" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d186.s3.p4" e1="DDI-DrugBank.d186.s3.e0"
            e2="DDI-DrugBank.d186.s3.e5" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d186.s3.p5" e1="DDI-DrugBank.d186.s3.e1"
            e2="DDI-DrugBank.d186.s3.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d186.s3.p6" e1="DDI-DrugBank.d186.s3.e1"
            e2="DDI-DrugBank.d186.s3.e3" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d186.s3.p7" e1="DDI-DrugBank.d186.s3.e1"
            e2="DDI-DrugBank.d186.s3.e4" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d186.s3.p8" e1="DDI-DrugBank.d186.s3.e1"
            e2="DDI-DrugBank.d186.s3.e5" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d186.s3.p9" e1="DDI-DrugBank.d186.s3.e2"
            e2="DDI-DrugBank.d186.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d186.s3.p10" e1="DDI-DrugBank.d186.s3.e2"
            e2="DDI-DrugBank.d186.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d186.s3.p11" e1="DDI-DrugBank.d186.s3.e2"
            e2="DDI-DrugBank.d186.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d186.s3.p12" e1="DDI-DrugBank.d186.s3.e3"
            e2="DDI-DrugBank.d186.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d186.s3.p13" e1="DDI-DrugBank.d186.s3.e3"
            e2="DDI-DrugBank.d186.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d186.s3.p14" e1="DDI-DrugBank.d186.s3.e4"
            e2="DDI-DrugBank.d186.s3.e5" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d186.s4" text="In a study of 12 schizophrenic patients coadministered oral haloperidol and rifampin, plasma haloperidol levels were decreased by a mean of 70% and mean scores on the Brief Psychiatric Rating Scale were increased from baseline.">
        <entity id="DDI-DrugBank.d186.s4.e0" charOffset="60-70"
            type="drug" text="haloperidol"/>
        <entity id="DDI-DrugBank.d186.s4.e1" charOffset="76-83"
            type="drug" text="rifampin"/>
        <entity id="DDI-DrugBank.d186.s4.e2" charOffset="93-103"
            type="drug" text="haloperidol"/>
        <pair id="DDI-DrugBank.d186.s4.p0" e1="DDI-DrugBank.d186.s4.e0"
            e2="DDI-DrugBank.d186.s4.e1" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d186.s4.p1" e1="DDI-DrugBank.d186.s4.e0"
            e2="DDI-DrugBank.d186.s4.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d186.s4.p2" e1="DDI-DrugBank.d186.s4.e1"
            e2="DDI-DrugBank.d186.s4.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d186.s5" text="In 5 other schizophrenic patients treated with oral haloperidol and rifampin, discontinuation of rifampin produced a mean 3.3-fold increase in haloperidol concentrations.">
        <entity id="DDI-DrugBank.d186.s5.e0" charOffset="52-62"
            type="drug" text="haloperidol"/>
        <entity id="DDI-DrugBank.d186.s5.e1" charOffset="68-75"
            type="drug" text="rifampin"/>
        <entity id="DDI-DrugBank.d186.s5.e2" charOffset="97-104"
            type="drug" text="rifampin"/>
        <entity id="DDI-DrugBank.d186.s5.e3" charOffset="143-153"
            type="drug" text="haloperidol"/>
        <pair id="DDI-DrugBank.d186.s5.p0" e1="DDI-DrugBank.d186.s5.e0"
            e2="DDI-DrugBank.d186.s5.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d186.s5.p1" e1="DDI-DrugBank.d186.s5.e0"
            e2="DDI-DrugBank.d186.s5.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d186.s5.p2" e1="DDI-DrugBank.d186.s5.e0"
            e2="DDI-DrugBank.d186.s5.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d186.s5.p3" e1="DDI-DrugBank.d186.s5.e1"
            e2="DDI-DrugBank.d186.s5.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d186.s5.p4" e1="DDI-DrugBank.d186.s5.e1"
            e2="DDI-DrugBank.d186.s5.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d186.s5.p5" e1="DDI-DrugBank.d186.s5.e2"
            e2="DDI-DrugBank.d186.s5.e3" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d186.s6" text="Thus, careful monitoring of clinical status is warranted when rifampin is administered or discontinued in haloperidol-treated patients.">
        <entity id="DDI-DrugBank.d186.s6.e0" charOffset="62-69"
            type="drug" text="rifampin"/>
        <entity id="DDI-DrugBank.d186.s6.e1" charOffset="106-116"
            type="drug" text="haloperidol"/>
        <pair id="DDI-DrugBank.d186.s6.p0" e1="DDI-DrugBank.d186.s6.e0"
            e2="DDI-DrugBank.d186.s6.e1" ddi="true" type="advise"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d514">
    <sentence id="DDI-DrugBank.d514.s0" text="Opioids are strong central nervous system depressants, but regular users develop physiological tolerance allowing gradually increased dosages.">
        <entity id="DDI-DrugBank.d514.s0.e0" charOffset="0-6"
            type="group" text="Opioids"/>
        <entity id="DDI-DrugBank.d514.s0.e1" charOffset="19-52"
            type="group" text="central nervous system depressants"/>
        <pair id="DDI-DrugBank.d514.s0.p0" e1="DDI-DrugBank.d514.s0.e0"
            e2="DDI-DrugBank.d514.s0.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d514.s1" text="In combination with other central nervous system depressants, heroin may still kill even experienced users, particularly if their tolerance to the drug has reduced or the strength of their usual dose has increased.">
        <entity id="DDI-DrugBank.d514.s1.e0" charOffset="26-59"
            type="group" text="central nervous system depressants"/>
        <entity id="DDI-DrugBank.d514.s1.e1" charOffset="62-67"
            type="drug_n" text="heroin"/>
        <pair id="DDI-DrugBank.d514.s1.p0" e1="DDI-DrugBank.d514.s1.e0"
            e2="DDI-DrugBank.d514.s1.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d514.s2" text="Toxicology studies of heroin-related deaths reveal frequent involvement of other central nervous system depressants, including alcohol, benzodiazepines such as diazepam (Valium), and, to a rising degree, methadone.">
        <entity id="DDI-DrugBank.d514.s2.e0" charOffset="22-27"
            type="drug_n" text="heroin"/>
        <entity id="DDI-DrugBank.d514.s2.e1" charOffset="81-114"
            type="group" text="central nervous system depressants"/>
        <entity id="DDI-DrugBank.d514.s2.e2" charOffset="127-133"
            type="drug" text="alcohol"/>
        <entity id="DDI-DrugBank.d514.s2.e3" charOffset="136-150"
            type="group" text="benzodiazepines"/>
        <entity id="DDI-DrugBank.d514.s2.e4" charOffset="160-167"
            type="drug" text="diazepam"/>
        <entity id="DDI-DrugBank.d514.s2.e5" charOffset="170-175"
            type="brand" text="Valium"/>
        <entity id="DDI-DrugBank.d514.s2.e6" charOffset="204-212"
            type="drug" text="methadone"/>
        <pair id="DDI-DrugBank.d514.s2.p0" e1="DDI-DrugBank.d514.s2.e0"
            e2="DDI-DrugBank.d514.s2.e1" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d514.s2.p1" e1="DDI-DrugBank.d514.s2.e0"
            e2="DDI-DrugBank.d514.s2.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d514.s2.p2" e1="DDI-DrugBank.d514.s2.e0"
            e2="DDI-DrugBank.d514.s2.e3" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d514.s2.p3" e1="DDI-DrugBank.d514.s2.e0"
            e2="DDI-DrugBank.d514.s2.e4" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d514.s2.p4" e1="DDI-DrugBank.d514.s2.e0"
            e2="DDI-DrugBank.d514.s2.e5" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d514.s2.p5" e1="DDI-DrugBank.d514.s2.e0"
            e2="DDI-DrugBank.d514.s2.e6" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d514.s2.p6" e1="DDI-DrugBank.d514.s2.e1"
            e2="DDI-DrugBank.d514.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d514.s2.p7" e1="DDI-DrugBank.d514.s2.e1"
            e2="DDI-DrugBank.d514.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d514.s2.p8" e1="DDI-DrugBank.d514.s2.e1"
            e2="DDI-DrugBank.d514.s2.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d514.s2.p9" e1="DDI-DrugBank.d514.s2.e1"
            e2="DDI-DrugBank.d514.s2.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d514.s2.p10" e1="DDI-DrugBank.d514.s2.e1"
            e2="DDI-DrugBank.d514.s2.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d514.s2.p11" e1="DDI-DrugBank.d514.s2.e2"
            e2="DDI-DrugBank.d514.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d514.s2.p12" e1="DDI-DrugBank.d514.s2.e2"
            e2="DDI-DrugBank.d514.s2.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d514.s2.p13" e1="DDI-DrugBank.d514.s2.e2"
            e2="DDI-DrugBank.d514.s2.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d514.s2.p14" e1="DDI-DrugBank.d514.s2.e2"
            e2="DDI-DrugBank.d514.s2.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d514.s2.p15" e1="DDI-DrugBank.d514.s2.e3"
            e2="DDI-DrugBank.d514.s2.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d514.s2.p16" e1="DDI-DrugBank.d514.s2.e3"
            e2="DDI-DrugBank.d514.s2.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d514.s2.p17" e1="DDI-DrugBank.d514.s2.e3"
            e2="DDI-DrugBank.d514.s2.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d514.s2.p18" e1="DDI-DrugBank.d514.s2.e4"
            e2="DDI-DrugBank.d514.s2.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d514.s2.p19" e1="DDI-DrugBank.d514.s2.e4"
            e2="DDI-DrugBank.d514.s2.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d514.s2.p20" e1="DDI-DrugBank.d514.s2.e5"
            e2="DDI-DrugBank.d514.s2.e6" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d514.s3" text="Ironically, benzodiazepines are often used in the treatment of heroin addiction while they cause much more severe withdrawal symptoms.">
        <entity id="DDI-DrugBank.d514.s3.e0" charOffset="12-26"
            type="group" text="benzodiazepines"/>
        <entity id="DDI-DrugBank.d514.s3.e1" charOffset="63-68"
            type="drug" text="heroin"/>
        <pair id="DDI-DrugBank.d514.s3.p0" e1="DDI-DrugBank.d514.s3.e0"
            e2="DDI-DrugBank.d514.s3.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d514.s4" text="Cocaine sometimes proves to be fatal when used in combination with heroin.">
        <entity id="DDI-DrugBank.d514.s4.e0" charOffset="0-6"
            type="drug" text="Cocaine"/>
        <entity id="DDI-DrugBank.d514.s4.e1" charOffset="67-72"
            type="drug_n" text="heroin"/>
        <pair id="DDI-DrugBank.d514.s4.p0" e1="DDI-DrugBank.d514.s4.e0"
            e2="DDI-DrugBank.d514.s4.e1" ddi="true" type="effect"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d17">
    <sentence id="DDI-DrugBank.d17.s0" text="Anticoagulants, oral">
        <entity id="DDI-DrugBank.d17.s0.e0" charOffset="0-13"
            type="group" text="Anticoagulants"/>
    </sentence>
    <sentence id="DDI-DrugBank.d17.s1" text="(Effects may be decreased when used concurrently with thiazide diuretics;">
        <entity id="DDI-DrugBank.d17.s1.e0" charOffset="54-71"
            type="group" text="thiazide diuretics"/>
    </sentence>
    <sentence id="DDI-DrugBank.d17.s2" text="dosage adjustments may be necessary.)"/>
    <sentence id="DDI-DrugBank.d17.s3" text="Antigout medications">
        <entity id="DDI-DrugBank.d17.s3.e0" charOffset="0-19"
            type="group" text="Antigout medications"/>
    </sentence>
    <sentence id="DDI-DrugBank.d17.s4" text="(Thiazide diuretics may raise the level of blood uric acid;">
        <entity id="DDI-DrugBank.d17.s4.e0" charOffset="1-18"
            type="group" text="Thiazide diuretics"/>
    </sentence>
    <sentence id="DDI-DrugBank.d17.s5" text="dosage adjustment of antigout medications may be necessary to control hyperuricemia and gout.)">
        <entity id="DDI-DrugBank.d17.s5.e0" charOffset="21-40"
            type="group" text="antigout medications"/>
    </sentence>
    <sentence id="DDI-DrugBank.d17.s6" text="Antihypertensive medications, other, especially diazoxide, or preanesthetic and anesthetic agents used in surgery or skeletal-muscle relaxants, nondepolarizing, used in surgery">
        <entity id="DDI-DrugBank.d17.s6.e0" charOffset="0-27"
            type="group" text="Antihypertensive medications"/>
        <entity id="DDI-DrugBank.d17.s6.e1" charOffset="48-56"
            type="drug" text="diazoxide"/>
        <entity id="DDI-DrugBank.d17.s6.e2" charOffset="65-74"
            type="group" text="anesthetic"/>
        <entity id="DDI-DrugBank.d17.s6.e3" charOffset="117-141"
            type="group" text="skeletal-muscle relaxants"/>
        <pair id="DDI-DrugBank.d17.s6.p0" e1="DDI-DrugBank.d17.s6.e0"
            e2="DDI-DrugBank.d17.s6.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d17.s6.p1" e1="DDI-DrugBank.d17.s6.e0"
            e2="DDI-DrugBank.d17.s6.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d17.s6.p2" e1="DDI-DrugBank.d17.s6.e0"
            e2="DDI-DrugBank.d17.s6.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d17.s6.p3" e1="DDI-DrugBank.d17.s6.e1"
            e2="DDI-DrugBank.d17.s6.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d17.s6.p4" e1="DDI-DrugBank.d17.s6.e1"
            e2="DDI-DrugBank.d17.s6.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d17.s6.p5" e1="DDI-DrugBank.d17.s6.e2"
            e2="DDI-DrugBank.d17.s6.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d17.s7" text="(Effects may be potentiated when used concurrently with thiazide diuretics;">
        <entity id="DDI-DrugBank.d17.s7.e0" charOffset="56-73"
            type="group" text="thiazide diuretics"/>
    </sentence>
    <sentence id="DDI-DrugBank.d17.s8" text="dosage adjustments may be necessary.)"/>
    <sentence id="DDI-DrugBank.d17.s9" text="Amphotericin B or Corticosteroids or Corticotropin (ACTH)">
        <entity id="DDI-DrugBank.d17.s9.e0" charOffset="0-13"
            type="drug" text="Amphotericin B"/>
        <entity id="DDI-DrugBank.d17.s9.e1" charOffset="18-32"
            type="group" text="Corticosteroids"/>
        <entity id="DDI-DrugBank.d17.s9.e2" charOffset="37-49"
            type="drug" text="Corticotropin"/>
        <entity id="DDI-DrugBank.d17.s9.e3" charOffset="52-55"
            type="drug" text="ACTH"/>
        <pair id="DDI-DrugBank.d17.s9.p0" e1="DDI-DrugBank.d17.s9.e0"
            e2="DDI-DrugBank.d17.s9.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d17.s9.p1" e1="DDI-DrugBank.d17.s9.e0"
            e2="DDI-DrugBank.d17.s9.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d17.s9.p2" e1="DDI-DrugBank.d17.s9.e0"
            e2="DDI-DrugBank.d17.s9.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d17.s9.p3" e1="DDI-DrugBank.d17.s9.e1"
            e2="DDI-DrugBank.d17.s9.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d17.s9.p4" e1="DDI-DrugBank.d17.s9.e1"
            e2="DDI-DrugBank.d17.s9.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d17.s9.p5" e1="DDI-DrugBank.d17.s9.e2"
            e2="DDI-DrugBank.d17.s9.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d17.s10" text="(Concurrent use with thiazide diuretics may intensify electrolyte imbalance, particularly hypokalemia.)">
        <entity id="DDI-DrugBank.d17.s10.e0" charOffset="21-38"
            type="group" text="thiazide diuretics"/>
    </sentence>
    <sentence id="DDI-DrugBank.d17.s11" text="Cardiac glycosides">
        <entity id="DDI-DrugBank.d17.s11.e0" charOffset="0-17"
            type="group" text="Cardiac glycosides"/>
    </sentence>
    <sentence id="DDI-DrugBank.d17.s12" text="(Concurrent use with thiazide diuretics may enhance the possibility of digitalis toxicity associated with hypokalemia.)">
        <entity id="DDI-DrugBank.d17.s12.e0" charOffset="21-38"
            type="group" text="thiazide diuretics"/>
        <entity id="DDI-DrugBank.d17.s12.e1" charOffset="71-79"
            type="group" text="digitalis"/>
        <pair id="DDI-DrugBank.d17.s12.p0" e1="DDI-DrugBank.d17.s12.e0"
            e2="DDI-DrugBank.d17.s12.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d17.s13" text="Colestipol">
        <entity id="DDI-DrugBank.d17.s13.e0" charOffset="0-9"
            type="drug" text="Colestipol"/>
    </sentence>
    <sentence id="DDI-DrugBank.d17.s14" text="(May inhibit gastrointestinal absorption of the thiazide diuretics;">
        <entity id="DDI-DrugBank.d17.s14.e0" charOffset="48-65"
            type="group" text="thiazide diuretics"/>
    </sentence>
    <sentence id="DDI-DrugBank.d17.s15" text="administration 1 hour before or 4 hours after colestipol is recommended.)">
        <entity id="DDI-DrugBank.d17.s15.e0" charOffset="46-55"
            type="drug" text="colestipol"/>
    </sentence>
    <sentence id="DDI-DrugBank.d17.s16" text="Hypoglycemics">
        <entity id="DDI-DrugBank.d17.s16.e0" charOffset="0-12"
            type="group" text="Hypoglycemics"/>
    </sentence>
    <sentence id="DDI-DrugBank.d17.s17" text="(Thiazide diuretics may raise blood glucose levels;">
        <entity id="DDI-DrugBank.d17.s17.e0" charOffset="1-18"
            type="group" text="Thiazide diuretics"/>
    </sentence>
    <sentence id="DDI-DrugBank.d17.s18" text="for adult-onset diabetics, dosage adjustment of hypoglycemic medications may be necessary during and after thiazide diuretic therapy;">
        <entity id="DDI-DrugBank.d17.s18.e0" charOffset="48-71"
            type="group" text="hypoglycemic medications"/>
        <entity id="DDI-DrugBank.d17.s18.e1" charOffset="107-123"
            type="group" text="thiazide diuretic"/>
        <pair id="DDI-DrugBank.d17.s18.p0" e1="DDI-DrugBank.d17.s18.e0"
            e2="DDI-DrugBank.d17.s18.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d17.s19" text="insulin requirements may be increased, decreased, or unchanged.)">
        <entity id="DDI-DrugBank.d17.s19.e0" charOffset="0-6"
            type="drug" text="insulin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d17.s20" text="Lithium salts">
        <entity id="DDI-DrugBank.d17.s20.e0" charOffset="0-6"
            type="drug" text="Lithium"/>
    </sentence>
    <sentence id="DDI-DrugBank.d17.s21" text="(Concurrent use with thiazide diuretics is not recommended, as they may provoke lithium toxicity because of reduced renal clearance.)">
        <entity id="DDI-DrugBank.d17.s21.e0" charOffset="21-38"
            type="group" text="thiazide diuretics"/>
        <entity id="DDI-DrugBank.d17.s21.e1" charOffset="80-86"
            type="drug" text="lithium"/>
        <pair id="DDI-DrugBank.d17.s21.p0" e1="DDI-DrugBank.d17.s21.e0"
            e2="DDI-DrugBank.d17.s21.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d17.s22" text="Methenamine">
        <entity id="DDI-DrugBank.d17.s22.e0" charOffset="0-10"
            type="drug" text="Methenamine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d17.s23" text="(Effectiveness may be decreased when used concurrently with thiazide diuretics because of alkalinization of the urine.)">
        <entity id="DDI-DrugBank.d17.s23.e0" charOffset="60-77"
            type="group" text="thiazide diuretics"/>
    </sentence>
    <sentence id="DDI-DrugBank.d17.s24" text="Nonsteroidal anti-inflammatory agents">
        <entity id="DDI-DrugBank.d17.s24.e0" charOffset="0-36"
            type="group" text="Nonsteroidal anti-inflammatory agents"/>
    </sentence>
    <sentence id="DDI-DrugBank.d17.s25" text="(In some patients, the steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium sparing, and thiazide diuretics.">
        <entity id="DDI-DrugBank.d17.s25.e0" charOffset="23-55"
            type="group" text="steroidal anti-inflammatory agent"/>
        <entity id="DDI-DrugBank.d17.s25.e1"
            charOffset="127-130;165-173" type="group" text="loop diuretics"/>
        <entity id="DDI-DrugBank.d17.s25.e2"
            charOffset="133-149;165-173" type="group" text="potassium sparing diuretics"/>
        <entity id="DDI-DrugBank.d17.s25.e3" charOffset="156-173"
            type="group" text="thiazide diuretics"/>
        <pair id="DDI-DrugBank.d17.s25.p0" e1="DDI-DrugBank.d17.s25.e0"
            e2="DDI-DrugBank.d17.s25.e1" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d17.s25.p1" e1="DDI-DrugBank.d17.s25.e0"
            e2="DDI-DrugBank.d17.s25.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d17.s25.p2" e1="DDI-DrugBank.d17.s25.e0"
            e2="DDI-DrugBank.d17.s25.e3" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d17.s25.p3" e1="DDI-DrugBank.d17.s25.e1"
            e2="DDI-DrugBank.d17.s25.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d17.s25.p4" e1="DDI-DrugBank.d17.s25.e1"
            e2="DDI-DrugBank.d17.s25.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d17.s25.p5" e1="DDI-DrugBank.d17.s25.e2"
            e2="DDI-DrugBank.d17.s25.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d17.s26" text="Therefore, when hydroflumethiazide and nonsteroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.)">
        <entity id="DDI-DrugBank.d17.s26.e0" charOffset="16-33"
            type="drug" text="hydroflumethiazide"/>
        <entity id="DDI-DrugBank.d17.s26.e1" charOffset="39-75"
            type="group" text="nonsteroidal anti-inflammatory agents"/>
        <entity id="DDI-DrugBank.d17.s26.e2" charOffset="182-189"
            type="group" text="diuretic"/>
        <pair id="DDI-DrugBank.d17.s26.p0" e1="DDI-DrugBank.d17.s26.e0"
            e2="DDI-DrugBank.d17.s26.e1" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d17.s26.p1" e1="DDI-DrugBank.d17.s26.e0"
            e2="DDI-DrugBank.d17.s26.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d17.s26.p2" e1="DDI-DrugBank.d17.s26.e1"
            e2="DDI-DrugBank.d17.s26.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d17.s27" text="Norepinephrine">
        <entity id="DDI-DrugBank.d17.s27.e0" charOffset="0-13"
            type="drug" text="Norepinephrine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d17.s28" text="(Thiazides may decrease arterial responsiveness to norepinephrine.">
        <entity id="DDI-DrugBank.d17.s28.e0" charOffset="1-9"
            type="group" text="Thiazides"/>
        <entity id="DDI-DrugBank.d17.s28.e1" charOffset="51-64"
            type="drug" text="norepinephrine"/>
        <pair id="DDI-DrugBank.d17.s28.p0" e1="DDI-DrugBank.d17.s28.e0"
            e2="DDI-DrugBank.d17.s28.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d17.s29" text="This diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use.)"/>
    <sentence id="DDI-DrugBank.d17.s30" text="Tubocurarine">
        <entity id="DDI-DrugBank.d17.s30.e0" charOffset="0-11"
            type="drug" text="Tubocurarine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d17.s31" text="(Thiazide drugs may increase the responsiveness to tubocurarine.)">
        <entity id="DDI-DrugBank.d17.s31.e0" charOffset="1-14"
            type="group" text="Thiazide drugs"/>
        <entity id="DDI-DrugBank.d17.s31.e1" charOffset="51-62"
            type="drug" text="tubocurarine"/>
        <pair id="DDI-DrugBank.d17.s31.p0" e1="DDI-DrugBank.d17.s31.e0"
            e2="DDI-DrugBank.d17.s31.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d17.s32" text="DIAGNOSTIC INTERFERENCE With expected physiologic effects: Blood and urine glucose levels (usually only in patients with a predisposition for glucose intolerance) and Serum bilirubin levels (by displacement from albumin binding) and Serum calcium levels (thiazide diuretics should be discontinued before parathyroid-function tests are carried out) and Serum uric acid levels (may be increased) Serum magnesium, potassium, and sodium levels (may be decreased;">
        <entity id="DDI-DrugBank.d17.s32.e0" charOffset="255-272"
            type="group" text="thiazide diuretics"/>
    </sentence>
    <sentence id="DDI-DrugBank.d17.s33" text="serum magnesium levels may increase in uremic patients) Serum protein-bound iodine (PBI) levels (may be decreased) Thiazides should be discontinued before carrying out tests for parathyroid function.">
        <entity id="DDI-DrugBank.d17.s33.e0" charOffset="115-123"
            type="group" text="Thiazides"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d418">
    <sentence id="DDI-DrugBank.d418.s0" text="No formal drug interaction studies have been conducted with Cyanokit.">
        <entity id="DDI-DrugBank.d418.s0.e0" charOffset="60-67"
            type="brand" text="Cyanokit"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d308">
    <sentence id="DDI-DrugBank.d308.s0" text="THE POTENTIATING ACTION OF HYDROXYZINE MUST BE CONSIDERED WHEN THE DRUG IS USED IN CONJUNCTION WITH CENTRAL NERVOUS SYSTEM DEPRESSANTS SUCH AS NARCOTICS, NON-NARCOTIC ANALGESICS AND BARBITURATES.">
        <entity id="DDI-DrugBank.d308.s0.e0" charOffset="27-37"
            type="drug" text="HYDROXYZINE"/>
        <entity id="DDI-DrugBank.d308.s0.e1" charOffset="100-133"
            type="group" text="CENTRAL NERVOUS SYSTEM DEPRESSANTS"/>
        <entity id="DDI-DrugBank.d308.s0.e2" charOffset="143-151"
            type="group" text="NARCOTICS"/>
        <entity id="DDI-DrugBank.d308.s0.e3" charOffset="154-176"
            type="group" text="NON-NARCOTIC ANALGESICS"/>
        <entity id="DDI-DrugBank.d308.s0.e4" charOffset="182-193"
            type="group" text="BARBITURATES"/>
        <pair id="DDI-DrugBank.d308.s0.p0" e1="DDI-DrugBank.d308.s0.e0"
            e2="DDI-DrugBank.d308.s0.e1" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d308.s0.p1" e1="DDI-DrugBank.d308.s0.e0"
            e2="DDI-DrugBank.d308.s0.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d308.s0.p2" e1="DDI-DrugBank.d308.s0.e0"
            e2="DDI-DrugBank.d308.s0.e3" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d308.s0.p3" e1="DDI-DrugBank.d308.s0.e0"
            e2="DDI-DrugBank.d308.s0.e4" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d308.s0.p4" e1="DDI-DrugBank.d308.s0.e1"
            e2="DDI-DrugBank.d308.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d308.s0.p5" e1="DDI-DrugBank.d308.s0.e1"
            e2="DDI-DrugBank.d308.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d308.s0.p6" e1="DDI-DrugBank.d308.s0.e1"
            e2="DDI-DrugBank.d308.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d308.s0.p7" e1="DDI-DrugBank.d308.s0.e2"
            e2="DDI-DrugBank.d308.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d308.s0.p8" e1="DDI-DrugBank.d308.s0.e2"
            e2="DDI-DrugBank.d308.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d308.s0.p9" e1="DDI-DrugBank.d308.s0.e3"
            e2="DDI-DrugBank.d308.s0.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d308.s1" text="Therefore when central nervous system depressants are administered concomitantly with hydroxyzine their dosage should be reduced.">
        <entity id="DDI-DrugBank.d308.s1.e0" charOffset="15-48"
            type="group" text="central nervous system depressants"/>
        <entity id="DDI-DrugBank.d308.s1.e1" charOffset="86-96"
            type="drug" text="hydroxyzine"/>
        <pair id="DDI-DrugBank.d308.s1.p0" e1="DDI-DrugBank.d308.s1.e0"
            e2="DDI-DrugBank.d308.s1.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d308.s2" text="Since drowsiness may occur with use of this drug, patients should be warned of this possibility and cautioned against driving a car or operating dangerous machinery while taking Atarax.">
        <entity id="DDI-DrugBank.d308.s2.e0" charOffset="178-183"
            type="brand" text="Atarax"/>
    </sentence>
    <sentence id="DDI-DrugBank.d308.s3" text="Patients should be advised against the simultaneous use of other CNS depressant drugs, and cautioned that the effect of alcohol may be increased.">
        <entity id="DDI-DrugBank.d308.s3.e0" charOffset="65-84"
            type="group" text="CNS depressant drugs"/>
        <entity id="DDI-DrugBank.d308.s3.e1" charOffset="120-126"
            type="drug" text="alcohol"/>
        <pair id="DDI-DrugBank.d308.s3.p0" e1="DDI-DrugBank.d308.s3.e0"
            e2="DDI-DrugBank.d308.s3.e1" ddi="false"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d515">
    <sentence id="DDI-DrugBank.d515.s0" text="The physician should be alert for possible combined drug actions, desirable or undesirable, involving ifosfamide even though ifosfamide has been used successfully concurrently with other drugs, including other cytotoxic drugs.">
        <entity id="DDI-DrugBank.d515.s0.e0" charOffset="102-111"
            type="drug" text="ifosfamide"/>
        <entity id="DDI-DrugBank.d515.s0.e1" charOffset="125-134"
            type="drug" text="ifosfamide"/>
        <pair id="DDI-DrugBank.d515.s0.p0" e1="DDI-DrugBank.d515.s0.e0"
            e2="DDI-DrugBank.d515.s0.e1" ddi="false"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d549">
    <sentence id="DDI-DrugBank.d549.s0" text="In studies in normal volunteers, there was no pharmacodynamic interaction between intravenous iloprost and either nifedipine, diltiazem, or captopril.">
        <entity id="DDI-DrugBank.d549.s0.e0" charOffset="94-101"
            type="drug" text="iloprost"/>
        <entity id="DDI-DrugBank.d549.s0.e1" charOffset="114-123"
            type="drug" text="nifedipine"/>
        <entity id="DDI-DrugBank.d549.s0.e2" charOffset="126-134"
            type="drug" text="diltiazem"/>
        <entity id="DDI-DrugBank.d549.s0.e3" charOffset="140-148"
            type="drug" text="captopril"/>
        <pair id="DDI-DrugBank.d549.s0.p0" e1="DDI-DrugBank.d549.s0.e0"
            e2="DDI-DrugBank.d549.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s0.p1" e1="DDI-DrugBank.d549.s0.e0"
            e2="DDI-DrugBank.d549.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s0.p2" e1="DDI-DrugBank.d549.s0.e0"
            e2="DDI-DrugBank.d549.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s0.p3" e1="DDI-DrugBank.d549.s0.e1"
            e2="DDI-DrugBank.d549.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s0.p4" e1="DDI-DrugBank.d549.s0.e1"
            e2="DDI-DrugBank.d549.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s0.p5" e1="DDI-DrugBank.d549.s0.e2"
            e2="DDI-DrugBank.d549.s0.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d549.s1" text="However, iloprost has the potential to increase the hypotensive effect of vasodilators and antihypertensive agents.">
        <entity id="DDI-DrugBank.d549.s1.e0" charOffset="9-16"
            type="drug" text="iloprost"/>
        <entity id="DDI-DrugBank.d549.s1.e1" charOffset="74-85"
            type="group" text="vasodilators"/>
        <entity id="DDI-DrugBank.d549.s1.e2" charOffset="91-113"
            type="group" text="antihypertensive agents"/>
        <pair id="DDI-DrugBank.d549.s1.p0" e1="DDI-DrugBank.d549.s1.e0"
            e2="DDI-DrugBank.d549.s1.e1" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d549.s1.p1" e1="DDI-DrugBank.d549.s1.e0"
            e2="DDI-DrugBank.d549.s1.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d549.s1.p2" e1="DDI-DrugBank.d549.s1.e1"
            e2="DDI-DrugBank.d549.s1.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d549.s2" text="Since iloprost inhibits platelet function, there is a potential for increased risk of bleeding, particularly in patients maintained on anticoagulants.">
        <entity id="DDI-DrugBank.d549.s2.e0" charOffset="6-13"
            type="drug" text="iloprost"/>
        <entity id="DDI-DrugBank.d549.s2.e1" charOffset="135-148"
            type="group" text="anticoagulants"/>
        <pair id="DDI-DrugBank.d549.s2.p0" e1="DDI-DrugBank.d549.s2.e0"
            e2="DDI-DrugBank.d549.s2.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d549.s3" text="During clinical trials, iloprost was used concurrently with anticoagulants, diuretics, cardiac glycosides, calcium channel blockers, analgesics, antipyretics, nonsteroidal antiinflammatories, corticosteroids, and other medications.">
        <entity id="DDI-DrugBank.d549.s3.e0" charOffset="24-31"
            type="drug" text="iloprost"/>
        <entity id="DDI-DrugBank.d549.s3.e1" charOffset="60-73"
            type="group" text="anticoagulants"/>
        <entity id="DDI-DrugBank.d549.s3.e2" charOffset="76-84"
            type="group" text="diuretics"/>
        <entity id="DDI-DrugBank.d549.s3.e3" charOffset="87-104"
            type="group" text="cardiac glycosides"/>
        <entity id="DDI-DrugBank.d549.s3.e4" charOffset="107-130"
            type="group" text="calcium channel blockers"/>
        <entity id="DDI-DrugBank.d549.s3.e5" charOffset="133-142"
            type="group" text="analgesics"/>
        <entity id="DDI-DrugBank.d549.s3.e6" charOffset="145-156"
            type="group" text="antipyretics"/>
        <entity id="DDI-DrugBank.d549.s3.e7" charOffset="159-189"
            type="group" text="nonsteroidal antiinflammatories"/>
        <entity id="DDI-DrugBank.d549.s3.e8" charOffset="192-206"
            type="group" text="corticosteroids"/>
        <pair id="DDI-DrugBank.d549.s3.p0" e1="DDI-DrugBank.d549.s3.e0"
            e2="DDI-DrugBank.d549.s3.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s3.p1" e1="DDI-DrugBank.d549.s3.e0"
            e2="DDI-DrugBank.d549.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s3.p2" e1="DDI-DrugBank.d549.s3.e0"
            e2="DDI-DrugBank.d549.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s3.p3" e1="DDI-DrugBank.d549.s3.e0"
            e2="DDI-DrugBank.d549.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s3.p4" e1="DDI-DrugBank.d549.s3.e0"
            e2="DDI-DrugBank.d549.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s3.p5" e1="DDI-DrugBank.d549.s3.e0"
            e2="DDI-DrugBank.d549.s3.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s3.p6" e1="DDI-DrugBank.d549.s3.e0"
            e2="DDI-DrugBank.d549.s3.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s3.p7" e1="DDI-DrugBank.d549.s3.e0"
            e2="DDI-DrugBank.d549.s3.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s3.p8" e1="DDI-DrugBank.d549.s3.e1"
            e2="DDI-DrugBank.d549.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s3.p9" e1="DDI-DrugBank.d549.s3.e1"
            e2="DDI-DrugBank.d549.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s3.p10" e1="DDI-DrugBank.d549.s3.e1"
            e2="DDI-DrugBank.d549.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s3.p11" e1="DDI-DrugBank.d549.s3.e1"
            e2="DDI-DrugBank.d549.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s3.p12" e1="DDI-DrugBank.d549.s3.e1"
            e2="DDI-DrugBank.d549.s3.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s3.p13" e1="DDI-DrugBank.d549.s3.e1"
            e2="DDI-DrugBank.d549.s3.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s3.p14" e1="DDI-DrugBank.d549.s3.e1"
            e2="DDI-DrugBank.d549.s3.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s3.p15" e1="DDI-DrugBank.d549.s3.e2"
            e2="DDI-DrugBank.d549.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s3.p16" e1="DDI-DrugBank.d549.s3.e2"
            e2="DDI-DrugBank.d549.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s3.p17" e1="DDI-DrugBank.d549.s3.e2"
            e2="DDI-DrugBank.d549.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s3.p18" e1="DDI-DrugBank.d549.s3.e2"
            e2="DDI-DrugBank.d549.s3.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s3.p19" e1="DDI-DrugBank.d549.s3.e2"
            e2="DDI-DrugBank.d549.s3.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s3.p20" e1="DDI-DrugBank.d549.s3.e2"
            e2="DDI-DrugBank.d549.s3.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s3.p21" e1="DDI-DrugBank.d549.s3.e3"
            e2="DDI-DrugBank.d549.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s3.p22" e1="DDI-DrugBank.d549.s3.e3"
            e2="DDI-DrugBank.d549.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s3.p23" e1="DDI-DrugBank.d549.s3.e3"
            e2="DDI-DrugBank.d549.s3.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s3.p24" e1="DDI-DrugBank.d549.s3.e3"
            e2="DDI-DrugBank.d549.s3.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s3.p25" e1="DDI-DrugBank.d549.s3.e3"
            e2="DDI-DrugBank.d549.s3.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s3.p26" e1="DDI-DrugBank.d549.s3.e4"
            e2="DDI-DrugBank.d549.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s3.p27" e1="DDI-DrugBank.d549.s3.e4"
            e2="DDI-DrugBank.d549.s3.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s3.p28" e1="DDI-DrugBank.d549.s3.e4"
            e2="DDI-DrugBank.d549.s3.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s3.p29" e1="DDI-DrugBank.d549.s3.e4"
            e2="DDI-DrugBank.d549.s3.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s3.p30" e1="DDI-DrugBank.d549.s3.e5"
            e2="DDI-DrugBank.d549.s3.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s3.p31" e1="DDI-DrugBank.d549.s3.e5"
            e2="DDI-DrugBank.d549.s3.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s3.p32" e1="DDI-DrugBank.d549.s3.e5"
            e2="DDI-DrugBank.d549.s3.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s3.p33" e1="DDI-DrugBank.d549.s3.e6"
            e2="DDI-DrugBank.d549.s3.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s3.p34" e1="DDI-DrugBank.d549.s3.e6"
            e2="DDI-DrugBank.d549.s3.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d549.s3.p35" e1="DDI-DrugBank.d549.s3.e7"
            e2="DDI-DrugBank.d549.s3.e8" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d549.s4" text="Intravenous infusion of iloprost had no effect on the pharmacokinetics of digoxin.">
        <entity id="DDI-DrugBank.d549.s4.e0" charOffset="24-31"
            type="drug" text="iloprost"/>
        <entity id="DDI-DrugBank.d549.s4.e1" charOffset="74-80"
            type="drug" text="digoxin"/>
        <pair id="DDI-DrugBank.d549.s4.p0" e1="DDI-DrugBank.d549.s4.e0"
            e2="DDI-DrugBank.d549.s4.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d549.s5" text="Acetylsalicylic acid did not alter the clearance (pharmacokinetics) of iloprost.">
        <entity id="DDI-DrugBank.d549.s5.e0" charOffset="0-19"
            type="drug" text="Acetylsalicylic acid"/>
        <entity id="DDI-DrugBank.d549.s5.e1" charOffset="71-78"
            type="drug" text="iloprost"/>
        <pair id="DDI-DrugBank.d549.s5.p0" e1="DDI-DrugBank.d549.s5.e0"
            e2="DDI-DrugBank.d549.s5.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d549.s6" text="Although clinical studies have not been conducted, in vitro studies of iloprost indicate that no relevant inhibition of cytochrome P450 drug metabolism would be expected.">
        <entity id="DDI-DrugBank.d549.s6.e0" charOffset="71-78"
            type="drug" text="iloprost"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d97">
    <sentence id="DDI-DrugBank.d97.s0" text="Indinavir is an inhibitor of the cytochrome P450 isoform CYP3A4.">
        <entity id="DDI-DrugBank.d97.s0.e0" charOffset="0-8" type="drug" text="Indinavir"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s1" text="Coadministration of CRIXIVAN and drugs primarily metabolized by CYP3A4 may result in increased plasma concentrations of the other drug, which could increase or prolong its therapeutic and adverse effects.">
        <entity id="DDI-DrugBank.d97.s1.e0" charOffset="20-27"
            type="brand" text="CRIXIVAN"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s2" text="Indinavir is metabolized by CYP3A4.">
        <entity id="DDI-DrugBank.d97.s2.e0" charOffset="0-8" type="drug" text="Indinavir"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s3" text="Drugs that induce CYP3A4 activity would be expected to increase the clearance of indinavir, resulting in lowered plasma concentrations of indinavir.">
        <entity id="DDI-DrugBank.d97.s3.e0" charOffset="81-89"
            type="drug" text="indinavir"/>
        <entity id="DDI-DrugBank.d97.s3.e1" charOffset="138-146"
            type="drug" text="indinavir"/>
        <pair id="DDI-DrugBank.d97.s3.p0" e1="DDI-DrugBank.d97.s3.e0"
            e2="DDI-DrugBank.d97.s3.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s4" text="Coadministration of CRIXIVAN and other drugs that inhibit CYP3A4 may decrease the clearance of indinavir and may result in increased plasma concentrations of indinavir.">
        <entity id="DDI-DrugBank.d97.s4.e0" charOffset="20-27"
            type="brand" text="CRIXIVAN"/>
        <entity id="DDI-DrugBank.d97.s4.e1" charOffset="95-103"
            type="drug" text="indinavir"/>
        <entity id="DDI-DrugBank.d97.s4.e2" charOffset="158-166"
            type="drug" text="indinavir"/>
        <pair id="DDI-DrugBank.d97.s4.p0" e1="DDI-DrugBank.d97.s4.e0"
            e2="DDI-DrugBank.d97.s4.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s4.p1" e1="DDI-DrugBank.d97.s4.e0"
            e2="DDI-DrugBank.d97.s4.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s4.p2" e1="DDI-DrugBank.d97.s4.e1"
            e2="DDI-DrugBank.d97.s4.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s5" text="Table 8"/>
    <sentence id="DDI-DrugBank.d97.s6" text="Drugs That Should Not Be Coadministered with CRIXIVAN">
        <entity id="DDI-DrugBank.d97.s6.e0" charOffset="45-52"
            type="brand" text="CRIXIVAN"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s7" text="Drug Class: Drug Name Clinical Comment"/>
    <sentence id="DDI-DrugBank.d97.s8" text="Antiarrhythmics: amiodarone">
        <entity id="DDI-DrugBank.d97.s8.e0" charOffset="0-14"
            type="group" text="Antiarrhythmics"/>
        <entity id="DDI-DrugBank.d97.s8.e1" charOffset="17-26"
            type="drug" text="amiodarone"/>
        <pair id="DDI-DrugBank.d97.s8.p0" e1="DDI-DrugBank.d97.s8.e0"
            e2="DDI-DrugBank.d97.s8.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s9" text="CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as cardiac arrhythmias."/>
    <sentence id="DDI-DrugBank.d97.s10" text="Ergot derivatives: dihydroergotamine, ergonovine, ergotamine, methylergonovine">
        <entity id="DDI-DrugBank.d97.s10.e0" charOffset="19-35"
            type="drug" text="dihydroergotamine"/>
        <entity id="DDI-DrugBank.d97.s10.e1" charOffset="38-47"
            type="drug" text="ergonovine"/>
        <entity id="DDI-DrugBank.d97.s10.e2" charOffset="50-59"
            type="drug" text="ergotamine"/>
        <entity id="DDI-DrugBank.d97.s10.e3" charOffset="62-77"
            type="drug" text="methylergonovine"/>
        <pair id="DDI-DrugBank.d97.s10.p0" e1="DDI-DrugBank.d97.s10.e0"
            e2="DDI-DrugBank.d97.s10.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s10.p1" e1="DDI-DrugBank.d97.s10.e0"
            e2="DDI-DrugBank.d97.s10.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s10.p2" e1="DDI-DrugBank.d97.s10.e0"
            e2="DDI-DrugBank.d97.s10.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s10.p3" e1="DDI-DrugBank.d97.s10.e1"
            e2="DDI-DrugBank.d97.s10.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s10.p4" e1="DDI-DrugBank.d97.s10.e1"
            e2="DDI-DrugBank.d97.s10.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s10.p5" e1="DDI-DrugBank.d97.s10.e2"
            e2="DDI-DrugBank.d97.s10.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s11" text="CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues."/>
    <sentence id="DDI-DrugBank.d97.s12" text="Sedative/hypnotics: midazolam, triazolam">
        <entity id="DDI-DrugBank.d97.s12.e0" charOffset="0-7"
            type="group" text="Sedative"/>
        <entity id="DDI-DrugBank.d97.s12.e1" charOffset="9-17"
            type="group" text="hypnotics"/>
        <entity id="DDI-DrugBank.d97.s12.e2" charOffset="20-28"
            type="drug" text="midazolam"/>
        <entity id="DDI-DrugBank.d97.s12.e3" charOffset="31-39"
            type="drug" text="triazolam"/>
        <pair id="DDI-DrugBank.d97.s12.p0" e1="DDI-DrugBank.d97.s12.e0"
            e2="DDI-DrugBank.d97.s12.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s12.p1" e1="DDI-DrugBank.d97.s12.e0"
            e2="DDI-DrugBank.d97.s12.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s12.p2" e1="DDI-DrugBank.d97.s12.e0"
            e2="DDI-DrugBank.d97.s12.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s12.p3" e1="DDI-DrugBank.d97.s12.e1"
            e2="DDI-DrugBank.d97.s12.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s12.p4" e1="DDI-DrugBank.d97.s12.e1"
            e2="DDI-DrugBank.d97.s12.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s12.p5" e1="DDI-DrugBank.d97.s12.e2"
            e2="DDI-DrugBank.d97.s12.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s13" text="CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression."/>
    <sentence id="DDI-DrugBank.d97.s14" text="GI motility agents: cisapride">
        <entity id="DDI-DrugBank.d97.s14.e0" charOffset="20-28"
            type="drug" text="cisapride"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s15" text="CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as cardiac arrhythmias."/>
    <sentence id="DDI-DrugBank.d97.s16" text="Neuroleptic: pimozide">
        <entity id="DDI-DrugBank.d97.s16.e0" charOffset="0-10"
            type="group" text="Neuroleptic"/>
        <entity id="DDI-DrugBank.d97.s16.e1" charOffset="13-20"
            type="drug" text="pimozide"/>
        <pair id="DDI-DrugBank.d97.s16.p0" e1="DDI-DrugBank.d97.s16.e0"
            e2="DDI-DrugBank.d97.s16.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s17" text="CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as cardiac arrhythmias."/>
    <sentence id="DDI-DrugBank.d97.s18" text="Herbal products: St. John s wort (Hypericum perforatum)"/>
    <sentence id="DDI-DrugBank.d97.s19" text="May lead to loss of virologic response and possible resistance to CRIXIVAN or to the class of protease inhibitors.">
        <entity id="DDI-DrugBank.d97.s19.e0" charOffset="66-73"
            type="brand" text="CRIXIVAN"/>
        <entity id="DDI-DrugBank.d97.s19.e1" charOffset="94-112"
            type="group" text="protease inhibitors"/>
        <pair id="DDI-DrugBank.d97.s19.p0" e1="DDI-DrugBank.d97.s19.e0"
            e2="DDI-DrugBank.d97.s19.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s20" text="Antimycobacterial: rifampin">
        <entity id="DDI-DrugBank.d97.s20.e0" charOffset="0-16"
            type="group" text="Antimycobacterial"/>
        <entity id="DDI-DrugBank.d97.s20.e1" charOffset="19-26"
            type="drug" text="rifampin"/>
        <pair id="DDI-DrugBank.d97.s20.p0" e1="DDI-DrugBank.d97.s20.e0"
            e2="DDI-DrugBank.d97.s20.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s21" text="May lead to loss of virologic response and possible resistance to CRIXIVAN or to the class of protease inhibitors or other coadministered antiretroviral agents.">
        <entity id="DDI-DrugBank.d97.s21.e0" charOffset="66-73"
            type="brand" text="CRIXIVAN"/>
        <entity id="DDI-DrugBank.d97.s21.e1" charOffset="94-112"
            type="group" text="protease inhibitors"/>
        <entity id="DDI-DrugBank.d97.s21.e2" charOffset="138-158"
            type="group" text="antiretroviral agents"/>
        <pair id="DDI-DrugBank.d97.s21.p0" e1="DDI-DrugBank.d97.s21.e0"
            e2="DDI-DrugBank.d97.s21.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s21.p1" e1="DDI-DrugBank.d97.s21.e0"
            e2="DDI-DrugBank.d97.s21.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s21.p2" e1="DDI-DrugBank.d97.s21.e1"
            e2="DDI-DrugBank.d97.s21.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s22" text="HMG-CoA Reductase inhibitors: lovastatin, simvastatin">
        <entity id="DDI-DrugBank.d97.s22.e0" charOffset="0-27"
            type="group" text="HMG-CoA Reductase inhibitors"/>
        <entity id="DDI-DrugBank.d97.s22.e1" charOffset="30-39"
            type="drug" text="lovastatin"/>
        <entity id="DDI-DrugBank.d97.s22.e2" charOffset="42-52"
            type="drug" text="simvastatin"/>
        <pair id="DDI-DrugBank.d97.s22.p0" e1="DDI-DrugBank.d97.s22.e0"
            e2="DDI-DrugBank.d97.s22.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s22.p1" e1="DDI-DrugBank.d97.s22.e0"
            e2="DDI-DrugBank.d97.s22.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s22.p2" e1="DDI-DrugBank.d97.s22.e1"
            e2="DDI-DrugBank.d97.s22.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s23" text="Potential for serious reactions such as risk of myopathy including rhabdomyolysis."/>
    <sentence id="DDI-DrugBank.d97.s24" text="Protease inhibitor: atazanavir">
        <entity id="DDI-DrugBank.d97.s24.e0" charOffset="0-17"
            type="group" text="Protease inhibitor"/>
        <entity id="DDI-DrugBank.d97.s24.e1" charOffset="20-29"
            type="drug" text="atazanavir"/>
        <pair id="DDI-DrugBank.d97.s24.p0" e1="DDI-DrugBank.d97.s24.e0"
            e2="DDI-DrugBank.d97.s24.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s25" text="Both CRIXIVAN and atazanavir are associated with indirect (unconjugated) hyperbilirubinemia.">
        <entity id="DDI-DrugBank.d97.s25.e0" charOffset="5-12"
            type="brand" text="CRIXIVAN"/>
        <entity id="DDI-DrugBank.d97.s25.e1" charOffset="18-27"
            type="drug" text="atazanavir"/>
        <pair id="DDI-DrugBank.d97.s25.p0" e1="DDI-DrugBank.d97.s25.e0"
            e2="DDI-DrugBank.d97.s25.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s26" text="Combinations of these drugs have not been studied and coadministration of CRIXIVAN and atazanavir is not recommended.">
        <entity id="DDI-DrugBank.d97.s26.e0" charOffset="74-81"
            type="brand" text="CRIXIVAN"/>
        <entity id="DDI-DrugBank.d97.s26.e1" charOffset="87-96"
            type="drug" text="atazanavir"/>
        <pair id="DDI-DrugBank.d97.s26.p0" e1="DDI-DrugBank.d97.s26.e0"
            e2="DDI-DrugBank.d97.s26.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s27" text="Table 9"/>
    <sentence id="DDI-DrugBank.d97.s28" text="Established and Other Potentially Significant Drug Interactions: Alteration in Dose or Regimen May Be Recommended Based on Drug Interaction Studies or Predicted Interaction"/>
    <sentence id="DDI-DrugBank.d97.s29" text="Drug Name"/>
    <sentence id="DDI-DrugBank.d97.s30" text="Effect"/>
    <sentence id="DDI-DrugBank.d97.s31" text="Clinical Comment"/>
    <sentence id="DDI-DrugBank.d97.s32" text="HIV Antiviral Agents">
        <entity id="DDI-DrugBank.d97.s32.e0" charOffset="0-19"
            type="group" text="HIV Antiviral Agents"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s33" text="Delavirdine">
        <entity id="DDI-DrugBank.d97.s33.e0" charOffset="0-10"
            type="drug" text="Delavirdine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s34" text="indinavir concentration">
        <entity id="DDI-DrugBank.d97.s34.e0" charOffset="0-8"
            type="drug" text="indinavir"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s35" text="Dose reduction of CRIXIVAN to 600 mg every 8 hours should be considered when taking delavirdine 400 mg three times a day.">
        <entity id="DDI-DrugBank.d97.s35.e0" charOffset="18-25"
            type="brand" text="CRIXIVAN"/>
        <entity id="DDI-DrugBank.d97.s35.e1" charOffset="84-94"
            type="drug" text="delavirdine"/>
        <pair id="DDI-DrugBank.d97.s35.p0" e1="DDI-DrugBank.d97.s35.e0"
            e2="DDI-DrugBank.d97.s35.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s36" text="Didanosine">
        <entity id="DDI-DrugBank.d97.s36.e0" charOffset="0-9"
            type="drug" text="Didanosine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s37" text="Indinavir and didanosine formulations containing buffer should be administered at least one hour apart on an empty stomach.">
        <entity id="DDI-DrugBank.d97.s37.e0" charOffset="0-8"
            type="drug" text="Indinavir"/>
        <entity id="DDI-DrugBank.d97.s37.e1" charOffset="14-23"
            type="drug" text="didanosine"/>
        <pair id="DDI-DrugBank.d97.s37.p0" e1="DDI-DrugBank.d97.s37.e0"
            e2="DDI-DrugBank.d97.s37.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s38" text="Efavirenz">
        <entity id="DDI-DrugBank.d97.s38.e0" charOffset="0-8"
            type="drug" text="Efavirenz"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s39" text="indinavir concentration">
        <entity id="DDI-DrugBank.d97.s39.e0" charOffset="0-8"
            type="drug" text="indinavir"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s40" text="The optimal dose of indinavir, when given in combination with efavirenz, is not known.">
        <entity id="DDI-DrugBank.d97.s40.e0" charOffset="20-28"
            type="drug" text="indinavir"/>
        <entity id="DDI-DrugBank.d97.s40.e1" charOffset="62-70"
            type="drug" text="efavirenz"/>
        <pair id="DDI-DrugBank.d97.s40.p0" e1="DDI-DrugBank.d97.s40.e0"
            e2="DDI-DrugBank.d97.s40.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s41" text="Increasing the indinavir dose to 1000 mg every 8 hours does not compensate for the increased indinavir metabolism due to efavirenz.">
        <entity id="DDI-DrugBank.d97.s41.e0" charOffset="15-23"
            type="drug" text="indinavir"/>
        <entity id="DDI-DrugBank.d97.s41.e1" charOffset="93-101"
            type="drug" text="indinavir"/>
        <entity id="DDI-DrugBank.d97.s41.e2" charOffset="121-129"
            type="drug" text="efavirenz"/>
        <pair id="DDI-DrugBank.d97.s41.p0" e1="DDI-DrugBank.d97.s41.e0"
            e2="DDI-DrugBank.d97.s41.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s41.p1" e1="DDI-DrugBank.d97.s41.e0"
            e2="DDI-DrugBank.d97.s41.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s41.p2" e1="DDI-DrugBank.d97.s41.e1"
            e2="DDI-DrugBank.d97.s41.e2" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s42" text="Nelfinavir">
        <entity id="DDI-DrugBank.d97.s42.e0" charOffset="0-9"
            type="drug" text="Nelfinavir"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s43" text="indinavir concentration">
        <entity id="DDI-DrugBank.d97.s43.e0" charOffset="0-8"
            type="drug" text="indinavir"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s44" text="The appropriate doses for this combination, with respect to efficacy and safety, have not been established."/>
    <sentence id="DDI-DrugBank.d97.s45" text="Nevirapine">
        <entity id="DDI-DrugBank.d97.s45.e0" charOffset="0-9"
            type="drug" text="Nevirapine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s46" text="indinavir concentration">
        <entity id="DDI-DrugBank.d97.s46.e0" charOffset="0-8"
            type="drug" text="indinavir"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s47" text="Indinavir concentrations may be decreased in the presence of nevirapine.">
        <entity id="DDI-DrugBank.d97.s47.e0" charOffset="0-8"
            type="drug" text="Indinavir"/>
        <entity id="DDI-DrugBank.d97.s47.e1" charOffset="61-70"
            type="drug" text="nevirapine"/>
        <pair id="DDI-DrugBank.d97.s47.p0" e1="DDI-DrugBank.d97.s47.e0"
            e2="DDI-DrugBank.d97.s47.e1" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s48" text="The appropriate doses for this combination, with respect to efficacy and safety, have not been established."/>
    <sentence id="DDI-DrugBank.d97.s49" text="Ritonavir">
        <entity id="DDI-DrugBank.d97.s49.e0" charOffset="0-8"
            type="drug" text="Ritonavir"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s50" text="indinavir concentration   ritonavir concentration">
        <entity id="DDI-DrugBank.d97.s50.e0" charOffset="0-8"
            type="drug" text="indinavir"/>
        <entity id="DDI-DrugBank.d97.s50.e1" charOffset="26-34"
            type="drug" text="ritonavir"/>
        <pair id="DDI-DrugBank.d97.s50.p0" e1="DDI-DrugBank.d97.s50.e0"
            e2="DDI-DrugBank.d97.s50.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s51" text="The appropriate doses for this combination, with respect to efficacy and safety, have not been established."/>
    <sentence id="DDI-DrugBank.d97.s52" text="Preliminary clinical data suggest that the incidence of nephrolithiasis is higher in patients receiving indinavir in combination with ritonavir than those receiving CRIXIVAN 800 mg q8h.">
        <entity id="DDI-DrugBank.d97.s52.e0" charOffset="104-112"
            type="drug" text="indinavir"/>
        <entity id="DDI-DrugBank.d97.s52.e1" charOffset="134-142"
            type="drug" text="ritonavir"/>
        <entity id="DDI-DrugBank.d97.s52.e2" charOffset="165-172"
            type="brand" text="CRIXIVAN"/>
        <pair id="DDI-DrugBank.d97.s52.p0" e1="DDI-DrugBank.d97.s52.e0"
            e2="DDI-DrugBank.d97.s52.e1" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d97.s52.p1" e1="DDI-DrugBank.d97.s52.e0"
            e2="DDI-DrugBank.d97.s52.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s52.p2" e1="DDI-DrugBank.d97.s52.e1"
            e2="DDI-DrugBank.d97.s52.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s53" text="Saquinavir">
        <entity id="DDI-DrugBank.d97.s53.e0" charOffset="0-9"
            type="drug" text="Saquinavir"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s54" text="saquinavir concentration">
        <entity id="DDI-DrugBank.d97.s54.e0" charOffset="0-9"
            type="drug" text="saquinavir"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s55" text="The appropriate doses for this combination, with respect to efficacy and safety, have not been established."/>
    <sentence id="DDI-DrugBank.d97.s56" text="Other Agents"/>
    <sentence id="DDI-DrugBank.d97.s57" text="Antiarrhythmics: bepridil, lidocaine (systemic) and quinidine">
        <entity id="DDI-DrugBank.d97.s57.e0" charOffset="0-14"
            type="group" text="Antiarrhythmics"/>
        <entity id="DDI-DrugBank.d97.s57.e1" charOffset="17-24"
            type="drug" text="bepridil"/>
        <entity id="DDI-DrugBank.d97.s57.e2" charOffset="27-35"
            type="drug" text="lidocaine"/>
        <entity id="DDI-DrugBank.d97.s57.e3" charOffset="52-60"
            type="drug" text="quinidine"/>
        <pair id="DDI-DrugBank.d97.s57.p0" e1="DDI-DrugBank.d97.s57.e0"
            e2="DDI-DrugBank.d97.s57.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s57.p1" e1="DDI-DrugBank.d97.s57.e0"
            e2="DDI-DrugBank.d97.s57.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s57.p2" e1="DDI-DrugBank.d97.s57.e0"
            e2="DDI-DrugBank.d97.s57.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s57.p3" e1="DDI-DrugBank.d97.s57.e1"
            e2="DDI-DrugBank.d97.s57.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s57.p4" e1="DDI-DrugBank.d97.s57.e1"
            e2="DDI-DrugBank.d97.s57.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s57.p5" e1="DDI-DrugBank.d97.s57.e2"
            e2="DDI-DrugBank.d97.s57.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s58" text="antiarrhythmic agents concentration">
        <entity id="DDI-DrugBank.d97.s58.e0" charOffset="0-20"
            type="group" text="antiarrhythmic agents"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s59" text="Caution is warranted and therapeutic concentration monitoring is recommended for antiarrhythmics when coadministered with CRIXIVAN.">
        <entity id="DDI-DrugBank.d97.s59.e0" charOffset="81-95"
            type="group" text="antiarrhythmics"/>
        <entity id="DDI-DrugBank.d97.s59.e1" charOffset="122-129"
            type="brand" text="CRIXIVAN"/>
        <pair id="DDI-DrugBank.d97.s59.p0" e1="DDI-DrugBank.d97.s59.e0"
            e2="DDI-DrugBank.d97.s59.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s60" text="Anticonvulsants: carbamazepine, phenobarbital, phenytoin">
        <entity id="DDI-DrugBank.d97.s60.e0" charOffset="0-14"
            type="group" text="Anticonvulsants"/>
        <entity id="DDI-DrugBank.d97.s60.e1" charOffset="17-29"
            type="drug" text="carbamazepine"/>
        <entity id="DDI-DrugBank.d97.s60.e2" charOffset="32-44"
            type="drug" text="phenobarbital"/>
        <entity id="DDI-DrugBank.d97.s60.e3" charOffset="47-55"
            type="drug" text="phenytoin"/>
        <pair id="DDI-DrugBank.d97.s60.p0" e1="DDI-DrugBank.d97.s60.e0"
            e2="DDI-DrugBank.d97.s60.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s60.p1" e1="DDI-DrugBank.d97.s60.e0"
            e2="DDI-DrugBank.d97.s60.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s60.p2" e1="DDI-DrugBank.d97.s60.e0"
            e2="DDI-DrugBank.d97.s60.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s60.p3" e1="DDI-DrugBank.d97.s60.e1"
            e2="DDI-DrugBank.d97.s60.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s60.p4" e1="DDI-DrugBank.d97.s60.e1"
            e2="DDI-DrugBank.d97.s60.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s60.p5" e1="DDI-DrugBank.d97.s60.e2"
            e2="DDI-DrugBank.d97.s60.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s61" text="indinavir concentration">
        <entity id="DDI-DrugBank.d97.s61.e0" charOffset="0-8"
            type="drug" text="indinavir"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s62" text="Use with caution."/>
    <sentence id="DDI-DrugBank.d97.s63" text="CRIXIVAN may not be effective due to decreased indinavir concentrations in patients taking these agents concomitantly.">
        <entity id="DDI-DrugBank.d97.s63.e0" charOffset="0-7"
            type="brand" text="CRIXIVAN"/>
        <entity id="DDI-DrugBank.d97.s63.e1" charOffset="47-55"
            type="drug" text="indinavir"/>
        <pair id="DDI-DrugBank.d97.s63.p0" e1="DDI-DrugBank.d97.s63.e0"
            e2="DDI-DrugBank.d97.s63.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s64" text="Calcium Channel Blockers, Dihydropyridine: e.g., felodipine, nifedipine, nicardipine">
        <entity id="DDI-DrugBank.d97.s64.e0" charOffset="0-23"
            type="group" text="Calcium Channel Blockers"/>
        <entity id="DDI-DrugBank.d97.s64.e1" charOffset="26-40"
            type="group" text="Dihydropyridine"/>
        <entity id="DDI-DrugBank.d97.s64.e2" charOffset="49-58"
            type="drug" text="felodipine"/>
        <entity id="DDI-DrugBank.d97.s64.e3" charOffset="61-70"
            type="drug" text="nifedipine"/>
        <entity id="DDI-DrugBank.d97.s64.e4" charOffset="73-83"
            type="drug" text="nicardipine"/>
        <pair id="DDI-DrugBank.d97.s64.p0" e1="DDI-DrugBank.d97.s64.e0"
            e2="DDI-DrugBank.d97.s64.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s64.p1" e1="DDI-DrugBank.d97.s64.e0"
            e2="DDI-DrugBank.d97.s64.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s64.p2" e1="DDI-DrugBank.d97.s64.e0"
            e2="DDI-DrugBank.d97.s64.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s64.p3" e1="DDI-DrugBank.d97.s64.e0"
            e2="DDI-DrugBank.d97.s64.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s64.p4" e1="DDI-DrugBank.d97.s64.e1"
            e2="DDI-DrugBank.d97.s64.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s64.p5" e1="DDI-DrugBank.d97.s64.e1"
            e2="DDI-DrugBank.d97.s64.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s64.p6" e1="DDI-DrugBank.d97.s64.e1"
            e2="DDI-DrugBank.d97.s64.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s64.p7" e1="DDI-DrugBank.d97.s64.e2"
            e2="DDI-DrugBank.d97.s64.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s64.p8" e1="DDI-DrugBank.d97.s64.e2"
            e2="DDI-DrugBank.d97.s64.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s64.p9" e1="DDI-DrugBank.d97.s64.e3"
            e2="DDI-DrugBank.d97.s64.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s65" text="dihydropyridine calcium channel blockers concentration">
        <entity id="DDI-DrugBank.d97.s65.e0" charOffset="0-39"
            type="group" text="dihydropyridine calcium channel blockers"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s66" text="Caution is warranted and clinical monitoring of patients is recommended."/>
    <sentence id="DDI-DrugBank.d97.s67" text="Clarithromycin">
        <entity id="DDI-DrugBank.d97.s67.e0" charOffset="0-13"
            type="drug" text="Clarithromycin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s68" text="clarithromycin concentration   indinavir concentration">
        <entity id="DDI-DrugBank.d97.s68.e0" charOffset="0-13"
            type="drug" text="clarithromycin"/>
        <entity id="DDI-DrugBank.d97.s68.e1" charOffset="31-39"
            type="drug" text="indinavir"/>
        <pair id="DDI-DrugBank.d97.s68.p0" e1="DDI-DrugBank.d97.s68.e0"
            e2="DDI-DrugBank.d97.s68.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s69" text="The appropriate doses for this combination, with respect to efficacy and safety, have not been established."/>
    <sentence id="DDI-DrugBank.d97.s70" text="HMG-CoA Reductase Inhibitor: atorvastatin">
        <entity id="DDI-DrugBank.d97.s70.e0" charOffset="0-26"
            type="group" text="HMG-CoA Reductase Inhibitor"/>
        <entity id="DDI-DrugBank.d97.s70.e1" charOffset="29-40"
            type="drug" text="atorvastatin"/>
        <pair id="DDI-DrugBank.d97.s70.p0" e1="DDI-DrugBank.d97.s70.e0"
            e2="DDI-DrugBank.d97.s70.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s71" text="atorvastatin concentration">
        <entity id="DDI-DrugBank.d97.s71.e0" charOffset="0-11"
            type="drug" text="atorvastatin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s72" text="Use lowest possible dose of atorvastatin with careful monitoring, or consider HMG-CoA reductase inhibitors that are not primarily metabolized by CYP3A4, such as pravastatin, fluvastatin, or rosuvastatin in combination with CRIXIVAN.">
        <entity id="DDI-DrugBank.d97.s72.e0" charOffset="28-39"
            type="drug" text="atorvastatin"/>
        <entity id="DDI-DrugBank.d97.s72.e1" charOffset="78-105"
            type="group" text="HMG-CoA reductase inhibitors"/>
        <entity id="DDI-DrugBank.d97.s72.e2" charOffset="161-171"
            type="drug" text="pravastatin"/>
        <entity id="DDI-DrugBank.d97.s72.e3" charOffset="174-184"
            type="drug" text="fluvastatin"/>
        <entity id="DDI-DrugBank.d97.s72.e4" charOffset="190-201"
            type="drug" text="rosuvastatin"/>
        <entity id="DDI-DrugBank.d97.s72.e5" charOffset="223-230"
            type="brand" text="CRIXIVAN"/>
        <pair id="DDI-DrugBank.d97.s72.p0" e1="DDI-DrugBank.d97.s72.e0"
            e2="DDI-DrugBank.d97.s72.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s72.p1" e1="DDI-DrugBank.d97.s72.e0"
            e2="DDI-DrugBank.d97.s72.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s72.p2" e1="DDI-DrugBank.d97.s72.e0"
            e2="DDI-DrugBank.d97.s72.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s72.p3" e1="DDI-DrugBank.d97.s72.e0"
            e2="DDI-DrugBank.d97.s72.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s72.p4" e1="DDI-DrugBank.d97.s72.e0"
            e2="DDI-DrugBank.d97.s72.e5" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d97.s72.p5" e1="DDI-DrugBank.d97.s72.e1"
            e2="DDI-DrugBank.d97.s72.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s72.p6" e1="DDI-DrugBank.d97.s72.e1"
            e2="DDI-DrugBank.d97.s72.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s72.p7" e1="DDI-DrugBank.d97.s72.e1"
            e2="DDI-DrugBank.d97.s72.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s72.p8" e1="DDI-DrugBank.d97.s72.e1"
            e2="DDI-DrugBank.d97.s72.e5" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d97.s72.p9" e1="DDI-DrugBank.d97.s72.e2"
            e2="DDI-DrugBank.d97.s72.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s72.p10" e1="DDI-DrugBank.d97.s72.e2"
            e2="DDI-DrugBank.d97.s72.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s72.p11" e1="DDI-DrugBank.d97.s72.e2"
            e2="DDI-DrugBank.d97.s72.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s72.p12" e1="DDI-DrugBank.d97.s72.e3"
            e2="DDI-DrugBank.d97.s72.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s72.p13" e1="DDI-DrugBank.d97.s72.e3"
            e2="DDI-DrugBank.d97.s72.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s72.p14" e1="DDI-DrugBank.d97.s72.e4"
            e2="DDI-DrugBank.d97.s72.e5" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s73" text="Immunosuppressants: cyclosporine, tacrolimus, sirolimus">
        <entity id="DDI-DrugBank.d97.s73.e0" charOffset="0-17"
            type="group" text="Immunosuppressants"/>
        <entity id="DDI-DrugBank.d97.s73.e1" charOffset="20-31"
            type="drug" text="cyclosporine"/>
        <entity id="DDI-DrugBank.d97.s73.e2" charOffset="34-43"
            type="drug" text="tacrolimus"/>
        <entity id="DDI-DrugBank.d97.s73.e3" charOffset="46-54"
            type="drug" text="sirolimus"/>
        <pair id="DDI-DrugBank.d97.s73.p0" e1="DDI-DrugBank.d97.s73.e0"
            e2="DDI-DrugBank.d97.s73.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s73.p1" e1="DDI-DrugBank.d97.s73.e0"
            e2="DDI-DrugBank.d97.s73.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s73.p2" e1="DDI-DrugBank.d97.s73.e0"
            e2="DDI-DrugBank.d97.s73.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s73.p3" e1="DDI-DrugBank.d97.s73.e1"
            e2="DDI-DrugBank.d97.s73.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s73.p4" e1="DDI-DrugBank.d97.s73.e1"
            e2="DDI-DrugBank.d97.s73.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s73.p5" e1="DDI-DrugBank.d97.s73.e2"
            e2="DDI-DrugBank.d97.s73.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s74" text="immunosuppressant agents concentration">
        <entity id="DDI-DrugBank.d97.s74.e0" charOffset="0-23"
            type="group" text="immunosuppressant agents"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s75" text="Plasma concentrations may be increased by CRIXIVAN.">
        <entity id="DDI-DrugBank.d97.s75.e0" charOffset="42-49"
            type="brand" text="CRIXIVAN"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s76" text="Itraconazole">
        <entity id="DDI-DrugBank.d97.s76.e0" charOffset="0-11"
            type="drug" text="Itraconazole"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s77" text="indinavir concentration">
        <entity id="DDI-DrugBank.d97.s77.e0" charOffset="0-8"
            type="drug" text="indinavir"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s78" text="Dose reduction of CRIXIVAN to 600 mg every 8 hours is recommended when administering itraconazole concurrently.">
        <entity id="DDI-DrugBank.d97.s78.e0" charOffset="18-25"
            type="brand" text="CRIXIVAN"/>
        <entity id="DDI-DrugBank.d97.s78.e1" charOffset="85-96"
            type="drug" text="itraconazole"/>
        <pair id="DDI-DrugBank.d97.s78.p0" e1="DDI-DrugBank.d97.s78.e0"
            e2="DDI-DrugBank.d97.s78.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s79" text="Ketoconazole">
        <entity id="DDI-DrugBank.d97.s79.e0" charOffset="0-11"
            type="drug" text="Ketoconazole"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s80" text="indinavir concentration">
        <entity id="DDI-DrugBank.d97.s80.e0" charOffset="0-8"
            type="drug" text="indinavir"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s81" text="Dose reduction of CRIXIVAN to 600 mg every 8 hours should be considered.">
        <entity id="DDI-DrugBank.d97.s81.e0" charOffset="18-25"
            type="brand" text="CRIXIVAN"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s82" text="Rifabutin">
        <entity id="DDI-DrugBank.d97.s82.e0" charOffset="0-8"
            type="drug" text="Rifabutin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s83" text="indinavir concentration   rifabutin concentration">
        <entity id="DDI-DrugBank.d97.s83.e0" charOffset="0-8"
            type="drug" text="indinavir"/>
        <entity id="DDI-DrugBank.d97.s83.e1" charOffset="26-34"
            type="drug" text="rifabutin"/>
        <pair id="DDI-DrugBank.d97.s83.p0" e1="DDI-DrugBank.d97.s83.e0"
            e2="DDI-DrugBank.d97.s83.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s84" text="Dose reduction of rifabutin to half the standard dose and a dose increase of CRIXIVAN to 1000 mg (three 333-mg capsules) every 8 hours are recommended when rifabutin and CRIXIVAN are coadministered.">
        <entity id="DDI-DrugBank.d97.s84.e0" charOffset="18-26"
            type="drug" text="rifabutin"/>
        <entity id="DDI-DrugBank.d97.s84.e1" charOffset="77-84"
            type="brand" text="CRIXIVAN"/>
        <entity id="DDI-DrugBank.d97.s84.e2" charOffset="156-164"
            type="drug" text="rifabutin"/>
        <entity id="DDI-DrugBank.d97.s84.e3" charOffset="170-177"
            type="brand" text="CRIXIVAN"/>
        <pair id="DDI-DrugBank.d97.s84.p0" e1="DDI-DrugBank.d97.s84.e0"
            e2="DDI-DrugBank.d97.s84.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s84.p1" e1="DDI-DrugBank.d97.s84.e0"
            e2="DDI-DrugBank.d97.s84.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s84.p2" e1="DDI-DrugBank.d97.s84.e0"
            e2="DDI-DrugBank.d97.s84.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s84.p3" e1="DDI-DrugBank.d97.s84.e1"
            e2="DDI-DrugBank.d97.s84.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s84.p4" e1="DDI-DrugBank.d97.s84.e1"
            e2="DDI-DrugBank.d97.s84.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d97.s84.p5" e1="DDI-DrugBank.d97.s84.e2"
            e2="DDI-DrugBank.d97.s84.e3" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s85" text="Sildenafil">
        <entity id="DDI-DrugBank.d97.s85.e0" charOffset="0-9"
            type="drug" text="Sildenafil"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s86" text="sildenafil concentration">
        <entity id="DDI-DrugBank.d97.s86.e0" charOffset="0-9"
            type="drug" text="sildenafil"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s87" text="Sildenafil dose should not exceed a maximum of 25 mg in a 48- hour period in patients receiving concomitant indinavir therapy.">
        <entity id="DDI-DrugBank.d97.s87.e0" charOffset="0-9"
            type="drug" text="Sildenafil"/>
        <entity id="DDI-DrugBank.d97.s87.e1" charOffset="108-116"
            type="drug" text="indinavir"/>
        <pair id="DDI-DrugBank.d97.s87.p0" e1="DDI-DrugBank.d97.s87.e0"
            e2="DDI-DrugBank.d97.s87.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s88" text="Tadalafil">
        <entity id="DDI-DrugBank.d97.s88.e0" charOffset="0-8"
            type="drug" text="Tadalafil"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s89" text="tadalafil concentration">
        <entity id="DDI-DrugBank.d97.s89.e0" charOffset="0-8"
            type="drug" text="tadalafil"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s90" text="Tadalafil dose should not exceed a maximum of 10 mg in a 72- hour period in patients receiving concomitant indinavir therapy.">
        <entity id="DDI-DrugBank.d97.s90.e0" charOffset="0-8"
            type="drug" text="Tadalafil"/>
        <entity id="DDI-DrugBank.d97.s90.e1" charOffset="107-115"
            type="drug" text="indinavir"/>
        <pair id="DDI-DrugBank.d97.s90.p0" e1="DDI-DrugBank.d97.s90.e0"
            e2="DDI-DrugBank.d97.s90.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s91" text="Vardenafil">
        <entity id="DDI-DrugBank.d97.s91.e0" charOffset="0-9"
            type="drug" text="Vardenafil"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s92" text="vardenafil concentration">
        <entity id="DDI-DrugBank.d97.s92.e0" charOffset="0-9"
            type="drug" text="vardenafil"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s93" text="Vardenafil dose should not exceed a maximum of 2.5 mg in a 24-hour period in patients receiving concomitant indinavir therapy.">
        <entity id="DDI-DrugBank.d97.s93.e0" charOffset="0-9"
            type="drug" text="Vardenafil"/>
        <entity id="DDI-DrugBank.d97.s93.e1" charOffset="108-116"
            type="drug" text="indinavir"/>
        <pair id="DDI-DrugBank.d97.s93.p0" e1="DDI-DrugBank.d97.s93.e0"
            e2="DDI-DrugBank.d97.s93.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d97.s94" text="Note:"/>
    <sentence id="DDI-DrugBank.d97.s95" text="= increase;"/>
    <sentence id="DDI-DrugBank.d97.s96" text="= decrease"/>
    <sentence id="DDI-DrugBank.d97.s97" text=""/>
</document>
<document id="DDI-DrugBank.d433">
    <sentence id="DDI-DrugBank.d433.s0" text="No formal drug interaction studies have been conducted with Rebif .">
        <entity id="DDI-DrugBank.d433.s0.e0" charOffset="60-64"
            type="brand" text="Rebif"/>
    </sentence>
    <sentence id="DDI-DrugBank.d433.s1" text="Due to its potential to cause neutropenia and lymphopenia, proper monitoring of patients is required if Rebif  is given in combination with myelosuppressive agents.">
        <entity id="DDI-DrugBank.d433.s1.e0" charOffset="104-108"
            type="brand" text="Rebif"/>
    </sentence>
    <sentence id="DDI-DrugBank.d433.s2" text="Also, the potential for hepatic injury should be considered when Rebif  is used in combination with other products associated with hepatic injury, or when new agents are added to the regimen of patients already on Rebif .">
        <entity id="DDI-DrugBank.d433.s2.e0" charOffset="65-69"
            type="brand" text="Rebif"/>
        <entity id="DDI-DrugBank.d433.s2.e1" charOffset="214-218"
            type="brand" text="Rebif"/>
        <pair id="DDI-DrugBank.d433.s2.p0" e1="DDI-DrugBank.d433.s2.e0"
            e2="DDI-DrugBank.d433.s2.e1" ddi="false"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d227">
    <sentence id="DDI-DrugBank.d227.s0" text="Isoflurane potentiates the muscle relaxant effect of all muscle relaxants, most notably nondepolarizing muscle relaxants, and MAC (minimum alveolar concentration) is reduced by concomitant administration of N 2O.">
        <entity id="DDI-DrugBank.d227.s0.e0" charOffset="0-9"
            type="drug" text="Isoflurane"/>
        <entity id="DDI-DrugBank.d227.s0.e1" charOffset="57-72"
            type="group" text="muscle relaxants"/>
        <entity id="DDI-DrugBank.d227.s0.e2" charOffset="88-119"
            type="group" text="nondepolarizing muscle relaxants"/>
        <pair id="DDI-DrugBank.d227.s0.p0" e1="DDI-DrugBank.d227.s0.e0"
            e2="DDI-DrugBank.d227.s0.e1" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d227.s0.p1" e1="DDI-DrugBank.d227.s0.e0"
            e2="DDI-DrugBank.d227.s0.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d227.s0.p2" e1="DDI-DrugBank.d227.s0.e1"
            e2="DDI-DrugBank.d227.s0.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d227.s1" text="See CLINICAL PHARMACOLOGY."/>
</document>
<document id="DDI-DrugBank.d465">
    <sentence id="DDI-DrugBank.d465.s0" text="The vasodilating effects of isosorbide dinitrate may be additive with those of other vasodilators.">
        <entity id="DDI-DrugBank.d465.s0.e0" charOffset="28-47"
            type="drug" text="isosorbide dinitrate"/>
        <entity id="DDI-DrugBank.d465.s0.e1" charOffset="85-96"
            type="group" text="vasodilators"/>
        <pair id="DDI-DrugBank.d465.s0.p0" e1="DDI-DrugBank.d465.s0.e0"
            e2="DDI-DrugBank.d465.s0.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d465.s1" text="Alcohol, in particular, has been found to exhibit additive effects of this variety.">
        <entity id="DDI-DrugBank.d465.s1.e0" charOffset="0-6"
            type="drug" text="Alcohol"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d163">
    <sentence id="DDI-DrugBank.d163.s0" text="Vitamin A: Because of the relationship of Accutane to vitamin A, patients should be advised against taking vitamin supplements containing vitamin A to avoid additive toxic effects">
        <entity id="DDI-DrugBank.d163.s0.e0" charOffset="0-8"
            type="group" text="Vitamin A"/>
        <entity id="DDI-DrugBank.d163.s0.e1" charOffset="42-49"
            type="brand" text="Accutane"/>
        <entity id="DDI-DrugBank.d163.s0.e2" charOffset="54-62"
            type="group" text="vitamin A"/>
        <entity id="DDI-DrugBank.d163.s0.e3" charOffset="107-125"
            type="group" text="vitamin supplements"/>
        <entity id="DDI-DrugBank.d163.s0.e4" charOffset="138-146"
            type="group" text="vitamin A"/>
        <pair id="DDI-DrugBank.d163.s0.p0" e1="DDI-DrugBank.d163.s0.e0"
            e2="DDI-DrugBank.d163.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d163.s0.p1" e1="DDI-DrugBank.d163.s0.e0"
            e2="DDI-DrugBank.d163.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d163.s0.p2" e1="DDI-DrugBank.d163.s0.e0"
            e2="DDI-DrugBank.d163.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d163.s0.p3" e1="DDI-DrugBank.d163.s0.e0"
            e2="DDI-DrugBank.d163.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d163.s0.p4" e1="DDI-DrugBank.d163.s0.e1"
            e2="DDI-DrugBank.d163.s0.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d163.s0.p5" e1="DDI-DrugBank.d163.s0.e1"
            e2="DDI-DrugBank.d163.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d163.s0.p6" e1="DDI-DrugBank.d163.s0.e1"
            e2="DDI-DrugBank.d163.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d163.s0.p7" e1="DDI-DrugBank.d163.s0.e2"
            e2="DDI-DrugBank.d163.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d163.s0.p8" e1="DDI-DrugBank.d163.s0.e2"
            e2="DDI-DrugBank.d163.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d163.s0.p9" e1="DDI-DrugBank.d163.s0.e3"
            e2="DDI-DrugBank.d163.s0.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d163.s1" text="."/>
    <sentence id="DDI-DrugBank.d163.s2" text="Tetracyclines: Concomitant treatment with Accutane and tetracyclines should be avoided because Accutane use has been associated with a number of cases of pseudotumor cerebri (benign intracranial hypertension), some of which involved concomitant use of tetracyclines">
        <entity id="DDI-DrugBank.d163.s2.e0" charOffset="0-12"
            type="group" text="Tetracyclines"/>
        <entity id="DDI-DrugBank.d163.s2.e1" charOffset="42-49"
            type="brand" text="Accutane"/>
        <entity id="DDI-DrugBank.d163.s2.e2" charOffset="55-67"
            type="group" text="tetracyclines"/>
        <entity id="DDI-DrugBank.d163.s2.e3" charOffset="95-102"
            type="brand" text="Accutane"/>
        <entity id="DDI-DrugBank.d163.s2.e4" charOffset="252-264"
            type="group" text="tetracyclines"/>
        <pair id="DDI-DrugBank.d163.s2.p0" e1="DDI-DrugBank.d163.s2.e0"
            e2="DDI-DrugBank.d163.s2.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d163.s2.p1" e1="DDI-DrugBank.d163.s2.e0"
            e2="DDI-DrugBank.d163.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d163.s2.p2" e1="DDI-DrugBank.d163.s2.e0"
            e2="DDI-DrugBank.d163.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d163.s2.p3" e1="DDI-DrugBank.d163.s2.e0"
            e2="DDI-DrugBank.d163.s2.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d163.s2.p4" e1="DDI-DrugBank.d163.s2.e1"
            e2="DDI-DrugBank.d163.s2.e2" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d163.s2.p5" e1="DDI-DrugBank.d163.s2.e1"
            e2="DDI-DrugBank.d163.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d163.s2.p6" e1="DDI-DrugBank.d163.s2.e1"
            e2="DDI-DrugBank.d163.s2.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d163.s2.p7" e1="DDI-DrugBank.d163.s2.e2"
            e2="DDI-DrugBank.d163.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d163.s2.p8" e1="DDI-DrugBank.d163.s2.e2"
            e2="DDI-DrugBank.d163.s2.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d163.s2.p9" e1="DDI-DrugBank.d163.s2.e3"
            e2="DDI-DrugBank.d163.s2.e4" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d163.s3" text="."/>
    <sentence id="DDI-DrugBank.d163.s4" text="Micro-dosed Progesterone Preparations: Micro-dosed progesterone preparations (minipills that do not contain an estrogen) may be an inadequate method of contraception during Accutane therapy.">
        <entity id="DDI-DrugBank.d163.s4.e0" charOffset="12-23"
            type="drug" text="Progesterone"/>
        <entity id="DDI-DrugBank.d163.s4.e1" charOffset="51-62"
            type="drug" text="progesterone"/>
        <entity id="DDI-DrugBank.d163.s4.e2" charOffset="111-118"
            type="group" text="estrogen"/>
        <entity id="DDI-DrugBank.d163.s4.e3" charOffset="173-180"
            type="brand" text="Accutane"/>
        <pair id="DDI-DrugBank.d163.s4.p0" e1="DDI-DrugBank.d163.s4.e0"
            e2="DDI-DrugBank.d163.s4.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d163.s4.p1" e1="DDI-DrugBank.d163.s4.e0"
            e2="DDI-DrugBank.d163.s4.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d163.s4.p2" e1="DDI-DrugBank.d163.s4.e0"
            e2="DDI-DrugBank.d163.s4.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d163.s4.p3" e1="DDI-DrugBank.d163.s4.e1"
            e2="DDI-DrugBank.d163.s4.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d163.s4.p4" e1="DDI-DrugBank.d163.s4.e1"
            e2="DDI-DrugBank.d163.s4.e3" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d163.s4.p5" e1="DDI-DrugBank.d163.s4.e2"
            e2="DDI-DrugBank.d163.s4.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d163.s5" text="Although other hormonal contraceptives are highly effective, there have been reports of pregnancy from women who have used combined oral contraceptives, as well as topical/injectable/implantable/insertable hormonal birth control products.">
        <entity id="DDI-DrugBank.d163.s5.e0" charOffset="15-37"
            type="group" text="hormonal contraceptives"/>
        <entity id="DDI-DrugBank.d163.s5.e1" charOffset="123-150"
            type="group" text="combined oral contraceptives"/>
        <pair id="DDI-DrugBank.d163.s5.p0" e1="DDI-DrugBank.d163.s5.e0"
            e2="DDI-DrugBank.d163.s5.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d163.s6" text="These reports are more frequent for women who use only a single method of contraception."/>
    <sentence id="DDI-DrugBank.d163.s7" text="It is not known if hormonal contraceptives differ in their effectiveness when used with Accutane.">
        <entity id="DDI-DrugBank.d163.s7.e0" charOffset="19-41"
            type="group" text="hormonal contraceptives"/>
        <entity id="DDI-DrugBank.d163.s7.e1" charOffset="88-95"
            type="brand" text="Accutane"/>
        <pair id="DDI-DrugBank.d163.s7.p0" e1="DDI-DrugBank.d163.s7.e0"
            e2="DDI-DrugBank.d163.s7.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d163.s8" text="Therefore, it is critically important for women of childbearing potential to select and commit to use 2 forms of effective contraception simultaneously, at least 1 of which must be a primary form, unless absolute abstinence is the chosen method, or the patient has undergone a hysterectomy"/>
    <sentence id="DDI-DrugBank.d163.s9" text="."/>
    <sentence id="DDI-DrugBank.d163.s10" text="Phenytoin: Accutane has not been shown to alter the pharmacokinetics of phenytoin in a study in seven healthy volunteers.">
        <entity id="DDI-DrugBank.d163.s10.e0" charOffset="0-8"
            type="drug" text="Phenytoin"/>
        <entity id="DDI-DrugBank.d163.s10.e1" charOffset="11-18"
            type="brand" text="Accutane"/>
        <entity id="DDI-DrugBank.d163.s10.e2" charOffset="72-80"
            type="drug" text="phenytoin"/>
        <pair id="DDI-DrugBank.d163.s10.p0"
            e1="DDI-DrugBank.d163.s10.e0" e2="DDI-DrugBank.d163.s10.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d163.s10.p1"
            e1="DDI-DrugBank.d163.s10.e0" e2="DDI-DrugBank.d163.s10.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d163.s10.p2"
            e1="DDI-DrugBank.d163.s10.e1" e2="DDI-DrugBank.d163.s10.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d163.s11" text="These results are consistent with the in vitro finding that neither isotretinoin nor its metabolites induce or inhibit the activity of the CYP 2C9 human hepatic P450 enzyme.">
        <entity id="DDI-DrugBank.d163.s11.e0" charOffset="68-79"
            type="drug" text="isotretinoin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d163.s12" text="Phenytoin is known to cause osteomalacia.">
        <entity id="DDI-DrugBank.d163.s12.e0" charOffset="0-8"
            type="drug" text="Phenytoin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d163.s13" text="No formal clinical studies have been conducted to assess if there is an interactive effect on bone loss between phenytoin and Accutane.">
        <entity id="DDI-DrugBank.d163.s13.e0" charOffset="112-120"
            type="drug" text="phenytoin"/>
        <entity id="DDI-DrugBank.d163.s13.e1" charOffset="126-133"
            type="brand" text="Accutane"/>
        <pair id="DDI-DrugBank.d163.s13.p0"
            e1="DDI-DrugBank.d163.s13.e0" e2="DDI-DrugBank.d163.s13.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d163.s14" text="Therefore, caution should be exercised when using these drugs together"/>
    <sentence id="DDI-DrugBank.d163.s15" text="."/>
    <sentence id="DDI-DrugBank.d163.s16" text="Systemic Corticosteroids: Systemic corticosteroids are known to cause osteoporosis.">
        <entity id="DDI-DrugBank.d163.s16.e0" charOffset="0-23"
            type="group" text="Systemic Corticosteroids"/>
        <entity id="DDI-DrugBank.d163.s16.e1" charOffset="26-49"
            type="group" text="Systemic corticosteroids"/>
        <pair id="DDI-DrugBank.d163.s16.p0"
            e1="DDI-DrugBank.d163.s16.e0" e2="DDI-DrugBank.d163.s16.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d163.s17" text="No formal clinical studies have been conducted to assess if there is an interactive effect on bone loss between systemic corticosteroids and Accutane.">
        <entity id="DDI-DrugBank.d163.s17.e0" charOffset="112-135"
            type="group" text="systemic corticosteroids"/>
        <entity id="DDI-DrugBank.d163.s17.e1" charOffset="141-148"
            type="brand" text="Accutane"/>
        <pair id="DDI-DrugBank.d163.s17.p0"
            e1="DDI-DrugBank.d163.s17.e0" e2="DDI-DrugBank.d163.s17.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d163.s18" text="Therefore, caution should be exercised when using these drugs together."/>
    <sentence id="DDI-DrugBank.d163.s19" text="Prescribers are advised to consult the package insert of medication administered concomitantly with hormonal contraceptives, since some medications may decrease the effectiveness of these birth control products.">
        <entity id="DDI-DrugBank.d163.s19.e0" charOffset="100-122"
            type="group" text="hormonal contraceptives"/>
    </sentence>
    <sentence id="DDI-DrugBank.d163.s20" text="Accutane use is associated with depression in some patients.">
        <entity id="DDI-DrugBank.d163.s20.e0" charOffset="0-7"
            type="brand" text="Accutane"/>
    </sentence>
    <sentence id="DDI-DrugBank.d163.s21" text="Pregnancies have been reported by users of combined hormonal contraceptives who also used some form of St. Johns Wort.">
        <entity id="DDI-DrugBank.d163.s21.e0" charOffset="43-74"
            type="group" text="combined hormonal contraceptives"/>
    </sentence>
    <sentence id="DDI-DrugBank.d163.s22" text="Laboratory Tests Pregnancy Test Female patients of childbearing potential must have negative results from 2 urine or serum pregnancy tests with a sensitivity of at least 25 mIU/mL before receiving the initial Accutane prescription.">
        <entity id="DDI-DrugBank.d163.s22.e0" charOffset="209-216"
            type="brand" text="Accutane"/>
    </sentence>
    <sentence id="DDI-DrugBank.d163.s23" text="The first test is obtained by the prescriber when the decision is made to pursue qualification of the patient for Accutane (a screening test).">
        <entity id="DDI-DrugBank.d163.s23.e0" charOffset="114-121"
            type="brand" text="Accutane"/>
    </sentence>
    <sentence id="DDI-DrugBank.d163.s24" text="The second pregnancy test (a confirmation test) should be done during the first 5 days of the menstrual period immediately preceding the beginning of Accutane therapy.">
        <entity id="DDI-DrugBank.d163.s24.e0" charOffset="150-157"
            type="brand" text="Accutane"/>
    </sentence>
    <sentence id="DDI-DrugBank.d163.s25" text="For patients with amenorrhea, the second test should be done at least 11 days after the last act of unprotected sexual intercourse (without using 2 effective forms of contraception)."/>
    <sentence id="DDI-DrugBank.d163.s26" text="Each month of therapy, the patient must have a negative result from a urine or serum pregnancy test."/>
    <sentence id="DDI-DrugBank.d163.s27" text="A pregnancy test must be repeated each month prior to the female patient receiving each prescription"/>
    <sentence id="DDI-DrugBank.d163.s28" text="."/>
    <sentence id="DDI-DrugBank.d163.s29" text="Lipids: Pretreatment and follow-up blood lipids should be obtained under fasting conditions."/>
    <sentence id="DDI-DrugBank.d163.s30" text="After consumption of alcohol, at least 36 hours should elapse before these determinations are made.">
        <entity id="DDI-DrugBank.d163.s30.e0" charOffset="21-27"
            type="drug" text="alcohol"/>
    </sentence>
    <sentence id="DDI-DrugBank.d163.s31" text="It is recommended that these tests be performed at weekly or biweekly intervals until the lipid response to Accutane is established.">
        <entity id="DDI-DrugBank.d163.s31.e0" charOffset="108-115"
            type="brand" text="Accutane"/>
    </sentence>
    <sentence id="DDI-DrugBank.d163.s32" text="The incidence of hypertriglyceridemia is 1 patient in 4 on Accutane therapy">
        <entity id="DDI-DrugBank.d163.s32.e0" charOffset="59-66"
            type="brand" text="Accutane"/>
    </sentence>
    <sentence id="DDI-DrugBank.d163.s33" text="."/>
    <sentence id="DDI-DrugBank.d163.s34" text="Liver Function Tests: Since elevations of liver enzymes have been observed during clinical trials, and hepatitis has been reported, pretreatment and follow-up liver function tests should be performed at weekly or biweekly intervals until the response to Accutane has been established">
        <entity id="DDI-DrugBank.d163.s34.e0" charOffset="254-261"
            type="brand" text="Accutane"/>
    </sentence>
    <sentence id="DDI-DrugBank.d163.s35" text="."/>
    <sentence id="DDI-DrugBank.d163.s36" text="Glucose: Some patients receiving Accutane have experienced problems in the control of their blood sugar.">
        <entity id="DDI-DrugBank.d163.s36.e0" charOffset="33-40"
            type="brand" text="Accutane"/>
    </sentence>
    <sentence id="DDI-DrugBank.d163.s37" text="In addition, new cases of diabetes have been diagnosed during Accutane therapy, although no causal relationship has been established">
        <entity id="DDI-DrugBank.d163.s37.e0" charOffset="62-69"
            type="brand" text="Accutane"/>
    </sentence>
    <sentence id="DDI-DrugBank.d163.s38" text="."/>
    <sentence id="DDI-DrugBank.d163.s39" text="CPK: Some patients undergoing vigorous physical activity while on Accutane therapy have experienced elevated CPK levels;">
        <entity id="DDI-DrugBank.d163.s39.e0" charOffset="66-73"
            type="brand" text="Accutane"/>
    </sentence>
    <sentence id="DDI-DrugBank.d163.s40" text="however, the clinical significance is unknown."/>
    <sentence id="DDI-DrugBank.d163.s41" text="There have been rare postmarketing reports of rhabdomyolysis, some associated with strenuous physical activity."/>
    <sentence id="DDI-DrugBank.d163.s42" text="In a clinical trial of 217 pediatric patients (12 to 17 years) with severe recalcitrant nodular acne, transient elevations in CPK were observed in 12% of patients, including those undergoing strenuous physical activity in association with reported musculoskeletal adverse events such as back pain, arthralgia, limb injury, or muscle sprain."/>
    <sentence id="DDI-DrugBank.d163.s43" text="In these patients, approximately half of the CPK elevations returned to normal within 2 weeks and half returned to normal within 4 weeks."/>
    <sentence id="DDI-DrugBank.d163.s44" text="No cases of rhabdomyolysis were reported in this trial."/>
</document>
<document id="DDI-DrugBank.d81">
    <sentence id="DDI-DrugBank.d81.s0" text="Nitroglycerin: DynaCirc  (isradipine) has been safely coadministered with nitroglycerin.">
        <entity id="DDI-DrugBank.d81.s0.e0" charOffset="0-12"
            type="drug" text="Nitroglycerin"/>
        <entity id="DDI-DrugBank.d81.s0.e1" charOffset="15-22"
            type="brand" text="DynaCirc"/>
        <entity id="DDI-DrugBank.d81.s0.e2" charOffset="26-35"
            type="drug" text="isradipine"/>
        <entity id="DDI-DrugBank.d81.s0.e3" charOffset="74-86"
            type="drug" text="nitroglycerin"/>
        <pair id="DDI-DrugBank.d81.s0.p0" e1="DDI-DrugBank.d81.s0.e0"
            e2="DDI-DrugBank.d81.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s0.p1" e1="DDI-DrugBank.d81.s0.e0"
            e2="DDI-DrugBank.d81.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s0.p2" e1="DDI-DrugBank.d81.s0.e0"
            e2="DDI-DrugBank.d81.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s0.p3" e1="DDI-DrugBank.d81.s0.e1"
            e2="DDI-DrugBank.d81.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s0.p4" e1="DDI-DrugBank.d81.s0.e1"
            e2="DDI-DrugBank.d81.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s0.p5" e1="DDI-DrugBank.d81.s0.e2"
            e2="DDI-DrugBank.d81.s0.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d81.s1" text="Hydrochlorothiazide: A study in normal healthy volunteers has shown that concomitant administration of DynaCirc  (isradipine) and hydrochlorothiazide does not result in altered pharmacoktnetics of either drug.">
        <entity id="DDI-DrugBank.d81.s1.e0" charOffset="0-18"
            type="drug" text="Hydrochlorothiazide"/>
        <entity id="DDI-DrugBank.d81.s1.e1" charOffset="103-110"
            type="brand" text="DynaCirc"/>
        <entity id="DDI-DrugBank.d81.s1.e2" charOffset="114-123"
            type="drug" text="isradipine"/>
        <entity id="DDI-DrugBank.d81.s1.e3" charOffset="130-148"
            type="drug" text="hydrochlorothiazide"/>
        <pair id="DDI-DrugBank.d81.s1.p0" e1="DDI-DrugBank.d81.s1.e0"
            e2="DDI-DrugBank.d81.s1.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s1.p1" e1="DDI-DrugBank.d81.s1.e0"
            e2="DDI-DrugBank.d81.s1.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s1.p2" e1="DDI-DrugBank.d81.s1.e0"
            e2="DDI-DrugBank.d81.s1.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s1.p3" e1="DDI-DrugBank.d81.s1.e1"
            e2="DDI-DrugBank.d81.s1.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s1.p4" e1="DDI-DrugBank.d81.s1.e1"
            e2="DDI-DrugBank.d81.s1.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s1.p5" e1="DDI-DrugBank.d81.s1.e2"
            e2="DDI-DrugBank.d81.s1.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d81.s2" text="In a study in hypertensive patients, addition of isradipine to existing hydrochlorothiazide therapy did not result in any unexpected adverse effects, and isradipine had an additional antihypertensive effect.">
        <entity id="DDI-DrugBank.d81.s2.e0" charOffset="49-58"
            type="drug" text="isradipine"/>
        <entity id="DDI-DrugBank.d81.s2.e1" charOffset="72-90"
            type="drug" text="hydrochlorothiazide"/>
        <entity id="DDI-DrugBank.d81.s2.e2" charOffset="154-163"
            type="drug" text="isradipine"/>
        <pair id="DDI-DrugBank.d81.s2.p0" e1="DDI-DrugBank.d81.s2.e0"
            e2="DDI-DrugBank.d81.s2.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s2.p1" e1="DDI-DrugBank.d81.s2.e0"
            e2="DDI-DrugBank.d81.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s2.p2" e1="DDI-DrugBank.d81.s2.e1"
            e2="DDI-DrugBank.d81.s2.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d81.s3" text="Propranolol: In a single dose study in normal volunteers, coadministration of propranolol had a small effect on the rate but no effect on the extent of isradipine bioavailability.">
        <entity id="DDI-DrugBank.d81.s3.e0" charOffset="0-10"
            type="drug" text="Propranolol"/>
        <entity id="DDI-DrugBank.d81.s3.e1" charOffset="78-88"
            type="drug" text="propranolol"/>
        <entity id="DDI-DrugBank.d81.s3.e2" charOffset="152-161"
            type="drug" text="isradipine"/>
        <pair id="DDI-DrugBank.d81.s3.p0" e1="DDI-DrugBank.d81.s3.e0"
            e2="DDI-DrugBank.d81.s3.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s3.p1" e1="DDI-DrugBank.d81.s3.e0"
            e2="DDI-DrugBank.d81.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s3.p2" e1="DDI-DrugBank.d81.s3.e1"
            e2="DDI-DrugBank.d81.s3.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d81.s4" text="Significant increases In AUC (27%) and Cmax (58%) and decreases in tmax (23%) of propranolol were noted in this study.">
        <entity id="DDI-DrugBank.d81.s4.e0" charOffset="81-91"
            type="drug" text="propranolol"/>
    </sentence>
    <sentence id="DDI-DrugBank.d81.s5" text="However, concomitant administration of 5 mg b.i.d. isradipine and 40 mg b.i.d.">
        <entity id="DDI-DrugBank.d81.s5.e0" charOffset="51-60"
            type="drug" text="isradipine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d81.s6" text="propranolol to healthy volunteers under steady-state conditions had no relevant effect on either drug s bioavailability, AUC and Cmax, differences were  20% between isradipine given singly and in combination with propranolol, and between propranolol given singly and in combination with isradipine.">
        <entity id="DDI-DrugBank.d81.s6.e0" charOffset="0-10"
            type="drug" text="propranolol"/>
        <entity id="DDI-DrugBank.d81.s6.e1" charOffset="165-174"
            type="drug" text="isradipine"/>
        <entity id="DDI-DrugBank.d81.s6.e2" charOffset="213-223"
            type="drug" text="propranolol"/>
        <entity id="DDI-DrugBank.d81.s6.e3" charOffset="238-248"
            type="drug" text="propranolol"/>
        <entity id="DDI-DrugBank.d81.s6.e4" charOffset="287-296"
            type="drug" text="isradipine"/>
        <pair id="DDI-DrugBank.d81.s6.p0" e1="DDI-DrugBank.d81.s6.e0"
            e2="DDI-DrugBank.d81.s6.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s6.p1" e1="DDI-DrugBank.d81.s6.e0"
            e2="DDI-DrugBank.d81.s6.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s6.p2" e1="DDI-DrugBank.d81.s6.e0"
            e2="DDI-DrugBank.d81.s6.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s6.p3" e1="DDI-DrugBank.d81.s6.e0"
            e2="DDI-DrugBank.d81.s6.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s6.p4" e1="DDI-DrugBank.d81.s6.e1"
            e2="DDI-DrugBank.d81.s6.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s6.p5" e1="DDI-DrugBank.d81.s6.e1"
            e2="DDI-DrugBank.d81.s6.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s6.p6" e1="DDI-DrugBank.d81.s6.e1"
            e2="DDI-DrugBank.d81.s6.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s6.p7" e1="DDI-DrugBank.d81.s6.e2"
            e2="DDI-DrugBank.d81.s6.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s6.p8" e1="DDI-DrugBank.d81.s6.e2"
            e2="DDI-DrugBank.d81.s6.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s6.p9" e1="DDI-DrugBank.d81.s6.e3"
            e2="DDI-DrugBank.d81.s6.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d81.s7" text="Cimetidine: In a study in healthy volunteers, a one-week course of cimetidine at 400 mg b.i.d. with a single 5 mg dose of isradipine on the sixth day showed an increase in isradipine mean peak plasma concentrations (36%) and significant increase in area under the curve (50%).">
        <entity id="DDI-DrugBank.d81.s7.e0" charOffset="0-9" type="drug" text="Cimetidine"/>
        <entity id="DDI-DrugBank.d81.s7.e1" charOffset="67-76"
            type="drug" text="cimetidine"/>
        <entity id="DDI-DrugBank.d81.s7.e2" charOffset="122-131"
            type="drug" text="isradipine"/>
        <entity id="DDI-DrugBank.d81.s7.e3" charOffset="172-181"
            type="drug" text="isradipine"/>
        <pair id="DDI-DrugBank.d81.s7.p0" e1="DDI-DrugBank.d81.s7.e0"
            e2="DDI-DrugBank.d81.s7.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s7.p1" e1="DDI-DrugBank.d81.s7.e0"
            e2="DDI-DrugBank.d81.s7.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s7.p2" e1="DDI-DrugBank.d81.s7.e0"
            e2="DDI-DrugBank.d81.s7.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s7.p3" e1="DDI-DrugBank.d81.s7.e1"
            e2="DDI-DrugBank.d81.s7.e2" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d81.s7.p4" e1="DDI-DrugBank.d81.s7.e1"
            e2="DDI-DrugBank.d81.s7.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s7.p5" e1="DDI-DrugBank.d81.s7.e2"
            e2="DDI-DrugBank.d81.s7.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d81.s8" text="If isradipine therapy is initiated in a patient currently receiving cimetidine careful monitoring for adverse reactions is advised and downward dose adjustment may be required.">
        <entity id="DDI-DrugBank.d81.s8.e0" charOffset="3-12"
            type="drug" text="isradipine"/>
        <entity id="DDI-DrugBank.d81.s8.e1" charOffset="68-77"
            type="drug" text="cimetidine"/>
        <pair id="DDI-DrugBank.d81.s8.p0" e1="DDI-DrugBank.d81.s8.e0"
            e2="DDI-DrugBank.d81.s8.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d81.s9" text="Rifampicin: In a study in healthy volunteers, a six-day course of rifampicin at 600 mg/day followed by a single 5 mg dose of isradipine resulted in a reduction in isradipine levels to below detectable limits.">
        <entity id="DDI-DrugBank.d81.s9.e0" charOffset="0-9" type="drug" text="Rifampicin"/>
        <entity id="DDI-DrugBank.d81.s9.e1" charOffset="66-75"
            type="drug" text="rifampicin"/>
        <entity id="DDI-DrugBank.d81.s9.e2" charOffset="125-134"
            type="drug" text="isradipine"/>
        <entity id="DDI-DrugBank.d81.s9.e3" charOffset="163-172"
            type="drug" text="isradipine"/>
        <pair id="DDI-DrugBank.d81.s9.p0" e1="DDI-DrugBank.d81.s9.e0"
            e2="DDI-DrugBank.d81.s9.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s9.p1" e1="DDI-DrugBank.d81.s9.e0"
            e2="DDI-DrugBank.d81.s9.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s9.p2" e1="DDI-DrugBank.d81.s9.e0"
            e2="DDI-DrugBank.d81.s9.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s9.p3" e1="DDI-DrugBank.d81.s9.e1"
            e2="DDI-DrugBank.d81.s9.e2" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d81.s9.p4" e1="DDI-DrugBank.d81.s9.e1"
            e2="DDI-DrugBank.d81.s9.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s9.p5" e1="DDI-DrugBank.d81.s9.e2"
            e2="DDI-DrugBank.d81.s9.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d81.s10" text="If rifampicin therapy is required, isradipine concentrations and therapeutic effects are likely to be markedly reduced or abolished as a consequence of increased metabolism and higher clearance of isradipine.">
        <entity id="DDI-DrugBank.d81.s10.e0" charOffset="3-12"
            type="drug" text="rifampicin"/>
        <entity id="DDI-DrugBank.d81.s10.e1" charOffset="35-44"
            type="drug" text="isradipine"/>
        <entity id="DDI-DrugBank.d81.s10.e2" charOffset="197-206"
            type="drug" text="isradipine"/>
        <pair id="DDI-DrugBank.d81.s10.p0" e1="DDI-DrugBank.d81.s10.e0"
            e2="DDI-DrugBank.d81.s10.e1" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d81.s10.p1" e1="DDI-DrugBank.d81.s10.e0"
            e2="DDI-DrugBank.d81.s10.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s10.p2" e1="DDI-DrugBank.d81.s10.e1"
            e2="DDI-DrugBank.d81.s10.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d81.s11" text="Warfarin: In a study in healthy volunteers, no clinically relevant pharmacokinetic or pharmacodynamic interaction between isradipine and racemic warfarin was seen when two single oral doses of warfarin (0.7 mg/kg body weight) were administered during 11 days of multipledose treatment with 5 mg b.i.d. isradipine.">
        <entity id="DDI-DrugBank.d81.s11.e0" charOffset="0-7"
            type="drug" text="Warfarin"/>
        <entity id="DDI-DrugBank.d81.s11.e1" charOffset="122-131"
            type="drug" text="isradipine"/>
        <entity id="DDI-DrugBank.d81.s11.e2" charOffset="145-152"
            type="drug" text="warfarin"/>
        <entity id="DDI-DrugBank.d81.s11.e3" charOffset="193-200"
            type="drug" text="warfarin"/>
        <entity id="DDI-DrugBank.d81.s11.e4" charOffset="302-311"
            type="drug" text="isradipine"/>
        <pair id="DDI-DrugBank.d81.s11.p0" e1="DDI-DrugBank.d81.s11.e0"
            e2="DDI-DrugBank.d81.s11.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s11.p1" e1="DDI-DrugBank.d81.s11.e0"
            e2="DDI-DrugBank.d81.s11.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s11.p2" e1="DDI-DrugBank.d81.s11.e0"
            e2="DDI-DrugBank.d81.s11.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s11.p3" e1="DDI-DrugBank.d81.s11.e0"
            e2="DDI-DrugBank.d81.s11.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s11.p4" e1="DDI-DrugBank.d81.s11.e1"
            e2="DDI-DrugBank.d81.s11.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s11.p5" e1="DDI-DrugBank.d81.s11.e1"
            e2="DDI-DrugBank.d81.s11.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s11.p6" e1="DDI-DrugBank.d81.s11.e1"
            e2="DDI-DrugBank.d81.s11.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s11.p7" e1="DDI-DrugBank.d81.s11.e2"
            e2="DDI-DrugBank.d81.s11.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s11.p8" e1="DDI-DrugBank.d81.s11.e2"
            e2="DDI-DrugBank.d81.s11.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s11.p9" e1="DDI-DrugBank.d81.s11.e3"
            e2="DDI-DrugBank.d81.s11.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d81.s12" text="Neither racemic warfarin nor isradipine binding to plasma proteins in vitro was altered by the addition of the other drug.">
        <entity id="DDI-DrugBank.d81.s12.e0" charOffset="16-23"
            type="drug" text="warfarin"/>
        <entity id="DDI-DrugBank.d81.s12.e1" charOffset="29-38"
            type="drug" text="isradipine"/>
        <pair id="DDI-DrugBank.d81.s12.p0" e1="DDI-DrugBank.d81.s12.e0"
            e2="DDI-DrugBank.d81.s12.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d81.s13" text="Digoxin: The concomitant administration of DynaCirc  (isradipine) and digoxin in a single-dose pharmacokinetic study did not affect renal, nonrenal and total body clearance of digoxin.">
        <entity id="DDI-DrugBank.d81.s13.e0" charOffset="0-6"
            type="drug" text="Digoxin"/>
        <entity id="DDI-DrugBank.d81.s13.e1" charOffset="43-50"
            type="brand" text="DynaCirc"/>
        <entity id="DDI-DrugBank.d81.s13.e2" charOffset="54-63"
            type="drug" text="isradipine"/>
        <entity id="DDI-DrugBank.d81.s13.e3" charOffset="70-76"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d81.s13.e4" charOffset="176-182"
            type="drug" text="digoxin"/>
        <pair id="DDI-DrugBank.d81.s13.p0" e1="DDI-DrugBank.d81.s13.e0"
            e2="DDI-DrugBank.d81.s13.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s13.p1" e1="DDI-DrugBank.d81.s13.e0"
            e2="DDI-DrugBank.d81.s13.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s13.p2" e1="DDI-DrugBank.d81.s13.e0"
            e2="DDI-DrugBank.d81.s13.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s13.p3" e1="DDI-DrugBank.d81.s13.e0"
            e2="DDI-DrugBank.d81.s13.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s13.p4" e1="DDI-DrugBank.d81.s13.e1"
            e2="DDI-DrugBank.d81.s13.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s13.p5" e1="DDI-DrugBank.d81.s13.e1"
            e2="DDI-DrugBank.d81.s13.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s13.p6" e1="DDI-DrugBank.d81.s13.e1"
            e2="DDI-DrugBank.d81.s13.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s13.p7" e1="DDI-DrugBank.d81.s13.e2"
            e2="DDI-DrugBank.d81.s13.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s13.p8" e1="DDI-DrugBank.d81.s13.e2"
            e2="DDI-DrugBank.d81.s13.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s13.p9" e1="DDI-DrugBank.d81.s13.e3"
            e2="DDI-DrugBank.d81.s13.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d81.s14" text="Fentanyl Anesthesia: Severe hypotension has been reported during fentanyl anesthesia with concomitant use of a beta blocker and a calcium channel blocker.">
        <entity id="DDI-DrugBank.d81.s14.e0" charOffset="0-7"
            type="drug" text="Fentanyl"/>
        <entity id="DDI-DrugBank.d81.s14.e1" charOffset="65-72"
            type="drug" text="fentanyl"/>
        <entity id="DDI-DrugBank.d81.s14.e2" charOffset="111-122"
            type="group" text="beta blocker"/>
        <entity id="DDI-DrugBank.d81.s14.e3" charOffset="130-152"
            type="group" text="calcium channel blocker"/>
        <pair id="DDI-DrugBank.d81.s14.p0" e1="DDI-DrugBank.d81.s14.e0"
            e2="DDI-DrugBank.d81.s14.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s14.p1" e1="DDI-DrugBank.d81.s14.e0"
            e2="DDI-DrugBank.d81.s14.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s14.p2" e1="DDI-DrugBank.d81.s14.e0"
            e2="DDI-DrugBank.d81.s14.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d81.s14.p3" e1="DDI-DrugBank.d81.s14.e1"
            e2="DDI-DrugBank.d81.s14.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d81.s14.p4" e1="DDI-DrugBank.d81.s14.e1"
            e2="DDI-DrugBank.d81.s14.e3" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d81.s14.p5" e1="DDI-DrugBank.d81.s14.e2"
            e2="DDI-DrugBank.d81.s14.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d81.s15" text="Even though such interactions have not been seen in clinical studies with DynaCirc  (isradipine), an increased volume of circulating fluids might be required if such an interaction were to occur.">
        <entity id="DDI-DrugBank.d81.s15.e0" charOffset="74-81"
            type="brand" text="DynaCirc"/>
        <entity id="DDI-DrugBank.d81.s15.e1" charOffset="85-94"
            type="drug" text="isradipine"/>
        <pair id="DDI-DrugBank.d81.s15.p0" e1="DDI-DrugBank.d81.s15.e0"
            e2="DDI-DrugBank.d81.s15.e1" ddi="false"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d95">
    <sentence id="DDI-DrugBank.d95.s0" text="Cyclosporine - L-arginine may counteract the antinaturetic effect of cyclosporin.">
        <entity id="DDI-DrugBank.d95.s0.e0" charOffset="0-11"
            type="drug" text="Cyclosporine"/>
        <entity id="DDI-DrugBank.d95.s0.e1" charOffset="15-24"
            type="drug" text="L-arginine"/>
        <entity id="DDI-DrugBank.d95.s0.e2" charOffset="69-79"
            type="drug" text="cyclosporin"/>
        <pair id="DDI-DrugBank.d95.s0.p0" e1="DDI-DrugBank.d95.s0.e0"
            e2="DDI-DrugBank.d95.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d95.s0.p1" e1="DDI-DrugBank.d95.s0.e0"
            e2="DDI-DrugBank.d95.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d95.s0.p2" e1="DDI-DrugBank.d95.s0.e1"
            e2="DDI-DrugBank.d95.s0.e2" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d95.s1" text="Ibuprofen - L-arginine may increase the absorption of ibuprofen if taken concomitantly.">
        <entity id="DDI-DrugBank.d95.s1.e0" charOffset="0-8" type="drug" text="Ibuprofen"/>
        <entity id="DDI-DrugBank.d95.s1.e1" charOffset="12-21"
            type="drug" text="L-arginine"/>
        <entity id="DDI-DrugBank.d95.s1.e2" charOffset="54-62"
            type="drug" text="ibuprofen"/>
        <pair id="DDI-DrugBank.d95.s1.p0" e1="DDI-DrugBank.d95.s1.e0"
            e2="DDI-DrugBank.d95.s1.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d95.s1.p1" e1="DDI-DrugBank.d95.s1.e0"
            e2="DDI-DrugBank.d95.s1.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d95.s1.p2" e1="DDI-DrugBank.d95.s1.e1"
            e2="DDI-DrugBank.d95.s1.e2" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d95.s2" text="Organic nitrates - L-arginine supplements theoretically may potentiate the effects of organic nitrates if taken concomitantly.">
        <entity id="DDI-DrugBank.d95.s2.e0" charOffset="8-15"
            type="group" text="nitrates"/>
        <entity id="DDI-DrugBank.d95.s2.e1" charOffset="19-28"
            type="drug" text="L-arginine"/>
        <entity id="DDI-DrugBank.d95.s2.e2" charOffset="94-101"
            type="drug" text="nitrates"/>
        <pair id="DDI-DrugBank.d95.s2.p0" e1="DDI-DrugBank.d95.s2.e0"
            e2="DDI-DrugBank.d95.s2.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d95.s2.p1" e1="DDI-DrugBank.d95.s2.e0"
            e2="DDI-DrugBank.d95.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d95.s2.p2" e1="DDI-DrugBank.d95.s2.e1"
            e2="DDI-DrugBank.d95.s2.e2" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d95.s3" text="Sildenafil citrate - Theoretically, L-arginine supplements taken concomitantly with sildenafil citrate, may potentiate the effects of the drug.">
        <entity id="DDI-DrugBank.d95.s3.e0" charOffset="0-17"
            type="drug" text="Sildenafil citrate"/>
        <entity id="DDI-DrugBank.d95.s3.e1" charOffset="36-45"
            type="drug" text="L-arginine"/>
        <entity id="DDI-DrugBank.d95.s3.e2" charOffset="84-101"
            type="drug" text="sildenafil citrate"/>
        <pair id="DDI-DrugBank.d95.s3.p0" e1="DDI-DrugBank.d95.s3.e0"
            e2="DDI-DrugBank.d95.s3.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d95.s3.p1" e1="DDI-DrugBank.d95.s3.e0"
            e2="DDI-DrugBank.d95.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d95.s3.p2" e1="DDI-DrugBank.d95.s3.e1"
            e2="DDI-DrugBank.d95.s3.e2" ddi="true" type="effect"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d41">
    <sentence id="DDI-DrugBank.d41.s0" text="Cholestyramine and Charcoal Administration of cholestyramine or activated charcoal in patients (n=13) and volunteers (n=96) resulted in a rapid and significant decrease in plasma M1 (the active metabolite of leflunomide) concentration .">
        <entity id="DDI-DrugBank.d41.s0.e0" charOffset="0-13"
            type="drug" text="Cholestyramine"/>
        <entity id="DDI-DrugBank.d41.s0.e1" charOffset="19-26"
            type="drug" text="Charcoal"/>
        <entity id="DDI-DrugBank.d41.s0.e2" charOffset="46-59"
            type="drug" text="cholestyramine"/>
        <entity id="DDI-DrugBank.d41.s0.e3" charOffset="64-81"
            type="drug" text="activated charcoal"/>
        <entity id="DDI-DrugBank.d41.s0.e4" charOffset="208-218"
            type="drug" text="leflunomide"/>
        <pair id="DDI-DrugBank.d41.s0.p0" e1="DDI-DrugBank.d41.s0.e0"
            e2="DDI-DrugBank.d41.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d41.s0.p1" e1="DDI-DrugBank.d41.s0.e0"
            e2="DDI-DrugBank.d41.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d41.s0.p2" e1="DDI-DrugBank.d41.s0.e0"
            e2="DDI-DrugBank.d41.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d41.s0.p3" e1="DDI-DrugBank.d41.s0.e0"
            e2="DDI-DrugBank.d41.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d41.s0.p4" e1="DDI-DrugBank.d41.s0.e1"
            e2="DDI-DrugBank.d41.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d41.s0.p5" e1="DDI-DrugBank.d41.s0.e1"
            e2="DDI-DrugBank.d41.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d41.s0.p6" e1="DDI-DrugBank.d41.s0.e1"
            e2="DDI-DrugBank.d41.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d41.s0.p7" e1="DDI-DrugBank.d41.s0.e2"
            e2="DDI-DrugBank.d41.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d41.s0.p8" e1="DDI-DrugBank.d41.s0.e2"
            e2="DDI-DrugBank.d41.s0.e4" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d41.s0.p9" e1="DDI-DrugBank.d41.s0.e3"
            e2="DDI-DrugBank.d41.s0.e4" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d41.s1" text="Hepatotoxic Drugs Increased side effects may occur when leflunomide is given concomitantly with hepatotoxic substances.">
        <entity id="DDI-DrugBank.d41.s1.e0" charOffset="56-66"
            type="drug" text="leflunomide"/>
    </sentence>
    <sentence id="DDI-DrugBank.d41.s2" text="This is also to be considered when leflunomide treatment is followed by such drugs without a drug elimination procedure.">
        <entity id="DDI-DrugBank.d41.s2.e0" charOffset="35-45"
            type="drug" text="leflunomide"/>
    </sentence>
    <sentence id="DDI-DrugBank.d41.s3" text="In a small (n=30) combination study of ARAVA with methotrexate, a 2- to 3-fold elevation in liver enzymes was seen in 5 of 30 patients.">
        <entity id="DDI-DrugBank.d41.s3.e0" charOffset="39-43"
            type="brand" text="ARAVA"/>
        <entity id="DDI-DrugBank.d41.s3.e1" charOffset="50-61"
            type="drug" text="methotrexate"/>
        <pair id="DDI-DrugBank.d41.s3.p0" e1="DDI-DrugBank.d41.s3.e0"
            e2="DDI-DrugBank.d41.s3.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d41.s4" text="All elevations resolved, 2 with continuation of both drugs and 3 after discontinuation of leflunomide.">
        <entity id="DDI-DrugBank.d41.s4.e0" charOffset="90-100"
            type="drug" text="leflunomide"/>
    </sentence>
    <sentence id="DDI-DrugBank.d41.s5" text="A  3-fold increase was seen in another 5 patients."/>
    <sentence id="DDI-DrugBank.d41.s6" text="All of these also resolved, 2 with continuation of both drugs and 3 after discontinuation of leflunomide.">
        <entity id="DDI-DrugBank.d41.s6.e0" charOffset="93-103"
            type="drug" text="leflunomide"/>
    </sentence>
    <sentence id="DDI-DrugBank.d41.s7" text="Three patients met ACR criteria for liver biopsy (1: Roegnik Grade I, 2: Roegnik Grade IIIa)."/>
    <sentence id="DDI-DrugBank.d41.s8" text="No pharmacokinetic interaction was identified."/>
    <sentence id="DDI-DrugBank.d41.s9" text="NSAIDs: In in vitro studies, M1 was shown to cause increases ranging from 13 - 50% in the free fraction of diclofenac and ibuprofen at concentrations in the clinical range.">
        <entity id="DDI-DrugBank.d41.s9.e0" charOffset="0-5"
            type="group" text="NSAIDs"/>
        <entity id="DDI-DrugBank.d41.s9.e1" charOffset="107-116"
            type="drug" text="diclofenac"/>
        <entity id="DDI-DrugBank.d41.s9.e2" charOffset="122-130"
            type="drug" text="ibuprofen"/>
        <pair id="DDI-DrugBank.d41.s9.p0" e1="DDI-DrugBank.d41.s9.e0"
            e2="DDI-DrugBank.d41.s9.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d41.s9.p1" e1="DDI-DrugBank.d41.s9.e0"
            e2="DDI-DrugBank.d41.s9.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d41.s9.p2" e1="DDI-DrugBank.d41.s9.e1"
            e2="DDI-DrugBank.d41.s9.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d41.s10" text="The clinical significance of this finding is unknown;"/>
    <sentence id="DDI-DrugBank.d41.s11" text="however, there was extensive concomitant use of NSAIDs in clinical studies and no differential effect was observed.">
        <entity id="DDI-DrugBank.d41.s11.e0" charOffset="48-53"
            type="group" text="NSAIDs"/>
    </sentence>
    <sentence id="DDI-DrugBank.d41.s12" text="Tolbutamide: In in vitro studies, M1 was shown to cause increases ranging from 13 - 50% in the free fraction of tolbutamide at concentrations in the clinical range.">
        <entity id="DDI-DrugBank.d41.s12.e0" charOffset="0-10"
            type="drug" text="Tolbutamide"/>
        <entity id="DDI-DrugBank.d41.s12.e1" charOffset="112-122"
            type="drug" text="tolbutamide"/>
        <pair id="DDI-DrugBank.d41.s12.p0" e1="DDI-DrugBank.d41.s12.e0"
            e2="DDI-DrugBank.d41.s12.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d41.s13" text="The clinical significance of this finding is unknown."/>
    <sentence id="DDI-DrugBank.d41.s14" text="Rifampin: Following concomitant administration of a single dose of ARAVA to subjects receiving multiple doses of rifampin, M1 peak levels were increased (~40%) over those seen when ARAVA was given alone.">
        <entity id="DDI-DrugBank.d41.s14.e0" charOffset="0-7"
            type="drug" text="Rifampin"/>
        <entity id="DDI-DrugBank.d41.s14.e1" charOffset="67-71"
            type="brand" text="ARAVA"/>
        <entity id="DDI-DrugBank.d41.s14.e2" charOffset="113-120"
            type="drug" text="rifampin"/>
        <entity id="DDI-DrugBank.d41.s14.e3" charOffset="181-185"
            type="brand" text="ARAVA"/>
        <pair id="DDI-DrugBank.d41.s14.p0" e1="DDI-DrugBank.d41.s14.e0"
            e2="DDI-DrugBank.d41.s14.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d41.s14.p1" e1="DDI-DrugBank.d41.s14.e0"
            e2="DDI-DrugBank.d41.s14.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d41.s14.p2" e1="DDI-DrugBank.d41.s14.e0"
            e2="DDI-DrugBank.d41.s14.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d41.s14.p3" e1="DDI-DrugBank.d41.s14.e1"
            e2="DDI-DrugBank.d41.s14.e2" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d41.s14.p4" e1="DDI-DrugBank.d41.s14.e1"
            e2="DDI-DrugBank.d41.s14.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d41.s14.p5" e1="DDI-DrugBank.d41.s14.e2"
            e2="DDI-DrugBank.d41.s14.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d41.s15" text="Because of the potential for ARAVA levels to continue to increase with multiple dosing, caution should be used if patients are to be receiving both ARAVA and rifampin.">
        <entity id="DDI-DrugBank.d41.s15.e0" charOffset="29-33"
            type="brand" text="ARAVA"/>
        <entity id="DDI-DrugBank.d41.s15.e1" charOffset="148-152"
            type="brand" text="ARAVA"/>
        <entity id="DDI-DrugBank.d41.s15.e2" charOffset="158-165"
            type="drug" text="rifampin"/>
        <pair id="DDI-DrugBank.d41.s15.p0" e1="DDI-DrugBank.d41.s15.e0"
            e2="DDI-DrugBank.d41.s15.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d41.s15.p1" e1="DDI-DrugBank.d41.s15.e0"
            e2="DDI-DrugBank.d41.s15.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d41.s15.p2" e1="DDI-DrugBank.d41.s15.e1"
            e2="DDI-DrugBank.d41.s15.e2" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d41.s16" text="Warfarin: Increased INR (International Normalized Ratio) when ARAVA and warfarin were co-administered has been rarely reported.">
        <entity id="DDI-DrugBank.d41.s16.e0" charOffset="0-7"
            type="drug" text="Warfarin"/>
        <entity id="DDI-DrugBank.d41.s16.e1" charOffset="62-66"
            type="brand" text="ARAVA"/>
        <entity id="DDI-DrugBank.d41.s16.e2" charOffset="72-79"
            type="drug" text="warfarin"/>
        <pair id="DDI-DrugBank.d41.s16.p0" e1="DDI-DrugBank.d41.s16.e0"
            e2="DDI-DrugBank.d41.s16.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d41.s16.p1" e1="DDI-DrugBank.d41.s16.e0"
            e2="DDI-DrugBank.d41.s16.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d41.s16.p2" e1="DDI-DrugBank.d41.s16.e1"
            e2="DDI-DrugBank.d41.s16.e2" ddi="true" type="effect"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d252">
    <sentence id="DDI-DrugBank.d252.s0" text="Although BETAGAN used alone has little or no effect on pupil size, mydriasis resulting from concomitant therapy with BETAGAN and epinephrine may occur.">
        <entity id="DDI-DrugBank.d252.s0.e0" charOffset="9-15"
            type="brand" text="BETAGAN"/>
        <entity id="DDI-DrugBank.d252.s0.e1" charOffset="117-123"
            type="brand" text="BETAGAN"/>
        <entity id="DDI-DrugBank.d252.s0.e2" charOffset="129-139"
            type="drug" text="epinephrine"/>
        <pair id="DDI-DrugBank.d252.s0.p0" e1="DDI-DrugBank.d252.s0.e0"
            e2="DDI-DrugBank.d252.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d252.s0.p1" e1="DDI-DrugBank.d252.s0.e0"
            e2="DDI-DrugBank.d252.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d252.s0.p2" e1="DDI-DrugBank.d252.s0.e1"
            e2="DDI-DrugBank.d252.s0.e2" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d252.s1" text="Close observation of the patient is recommended when a beta-blocker is administered to patients receiving catecholamine-depleting drugs such as reserpine, because of possible additive effects and the production of hypotension and/or marked bradycardia, which may produce vertigo, syncope or postural hypotension.">
        <entity id="DDI-DrugBank.d252.s1.e0" charOffset="55-66"
            type="group" text="beta-blocker"/>
        <entity id="DDI-DrugBank.d252.s1.e1" charOffset="144-152"
            type="drug" text="reserpine"/>
        <pair id="DDI-DrugBank.d252.s1.p0" e1="DDI-DrugBank.d252.s1.e0"
            e2="DDI-DrugBank.d252.s1.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d252.s2" text="Patients receiving beta-adrenergic blocking agents along with either oral or intravenous calcium antagonists should be monitored for possible atrioventricular conduction disturbances, left ventricular failure and hypotension.">
        <entity id="DDI-DrugBank.d252.s2.e0" charOffset="19-49"
            type="group" text="beta-adrenergic blocking agents"/>
        <entity id="DDI-DrugBank.d252.s2.e1" charOffset="89-107"
            type="group" text="calcium antagonists"/>
        <pair id="DDI-DrugBank.d252.s2.p0" e1="DDI-DrugBank.d252.s2.e0"
            e2="DDI-DrugBank.d252.s2.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d252.s3" text="In patients with impaired cardiac function, simultaneous use should be avoided altogether."/>
    <sentence id="DDI-DrugBank.d252.s4" text="The concomitant use of beta-adrenergic blocking agents with digitalis and calcium antagonists may have additive effects on prolonging atrioventricular conduction time.">
        <entity id="DDI-DrugBank.d252.s4.e0" charOffset="23-53"
            type="group" text="beta-adrenergic blocking agents"/>
        <entity id="DDI-DrugBank.d252.s4.e1" charOffset="60-68"
            type="group" text="digitalis"/>
        <entity id="DDI-DrugBank.d252.s4.e2" charOffset="74-92"
            type="group" text="calcium antagonists"/>
        <pair id="DDI-DrugBank.d252.s4.p0" e1="DDI-DrugBank.d252.s4.e0"
            e2="DDI-DrugBank.d252.s4.e1" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d252.s4.p1" e1="DDI-DrugBank.d252.s4.e0"
            e2="DDI-DrugBank.d252.s4.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d252.s4.p2" e1="DDI-DrugBank.d252.s4.e1"
            e2="DDI-DrugBank.d252.s4.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d252.s5" text="Phenothiazine-related compounds and beta-adrenergic blocking agents may have additive hypotensite effects due to the inhibition of each other s metabolism.">
        <entity id="DDI-DrugBank.d252.s5.e0" charOffset="0-30"
            type="group" text="Phenothiazine-related compounds"/>
        <entity id="DDI-DrugBank.d252.s5.e1" charOffset="36-66"
            type="group" text="beta-adrenergic blocking agents"/>
        <pair id="DDI-DrugBank.d252.s5.p0" e1="DDI-DrugBank.d252.s5.e0"
            e2="DDI-DrugBank.d252.s5.e1" ddi="true" type="mechanism"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d320">
    <sentence id="DDI-DrugBank.d320.s0" text="Chirocaine   should be used with caution in patients receiving other local anesthetics or agents structurally related to amide-type local anesthetics since the toxic effects of these drugs could be additive.">
        <entity id="DDI-DrugBank.d320.s0.e0" charOffset="0-9"
            type="brand" text="Chirocaine"/>
        <entity id="DDI-DrugBank.d320.s0.e1" charOffset="75-85"
            type="group" text="anesthetics"/>
        <pair id="DDI-DrugBank.d320.s0.p0" e1="DDI-DrugBank.d320.s0.e0"
            e2="DDI-DrugBank.d320.s0.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d320.s1" text="In vitro studies indicate CYP3A4 isoform and CYP1A2 isoform mediate the metabolism of levobupivacaine to desbutyl levobupivacaine and 3-hydroxy levobupivacaine, respectively.">
        <entity id="DDI-DrugBank.d320.s1.e0" charOffset="86-100"
            type="drug" text="levobupivacaine"/>
        <entity id="DDI-DrugBank.d320.s1.e1" charOffset="105-128"
            type="drug_n" text="desbutyl levobupivacaine"/>
        <entity id="DDI-DrugBank.d320.s1.e2" charOffset="134-158"
            type="drug_n" text="3-hydroxy levobupivacaine"/>
        <pair id="DDI-DrugBank.d320.s1.p0" e1="DDI-DrugBank.d320.s1.e0"
            e2="DDI-DrugBank.d320.s1.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d320.s1.p1" e1="DDI-DrugBank.d320.s1.e0"
            e2="DDI-DrugBank.d320.s1.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d320.s1.p2" e1="DDI-DrugBank.d320.s1.e1"
            e2="DDI-DrugBank.d320.s1.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d320.s2" text="Thus agents likely to be concomitantly administered with Chirocaine that are metabolized by this isoenzyme family may potentially interact with Chirocaine.">
        <entity id="DDI-DrugBank.d320.s2.e0" charOffset="57-66"
            type="brand" text="Chirocaine"/>
        <entity id="DDI-DrugBank.d320.s2.e1" charOffset="144-153"
            type="brand" text="Chirocaine"/>
        <pair id="DDI-DrugBank.d320.s2.p0" e1="DDI-DrugBank.d320.s2.e0"
            e2="DDI-DrugBank.d320.s2.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d320.s3" text="Although no clinical studies have been conducted, it is likely that the metabolism of levobupivacaine may be affected by the known CYP3A4 inducers (such as phenytoin, phenobarbital, rifampin), CYP3A4 inhibitors (azole antimycotics e.g., ketoconazole;">
        <entity id="DDI-DrugBank.d320.s3.e0" charOffset="86-100"
            type="drug" text="levobupivacaine"/>
        <entity id="DDI-DrugBank.d320.s3.e1" charOffset="156-164"
            type="drug" text="phenytoin"/>
        <entity id="DDI-DrugBank.d320.s3.e2" charOffset="167-179"
            type="drug" text="phenobarbital"/>
        <entity id="DDI-DrugBank.d320.s3.e3" charOffset="182-189"
            type="drug" text="rifampin"/>
        <entity id="DDI-DrugBank.d320.s3.e4" charOffset="237-248"
            type="drug" text="ketoconazole"/>
        <pair id="DDI-DrugBank.d320.s3.p0" e1="DDI-DrugBank.d320.s3.e0"
            e2="DDI-DrugBank.d320.s3.e1" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d320.s3.p1" e1="DDI-DrugBank.d320.s3.e0"
            e2="DDI-DrugBank.d320.s3.e2" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d320.s3.p2" e1="DDI-DrugBank.d320.s3.e0"
            e2="DDI-DrugBank.d320.s3.e3" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d320.s3.p3" e1="DDI-DrugBank.d320.s3.e0"
            e2="DDI-DrugBank.d320.s3.e4" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d320.s3.p4" e1="DDI-DrugBank.d320.s3.e1"
            e2="DDI-DrugBank.d320.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d320.s3.p5" e1="DDI-DrugBank.d320.s3.e1"
            e2="DDI-DrugBank.d320.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d320.s3.p6" e1="DDI-DrugBank.d320.s3.e1"
            e2="DDI-DrugBank.d320.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d320.s3.p7" e1="DDI-DrugBank.d320.s3.e2"
            e2="DDI-DrugBank.d320.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d320.s3.p8" e1="DDI-DrugBank.d320.s3.e2"
            e2="DDI-DrugBank.d320.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d320.s3.p9" e1="DDI-DrugBank.d320.s3.e3"
            e2="DDI-DrugBank.d320.s3.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d320.s4" text="certain protease inhibitors e.g., ritanovir;">
        <entity id="DDI-DrugBank.d320.s4.e0" charOffset="8-26"
            type="group" text="protease inhibitors"/>
    </sentence>
    <sentence id="DDI-DrugBank.d320.s5" text="macrolide antibiotics e.g., erythromycin;">
        <entity id="DDI-DrugBank.d320.s5.e0" charOffset="0-20"
            type="group" text="macrolide antibiotics"/>
        <entity id="DDI-DrugBank.d320.s5.e1" charOffset="28-39"
            type="drug" text="erythromycin"/>
        <pair id="DDI-DrugBank.d320.s5.p0" e1="DDI-DrugBank.d320.s5.e0"
            e2="DDI-DrugBank.d320.s5.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d320.s6" text="and calcium channel antagonists e.g., verapamil), CYP1A2 inducers (omeprazole) and CYP1A2 inhibitors (furafylline and clarithromycin).">
        <entity id="DDI-DrugBank.d320.s6.e0" charOffset="4-30"
            type="group" text="calcium channel antagonists"/>
        <entity id="DDI-DrugBank.d320.s6.e1" charOffset="38-46"
            type="drug" text="verapamil"/>
        <entity id="DDI-DrugBank.d320.s6.e2" charOffset="67-76"
            type="drug" text="omeprazole"/>
        <entity id="DDI-DrugBank.d320.s6.e3" charOffset="102-112"
            type="drug" text="furafylline"/>
        <entity id="DDI-DrugBank.d320.s6.e4" charOffset="118-131"
            type="drug" text="clarithromycin"/>
        <pair id="DDI-DrugBank.d320.s6.p0" e1="DDI-DrugBank.d320.s6.e0"
            e2="DDI-DrugBank.d320.s6.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d320.s6.p1" e1="DDI-DrugBank.d320.s6.e0"
            e2="DDI-DrugBank.d320.s6.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d320.s6.p2" e1="DDI-DrugBank.d320.s6.e0"
            e2="DDI-DrugBank.d320.s6.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d320.s6.p3" e1="DDI-DrugBank.d320.s6.e0"
            e2="DDI-DrugBank.d320.s6.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d320.s6.p4" e1="DDI-DrugBank.d320.s6.e1"
            e2="DDI-DrugBank.d320.s6.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d320.s6.p5" e1="DDI-DrugBank.d320.s6.e1"
            e2="DDI-DrugBank.d320.s6.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d320.s6.p6" e1="DDI-DrugBank.d320.s6.e1"
            e2="DDI-DrugBank.d320.s6.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d320.s6.p7" e1="DDI-DrugBank.d320.s6.e2"
            e2="DDI-DrugBank.d320.s6.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d320.s6.p8" e1="DDI-DrugBank.d320.s6.e2"
            e2="DDI-DrugBank.d320.s6.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d320.s6.p9" e1="DDI-DrugBank.d320.s6.e3"
            e2="DDI-DrugBank.d320.s6.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d320.s7" text="Dosage adjustment may be warranted when levobupivacaine is concurrently administered with CYP3A4 inhibitors and CYP1A2 inhibitors as systemic levobupivacaine levels may rise resulting in toxicity.">
        <entity id="DDI-DrugBank.d320.s7.e0" charOffset="40-54"
            type="drug" text="levobupivacaine"/>
        <entity id="DDI-DrugBank.d320.s7.e1" charOffset="142-156"
            type="drug" text="levobupivacaine"/>
        <pair id="DDI-DrugBank.d320.s7.p0" e1="DDI-DrugBank.d320.s7.e0"
            e2="DDI-DrugBank.d320.s7.e1" ddi="false"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d454">
    <sentence id="DDI-DrugBank.d454.s0" text="- Lofexidine may enhance the CNS depressive effects of alcohol, barbiturates and other sedatives">
        <entity id="DDI-DrugBank.d454.s0.e0" charOffset="2-11"
            type="drug" text="Lofexidine"/>
        <entity id="DDI-DrugBank.d454.s0.e1" charOffset="55-61"
            type="drug" text="alcohol"/>
        <entity id="DDI-DrugBank.d454.s0.e2" charOffset="64-75"
            type="group" text="barbiturates"/>
        <entity id="DDI-DrugBank.d454.s0.e3" charOffset="87-95"
            type="group" text="sedatives"/>
        <pair id="DDI-DrugBank.d454.s0.p0" e1="DDI-DrugBank.d454.s0.e0"
            e2="DDI-DrugBank.d454.s0.e1" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d454.s0.p1" e1="DDI-DrugBank.d454.s0.e0"
            e2="DDI-DrugBank.d454.s0.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d454.s0.p2" e1="DDI-DrugBank.d454.s0.e0"
            e2="DDI-DrugBank.d454.s0.e3" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d454.s0.p3" e1="DDI-DrugBank.d454.s0.e1"
            e2="DDI-DrugBank.d454.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d454.s0.p4" e1="DDI-DrugBank.d454.s0.e1"
            e2="DDI-DrugBank.d454.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d454.s0.p5" e1="DDI-DrugBank.d454.s0.e2"
            e2="DDI-DrugBank.d454.s0.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d454.s1" text="."/>
    <sentence id="DDI-DrugBank.d454.s2" text="- Lofexidine may enhance the effects of anti-hypertensive drug therapy">
        <entity id="DDI-DrugBank.d454.s2.e0" charOffset="2-11"
            type="drug" text="Lofexidine"/>
        <entity id="DDI-DrugBank.d454.s2.e1" charOffset="40-61"
            type="group" text="anti-hypertensive drug"/>
        <pair id="DDI-DrugBank.d454.s2.p0" e1="DDI-DrugBank.d454.s2.e0"
            e2="DDI-DrugBank.d454.s2.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d454.s3" text="."/>
    <sentence id="DDI-DrugBank.d454.s4" text="- Concomitant use of tricyclic antidepressants may reduce the efficacy of lofexidine.">
        <entity id="DDI-DrugBank.d454.s4.e0" charOffset="21-45"
            type="group" text="tricyclic antidepressants"/>
        <entity id="DDI-DrugBank.d454.s4.e1" charOffset="74-83"
            type="drug" text="lofexidine"/>
        <pair id="DDI-DrugBank.d454.s4.p0" e1="DDI-DrugBank.d454.s4.e0"
            e2="DDI-DrugBank.d454.s4.e1" ddi="true" type="effect"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d30">
    <sentence id="DDI-DrugBank.d30.s0" text="No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.">
        <entity id="DDI-DrugBank.d30.s0.e0" charOffset="98-116"
            type="drug" text="hydrochlorothiazide"/>
        <entity id="DDI-DrugBank.d30.s0.e1" charOffset="119-125"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d30.s0.e2" charOffset="128-135"
            type="drug" text="warfarin"/>
        <entity id="DDI-DrugBank.d30.s0.e3" charOffset="138-147"
            type="drug" text="cimetidine"/>
        <entity id="DDI-DrugBank.d30.s0.e4" charOffset="153-165"
            type="drug" text="phenobarbital"/>
        <pair id="DDI-DrugBank.d30.s0.p0" e1="DDI-DrugBank.d30.s0.e0"
            e2="DDI-DrugBank.d30.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d30.s0.p1" e1="DDI-DrugBank.d30.s0.e0"
            e2="DDI-DrugBank.d30.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d30.s0.p2" e1="DDI-DrugBank.d30.s0.e0"
            e2="DDI-DrugBank.d30.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d30.s0.p3" e1="DDI-DrugBank.d30.s0.e0"
            e2="DDI-DrugBank.d30.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d30.s0.p4" e1="DDI-DrugBank.d30.s0.e1"
            e2="DDI-DrugBank.d30.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d30.s0.p5" e1="DDI-DrugBank.d30.s0.e1"
            e2="DDI-DrugBank.d30.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d30.s0.p6" e1="DDI-DrugBank.d30.s0.e1"
            e2="DDI-DrugBank.d30.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d30.s0.p7" e1="DDI-DrugBank.d30.s0.e2"
            e2="DDI-DrugBank.d30.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d30.s0.p8" e1="DDI-DrugBank.d30.s0.e2"
            e2="DDI-DrugBank.d30.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d30.s0.p9" e1="DDI-DrugBank.d30.s0.e3"
            e2="DDI-DrugBank.d30.s0.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d30.s1" text="Rifampin, an inducer of drug metabolism, decreased the concentrations of losartan and its active metabolite.">
        <entity id="DDI-DrugBank.d30.s1.e0" charOffset="0-7" type="drug" text="Rifampin"/>
        <entity id="DDI-DrugBank.d30.s1.e1" charOffset="73-80"
            type="drug" text="losartan"/>
        <pair id="DDI-DrugBank.d30.s1.p0" e1="DDI-DrugBank.d30.s1.e0"
            e2="DDI-DrugBank.d30.s1.e1" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d30.s2" text="In humans, two inhibitors of P450 3A4 have been studied."/>
    <sentence id="DDI-DrugBank.d30.s3" text="Ketoconazole did not affect the conversion of losartan to the active metabolite after intravenous administration of losartan, and erythromycin had no clinically significant effect after oral administration.">
        <entity id="DDI-DrugBank.d30.s3.e0" charOffset="0-11"
            type="drug" text="Ketoconazole"/>
        <entity id="DDI-DrugBank.d30.s3.e1" charOffset="46-53"
            type="drug" text="losartan"/>
        <entity id="DDI-DrugBank.d30.s3.e2" charOffset="116-123"
            type="drug" text="losartan"/>
        <entity id="DDI-DrugBank.d30.s3.e3" charOffset="130-141"
            type="drug" text="erythromycin"/>
        <pair id="DDI-DrugBank.d30.s3.p0" e1="DDI-DrugBank.d30.s3.e0"
            e2="DDI-DrugBank.d30.s3.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d30.s3.p1" e1="DDI-DrugBank.d30.s3.e0"
            e2="DDI-DrugBank.d30.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d30.s3.p2" e1="DDI-DrugBank.d30.s3.e0"
            e2="DDI-DrugBank.d30.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d30.s3.p3" e1="DDI-DrugBank.d30.s3.e1"
            e2="DDI-DrugBank.d30.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d30.s3.p4" e1="DDI-DrugBank.d30.s3.e1"
            e2="DDI-DrugBank.d30.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d30.s3.p5" e1="DDI-DrugBank.d30.s3.e2"
            e2="DDI-DrugBank.d30.s3.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d30.s4" text="Fluconazole, an inhibitor of P450 2C9, decreased active metabolite concentration and increased losartan concentration.">
        <entity id="DDI-DrugBank.d30.s4.e0" charOffset="0-10"
            type="drug" text="Fluconazole"/>
        <entity id="DDI-DrugBank.d30.s4.e1" charOffset="95-102"
            type="drug" text="losartan"/>
        <pair id="DDI-DrugBank.d30.s4.p0" e1="DDI-DrugBank.d30.s4.e0"
            e2="DDI-DrugBank.d30.s4.e1" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d30.s5" text="The pharmacodynamic consequences of concomitant use of losartan and inhibitors of P450 2C9 have not been examined.">
        <entity id="DDI-DrugBank.d30.s5.e0" charOffset="55-62"
            type="drug" text="losartan"/>
    </sentence>
    <sentence id="DDI-DrugBank.d30.s6" text="Subjects who do not metabolize losartan to active metabolite have been shown to have a specific, rare defect in cytochrome P450 2C9.">
        <entity id="DDI-DrugBank.d30.s6.e0" charOffset="31-38"
            type="drug" text="losartan"/>
    </sentence>
    <sentence id="DDI-DrugBank.d30.s7" text="These data suggest that the conversion of losartan to its active metabolite is mediated primarily by P450 2C9 and not P450 3A4.">
        <entity id="DDI-DrugBank.d30.s7.e0" charOffset="42-49"
            type="drug" text="losartan"/>
    </sentence>
    <sentence id="DDI-DrugBank.d30.s8" text="As with other drugs that block angiotensin II or its effects, concomitant use of potassium-sparing diuretics (e.g., spironolactone, triamterene, amiloride), potassium supplements, or salt substitutes containing potassium may lead to increases in serum potassium.">
        <entity id="DDI-DrugBank.d30.s8.e0" charOffset="81-107"
            type="group" text="potassium-sparing diuretics"/>
        <entity id="DDI-DrugBank.d30.s8.e1" charOffset="116-129"
            type="drug" text="spironolactone"/>
        <entity id="DDI-DrugBank.d30.s8.e2" charOffset="132-142"
            type="drug" text="triamterene"/>
        <entity id="DDI-DrugBank.d30.s8.e3" charOffset="145-153"
            type="drug" text="amiloride"/>
        <entity id="DDI-DrugBank.d30.s8.e4" charOffset="157-165"
            type="drug" text="potassium"/>
        <pair id="DDI-DrugBank.d30.s8.p0" e1="DDI-DrugBank.d30.s8.e0"
            e2="DDI-DrugBank.d30.s8.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d30.s8.p1" e1="DDI-DrugBank.d30.s8.e0"
            e2="DDI-DrugBank.d30.s8.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d30.s8.p2" e1="DDI-DrugBank.d30.s8.e0"
            e2="DDI-DrugBank.d30.s8.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d30.s8.p3" e1="DDI-DrugBank.d30.s8.e0"
            e2="DDI-DrugBank.d30.s8.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d30.s8.p4" e1="DDI-DrugBank.d30.s8.e1"
            e2="DDI-DrugBank.d30.s8.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d30.s8.p5" e1="DDI-DrugBank.d30.s8.e1"
            e2="DDI-DrugBank.d30.s8.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d30.s8.p6" e1="DDI-DrugBank.d30.s8.e1"
            e2="DDI-DrugBank.d30.s8.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d30.s8.p7" e1="DDI-DrugBank.d30.s8.e2"
            e2="DDI-DrugBank.d30.s8.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d30.s8.p8" e1="DDI-DrugBank.d30.s8.e2"
            e2="DDI-DrugBank.d30.s8.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d30.s8.p9" e1="DDI-DrugBank.d30.s8.e3"
            e2="DDI-DrugBank.d30.s8.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d30.s9" text="As with other antihypertensive agents, the antihypertensive effect of losartan may be blunted by the non-steroidal anti-inflammatory drug indomethacin">
        <entity id="DDI-DrugBank.d30.s9.e0" charOffset="14-36"
            type="group" text="antihypertensive agents"/>
        <entity id="DDI-DrugBank.d30.s9.e1" charOffset="70-77"
            type="drug" text="losartan"/>
        <entity id="DDI-DrugBank.d30.s9.e2" charOffset="101-136"
            type="group" text="non-steroidal anti-inflammatory drug"/>
        <entity id="DDI-DrugBank.d30.s9.e3" charOffset="138-149"
            type="drug" text="indomethacin"/>
        <pair id="DDI-DrugBank.d30.s9.p0" e1="DDI-DrugBank.d30.s9.e0"
            e2="DDI-DrugBank.d30.s9.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d30.s9.p1" e1="DDI-DrugBank.d30.s9.e0"
            e2="DDI-DrugBank.d30.s9.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d30.s9.p2" e1="DDI-DrugBank.d30.s9.e0"
            e2="DDI-DrugBank.d30.s9.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d30.s9.p3" e1="DDI-DrugBank.d30.s9.e1"
            e2="DDI-DrugBank.d30.s9.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d30.s9.p4" e1="DDI-DrugBank.d30.s9.e1"
            e2="DDI-DrugBank.d30.s9.e3" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d30.s9.p5" e1="DDI-DrugBank.d30.s9.e2"
            e2="DDI-DrugBank.d30.s9.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d30.s10" text="."/>
    <sentence id="DDI-DrugBank.d30.s11" text=""/>
</document>
<document id="DDI-DrugBank.d530">
    <sentence id="DDI-DrugBank.d530.s0" text="Non-selective monoamine oxidase (MAO) inhibitors - including phenelzine sulfate, tranylcypromine sulfate and pargyline HC1.">
        <entity id="DDI-DrugBank.d530.s0.e0" charOffset="0-47"
            type="group" text="Non-selective monoamine oxidase (MAO) inhibitors"/>
        <entity id="DDI-DrugBank.d530.s0.e1" charOffset="61-78"
            type="drug" text="phenelzine sulfate"/>
        <entity id="DDI-DrugBank.d530.s0.e2" charOffset="81-103"
            type="drug" text="tranylcypromine sulfate"/>
        <entity id="DDI-DrugBank.d530.s0.e3" charOffset="109-117"
            type="drug" text="pargyline"/>
        <pair id="DDI-DrugBank.d530.s0.p0" e1="DDI-DrugBank.d530.s0.e0"
            e2="DDI-DrugBank.d530.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d530.s0.p1" e1="DDI-DrugBank.d530.s0.e0"
            e2="DDI-DrugBank.d530.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d530.s0.p2" e1="DDI-DrugBank.d530.s0.e0"
            e2="DDI-DrugBank.d530.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d530.s0.p3" e1="DDI-DrugBank.d530.s0.e1"
            e2="DDI-DrugBank.d530.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d530.s0.p4" e1="DDI-DrugBank.d530.s0.e1"
            e2="DDI-DrugBank.d530.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d530.s0.p5" e1="DDI-DrugBank.d530.s0.e2"
            e2="DDI-DrugBank.d530.s0.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d530.s1" text="Concomitant use of L-phenylalanine and non-selective MAO inhibitors may cause hypertension.">
        <entity id="DDI-DrugBank.d530.s1.e0" charOffset="19-33"
            type="drug" text="L-phenylalanine"/>
        <entity id="DDI-DrugBank.d530.s1.e1" charOffset="39-66"
            type="group" text="non-selective MAO inhibitors"/>
        <pair id="DDI-DrugBank.d530.s1.p0" e1="DDI-DrugBank.d530.s1.e0"
            e2="DDI-DrugBank.d530.s1.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d530.s2" text="Selegiline - L-phenylalanine and the selective MAO inhibitor selegiline may have synergistic antidepressant activity if used concomitantly.">
        <entity id="DDI-DrugBank.d530.s2.e0" charOffset="0-9"
            type="drug" text="Selegiline"/>
        <entity id="DDI-DrugBank.d530.s2.e1" charOffset="13-27"
            type="drug" text="L-phenylalanine"/>
        <entity id="DDI-DrugBank.d530.s2.e2" charOffset="37-59"
            type="group" text="selective MAO inhibitor"/>
        <entity id="DDI-DrugBank.d530.s2.e3" charOffset="61-70"
            type="drug" text="selegiline"/>
        <pair id="DDI-DrugBank.d530.s2.p0" e1="DDI-DrugBank.d530.s2.e0"
            e2="DDI-DrugBank.d530.s2.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d530.s2.p1" e1="DDI-DrugBank.d530.s2.e0"
            e2="DDI-DrugBank.d530.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d530.s2.p2" e1="DDI-DrugBank.d530.s2.e0"
            e2="DDI-DrugBank.d530.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d530.s2.p3" e1="DDI-DrugBank.d530.s2.e1"
            e2="DDI-DrugBank.d530.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d530.s2.p4" e1="DDI-DrugBank.d530.s2.e1"
            e2="DDI-DrugBank.d530.s2.e3" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d530.s2.p5" e1="DDI-DrugBank.d530.s2.e2"
            e2="DDI-DrugBank.d530.s2.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d530.s3" text="Neuroleptic Drugs - L-phenylalanine may potentiate the tardive dyskinesia side reactions of neuroleptic drugs if used concomitantly with them.">
        <entity id="DDI-DrugBank.d530.s3.e0" charOffset="0-16"
            type="group" text="Neuroleptic Drugs"/>
        <entity id="DDI-DrugBank.d530.s3.e1" charOffset="20-34"
            type="drug" text="L-phenylalanine"/>
        <entity id="DDI-DrugBank.d530.s3.e2" charOffset="92-108"
            type="group" text="neuroleptic drugs"/>
        <pair id="DDI-DrugBank.d530.s3.p0" e1="DDI-DrugBank.d530.s3.e0"
            e2="DDI-DrugBank.d530.s3.e1" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d530.s3.p1" e1="DDI-DrugBank.d530.s3.e0"
            e2="DDI-DrugBank.d530.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d530.s3.p2" e1="DDI-DrugBank.d530.s3.e1"
            e2="DDI-DrugBank.d530.s3.e2" ddi="false"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d643">
    <sentence id="DDI-DrugBank.d643.s0" text="Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).">
        <entity id="DDI-DrugBank.d643.s0.e0" charOffset="0-8"
            type="drug" text="Melatonin"/>
        <entity id="DDI-DrugBank.d643.s0.e1" charOffset="49-55"
            type="brand" text="aspirin"/>
        <entity id="DDI-DrugBank.d643.s0.e2" charOffset="67-72"
            type="group" text="NSAIDs"/>
        <entity id="DDI-DrugBank.d643.s0.e3" charOffset="85-93"
            type="drug" text="melatonin"/>
        <entity id="DDI-DrugBank.d643.s0.e4" charOffset="104-114"
            type="drug" text="fluvoxamine"/>
        <entity id="DDI-DrugBank.d643.s0.e5" charOffset="141-149"
            type="drug" text="melatonin"/>
        <entity id="DDI-DrugBank.d643.s0.e6" charOffset="188-200"
            type="group" text="beta blockers"/>
        <entity id="DDI-DrugBank.d643.s0.e7" charOffset="216-224"
            type="drug" text="melatonin"/>
        <entity id="DDI-DrugBank.d643.s0.e8" charOffset="235-244"
            type="drug" text="fluoxetine"/>
        <entity id="DDI-DrugBank.d643.s0.e9" charOffset="299-307"
            type="group" text="progestin"/>
        <entity id="DDI-DrugBank.d643.s0.e10" charOffset="330-338"
            type="drug" text="melatonin"/>
        <entity id="DDI-DrugBank.d643.s0.e11" charOffset="345-353"
            type="group" text="progestin"/>
        <entity id="DDI-DrugBank.d643.s0.e12" charOffset="395-409"
            type="group" text="benzodiazepenes"/>
        <entity id="DDI-DrugBank.d643.s0.e13" charOffset="521-535"
            type="group" text="corticosteroids"/>
        <entity id="DDI-DrugBank.d643.s0.e14" charOffset="558-566"
            type="drug" text="melatonin"/>
        <entity id="DDI-DrugBank.d643.s0.e15" charOffset="572-586"
            type="group" text="corticosteroids"/>
        <entity id="DDI-DrugBank.d643.s0.e16" charOffset="627-641"
            type="group" text="corticosteroids"/>
        <pair id="DDI-DrugBank.d643.s0.p0" e1="DDI-DrugBank.d643.s0.e0"
            e2="DDI-DrugBank.d643.s0.e1" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d643.s0.p1" e1="DDI-DrugBank.d643.s0.e0"
            e2="DDI-DrugBank.d643.s0.e2" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d643.s0.p2" e1="DDI-DrugBank.d643.s0.e0"
            e2="DDI-DrugBank.d643.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p3" e1="DDI-DrugBank.d643.s0.e0"
            e2="DDI-DrugBank.d643.s0.e4" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d643.s0.p4" e1="DDI-DrugBank.d643.s0.e0"
            e2="DDI-DrugBank.d643.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p5" e1="DDI-DrugBank.d643.s0.e0"
            e2="DDI-DrugBank.d643.s0.e6" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d643.s0.p6" e1="DDI-DrugBank.d643.s0.e0"
            e2="DDI-DrugBank.d643.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p7" e1="DDI-DrugBank.d643.s0.e0"
            e2="DDI-DrugBank.d643.s0.e8" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d643.s0.p8" e1="DDI-DrugBank.d643.s0.e0"
            e2="DDI-DrugBank.d643.s0.e9" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d643.s0.p9" e1="DDI-DrugBank.d643.s0.e0"
            e2="DDI-DrugBank.d643.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p10" e1="DDI-DrugBank.d643.s0.e0"
            e2="DDI-DrugBank.d643.s0.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p11" e1="DDI-DrugBank.d643.s0.e0"
            e2="DDI-DrugBank.d643.s0.e12" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d643.s0.p12" e1="DDI-DrugBank.d643.s0.e0"
            e2="DDI-DrugBank.d643.s0.e13" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d643.s0.p13" e1="DDI-DrugBank.d643.s0.e0"
            e2="DDI-DrugBank.d643.s0.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p14" e1="DDI-DrugBank.d643.s0.e0"
            e2="DDI-DrugBank.d643.s0.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p15" e1="DDI-DrugBank.d643.s0.e0"
            e2="DDI-DrugBank.d643.s0.e16" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p16" e1="DDI-DrugBank.d643.s0.e1"
            e2="DDI-DrugBank.d643.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p17" e1="DDI-DrugBank.d643.s0.e1"
            e2="DDI-DrugBank.d643.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p18" e1="DDI-DrugBank.d643.s0.e1"
            e2="DDI-DrugBank.d643.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p19" e1="DDI-DrugBank.d643.s0.e1"
            e2="DDI-DrugBank.d643.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p20" e1="DDI-DrugBank.d643.s0.e1"
            e2="DDI-DrugBank.d643.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p21" e1="DDI-DrugBank.d643.s0.e1"
            e2="DDI-DrugBank.d643.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p22" e1="DDI-DrugBank.d643.s0.e1"
            e2="DDI-DrugBank.d643.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p23" e1="DDI-DrugBank.d643.s0.e1"
            e2="DDI-DrugBank.d643.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p24" e1="DDI-DrugBank.d643.s0.e1"
            e2="DDI-DrugBank.d643.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p25" e1="DDI-DrugBank.d643.s0.e1"
            e2="DDI-DrugBank.d643.s0.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p26" e1="DDI-DrugBank.d643.s0.e1"
            e2="DDI-DrugBank.d643.s0.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p27" e1="DDI-DrugBank.d643.s0.e1"
            e2="DDI-DrugBank.d643.s0.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p28" e1="DDI-DrugBank.d643.s0.e1"
            e2="DDI-DrugBank.d643.s0.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p29" e1="DDI-DrugBank.d643.s0.e1"
            e2="DDI-DrugBank.d643.s0.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p30" e1="DDI-DrugBank.d643.s0.e1"
            e2="DDI-DrugBank.d643.s0.e16" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p31" e1="DDI-DrugBank.d643.s0.e2"
            e2="DDI-DrugBank.d643.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p32" e1="DDI-DrugBank.d643.s0.e2"
            e2="DDI-DrugBank.d643.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p33" e1="DDI-DrugBank.d643.s0.e2"
            e2="DDI-DrugBank.d643.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p34" e1="DDI-DrugBank.d643.s0.e2"
            e2="DDI-DrugBank.d643.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p35" e1="DDI-DrugBank.d643.s0.e2"
            e2="DDI-DrugBank.d643.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p36" e1="DDI-DrugBank.d643.s0.e2"
            e2="DDI-DrugBank.d643.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p37" e1="DDI-DrugBank.d643.s0.e2"
            e2="DDI-DrugBank.d643.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p38" e1="DDI-DrugBank.d643.s0.e2"
            e2="DDI-DrugBank.d643.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p39" e1="DDI-DrugBank.d643.s0.e2"
            e2="DDI-DrugBank.d643.s0.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p40" e1="DDI-DrugBank.d643.s0.e2"
            e2="DDI-DrugBank.d643.s0.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p41" e1="DDI-DrugBank.d643.s0.e2"
            e2="DDI-DrugBank.d643.s0.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p42" e1="DDI-DrugBank.d643.s0.e2"
            e2="DDI-DrugBank.d643.s0.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p43" e1="DDI-DrugBank.d643.s0.e2"
            e2="DDI-DrugBank.d643.s0.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p44" e1="DDI-DrugBank.d643.s0.e2"
            e2="DDI-DrugBank.d643.s0.e16" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p45" e1="DDI-DrugBank.d643.s0.e3"
            e2="DDI-DrugBank.d643.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p46" e1="DDI-DrugBank.d643.s0.e3"
            e2="DDI-DrugBank.d643.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p47" e1="DDI-DrugBank.d643.s0.e3"
            e2="DDI-DrugBank.d643.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p48" e1="DDI-DrugBank.d643.s0.e3"
            e2="DDI-DrugBank.d643.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p49" e1="DDI-DrugBank.d643.s0.e3"
            e2="DDI-DrugBank.d643.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p50" e1="DDI-DrugBank.d643.s0.e3"
            e2="DDI-DrugBank.d643.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p51" e1="DDI-DrugBank.d643.s0.e3"
            e2="DDI-DrugBank.d643.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p52" e1="DDI-DrugBank.d643.s0.e3"
            e2="DDI-DrugBank.d643.s0.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p53" e1="DDI-DrugBank.d643.s0.e3"
            e2="DDI-DrugBank.d643.s0.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p54" e1="DDI-DrugBank.d643.s0.e3"
            e2="DDI-DrugBank.d643.s0.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p55" e1="DDI-DrugBank.d643.s0.e3"
            e2="DDI-DrugBank.d643.s0.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p56" e1="DDI-DrugBank.d643.s0.e3"
            e2="DDI-DrugBank.d643.s0.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p57" e1="DDI-DrugBank.d643.s0.e3"
            e2="DDI-DrugBank.d643.s0.e16" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p58" e1="DDI-DrugBank.d643.s0.e4"
            e2="DDI-DrugBank.d643.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p59" e1="DDI-DrugBank.d643.s0.e4"
            e2="DDI-DrugBank.d643.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p60" e1="DDI-DrugBank.d643.s0.e4"
            e2="DDI-DrugBank.d643.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p61" e1="DDI-DrugBank.d643.s0.e4"
            e2="DDI-DrugBank.d643.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p62" e1="DDI-DrugBank.d643.s0.e4"
            e2="DDI-DrugBank.d643.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p63" e1="DDI-DrugBank.d643.s0.e4"
            e2="DDI-DrugBank.d643.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p64" e1="DDI-DrugBank.d643.s0.e4"
            e2="DDI-DrugBank.d643.s0.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p65" e1="DDI-DrugBank.d643.s0.e4"
            e2="DDI-DrugBank.d643.s0.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p66" e1="DDI-DrugBank.d643.s0.e4"
            e2="DDI-DrugBank.d643.s0.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p67" e1="DDI-DrugBank.d643.s0.e4"
            e2="DDI-DrugBank.d643.s0.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p68" e1="DDI-DrugBank.d643.s0.e4"
            e2="DDI-DrugBank.d643.s0.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p69" e1="DDI-DrugBank.d643.s0.e4"
            e2="DDI-DrugBank.d643.s0.e16" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p70" e1="DDI-DrugBank.d643.s0.e5"
            e2="DDI-DrugBank.d643.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p71" e1="DDI-DrugBank.d643.s0.e5"
            e2="DDI-DrugBank.d643.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p72" e1="DDI-DrugBank.d643.s0.e5"
            e2="DDI-DrugBank.d643.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p73" e1="DDI-DrugBank.d643.s0.e5"
            e2="DDI-DrugBank.d643.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p74" e1="DDI-DrugBank.d643.s0.e5"
            e2="DDI-DrugBank.d643.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p75" e1="DDI-DrugBank.d643.s0.e5"
            e2="DDI-DrugBank.d643.s0.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p76" e1="DDI-DrugBank.d643.s0.e5"
            e2="DDI-DrugBank.d643.s0.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p77" e1="DDI-DrugBank.d643.s0.e5"
            e2="DDI-DrugBank.d643.s0.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p78" e1="DDI-DrugBank.d643.s0.e5"
            e2="DDI-DrugBank.d643.s0.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p79" e1="DDI-DrugBank.d643.s0.e5"
            e2="DDI-DrugBank.d643.s0.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p80" e1="DDI-DrugBank.d643.s0.e5"
            e2="DDI-DrugBank.d643.s0.e16" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p81" e1="DDI-DrugBank.d643.s0.e6"
            e2="DDI-DrugBank.d643.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p82" e1="DDI-DrugBank.d643.s0.e6"
            e2="DDI-DrugBank.d643.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p83" e1="DDI-DrugBank.d643.s0.e6"
            e2="DDI-DrugBank.d643.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p84" e1="DDI-DrugBank.d643.s0.e6"
            e2="DDI-DrugBank.d643.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p85" e1="DDI-DrugBank.d643.s0.e6"
            e2="DDI-DrugBank.d643.s0.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p86" e1="DDI-DrugBank.d643.s0.e6"
            e2="DDI-DrugBank.d643.s0.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p87" e1="DDI-DrugBank.d643.s0.e6"
            e2="DDI-DrugBank.d643.s0.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p88" e1="DDI-DrugBank.d643.s0.e6"
            e2="DDI-DrugBank.d643.s0.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p89" e1="DDI-DrugBank.d643.s0.e6"
            e2="DDI-DrugBank.d643.s0.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p90" e1="DDI-DrugBank.d643.s0.e6"
            e2="DDI-DrugBank.d643.s0.e16" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p91" e1="DDI-DrugBank.d643.s0.e7"
            e2="DDI-DrugBank.d643.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p92" e1="DDI-DrugBank.d643.s0.e7"
            e2="DDI-DrugBank.d643.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p93" e1="DDI-DrugBank.d643.s0.e7"
            e2="DDI-DrugBank.d643.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p94" e1="DDI-DrugBank.d643.s0.e7"
            e2="DDI-DrugBank.d643.s0.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p95" e1="DDI-DrugBank.d643.s0.e7"
            e2="DDI-DrugBank.d643.s0.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p96" e1="DDI-DrugBank.d643.s0.e7"
            e2="DDI-DrugBank.d643.s0.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p97" e1="DDI-DrugBank.d643.s0.e7"
            e2="DDI-DrugBank.d643.s0.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p98" e1="DDI-DrugBank.d643.s0.e7"
            e2="DDI-DrugBank.d643.s0.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p99" e1="DDI-DrugBank.d643.s0.e7"
            e2="DDI-DrugBank.d643.s0.e16" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p100"
            e1="DDI-DrugBank.d643.s0.e8" e2="DDI-DrugBank.d643.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p101"
            e1="DDI-DrugBank.d643.s0.e8" e2="DDI-DrugBank.d643.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p102"
            e1="DDI-DrugBank.d643.s0.e8" e2="DDI-DrugBank.d643.s0.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p103"
            e1="DDI-DrugBank.d643.s0.e8" e2="DDI-DrugBank.d643.s0.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p104"
            e1="DDI-DrugBank.d643.s0.e8" e2="DDI-DrugBank.d643.s0.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p105"
            e1="DDI-DrugBank.d643.s0.e8" e2="DDI-DrugBank.d643.s0.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p106"
            e1="DDI-DrugBank.d643.s0.e8" e2="DDI-DrugBank.d643.s0.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p107"
            e1="DDI-DrugBank.d643.s0.e8" e2="DDI-DrugBank.d643.s0.e16" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p108"
            e1="DDI-DrugBank.d643.s0.e9" e2="DDI-DrugBank.d643.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p109"
            e1="DDI-DrugBank.d643.s0.e9" e2="DDI-DrugBank.d643.s0.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p110"
            e1="DDI-DrugBank.d643.s0.e9" e2="DDI-DrugBank.d643.s0.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p111"
            e1="DDI-DrugBank.d643.s0.e9" e2="DDI-DrugBank.d643.s0.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p112"
            e1="DDI-DrugBank.d643.s0.e9" e2="DDI-DrugBank.d643.s0.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p113"
            e1="DDI-DrugBank.d643.s0.e9" e2="DDI-DrugBank.d643.s0.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p114"
            e1="DDI-DrugBank.d643.s0.e9" e2="DDI-DrugBank.d643.s0.e16" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p115"
            e1="DDI-DrugBank.d643.s0.e10" e2="DDI-DrugBank.d643.s0.e11"
            ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d643.s0.p116"
            e1="DDI-DrugBank.d643.s0.e10" e2="DDI-DrugBank.d643.s0.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p117"
            e1="DDI-DrugBank.d643.s0.e10" e2="DDI-DrugBank.d643.s0.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p118"
            e1="DDI-DrugBank.d643.s0.e10" e2="DDI-DrugBank.d643.s0.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p119"
            e1="DDI-DrugBank.d643.s0.e10" e2="DDI-DrugBank.d643.s0.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p120"
            e1="DDI-DrugBank.d643.s0.e10" e2="DDI-DrugBank.d643.s0.e16" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p121"
            e1="DDI-DrugBank.d643.s0.e11" e2="DDI-DrugBank.d643.s0.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p122"
            e1="DDI-DrugBank.d643.s0.e11" e2="DDI-DrugBank.d643.s0.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p123"
            e1="DDI-DrugBank.d643.s0.e11" e2="DDI-DrugBank.d643.s0.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p124"
            e1="DDI-DrugBank.d643.s0.e11" e2="DDI-DrugBank.d643.s0.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p125"
            e1="DDI-DrugBank.d643.s0.e11" e2="DDI-DrugBank.d643.s0.e16" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p126"
            e1="DDI-DrugBank.d643.s0.e12" e2="DDI-DrugBank.d643.s0.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p127"
            e1="DDI-DrugBank.d643.s0.e12" e2="DDI-DrugBank.d643.s0.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p128"
            e1="DDI-DrugBank.d643.s0.e12" e2="DDI-DrugBank.d643.s0.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p129"
            e1="DDI-DrugBank.d643.s0.e12" e2="DDI-DrugBank.d643.s0.e16" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p130"
            e1="DDI-DrugBank.d643.s0.e13" e2="DDI-DrugBank.d643.s0.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p131"
            e1="DDI-DrugBank.d643.s0.e13" e2="DDI-DrugBank.d643.s0.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p132"
            e1="DDI-DrugBank.d643.s0.e13" e2="DDI-DrugBank.d643.s0.e16" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p133"
            e1="DDI-DrugBank.d643.s0.e14" e2="DDI-DrugBank.d643.s0.e15"
            ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d643.s0.p134"
            e1="DDI-DrugBank.d643.s0.e14" e2="DDI-DrugBank.d643.s0.e16" ddi="false"/>
        <pair id="DDI-DrugBank.d643.s0.p135"
            e1="DDI-DrugBank.d643.s0.e15" e2="DDI-DrugBank.d643.s0.e16" ddi="false"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d746">
    <sentence id="DDI-DrugBank.d746.s0" text="ARAMINE should be used with caution in digitalized patients, since the combination of digitalis and sympathomimetic amines may cause ectopic arrhythmias. ">
        <entity id="DDI-DrugBank.d746.s0.e0" charOffset="0-6"
            type="brand" text="ARAMINE"/>
        <entity id="DDI-DrugBank.d746.s0.e1" charOffset="86-94"
            type="group" text="digitalis"/>
        <entity id="DDI-DrugBank.d746.s0.e2" charOffset="100-121"
            type="group" text="sympathomimetic amines"/>
        <pair id="DDI-DrugBank.d746.s0.p0" e1="DDI-DrugBank.d746.s0.e0"
            e2="DDI-DrugBank.d746.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d746.s0.p1" e1="DDI-DrugBank.d746.s0.e0"
            e2="DDI-DrugBank.d746.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d746.s0.p2" e1="DDI-DrugBank.d746.s0.e1"
            e2="DDI-DrugBank.d746.s0.e2" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d746.s1" text="Monoamine oxidase inhibitors or tricyclic antidepressants may potentiate the action of sympathomimetic amines. ">
        <entity id="DDI-DrugBank.d746.s1.e0" charOffset="0-27"
            type="group" text="Monoamine oxidase inhibitors"/>
        <entity id="DDI-DrugBank.d746.s1.e1" charOffset="32-56"
            type="group" text="tricyclic antidepressants"/>
        <entity id="DDI-DrugBank.d746.s1.e2" charOffset="87-108"
            type="group" text="sympathomimetic amines"/>
        <pair id="DDI-DrugBank.d746.s1.p0" e1="DDI-DrugBank.d746.s1.e0"
            e2="DDI-DrugBank.d746.s1.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d746.s1.p1" e1="DDI-DrugBank.d746.s1.e0"
            e2="DDI-DrugBank.d746.s1.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d746.s1.p2" e1="DDI-DrugBank.d746.s1.e1"
            e2="DDI-DrugBank.d746.s1.e2" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d746.s2" text="Therefore, when initiating pressor therapy in patients receiving these drugs, the initial dose should be small and given with caution."/>
</document>
<document id="DDI-DrugBank.d630">
    <sentence id="DDI-DrugBank.d630.s0" text="Methazolamide should be used with caution in patients on steroid therapy because of the potential for developing hypokalemia. ">
        <entity id="DDI-DrugBank.d630.s0.e0" charOffset="0-12"
            type="drug" text="Methazolamide"/>
    </sentence>
    <sentence id="DDI-DrugBank.d630.s1" text="Caution is advised for patients receiving high-dose aspirin and methazolamide concomitantly, as anorexia, tachypnea, lethargy, coma and death have been reported with concomitant use of high-dose aspirin and carbonic anhydrase inhibitors.">
        <entity id="DDI-DrugBank.d630.s1.e0" charOffset="52-58"
            type="brand" text="aspirin"/>
        <entity id="DDI-DrugBank.d630.s1.e1" charOffset="64-76"
            type="drug" text="methazolamide"/>
        <entity id="DDI-DrugBank.d630.s1.e2" charOffset="195-201"
            type="brand" text="aspirin"/>
        <entity id="DDI-DrugBank.d630.s1.e3" charOffset="207-235"
            type="group" text="carbonic anhydrase inhibitors"/>
        <pair id="DDI-DrugBank.d630.s1.p0" e1="DDI-DrugBank.d630.s1.e0"
            e2="DDI-DrugBank.d630.s1.e1" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d630.s1.p1" e1="DDI-DrugBank.d630.s1.e0"
            e2="DDI-DrugBank.d630.s1.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d630.s1.p2" e1="DDI-DrugBank.d630.s1.e0"
            e2="DDI-DrugBank.d630.s1.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d630.s1.p3" e1="DDI-DrugBank.d630.s1.e1"
            e2="DDI-DrugBank.d630.s1.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d630.s1.p4" e1="DDI-DrugBank.d630.s1.e1"
            e2="DDI-DrugBank.d630.s1.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d630.s1.p5" e1="DDI-DrugBank.d630.s1.e2"
            e2="DDI-DrugBank.d630.s1.e3" ddi="true" type="effect"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d756">
    <sentence id="DDI-DrugBank.d756.s0" text="Dosages of concomitantly administered opioids should be reduced by approximately half, because levomepromazine amplifies the therapeutic actions and side-effects of opioids. ">
        <entity id="DDI-DrugBank.d756.s0.e0" charOffset="38-44"
            type="group" text="opioids"/>
        <entity id="DDI-DrugBank.d756.s0.e1" charOffset="95-109"
            type="drug" text="levomepromazine"/>
        <entity id="DDI-DrugBank.d756.s0.e2" charOffset="165-171"
            type="group" text="opioids"/>
        <pair id="DDI-DrugBank.d756.s0.p0" e1="DDI-DrugBank.d756.s0.e0"
            e2="DDI-DrugBank.d756.s0.e1" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d756.s0.p1" e1="DDI-DrugBank.d756.s0.e0"
            e2="DDI-DrugBank.d756.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d756.s0.p2" e1="DDI-DrugBank.d756.s0.e1"
            e2="DDI-DrugBank.d756.s0.e2" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d756.s1" text="Combination with tramadol (Ultram) is associated with increased risk of seizures. ">
        <entity id="DDI-DrugBank.d756.s1.e0" charOffset="17-24"
            type="drug" text="tramadol"/>
        <entity id="DDI-DrugBank.d756.s1.e1" charOffset="27-32"
            type="brand" text="Ultram"/>
        <pair id="DDI-DrugBank.d756.s1.p0" e1="DDI-DrugBank.d756.s1.e0"
            e2="DDI-DrugBank.d756.s1.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d756.s2" text="Additive sedative effects and confusional states may emerge if levomepromazine is given with benzodiazepines or barbiturates. ">
        <entity id="DDI-DrugBank.d756.s2.e0" charOffset="63-77"
            type="drug" text="levomepromazine"/>
        <entity id="DDI-DrugBank.d756.s2.e1" charOffset="93-107"
            type="group" text="benzodiazepines"/>
        <entity id="DDI-DrugBank.d756.s2.e2" charOffset="112-123"
            type="group" text="barbiturates"/>
        <pair id="DDI-DrugBank.d756.s2.p0" e1="DDI-DrugBank.d756.s2.e0"
            e2="DDI-DrugBank.d756.s2.e1" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d756.s2.p1" e1="DDI-DrugBank.d756.s2.e0"
            e2="DDI-DrugBank.d756.s2.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d756.s2.p2" e1="DDI-DrugBank.d756.s2.e1"
            e2="DDI-DrugBank.d756.s2.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d756.s3" text="This may be avoided by using the lowest dose possible with the substances in question. "/>
    <sentence id="DDI-DrugBank.d756.s4" text="Exert particular caution in combining levomepromazine with other anticholinergic drugs (tricyclic antidepressants and antiparkinsonian-agents): Particularly the elderly may develop delirium, high fever, severe obstipation, even ileus and glaucoma. ">
        <entity id="DDI-DrugBank.d756.s4.e0" charOffset="38-52"
            type="drug" text="levomepromazine"/>
        <entity id="DDI-DrugBank.d756.s4.e1" charOffset="65-85"
            type="group" text="anticholinergic drugs"/>
        <entity id="DDI-DrugBank.d756.s4.e2" charOffset="88-112"
            type="group" text="tricyclic antidepressants"/>
        <entity id="DDI-DrugBank.d756.s4.e3" charOffset="118-140"
            type="group" text="antiparkinsonian-agents"/>
        <pair id="DDI-DrugBank.d756.s4.p0" e1="DDI-DrugBank.d756.s4.e0"
            e2="DDI-DrugBank.d756.s4.e1" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d756.s4.p1" e1="DDI-DrugBank.d756.s4.e0"
            e2="DDI-DrugBank.d756.s4.e2" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d756.s4.p2" e1="DDI-DrugBank.d756.s4.e0"
            e2="DDI-DrugBank.d756.s4.e3" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d756.s4.p3" e1="DDI-DrugBank.d756.s4.e1"
            e2="DDI-DrugBank.d756.s4.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d756.s4.p4" e1="DDI-DrugBank.d756.s4.e1"
            e2="DDI-DrugBank.d756.s4.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d756.s4.p5" e1="DDI-DrugBank.d756.s4.e2"
            e2="DDI-DrugBank.d756.s4.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d756.s5" text="Reduce both the dose of levomepromazine and the dose of the other drug. ">
        <entity id="DDI-DrugBank.d756.s5.e0" charOffset="24-38"
            type="drug" text="levomepromazine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d756.s6" text="If possible, avoid such combinations. "/>
    <sentence id="DDI-DrugBank.d756.s7" text="Caffeine and/or stimulantes of the ephedrine/amphetamine type may counteract the specific actions of levomepromazine. ">
        <entity id="DDI-DrugBank.d756.s7.e0" charOffset="0-7"
            type="drug" text="Caffeine"/>
        <entity id="DDI-DrugBank.d756.s7.e1" charOffset="35-43"
            type="drug" text="ephedrine"/>
        <entity id="DDI-DrugBank.d756.s7.e2" charOffset="45-55"
            type="drug" text="amphetamine"/>
        <entity id="DDI-DrugBank.d756.s7.e3" charOffset="101-115"
            type="drug" text="levomepromazine"/>
        <pair id="DDI-DrugBank.d756.s7.p0" e1="DDI-DrugBank.d756.s7.e0"
            e2="DDI-DrugBank.d756.s7.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d756.s7.p1" e1="DDI-DrugBank.d756.s7.e0"
            e2="DDI-DrugBank.d756.s7.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d756.s7.p2" e1="DDI-DrugBank.d756.s7.e0"
            e2="DDI-DrugBank.d756.s7.e3" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d756.s7.p3" e1="DDI-DrugBank.d756.s7.e1"
            e2="DDI-DrugBank.d756.s7.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d756.s7.p4" e1="DDI-DrugBank.d756.s7.e1"
            e2="DDI-DrugBank.d756.s7.e3" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d756.s7.p5" e1="DDI-DrugBank.d756.s7.e2"
            e2="DDI-DrugBank.d756.s7.e3" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d756.s8" text="Concomitant use of these substances should be avoided. "/>
    <sentence id="DDI-DrugBank.d756.s9" text="Coffee and black tea should be avoided because they decrease the absorption of levomepromazine considerably. ">
        <entity id="DDI-DrugBank.d756.s9.e0" charOffset="79-93"
            type="drug" text="levomepromazine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d756.s10" text="The same is true for antacids; ">
        <entity id="DDI-DrugBank.d756.s10.e0" charOffset="21-28"
            type="group" text="antacids"/>
    </sentence>
    <sentence id="DDI-DrugBank.d756.s11" text="these should be given 1 to 2 hours before or after oral administration of leveomepromazine.">
        <entity id="DDI-DrugBank.d756.s11.e0" charOffset="74-89"
            type="drug" text="leveomepromazine"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d736">
    <sentence id="DDI-DrugBank.d736.s0" text="Hypokalemia can sensitize or exaggerate the response of the heart to the toxic effects of digitalis (e.g., increased ventricular irritability). ">
        <entity id="DDI-DrugBank.d736.s0.e0" charOffset="90-98"
            type="group" text="digitalis"/>
    </sentence>
    <sentence id="DDI-DrugBank.d736.s1" text="Hypokalemia may develop during concomitant use of steroids or ACTH. ">
        <entity id="DDI-DrugBank.d736.s1.e0" charOffset="50-57"
            type="group" text="steroids"/>
        <entity id="DDI-DrugBank.d736.s1.e1" charOffset="62-65"
            type="drug" text="ACTH"/>
        <pair id="DDI-DrugBank.d736.s1.p0" e1="DDI-DrugBank.d736.s1.e0"
            e2="DDI-DrugBank.d736.s1.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d736.s2" text="Insulin requirements in diabetic patients may be increased, decreased, or unchanged. ">
        <entity id="DDI-DrugBank.d736.s2.e0" charOffset="0-6"
            type="drug" text="Insulin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d736.s3" text="Thiazides may decrease arterial responsiveness to norepinephrine. ">
        <entity id="DDI-DrugBank.d736.s3.e0" charOffset="0-8"
            type="group" text="Thiazides"/>
        <entity id="DDI-DrugBank.d736.s3.e1" charOffset="50-63"
            type="drug" text="norepinephrine"/>
        <pair id="DDI-DrugBank.d736.s3.p0" e1="DDI-DrugBank.d736.s3.e0"
            e2="DDI-DrugBank.d736.s3.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d736.s4" text="This diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use. "/>
    <sentence id="DDI-DrugBank.d736.s5" text="Thiazide drugs may increase the responsiveness of tubocurarine. ">
        <entity id="DDI-DrugBank.d736.s5.e0" charOffset="0-13"
            type="group" text="Thiazide drugs"/>
        <entity id="DDI-DrugBank.d736.s5.e1" charOffset="50-61"
            type="drug" text="tubocurarine"/>
        <pair id="DDI-DrugBank.d736.s5.p0" e1="DDI-DrugBank.d736.s5.e0"
            e2="DDI-DrugBank.d736.s5.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d736.s6" text="Lithium renal clearance is reduced by thiazides, increasing the risk of lithium toxicity. ">
        <entity id="DDI-DrugBank.d736.s6.e0" charOffset="0-6"
            type="drug" text="Lithium"/>
        <entity id="DDI-DrugBank.d736.s6.e1" charOffset="38-46"
            type="group" text="thiazides"/>
        <entity id="DDI-DrugBank.d736.s6.e2" charOffset="72-78"
            type="drug" text="lithium"/>
        <pair id="DDI-DrugBank.d736.s6.p0" e1="DDI-DrugBank.d736.s6.e0"
            e2="DDI-DrugBank.d736.s6.e1" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d736.s6.p1" e1="DDI-DrugBank.d736.s6.e0"
            e2="DDI-DrugBank.d736.s6.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d736.s6.p2" e1="DDI-DrugBank.d736.s6.e1"
            e2="DDI-DrugBank.d736.s6.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d736.s7" text="Thiazides may add to or potentiate the action of other antihypertensive drugs. ">
        <entity id="DDI-DrugBank.d736.s7.e0" charOffset="0-8"
            type="group" text="Thiazides"/>
        <entity id="DDI-DrugBank.d736.s7.e1" charOffset="55-76"
            type="group" text="antihypertensive drugs"/>
        <pair id="DDI-DrugBank.d736.s7.p0" e1="DDI-DrugBank.d736.s7.e0"
            e2="DDI-DrugBank.d736.s7.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d736.s8" text="Potentiation occurs with ganglionic or peripheral adrenergic blocking drugs.">
        <entity id="DDI-DrugBank.d736.s8.e0" charOffset="25-34;50-74"
            type="group" text="ganglionic adrenergic blocking drugs"/>
        <entity id="DDI-DrugBank.d736.s8.e1" charOffset="39-74"
            type="group" text="peripheral adrenergic blocking drugs"/>
        <pair id="DDI-DrugBank.d736.s8.p0" e1="DDI-DrugBank.d736.s8.e0"
            e2="DDI-DrugBank.d736.s8.e1" ddi="false"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d706">
    <sentence id="DDI-DrugBank.d706.s0" text="Catecholamine-depleting drugs (e.g., reserpine) may have an additive effect when given with beta-blocking agents. ">
        <entity id="DDI-DrugBank.d706.s0.e0" charOffset="37-45"
            type="drug" text="reserpine"/>
        <entity id="DDI-DrugBank.d706.s0.e1" charOffset="92-111"
            type="group" text="beta-blocking agents"/>
        <pair id="DDI-DrugBank.d706.s0.p0" e1="DDI-DrugBank.d706.s0.e0"
            e2="DDI-DrugBank.d706.s0.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d706.s1" text="Patients treated with extended release metoprolol succinate plus a catecholamine depletor should therefore be closely observed for evidence of hypotension or marked bradycardia, which may produce vertigo, syncope, or postural hypotension.">
        <entity id="DDI-DrugBank.d706.s1.e0" charOffset="39-58"
            type="drug" text="metoprolol succinate"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d715">
    <sentence id="DDI-DrugBank.d715.s0" text="Caution should be observed in administering DEMSER to patients receiving phenothiazines or haloperidol because the extrapyramidal effects of these drugs can be expected to be potentiated by inhibition of catecholamine synthesis. ">
        <entity id="DDI-DrugBank.d715.s0.e0" charOffset="44-49"
            type="brand" text="DEMSER"/>
        <entity id="DDI-DrugBank.d715.s0.e1" charOffset="73-86"
            type="group" text="phenothiazines"/>
        <entity id="DDI-DrugBank.d715.s0.e2" charOffset="91-101"
            type="drug" text="haloperidol"/>
        <pair id="DDI-DrugBank.d715.s0.p0" e1="DDI-DrugBank.d715.s0.e0"
            e2="DDI-DrugBank.d715.s0.e1" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d715.s0.p1" e1="DDI-DrugBank.d715.s0.e0"
            e2="DDI-DrugBank.d715.s0.e2" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d715.s0.p2" e1="DDI-DrugBank.d715.s0.e1"
            e2="DDI-DrugBank.d715.s0.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d715.s1" text="Concurrent use of DEMSER with alcohol or other CNS depressants can increase their sedative effects.">
        <entity id="DDI-DrugBank.d715.s1.e0" charOffset="18-23"
            type="brand" text="DEMSER"/>
        <entity id="DDI-DrugBank.d715.s1.e1" charOffset="30-36"
            type="drug" text="alcohol"/>
        <entity id="DDI-DrugBank.d715.s1.e2" charOffset="47-61"
            type="drug" text="CNS depressants"/>
        <pair id="DDI-DrugBank.d715.s1.p0" e1="DDI-DrugBank.d715.s1.e0"
            e2="DDI-DrugBank.d715.s1.e1" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d715.s1.p1" e1="DDI-DrugBank.d715.s1.e0"
            e2="DDI-DrugBank.d715.s1.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d715.s1.p2" e1="DDI-DrugBank.d715.s1.e1"
            e2="DDI-DrugBank.d715.s1.e2" ddi="false"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d640">
    <sentence id="DDI-DrugBank.d640.s0" text="Diuretics: Excessive reductions in blood pressure may occur in patients on diuretic therapy when ACE inhibitors are started. ">
        <entity id="DDI-DrugBank.d640.s0.e0" charOffset="0-8"
            type="group" text="Diuretics"/>
        <entity id="DDI-DrugBank.d640.s0.e1" charOffset="97-110"
            type="group" text="ACE inhibitors"/>
        <pair id="DDI-DrugBank.d640.s0.p0" e1="DDI-DrugBank.d640.s0.e0"
            e2="DDI-DrugBank.d640.s0.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d640.s1" text="The possibility of hypotensive effects with UNIVASC    can be minimized by discontinuing diuretic therapy for several days or cautiously increasing salt intake before initiation of treatment with UNIVASC   . If this is not possible, the starting dose of moexpril should be reduced.. ">
        <entity id="DDI-DrugBank.d640.s1.e0" charOffset="44-50"
            type="brand" text="UNIVASC"/>
        <entity id="DDI-DrugBank.d640.s1.e1" charOffset="196-202"
            type="brand" text="UNIVASC"/>
        <entity id="DDI-DrugBank.d640.s1.e2" charOffset="254-261"
            type="drug" text="moexpril"/>
        <pair id="DDI-DrugBank.d640.s1.p0" e1="DDI-DrugBank.d640.s1.e0"
            e2="DDI-DrugBank.d640.s1.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s1.p1" e1="DDI-DrugBank.d640.s1.e0"
            e2="DDI-DrugBank.d640.s1.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s1.p2" e1="DDI-DrugBank.d640.s1.e1"
            e2="DDI-DrugBank.d640.s1.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d640.s2" text="Potassium Supplements and Potassium-Sparing Diuretics: UNIVASC    can increase serum potassium because it decreases aldosterone secretion. ">
        <entity id="DDI-DrugBank.d640.s2.e0" charOffset="0-8"
            type="drug" text="Potassium"/>
        <entity id="DDI-DrugBank.d640.s2.e1" charOffset="26-52"
            type="group" text="Potassium-Sparing Diuretics"/>
        <entity id="DDI-DrugBank.d640.s2.e2" charOffset="55-61"
            type="brand" text="UNIVASC"/>
        <pair id="DDI-DrugBank.d640.s2.p0" e1="DDI-DrugBank.d640.s2.e0"
            e2="DDI-DrugBank.d640.s2.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s2.p1" e1="DDI-DrugBank.d640.s2.e0"
            e2="DDI-DrugBank.d640.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s2.p2" e1="DDI-DrugBank.d640.s2.e1"
            e2="DDI-DrugBank.d640.s2.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d640.s3" text="Use of potassium-sparing diuretics (spironolactone, triamterene, amiloride) or potassium supplements concomitantly with ACE inhibitors can increase the risk of hyperkalemia. ">
        <entity id="DDI-DrugBank.d640.s3.e0" charOffset="7-33"
            type="group" text="potassium-sparing diuretics"/>
        <entity id="DDI-DrugBank.d640.s3.e1" charOffset="36-49"
            type="drug" text="spironolactone"/>
        <entity id="DDI-DrugBank.d640.s3.e2" charOffset="52-62"
            type="drug" text="triamterene"/>
        <entity id="DDI-DrugBank.d640.s3.e3" charOffset="65-73"
            type="drug" text="amiloride"/>
        <entity id="DDI-DrugBank.d640.s3.e4" charOffset="79-87"
            type="drug" text="potassium"/>
        <entity id="DDI-DrugBank.d640.s3.e5" charOffset="120-133"
            type="group" text="ACE inhibitors"/>
        <pair id="DDI-DrugBank.d640.s3.p0" e1="DDI-DrugBank.d640.s3.e0"
            e2="DDI-DrugBank.d640.s3.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s3.p1" e1="DDI-DrugBank.d640.s3.e0"
            e2="DDI-DrugBank.d640.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s3.p2" e1="DDI-DrugBank.d640.s3.e0"
            e2="DDI-DrugBank.d640.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s3.p3" e1="DDI-DrugBank.d640.s3.e0"
            e2="DDI-DrugBank.d640.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s3.p4" e1="DDI-DrugBank.d640.s3.e0"
            e2="DDI-DrugBank.d640.s3.e5" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d640.s3.p5" e1="DDI-DrugBank.d640.s3.e1"
            e2="DDI-DrugBank.d640.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s3.p6" e1="DDI-DrugBank.d640.s3.e1"
            e2="DDI-DrugBank.d640.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s3.p7" e1="DDI-DrugBank.d640.s3.e1"
            e2="DDI-DrugBank.d640.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s3.p8" e1="DDI-DrugBank.d640.s3.e1"
            e2="DDI-DrugBank.d640.s3.e5" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d640.s3.p9" e1="DDI-DrugBank.d640.s3.e2"
            e2="DDI-DrugBank.d640.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s3.p10" e1="DDI-DrugBank.d640.s3.e2"
            e2="DDI-DrugBank.d640.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s3.p11" e1="DDI-DrugBank.d640.s3.e2"
            e2="DDI-DrugBank.d640.s3.e5" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d640.s3.p12" e1="DDI-DrugBank.d640.s3.e3"
            e2="DDI-DrugBank.d640.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s3.p13" e1="DDI-DrugBank.d640.s3.e3"
            e2="DDI-DrugBank.d640.s3.e5" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d640.s3.p14" e1="DDI-DrugBank.d640.s3.e4"
            e2="DDI-DrugBank.d640.s3.e5" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d640.s4" text="Therefore, if concomitant use of such agents is indicated, they should be given with caution and the patient's serum potassium should be monitored. "/>
    <sentence id="DDI-DrugBank.d640.s5" text="Oral Anticoagulants: Interaction studies with warfarin failed to identify any clinically important effect on the serum concentrations of the anticoagulant or on its anticoagulant effect. ">
        <entity id="DDI-DrugBank.d640.s5.e0" charOffset="5-18"
            type="group" text="Anticoagulants"/>
        <entity id="DDI-DrugBank.d640.s5.e1" charOffset="46-53"
            type="drug" text="warfarin"/>
        <entity id="DDI-DrugBank.d640.s5.e2" charOffset="141-153"
            type="group" text="anticoagulant"/>
        <pair id="DDI-DrugBank.d640.s5.p0" e1="DDI-DrugBank.d640.s5.e0"
            e2="DDI-DrugBank.d640.s5.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s5.p1" e1="DDI-DrugBank.d640.s5.e0"
            e2="DDI-DrugBank.d640.s5.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s5.p2" e1="DDI-DrugBank.d640.s5.e1"
            e2="DDI-DrugBank.d640.s5.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d640.s6" text="Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium. ">
        <entity id="DDI-DrugBank.d640.s6.e0" charOffset="0-6"
            type="drug" text="Lithium"/>
        <entity id="DDI-DrugBank.d640.s6.e1" charOffset="25-31"
            type="drug" text="lithium"/>
        <entity id="DDI-DrugBank.d640.s6.e2" charOffset="56-62"
            type="drug" text="lithium"/>
        <entity id="DDI-DrugBank.d640.s6.e3" charOffset="114-127"
            type="group" text="ACE inhibitors"/>
        <entity id="DDI-DrugBank.d640.s6.e4" charOffset="149-155"
            type="drug" text="lithium"/>
        <pair id="DDI-DrugBank.d640.s6.p0" e1="DDI-DrugBank.d640.s6.e0"
            e2="DDI-DrugBank.d640.s6.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s6.p1" e1="DDI-DrugBank.d640.s6.e0"
            e2="DDI-DrugBank.d640.s6.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s6.p2" e1="DDI-DrugBank.d640.s6.e0"
            e2="DDI-DrugBank.d640.s6.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s6.p3" e1="DDI-DrugBank.d640.s6.e0"
            e2="DDI-DrugBank.d640.s6.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s6.p4" e1="DDI-DrugBank.d640.s6.e1"
            e2="DDI-DrugBank.d640.s6.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s6.p5" e1="DDI-DrugBank.d640.s6.e1"
            e2="DDI-DrugBank.d640.s6.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s6.p6" e1="DDI-DrugBank.d640.s6.e1"
            e2="DDI-DrugBank.d640.s6.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s6.p7" e1="DDI-DrugBank.d640.s6.e2"
            e2="DDI-DrugBank.d640.s6.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s6.p8" e1="DDI-DrugBank.d640.s6.e2"
            e2="DDI-DrugBank.d640.s6.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s6.p9" e1="DDI-DrugBank.d640.s6.e3"
            e2="DDI-DrugBank.d640.s6.e4" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d640.s7" text="These drugs should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended. ">
        <entity id="DDI-DrugBank.d640.s7.e0" charOffset="84-90"
            type="drug" text="lithium"/>
    </sentence>
    <sentence id="DDI-DrugBank.d640.s8" text="If a diuretic is also used, the risk of lithium toxicity may be increased. ">
        <entity id="DDI-DrugBank.d640.s8.e0" charOffset="5-12"
            type="group" text="diuretic"/>
        <entity id="DDI-DrugBank.d640.s8.e1" charOffset="40-46"
            type="drug" text="lithium"/>
        <pair id="DDI-DrugBank.d640.s8.p0" e1="DDI-DrugBank.d640.s8.e0"
            e2="DDI-DrugBank.d640.s8.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d640.s9" text="Other Agents: No clinically important pharmacokinetic interactions occurred when UNIVASC    was administered concomitantly with hydrochlorothiazide, digoxin, or cimetidine. ">
        <entity id="DDI-DrugBank.d640.s9.e0" charOffset="81-87"
            type="brand" text="UNIVASC"/>
        <entity id="DDI-DrugBank.d640.s9.e1" charOffset="128-146"
            type="drug" text="hydrochlorothiazide"/>
        <entity id="DDI-DrugBank.d640.s9.e2" charOffset="149-155"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d640.s9.e3" charOffset="161-170"
            type="drug" text="cimetidine"/>
        <pair id="DDI-DrugBank.d640.s9.p0" e1="DDI-DrugBank.d640.s9.e0"
            e2="DDI-DrugBank.d640.s9.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s9.p1" e1="DDI-DrugBank.d640.s9.e0"
            e2="DDI-DrugBank.d640.s9.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s9.p2" e1="DDI-DrugBank.d640.s9.e0"
            e2="DDI-DrugBank.d640.s9.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s9.p3" e1="DDI-DrugBank.d640.s9.e1"
            e2="DDI-DrugBank.d640.s9.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s9.p4" e1="DDI-DrugBank.d640.s9.e1"
            e2="DDI-DrugBank.d640.s9.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s9.p5" e1="DDI-DrugBank.d640.s9.e2"
            e2="DDI-DrugBank.d640.s9.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d640.s10" text="UNIVASC    has been used in clinical trials concomitantly with calcium-channel-blocking agents, diuretics, H2 blockers, digoxin, oral hypoglycemic agents, and cholesterol-lowering agents. ">
        <entity id="DDI-DrugBank.d640.s10.e0" charOffset="0-6"
            type="brand" text="UNIVASC"/>
        <entity id="DDI-DrugBank.d640.s10.e1" charOffset="63-93"
            type="group" text="calcium-channel-blocking agents"/>
        <entity id="DDI-DrugBank.d640.s10.e2" charOffset="96-104"
            type="group" text="diuretics"/>
        <entity id="DDI-DrugBank.d640.s10.e3" charOffset="107-117"
            type="group" text="H2 blockers"/>
        <entity id="DDI-DrugBank.d640.s10.e4" charOffset="120-126"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d640.s10.e5" charOffset="134-152"
            type="group" text="hypoglycemic agents"/>
        <pair id="DDI-DrugBank.d640.s10.p0"
            e1="DDI-DrugBank.d640.s10.e0" e2="DDI-DrugBank.d640.s10.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s10.p1"
            e1="DDI-DrugBank.d640.s10.e0" e2="DDI-DrugBank.d640.s10.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s10.p2"
            e1="DDI-DrugBank.d640.s10.e0" e2="DDI-DrugBank.d640.s10.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s10.p3"
            e1="DDI-DrugBank.d640.s10.e0" e2="DDI-DrugBank.d640.s10.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s10.p4"
            e1="DDI-DrugBank.d640.s10.e0" e2="DDI-DrugBank.d640.s10.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s10.p5"
            e1="DDI-DrugBank.d640.s10.e1" e2="DDI-DrugBank.d640.s10.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s10.p6"
            e1="DDI-DrugBank.d640.s10.e1" e2="DDI-DrugBank.d640.s10.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s10.p7"
            e1="DDI-DrugBank.d640.s10.e1" e2="DDI-DrugBank.d640.s10.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s10.p8"
            e1="DDI-DrugBank.d640.s10.e1" e2="DDI-DrugBank.d640.s10.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s10.p9"
            e1="DDI-DrugBank.d640.s10.e2" e2="DDI-DrugBank.d640.s10.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s10.p10"
            e1="DDI-DrugBank.d640.s10.e2" e2="DDI-DrugBank.d640.s10.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s10.p11"
            e1="DDI-DrugBank.d640.s10.e2" e2="DDI-DrugBank.d640.s10.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s10.p12"
            e1="DDI-DrugBank.d640.s10.e3" e2="DDI-DrugBank.d640.s10.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s10.p13"
            e1="DDI-DrugBank.d640.s10.e3" e2="DDI-DrugBank.d640.s10.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d640.s10.p14"
            e1="DDI-DrugBank.d640.s10.e4" e2="DDI-DrugBank.d640.s10.e5" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d640.s11" text="There was no evidence of clinically important adverse interactions."/>
</document>
<document id="DDI-DrugBank.d580">
    <sentence id="DDI-DrugBank.d580.s0" text="In clinical studies, the concurrent administration of the ASMANEX TWISTHALER    inhaler and other drugs commonly used in the treatment of asthma was not associated with any unusual adverse events. ">
        <entity id="DDI-DrugBank.d580.s0.e0" charOffset="58-75"
            type="brand" text="ASMANEX TWISTHALER"/>
    </sentence>
    <sentence id="DDI-DrugBank.d580.s1" text="However, ketoconazole, a potent inhibitor of cytochrome P450 3A4, may increase plasma levels of mometasone furoate during concomitant dosing.">
        <entity id="DDI-DrugBank.d580.s1.e0" charOffset="9-20"
            type="drug" text="ketoconazole"/>
        <entity id="DDI-DrugBank.d580.s1.e1" charOffset="96-113"
            type="drug" text="mometasone furoate"/>
        <pair id="DDI-DrugBank.d580.s1.p0" e1="DDI-DrugBank.d580.s1.e0"
            e2="DDI-DrugBank.d580.s1.e1" ddi="true" type="mechanism"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d739">
    <sentence id="DDI-DrugBank.d739.s0" text="Montelukast at a Dose of 10 mg Once Daily Dosed to Pharmacokinetic Steady State  - did not cause clinically significant changes in the kinetics of a single intravenous dose of theophylline (predominantly a cytochrome P450 1A2 substrate). ">
        <entity id="DDI-DrugBank.d739.s0.e0" charOffset="0-10"
            type="drug" text="Montelukast"/>
        <entity id="DDI-DrugBank.d739.s0.e1" charOffset="176-187"
            type="drug" text="theophylline"/>
        <pair id="DDI-DrugBank.d739.s0.p0" e1="DDI-DrugBank.d739.s0.e0"
            e2="DDI-DrugBank.d739.s0.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d739.s1" text="- did not change the pharmacokinetic profile of warfarin (a substrate of cytochromes P450 2A6 and 2C9) or influence the effect of a single 30-mg oral dose of warfarin on prothrombin time or the INR (International Normalized Ratio). ">
        <entity id="DDI-DrugBank.d739.s1.e0" charOffset="48-55"
            type="drug" text="warfarin"/>
        <entity id="DDI-DrugBank.d739.s1.e1" charOffset="158-165"
            type="drug" text="warfarin"/>
        <pair id="DDI-DrugBank.d739.s1.p0" e1="DDI-DrugBank.d739.s1.e0"
            e2="DDI-DrugBank.d739.s1.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d739.s2" text="- did not change the pharmacokinetic profile or urinary excretion of immunoreactive digoxin. ">
        <entity id="DDI-DrugBank.d739.s2.e0" charOffset="84-90"
            type="drug" text="digoxin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d739.s3" text="- did not change the plasma concentration profile of terfenadine (a substrate of cytochrome P450 3A4) or fexofenadine, its carboxylated metabolite, and did not prolong the QTc interval following co-administration with terfenadine 60 mg twice daily. ">
        <entity id="DDI-DrugBank.d739.s3.e0" charOffset="53-63"
            type="drug" text="terfenadine"/>
        <entity id="DDI-DrugBank.d739.s3.e1" charOffset="105-116"
            type="drug" text="fexofenadine"/>
        <entity id="DDI-DrugBank.d739.s3.e2" charOffset="218-228"
            type="drug" text="terfenadine"/>
        <pair id="DDI-DrugBank.d739.s3.p0" e1="DDI-DrugBank.d739.s3.e0"
            e2="DDI-DrugBank.d739.s3.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s3.p1" e1="DDI-DrugBank.d739.s3.e0"
            e2="DDI-DrugBank.d739.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s3.p2" e1="DDI-DrugBank.d739.s3.e1"
            e2="DDI-DrugBank.d739.s3.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d739.s4" text="Montelukast at Doses of    100 mg Daily Dosed to Pharmacokinetic Steady State:  - did not significantly alter the plasma concentrations of either component of an oral contraceptive containing norethindrone 1 mg/ethinyl estradiol 35 mcg. ">
        <entity id="DDI-DrugBank.d739.s4.e0" charOffset="0-10"
            type="drug" text="Montelukast"/>
        <entity id="DDI-DrugBank.d739.s4.e1" charOffset="167-179"
            type="group" text="contraceptive"/>
        <entity id="DDI-DrugBank.d739.s4.e2" charOffset="192-204"
            type="drug" text="norethindrone"/>
        <entity id="DDI-DrugBank.d739.s4.e3" charOffset="219-227"
            type="drug" text="estradiol"/>
        <pair id="DDI-DrugBank.d739.s4.p0" e1="DDI-DrugBank.d739.s4.e0"
            e2="DDI-DrugBank.d739.s4.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s4.p1" e1="DDI-DrugBank.d739.s4.e0"
            e2="DDI-DrugBank.d739.s4.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s4.p2" e1="DDI-DrugBank.d739.s4.e0"
            e2="DDI-DrugBank.d739.s4.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s4.p3" e1="DDI-DrugBank.d739.s4.e1"
            e2="DDI-DrugBank.d739.s4.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s4.p4" e1="DDI-DrugBank.d739.s4.e1"
            e2="DDI-DrugBank.d739.s4.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s4.p5" e1="DDI-DrugBank.d739.s4.e2"
            e2="DDI-DrugBank.d739.s4.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d739.s5" text="- did not cause any clinically significant change in plasma profiles of prednisone or prednisolone following administration of either oral prednisone or intravenous prednisolone.  ">
        <entity id="DDI-DrugBank.d739.s5.e0" charOffset="72-81"
            type="drug" text="prednisone"/>
        <entity id="DDI-DrugBank.d739.s5.e1" charOffset="86-97"
            type="drug" text="prednisolone"/>
        <entity id="DDI-DrugBank.d739.s5.e2" charOffset="139-148"
            type="drug" text="prednisone"/>
        <entity id="DDI-DrugBank.d739.s5.e3" charOffset="165-176"
            type="drug" text="prednisolone"/>
        <pair id="DDI-DrugBank.d739.s5.p0" e1="DDI-DrugBank.d739.s5.e0"
            e2="DDI-DrugBank.d739.s5.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s5.p1" e1="DDI-DrugBank.d739.s5.e0"
            e2="DDI-DrugBank.d739.s5.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s5.p2" e1="DDI-DrugBank.d739.s5.e0"
            e2="DDI-DrugBank.d739.s5.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s5.p3" e1="DDI-DrugBank.d739.s5.e1"
            e2="DDI-DrugBank.d739.s5.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s5.p4" e1="DDI-DrugBank.d739.s5.e1"
            e2="DDI-DrugBank.d739.s5.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s5.p5" e1="DDI-DrugBank.d739.s5.e2"
            e2="DDI-DrugBank.d739.s5.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d739.s6" text="Phenobarbital, which induces hepatic metabolism, decreased the AUC of montelukast approximately 40% following a single 10-mg dose of montelukast. ">
        <entity id="DDI-DrugBank.d739.s6.e0" charOffset="0-12"
            type="drug" text="Phenobarbital"/>
        <entity id="DDI-DrugBank.d739.s6.e1" charOffset="70-80"
            type="drug" text="montelukast"/>
        <entity id="DDI-DrugBank.d739.s6.e2" charOffset="133-143"
            type="drug" text="montelukast"/>
        <pair id="DDI-DrugBank.d739.s6.p0" e1="DDI-DrugBank.d739.s6.e0"
            e2="DDI-DrugBank.d739.s6.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s6.p1" e1="DDI-DrugBank.d739.s6.e0"
            e2="DDI-DrugBank.d739.s6.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s6.p2" e1="DDI-DrugBank.d739.s6.e1"
            e2="DDI-DrugBank.d739.s6.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d739.s7" text="No dosage adjustment for montelukast is recommended. ">
        <entity id="DDI-DrugBank.d739.s7.e0" charOffset="25-35"
            type="drug" text="montelukast"/>
    </sentence>
    <sentence id="DDI-DrugBank.d739.s8" text="It is reasonable to employ appropriate clinical monitoring when potent cytochrome P450 enzyme inducers, such as phenobarbital or rifampin, are co-administered with montelukast. ">
        <entity id="DDI-DrugBank.d739.s8.e0" charOffset="112-124"
            type="drug" text="phenobarbital"/>
        <entity id="DDI-DrugBank.d739.s8.e1" charOffset="129-136"
            type="drug" text="rifampin"/>
        <entity id="DDI-DrugBank.d739.s8.e2" charOffset="164-174"
            type="drug" text="montelukast"/>
        <pair id="DDI-DrugBank.d739.s8.p0" e1="DDI-DrugBank.d739.s8.e0"
            e2="DDI-DrugBank.d739.s8.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s8.p1" e1="DDI-DrugBank.d739.s8.e0"
            e2="DDI-DrugBank.d739.s8.e2" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d739.s8.p2" e1="DDI-DrugBank.d739.s8.e1"
            e2="DDI-DrugBank.d739.s8.e2" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d739.s9" text="Montelukast has been administered with other therapies routinely used in the prophylaxis and chronic treatment of asthma with no apparent increase in adverse reactions. ">
        <entity id="DDI-DrugBank.d739.s9.e0" charOffset="0-10"
            type="drug" text="Montelukast"/>
    </sentence>
    <sentence id="DDI-DrugBank.d739.s10" text="In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and warfarin. ">
        <entity id="DDI-DrugBank.d739.s10.e0" charOffset="62-72"
            type="drug" text="montelukast"/>
        <entity id="DDI-DrugBank.d739.s10.e1" charOffset="164-175"
            type="drug" text="theophylline"/>
        <entity id="DDI-DrugBank.d739.s10.e2" charOffset="178-187"
            type="drug" text="prednisone"/>
        <entity id="DDI-DrugBank.d739.s10.e3" charOffset="190-201"
            type="drug" text="prednisolone"/>
        <entity id="DDI-DrugBank.d739.s10.e4" charOffset="209-222"
            type="group" text="contraceptives"/>
        <entity id="DDI-DrugBank.d739.s10.e5" charOffset="225-237"
            type="drug" text="norethindrone"/>
        <entity id="DDI-DrugBank.d739.s10.e6" charOffset="244-260"
            type="drug" text="ethinyl estradiol"/>
        <entity id="DDI-DrugBank.d739.s10.e7" charOffset="271-281"
            type="drug" text="terfenadine"/>
        <entity id="DDI-DrugBank.d739.s10.e8" charOffset="284-290"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d739.s10.e9" charOffset="297-304"
            type="drug" text="warfarin"/>
        <pair id="DDI-DrugBank.d739.s10.p0"
            e1="DDI-DrugBank.d739.s10.e0" e2="DDI-DrugBank.d739.s10.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p1"
            e1="DDI-DrugBank.d739.s10.e0" e2="DDI-DrugBank.d739.s10.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p2"
            e1="DDI-DrugBank.d739.s10.e0" e2="DDI-DrugBank.d739.s10.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p3"
            e1="DDI-DrugBank.d739.s10.e0" e2="DDI-DrugBank.d739.s10.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p4"
            e1="DDI-DrugBank.d739.s10.e0" e2="DDI-DrugBank.d739.s10.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p5"
            e1="DDI-DrugBank.d739.s10.e0" e2="DDI-DrugBank.d739.s10.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p6"
            e1="DDI-DrugBank.d739.s10.e0" e2="DDI-DrugBank.d739.s10.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p7"
            e1="DDI-DrugBank.d739.s10.e0" e2="DDI-DrugBank.d739.s10.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p8"
            e1="DDI-DrugBank.d739.s10.e0" e2="DDI-DrugBank.d739.s10.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p9"
            e1="DDI-DrugBank.d739.s10.e1" e2="DDI-DrugBank.d739.s10.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p10"
            e1="DDI-DrugBank.d739.s10.e1" e2="DDI-DrugBank.d739.s10.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p11"
            e1="DDI-DrugBank.d739.s10.e1" e2="DDI-DrugBank.d739.s10.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p12"
            e1="DDI-DrugBank.d739.s10.e1" e2="DDI-DrugBank.d739.s10.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p13"
            e1="DDI-DrugBank.d739.s10.e1" e2="DDI-DrugBank.d739.s10.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p14"
            e1="DDI-DrugBank.d739.s10.e1" e2="DDI-DrugBank.d739.s10.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p15"
            e1="DDI-DrugBank.d739.s10.e1" e2="DDI-DrugBank.d739.s10.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p16"
            e1="DDI-DrugBank.d739.s10.e1" e2="DDI-DrugBank.d739.s10.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p17"
            e1="DDI-DrugBank.d739.s10.e2" e2="DDI-DrugBank.d739.s10.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p18"
            e1="DDI-DrugBank.d739.s10.e2" e2="DDI-DrugBank.d739.s10.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p19"
            e1="DDI-DrugBank.d739.s10.e2" e2="DDI-DrugBank.d739.s10.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p20"
            e1="DDI-DrugBank.d739.s10.e2" e2="DDI-DrugBank.d739.s10.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p21"
            e1="DDI-DrugBank.d739.s10.e2" e2="DDI-DrugBank.d739.s10.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p22"
            e1="DDI-DrugBank.d739.s10.e2" e2="DDI-DrugBank.d739.s10.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p23"
            e1="DDI-DrugBank.d739.s10.e2" e2="DDI-DrugBank.d739.s10.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p24"
            e1="DDI-DrugBank.d739.s10.e3" e2="DDI-DrugBank.d739.s10.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p25"
            e1="DDI-DrugBank.d739.s10.e3" e2="DDI-DrugBank.d739.s10.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p26"
            e1="DDI-DrugBank.d739.s10.e3" e2="DDI-DrugBank.d739.s10.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p27"
            e1="DDI-DrugBank.d739.s10.e3" e2="DDI-DrugBank.d739.s10.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p28"
            e1="DDI-DrugBank.d739.s10.e3" e2="DDI-DrugBank.d739.s10.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p29"
            e1="DDI-DrugBank.d739.s10.e3" e2="DDI-DrugBank.d739.s10.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p30"
            e1="DDI-DrugBank.d739.s10.e4" e2="DDI-DrugBank.d739.s10.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p31"
            e1="DDI-DrugBank.d739.s10.e4" e2="DDI-DrugBank.d739.s10.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p32"
            e1="DDI-DrugBank.d739.s10.e4" e2="DDI-DrugBank.d739.s10.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p33"
            e1="DDI-DrugBank.d739.s10.e4" e2="DDI-DrugBank.d739.s10.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p34"
            e1="DDI-DrugBank.d739.s10.e4" e2="DDI-DrugBank.d739.s10.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p35"
            e1="DDI-DrugBank.d739.s10.e5" e2="DDI-DrugBank.d739.s10.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p36"
            e1="DDI-DrugBank.d739.s10.e5" e2="DDI-DrugBank.d739.s10.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p37"
            e1="DDI-DrugBank.d739.s10.e5" e2="DDI-DrugBank.d739.s10.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p38"
            e1="DDI-DrugBank.d739.s10.e5" e2="DDI-DrugBank.d739.s10.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p39"
            e1="DDI-DrugBank.d739.s10.e6" e2="DDI-DrugBank.d739.s10.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p40"
            e1="DDI-DrugBank.d739.s10.e6" e2="DDI-DrugBank.d739.s10.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p41"
            e1="DDI-DrugBank.d739.s10.e6" e2="DDI-DrugBank.d739.s10.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p42"
            e1="DDI-DrugBank.d739.s10.e7" e2="DDI-DrugBank.d739.s10.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p43"
            e1="DDI-DrugBank.d739.s10.e7" e2="DDI-DrugBank.d739.s10.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s10.p44"
            e1="DDI-DrugBank.d739.s10.e8" e2="DDI-DrugBank.d739.s10.e9" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d739.s11" text="Although additional specific interaction studies were not performed, montelukast was used concomitantly with a wide range of commonly prescribed drugs in clinical studies without evidence of clinical adverse interactions. ">
        <entity id="DDI-DrugBank.d739.s11.e0" charOffset="69-79"
            type="drug" text="montelukast"/>
    </sentence>
    <sentence id="DDI-DrugBank.d739.s12" text="These medications included thyroid hormones, sedative hypnotics, non-steroidal anti-inflammatory agents, benzodiazepines, and decongestants. ">
        <entity id="DDI-DrugBank.d739.s12.e0" charOffset="27-42"
            type="group" text="thyroid hormones"/>
        <entity id="DDI-DrugBank.d739.s12.e1" charOffset="45-62"
            type="group" text="sedative hypnotics"/>
        <entity id="DDI-DrugBank.d739.s12.e2" charOffset="65-102"
            type="group" text="non-steroidal anti-inflammatory agents"/>
        <entity id="DDI-DrugBank.d739.s12.e3" charOffset="105-119"
            type="group" text="benzodiazepines"/>
        <entity id="DDI-DrugBank.d739.s12.e4" charOffset="126-138"
            type="group" text="decongestants"/>
        <pair id="DDI-DrugBank.d739.s12.p0"
            e1="DDI-DrugBank.d739.s12.e0" e2="DDI-DrugBank.d739.s12.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s12.p1"
            e1="DDI-DrugBank.d739.s12.e0" e2="DDI-DrugBank.d739.s12.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s12.p2"
            e1="DDI-DrugBank.d739.s12.e0" e2="DDI-DrugBank.d739.s12.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s12.p3"
            e1="DDI-DrugBank.d739.s12.e0" e2="DDI-DrugBank.d739.s12.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s12.p4"
            e1="DDI-DrugBank.d739.s12.e1" e2="DDI-DrugBank.d739.s12.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s12.p5"
            e1="DDI-DrugBank.d739.s12.e1" e2="DDI-DrugBank.d739.s12.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s12.p6"
            e1="DDI-DrugBank.d739.s12.e1" e2="DDI-DrugBank.d739.s12.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s12.p7"
            e1="DDI-DrugBank.d739.s12.e2" e2="DDI-DrugBank.d739.s12.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s12.p8"
            e1="DDI-DrugBank.d739.s12.e2" e2="DDI-DrugBank.d739.s12.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s12.p9"
            e1="DDI-DrugBank.d739.s12.e3" e2="DDI-DrugBank.d739.s12.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d739.s13" text="Phenobarbital, which induces hepatic metabolism, decreased the AUC of montelukast approximately 40% following a single 10-mg dose of montelukast. ">
        <entity id="DDI-DrugBank.d739.s13.e0" charOffset="0-12"
            type="drug" text="Phenobarbital"/>
        <entity id="DDI-DrugBank.d739.s13.e1" charOffset="70-80"
            type="drug" text="montelukast"/>
        <entity id="DDI-DrugBank.d739.s13.e2" charOffset="133-143"
            type="drug" text="montelukast"/>
        <pair id="DDI-DrugBank.d739.s13.p0"
            e1="DDI-DrugBank.d739.s13.e0" e2="DDI-DrugBank.d739.s13.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s13.p1"
            e1="DDI-DrugBank.d739.s13.e0" e2="DDI-DrugBank.d739.s13.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s13.p2"
            e1="DDI-DrugBank.d739.s13.e1" e2="DDI-DrugBank.d739.s13.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d739.s14" text="No dosage adjustment for montelukast is recommended. ">
        <entity id="DDI-DrugBank.d739.s14.e0" charOffset="25-35"
            type="drug" text="montelukast"/>
    </sentence>
    <sentence id="DDI-DrugBank.d739.s15" text="It is reasonable to employ appropriate clinical monitoring when potent cytochrome P450 enzyme inducers, such as phenobarbital or rifampin, are co-administered with montelukast.">
        <entity id="DDI-DrugBank.d739.s15.e0" charOffset="112-124"
            type="drug" text="phenobarbital"/>
        <entity id="DDI-DrugBank.d739.s15.e1" charOffset="129-136"
            type="drug" text="rifampin"/>
        <entity id="DDI-DrugBank.d739.s15.e2" charOffset="164-174"
            type="drug" text="montelukast"/>
        <pair id="DDI-DrugBank.d739.s15.p0"
            e1="DDI-DrugBank.d739.s15.e0" e2="DDI-DrugBank.d739.s15.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d739.s15.p1"
            e1="DDI-DrugBank.d739.s15.e0" e2="DDI-DrugBank.d739.s15.e2"
            ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d739.s15.p2"
            e1="DDI-DrugBank.d739.s15.e1" e2="DDI-DrugBank.d739.s15.e2"
            ddi="true" type="advise"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d346">
    <sentence id="DDI-DrugBank.d346.s0" text="Studies to evaluate possible interactions between REVIA and drugs other than opiates have not been performed.">
        <entity id="DDI-DrugBank.d346.s0.e0" charOffset="50-54"
            type="brand" text="REVIA"/>
        <entity id="DDI-DrugBank.d346.s0.e1" charOffset="77-83"
            type="group" text="opiates"/>
        <pair id="DDI-DrugBank.d346.s0.p0" e1="DDI-DrugBank.d346.s0.e0"
            e2="DDI-DrugBank.d346.s0.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d346.s1" text="Consequently, caution is advised if the concomitant administration of REVIA and other drugs is required.">
        <entity id="DDI-DrugBank.d346.s1.e0" charOffset="70-74"
            type="brand" text="REVIA"/>
    </sentence>
    <sentence id="DDI-DrugBank.d346.s2" text="The safety and efficacy of concomitant use of REVIA and disulfiram is unknown, and the concomitant use of two potentially hepatotoxic medications is not ordinarily recommended unless the probable benefits outweigh the known risks.">
        <entity id="DDI-DrugBank.d346.s2.e0" charOffset="46-50"
            type="brand" text="REVIA"/>
        <entity id="DDI-DrugBank.d346.s2.e1" charOffset="56-65"
            type="drug" text="disulfiram"/>
        <pair id="DDI-DrugBank.d346.s2.p0" e1="DDI-DrugBank.d346.s2.e0"
            e2="DDI-DrugBank.d346.s2.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d346.s3" text="Lethargy and somnolence have been reported following doses of REVIA and thioridazine.">
        <entity id="DDI-DrugBank.d346.s3.e0" charOffset="62-66"
            type="brand" text="REVIA"/>
        <entity id="DDI-DrugBank.d346.s3.e1" charOffset="72-83"
            type="drug" text="thioridazine"/>
        <pair id="DDI-DrugBank.d346.s3.p0" e1="DDI-DrugBank.d346.s3.e0"
            e2="DDI-DrugBank.d346.s3.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d346.s4" text="Patients taking REVIA may not benefit from opioid containing medicines, such as cough and cold preparations, antidiarrheal preparations, and opioid analgesics.">
        <entity id="DDI-DrugBank.d346.s4.e0" charOffset="16-20"
            type="brand" text="REVIA"/>
        <entity id="DDI-DrugBank.d346.s4.e1" charOffset="43-48"
            type="group" text="opioid"/>
        <entity id="DDI-DrugBank.d346.s4.e2" charOffset="141-157"
            type="group" text="opioid analgesics"/>
        <pair id="DDI-DrugBank.d346.s4.p0" e1="DDI-DrugBank.d346.s4.e0"
            e2="DDI-DrugBank.d346.s4.e1" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d346.s4.p1" e1="DDI-DrugBank.d346.s4.e0"
            e2="DDI-DrugBank.d346.s4.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d346.s4.p2" e1="DDI-DrugBank.d346.s4.e1"
            e2="DDI-DrugBank.d346.s4.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d346.s5" text="In an emergency situation when opioid analgesia must be administered to a patient receiving REVIA, the amount of opioid required may be greater than usual, and the resulting respiratory depression may be deeper and more prolonged.">
        <entity id="DDI-DrugBank.d346.s5.e0" charOffset="92-96"
            type="brand" text="REVIA"/>
        <entity id="DDI-DrugBank.d346.s5.e1" charOffset="113-118"
            type="group" text="opioid"/>
        <pair id="DDI-DrugBank.d346.s5.p0" e1="DDI-DrugBank.d346.s5.e0"
            e2="DDI-DrugBank.d346.s5.e1" ddi="true" type="effect"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d14">
    <sentence id="DDI-DrugBank.d14.s0" text="The vasodilating effects of nitroglycerin may be additive with those of other vasodilators.">
        <entity id="DDI-DrugBank.d14.s0.e0" charOffset="28-40"
            type="drug" text="nitroglycerin"/>
        <entity id="DDI-DrugBank.d14.s0.e1" charOffset="78-89"
            type="group" text="vasodilators"/>
        <pair id="DDI-DrugBank.d14.s0.p0" e1="DDI-DrugBank.d14.s0.e0"
            e2="DDI-DrugBank.d14.s0.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d14.s1" text="Alcohol, in particular, has been found to exhibit additive effects of this variety.">
        <entity id="DDI-DrugBank.d14.s1.e0" charOffset="0-6" type="drug" text="Alcohol"/>
    </sentence>
    <sentence id="DDI-DrugBank.d14.s2" text="Marked symptomatic orthostatic hypotension has been reported when calcium channel blockers and organic nitrates were used in combination.">
        <entity id="DDI-DrugBank.d14.s2.e0" charOffset="66-89"
            type="group" text="calcium channel blockers"/>
        <entity id="DDI-DrugBank.d14.s2.e1" charOffset="103-110"
            type="group" text="nitrates"/>
        <pair id="DDI-DrugBank.d14.s2.p0" e1="DDI-DrugBank.d14.s2.e0"
            e2="DDI-DrugBank.d14.s2.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d14.s3" text="Dose adjustments of either class of agents may be necessary."/>
</document>
<document id="DDI-DrugBank.d475">
    <sentence id="DDI-DrugBank.d475.s0" text="No interactions have been observed between nizatidine and theophylline, chlordiazepoxide, lorazepam, lidocaine, phenytoin, and warfarin.">
        <entity id="DDI-DrugBank.d475.s0.e0" charOffset="43-52"
            type="drug" text="nizatidine"/>
        <entity id="DDI-DrugBank.d475.s0.e1" charOffset="58-69"
            type="drug" text="theophylline"/>
        <entity id="DDI-DrugBank.d475.s0.e2" charOffset="72-87"
            type="drug" text="chlordiazepoxide"/>
        <entity id="DDI-DrugBank.d475.s0.e3" charOffset="90-98"
            type="drug" text="lorazepam"/>
        <entity id="DDI-DrugBank.d475.s0.e4" charOffset="101-109"
            type="drug" text="lidocaine"/>
        <entity id="DDI-DrugBank.d475.s0.e5" charOffset="112-120"
            type="drug" text="phenytoin"/>
        <entity id="DDI-DrugBank.d475.s0.e6" charOffset="127-134"
            type="drug" text="warfarin"/>
        <pair id="DDI-DrugBank.d475.s0.p0" e1="DDI-DrugBank.d475.s0.e0"
            e2="DDI-DrugBank.d475.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d475.s0.p1" e1="DDI-DrugBank.d475.s0.e0"
            e2="DDI-DrugBank.d475.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d475.s0.p2" e1="DDI-DrugBank.d475.s0.e0"
            e2="DDI-DrugBank.d475.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d475.s0.p3" e1="DDI-DrugBank.d475.s0.e0"
            e2="DDI-DrugBank.d475.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d475.s0.p4" e1="DDI-DrugBank.d475.s0.e0"
            e2="DDI-DrugBank.d475.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d475.s0.p5" e1="DDI-DrugBank.d475.s0.e0"
            e2="DDI-DrugBank.d475.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d475.s0.p6" e1="DDI-DrugBank.d475.s0.e1"
            e2="DDI-DrugBank.d475.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d475.s0.p7" e1="DDI-DrugBank.d475.s0.e1"
            e2="DDI-DrugBank.d475.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d475.s0.p8" e1="DDI-DrugBank.d475.s0.e1"
            e2="DDI-DrugBank.d475.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d475.s0.p9" e1="DDI-DrugBank.d475.s0.e1"
            e2="DDI-DrugBank.d475.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d475.s0.p10" e1="DDI-DrugBank.d475.s0.e1"
            e2="DDI-DrugBank.d475.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d475.s0.p11" e1="DDI-DrugBank.d475.s0.e2"
            e2="DDI-DrugBank.d475.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d475.s0.p12" e1="DDI-DrugBank.d475.s0.e2"
            e2="DDI-DrugBank.d475.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d475.s0.p13" e1="DDI-DrugBank.d475.s0.e2"
            e2="DDI-DrugBank.d475.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d475.s0.p14" e1="DDI-DrugBank.d475.s0.e2"
            e2="DDI-DrugBank.d475.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d475.s0.p15" e1="DDI-DrugBank.d475.s0.e3"
            e2="DDI-DrugBank.d475.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d475.s0.p16" e1="DDI-DrugBank.d475.s0.e3"
            e2="DDI-DrugBank.d475.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d475.s0.p17" e1="DDI-DrugBank.d475.s0.e3"
            e2="DDI-DrugBank.d475.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d475.s0.p18" e1="DDI-DrugBank.d475.s0.e4"
            e2="DDI-DrugBank.d475.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d475.s0.p19" e1="DDI-DrugBank.d475.s0.e4"
            e2="DDI-DrugBank.d475.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d475.s0.p20" e1="DDI-DrugBank.d475.s0.e5"
            e2="DDI-DrugBank.d475.s0.e6" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d475.s1" text="Nizatidine does not inhibit the cytochrome P-450-linked drug-metabolizing enzyme system;">
        <entity id="DDI-DrugBank.d475.s1.e0" charOffset="0-9"
            type="drug" text="Nizatidine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d475.s2" text="therefore, drug interactions mediated by inhibition of hepatic metabolism are not expected to occur."/>
    <sentence id="DDI-DrugBank.d475.s3" text="In patients given very high doses (3900 mg) of aspirin daily, increases in serum salicylate levels were seen when nizatidine, 150 mg b.i.d., was administered concurrently.">
        <entity id="DDI-DrugBank.d475.s3.e0" charOffset="47-53"
            type="brand" text="aspirin"/>
        <entity id="DDI-DrugBank.d475.s3.e1" charOffset="81-90"
            type="group" text="salicylate"/>
        <entity id="DDI-DrugBank.d475.s3.e2" charOffset="114-123"
            type="drug" text="nizatidine"/>
        <pair id="DDI-DrugBank.d475.s3.p0" e1="DDI-DrugBank.d475.s3.e0"
            e2="DDI-DrugBank.d475.s3.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d475.s3.p1" e1="DDI-DrugBank.d475.s3.e0"
            e2="DDI-DrugBank.d475.s3.e2" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d475.s3.p2" e1="DDI-DrugBank.d475.s3.e1"
            e2="DDI-DrugBank.d475.s3.e2" ddi="false"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d761">
    <sentence id="DDI-DrugBank.d761.s0" text="Alcohol: In a multiple-dose study in 30 normal weight subjects, coadministration of XENICAL and 40 grams of alcohol (e.g., approximately 3 glasses of wine) did not result in alteration of alcohol pharmacokinetics, orlistat pharmacodynamics (fecal fat excretion), or systemic exposure to orlistat. ">
        <entity id="DDI-DrugBank.d761.s0.e0" charOffset="0-6"
            type="drug" text="Alcohol"/>
        <entity id="DDI-DrugBank.d761.s0.e1" charOffset="84-90"
            type="brand" text="XENICAL"/>
        <entity id="DDI-DrugBank.d761.s0.e2" charOffset="108-114"
            type="drug" text="alcohol"/>
        <entity id="DDI-DrugBank.d761.s0.e3" charOffset="188-194"
            type="drug" text="alcohol"/>
        <entity id="DDI-DrugBank.d761.s0.e4" charOffset="214-221"
            type="drug" text="orlistat"/>
        <entity id="DDI-DrugBank.d761.s0.e5" charOffset="287-294"
            type="drug" text="orlistat"/>
        <pair id="DDI-DrugBank.d761.s0.p0" e1="DDI-DrugBank.d761.s0.e0"
            e2="DDI-DrugBank.d761.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s0.p1" e1="DDI-DrugBank.d761.s0.e0"
            e2="DDI-DrugBank.d761.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s0.p2" e1="DDI-DrugBank.d761.s0.e0"
            e2="DDI-DrugBank.d761.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s0.p3" e1="DDI-DrugBank.d761.s0.e0"
            e2="DDI-DrugBank.d761.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s0.p4" e1="DDI-DrugBank.d761.s0.e0"
            e2="DDI-DrugBank.d761.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s0.p5" e1="DDI-DrugBank.d761.s0.e1"
            e2="DDI-DrugBank.d761.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s0.p6" e1="DDI-DrugBank.d761.s0.e1"
            e2="DDI-DrugBank.d761.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s0.p7" e1="DDI-DrugBank.d761.s0.e1"
            e2="DDI-DrugBank.d761.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s0.p8" e1="DDI-DrugBank.d761.s0.e1"
            e2="DDI-DrugBank.d761.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s0.p9" e1="DDI-DrugBank.d761.s0.e2"
            e2="DDI-DrugBank.d761.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s0.p10" e1="DDI-DrugBank.d761.s0.e2"
            e2="DDI-DrugBank.d761.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s0.p11" e1="DDI-DrugBank.d761.s0.e2"
            e2="DDI-DrugBank.d761.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s0.p12" e1="DDI-DrugBank.d761.s0.e3"
            e2="DDI-DrugBank.d761.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s0.p13" e1="DDI-DrugBank.d761.s0.e3"
            e2="DDI-DrugBank.d761.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s0.p14" e1="DDI-DrugBank.d761.s0.e4"
            e2="DDI-DrugBank.d761.s0.e5" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d761.s1" text="Cyclosporine: Preliminary data from a XENICAL and cyclosporine drug interaction study indicate a reduction in cyclosporine plasma levels when XENICAL was coadministered with cyclosporine. ">
        <entity id="DDI-DrugBank.d761.s1.e0" charOffset="0-11"
            type="drug" text="Cyclosporine"/>
        <entity id="DDI-DrugBank.d761.s1.e1" charOffset="38-44"
            type="brand" text="XENICAL"/>
        <entity id="DDI-DrugBank.d761.s1.e2" charOffset="50-61"
            type="drug" text="cyclosporine"/>
        <entity id="DDI-DrugBank.d761.s1.e3" charOffset="110-121"
            type="drug" text="cyclosporine"/>
        <entity id="DDI-DrugBank.d761.s1.e4" charOffset="142-148"
            type="brand" text="XENICAL"/>
        <entity id="DDI-DrugBank.d761.s1.e5" charOffset="174-185"
            type="drug" text="cyclosporine"/>
        <pair id="DDI-DrugBank.d761.s1.p0" e1="DDI-DrugBank.d761.s1.e0"
            e2="DDI-DrugBank.d761.s1.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s1.p1" e1="DDI-DrugBank.d761.s1.e0"
            e2="DDI-DrugBank.d761.s1.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s1.p2" e1="DDI-DrugBank.d761.s1.e0"
            e2="DDI-DrugBank.d761.s1.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s1.p3" e1="DDI-DrugBank.d761.s1.e0"
            e2="DDI-DrugBank.d761.s1.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s1.p4" e1="DDI-DrugBank.d761.s1.e0"
            e2="DDI-DrugBank.d761.s1.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s1.p5" e1="DDI-DrugBank.d761.s1.e1"
            e2="DDI-DrugBank.d761.s1.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s1.p6" e1="DDI-DrugBank.d761.s1.e1"
            e2="DDI-DrugBank.d761.s1.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s1.p7" e1="DDI-DrugBank.d761.s1.e1"
            e2="DDI-DrugBank.d761.s1.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s1.p8" e1="DDI-DrugBank.d761.s1.e1"
            e2="DDI-DrugBank.d761.s1.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s1.p9" e1="DDI-DrugBank.d761.s1.e2"
            e2="DDI-DrugBank.d761.s1.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s1.p10" e1="DDI-DrugBank.d761.s1.e2"
            e2="DDI-DrugBank.d761.s1.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s1.p11" e1="DDI-DrugBank.d761.s1.e2"
            e2="DDI-DrugBank.d761.s1.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s1.p12" e1="DDI-DrugBank.d761.s1.e3"
            e2="DDI-DrugBank.d761.s1.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s1.p13" e1="DDI-DrugBank.d761.s1.e3"
            e2="DDI-DrugBank.d761.s1.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s1.p14" e1="DDI-DrugBank.d761.s1.e4"
            e2="DDI-DrugBank.d761.s1.e5" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d761.s2" text="Digoxin: In 12 normal-weight subjects receiving XENICAL 120 mg three times a day for 6 days, XENICAL did not alter the pharmacokinetics of a single dose of digoxin. ">
        <entity id="DDI-DrugBank.d761.s2.e0" charOffset="0-6"
            type="drug" text="Digoxin"/>
        <entity id="DDI-DrugBank.d761.s2.e1" charOffset="48-54"
            type="brand" text="XENICAL"/>
        <entity id="DDI-DrugBank.d761.s2.e2" charOffset="93-99"
            type="brand" text="XENICAL"/>
        <entity id="DDI-DrugBank.d761.s2.e3" charOffset="156-162"
            type="drug" text="digoxin"/>
        <pair id="DDI-DrugBank.d761.s2.p0" e1="DDI-DrugBank.d761.s2.e0"
            e2="DDI-DrugBank.d761.s2.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s2.p1" e1="DDI-DrugBank.d761.s2.e0"
            e2="DDI-DrugBank.d761.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s2.p2" e1="DDI-DrugBank.d761.s2.e0"
            e2="DDI-DrugBank.d761.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s2.p3" e1="DDI-DrugBank.d761.s2.e1"
            e2="DDI-DrugBank.d761.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s2.p4" e1="DDI-DrugBank.d761.s2.e1"
            e2="DDI-DrugBank.d761.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s2.p5" e1="DDI-DrugBank.d761.s2.e2"
            e2="DDI-DrugBank.d761.s2.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d761.s3" text="Fat-soluble Vitamin Supplements and Analogues: A pharmacokinetic interaction study showed a 30% reduction in beta-carotene supplement absorption when concomitantly administered with XENICAL. ">
        <entity id="DDI-DrugBank.d761.s3.e0" charOffset="0-30"
            type="group" text="Fat-soluble Vitamin Supplements"/>
        <entity id="DDI-DrugBank.d761.s3.e1" charOffset="109-121"
            type="drug" text="beta-carotene"/>
        <entity id="DDI-DrugBank.d761.s3.e2" charOffset="182-188"
            type="brand" text="XENICAL"/>
        <pair id="DDI-DrugBank.d761.s3.p0" e1="DDI-DrugBank.d761.s3.e0"
            e2="DDI-DrugBank.d761.s3.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s3.p1" e1="DDI-DrugBank.d761.s3.e0"
            e2="DDI-DrugBank.d761.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s3.p2" e1="DDI-DrugBank.d761.s3.e1"
            e2="DDI-DrugBank.d761.s3.e2" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d761.s4" text="XENICAL inhibited absorption of a vitamin E acetate supplement by approximately 60%. ">
        <entity id="DDI-DrugBank.d761.s4.e0" charOffset="0-6"
            type="brand" text="XENICAL"/>
        <entity id="DDI-DrugBank.d761.s4.e1" charOffset="34-50"
            type="drug" text="vitamin E acetate"/>
        <pair id="DDI-DrugBank.d761.s4.p0" e1="DDI-DrugBank.d761.s4.e0"
            e2="DDI-DrugBank.d761.s4.e1" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d761.s5" text="The effect of orlistat on the absorption of supplemental vitamin D, vitamin A, and nutritionally-derived vitamin K is not known at this time. ">
        <entity id="DDI-DrugBank.d761.s5.e0" charOffset="14-21"
            type="drug" text="orlistat"/>
        <entity id="DDI-DrugBank.d761.s5.e1" charOffset="57-65"
            type="group" text="vitamin D"/>
        <entity id="DDI-DrugBank.d761.s5.e2" charOffset="68-76"
            type="group" text="vitamin A"/>
        <entity id="DDI-DrugBank.d761.s5.e3" charOffset="105-113"
            type="group" text="vitamin K"/>
        <pair id="DDI-DrugBank.d761.s5.p0" e1="DDI-DrugBank.d761.s5.e0"
            e2="DDI-DrugBank.d761.s5.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s5.p1" e1="DDI-DrugBank.d761.s5.e0"
            e2="DDI-DrugBank.d761.s5.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s5.p2" e1="DDI-DrugBank.d761.s5.e0"
            e2="DDI-DrugBank.d761.s5.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s5.p3" e1="DDI-DrugBank.d761.s5.e1"
            e2="DDI-DrugBank.d761.s5.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s5.p4" e1="DDI-DrugBank.d761.s5.e1"
            e2="DDI-DrugBank.d761.s5.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s5.p5" e1="DDI-DrugBank.d761.s5.e2"
            e2="DDI-DrugBank.d761.s5.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d761.s6" text="Glyburide: In 12 normal-weight subjects receiving orlistat 80 mg three times a day for 5 days, orlistat did not alter the pharmacokinetics or pharmacodynamics (blood glucose-lowering) of glyburide. ">
        <entity id="DDI-DrugBank.d761.s6.e0" charOffset="0-8"
            type="drug" text="Glyburide"/>
        <entity id="DDI-DrugBank.d761.s6.e1" charOffset="50-57"
            type="drug" text="orlistat"/>
        <entity id="DDI-DrugBank.d761.s6.e2" charOffset="95-102"
            type="drug" text="orlistat"/>
        <entity id="DDI-DrugBank.d761.s6.e3" charOffset="187-195"
            type="drug" text="glyburide"/>
        <pair id="DDI-DrugBank.d761.s6.p0" e1="DDI-DrugBank.d761.s6.e0"
            e2="DDI-DrugBank.d761.s6.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s6.p1" e1="DDI-DrugBank.d761.s6.e0"
            e2="DDI-DrugBank.d761.s6.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s6.p2" e1="DDI-DrugBank.d761.s6.e0"
            e2="DDI-DrugBank.d761.s6.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s6.p3" e1="DDI-DrugBank.d761.s6.e1"
            e2="DDI-DrugBank.d761.s6.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s6.p4" e1="DDI-DrugBank.d761.s6.e1"
            e2="DDI-DrugBank.d761.s6.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s6.p5" e1="DDI-DrugBank.d761.s6.e2"
            e2="DDI-DrugBank.d761.s6.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d761.s7" text="Nifedipine (extended-release tablets): In 17 normal-weight subjects receiving XENICAL 120 mg three times a day for 6 days, XENICAL did not alter the bioavailability of nifedipine (extended-release tablets). ">
        <entity id="DDI-DrugBank.d761.s7.e0" charOffset="0-9"
            type="drug" text="Nifedipine"/>
        <entity id="DDI-DrugBank.d761.s7.e1" charOffset="78-84"
            type="brand" text="XENICAL"/>
        <entity id="DDI-DrugBank.d761.s7.e2" charOffset="123-129"
            type="brand" text="XENICAL"/>
        <entity id="DDI-DrugBank.d761.s7.e3" charOffset="168-177"
            type="drug" text="nifedipine"/>
        <pair id="DDI-DrugBank.d761.s7.p0" e1="DDI-DrugBank.d761.s7.e0"
            e2="DDI-DrugBank.d761.s7.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s7.p1" e1="DDI-DrugBank.d761.s7.e0"
            e2="DDI-DrugBank.d761.s7.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s7.p2" e1="DDI-DrugBank.d761.s7.e0"
            e2="DDI-DrugBank.d761.s7.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s7.p3" e1="DDI-DrugBank.d761.s7.e1"
            e2="DDI-DrugBank.d761.s7.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s7.p4" e1="DDI-DrugBank.d761.s7.e1"
            e2="DDI-DrugBank.d761.s7.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s7.p5" e1="DDI-DrugBank.d761.s7.e2"
            e2="DDI-DrugBank.d761.s7.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d761.s8" text="Oral Contraceptives: In 20 normal-weight female subjects, the treatment of XENICAL 120 mg three times a day for 23 days resulted in no changes in the ovulation-suppressing action of oral contraceptives. ">
        <entity id="DDI-DrugBank.d761.s8.e0" charOffset="5-18"
            type="group" text="Contraceptives"/>
        <entity id="DDI-DrugBank.d761.s8.e1" charOffset="75-81"
            type="brand" text="XENICAL"/>
        <entity id="DDI-DrugBank.d761.s8.e2" charOffset="187-200"
            type="group" text="contraceptives"/>
        <pair id="DDI-DrugBank.d761.s8.p0" e1="DDI-DrugBank.d761.s8.e0"
            e2="DDI-DrugBank.d761.s8.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s8.p1" e1="DDI-DrugBank.d761.s8.e0"
            e2="DDI-DrugBank.d761.s8.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s8.p2" e1="DDI-DrugBank.d761.s8.e1"
            e2="DDI-DrugBank.d761.s8.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d761.s9" text="Phenytoin: In 12 normal-weight subjects receiving XENICAL 120 mg three times a day for 7 days, XENICAL did not alter the pharmacokinetics of a single 300-mg dose of phenytoin. ">
        <entity id="DDI-DrugBank.d761.s9.e0" charOffset="0-8"
            type="drug" text="Phenytoin"/>
        <entity id="DDI-DrugBank.d761.s9.e1" charOffset="50-56"
            type="brand" text="XENICAL"/>
        <entity id="DDI-DrugBank.d761.s9.e2" charOffset="95-101"
            type="brand" text="XENICAL"/>
        <entity id="DDI-DrugBank.d761.s9.e3" charOffset="165-173"
            type="drug" text="phenytoin"/>
        <pair id="DDI-DrugBank.d761.s9.p0" e1="DDI-DrugBank.d761.s9.e0"
            e2="DDI-DrugBank.d761.s9.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s9.p1" e1="DDI-DrugBank.d761.s9.e0"
            e2="DDI-DrugBank.d761.s9.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s9.p2" e1="DDI-DrugBank.d761.s9.e0"
            e2="DDI-DrugBank.d761.s9.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s9.p3" e1="DDI-DrugBank.d761.s9.e1"
            e2="DDI-DrugBank.d761.s9.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s9.p4" e1="DDI-DrugBank.d761.s9.e1"
            e2="DDI-DrugBank.d761.s9.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s9.p5" e1="DDI-DrugBank.d761.s9.e2"
            e2="DDI-DrugBank.d761.s9.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d761.s10" text="Pravastatin: In a 2-way crossover study of 24 normal-weight, mildly hypercholesterolemic patients receiving XENICAL 120 mg three times a day for 6 days, XENICAL did not affect the pharmacokinetics of pravastatin. ">
        <entity id="DDI-DrugBank.d761.s10.e0" charOffset="0-10"
            type="drug" text="Pravastatin"/>
        <entity id="DDI-DrugBank.d761.s10.e1" charOffset="108-114"
            type="brand" text="XENICAL"/>
        <entity id="DDI-DrugBank.d761.s10.e2" charOffset="153-159"
            type="brand" text="XENICAL"/>
        <entity id="DDI-DrugBank.d761.s10.e3" charOffset="200-210"
            type="drug" text="pravastatin"/>
        <pair id="DDI-DrugBank.d761.s10.p0"
            e1="DDI-DrugBank.d761.s10.e0" e2="DDI-DrugBank.d761.s10.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s10.p1"
            e1="DDI-DrugBank.d761.s10.e0" e2="DDI-DrugBank.d761.s10.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s10.p2"
            e1="DDI-DrugBank.d761.s10.e0" e2="DDI-DrugBank.d761.s10.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s10.p3"
            e1="DDI-DrugBank.d761.s10.e1" e2="DDI-DrugBank.d761.s10.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s10.p4"
            e1="DDI-DrugBank.d761.s10.e1" e2="DDI-DrugBank.d761.s10.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s10.p5"
            e1="DDI-DrugBank.d761.s10.e2" e2="DDI-DrugBank.d761.s10.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d761.s11" text="Warfarin: In 12 normal-weight subjects, administration of XENICAL 120 mg three times a day for 16 days did not result in any change in either warfarin pharmacokinetics (both R- and S-enantiomers) or pharmacodynamics (prothrombin time and serum Factor VII). ">
        <entity id="DDI-DrugBank.d761.s11.e0" charOffset="0-7"
            type="drug" text="Warfarin"/>
        <entity id="DDI-DrugBank.d761.s11.e1" charOffset="58-64"
            type="brand" text="XENICAL"/>
        <entity id="DDI-DrugBank.d761.s11.e2" charOffset="142-149"
            type="drug" text="warfarin"/>
        <pair id="DDI-DrugBank.d761.s11.p0"
            e1="DDI-DrugBank.d761.s11.e0" e2="DDI-DrugBank.d761.s11.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s11.p1"
            e1="DDI-DrugBank.d761.s11.e0" e2="DDI-DrugBank.d761.s11.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s11.p2"
            e1="DDI-DrugBank.d761.s11.e1" e2="DDI-DrugBank.d761.s11.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d761.s12" text="Although undercarboxylated osteocalcin, a marker of vitamin K nutritional status, was unaltered with XENICAL administration, vitamin K levels tended to decline in subjects taking XENICAL. ">
        <entity id="DDI-DrugBank.d761.s12.e0" charOffset="101-107"
            type="brand" text="XENICAL"/>
        <entity id="DDI-DrugBank.d761.s12.e1" charOffset="179-185"
            type="brand" text="XENICAL"/>
        <pair id="DDI-DrugBank.d761.s12.p0"
            e1="DDI-DrugBank.d761.s12.e0" e2="DDI-DrugBank.d761.s12.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d761.s13" text="Therefore, as vitamin K absorption may be decreased with XENICAL, patients on chronic stable doses of warfarin who are prescribed XENICAL should be monitored closely for changes in coagulation parameters.">
        <entity id="DDI-DrugBank.d761.s13.e0" charOffset="14-22"
            type="group" text="vitamin K"/>
        <entity id="DDI-DrugBank.d761.s13.e1" charOffset="57-63"
            type="brand" text="XENICAL"/>
        <entity id="DDI-DrugBank.d761.s13.e2" charOffset="102-109"
            type="drug" text="warfarin"/>
        <entity id="DDI-DrugBank.d761.s13.e3" charOffset="130-136"
            type="brand" text="XENICAL"/>
        <pair id="DDI-DrugBank.d761.s13.p0"
            e1="DDI-DrugBank.d761.s13.e0" e2="DDI-DrugBank.d761.s13.e1"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d761.s13.p1"
            e1="DDI-DrugBank.d761.s13.e0" e2="DDI-DrugBank.d761.s13.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s13.p2"
            e1="DDI-DrugBank.d761.s13.e0" e2="DDI-DrugBank.d761.s13.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s13.p3"
            e1="DDI-DrugBank.d761.s13.e1" e2="DDI-DrugBank.d761.s13.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s13.p4"
            e1="DDI-DrugBank.d761.s13.e1" e2="DDI-DrugBank.d761.s13.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d761.s13.p5"
            e1="DDI-DrugBank.d761.s13.e2" e2="DDI-DrugBank.d761.s13.e3"
            ddi="true" type="advise"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d744">
    <sentence id="DDI-DrugBank.d744.s0" text="Acromegalic patients with diabetes mellitus being treated with insulin and/or oral hypoglycemic agents may require dose reductions of these therapeutic agents after the initiation of therapy with SOMAVERT. ">
        <entity id="DDI-DrugBank.d744.s0.e0" charOffset="63-69"
            type="drug" text="insulin"/>
        <entity id="DDI-DrugBank.d744.s0.e1" charOffset="83-94"
            type="group" text="hypoglycemic"/>
        <entity id="DDI-DrugBank.d744.s0.e2" charOffset="196-203"
            type="brand" text="SOMAVERT"/>
        <pair id="DDI-DrugBank.d744.s0.p0" e1="DDI-DrugBank.d744.s0.e0"
            e2="DDI-DrugBank.d744.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d744.s0.p1" e1="DDI-DrugBank.d744.s0.e0"
            e2="DDI-DrugBank.d744.s0.e2" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d744.s0.p2" e1="DDI-DrugBank.d744.s0.e1"
            e2="DDI-DrugBank.d744.s0.e2" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d744.s1" text="In clinical studies, patients on opioids often needed higher serum pegvisomant concentrations to achieve appropriate IGF-I suppression compared with patients not receiving opioids. ">
        <entity id="DDI-DrugBank.d744.s1.e0" charOffset="33-39"
            type="group" text="opioids"/>
        <entity id="DDI-DrugBank.d744.s1.e1" charOffset="67-77"
            type="drug" text="pegvisomant"/>
        <entity id="DDI-DrugBank.d744.s1.e2" charOffset="172-178"
            type="group" text="opioids"/>
        <pair id="DDI-DrugBank.d744.s1.p0" e1="DDI-DrugBank.d744.s1.e0"
            e2="DDI-DrugBank.d744.s1.e1" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d744.s1.p1" e1="DDI-DrugBank.d744.s1.e0"
            e2="DDI-DrugBank.d744.s1.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d744.s1.p2" e1="DDI-DrugBank.d744.s1.e1"
            e2="DDI-DrugBank.d744.s1.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d744.s2" text="The mechanism of this interaction is not known."/>
</document>
<document id="DDI-DrugBank.d671">
    <sentence id="DDI-DrugBank.d671.s0" text="The interaction of CYLERT (pemoline) with other drugs has not been studied in humans. ">
        <entity id="DDI-DrugBank.d671.s0.e0" charOffset="19-24"
            type="brand" text="CYLERT"/>
        <entity id="DDI-DrugBank.d671.s0.e1" charOffset="27-34"
            type="drug" text="pemoline"/>
        <pair id="DDI-DrugBank.d671.s0.p0" e1="DDI-DrugBank.d671.s0.e0"
            e2="DDI-DrugBank.d671.s0.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d671.s1" text="Patients who are receiving CYLERT concurrently with other drugs, especially drugs with CNS activity, should be monitored carefully. ">
        <entity id="DDI-DrugBank.d671.s1.e0" charOffset="27-32"
            type="brand" text="CYLERT"/>
    </sentence>
    <sentence id="DDI-DrugBank.d671.s2" text="Decreased seizure threshold has been reported in patients receiving CYLERT concomitantly with antiepileptic medications.">
        <entity id="DDI-DrugBank.d671.s2.e0" charOffset="68-73"
            type="brand" text="CYLERT"/>
        <entity id="DDI-DrugBank.d671.s2.e1" charOffset="94-118"
            type="group" text="antiepileptic medications"/>
        <pair id="DDI-DrugBank.d671.s2.p0" e1="DDI-DrugBank.d671.s2.e0"
            e2="DDI-DrugBank.d671.s2.e1" ddi="true" type="effect"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d635">
    <sentence id="DDI-DrugBank.d635.s0" text="Other short-acting beta adrenergic aerosol bronchodilators should not be used concomitantly with MAXAIR AUTOHALER because they may have additive effects.">
        <entity id="DDI-DrugBank.d635.s0.e0" charOffset="6-57"
            type="group" text="short-acting beta adrenergic aerosol bronchodilators"/>
        <entity id="DDI-DrugBank.d635.s0.e1" charOffset="97-112"
            type="brand" text="MAXAIR AUTOHALER"/>
        <pair id="DDI-DrugBank.d635.s0.p0" e1="DDI-DrugBank.d635.s0.e0"
            e2="DDI-DrugBank.d635.s0.e1" ddi="true" type="advise"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d622">
    <sentence id="DDI-DrugBank.d622.s0" text="When atropine and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected when atropine is used alone. ">
        <entity id="DDI-DrugBank.d622.s0.e0" charOffset="5-12"
            type="drug" text="atropine"/>
        <entity id="DDI-DrugBank.d622.s0.e1" charOffset="18-28"
            type="drug" text="pralidoxime"/>
        <entity id="DDI-DrugBank.d622.s0.e2" charOffset="189-196"
            type="drug" text="atropine"/>
        <pair id="DDI-DrugBank.d622.s0.p0" e1="DDI-DrugBank.d622.s0.e0"
            e2="DDI-DrugBank.d622.s0.e1" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d622.s0.p1" e1="DDI-DrugBank.d622.s0.e0"
            e2="DDI-DrugBank.d622.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d622.s0.p2" e1="DDI-DrugBank.d622.s0.e1"
            e2="DDI-DrugBank.d622.s0.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d622.s1" text="This is especially true if the total dose of atropine has been large and the administration of pralidoxime has been delayed. ">
        <entity id="DDI-DrugBank.d622.s1.e0" charOffset="45-52"
            type="drug" text="atropine"/>
        <entity id="DDI-DrugBank.d622.s1.e1" charOffset="95-105"
            type="drug" text="pralidoxime"/>
        <pair id="DDI-DrugBank.d622.s1.p0" e1="DDI-DrugBank.d622.s1.e0"
            e2="DDI-DrugBank.d622.s1.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d622.s2" text="2 - 4 The following precautions should be kept in mind in the treatment of anticholinesterase poisoning, although they do not bear directly on the use of pralidoxime: since barbiturates are potentiated by the anticholinesterases, they should be used cautiously in the treatment of convulsions; ">
        <entity id="DDI-DrugBank.d622.s2.e0" charOffset="154-164"
            type="drug" text="pralidoxime"/>
        <entity id="DDI-DrugBank.d622.s2.e1" charOffset="173-184"
            type="group" text="barbiturates"/>
        <entity id="DDI-DrugBank.d622.s2.e2" charOffset="209-227"
            type="group" text="anticholinesterases"/>
        <pair id="DDI-DrugBank.d622.s2.p0" e1="DDI-DrugBank.d622.s2.e0"
            e2="DDI-DrugBank.d622.s2.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d622.s2.p1" e1="DDI-DrugBank.d622.s2.e0"
            e2="DDI-DrugBank.d622.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d622.s2.p2" e1="DDI-DrugBank.d622.s2.e1"
            e2="DDI-DrugBank.d622.s2.e2" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d622.s3" text="morphine, theophylline, aminophylline, succinylcholine, reserpine, and phenothiazine-type tranquilizers should be avoided in patients with organophosphate poisoning.">
        <entity id="DDI-DrugBank.d622.s3.e0" charOffset="0-7"
            type="drug" text="morphine"/>
        <entity id="DDI-DrugBank.d622.s3.e1" charOffset="10-21"
            type="drug" text="theophylline"/>
        <entity id="DDI-DrugBank.d622.s3.e2" charOffset="24-36"
            type="drug" text="aminophylline"/>
        <entity id="DDI-DrugBank.d622.s3.e3" charOffset="39-53"
            type="drug" text="succinylcholine"/>
        <entity id="DDI-DrugBank.d622.s3.e4" charOffset="56-64"
            type="drug" text="reserpine"/>
        <entity id="DDI-DrugBank.d622.s3.e5" charOffset="71-102"
            type="group" text="phenothiazine-type tranquilizers"/>
        <pair id="DDI-DrugBank.d622.s3.p0" e1="DDI-DrugBank.d622.s3.e0"
            e2="DDI-DrugBank.d622.s3.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d622.s3.p1" e1="DDI-DrugBank.d622.s3.e0"
            e2="DDI-DrugBank.d622.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d622.s3.p2" e1="DDI-DrugBank.d622.s3.e0"
            e2="DDI-DrugBank.d622.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d622.s3.p3" e1="DDI-DrugBank.d622.s3.e0"
            e2="DDI-DrugBank.d622.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d622.s3.p4" e1="DDI-DrugBank.d622.s3.e0"
            e2="DDI-DrugBank.d622.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d622.s3.p5" e1="DDI-DrugBank.d622.s3.e1"
            e2="DDI-DrugBank.d622.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d622.s3.p6" e1="DDI-DrugBank.d622.s3.e1"
            e2="DDI-DrugBank.d622.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d622.s3.p7" e1="DDI-DrugBank.d622.s3.e1"
            e2="DDI-DrugBank.d622.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d622.s3.p8" e1="DDI-DrugBank.d622.s3.e1"
            e2="DDI-DrugBank.d622.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d622.s3.p9" e1="DDI-DrugBank.d622.s3.e2"
            e2="DDI-DrugBank.d622.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d622.s3.p10" e1="DDI-DrugBank.d622.s3.e2"
            e2="DDI-DrugBank.d622.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d622.s3.p11" e1="DDI-DrugBank.d622.s3.e2"
            e2="DDI-DrugBank.d622.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d622.s3.p12" e1="DDI-DrugBank.d622.s3.e3"
            e2="DDI-DrugBank.d622.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d622.s3.p13" e1="DDI-DrugBank.d622.s3.e3"
            e2="DDI-DrugBank.d622.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d622.s3.p14" e1="DDI-DrugBank.d622.s3.e4"
            e2="DDI-DrugBank.d622.s3.e5" ddi="false"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d737">
    <sentence id="DDI-DrugBank.d737.s0" text="Carbidopa/Levodopa: Carbidopa/Levodopa does not influence the pharmacokinetics of pramipexole in healthy volunteers (N= 10). ">
        <entity id="DDI-DrugBank.d737.s0.e0" charOffset="0-8"
            type="drug" text="Carbidopa"/>
        <entity id="DDI-DrugBank.d737.s0.e1" charOffset="10-17"
            type="drug" text="Levodopa"/>
        <entity id="DDI-DrugBank.d737.s0.e2" charOffset="20-28"
            type="drug" text="Carbidopa"/>
        <entity id="DDI-DrugBank.d737.s0.e3" charOffset="30-37"
            type="drug" text="Levodopa"/>
        <entity id="DDI-DrugBank.d737.s0.e4" charOffset="82-92"
            type="drug" text="pramipexole"/>
        <pair id="DDI-DrugBank.d737.s0.p0" e1="DDI-DrugBank.d737.s0.e0"
            e2="DDI-DrugBank.d737.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s0.p1" e1="DDI-DrugBank.d737.s0.e0"
            e2="DDI-DrugBank.d737.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s0.p2" e1="DDI-DrugBank.d737.s0.e0"
            e2="DDI-DrugBank.d737.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s0.p3" e1="DDI-DrugBank.d737.s0.e0"
            e2="DDI-DrugBank.d737.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s0.p4" e1="DDI-DrugBank.d737.s0.e1"
            e2="DDI-DrugBank.d737.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s0.p5" e1="DDI-DrugBank.d737.s0.e1"
            e2="DDI-DrugBank.d737.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s0.p6" e1="DDI-DrugBank.d737.s0.e1"
            e2="DDI-DrugBank.d737.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s0.p7" e1="DDI-DrugBank.d737.s0.e2"
            e2="DDI-DrugBank.d737.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s0.p8" e1="DDI-DrugBank.d737.s0.e2"
            e2="DDI-DrugBank.d737.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s0.p9" e1="DDI-DrugBank.d737.s0.e3"
            e2="DDI-DrugBank.d737.s0.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d737.s1" text="5 hours. "/>
    <sentence id="DDI-DrugBank.d737.s2" text="Selegiline: In healthy volunteers (N= 11), selegiline did not influence the pharmacokinetics of pramipexole. ">
        <entity id="DDI-DrugBank.d737.s2.e0" charOffset="0-9"
            type="drug" text="Selegiline"/>
        <entity id="DDI-DrugBank.d737.s2.e1" charOffset="43-52"
            type="drug" text="selegiline"/>
        <entity id="DDI-DrugBank.d737.s2.e2" charOffset="96-106"
            type="drug" text="pramipexole"/>
        <pair id="DDI-DrugBank.d737.s2.p0" e1="DDI-DrugBank.d737.s2.e0"
            e2="DDI-DrugBank.d737.s2.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s2.p1" e1="DDI-DrugBank.d737.s2.e0"
            e2="DDI-DrugBank.d737.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s2.p2" e1="DDI-DrugBank.d737.s2.e1"
            e2="DDI-DrugBank.d737.s2.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d737.s3" text="Amantadine: Population pharmacokinetic analysis suggests that amantadine is unlikely to alter the oral clearance of pramipexole (N= 54). ">
        <entity id="DDI-DrugBank.d737.s3.e0" charOffset="0-9"
            type="drug" text="Amantadine"/>
        <entity id="DDI-DrugBank.d737.s3.e1" charOffset="62-71"
            type="drug" text="amantadine"/>
        <entity id="DDI-DrugBank.d737.s3.e2" charOffset="116-126"
            type="drug" text="pramipexole"/>
        <pair id="DDI-DrugBank.d737.s3.p0" e1="DDI-DrugBank.d737.s3.e0"
            e2="DDI-DrugBank.d737.s3.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s3.p1" e1="DDI-DrugBank.d737.s3.e0"
            e2="DDI-DrugBank.d737.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s3.p2" e1="DDI-DrugBank.d737.s3.e1"
            e2="DDI-DrugBank.d737.s3.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d737.s4" text="Cimetidine: Cimetidine, a known inhibitor of renal tubular secretion of organic bases via the cationic transport system, caused a 50% increase in pramipexole AUC and a 40% increase in half-life (N= 12). ">
        <entity id="DDI-DrugBank.d737.s4.e0" charOffset="0-9"
            type="drug" text="Cimetidine"/>
        <entity id="DDI-DrugBank.d737.s4.e1" charOffset="12-21"
            type="drug" text="Cimetidine"/>
        <entity id="DDI-DrugBank.d737.s4.e2" charOffset="146-156"
            type="drug" text="pramipexole"/>
        <pair id="DDI-DrugBank.d737.s4.p0" e1="DDI-DrugBank.d737.s4.e0"
            e2="DDI-DrugBank.d737.s4.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s4.p1" e1="DDI-DrugBank.d737.s4.e0"
            e2="DDI-DrugBank.d737.s4.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s4.p2" e1="DDI-DrugBank.d737.s4.e1"
            e2="DDI-DrugBank.d737.s4.e2" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d737.s5" text="Probenecid: Probenecid, a known inhibitor of renal tubular secretion of organic acids via the aruonic transporter, did not noticeably influence pramipexole pharmacokinetics (N= 12). ">
        <entity id="DDI-DrugBank.d737.s5.e0" charOffset="0-9"
            type="drug" text="Probenecid"/>
        <entity id="DDI-DrugBank.d737.s5.e1" charOffset="12-21"
            type="drug" text="Probenecid"/>
        <entity id="DDI-DrugBank.d737.s5.e2" charOffset="144-154"
            type="drug" text="pramipexole"/>
        <pair id="DDI-DrugBank.d737.s5.p0" e1="DDI-DrugBank.d737.s5.e0"
            e2="DDI-DrugBank.d737.s5.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s5.p1" e1="DDI-DrugBank.d737.s5.e0"
            e2="DDI-DrugBank.d737.s5.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s5.p2" e1="DDI-DrugBank.d737.s5.e1"
            e2="DDI-DrugBank.d737.s5.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d737.s6" text="Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. ">
        <entity id="DDI-DrugBank.d737.s6.e0" charOffset="178-187"
            type="drug" text="cimetidine"/>
        <entity id="DDI-DrugBank.d737.s6.e1" charOffset="190-199"
            type="drug" text="ranitidine"/>
        <entity id="DDI-DrugBank.d737.s6.e2" charOffset="202-210"
            type="drug" text="diltiazem"/>
        <entity id="DDI-DrugBank.d737.s6.e3" charOffset="213-223"
            type="drug" text="triamterene"/>
        <entity id="DDI-DrugBank.d737.s6.e4" charOffset="226-234"
            type="drug" text="verapamil"/>
        <entity id="DDI-DrugBank.d737.s6.e5" charOffset="237-245"
            type="drug" text="quinidine"/>
        <entity id="DDI-DrugBank.d737.s6.e6" charOffset="252-258"
            type="drug" text="quinine"/>
        <entity id="DDI-DrugBank.d737.s6.e7" charOffset="293-303"
            type="drug" text="pramipexole"/>
        <entity id="DDI-DrugBank.d737.s6.e8" charOffset="379-392"
            type="group" text="cephalosporins"/>
        <entity id="DDI-DrugBank.d737.s6.e9" charOffset="395-405"
            type="group" text="penicillins"/>
        <entity id="DDI-DrugBank.d737.s6.e10" charOffset="408-419"
            type="drug" text="indomethacin"/>
        <entity id="DDI-DrugBank.d737.s6.e11" charOffset="422-440"
            type="drug" text="hydrochlorothiazide"/>
        <entity id="DDI-DrugBank.d737.s6.e12" charOffset="447-460"
            type="drug" text="chlorpropamide"/>
        <entity id="DDI-DrugBank.d737.s6.e13" charOffset="521-531"
            type="drug" text="pramipexole"/>
        <pair id="DDI-DrugBank.d737.s6.p0" e1="DDI-DrugBank.d737.s6.e0"
            e2="DDI-DrugBank.d737.s6.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p1" e1="DDI-DrugBank.d737.s6.e0"
            e2="DDI-DrugBank.d737.s6.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p2" e1="DDI-DrugBank.d737.s6.e0"
            e2="DDI-DrugBank.d737.s6.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p3" e1="DDI-DrugBank.d737.s6.e0"
            e2="DDI-DrugBank.d737.s6.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p4" e1="DDI-DrugBank.d737.s6.e0"
            e2="DDI-DrugBank.d737.s6.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p5" e1="DDI-DrugBank.d737.s6.e0"
            e2="DDI-DrugBank.d737.s6.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p6" e1="DDI-DrugBank.d737.s6.e0"
            e2="DDI-DrugBank.d737.s6.e7" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d737.s6.p7" e1="DDI-DrugBank.d737.s6.e0"
            e2="DDI-DrugBank.d737.s6.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p8" e1="DDI-DrugBank.d737.s6.e0"
            e2="DDI-DrugBank.d737.s6.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p9" e1="DDI-DrugBank.d737.s6.e0"
            e2="DDI-DrugBank.d737.s6.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p10" e1="DDI-DrugBank.d737.s6.e0"
            e2="DDI-DrugBank.d737.s6.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p11" e1="DDI-DrugBank.d737.s6.e0"
            e2="DDI-DrugBank.d737.s6.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p12" e1="DDI-DrugBank.d737.s6.e0"
            e2="DDI-DrugBank.d737.s6.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p13" e1="DDI-DrugBank.d737.s6.e1"
            e2="DDI-DrugBank.d737.s6.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p14" e1="DDI-DrugBank.d737.s6.e1"
            e2="DDI-DrugBank.d737.s6.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p15" e1="DDI-DrugBank.d737.s6.e1"
            e2="DDI-DrugBank.d737.s6.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p16" e1="DDI-DrugBank.d737.s6.e1"
            e2="DDI-DrugBank.d737.s6.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p17" e1="DDI-DrugBank.d737.s6.e1"
            e2="DDI-DrugBank.d737.s6.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p18" e1="DDI-DrugBank.d737.s6.e1"
            e2="DDI-DrugBank.d737.s6.e7" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d737.s6.p19" e1="DDI-DrugBank.d737.s6.e1"
            e2="DDI-DrugBank.d737.s6.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p20" e1="DDI-DrugBank.d737.s6.e1"
            e2="DDI-DrugBank.d737.s6.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p21" e1="DDI-DrugBank.d737.s6.e1"
            e2="DDI-DrugBank.d737.s6.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p22" e1="DDI-DrugBank.d737.s6.e1"
            e2="DDI-DrugBank.d737.s6.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p23" e1="DDI-DrugBank.d737.s6.e1"
            e2="DDI-DrugBank.d737.s6.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p24" e1="DDI-DrugBank.d737.s6.e1"
            e2="DDI-DrugBank.d737.s6.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p25" e1="DDI-DrugBank.d737.s6.e2"
            e2="DDI-DrugBank.d737.s6.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p26" e1="DDI-DrugBank.d737.s6.e2"
            e2="DDI-DrugBank.d737.s6.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p27" e1="DDI-DrugBank.d737.s6.e2"
            e2="DDI-DrugBank.d737.s6.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p28" e1="DDI-DrugBank.d737.s6.e2"
            e2="DDI-DrugBank.d737.s6.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p29" e1="DDI-DrugBank.d737.s6.e2"
            e2="DDI-DrugBank.d737.s6.e7" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d737.s6.p30" e1="DDI-DrugBank.d737.s6.e2"
            e2="DDI-DrugBank.d737.s6.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p31" e1="DDI-DrugBank.d737.s6.e2"
            e2="DDI-DrugBank.d737.s6.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p32" e1="DDI-DrugBank.d737.s6.e2"
            e2="DDI-DrugBank.d737.s6.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p33" e1="DDI-DrugBank.d737.s6.e2"
            e2="DDI-DrugBank.d737.s6.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p34" e1="DDI-DrugBank.d737.s6.e2"
            e2="DDI-DrugBank.d737.s6.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p35" e1="DDI-DrugBank.d737.s6.e2"
            e2="DDI-DrugBank.d737.s6.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p36" e1="DDI-DrugBank.d737.s6.e3"
            e2="DDI-DrugBank.d737.s6.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p37" e1="DDI-DrugBank.d737.s6.e3"
            e2="DDI-DrugBank.d737.s6.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p38" e1="DDI-DrugBank.d737.s6.e3"
            e2="DDI-DrugBank.d737.s6.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p39" e1="DDI-DrugBank.d737.s6.e3"
            e2="DDI-DrugBank.d737.s6.e7" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d737.s6.p40" e1="DDI-DrugBank.d737.s6.e3"
            e2="DDI-DrugBank.d737.s6.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p41" e1="DDI-DrugBank.d737.s6.e3"
            e2="DDI-DrugBank.d737.s6.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p42" e1="DDI-DrugBank.d737.s6.e3"
            e2="DDI-DrugBank.d737.s6.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p43" e1="DDI-DrugBank.d737.s6.e3"
            e2="DDI-DrugBank.d737.s6.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p44" e1="DDI-DrugBank.d737.s6.e3"
            e2="DDI-DrugBank.d737.s6.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p45" e1="DDI-DrugBank.d737.s6.e3"
            e2="DDI-DrugBank.d737.s6.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p46" e1="DDI-DrugBank.d737.s6.e4"
            e2="DDI-DrugBank.d737.s6.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p47" e1="DDI-DrugBank.d737.s6.e4"
            e2="DDI-DrugBank.d737.s6.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p48" e1="DDI-DrugBank.d737.s6.e4"
            e2="DDI-DrugBank.d737.s6.e7" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d737.s6.p49" e1="DDI-DrugBank.d737.s6.e4"
            e2="DDI-DrugBank.d737.s6.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p50" e1="DDI-DrugBank.d737.s6.e4"
            e2="DDI-DrugBank.d737.s6.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p51" e1="DDI-DrugBank.d737.s6.e4"
            e2="DDI-DrugBank.d737.s6.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p52" e1="DDI-DrugBank.d737.s6.e4"
            e2="DDI-DrugBank.d737.s6.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p53" e1="DDI-DrugBank.d737.s6.e4"
            e2="DDI-DrugBank.d737.s6.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p54" e1="DDI-DrugBank.d737.s6.e4"
            e2="DDI-DrugBank.d737.s6.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p55" e1="DDI-DrugBank.d737.s6.e5"
            e2="DDI-DrugBank.d737.s6.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p56" e1="DDI-DrugBank.d737.s6.e5"
            e2="DDI-DrugBank.d737.s6.e7" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d737.s6.p57" e1="DDI-DrugBank.d737.s6.e5"
            e2="DDI-DrugBank.d737.s6.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p58" e1="DDI-DrugBank.d737.s6.e5"
            e2="DDI-DrugBank.d737.s6.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p59" e1="DDI-DrugBank.d737.s6.e5"
            e2="DDI-DrugBank.d737.s6.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p60" e1="DDI-DrugBank.d737.s6.e5"
            e2="DDI-DrugBank.d737.s6.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p61" e1="DDI-DrugBank.d737.s6.e5"
            e2="DDI-DrugBank.d737.s6.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p62" e1="DDI-DrugBank.d737.s6.e5"
            e2="DDI-DrugBank.d737.s6.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p63" e1="DDI-DrugBank.d737.s6.e6"
            e2="DDI-DrugBank.d737.s6.e7" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d737.s6.p64" e1="DDI-DrugBank.d737.s6.e6"
            e2="DDI-DrugBank.d737.s6.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p65" e1="DDI-DrugBank.d737.s6.e6"
            e2="DDI-DrugBank.d737.s6.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p66" e1="DDI-DrugBank.d737.s6.e6"
            e2="DDI-DrugBank.d737.s6.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p67" e1="DDI-DrugBank.d737.s6.e6"
            e2="DDI-DrugBank.d737.s6.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p68" e1="DDI-DrugBank.d737.s6.e6"
            e2="DDI-DrugBank.d737.s6.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p69" e1="DDI-DrugBank.d737.s6.e6"
            e2="DDI-DrugBank.d737.s6.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p70" e1="DDI-DrugBank.d737.s6.e7"
            e2="DDI-DrugBank.d737.s6.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p71" e1="DDI-DrugBank.d737.s6.e7"
            e2="DDI-DrugBank.d737.s6.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p72" e1="DDI-DrugBank.d737.s6.e7"
            e2="DDI-DrugBank.d737.s6.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p73" e1="DDI-DrugBank.d737.s6.e7"
            e2="DDI-DrugBank.d737.s6.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p74" e1="DDI-DrugBank.d737.s6.e7"
            e2="DDI-DrugBank.d737.s6.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p75" e1="DDI-DrugBank.d737.s6.e7"
            e2="DDI-DrugBank.d737.s6.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p76" e1="DDI-DrugBank.d737.s6.e8"
            e2="DDI-DrugBank.d737.s6.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p77" e1="DDI-DrugBank.d737.s6.e8"
            e2="DDI-DrugBank.d737.s6.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p78" e1="DDI-DrugBank.d737.s6.e8"
            e2="DDI-DrugBank.d737.s6.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p79" e1="DDI-DrugBank.d737.s6.e8"
            e2="DDI-DrugBank.d737.s6.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p80" e1="DDI-DrugBank.d737.s6.e8"
            e2="DDI-DrugBank.d737.s6.e13" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d737.s6.p81" e1="DDI-DrugBank.d737.s6.e9"
            e2="DDI-DrugBank.d737.s6.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p82" e1="DDI-DrugBank.d737.s6.e9"
            e2="DDI-DrugBank.d737.s6.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p83" e1="DDI-DrugBank.d737.s6.e9"
            e2="DDI-DrugBank.d737.s6.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p84" e1="DDI-DrugBank.d737.s6.e9"
            e2="DDI-DrugBank.d737.s6.e13" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d737.s6.p85"
            e1="DDI-DrugBank.d737.s6.e10" e2="DDI-DrugBank.d737.s6.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p86"
            e1="DDI-DrugBank.d737.s6.e10" e2="DDI-DrugBank.d737.s6.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p87"
            e1="DDI-DrugBank.d737.s6.e10" e2="DDI-DrugBank.d737.s6.e13"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d737.s6.p88"
            e1="DDI-DrugBank.d737.s6.e11" e2="DDI-DrugBank.d737.s6.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s6.p89"
            e1="DDI-DrugBank.d737.s6.e11" e2="DDI-DrugBank.d737.s6.e13"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d737.s6.p90"
            e1="DDI-DrugBank.d737.s6.e12" e2="DDI-DrugBank.d737.s6.e13"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d737.s7" text="CYP interactions: Inhibitors of cytochrome P450 enzymes would not be expected to affect pramipexole elimination because pramipexole is not appreciably metabolized by these enzymes in vivo or in vitro. ">
        <entity id="DDI-DrugBank.d737.s7.e0" charOffset="88-98"
            type="drug" text="pramipexole"/>
        <entity id="DDI-DrugBank.d737.s7.e1" charOffset="120-130"
            type="drug" text="pramipexole"/>
        <pair id="DDI-DrugBank.d737.s7.p0" e1="DDI-DrugBank.d737.s7.e0"
            e2="DDI-DrugBank.d737.s7.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d737.s8" text="Pramipexole does not inhibit CYP enzymes CYPIA2, CYP2C9, CYP2CI9, CYP2EI, and CYP3A4. ">
        <entity id="DDI-DrugBank.d737.s8.e0" charOffset="0-10"
            type="drug" text="Pramipexole"/>
    </sentence>
    <sentence id="DDI-DrugBank.d737.s9" text="Inhibition of CYP2D6 was observed with an apparent Ki of 30 uM, indicating that pramipexole will not inhibit CYP enzymes at plasma concentrations observed following the highest recommended clinical dose (1.5 mg tid). ">
        <entity id="DDI-DrugBank.d737.s9.e0" charOffset="80-90"
            type="drug" text="pramipexole"/>
    </sentence>
    <sentence id="DDI-DrugBank.d737.s10" text="Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX. ">
        <entity id="DDI-DrugBank.d737.s10.e0" charOffset="0-19"
            type="group" text="Dopamine antagonists"/>
        <entity id="DDI-DrugBank.d737.s10.e1" charOffset="28-38"
            type="drug" text="pramipexole"/>
        <entity id="DDI-DrugBank.d737.s10.e2" charOffset="45-60"
            type="group" text="dopamine agonist"/>
        <entity id="DDI-DrugBank.d737.s10.e3" charOffset="83-102"
            type="group" text="dopamine antagonists"/>
        <entity id="DDI-DrugBank.d737.s10.e4" charOffset="117-128"
            type="group" text="neuroleptics"/>
        <entity id="DDI-DrugBank.d737.s10.e5" charOffset="131-144"
            type="group" text="phenothiazines"/>
        <entity id="DDI-DrugBank.d737.s10.e6" charOffset="147-160"
            type="group" text="butyrophenones"/>
        <entity id="DDI-DrugBank.d737.s10.e7" charOffset="163-175"
            type="group" text="thioxanthenes"/>
        <entity id="DDI-DrugBank.d737.s10.e8" charOffset="181-194"
            type="group" text="metoclopramide"/>
        <entity id="DDI-DrugBank.d737.s10.e9" charOffset="231-237"
            type="brand" text="MIRAPEX"/>
        <pair id="DDI-DrugBank.d737.s10.p0"
            e1="DDI-DrugBank.d737.s10.e0" e2="DDI-DrugBank.d737.s10.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p1"
            e1="DDI-DrugBank.d737.s10.e0" e2="DDI-DrugBank.d737.s10.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p2"
            e1="DDI-DrugBank.d737.s10.e0" e2="DDI-DrugBank.d737.s10.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p3"
            e1="DDI-DrugBank.d737.s10.e0" e2="DDI-DrugBank.d737.s10.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p4"
            e1="DDI-DrugBank.d737.s10.e0" e2="DDI-DrugBank.d737.s10.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p5"
            e1="DDI-DrugBank.d737.s10.e0" e2="DDI-DrugBank.d737.s10.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p6"
            e1="DDI-DrugBank.d737.s10.e0" e2="DDI-DrugBank.d737.s10.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p7"
            e1="DDI-DrugBank.d737.s10.e0" e2="DDI-DrugBank.d737.s10.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p8"
            e1="DDI-DrugBank.d737.s10.e0" e2="DDI-DrugBank.d737.s10.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p9"
            e1="DDI-DrugBank.d737.s10.e1" e2="DDI-DrugBank.d737.s10.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p10"
            e1="DDI-DrugBank.d737.s10.e1" e2="DDI-DrugBank.d737.s10.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p11"
            e1="DDI-DrugBank.d737.s10.e1" e2="DDI-DrugBank.d737.s10.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p12"
            e1="DDI-DrugBank.d737.s10.e1" e2="DDI-DrugBank.d737.s10.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p13"
            e1="DDI-DrugBank.d737.s10.e1" e2="DDI-DrugBank.d737.s10.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p14"
            e1="DDI-DrugBank.d737.s10.e1" e2="DDI-DrugBank.d737.s10.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p15"
            e1="DDI-DrugBank.d737.s10.e1" e2="DDI-DrugBank.d737.s10.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p16"
            e1="DDI-DrugBank.d737.s10.e1" e2="DDI-DrugBank.d737.s10.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p17"
            e1="DDI-DrugBank.d737.s10.e2" e2="DDI-DrugBank.d737.s10.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p18"
            e1="DDI-DrugBank.d737.s10.e2" e2="DDI-DrugBank.d737.s10.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p19"
            e1="DDI-DrugBank.d737.s10.e2" e2="DDI-DrugBank.d737.s10.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p20"
            e1="DDI-DrugBank.d737.s10.e2" e2="DDI-DrugBank.d737.s10.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p21"
            e1="DDI-DrugBank.d737.s10.e2" e2="DDI-DrugBank.d737.s10.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p22"
            e1="DDI-DrugBank.d737.s10.e2" e2="DDI-DrugBank.d737.s10.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p23"
            e1="DDI-DrugBank.d737.s10.e2" e2="DDI-DrugBank.d737.s10.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p24"
            e1="DDI-DrugBank.d737.s10.e3" e2="DDI-DrugBank.d737.s10.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p25"
            e1="DDI-DrugBank.d737.s10.e3" e2="DDI-DrugBank.d737.s10.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p26"
            e1="DDI-DrugBank.d737.s10.e3" e2="DDI-DrugBank.d737.s10.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p27"
            e1="DDI-DrugBank.d737.s10.e3" e2="DDI-DrugBank.d737.s10.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p28"
            e1="DDI-DrugBank.d737.s10.e3" e2="DDI-DrugBank.d737.s10.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p29"
            e1="DDI-DrugBank.d737.s10.e3" e2="DDI-DrugBank.d737.s10.e9"
            ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d737.s10.p30"
            e1="DDI-DrugBank.d737.s10.e4" e2="DDI-DrugBank.d737.s10.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p31"
            e1="DDI-DrugBank.d737.s10.e4" e2="DDI-DrugBank.d737.s10.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p32"
            e1="DDI-DrugBank.d737.s10.e4" e2="DDI-DrugBank.d737.s10.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p33"
            e1="DDI-DrugBank.d737.s10.e4" e2="DDI-DrugBank.d737.s10.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p34"
            e1="DDI-DrugBank.d737.s10.e4" e2="DDI-DrugBank.d737.s10.e9"
            ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d737.s10.p35"
            e1="DDI-DrugBank.d737.s10.e5" e2="DDI-DrugBank.d737.s10.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p36"
            e1="DDI-DrugBank.d737.s10.e5" e2="DDI-DrugBank.d737.s10.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p37"
            e1="DDI-DrugBank.d737.s10.e5" e2="DDI-DrugBank.d737.s10.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p38"
            e1="DDI-DrugBank.d737.s10.e5" e2="DDI-DrugBank.d737.s10.e9"
            ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d737.s10.p39"
            e1="DDI-DrugBank.d737.s10.e6" e2="DDI-DrugBank.d737.s10.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p40"
            e1="DDI-DrugBank.d737.s10.e6" e2="DDI-DrugBank.d737.s10.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p41"
            e1="DDI-DrugBank.d737.s10.e6" e2="DDI-DrugBank.d737.s10.e9"
            ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d737.s10.p42"
            e1="DDI-DrugBank.d737.s10.e7" e2="DDI-DrugBank.d737.s10.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d737.s10.p43"
            e1="DDI-DrugBank.d737.s10.e7" e2="DDI-DrugBank.d737.s10.e9"
            ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d737.s10.p44"
            e1="DDI-DrugBank.d737.s10.e8" e2="DDI-DrugBank.d737.s10.e9"
            ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d737.s11" text="Drug/ Laboratory Test Interactions There are no known interactions between MIRAPEX and laboratory tests.">
        <entity id="DDI-DrugBank.d737.s11.e0" charOffset="75-81"
            type="brand" text="MIRAPEX"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d632">
    <sentence id="DDI-DrugBank.d632.s0" text="Due to its effects on gastric emptying, SYMLIN therapy should not be considered for patients taking drugs that alter gastrointestinal motility (e.g., anticholinergic agents such as atropine) and agents that slow the intestinal absorption of nutrients (e.g., alpha glucosidase inhibitors). ">
        <entity id="DDI-DrugBank.d632.s0.e0" charOffset="40-45"
            type="brand" text="SYMLIN"/>
        <entity id="DDI-DrugBank.d632.s0.e1" charOffset="150-171"
            type="group" text="anticholinergic agents"/>
        <entity id="DDI-DrugBank.d632.s0.e2" charOffset="181-188"
            type="drug" text="atropine"/>
        <entity id="DDI-DrugBank.d632.s0.e3" charOffset="258-285"
            type="group" text="alpha glucosidase inhibitors"/>
        <pair id="DDI-DrugBank.d632.s0.p0" e1="DDI-DrugBank.d632.s0.e0"
            e2="DDI-DrugBank.d632.s0.e1" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d632.s0.p1" e1="DDI-DrugBank.d632.s0.e0"
            e2="DDI-DrugBank.d632.s0.e2" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d632.s0.p2" e1="DDI-DrugBank.d632.s0.e0"
            e2="DDI-DrugBank.d632.s0.e3" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d632.s0.p3" e1="DDI-DrugBank.d632.s0.e1"
            e2="DDI-DrugBank.d632.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d632.s0.p4" e1="DDI-DrugBank.d632.s0.e1"
            e2="DDI-DrugBank.d632.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d632.s0.p5" e1="DDI-DrugBank.d632.s0.e2"
            e2="DDI-DrugBank.d632.s0.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d632.s1" text="Patients using these drugs have not been studied in clinical trials. "/>
    <sentence id="DDI-DrugBank.d632.s2" text="SYMLIN has the potential to delay the absorption of concomitantly administered oral medications. ">
        <entity id="DDI-DrugBank.d632.s2.e0" charOffset="0-5"
            type="brand" text="SYMLIN"/>
    </sentence>
    <sentence id="DDI-DrugBank.d632.s3" text="When the rapid onset of a concomitant orally administered agent is a critical determinant of effectiveness (such as analgesics), the agent should be administered at least 1 hour prior to or 2 hours after SYMLIN injection. ">
        <entity id="DDI-DrugBank.d632.s3.e0" charOffset="116-125"
            type="group" text="analgesics"/>
        <entity id="DDI-DrugBank.d632.s3.e1" charOffset="204-209"
            type="brand" text="SYMLIN"/>
        <pair id="DDI-DrugBank.d632.s3.p0" e1="DDI-DrugBank.d632.s3.e0"
            e2="DDI-DrugBank.d632.s3.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d632.s4" text="In clinical trials, the concomitant use of sulfonylureas or biguanides did not alter the adverse event profile of SYMLIN. ">
        <entity id="DDI-DrugBank.d632.s4.e0" charOffset="43-55"
            type="group" text="sulfonylureas"/>
        <entity id="DDI-DrugBank.d632.s4.e1" charOffset="60-69"
            type="group" text="biguanides"/>
        <entity id="DDI-DrugBank.d632.s4.e2" charOffset="114-119"
            type="brand" text="SYMLIN"/>
        <pair id="DDI-DrugBank.d632.s4.p0" e1="DDI-DrugBank.d632.s4.e0"
            e2="DDI-DrugBank.d632.s4.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d632.s4.p1" e1="DDI-DrugBank.d632.s4.e0"
            e2="DDI-DrugBank.d632.s4.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d632.s4.p2" e1="DDI-DrugBank.d632.s4.e1"
            e2="DDI-DrugBank.d632.s4.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d632.s5" text="No formal interaction studies have been performed to assess the effect of SYMLIN on the kinetics of oral antidiabetic agents. ">
        <entity id="DDI-DrugBank.d632.s5.e0" charOffset="74-79"
            type="brand" text="SYMLIN"/>
        <entity id="DDI-DrugBank.d632.s5.e1" charOffset="105-123"
            type="group" text="antidiabetic agents"/>
        <pair id="DDI-DrugBank.d632.s5.p0" e1="DDI-DrugBank.d632.s5.e0"
            e2="DDI-DrugBank.d632.s5.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d632.s6" text="Mixing SYMLIN and Insulin The pharmacokinetic parameters of SYMLIN were altered when mixed with regular, NPH, and 70/30 premixed formulations of recombinant human insulin immediately prior to injection. ">
        <entity id="DDI-DrugBank.d632.s6.e0" charOffset="7-12"
            type="brand" text="SYMLIN"/>
        <entity id="DDI-DrugBank.d632.s6.e1" charOffset="18-24"
            type="drug" text="Insulin"/>
        <entity id="DDI-DrugBank.d632.s6.e2" charOffset="60-65"
            type="brand" text="SYMLIN"/>
        <entity id="DDI-DrugBank.d632.s6.e3" charOffset="157-169"
            type="drug" text="human insulin"/>
        <pair id="DDI-DrugBank.d632.s6.p0" e1="DDI-DrugBank.d632.s6.e0"
            e2="DDI-DrugBank.d632.s6.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d632.s6.p1" e1="DDI-DrugBank.d632.s6.e0"
            e2="DDI-DrugBank.d632.s6.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d632.s6.p2" e1="DDI-DrugBank.d632.s6.e0"
            e2="DDI-DrugBank.d632.s6.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d632.s6.p3" e1="DDI-DrugBank.d632.s6.e1"
            e2="DDI-DrugBank.d632.s6.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d632.s6.p4" e1="DDI-DrugBank.d632.s6.e1"
            e2="DDI-DrugBank.d632.s6.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d632.s6.p5" e1="DDI-DrugBank.d632.s6.e2"
            e2="DDI-DrugBank.d632.s6.e3" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d632.s7" text="Thus, SYMLIN and insulin should not be mixed and must be administered separately.">
        <entity id="DDI-DrugBank.d632.s7.e0" charOffset="6-11"
            type="brand" text="SYMLIN"/>
        <entity id="DDI-DrugBank.d632.s7.e1" charOffset="17-23"
            type="drug" text="insulin"/>
        <pair id="DDI-DrugBank.d632.s7.p0" e1="DDI-DrugBank.d632.s7.e0"
            e2="DDI-DrugBank.d632.s7.e1" ddi="false"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d734">
    <sentence id="DDI-DrugBank.d734.s0" text="Thiazide diuretics may accentuate the orthostatic hypotension that may occur with phenothiazines. ">
        <entity id="DDI-DrugBank.d734.s0.e0" charOffset="0-17"
            type="group" text="Thiazide diuretics"/>
        <entity id="DDI-DrugBank.d734.s0.e1" charOffset="82-95"
            type="group" text="phenothiazines"/>
        <pair id="DDI-DrugBank.d734.s0.p0" e1="DDI-DrugBank.d734.s0.e0"
            e2="DDI-DrugBank.d734.s0.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d734.s1" text="Antihypertensive effects of guanethidine and related compounds may be counteracted when phenothiazines are used concomitantly. ">
        <entity id="DDI-DrugBank.d734.s1.e0" charOffset="28-39"
            type="drug" text="guanethidine"/>
        <entity id="DDI-DrugBank.d734.s1.e1" charOffset="88-101"
            type="group" text="phenothiazines"/>
        <pair id="DDI-DrugBank.d734.s1.p0" e1="DDI-DrugBank.d734.s1.e0"
            e2="DDI-DrugBank.d734.s1.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d734.s2" text="Concomitant administration of propranolol with phenothiazines results in increased plasma levels of both drugs.">
        <entity id="DDI-DrugBank.d734.s2.e0" charOffset="30-40"
            type="drug" text="propranolol"/>
        <entity id="DDI-DrugBank.d734.s2.e1" charOffset="47-60"
            type="group" text="phenothiazines"/>
        <pair id="DDI-DrugBank.d734.s2.p0" e1="DDI-DrugBank.d734.s2.e0"
            e2="DDI-DrugBank.d734.s2.e1" ddi="true" type="mechanism"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d590">
    <sentence id="DDI-DrugBank.d590.s0" text="Coadministration of TRITEC with clarithromycin resulted in increased plasma ranitidine concentrations (57%), increased plasma bismuth trough concentrations (48%), and increased 14- hydroxy- clarithromycin plasma concentrations (31%). ">
        <entity id="DDI-DrugBank.d590.s0.e0" charOffset="20-25"
            type="brand" text="TRITEC"/>
        <entity id="DDI-DrugBank.d590.s0.e1" charOffset="32-45"
            type="drug" text="clarithromycin"/>
        <entity id="DDI-DrugBank.d590.s0.e2" charOffset="76-85"
            type="drug" text="ranitidine"/>
        <entity id="DDI-DrugBank.d590.s0.e3" charOffset="177-203"
            type="drug_n" text="14- hydroxy- clarithromycin"/>
        <pair id="DDI-DrugBank.d590.s0.p0" e1="DDI-DrugBank.d590.s0.e0"
            e2="DDI-DrugBank.d590.s0.e1" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d590.s0.p1" e1="DDI-DrugBank.d590.s0.e0"
            e2="DDI-DrugBank.d590.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d590.s0.p2" e1="DDI-DrugBank.d590.s0.e0"
            e2="DDI-DrugBank.d590.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d590.s0.p3" e1="DDI-DrugBank.d590.s0.e1"
            e2="DDI-DrugBank.d590.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d590.s0.p4" e1="DDI-DrugBank.d590.s0.e1"
            e2="DDI-DrugBank.d590.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d590.s0.p5" e1="DDI-DrugBank.d590.s0.e2"
            e2="DDI-DrugBank.d590.s0.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d590.s1" text="Coadministration with aspirin results in a slight decrease in the rate of salicylate absorption that is clinically unimportant. ">
        <entity id="DDI-DrugBank.d590.s1.e0" charOffset="22-28"
            type="brand" text="aspirin"/>
        <entity id="DDI-DrugBank.d590.s1.e1" charOffset="74-83"
            type="group" text="salicylate"/>
        <pair id="DDI-DrugBank.d590.s1.p0" e1="DDI-DrugBank.d590.s1.e0"
            e2="DDI-DrugBank.d590.s1.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d590.s2" text="Coadministration with a high dose of antacid (170 mEq) results in a 28% decrease in plasma concentrations of ranitidine and may decrease plasma concentrations of bismuth from TRITEC. ">
        <entity id="DDI-DrugBank.d590.s2.e0" charOffset="37-43"
            type="group" text="antacid"/>
        <entity id="DDI-DrugBank.d590.s2.e1" charOffset="109-118"
            type="drug" text="ranitidine"/>
        <entity id="DDI-DrugBank.d590.s2.e2" charOffset="175-180"
            type="brand" text="TRITEC"/>
        <pair id="DDI-DrugBank.d590.s2.p0" e1="DDI-DrugBank.d590.s2.e0"
            e2="DDI-DrugBank.d590.s2.e1" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d590.s2.p1" e1="DDI-DrugBank.d590.s2.e0"
            e2="DDI-DrugBank.d590.s2.e2" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d590.s2.p2" e1="DDI-DrugBank.d590.s2.e1"
            e2="DDI-DrugBank.d590.s2.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d590.s3" text="These effects are clinically insignificant. "/>
    <sentence id="DDI-DrugBank.d590.s4" text="For information on drug interactions associated with ranitidine, refer to the ZANTAC     package insert.">
        <entity id="DDI-DrugBank.d590.s4.e0" charOffset="53-62"
            type="drug" text="ranitidine"/>
        <entity id="DDI-DrugBank.d590.s4.e1" charOffset="78-83"
            type="brand" text="ZANTAC"/>
        <pair id="DDI-DrugBank.d590.s4.p0" e1="DDI-DrugBank.d590.s4.e0"
            e2="DDI-DrugBank.d590.s4.e1" ddi="false"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d654">
    <sentence id="DDI-DrugBank.d654.s0" text="Co-administration of oral ketoconazole 200 mg twice daily increased retapamulin geometric mean AUC(0-24) and Cmax by 81% after topical application of retapamulin ointment, 1% on the abraded skin of healthy adult males. ">
        <entity id="DDI-DrugBank.d654.s0.e0" charOffset="26-37"
            type="drug" text="ketoconazole"/>
        <entity id="DDI-DrugBank.d654.s0.e1" charOffset="68-78"
            type="drug" text="retapamulin"/>
        <entity id="DDI-DrugBank.d654.s0.e2" charOffset="150-160"
            type="drug" text="retapamulin"/>
        <pair id="DDI-DrugBank.d654.s0.p0" e1="DDI-DrugBank.d654.s0.e0"
            e2="DDI-DrugBank.d654.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d654.s0.p1" e1="DDI-DrugBank.d654.s0.e0"
            e2="DDI-DrugBank.d654.s0.e2" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d654.s0.p2" e1="DDI-DrugBank.d654.s0.e1"
            e2="DDI-DrugBank.d654.s0.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d654.s1" text="Due to low systemic exposure to retapamulin following topical application in patients, dosage adjustments for retapamulin are unnecessary when co-administered with CYP3A4 inhibitors, such as ketoconazole. ">
        <entity id="DDI-DrugBank.d654.s1.e0" charOffset="32-42"
            type="drug" text="retapamulin"/>
        <entity id="DDI-DrugBank.d654.s1.e1" charOffset="110-120"
            type="drug" text="retapamulin"/>
        <entity id="DDI-DrugBank.d654.s1.e2" charOffset="191-202"
            type="drug" text="ketoconazole"/>
        <pair id="DDI-DrugBank.d654.s1.p0" e1="DDI-DrugBank.d654.s1.e0"
            e2="DDI-DrugBank.d654.s1.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d654.s1.p1" e1="DDI-DrugBank.d654.s1.e0"
            e2="DDI-DrugBank.d654.s1.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d654.s1.p2" e1="DDI-DrugBank.d654.s1.e1"
            e2="DDI-DrugBank.d654.s1.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d654.s2" text="Based on in vitro P450 inhibition studies and the low systemic exposure observed following topical application of ALTABAX, retapamulin is unlikely to affect the metabolism of other P450 substrates. ">
        <entity id="DDI-DrugBank.d654.s2.e0" charOffset="114-120"
            type="brand" text="ALTABAX"/>
        <entity id="DDI-DrugBank.d654.s2.e1" charOffset="123-133"
            type="drug" text="retapamulin"/>
        <pair id="DDI-DrugBank.d654.s2.p0" e1="DDI-DrugBank.d654.s2.e0"
            e2="DDI-DrugBank.d654.s2.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d654.s3" text="The effect of concurrent application of ALTABAX and other topical products to the same area of skin has not been studied.">
        <entity id="DDI-DrugBank.d654.s3.e0" charOffset="40-46"
            type="brand" text="ALTABAX"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d124">
    <sentence id="DDI-DrugBank.d124.s0" text="DRUG INTERACTIONS"/>
    <sentence id="DDI-DrugBank.d124.s1" text="Several drug interaction studies have been completed with both INVIRASE and FORTOVASE.">
        <entity id="DDI-DrugBank.d124.s1.e0" charOffset="63-70"
            type="brand" text="INVIRASE"/>
        <entity id="DDI-DrugBank.d124.s1.e1" charOffset="76-84"
            type="brand" text="FORTOVASE"/>
        <pair id="DDI-DrugBank.d124.s1.p0" e1="DDI-DrugBank.d124.s1.e0"
            e2="DDI-DrugBank.d124.s1.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d124.s2" text="Observations from drug interaction studies with FORTOVASE may not be predictive for INVIRASE.">
        <entity id="DDI-DrugBank.d124.s2.e0" charOffset="48-56"
            type="brand" text="FORTOVASE"/>
        <entity id="DDI-DrugBank.d124.s2.e1" charOffset="84-91"
            type="brand" text="INVIRASE"/>
        <pair id="DDI-DrugBank.d124.s2.p0" e1="DDI-DrugBank.d124.s2.e0"
            e2="DDI-DrugBank.d124.s2.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d124.s3" text="Because ritonavir is coadministered, prescribers should also refer to the prescribing information for ritonavir regarding drug interactions associated with this agent.">
        <entity id="DDI-DrugBank.d124.s3.e0" charOffset="8-16"
            type="drug" text="ritonavir"/>
        <entity id="DDI-DrugBank.d124.s3.e1" charOffset="102-110"
            type="drug" text="ritonavir"/>
        <pair id="DDI-DrugBank.d124.s3.p0" e1="DDI-DrugBank.d124.s3.e0"
            e2="DDI-DrugBank.d124.s3.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d124.s4" text="The metabolism of saquinavir is mediated by cytochrome P450, with the specific isoenzyme CYP3A4 responsible for 90% of the hepatic metabolism.">
        <entity id="DDI-DrugBank.d124.s4.e0" charOffset="18-27"
            type="drug" text="saquinavir"/>
    </sentence>
    <sentence id="DDI-DrugBank.d124.s5" text="Additionally, saquinavir is a substrate for P-Glycoprotein (Pgp).">
        <entity id="DDI-DrugBank.d124.s5.e0" charOffset="14-23"
            type="drug" text="saquinavir"/>
    </sentence>
    <sentence id="DDI-DrugBank.d124.s6" text="Therefore, drugs that affect CYP3A4 and/or Pgp, may modify the pharmacokinetics of saquinavir.">
        <entity id="DDI-DrugBank.d124.s6.e0" charOffset="83-92"
            type="drug" text="saquinavir"/>
    </sentence>
    <sentence id="DDI-DrugBank.d124.s7" text="Similarly, saquinavir might also modify the pharmacokinetics of other drugs that are substrates for CYP3A4 or Pgp.">
        <entity id="DDI-DrugBank.d124.s7.e0" charOffset="11-20"
            type="drug" text="saquinavir"/>
    </sentence>
    <sentence id="DDI-DrugBank.d124.s8" text="Drugs that are contraindicated specifically due to the expected magnitude of interaction and potential for serious adverse events are listed CONTRAINDICATIONS."/>
    <sentence id="DDI-DrugBank.d124.s9" text="Additional drugs that are not recommended for coadministration with INVIRASE and ritonavir are included below.">
        <entity id="DDI-DrugBank.d124.s9.e0" charOffset="68-75"
            type="brand" text="INVIRASE"/>
        <entity id="DDI-DrugBank.d124.s9.e1" charOffset="81-89"
            type="drug" text="ritonavir"/>
        <pair id="DDI-DrugBank.d124.s9.p0" e1="DDI-DrugBank.d124.s9.e0"
            e2="DDI-DrugBank.d124.s9.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d124.s10" text="These recommendations are based on either drug interaction studies or predicted interactions due to the expected magnitude of interaction and potential for serious events or loss of efficacy."/>
    <sentence id="DDI-DrugBank.d124.s11" text="With some agents, the metabolism may be induced, resulting in decreased concentrations."/>
    <sentence id="DDI-DrugBank.d124.s12" text="Drugs That Should Not Be Coadministered With INVIRASE/Ritonavir">
        <entity id="DDI-DrugBank.d124.s12.e0" charOffset="45-52"
            type="brand" text="INVIRASE"/>
        <entity id="DDI-DrugBank.d124.s12.e1" charOffset="54-62"
            type="drug" text="Ritonavir"/>
        <pair id="DDI-DrugBank.d124.s12.p0"
            e1="DDI-DrugBank.d124.s12.e0" e2="DDI-DrugBank.d124.s12.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d124.s13" text="Drug Class: Drug Name Clinical Comment"/>
    <sentence id="DDI-DrugBank.d124.s14" text="Antiarrhythmics: Amiodarone, bepridil, flecainide, propafenone, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.">
        <entity id="DDI-DrugBank.d124.s14.e0" charOffset="0-14"
            type="group" text="Antiarrhythmics"/>
        <entity id="DDI-DrugBank.d124.s14.e1" charOffset="17-26"
            type="drug" text="Amiodarone"/>
        <entity id="DDI-DrugBank.d124.s14.e2" charOffset="29-36"
            type="drug" text="bepridil"/>
        <entity id="DDI-DrugBank.d124.s14.e3" charOffset="39-48"
            type="drug" text="flecainide"/>
        <entity id="DDI-DrugBank.d124.s14.e4" charOffset="51-61"
            type="drug" text="propafenone"/>
        <entity id="DDI-DrugBank.d124.s14.e5" charOffset="64-72"
            type="drug" text="quinidine"/>
        <pair id="DDI-DrugBank.d124.s14.p0"
            e1="DDI-DrugBank.d124.s14.e0" e2="DDI-DrugBank.d124.s14.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s14.p1"
            e1="DDI-DrugBank.d124.s14.e0" e2="DDI-DrugBank.d124.s14.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s14.p2"
            e1="DDI-DrugBank.d124.s14.e0" e2="DDI-DrugBank.d124.s14.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s14.p3"
            e1="DDI-DrugBank.d124.s14.e0" e2="DDI-DrugBank.d124.s14.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s14.p4"
            e1="DDI-DrugBank.d124.s14.e0" e2="DDI-DrugBank.d124.s14.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s14.p5"
            e1="DDI-DrugBank.d124.s14.e1" e2="DDI-DrugBank.d124.s14.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s14.p6"
            e1="DDI-DrugBank.d124.s14.e1" e2="DDI-DrugBank.d124.s14.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s14.p7"
            e1="DDI-DrugBank.d124.s14.e1" e2="DDI-DrugBank.d124.s14.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s14.p8"
            e1="DDI-DrugBank.d124.s14.e1" e2="DDI-DrugBank.d124.s14.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s14.p9"
            e1="DDI-DrugBank.d124.s14.e2" e2="DDI-DrugBank.d124.s14.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s14.p10"
            e1="DDI-DrugBank.d124.s14.e2" e2="DDI-DrugBank.d124.s14.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s14.p11"
            e1="DDI-DrugBank.d124.s14.e2" e2="DDI-DrugBank.d124.s14.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s14.p12"
            e1="DDI-DrugBank.d124.s14.e3" e2="DDI-DrugBank.d124.s14.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s14.p13"
            e1="DDI-DrugBank.d124.s14.e3" e2="DDI-DrugBank.d124.s14.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s14.p14"
            e1="DDI-DrugBank.d124.s14.e4" e2="DDI-DrugBank.d124.s14.e5" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d124.s15" text="Antihistamines: astemizole*, terfenadine* CONTRAINDICATED due to potential for serious and/or life-threatening cardiac arrhythmias.">
        <entity id="DDI-DrugBank.d124.s15.e0" charOffset="0-13"
            type="drug" text="Antihistamines"/>
        <entity id="DDI-DrugBank.d124.s15.e1" charOffset="16-25"
            type="drug" text="astemizole"/>
        <entity id="DDI-DrugBank.d124.s15.e2" charOffset="29-39"
            type="drug" text="terfenadine"/>
        <pair id="DDI-DrugBank.d124.s15.p0"
            e1="DDI-DrugBank.d124.s15.e0" e2="DDI-DrugBank.d124.s15.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s15.p1"
            e1="DDI-DrugBank.d124.s15.e0" e2="DDI-DrugBank.d124.s15.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s15.p2"
            e1="DDI-DrugBank.d124.s15.e1" e2="DDI-DrugBank.d124.s15.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d124.s16" text="Ergot Derivatives: Dihydroergotamine, ergonovine, ergotamine, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.">
        <entity id="DDI-DrugBank.d124.s16.e0" charOffset="0-16"
            type="group" text="Ergot Derivatives"/>
        <entity id="DDI-DrugBank.d124.s16.e1" charOffset="19-35"
            type="drug" text="Dihydroergotamine"/>
        <entity id="DDI-DrugBank.d124.s16.e2" charOffset="38-47"
            type="drug" text="ergonovine"/>
        <entity id="DDI-DrugBank.d124.s16.e3" charOffset="50-59"
            type="drug" text="ergotamine"/>
        <entity id="DDI-DrugBank.d124.s16.e4" charOffset="62-77"
            type="drug" text="methylergonovine"/>
        <entity id="DDI-DrugBank.d124.s16.e5" charOffset="169-173"
            type="group" text="ergot"/>
        <pair id="DDI-DrugBank.d124.s16.p0"
            e1="DDI-DrugBank.d124.s16.e0" e2="DDI-DrugBank.d124.s16.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s16.p1"
            e1="DDI-DrugBank.d124.s16.e0" e2="DDI-DrugBank.d124.s16.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s16.p2"
            e1="DDI-DrugBank.d124.s16.e0" e2="DDI-DrugBank.d124.s16.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s16.p3"
            e1="DDI-DrugBank.d124.s16.e0" e2="DDI-DrugBank.d124.s16.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s16.p4"
            e1="DDI-DrugBank.d124.s16.e0" e2="DDI-DrugBank.d124.s16.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s16.p5"
            e1="DDI-DrugBank.d124.s16.e1" e2="DDI-DrugBank.d124.s16.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s16.p6"
            e1="DDI-DrugBank.d124.s16.e1" e2="DDI-DrugBank.d124.s16.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s16.p7"
            e1="DDI-DrugBank.d124.s16.e1" e2="DDI-DrugBank.d124.s16.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s16.p8"
            e1="DDI-DrugBank.d124.s16.e1" e2="DDI-DrugBank.d124.s16.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s16.p9"
            e1="DDI-DrugBank.d124.s16.e2" e2="DDI-DrugBank.d124.s16.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s16.p10"
            e1="DDI-DrugBank.d124.s16.e2" e2="DDI-DrugBank.d124.s16.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s16.p11"
            e1="DDI-DrugBank.d124.s16.e2" e2="DDI-DrugBank.d124.s16.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s16.p12"
            e1="DDI-DrugBank.d124.s16.e3" e2="DDI-DrugBank.d124.s16.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s16.p13"
            e1="DDI-DrugBank.d124.s16.e3" e2="DDI-DrugBank.d124.s16.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s16.p14"
            e1="DDI-DrugBank.d124.s16.e4" e2="DDI-DrugBank.d124.s16.e5" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d124.s17" text="Antimycobacterial Agents: rifampin CONTRAINDICATED since the coadministration of this product with saquinavir in an antiretroviral regimen reduces the plasma concentrations of saquinavir.">
        <entity id="DDI-DrugBank.d124.s17.e0" charOffset="0-23"
            type="group" text="Antimycobacterial Agents"/>
        <entity id="DDI-DrugBank.d124.s17.e1" charOffset="26-33"
            type="drug" text="rifampin"/>
        <entity id="DDI-DrugBank.d124.s17.e2" charOffset="99-108"
            type="drug" text="saquinavir"/>
        <entity id="DDI-DrugBank.d124.s17.e3" charOffset="116-129"
            type="group" text="antiretroviral"/>
        <entity id="DDI-DrugBank.d124.s17.e4" charOffset="176-185"
            type="drug" text="saquinavir"/>
        <pair id="DDI-DrugBank.d124.s17.p0"
            e1="DDI-DrugBank.d124.s17.e0" e2="DDI-DrugBank.d124.s17.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s17.p1"
            e1="DDI-DrugBank.d124.s17.e0" e2="DDI-DrugBank.d124.s17.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s17.p2"
            e1="DDI-DrugBank.d124.s17.e0" e2="DDI-DrugBank.d124.s17.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s17.p3"
            e1="DDI-DrugBank.d124.s17.e0" e2="DDI-DrugBank.d124.s17.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s17.p4"
            e1="DDI-DrugBank.d124.s17.e1" e2="DDI-DrugBank.d124.s17.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s17.p5"
            e1="DDI-DrugBank.d124.s17.e1" e2="DDI-DrugBank.d124.s17.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s17.p6"
            e1="DDI-DrugBank.d124.s17.e1" e2="DDI-DrugBank.d124.s17.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s17.p7"
            e1="DDI-DrugBank.d124.s17.e2" e2="DDI-DrugBank.d124.s17.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s17.p8"
            e1="DDI-DrugBank.d124.s17.e2" e2="DDI-DrugBank.d124.s17.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s17.p9"
            e1="DDI-DrugBank.d124.s17.e3" e2="DDI-DrugBank.d124.s17.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d124.s18" text="Garlic Capsules Garlic capsules should not be used while taking saquinavir (FORTOVASE) as the sole protease inhibitor due to the risk of decreased saquinavir plasma concentrations.">
        <entity id="DDI-DrugBank.d124.s18.e0" charOffset="64-73"
            type="drug" text="saquinavir"/>
        <entity id="DDI-DrugBank.d124.s18.e1" charOffset="76-84"
            type="brand" text="FORTOVASE"/>
        <entity id="DDI-DrugBank.d124.s18.e2" charOffset="99-116"
            type="group" text="protease inhibitor"/>
        <entity id="DDI-DrugBank.d124.s18.e3" charOffset="147-156"
            type="drug" text="saquinavir"/>
        <pair id="DDI-DrugBank.d124.s18.p0"
            e1="DDI-DrugBank.d124.s18.e0" e2="DDI-DrugBank.d124.s18.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s18.p1"
            e1="DDI-DrugBank.d124.s18.e0" e2="DDI-DrugBank.d124.s18.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s18.p2"
            e1="DDI-DrugBank.d124.s18.e0" e2="DDI-DrugBank.d124.s18.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s18.p3"
            e1="DDI-DrugBank.d124.s18.e1" e2="DDI-DrugBank.d124.s18.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s18.p4"
            e1="DDI-DrugBank.d124.s18.e1" e2="DDI-DrugBank.d124.s18.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s18.p5"
            e1="DDI-DrugBank.d124.s18.e2" e2="DDI-DrugBank.d124.s18.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d124.s19" text="No data are available for the coadministration of INVIRASE/ritonavir or FORTOVASE/ritonavir and garlic capsules.">
        <entity id="DDI-DrugBank.d124.s19.e0" charOffset="50-57"
            type="brand" text="INVIRASE"/>
        <entity id="DDI-DrugBank.d124.s19.e1" charOffset="59-67"
            type="drug" text="ritonavir"/>
        <entity id="DDI-DrugBank.d124.s19.e2" charOffset="72-80"
            type="brand" text="FORTOVASE"/>
        <entity id="DDI-DrugBank.d124.s19.e3" charOffset="82-90"
            type="drug" text="ritonavir"/>
        <pair id="DDI-DrugBank.d124.s19.p0"
            e1="DDI-DrugBank.d124.s19.e0" e2="DDI-DrugBank.d124.s19.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s19.p1"
            e1="DDI-DrugBank.d124.s19.e0" e2="DDI-DrugBank.d124.s19.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s19.p2"
            e1="DDI-DrugBank.d124.s19.e0" e2="DDI-DrugBank.d124.s19.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s19.p3"
            e1="DDI-DrugBank.d124.s19.e1" e2="DDI-DrugBank.d124.s19.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s19.p4"
            e1="DDI-DrugBank.d124.s19.e1" e2="DDI-DrugBank.d124.s19.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s19.p5"
            e1="DDI-DrugBank.d124.s19.e2" e2="DDI-DrugBank.d124.s19.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d124.s20" text="GI Motility Agent: cisapride* CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as cardiac arrhythmias.">
        <entity id="DDI-DrugBank.d124.s20.e0" charOffset="19-27"
            type="drug" text="cisapride"/>
    </sentence>
    <sentence id="DDI-DrugBank.d124.s21" text="Herbal Products: St. John s wort (hypericum perforatum) WARNING coadministration may lead to loss of virologic response and possible resistance to INVIRASE or to the class of protease inhibitors.">
        <entity id="DDI-DrugBank.d124.s21.e0" charOffset="147-154"
            type="brand" text="INVIRASE"/>
    </sentence>
    <sentence id="DDI-DrugBank.d124.s22" text="HMG-CoA Reductase Inhibitors: lovastatin, simvastatin WARNING potential for serious reactions such as risk of myopathy including rhabdomyolysis.">
        <entity id="DDI-DrugBank.d124.s22.e0" charOffset="0-27"
            type="group" text="HMG-CoA Reductase Inhibitors"/>
        <entity id="DDI-DrugBank.d124.s22.e1" charOffset="30-39"
            type="drug" text="lovastatin"/>
        <entity id="DDI-DrugBank.d124.s22.e2" charOffset="42-52"
            type="drug" text="simvastatin"/>
        <pair id="DDI-DrugBank.d124.s22.p0"
            e1="DDI-DrugBank.d124.s22.e0" e2="DDI-DrugBank.d124.s22.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s22.p1"
            e1="DDI-DrugBank.d124.s22.e0" e2="DDI-DrugBank.d124.s22.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s22.p2"
            e1="DDI-DrugBank.d124.s22.e1" e2="DDI-DrugBank.d124.s22.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d124.s23" text="Sedatives/Hypnotics: triazolam, midazolam CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression.">
        <entity id="DDI-DrugBank.d124.s23.e0" charOffset="0-8"
            type="group" text="Sedatives"/>
        <entity id="DDI-DrugBank.d124.s23.e1" charOffset="10-18"
            type="group" text="Hypnotics"/>
        <entity id="DDI-DrugBank.d124.s23.e2" charOffset="21-29"
            type="drug" text="triazolam"/>
        <entity id="DDI-DrugBank.d124.s23.e3" charOffset="32-40"
            type="drug" text="midazolam"/>
        <pair id="DDI-DrugBank.d124.s23.p0"
            e1="DDI-DrugBank.d124.s23.e0" e2="DDI-DrugBank.d124.s23.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s23.p1"
            e1="DDI-DrugBank.d124.s23.e0" e2="DDI-DrugBank.d124.s23.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s23.p2"
            e1="DDI-DrugBank.d124.s23.e0" e2="DDI-DrugBank.d124.s23.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s23.p3"
            e1="DDI-DrugBank.d124.s23.e1" e2="DDI-DrugBank.d124.s23.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s23.p4"
            e1="DDI-DrugBank.d124.s23.e1" e2="DDI-DrugBank.d124.s23.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s23.p5"
            e1="DDI-DrugBank.d124.s23.e2" e2="DDI-DrugBank.d124.s23.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d124.s24" text="* No longer marketed in the US."/>
    <sentence id="DDI-DrugBank.d124.s25" text="Drugs That Are Mainly Metabolized by CYP3A4"/>
    <sentence id="DDI-DrugBank.d124.s26" text="Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;">
        <entity id="DDI-DrugBank.d124.s26.e0" charOffset="122-145"
            type="group" text="calcium channel blockers"/>
        <entity id="DDI-DrugBank.d124.s26.e1" charOffset="148-154"
            type="drug" text="dapsone"/>
        <entity id="DDI-DrugBank.d124.s26.e2" charOffset="157-168"
            type="drug" text="disopyramide"/>
        <entity id="DDI-DrugBank.d124.s26.e3" charOffset="171-177"
            type="drug" text="quinine"/>
        <entity id="DDI-DrugBank.d124.s26.e4" charOffset="180-189"
            type="drug" text="amiodarone"/>
        <entity id="DDI-DrugBank.d124.s26.e5" charOffset="192-200"
            type="drug" text="quinidine"/>
        <entity id="DDI-DrugBank.d124.s26.e6" charOffset="203-210"
            type="drug" text="warfarin"/>
        <entity id="DDI-DrugBank.d124.s26.e7" charOffset="213-222"
            type="drug" text="tacrolimus"/>
        <entity id="DDI-DrugBank.d124.s26.e8" charOffset="225-236"
            type="drug" text="cyclosporine"/>
        <entity id="DDI-DrugBank.d124.s26.e9" charOffset="239-255"
            type="group" text="ergot derivatives"/>
        <entity id="DDI-DrugBank.d124.s26.e10" charOffset="258-265"
            type="drug" text="pimozide"/>
        <entity id="DDI-DrugBank.d124.s26.e11" charOffset="268-280"
            type="drug" text="carbamazepine"/>
        <entity id="DDI-DrugBank.d124.s26.e12" charOffset="283-290"
            type="drug" text="fentanyl"/>
        <entity id="DDI-DrugBank.d124.s26.e13" charOffset="293-302"
            type="drug" text="alfentanyl"/>
        <entity id="DDI-DrugBank.d124.s26.e14" charOffset="305-314"
            type="drug" text="alprazolam"/>
        <entity id="DDI-DrugBank.d124.s26.e15" charOffset="321-329"
            type="drug" text="triazolam"/>
        <entity id="DDI-DrugBank.d124.s26.e16" charOffset="397-406"
            type="drug" text="saquinavir"/>
        <pair id="DDI-DrugBank.d124.s26.p0"
            e1="DDI-DrugBank.d124.s26.e0" e2="DDI-DrugBank.d124.s26.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p1"
            e1="DDI-DrugBank.d124.s26.e0" e2="DDI-DrugBank.d124.s26.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p2"
            e1="DDI-DrugBank.d124.s26.e0" e2="DDI-DrugBank.d124.s26.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p3"
            e1="DDI-DrugBank.d124.s26.e0" e2="DDI-DrugBank.d124.s26.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p4"
            e1="DDI-DrugBank.d124.s26.e0" e2="DDI-DrugBank.d124.s26.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p5"
            e1="DDI-DrugBank.d124.s26.e0" e2="DDI-DrugBank.d124.s26.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p6"
            e1="DDI-DrugBank.d124.s26.e0" e2="DDI-DrugBank.d124.s26.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p7"
            e1="DDI-DrugBank.d124.s26.e0" e2="DDI-DrugBank.d124.s26.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p8"
            e1="DDI-DrugBank.d124.s26.e0" e2="DDI-DrugBank.d124.s26.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p9"
            e1="DDI-DrugBank.d124.s26.e0" e2="DDI-DrugBank.d124.s26.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p10"
            e1="DDI-DrugBank.d124.s26.e0" e2="DDI-DrugBank.d124.s26.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p11"
            e1="DDI-DrugBank.d124.s26.e0" e2="DDI-DrugBank.d124.s26.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p12"
            e1="DDI-DrugBank.d124.s26.e0" e2="DDI-DrugBank.d124.s26.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p13"
            e1="DDI-DrugBank.d124.s26.e0" e2="DDI-DrugBank.d124.s26.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p14"
            e1="DDI-DrugBank.d124.s26.e0" e2="DDI-DrugBank.d124.s26.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p15"
            e1="DDI-DrugBank.d124.s26.e0" e2="DDI-DrugBank.d124.s26.e16"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d124.s26.p16"
            e1="DDI-DrugBank.d124.s26.e1" e2="DDI-DrugBank.d124.s26.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p17"
            e1="DDI-DrugBank.d124.s26.e1" e2="DDI-DrugBank.d124.s26.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p18"
            e1="DDI-DrugBank.d124.s26.e1" e2="DDI-DrugBank.d124.s26.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p19"
            e1="DDI-DrugBank.d124.s26.e1" e2="DDI-DrugBank.d124.s26.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p20"
            e1="DDI-DrugBank.d124.s26.e1" e2="DDI-DrugBank.d124.s26.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p21"
            e1="DDI-DrugBank.d124.s26.e1" e2="DDI-DrugBank.d124.s26.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p22"
            e1="DDI-DrugBank.d124.s26.e1" e2="DDI-DrugBank.d124.s26.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p23"
            e1="DDI-DrugBank.d124.s26.e1" e2="DDI-DrugBank.d124.s26.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p24"
            e1="DDI-DrugBank.d124.s26.e1" e2="DDI-DrugBank.d124.s26.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p25"
            e1="DDI-DrugBank.d124.s26.e1" e2="DDI-DrugBank.d124.s26.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p26"
            e1="DDI-DrugBank.d124.s26.e1" e2="DDI-DrugBank.d124.s26.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p27"
            e1="DDI-DrugBank.d124.s26.e1" e2="DDI-DrugBank.d124.s26.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p28"
            e1="DDI-DrugBank.d124.s26.e1" e2="DDI-DrugBank.d124.s26.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p29"
            e1="DDI-DrugBank.d124.s26.e1" e2="DDI-DrugBank.d124.s26.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p30"
            e1="DDI-DrugBank.d124.s26.e1" e2="DDI-DrugBank.d124.s26.e16"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d124.s26.p31"
            e1="DDI-DrugBank.d124.s26.e2" e2="DDI-DrugBank.d124.s26.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p32"
            e1="DDI-DrugBank.d124.s26.e2" e2="DDI-DrugBank.d124.s26.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p33"
            e1="DDI-DrugBank.d124.s26.e2" e2="DDI-DrugBank.d124.s26.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p34"
            e1="DDI-DrugBank.d124.s26.e2" e2="DDI-DrugBank.d124.s26.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p35"
            e1="DDI-DrugBank.d124.s26.e2" e2="DDI-DrugBank.d124.s26.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p36"
            e1="DDI-DrugBank.d124.s26.e2" e2="DDI-DrugBank.d124.s26.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p37"
            e1="DDI-DrugBank.d124.s26.e2" e2="DDI-DrugBank.d124.s26.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p38"
            e1="DDI-DrugBank.d124.s26.e2" e2="DDI-DrugBank.d124.s26.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p39"
            e1="DDI-DrugBank.d124.s26.e2" e2="DDI-DrugBank.d124.s26.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p40"
            e1="DDI-DrugBank.d124.s26.e2" e2="DDI-DrugBank.d124.s26.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p41"
            e1="DDI-DrugBank.d124.s26.e2" e2="DDI-DrugBank.d124.s26.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p42"
            e1="DDI-DrugBank.d124.s26.e2" e2="DDI-DrugBank.d124.s26.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p43"
            e1="DDI-DrugBank.d124.s26.e2" e2="DDI-DrugBank.d124.s26.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p44"
            e1="DDI-DrugBank.d124.s26.e2" e2="DDI-DrugBank.d124.s26.e16"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d124.s26.p45"
            e1="DDI-DrugBank.d124.s26.e3" e2="DDI-DrugBank.d124.s26.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p46"
            e1="DDI-DrugBank.d124.s26.e3" e2="DDI-DrugBank.d124.s26.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p47"
            e1="DDI-DrugBank.d124.s26.e3" e2="DDI-DrugBank.d124.s26.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p48"
            e1="DDI-DrugBank.d124.s26.e3" e2="DDI-DrugBank.d124.s26.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p49"
            e1="DDI-DrugBank.d124.s26.e3" e2="DDI-DrugBank.d124.s26.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p50"
            e1="DDI-DrugBank.d124.s26.e3" e2="DDI-DrugBank.d124.s26.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p51"
            e1="DDI-DrugBank.d124.s26.e3" e2="DDI-DrugBank.d124.s26.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p52"
            e1="DDI-DrugBank.d124.s26.e3" e2="DDI-DrugBank.d124.s26.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p53"
            e1="DDI-DrugBank.d124.s26.e3" e2="DDI-DrugBank.d124.s26.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p54"
            e1="DDI-DrugBank.d124.s26.e3" e2="DDI-DrugBank.d124.s26.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p55"
            e1="DDI-DrugBank.d124.s26.e3" e2="DDI-DrugBank.d124.s26.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p56"
            e1="DDI-DrugBank.d124.s26.e3" e2="DDI-DrugBank.d124.s26.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p57"
            e1="DDI-DrugBank.d124.s26.e3" e2="DDI-DrugBank.d124.s26.e16"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d124.s26.p58"
            e1="DDI-DrugBank.d124.s26.e4" e2="DDI-DrugBank.d124.s26.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p59"
            e1="DDI-DrugBank.d124.s26.e4" e2="DDI-DrugBank.d124.s26.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p60"
            e1="DDI-DrugBank.d124.s26.e4" e2="DDI-DrugBank.d124.s26.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p61"
            e1="DDI-DrugBank.d124.s26.e4" e2="DDI-DrugBank.d124.s26.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p62"
            e1="DDI-DrugBank.d124.s26.e4" e2="DDI-DrugBank.d124.s26.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p63"
            e1="DDI-DrugBank.d124.s26.e4" e2="DDI-DrugBank.d124.s26.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p64"
            e1="DDI-DrugBank.d124.s26.e4" e2="DDI-DrugBank.d124.s26.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p65"
            e1="DDI-DrugBank.d124.s26.e4" e2="DDI-DrugBank.d124.s26.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p66"
            e1="DDI-DrugBank.d124.s26.e4" e2="DDI-DrugBank.d124.s26.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p67"
            e1="DDI-DrugBank.d124.s26.e4" e2="DDI-DrugBank.d124.s26.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p68"
            e1="DDI-DrugBank.d124.s26.e4" e2="DDI-DrugBank.d124.s26.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p69"
            e1="DDI-DrugBank.d124.s26.e4" e2="DDI-DrugBank.d124.s26.e16"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d124.s26.p70"
            e1="DDI-DrugBank.d124.s26.e5" e2="DDI-DrugBank.d124.s26.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p71"
            e1="DDI-DrugBank.d124.s26.e5" e2="DDI-DrugBank.d124.s26.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p72"
            e1="DDI-DrugBank.d124.s26.e5" e2="DDI-DrugBank.d124.s26.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p73"
            e1="DDI-DrugBank.d124.s26.e5" e2="DDI-DrugBank.d124.s26.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p74"
            e1="DDI-DrugBank.d124.s26.e5" e2="DDI-DrugBank.d124.s26.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p75"
            e1="DDI-DrugBank.d124.s26.e5" e2="DDI-DrugBank.d124.s26.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p76"
            e1="DDI-DrugBank.d124.s26.e5" e2="DDI-DrugBank.d124.s26.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p77"
            e1="DDI-DrugBank.d124.s26.e5" e2="DDI-DrugBank.d124.s26.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p78"
            e1="DDI-DrugBank.d124.s26.e5" e2="DDI-DrugBank.d124.s26.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p79"
            e1="DDI-DrugBank.d124.s26.e5" e2="DDI-DrugBank.d124.s26.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p80"
            e1="DDI-DrugBank.d124.s26.e5" e2="DDI-DrugBank.d124.s26.e16"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d124.s26.p81"
            e1="DDI-DrugBank.d124.s26.e6" e2="DDI-DrugBank.d124.s26.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p82"
            e1="DDI-DrugBank.d124.s26.e6" e2="DDI-DrugBank.d124.s26.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p83"
            e1="DDI-DrugBank.d124.s26.e6" e2="DDI-DrugBank.d124.s26.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p84"
            e1="DDI-DrugBank.d124.s26.e6" e2="DDI-DrugBank.d124.s26.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p85"
            e1="DDI-DrugBank.d124.s26.e6" e2="DDI-DrugBank.d124.s26.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p86"
            e1="DDI-DrugBank.d124.s26.e6" e2="DDI-DrugBank.d124.s26.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p87"
            e1="DDI-DrugBank.d124.s26.e6" e2="DDI-DrugBank.d124.s26.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p88"
            e1="DDI-DrugBank.d124.s26.e6" e2="DDI-DrugBank.d124.s26.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p89"
            e1="DDI-DrugBank.d124.s26.e6" e2="DDI-DrugBank.d124.s26.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p90"
            e1="DDI-DrugBank.d124.s26.e6" e2="DDI-DrugBank.d124.s26.e16"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d124.s26.p91"
            e1="DDI-DrugBank.d124.s26.e7" e2="DDI-DrugBank.d124.s26.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p92"
            e1="DDI-DrugBank.d124.s26.e7" e2="DDI-DrugBank.d124.s26.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p93"
            e1="DDI-DrugBank.d124.s26.e7" e2="DDI-DrugBank.d124.s26.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p94"
            e1="DDI-DrugBank.d124.s26.e7" e2="DDI-DrugBank.d124.s26.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p95"
            e1="DDI-DrugBank.d124.s26.e7" e2="DDI-DrugBank.d124.s26.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p96"
            e1="DDI-DrugBank.d124.s26.e7" e2="DDI-DrugBank.d124.s26.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p97"
            e1="DDI-DrugBank.d124.s26.e7" e2="DDI-DrugBank.d124.s26.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p98"
            e1="DDI-DrugBank.d124.s26.e7" e2="DDI-DrugBank.d124.s26.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p99"
            e1="DDI-DrugBank.d124.s26.e7" e2="DDI-DrugBank.d124.s26.e16"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d124.s26.p100"
            e1="DDI-DrugBank.d124.s26.e8" e2="DDI-DrugBank.d124.s26.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p101"
            e1="DDI-DrugBank.d124.s26.e8" e2="DDI-DrugBank.d124.s26.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p102"
            e1="DDI-DrugBank.d124.s26.e8" e2="DDI-DrugBank.d124.s26.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p103"
            e1="DDI-DrugBank.d124.s26.e8" e2="DDI-DrugBank.d124.s26.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p104"
            e1="DDI-DrugBank.d124.s26.e8" e2="DDI-DrugBank.d124.s26.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p105"
            e1="DDI-DrugBank.d124.s26.e8" e2="DDI-DrugBank.d124.s26.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p106"
            e1="DDI-DrugBank.d124.s26.e8" e2="DDI-DrugBank.d124.s26.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p107"
            e1="DDI-DrugBank.d124.s26.e8" e2="DDI-DrugBank.d124.s26.e16"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d124.s26.p108"
            e1="DDI-DrugBank.d124.s26.e9" e2="DDI-DrugBank.d124.s26.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p109"
            e1="DDI-DrugBank.d124.s26.e9" e2="DDI-DrugBank.d124.s26.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p110"
            e1="DDI-DrugBank.d124.s26.e9" e2="DDI-DrugBank.d124.s26.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p111"
            e1="DDI-DrugBank.d124.s26.e9" e2="DDI-DrugBank.d124.s26.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p112"
            e1="DDI-DrugBank.d124.s26.e9" e2="DDI-DrugBank.d124.s26.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p113"
            e1="DDI-DrugBank.d124.s26.e9" e2="DDI-DrugBank.d124.s26.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p114"
            e1="DDI-DrugBank.d124.s26.e9" e2="DDI-DrugBank.d124.s26.e16"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d124.s26.p115"
            e1="DDI-DrugBank.d124.s26.e10"
            e2="DDI-DrugBank.d124.s26.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p116"
            e1="DDI-DrugBank.d124.s26.e10"
            e2="DDI-DrugBank.d124.s26.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p117"
            e1="DDI-DrugBank.d124.s26.e10"
            e2="DDI-DrugBank.d124.s26.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p118"
            e1="DDI-DrugBank.d124.s26.e10"
            e2="DDI-DrugBank.d124.s26.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p119"
            e1="DDI-DrugBank.d124.s26.e10"
            e2="DDI-DrugBank.d124.s26.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p120"
            e1="DDI-DrugBank.d124.s26.e10"
            e2="DDI-DrugBank.d124.s26.e16" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d124.s26.p121"
            e1="DDI-DrugBank.d124.s26.e11"
            e2="DDI-DrugBank.d124.s26.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p122"
            e1="DDI-DrugBank.d124.s26.e11"
            e2="DDI-DrugBank.d124.s26.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p123"
            e1="DDI-DrugBank.d124.s26.e11"
            e2="DDI-DrugBank.d124.s26.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p124"
            e1="DDI-DrugBank.d124.s26.e11"
            e2="DDI-DrugBank.d124.s26.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p125"
            e1="DDI-DrugBank.d124.s26.e11"
            e2="DDI-DrugBank.d124.s26.e16" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d124.s26.p126"
            e1="DDI-DrugBank.d124.s26.e12"
            e2="DDI-DrugBank.d124.s26.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p127"
            e1="DDI-DrugBank.d124.s26.e12"
            e2="DDI-DrugBank.d124.s26.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p128"
            e1="DDI-DrugBank.d124.s26.e12"
            e2="DDI-DrugBank.d124.s26.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p129"
            e1="DDI-DrugBank.d124.s26.e12"
            e2="DDI-DrugBank.d124.s26.e16" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d124.s26.p130"
            e1="DDI-DrugBank.d124.s26.e13"
            e2="DDI-DrugBank.d124.s26.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p131"
            e1="DDI-DrugBank.d124.s26.e13"
            e2="DDI-DrugBank.d124.s26.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p132"
            e1="DDI-DrugBank.d124.s26.e13"
            e2="DDI-DrugBank.d124.s26.e16" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d124.s26.p133"
            e1="DDI-DrugBank.d124.s26.e14"
            e2="DDI-DrugBank.d124.s26.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s26.p134"
            e1="DDI-DrugBank.d124.s26.e14"
            e2="DDI-DrugBank.d124.s26.e16" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d124.s26.p135"
            e1="DDI-DrugBank.d124.s26.e15"
            e2="DDI-DrugBank.d124.s26.e16" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d124.s27" text="therefore, these combinations should be used with caution."/>
    <sentence id="DDI-DrugBank.d124.s28" text="Since INVIRASE is coadministered with ritonavir, the ritonavir label should be reviewed for additional drugs that should not be coadministered.">
        <entity id="DDI-DrugBank.d124.s28.e0" charOffset="6-13"
            type="brand" text="INVIRASE"/>
        <entity id="DDI-DrugBank.d124.s28.e1" charOffset="38-46"
            type="drug" text="ritonavir"/>
        <entity id="DDI-DrugBank.d124.s28.e2" charOffset="53-61"
            type="drug" text="ritonavir"/>
        <pair id="DDI-DrugBank.d124.s28.p0"
            e1="DDI-DrugBank.d124.s28.e0" e2="DDI-DrugBank.d124.s28.e1"
            ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d124.s28.p1"
            e1="DDI-DrugBank.d124.s28.e0" e2="DDI-DrugBank.d124.s28.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s28.p2"
            e1="DDI-DrugBank.d124.s28.e1" e2="DDI-DrugBank.d124.s28.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d124.s29" text="Inducers of CYP3A4"/>
    <sentence id="DDI-DrugBank.d124.s30" text="Coadministration with compounds that are potent inducers of CYP3A4 (eg, phenobarbital, phenytoin, dexamethasone, carbamazepine) may result in decreased plasma levels of saquinavir.">
        <entity id="DDI-DrugBank.d124.s30.e0" charOffset="72-84"
            type="drug" text="phenobarbital"/>
        <entity id="DDI-DrugBank.d124.s30.e1" charOffset="87-95"
            type="drug" text="phenytoin"/>
        <entity id="DDI-DrugBank.d124.s30.e2" charOffset="98-110"
            type="drug" text="dexamethasone"/>
        <entity id="DDI-DrugBank.d124.s30.e3" charOffset="113-125"
            type="drug" text="carbamazepine"/>
        <entity id="DDI-DrugBank.d124.s30.e4" charOffset="169-178"
            type="drug" text="saquinavir"/>
        <pair id="DDI-DrugBank.d124.s30.p0"
            e1="DDI-DrugBank.d124.s30.e0" e2="DDI-DrugBank.d124.s30.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s30.p1"
            e1="DDI-DrugBank.d124.s30.e0" e2="DDI-DrugBank.d124.s30.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s30.p2"
            e1="DDI-DrugBank.d124.s30.e0" e2="DDI-DrugBank.d124.s30.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s30.p3"
            e1="DDI-DrugBank.d124.s30.e0" e2="DDI-DrugBank.d124.s30.e4"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d124.s30.p4"
            e1="DDI-DrugBank.d124.s30.e1" e2="DDI-DrugBank.d124.s30.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s30.p5"
            e1="DDI-DrugBank.d124.s30.e1" e2="DDI-DrugBank.d124.s30.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s30.p6"
            e1="DDI-DrugBank.d124.s30.e1" e2="DDI-DrugBank.d124.s30.e4"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d124.s30.p7"
            e1="DDI-DrugBank.d124.s30.e2" e2="DDI-DrugBank.d124.s30.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d124.s30.p8"
            e1="DDI-DrugBank.d124.s30.e2" e2="DDI-DrugBank.d124.s30.e4"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d124.s30.p9"
            e1="DDI-DrugBank.d124.s30.e3" e2="DDI-DrugBank.d124.s30.e4"
            ddi="true" type="mechanism"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d694">
    <sentence id="DDI-DrugBank.d694.s0" text="Digoxin: There was a slight increase in the area under the curve (AUC, 11%) and mean peak drug concentration (Cmax, 18%) of digoxin with the co-administration of 100 mg sitagliptin for 10 days. ">
        <entity id="DDI-DrugBank.d694.s0.e0" charOffset="0-6"
            type="drug" text="Digoxin"/>
        <entity id="DDI-DrugBank.d694.s0.e1" charOffset="124-130"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d694.s0.e2" charOffset="169-179"
            type="drug" text="sitagliptin"/>
        <pair id="DDI-DrugBank.d694.s0.p0" e1="DDI-DrugBank.d694.s0.e0"
            e2="DDI-DrugBank.d694.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d694.s0.p1" e1="DDI-DrugBank.d694.s0.e0"
            e2="DDI-DrugBank.d694.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d694.s0.p2" e1="DDI-DrugBank.d694.s0.e1"
            e2="DDI-DrugBank.d694.s0.e2" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d694.s1" text="Patients receiving digoxin should be monitored appropriately. ">
        <entity id="DDI-DrugBank.d694.s1.e0" charOffset="19-25"
            type="drug" text="digoxin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d694.s2" text="No dosage adjustment of digoxin or JANUVIA is recommended.">
        <entity id="DDI-DrugBank.d694.s2.e0" charOffset="24-30"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d694.s2.e1" charOffset="35-41"
            type="brand" text="JANUVIA"/>
        <pair id="DDI-DrugBank.d694.s2.p0" e1="DDI-DrugBank.d694.s2.e0"
            e2="DDI-DrugBank.d694.s2.e1" ddi="false"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d65">
    <sentence id="DDI-DrugBank.d65.s0" text="Sulfacetamide preparations are incompatible with silver preparations.">
        <entity id="DDI-DrugBank.d65.s0.e0" charOffset="0-12"
            type="drug" text="Sulfacetamide"/>
        <entity id="DDI-DrugBank.d65.s0.e1" charOffset="49-54"
            type="drug" text="silver"/>
        <pair id="DDI-DrugBank.d65.s0.p0" e1="DDI-DrugBank.d65.s0.e0"
            e2="DDI-DrugBank.d65.s0.e1" ddi="true" type="int"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d179">
    <sentence id="DDI-DrugBank.d179.s0" text="Interations"/>
    <sentence id="DDI-DrugBank.d179.s1" text="Sulfapyridine may interact with any of the following: - Acetaminophen (e.g., Tylenol) (with long-term, high-dose use) or">
        <entity id="DDI-DrugBank.d179.s1.e0" charOffset="0-12"
            type="drug" text="Sulfapyridine"/>
        <entity id="DDI-DrugBank.d179.s1.e1" charOffset="56-68"
            type="drug" text="Acetaminophen"/>
        <entity id="DDI-DrugBank.d179.s1.e2" charOffset="77-83"
            type="brand" text="Tylenol"/>
        <pair id="DDI-DrugBank.d179.s1.p0" e1="DDI-DrugBank.d179.s1.e0"
            e2="DDI-DrugBank.d179.s1.e1" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d179.s1.p1" e1="DDI-DrugBank.d179.s1.e0"
            e2="DDI-DrugBank.d179.s1.e2" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d179.s1.p2" e1="DDI-DrugBank.d179.s1.e1"
            e2="DDI-DrugBank.d179.s1.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s2" text="- Amiodarone (e.g., Cordarone) or">
        <entity id="DDI-DrugBank.d179.s2.e0" charOffset="2-11"
            type="drug" text="Amiodarone"/>
        <entity id="DDI-DrugBank.d179.s2.e1" charOffset="20-28"
            type="brand" text="Cordarone"/>
        <pair id="DDI-DrugBank.d179.s2.p0" e1="DDI-DrugBank.d179.s2.e0"
            e2="DDI-DrugBank.d179.s2.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s3" text="- Anabolic steroids (nandrolone [e.g., Anabolin], oxandrolone [e.g., Anavar], oxymetholone [e.g., Anadrol], stanozolol [e.g., Winstrol]) or">
        <entity id="DDI-DrugBank.d179.s3.e0" charOffset="2-18"
            type="group" text="Anabolic steroids"/>
        <entity id="DDI-DrugBank.d179.s3.e1" charOffset="21-30"
            type="drug" text="nandrolone"/>
        <entity id="DDI-DrugBank.d179.s3.e2" charOffset="39-46"
            type="brand" text="Anabolin"/>
        <entity id="DDI-DrugBank.d179.s3.e3" charOffset="50-60"
            type="drug" text="oxandrolone"/>
        <entity id="DDI-DrugBank.d179.s3.e4" charOffset="69-74"
            type="brand" text="Anavar"/>
        <entity id="DDI-DrugBank.d179.s3.e5" charOffset="78-89"
            type="drug" text="oxymetholone"/>
        <entity id="DDI-DrugBank.d179.s3.e6" charOffset="98-104"
            type="brand" text="Anadrol"/>
        <entity id="DDI-DrugBank.d179.s3.e7" charOffset="108-117"
            type="drug" text="stanozolol"/>
        <entity id="DDI-DrugBank.d179.s3.e8" charOffset="126-133"
            type="brand" text="Winstrol"/>
        <pair id="DDI-DrugBank.d179.s3.p0" e1="DDI-DrugBank.d179.s3.e0"
            e2="DDI-DrugBank.d179.s3.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s3.p1" e1="DDI-DrugBank.d179.s3.e0"
            e2="DDI-DrugBank.d179.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s3.p2" e1="DDI-DrugBank.d179.s3.e0"
            e2="DDI-DrugBank.d179.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s3.p3" e1="DDI-DrugBank.d179.s3.e0"
            e2="DDI-DrugBank.d179.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s3.p4" e1="DDI-DrugBank.d179.s3.e0"
            e2="DDI-DrugBank.d179.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s3.p5" e1="DDI-DrugBank.d179.s3.e0"
            e2="DDI-DrugBank.d179.s3.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s3.p6" e1="DDI-DrugBank.d179.s3.e0"
            e2="DDI-DrugBank.d179.s3.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s3.p7" e1="DDI-DrugBank.d179.s3.e0"
            e2="DDI-DrugBank.d179.s3.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s3.p8" e1="DDI-DrugBank.d179.s3.e1"
            e2="DDI-DrugBank.d179.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s3.p9" e1="DDI-DrugBank.d179.s3.e1"
            e2="DDI-DrugBank.d179.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s3.p10" e1="DDI-DrugBank.d179.s3.e1"
            e2="DDI-DrugBank.d179.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s3.p11" e1="DDI-DrugBank.d179.s3.e1"
            e2="DDI-DrugBank.d179.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s3.p12" e1="DDI-DrugBank.d179.s3.e1"
            e2="DDI-DrugBank.d179.s3.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s3.p13" e1="DDI-DrugBank.d179.s3.e1"
            e2="DDI-DrugBank.d179.s3.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s3.p14" e1="DDI-DrugBank.d179.s3.e1"
            e2="DDI-DrugBank.d179.s3.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s3.p15" e1="DDI-DrugBank.d179.s3.e2"
            e2="DDI-DrugBank.d179.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s3.p16" e1="DDI-DrugBank.d179.s3.e2"
            e2="DDI-DrugBank.d179.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s3.p17" e1="DDI-DrugBank.d179.s3.e2"
            e2="DDI-DrugBank.d179.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s3.p18" e1="DDI-DrugBank.d179.s3.e2"
            e2="DDI-DrugBank.d179.s3.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s3.p19" e1="DDI-DrugBank.d179.s3.e2"
            e2="DDI-DrugBank.d179.s3.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s3.p20" e1="DDI-DrugBank.d179.s3.e2"
            e2="DDI-DrugBank.d179.s3.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s3.p21" e1="DDI-DrugBank.d179.s3.e3"
            e2="DDI-DrugBank.d179.s3.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s3.p22" e1="DDI-DrugBank.d179.s3.e3"
            e2="DDI-DrugBank.d179.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s3.p23" e1="DDI-DrugBank.d179.s3.e3"
            e2="DDI-DrugBank.d179.s3.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s3.p24" e1="DDI-DrugBank.d179.s3.e3"
            e2="DDI-DrugBank.d179.s3.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s3.p25" e1="DDI-DrugBank.d179.s3.e3"
            e2="DDI-DrugBank.d179.s3.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s3.p26" e1="DDI-DrugBank.d179.s3.e4"
            e2="DDI-DrugBank.d179.s3.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s3.p27" e1="DDI-DrugBank.d179.s3.e4"
            e2="DDI-DrugBank.d179.s3.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s3.p28" e1="DDI-DrugBank.d179.s3.e4"
            e2="DDI-DrugBank.d179.s3.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s3.p29" e1="DDI-DrugBank.d179.s3.e4"
            e2="DDI-DrugBank.d179.s3.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s3.p30" e1="DDI-DrugBank.d179.s3.e5"
            e2="DDI-DrugBank.d179.s3.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s3.p31" e1="DDI-DrugBank.d179.s3.e5"
            e2="DDI-DrugBank.d179.s3.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s3.p32" e1="DDI-DrugBank.d179.s3.e5"
            e2="DDI-DrugBank.d179.s3.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s3.p33" e1="DDI-DrugBank.d179.s3.e6"
            e2="DDI-DrugBank.d179.s3.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s3.p34" e1="DDI-DrugBank.d179.s3.e6"
            e2="DDI-DrugBank.d179.s3.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s3.p35" e1="DDI-DrugBank.d179.s3.e7"
            e2="DDI-DrugBank.d179.s3.e8" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s4" text="- Androgens (male hormones) or">
        <entity id="DDI-DrugBank.d179.s4.e0" charOffset="2-10"
            type="group" text="Androgens"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s5" text="- Antithyroid agents (medicine for overactive thyroid) or">
        <entity id="DDI-DrugBank.d179.s5.e0" charOffset="2-19"
            type="group" text="Antithyroid agents"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s6" text="- Carbamazepine (e.g., Tegretol) or">
        <entity id="DDI-DrugBank.d179.s6.e0" charOffset="2-14"
            type="drug" text="Carbamazepine"/>
        <entity id="DDI-DrugBank.d179.s6.e1" charOffset="23-30"
            type="brand" text="Tegretol"/>
        <pair id="DDI-DrugBank.d179.s6.p0" e1="DDI-DrugBank.d179.s6.e0"
            e2="DDI-DrugBank.d179.s6.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s7" text="- Carmustine (e.g., BiCNU) or">
        <entity id="DDI-DrugBank.d179.s7.e0" charOffset="2-11"
            type="drug" text="Carmustine"/>
        <entity id="DDI-DrugBank.d179.s7.e1" charOffset="20-24"
            type="brand" text="BiCNU"/>
        <pair id="DDI-DrugBank.d179.s7.p0" e1="DDI-DrugBank.d179.s7.e0"
            e2="DDI-DrugBank.d179.s7.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s8" text="- Chloroquine (e.g., Aralen) or">
        <entity id="DDI-DrugBank.d179.s8.e0" charOffset="2-12"
            type="drug" text="Chloroquine"/>
        <entity id="DDI-DrugBank.d179.s8.e1" charOffset="21-26"
            type="brand" text="Aralen"/>
        <pair id="DDI-DrugBank.d179.s8.p0" e1="DDI-DrugBank.d179.s8.e0"
            e2="DDI-DrugBank.d179.s8.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s9" text="- Dantrolene (e.g., Dantrium) or">
        <entity id="DDI-DrugBank.d179.s9.e0" charOffset="2-11"
            type="drug" text="Dantrolene"/>
        <entity id="DDI-DrugBank.d179.s9.e1" charOffset="20-27"
            type="brand" text="Dantrium"/>
        <pair id="DDI-DrugBank.d179.s9.p0" e1="DDI-DrugBank.d179.s9.e0"
            e2="DDI-DrugBank.d179.s9.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s10" text="- Daunorubicin (e.g., Cerubidine) or">
        <entity id="DDI-DrugBank.d179.s10.e0" charOffset="2-13"
            type="drug" text="Daunorubicin"/>
        <entity id="DDI-DrugBank.d179.s10.e1" charOffset="22-31"
            type="brand" text="Cerubidine"/>
        <pair id="DDI-DrugBank.d179.s10.p0"
            e1="DDI-DrugBank.d179.s10.e0" e2="DDI-DrugBank.d179.s10.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s11" text="- Disulfiram (e.g., Antabuse) or">
        <entity id="DDI-DrugBank.d179.s11.e0" charOffset="2-11"
            type="drug" text="Disulfiram"/>
        <entity id="DDI-DrugBank.d179.s11.e1" charOffset="20-27"
            type="brand" text="Antabuse"/>
        <pair id="DDI-DrugBank.d179.s11.p0"
            e1="DDI-DrugBank.d179.s11.e0" e2="DDI-DrugBank.d179.s11.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s12" text="- Divalproex (e.g., Depakote) or">
        <entity id="DDI-DrugBank.d179.s12.e0" charOffset="2-11"
            type="drug" text="Divalproex"/>
        <entity id="DDI-DrugBank.d179.s12.e1" charOffset="20-27"
            type="brand" text="Depakote"/>
        <pair id="DDI-DrugBank.d179.s12.p0"
            e1="DDI-DrugBank.d179.s12.e0" e2="DDI-DrugBank.d179.s12.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s13" text="- Estrogens (female hormones) or">
        <entity id="DDI-DrugBank.d179.s13.e0" charOffset="2-10"
            type="group" text="Estrogens"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s14" text="- Etretinate (e.g., Tegison) or">
        <entity id="DDI-DrugBank.d179.s14.e0" charOffset="2-11"
            type="drug" text="Etretinate"/>
        <entity id="DDI-DrugBank.d179.s14.e1" charOffset="20-26"
            type="brand" text="Tegison"/>
        <pair id="DDI-DrugBank.d179.s14.p0"
            e1="DDI-DrugBank.d179.s14.e0" e2="DDI-DrugBank.d179.s14.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s15" text="- Gold salts (medicine for arthritis) or">
        <entity id="DDI-DrugBank.d179.s15.e0" charOffset="2-5"
            type="drug" text="Gold"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s16" text="- Hydroxychloroquine (e.g., Plaquenil) or">
        <entity id="DDI-DrugBank.d179.s16.e0" charOffset="2-19"
            type="drug" text="Hydroxychloroquine"/>
        <entity id="DDI-DrugBank.d179.s16.e1" charOffset="28-36"
            type="brand" text="Plaquenil"/>
        <pair id="DDI-DrugBank.d179.s16.p0"
            e1="DDI-DrugBank.d179.s16.e0" e2="DDI-DrugBank.d179.s16.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s17" text="- Mercaptopurine (e.g., Purinethol) or">
        <entity id="DDI-DrugBank.d179.s17.e0" charOffset="2-15"
            type="drug" text="Mercaptopurine"/>
        <entity id="DDI-DrugBank.d179.s17.e1" charOffset="24-33"
            type="brand" text="Purinethol"/>
        <pair id="DDI-DrugBank.d179.s17.p0"
            e1="DDI-DrugBank.d179.s17.e0" e2="DDI-DrugBank.d179.s17.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s18" text="- Naltrexone (e.g., Trexan) (with long-term, high-dose use) or">
        <entity id="DDI-DrugBank.d179.s18.e0" charOffset="2-11"
            type="drug" text="Naltrexone"/>
        <entity id="DDI-DrugBank.d179.s18.e1" charOffset="20-25"
            type="brand" text="Trexan"/>
        <pair id="DDI-DrugBank.d179.s18.p0"
            e1="DDI-DrugBank.d179.s18.e0" e2="DDI-DrugBank.d179.s18.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s19" text="- Oral contraceptives (birth control pills) containing estrogen or">
        <entity id="DDI-DrugBank.d179.s19.e0" charOffset="7-20"
            type="group" text="contraceptives"/>
        <entity id="DDI-DrugBank.d179.s19.e1" charOffset="55-62"
            type="group" text="estrogen"/>
        <pair id="DDI-DrugBank.d179.s19.p0"
            e1="DDI-DrugBank.d179.s19.e0" e2="DDI-DrugBank.d179.s19.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s20" text="- Other anti-infectives by mouth or by injection (medicine for infection) or">
        <entity id="DDI-DrugBank.d179.s20.e0" charOffset="8-22"
            type="group" text="anti-infectives"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s21" text="- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or">
        <entity id="DDI-DrugBank.d179.s21.e0" charOffset="2-15"
            type="group" text="Phenothiazines"/>
        <entity id="DDI-DrugBank.d179.s21.e1" charOffset="18-31"
            type="drug" text="acetophenazine"/>
        <entity id="DDI-DrugBank.d179.s21.e2" charOffset="40-45"
            type="brand" text="Tindal"/>
        <entity id="DDI-DrugBank.d179.s21.e3" charOffset="49-62"
            type="drug" text="chlorpromazine"/>
        <entity id="DDI-DrugBank.d179.s21.e4" charOffset="71-79"
            type="brand" text="Thorazine"/>
        <entity id="DDI-DrugBank.d179.s21.e5" charOffset="83-94"
            type="drug" text="fluphenazine"/>
        <entity id="DDI-DrugBank.d179.s21.e6" charOffset="103-110"
            type="brand" text="Prolixin"/>
        <entity id="DDI-DrugBank.d179.s21.e7" charOffset="114-125"
            type="brand" text="mesoridazine"/>
        <entity id="DDI-DrugBank.d179.s21.e8" charOffset="134-141"
            type="brand" text="Serentil"/>
        <entity id="DDI-DrugBank.d179.s21.e9" charOffset="145-156"
            type="drug" text="perphenazine"/>
        <entity id="DDI-DrugBank.d179.s21.e10" charOffset="165-172"
            type="brand" text="Trilafon"/>
        <entity id="DDI-DrugBank.d179.s21.e11" charOffset="176-191"
            type="drug" text="prochlorperazine"/>
        <entity id="DDI-DrugBank.d179.s21.e12" charOffset="200-208"
            type="brand" text="Compazine"/>
        <entity id="DDI-DrugBank.d179.s21.e13" charOffset="212-220"
            type="drug" text="promazine"/>
        <entity id="DDI-DrugBank.d179.s21.e14" charOffset="229-235"
            type="brand" text="Sparine"/>
        <entity id="DDI-DrugBank.d179.s21.e15" charOffset="239-250"
            type="drug" text="promethazine"/>
        <entity id="DDI-DrugBank.d179.s21.e16" charOffset="259-267"
            type="brand" text="Phenergan"/>
        <entity id="DDI-DrugBank.d179.s21.e17" charOffset="271-282"
            type="drug" text="thioridazine"/>
        <entity id="DDI-DrugBank.d179.s21.e18" charOffset="291-298"
            type="brand" text="Mellaril"/>
        <entity id="DDI-DrugBank.d179.s21.e19" charOffset="302-316"
            type="drug" text="trifluoperazine"/>
        <entity id="DDI-DrugBank.d179.s21.e20" charOffset="325-333"
            type="brand" text="Stelazine"/>
        <entity id="DDI-DrugBank.d179.s21.e21" charOffset="337-351"
            type="drug" text="triflupromazine"/>
        <entity id="DDI-DrugBank.d179.s21.e22" charOffset="360-366"
            type="brand" text="Vesprin"/>
        <entity id="DDI-DrugBank.d179.s21.e23" charOffset="370-381"
            type="drug" text="trimeprazine"/>
        <entity id="DDI-DrugBank.d179.s21.e24" charOffset="390-396"
            type="brand" text="Temaril"/>
        <pair id="DDI-DrugBank.d179.s21.p0"
            e1="DDI-DrugBank.d179.s21.e0" e2="DDI-DrugBank.d179.s21.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p1"
            e1="DDI-DrugBank.d179.s21.e0" e2="DDI-DrugBank.d179.s21.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p2"
            e1="DDI-DrugBank.d179.s21.e0" e2="DDI-DrugBank.d179.s21.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p3"
            e1="DDI-DrugBank.d179.s21.e0" e2="DDI-DrugBank.d179.s21.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p4"
            e1="DDI-DrugBank.d179.s21.e0" e2="DDI-DrugBank.d179.s21.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p5"
            e1="DDI-DrugBank.d179.s21.e0" e2="DDI-DrugBank.d179.s21.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p6"
            e1="DDI-DrugBank.d179.s21.e0" e2="DDI-DrugBank.d179.s21.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p7"
            e1="DDI-DrugBank.d179.s21.e0" e2="DDI-DrugBank.d179.s21.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p8"
            e1="DDI-DrugBank.d179.s21.e0" e2="DDI-DrugBank.d179.s21.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p9"
            e1="DDI-DrugBank.d179.s21.e0" e2="DDI-DrugBank.d179.s21.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p10"
            e1="DDI-DrugBank.d179.s21.e0" e2="DDI-DrugBank.d179.s21.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p11"
            e1="DDI-DrugBank.d179.s21.e0" e2="DDI-DrugBank.d179.s21.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p12"
            e1="DDI-DrugBank.d179.s21.e0" e2="DDI-DrugBank.d179.s21.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p13"
            e1="DDI-DrugBank.d179.s21.e0" e2="DDI-DrugBank.d179.s21.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p14"
            e1="DDI-DrugBank.d179.s21.e0" e2="DDI-DrugBank.d179.s21.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p15"
            e1="DDI-DrugBank.d179.s21.e0" e2="DDI-DrugBank.d179.s21.e16" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p16"
            e1="DDI-DrugBank.d179.s21.e0" e2="DDI-DrugBank.d179.s21.e17" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p17"
            e1="DDI-DrugBank.d179.s21.e0" e2="DDI-DrugBank.d179.s21.e18" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p18"
            e1="DDI-DrugBank.d179.s21.e0" e2="DDI-DrugBank.d179.s21.e19" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p19"
            e1="DDI-DrugBank.d179.s21.e0" e2="DDI-DrugBank.d179.s21.e20" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p20"
            e1="DDI-DrugBank.d179.s21.e0" e2="DDI-DrugBank.d179.s21.e21" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p21"
            e1="DDI-DrugBank.d179.s21.e0" e2="DDI-DrugBank.d179.s21.e22" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p22"
            e1="DDI-DrugBank.d179.s21.e0" e2="DDI-DrugBank.d179.s21.e23" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p23"
            e1="DDI-DrugBank.d179.s21.e0" e2="DDI-DrugBank.d179.s21.e24" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p24"
            e1="DDI-DrugBank.d179.s21.e1" e2="DDI-DrugBank.d179.s21.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p25"
            e1="DDI-DrugBank.d179.s21.e1" e2="DDI-DrugBank.d179.s21.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p26"
            e1="DDI-DrugBank.d179.s21.e1" e2="DDI-DrugBank.d179.s21.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p27"
            e1="DDI-DrugBank.d179.s21.e1" e2="DDI-DrugBank.d179.s21.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p28"
            e1="DDI-DrugBank.d179.s21.e1" e2="DDI-DrugBank.d179.s21.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p29"
            e1="DDI-DrugBank.d179.s21.e1" e2="DDI-DrugBank.d179.s21.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p30"
            e1="DDI-DrugBank.d179.s21.e1" e2="DDI-DrugBank.d179.s21.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p31"
            e1="DDI-DrugBank.d179.s21.e1" e2="DDI-DrugBank.d179.s21.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p32"
            e1="DDI-DrugBank.d179.s21.e1" e2="DDI-DrugBank.d179.s21.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p33"
            e1="DDI-DrugBank.d179.s21.e1" e2="DDI-DrugBank.d179.s21.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p34"
            e1="DDI-DrugBank.d179.s21.e1" e2="DDI-DrugBank.d179.s21.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p35"
            e1="DDI-DrugBank.d179.s21.e1" e2="DDI-DrugBank.d179.s21.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p36"
            e1="DDI-DrugBank.d179.s21.e1" e2="DDI-DrugBank.d179.s21.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p37"
            e1="DDI-DrugBank.d179.s21.e1" e2="DDI-DrugBank.d179.s21.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p38"
            e1="DDI-DrugBank.d179.s21.e1" e2="DDI-DrugBank.d179.s21.e16" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p39"
            e1="DDI-DrugBank.d179.s21.e1" e2="DDI-DrugBank.d179.s21.e17" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p40"
            e1="DDI-DrugBank.d179.s21.e1" e2="DDI-DrugBank.d179.s21.e18" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p41"
            e1="DDI-DrugBank.d179.s21.e1" e2="DDI-DrugBank.d179.s21.e19" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p42"
            e1="DDI-DrugBank.d179.s21.e1" e2="DDI-DrugBank.d179.s21.e20" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p43"
            e1="DDI-DrugBank.d179.s21.e1" e2="DDI-DrugBank.d179.s21.e21" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p44"
            e1="DDI-DrugBank.d179.s21.e1" e2="DDI-DrugBank.d179.s21.e22" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p45"
            e1="DDI-DrugBank.d179.s21.e1" e2="DDI-DrugBank.d179.s21.e23" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p46"
            e1="DDI-DrugBank.d179.s21.e1" e2="DDI-DrugBank.d179.s21.e24" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p47"
            e1="DDI-DrugBank.d179.s21.e2" e2="DDI-DrugBank.d179.s21.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p48"
            e1="DDI-DrugBank.d179.s21.e2" e2="DDI-DrugBank.d179.s21.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p49"
            e1="DDI-DrugBank.d179.s21.e2" e2="DDI-DrugBank.d179.s21.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p50"
            e1="DDI-DrugBank.d179.s21.e2" e2="DDI-DrugBank.d179.s21.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p51"
            e1="DDI-DrugBank.d179.s21.e2" e2="DDI-DrugBank.d179.s21.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p52"
            e1="DDI-DrugBank.d179.s21.e2" e2="DDI-DrugBank.d179.s21.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p53"
            e1="DDI-DrugBank.d179.s21.e2" e2="DDI-DrugBank.d179.s21.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p54"
            e1="DDI-DrugBank.d179.s21.e2" e2="DDI-DrugBank.d179.s21.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p55"
            e1="DDI-DrugBank.d179.s21.e2" e2="DDI-DrugBank.d179.s21.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p56"
            e1="DDI-DrugBank.d179.s21.e2" e2="DDI-DrugBank.d179.s21.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p57"
            e1="DDI-DrugBank.d179.s21.e2" e2="DDI-DrugBank.d179.s21.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p58"
            e1="DDI-DrugBank.d179.s21.e2" e2="DDI-DrugBank.d179.s21.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p59"
            e1="DDI-DrugBank.d179.s21.e2" e2="DDI-DrugBank.d179.s21.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p60"
            e1="DDI-DrugBank.d179.s21.e2" e2="DDI-DrugBank.d179.s21.e16" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p61"
            e1="DDI-DrugBank.d179.s21.e2" e2="DDI-DrugBank.d179.s21.e17" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p62"
            e1="DDI-DrugBank.d179.s21.e2" e2="DDI-DrugBank.d179.s21.e18" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p63"
            e1="DDI-DrugBank.d179.s21.e2" e2="DDI-DrugBank.d179.s21.e19" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p64"
            e1="DDI-DrugBank.d179.s21.e2" e2="DDI-DrugBank.d179.s21.e20" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p65"
            e1="DDI-DrugBank.d179.s21.e2" e2="DDI-DrugBank.d179.s21.e21" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p66"
            e1="DDI-DrugBank.d179.s21.e2" e2="DDI-DrugBank.d179.s21.e22" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p67"
            e1="DDI-DrugBank.d179.s21.e2" e2="DDI-DrugBank.d179.s21.e23" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p68"
            e1="DDI-DrugBank.d179.s21.e2" e2="DDI-DrugBank.d179.s21.e24" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p69"
            e1="DDI-DrugBank.d179.s21.e3" e2="DDI-DrugBank.d179.s21.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p70"
            e1="DDI-DrugBank.d179.s21.e3" e2="DDI-DrugBank.d179.s21.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p71"
            e1="DDI-DrugBank.d179.s21.e3" e2="DDI-DrugBank.d179.s21.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p72"
            e1="DDI-DrugBank.d179.s21.e3" e2="DDI-DrugBank.d179.s21.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p73"
            e1="DDI-DrugBank.d179.s21.e3" e2="DDI-DrugBank.d179.s21.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p74"
            e1="DDI-DrugBank.d179.s21.e3" e2="DDI-DrugBank.d179.s21.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p75"
            e1="DDI-DrugBank.d179.s21.e3" e2="DDI-DrugBank.d179.s21.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p76"
            e1="DDI-DrugBank.d179.s21.e3" e2="DDI-DrugBank.d179.s21.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p77"
            e1="DDI-DrugBank.d179.s21.e3" e2="DDI-DrugBank.d179.s21.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p78"
            e1="DDI-DrugBank.d179.s21.e3" e2="DDI-DrugBank.d179.s21.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p79"
            e1="DDI-DrugBank.d179.s21.e3" e2="DDI-DrugBank.d179.s21.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p80"
            e1="DDI-DrugBank.d179.s21.e3" e2="DDI-DrugBank.d179.s21.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p81"
            e1="DDI-DrugBank.d179.s21.e3" e2="DDI-DrugBank.d179.s21.e16" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p82"
            e1="DDI-DrugBank.d179.s21.e3" e2="DDI-DrugBank.d179.s21.e17" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p83"
            e1="DDI-DrugBank.d179.s21.e3" e2="DDI-DrugBank.d179.s21.e18" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p84"
            e1="DDI-DrugBank.d179.s21.e3" e2="DDI-DrugBank.d179.s21.e19" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p85"
            e1="DDI-DrugBank.d179.s21.e3" e2="DDI-DrugBank.d179.s21.e20" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p86"
            e1="DDI-DrugBank.d179.s21.e3" e2="DDI-DrugBank.d179.s21.e21" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p87"
            e1="DDI-DrugBank.d179.s21.e3" e2="DDI-DrugBank.d179.s21.e22" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p88"
            e1="DDI-DrugBank.d179.s21.e3" e2="DDI-DrugBank.d179.s21.e23" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p89"
            e1="DDI-DrugBank.d179.s21.e3" e2="DDI-DrugBank.d179.s21.e24" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p90"
            e1="DDI-DrugBank.d179.s21.e4" e2="DDI-DrugBank.d179.s21.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p91"
            e1="DDI-DrugBank.d179.s21.e4" e2="DDI-DrugBank.d179.s21.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p92"
            e1="DDI-DrugBank.d179.s21.e4" e2="DDI-DrugBank.d179.s21.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p93"
            e1="DDI-DrugBank.d179.s21.e4" e2="DDI-DrugBank.d179.s21.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p94"
            e1="DDI-DrugBank.d179.s21.e4" e2="DDI-DrugBank.d179.s21.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p95"
            e1="DDI-DrugBank.d179.s21.e4" e2="DDI-DrugBank.d179.s21.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p96"
            e1="DDI-DrugBank.d179.s21.e4" e2="DDI-DrugBank.d179.s21.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p97"
            e1="DDI-DrugBank.d179.s21.e4" e2="DDI-DrugBank.d179.s21.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p98"
            e1="DDI-DrugBank.d179.s21.e4" e2="DDI-DrugBank.d179.s21.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p99"
            e1="DDI-DrugBank.d179.s21.e4" e2="DDI-DrugBank.d179.s21.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p100"
            e1="DDI-DrugBank.d179.s21.e4" e2="DDI-DrugBank.d179.s21.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p101"
            e1="DDI-DrugBank.d179.s21.e4" e2="DDI-DrugBank.d179.s21.e16" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p102"
            e1="DDI-DrugBank.d179.s21.e4" e2="DDI-DrugBank.d179.s21.e17" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p103"
            e1="DDI-DrugBank.d179.s21.e4" e2="DDI-DrugBank.d179.s21.e18" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p104"
            e1="DDI-DrugBank.d179.s21.e4" e2="DDI-DrugBank.d179.s21.e19" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p105"
            e1="DDI-DrugBank.d179.s21.e4" e2="DDI-DrugBank.d179.s21.e20" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p106"
            e1="DDI-DrugBank.d179.s21.e4" e2="DDI-DrugBank.d179.s21.e21" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p107"
            e1="DDI-DrugBank.d179.s21.e4" e2="DDI-DrugBank.d179.s21.e22" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p108"
            e1="DDI-DrugBank.d179.s21.e4" e2="DDI-DrugBank.d179.s21.e23" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p109"
            e1="DDI-DrugBank.d179.s21.e4" e2="DDI-DrugBank.d179.s21.e24" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p110"
            e1="DDI-DrugBank.d179.s21.e5" e2="DDI-DrugBank.d179.s21.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p111"
            e1="DDI-DrugBank.d179.s21.e5" e2="DDI-DrugBank.d179.s21.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p112"
            e1="DDI-DrugBank.d179.s21.e5" e2="DDI-DrugBank.d179.s21.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p113"
            e1="DDI-DrugBank.d179.s21.e5" e2="DDI-DrugBank.d179.s21.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p114"
            e1="DDI-DrugBank.d179.s21.e5" e2="DDI-DrugBank.d179.s21.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p115"
            e1="DDI-DrugBank.d179.s21.e5" e2="DDI-DrugBank.d179.s21.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p116"
            e1="DDI-DrugBank.d179.s21.e5" e2="DDI-DrugBank.d179.s21.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p117"
            e1="DDI-DrugBank.d179.s21.e5" e2="DDI-DrugBank.d179.s21.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p118"
            e1="DDI-DrugBank.d179.s21.e5" e2="DDI-DrugBank.d179.s21.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p119"
            e1="DDI-DrugBank.d179.s21.e5" e2="DDI-DrugBank.d179.s21.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p120"
            e1="DDI-DrugBank.d179.s21.e5" e2="DDI-DrugBank.d179.s21.e16" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p121"
            e1="DDI-DrugBank.d179.s21.e5" e2="DDI-DrugBank.d179.s21.e17" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p122"
            e1="DDI-DrugBank.d179.s21.e5" e2="DDI-DrugBank.d179.s21.e18" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p123"
            e1="DDI-DrugBank.d179.s21.e5" e2="DDI-DrugBank.d179.s21.e19" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p124"
            e1="DDI-DrugBank.d179.s21.e5" e2="DDI-DrugBank.d179.s21.e20" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p125"
            e1="DDI-DrugBank.d179.s21.e5" e2="DDI-DrugBank.d179.s21.e21" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p126"
            e1="DDI-DrugBank.d179.s21.e5" e2="DDI-DrugBank.d179.s21.e22" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p127"
            e1="DDI-DrugBank.d179.s21.e5" e2="DDI-DrugBank.d179.s21.e23" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p128"
            e1="DDI-DrugBank.d179.s21.e5" e2="DDI-DrugBank.d179.s21.e24" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p129"
            e1="DDI-DrugBank.d179.s21.e6" e2="DDI-DrugBank.d179.s21.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p130"
            e1="DDI-DrugBank.d179.s21.e6" e2="DDI-DrugBank.d179.s21.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p131"
            e1="DDI-DrugBank.d179.s21.e6" e2="DDI-DrugBank.d179.s21.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p132"
            e1="DDI-DrugBank.d179.s21.e6" e2="DDI-DrugBank.d179.s21.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p133"
            e1="DDI-DrugBank.d179.s21.e6" e2="DDI-DrugBank.d179.s21.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p134"
            e1="DDI-DrugBank.d179.s21.e6" e2="DDI-DrugBank.d179.s21.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p135"
            e1="DDI-DrugBank.d179.s21.e6" e2="DDI-DrugBank.d179.s21.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p136"
            e1="DDI-DrugBank.d179.s21.e6" e2="DDI-DrugBank.d179.s21.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p137"
            e1="DDI-DrugBank.d179.s21.e6" e2="DDI-DrugBank.d179.s21.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p138"
            e1="DDI-DrugBank.d179.s21.e6" e2="DDI-DrugBank.d179.s21.e16" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p139"
            e1="DDI-DrugBank.d179.s21.e6" e2="DDI-DrugBank.d179.s21.e17" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p140"
            e1="DDI-DrugBank.d179.s21.e6" e2="DDI-DrugBank.d179.s21.e18" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p141"
            e1="DDI-DrugBank.d179.s21.e6" e2="DDI-DrugBank.d179.s21.e19" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p142"
            e1="DDI-DrugBank.d179.s21.e6" e2="DDI-DrugBank.d179.s21.e20" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p143"
            e1="DDI-DrugBank.d179.s21.e6" e2="DDI-DrugBank.d179.s21.e21" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p144"
            e1="DDI-DrugBank.d179.s21.e6" e2="DDI-DrugBank.d179.s21.e22" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p145"
            e1="DDI-DrugBank.d179.s21.e6" e2="DDI-DrugBank.d179.s21.e23" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p146"
            e1="DDI-DrugBank.d179.s21.e6" e2="DDI-DrugBank.d179.s21.e24" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p147"
            e1="DDI-DrugBank.d179.s21.e7" e2="DDI-DrugBank.d179.s21.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p148"
            e1="DDI-DrugBank.d179.s21.e7" e2="DDI-DrugBank.d179.s21.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p149"
            e1="DDI-DrugBank.d179.s21.e7" e2="DDI-DrugBank.d179.s21.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p150"
            e1="DDI-DrugBank.d179.s21.e7" e2="DDI-DrugBank.d179.s21.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p151"
            e1="DDI-DrugBank.d179.s21.e7" e2="DDI-DrugBank.d179.s21.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p152"
            e1="DDI-DrugBank.d179.s21.e7" e2="DDI-DrugBank.d179.s21.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p153"
            e1="DDI-DrugBank.d179.s21.e7" e2="DDI-DrugBank.d179.s21.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p154"
            e1="DDI-DrugBank.d179.s21.e7" e2="DDI-DrugBank.d179.s21.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p155"
            e1="DDI-DrugBank.d179.s21.e7" e2="DDI-DrugBank.d179.s21.e16" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p156"
            e1="DDI-DrugBank.d179.s21.e7" e2="DDI-DrugBank.d179.s21.e17" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p157"
            e1="DDI-DrugBank.d179.s21.e7" e2="DDI-DrugBank.d179.s21.e18" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p158"
            e1="DDI-DrugBank.d179.s21.e7" e2="DDI-DrugBank.d179.s21.e19" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p159"
            e1="DDI-DrugBank.d179.s21.e7" e2="DDI-DrugBank.d179.s21.e20" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p160"
            e1="DDI-DrugBank.d179.s21.e7" e2="DDI-DrugBank.d179.s21.e21" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p161"
            e1="DDI-DrugBank.d179.s21.e7" e2="DDI-DrugBank.d179.s21.e22" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p162"
            e1="DDI-DrugBank.d179.s21.e7" e2="DDI-DrugBank.d179.s21.e23" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p163"
            e1="DDI-DrugBank.d179.s21.e7" e2="DDI-DrugBank.d179.s21.e24" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p164"
            e1="DDI-DrugBank.d179.s21.e8" e2="DDI-DrugBank.d179.s21.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p165"
            e1="DDI-DrugBank.d179.s21.e8" e2="DDI-DrugBank.d179.s21.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p166"
            e1="DDI-DrugBank.d179.s21.e8" e2="DDI-DrugBank.d179.s21.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p167"
            e1="DDI-DrugBank.d179.s21.e8" e2="DDI-DrugBank.d179.s21.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p168"
            e1="DDI-DrugBank.d179.s21.e8" e2="DDI-DrugBank.d179.s21.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p169"
            e1="DDI-DrugBank.d179.s21.e8" e2="DDI-DrugBank.d179.s21.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p170"
            e1="DDI-DrugBank.d179.s21.e8" e2="DDI-DrugBank.d179.s21.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p171"
            e1="DDI-DrugBank.d179.s21.e8" e2="DDI-DrugBank.d179.s21.e16" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p172"
            e1="DDI-DrugBank.d179.s21.e8" e2="DDI-DrugBank.d179.s21.e17" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p173"
            e1="DDI-DrugBank.d179.s21.e8" e2="DDI-DrugBank.d179.s21.e18" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p174"
            e1="DDI-DrugBank.d179.s21.e8" e2="DDI-DrugBank.d179.s21.e19" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p175"
            e1="DDI-DrugBank.d179.s21.e8" e2="DDI-DrugBank.d179.s21.e20" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p176"
            e1="DDI-DrugBank.d179.s21.e8" e2="DDI-DrugBank.d179.s21.e21" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p177"
            e1="DDI-DrugBank.d179.s21.e8" e2="DDI-DrugBank.d179.s21.e22" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p178"
            e1="DDI-DrugBank.d179.s21.e8" e2="DDI-DrugBank.d179.s21.e23" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p179"
            e1="DDI-DrugBank.d179.s21.e8" e2="DDI-DrugBank.d179.s21.e24" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p180"
            e1="DDI-DrugBank.d179.s21.e9" e2="DDI-DrugBank.d179.s21.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p181"
            e1="DDI-DrugBank.d179.s21.e9" e2="DDI-DrugBank.d179.s21.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p182"
            e1="DDI-DrugBank.d179.s21.e9" e2="DDI-DrugBank.d179.s21.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p183"
            e1="DDI-DrugBank.d179.s21.e9" e2="DDI-DrugBank.d179.s21.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p184"
            e1="DDI-DrugBank.d179.s21.e9" e2="DDI-DrugBank.d179.s21.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p185"
            e1="DDI-DrugBank.d179.s21.e9" e2="DDI-DrugBank.d179.s21.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p186"
            e1="DDI-DrugBank.d179.s21.e9" e2="DDI-DrugBank.d179.s21.e16" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p187"
            e1="DDI-DrugBank.d179.s21.e9" e2="DDI-DrugBank.d179.s21.e17" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p188"
            e1="DDI-DrugBank.d179.s21.e9" e2="DDI-DrugBank.d179.s21.e18" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p189"
            e1="DDI-DrugBank.d179.s21.e9" e2="DDI-DrugBank.d179.s21.e19" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p190"
            e1="DDI-DrugBank.d179.s21.e9" e2="DDI-DrugBank.d179.s21.e20" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p191"
            e1="DDI-DrugBank.d179.s21.e9" e2="DDI-DrugBank.d179.s21.e21" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p192"
            e1="DDI-DrugBank.d179.s21.e9" e2="DDI-DrugBank.d179.s21.e22" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p193"
            e1="DDI-DrugBank.d179.s21.e9" e2="DDI-DrugBank.d179.s21.e23" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p194"
            e1="DDI-DrugBank.d179.s21.e9" e2="DDI-DrugBank.d179.s21.e24" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p195"
            e1="DDI-DrugBank.d179.s21.e10"
            e2="DDI-DrugBank.d179.s21.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p196"
            e1="DDI-DrugBank.d179.s21.e10"
            e2="DDI-DrugBank.d179.s21.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p197"
            e1="DDI-DrugBank.d179.s21.e10"
            e2="DDI-DrugBank.d179.s21.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p198"
            e1="DDI-DrugBank.d179.s21.e10"
            e2="DDI-DrugBank.d179.s21.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p199"
            e1="DDI-DrugBank.d179.s21.e10"
            e2="DDI-DrugBank.d179.s21.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p200"
            e1="DDI-DrugBank.d179.s21.e10"
            e2="DDI-DrugBank.d179.s21.e16" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p201"
            e1="DDI-DrugBank.d179.s21.e10"
            e2="DDI-DrugBank.d179.s21.e17" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p202"
            e1="DDI-DrugBank.d179.s21.e10"
            e2="DDI-DrugBank.d179.s21.e18" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p203"
            e1="DDI-DrugBank.d179.s21.e10"
            e2="DDI-DrugBank.d179.s21.e19" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p204"
            e1="DDI-DrugBank.d179.s21.e10"
            e2="DDI-DrugBank.d179.s21.e20" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p205"
            e1="DDI-DrugBank.d179.s21.e10"
            e2="DDI-DrugBank.d179.s21.e21" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p206"
            e1="DDI-DrugBank.d179.s21.e10"
            e2="DDI-DrugBank.d179.s21.e22" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p207"
            e1="DDI-DrugBank.d179.s21.e10"
            e2="DDI-DrugBank.d179.s21.e23" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p208"
            e1="DDI-DrugBank.d179.s21.e10"
            e2="DDI-DrugBank.d179.s21.e24" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p209"
            e1="DDI-DrugBank.d179.s21.e11"
            e2="DDI-DrugBank.d179.s21.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p210"
            e1="DDI-DrugBank.d179.s21.e11"
            e2="DDI-DrugBank.d179.s21.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p211"
            e1="DDI-DrugBank.d179.s21.e11"
            e2="DDI-DrugBank.d179.s21.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p212"
            e1="DDI-DrugBank.d179.s21.e11"
            e2="DDI-DrugBank.d179.s21.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p213"
            e1="DDI-DrugBank.d179.s21.e11"
            e2="DDI-DrugBank.d179.s21.e16" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p214"
            e1="DDI-DrugBank.d179.s21.e11"
            e2="DDI-DrugBank.d179.s21.e17" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p215"
            e1="DDI-DrugBank.d179.s21.e11"
            e2="DDI-DrugBank.d179.s21.e18" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p216"
            e1="DDI-DrugBank.d179.s21.e11"
            e2="DDI-DrugBank.d179.s21.e19" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p217"
            e1="DDI-DrugBank.d179.s21.e11"
            e2="DDI-DrugBank.d179.s21.e20" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p218"
            e1="DDI-DrugBank.d179.s21.e11"
            e2="DDI-DrugBank.d179.s21.e21" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p219"
            e1="DDI-DrugBank.d179.s21.e11"
            e2="DDI-DrugBank.d179.s21.e22" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p220"
            e1="DDI-DrugBank.d179.s21.e11"
            e2="DDI-DrugBank.d179.s21.e23" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p221"
            e1="DDI-DrugBank.d179.s21.e11"
            e2="DDI-DrugBank.d179.s21.e24" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p222"
            e1="DDI-DrugBank.d179.s21.e12"
            e2="DDI-DrugBank.d179.s21.e13" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p223"
            e1="DDI-DrugBank.d179.s21.e12"
            e2="DDI-DrugBank.d179.s21.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p224"
            e1="DDI-DrugBank.d179.s21.e12"
            e2="DDI-DrugBank.d179.s21.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p225"
            e1="DDI-DrugBank.d179.s21.e12"
            e2="DDI-DrugBank.d179.s21.e16" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p226"
            e1="DDI-DrugBank.d179.s21.e12"
            e2="DDI-DrugBank.d179.s21.e17" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p227"
            e1="DDI-DrugBank.d179.s21.e12"
            e2="DDI-DrugBank.d179.s21.e18" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p228"
            e1="DDI-DrugBank.d179.s21.e12"
            e2="DDI-DrugBank.d179.s21.e19" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p229"
            e1="DDI-DrugBank.d179.s21.e12"
            e2="DDI-DrugBank.d179.s21.e20" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p230"
            e1="DDI-DrugBank.d179.s21.e12"
            e2="DDI-DrugBank.d179.s21.e21" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p231"
            e1="DDI-DrugBank.d179.s21.e12"
            e2="DDI-DrugBank.d179.s21.e22" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p232"
            e1="DDI-DrugBank.d179.s21.e12"
            e2="DDI-DrugBank.d179.s21.e23" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p233"
            e1="DDI-DrugBank.d179.s21.e12"
            e2="DDI-DrugBank.d179.s21.e24" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p234"
            e1="DDI-DrugBank.d179.s21.e13"
            e2="DDI-DrugBank.d179.s21.e14" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p235"
            e1="DDI-DrugBank.d179.s21.e13"
            e2="DDI-DrugBank.d179.s21.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p236"
            e1="DDI-DrugBank.d179.s21.e13"
            e2="DDI-DrugBank.d179.s21.e16" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p237"
            e1="DDI-DrugBank.d179.s21.e13"
            e2="DDI-DrugBank.d179.s21.e17" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p238"
            e1="DDI-DrugBank.d179.s21.e13"
            e2="DDI-DrugBank.d179.s21.e18" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p239"
            e1="DDI-DrugBank.d179.s21.e13"
            e2="DDI-DrugBank.d179.s21.e19" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p240"
            e1="DDI-DrugBank.d179.s21.e13"
            e2="DDI-DrugBank.d179.s21.e20" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p241"
            e1="DDI-DrugBank.d179.s21.e13"
            e2="DDI-DrugBank.d179.s21.e21" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p242"
            e1="DDI-DrugBank.d179.s21.e13"
            e2="DDI-DrugBank.d179.s21.e22" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p243"
            e1="DDI-DrugBank.d179.s21.e13"
            e2="DDI-DrugBank.d179.s21.e23" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p244"
            e1="DDI-DrugBank.d179.s21.e13"
            e2="DDI-DrugBank.d179.s21.e24" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p245"
            e1="DDI-DrugBank.d179.s21.e14"
            e2="DDI-DrugBank.d179.s21.e15" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p246"
            e1="DDI-DrugBank.d179.s21.e14"
            e2="DDI-DrugBank.d179.s21.e16" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p247"
            e1="DDI-DrugBank.d179.s21.e14"
            e2="DDI-DrugBank.d179.s21.e17" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p248"
            e1="DDI-DrugBank.d179.s21.e14"
            e2="DDI-DrugBank.d179.s21.e18" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p249"
            e1="DDI-DrugBank.d179.s21.e14"
            e2="DDI-DrugBank.d179.s21.e19" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p250"
            e1="DDI-DrugBank.d179.s21.e14"
            e2="DDI-DrugBank.d179.s21.e20" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p251"
            e1="DDI-DrugBank.d179.s21.e14"
            e2="DDI-DrugBank.d179.s21.e21" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p252"
            e1="DDI-DrugBank.d179.s21.e14"
            e2="DDI-DrugBank.d179.s21.e22" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p253"
            e1="DDI-DrugBank.d179.s21.e14"
            e2="DDI-DrugBank.d179.s21.e23" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p254"
            e1="DDI-DrugBank.d179.s21.e14"
            e2="DDI-DrugBank.d179.s21.e24" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p255"
            e1="DDI-DrugBank.d179.s21.e15"
            e2="DDI-DrugBank.d179.s21.e16" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p256"
            e1="DDI-DrugBank.d179.s21.e15"
            e2="DDI-DrugBank.d179.s21.e17" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p257"
            e1="DDI-DrugBank.d179.s21.e15"
            e2="DDI-DrugBank.d179.s21.e18" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p258"
            e1="DDI-DrugBank.d179.s21.e15"
            e2="DDI-DrugBank.d179.s21.e19" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p259"
            e1="DDI-DrugBank.d179.s21.e15"
            e2="DDI-DrugBank.d179.s21.e20" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p260"
            e1="DDI-DrugBank.d179.s21.e15"
            e2="DDI-DrugBank.d179.s21.e21" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p261"
            e1="DDI-DrugBank.d179.s21.e15"
            e2="DDI-DrugBank.d179.s21.e22" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p262"
            e1="DDI-DrugBank.d179.s21.e15"
            e2="DDI-DrugBank.d179.s21.e23" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p263"
            e1="DDI-DrugBank.d179.s21.e15"
            e2="DDI-DrugBank.d179.s21.e24" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p264"
            e1="DDI-DrugBank.d179.s21.e16"
            e2="DDI-DrugBank.d179.s21.e17" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p265"
            e1="DDI-DrugBank.d179.s21.e16"
            e2="DDI-DrugBank.d179.s21.e18" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p266"
            e1="DDI-DrugBank.d179.s21.e16"
            e2="DDI-DrugBank.d179.s21.e19" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p267"
            e1="DDI-DrugBank.d179.s21.e16"
            e2="DDI-DrugBank.d179.s21.e20" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p268"
            e1="DDI-DrugBank.d179.s21.e16"
            e2="DDI-DrugBank.d179.s21.e21" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p269"
            e1="DDI-DrugBank.d179.s21.e16"
            e2="DDI-DrugBank.d179.s21.e22" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p270"
            e1="DDI-DrugBank.d179.s21.e16"
            e2="DDI-DrugBank.d179.s21.e23" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p271"
            e1="DDI-DrugBank.d179.s21.e16"
            e2="DDI-DrugBank.d179.s21.e24" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p272"
            e1="DDI-DrugBank.d179.s21.e17"
            e2="DDI-DrugBank.d179.s21.e18" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p273"
            e1="DDI-DrugBank.d179.s21.e17"
            e2="DDI-DrugBank.d179.s21.e19" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p274"
            e1="DDI-DrugBank.d179.s21.e17"
            e2="DDI-DrugBank.d179.s21.e20" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p275"
            e1="DDI-DrugBank.d179.s21.e17"
            e2="DDI-DrugBank.d179.s21.e21" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p276"
            e1="DDI-DrugBank.d179.s21.e17"
            e2="DDI-DrugBank.d179.s21.e22" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p277"
            e1="DDI-DrugBank.d179.s21.e17"
            e2="DDI-DrugBank.d179.s21.e23" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p278"
            e1="DDI-DrugBank.d179.s21.e17"
            e2="DDI-DrugBank.d179.s21.e24" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p279"
            e1="DDI-DrugBank.d179.s21.e18"
            e2="DDI-DrugBank.d179.s21.e19" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p280"
            e1="DDI-DrugBank.d179.s21.e18"
            e2="DDI-DrugBank.d179.s21.e20" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p281"
            e1="DDI-DrugBank.d179.s21.e18"
            e2="DDI-DrugBank.d179.s21.e21" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p282"
            e1="DDI-DrugBank.d179.s21.e18"
            e2="DDI-DrugBank.d179.s21.e22" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p283"
            e1="DDI-DrugBank.d179.s21.e18"
            e2="DDI-DrugBank.d179.s21.e23" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p284"
            e1="DDI-DrugBank.d179.s21.e18"
            e2="DDI-DrugBank.d179.s21.e24" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p285"
            e1="DDI-DrugBank.d179.s21.e19"
            e2="DDI-DrugBank.d179.s21.e20" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p286"
            e1="DDI-DrugBank.d179.s21.e19"
            e2="DDI-DrugBank.d179.s21.e21" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p287"
            e1="DDI-DrugBank.d179.s21.e19"
            e2="DDI-DrugBank.d179.s21.e22" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p288"
            e1="DDI-DrugBank.d179.s21.e19"
            e2="DDI-DrugBank.d179.s21.e23" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p289"
            e1="DDI-DrugBank.d179.s21.e19"
            e2="DDI-DrugBank.d179.s21.e24" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p290"
            e1="DDI-DrugBank.d179.s21.e20"
            e2="DDI-DrugBank.d179.s21.e21" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p291"
            e1="DDI-DrugBank.d179.s21.e20"
            e2="DDI-DrugBank.d179.s21.e22" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p292"
            e1="DDI-DrugBank.d179.s21.e20"
            e2="DDI-DrugBank.d179.s21.e23" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p293"
            e1="DDI-DrugBank.d179.s21.e20"
            e2="DDI-DrugBank.d179.s21.e24" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p294"
            e1="DDI-DrugBank.d179.s21.e21"
            e2="DDI-DrugBank.d179.s21.e22" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p295"
            e1="DDI-DrugBank.d179.s21.e21"
            e2="DDI-DrugBank.d179.s21.e23" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p296"
            e1="DDI-DrugBank.d179.s21.e21"
            e2="DDI-DrugBank.d179.s21.e24" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p297"
            e1="DDI-DrugBank.d179.s21.e22"
            e2="DDI-DrugBank.d179.s21.e23" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p298"
            e1="DDI-DrugBank.d179.s21.e22"
            e2="DDI-DrugBank.d179.s21.e24" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s21.p299"
            e1="DDI-DrugBank.d179.s21.e23"
            e2="DDI-DrugBank.d179.s21.e24" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s22" text="- Plicamycin (e.g., Mithracin) or">
        <entity id="DDI-DrugBank.d179.s22.e0" charOffset="2-11"
            type="drug" text="Plicamycin"/>
        <entity id="DDI-DrugBank.d179.s22.e1" charOffset="20-28"
            type="brand" text="Mithracin"/>
        <pair id="DDI-DrugBank.d179.s22.p0"
            e1="DDI-DrugBank.d179.s22.e0" e2="DDI-DrugBank.d179.s22.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s23" text="- Valproic acid (e.g., Depakene) Use of sulfapyridine with these medicines may increase the chance of side effects affecting the liver">
        <entity id="DDI-DrugBank.d179.s23.e0" charOffset="2-14"
            type="drug" text="Valproic acid"/>
        <entity id="DDI-DrugBank.d179.s23.e1" charOffset="23-30"
            type="brand" text="Depakene"/>
        <entity id="DDI-DrugBank.d179.s23.e2" charOffset="40-52"
            type="drug" text="sulfapyridine"/>
        <pair id="DDI-DrugBank.d179.s23.p0"
            e1="DDI-DrugBank.d179.s23.e0" e2="DDI-DrugBank.d179.s23.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s23.p1"
            e1="DDI-DrugBank.d179.s23.e0" e2="DDI-DrugBank.d179.s23.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s23.p2"
            e1="DDI-DrugBank.d179.s23.e1" e2="DDI-DrugBank.d179.s23.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s24" text="- Acetohydroxamic acid (e.g., Lithostat) or">
        <entity id="DDI-DrugBank.d179.s24.e0" charOffset="2-21"
            type="drug" text="Acetohydroxamic acid"/>
        <entity id="DDI-DrugBank.d179.s24.e1" charOffset="30-38"
            type="brand" text="Lithostat"/>
        <pair id="DDI-DrugBank.d179.s24.p0"
            e1="DDI-DrugBank.d179.s24.e0" e2="DDI-DrugBank.d179.s24.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s25" text="- Dapsone or">
        <entity id="DDI-DrugBank.d179.s25.e0" charOffset="2-8"
            type="drug" text="Dapsone"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s26" text="- Furazolidone (e.g., Furoxone) or">
        <entity id="DDI-DrugBank.d179.s26.e0" charOffset="2-13"
            type="drug" text="Furazolidone"/>
        <entity id="DDI-DrugBank.d179.s26.e1" charOffset="22-29"
            type="brand" text="Furoxone"/>
        <pair id="DDI-DrugBank.d179.s26.p0"
            e1="DDI-DrugBank.d179.s26.e0" e2="DDI-DrugBank.d179.s26.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s27" text="- Nitrofurantoin (e.g., Furadantin) or">
        <entity id="DDI-DrugBank.d179.s27.e0" charOffset="2-15"
            type="drug" text="Nitrofurantoin"/>
        <entity id="DDI-DrugBank.d179.s27.e1" charOffset="24-33"
            type="brand" text="Furadantin"/>
        <pair id="DDI-DrugBank.d179.s27.p0"
            e1="DDI-DrugBank.d179.s27.e0" e2="DDI-DrugBank.d179.s27.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s28" text="- Primaquine or">
        <entity id="DDI-DrugBank.d179.s28.e0" charOffset="2-11"
            type="drug" text="Primaquine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s29" text="- Procainamide (e.g., Pronestyl) or">
        <entity id="DDI-DrugBank.d179.s29.e0" charOffset="2-13"
            type="drug" text="Procainamide"/>
        <entity id="DDI-DrugBank.d179.s29.e1" charOffset="22-30"
            type="brand" text="Pronestyl"/>
        <pair id="DDI-DrugBank.d179.s29.p0"
            e1="DDI-DrugBank.d179.s29.e0" e2="DDI-DrugBank.d179.s29.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s30" text="- Quinidine (e.g., Quinidex) or">
        <entity id="DDI-DrugBank.d179.s30.e0" charOffset="2-10"
            type="drug" text="Quinidine"/>
        <entity id="DDI-DrugBank.d179.s30.e1" charOffset="19-26"
            type="brand" text="Quinidex"/>
        <pair id="DDI-DrugBank.d179.s30.p0"
            e1="DDI-DrugBank.d179.s30.e0" e2="DDI-DrugBank.d179.s30.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s31" text="- Quinine (e.g., Quinamm) or">
        <entity id="DDI-DrugBank.d179.s31.e0" charOffset="2-8"
            type="drug" text="Quinine"/>
        <entity id="DDI-DrugBank.d179.s31.e1" charOffset="17-23"
            type="brand" text="Quinamm"/>
        <pair id="DDI-DrugBank.d179.s31.p0"
            e1="DDI-DrugBank.d179.s31.e0" e2="DDI-DrugBank.d179.s31.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s32" text="- Sulfoxone (e.g., Diasone) or">
        <entity id="DDI-DrugBank.d179.s32.e0" charOffset="2-10"
            type="drug" text="Sulfoxone"/>
        <entity id="DDI-DrugBank.d179.s32.e1" charOffset="19-25"
            type="brand" text="Diasone"/>
        <pair id="DDI-DrugBank.d179.s32.p0"
            e1="DDI-DrugBank.d179.s32.e0" e2="DDI-DrugBank.d179.s32.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s33" text="- Vitamin K (e.g., AquaMEPHYTON, Synkayvite) Use of sulfapyridine with these medicines may increase the chance of side effects affecting the blood">
        <entity id="DDI-DrugBank.d179.s33.e0" charOffset="2-10"
            type="group" text="Vitamin K"/>
        <entity id="DDI-DrugBank.d179.s33.e1" charOffset="19-30"
            type="brand" text="AquaMEPHYTON"/>
        <entity id="DDI-DrugBank.d179.s33.e2" charOffset="33-42"
            type="brand" text="Synkayvite"/>
        <entity id="DDI-DrugBank.d179.s33.e3" charOffset="52-64"
            type="drug" text="sulfapyridine"/>
        <pair id="DDI-DrugBank.d179.s33.p0"
            e1="DDI-DrugBank.d179.s33.e0" e2="DDI-DrugBank.d179.s33.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s33.p1"
            e1="DDI-DrugBank.d179.s33.e0" e2="DDI-DrugBank.d179.s33.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s33.p2"
            e1="DDI-DrugBank.d179.s33.e0" e2="DDI-DrugBank.d179.s33.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s33.p3"
            e1="DDI-DrugBank.d179.s33.e1" e2="DDI-DrugBank.d179.s33.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s33.p4"
            e1="DDI-DrugBank.d179.s33.e1" e2="DDI-DrugBank.d179.s33.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s33.p5"
            e1="DDI-DrugBank.d179.s33.e2" e2="DDI-DrugBank.d179.s33.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s34" text="- Anticoagulants (blood thinners) or">
        <entity id="DDI-DrugBank.d179.s34.e0" charOffset="2-15"
            type="group" text="Anticoagulants"/>
        <entity id="DDI-DrugBank.d179.s34.e1" charOffset="18-34"
            type="group" text="blood thinners"/>
        <pair id="DDI-DrugBank.d179.s34.p0"
            e1="DDI-DrugBank.d179.s34.e0" e2="DDI-DrugBank.d179.s34.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s35" text="- Ethotoin (e.g., Peganone) or">
        <entity id="DDI-DrugBank.d179.s35.e0" charOffset="2-9"
            type="drug" text="Ethotoin"/>
        <entity id="DDI-DrugBank.d179.s35.e1" charOffset="18-25"
            type="brand" text="Peganone"/>
        <pair id="DDI-DrugBank.d179.s35.p0"
            e1="DDI-DrugBank.d179.s35.e0" e2="DDI-DrugBank.d179.s35.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s36" text="- Mephenytoin (e.g., Mesantoin) Use of sulfapyridine with these medicines may increase the chance of side effects of these medicines">
        <entity id="DDI-DrugBank.d179.s36.e0" charOffset="2-12"
            type="drug" text="Mephenytoin"/>
        <entity id="DDI-DrugBank.d179.s36.e1" charOffset="21-29"
            type="brand" text="Mesantoin"/>
        <entity id="DDI-DrugBank.d179.s36.e2" charOffset="39-51"
            type="drug" text="sulfapyridine"/>
        <pair id="DDI-DrugBank.d179.s36.p0"
            e1="DDI-DrugBank.d179.s36.e0" e2="DDI-DrugBank.d179.s36.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s36.p1"
            e1="DDI-DrugBank.d179.s36.e0" e2="DDI-DrugBank.d179.s36.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s36.p2"
            e1="DDI-DrugBank.d179.s36.e1" e2="DDI-DrugBank.d179.s36.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s37" text="- Antidiabetics, oral (diabetes medicine you take by mouth) Use of oral antidiabetics with sulfapyridine may increase the chance of side effects affecting the blood and/or the side effects or oral antidiabetics">
        <entity id="DDI-DrugBank.d179.s37.e0" charOffset="2-14"
            type="group" text="Antidiabetics"/>
        <entity id="DDI-DrugBank.d179.s37.e1" charOffset="72-84"
            type="group" text="antidiabetics"/>
        <entity id="DDI-DrugBank.d179.s37.e2" charOffset="91-103"
            type="drug" text="sulfapyridine"/>
        <entity id="DDI-DrugBank.d179.s37.e3" charOffset="197-209"
            type="group" text="antidiabetics"/>
        <pair id="DDI-DrugBank.d179.s37.p0"
            e1="DDI-DrugBank.d179.s37.e0" e2="DDI-DrugBank.d179.s37.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s37.p1"
            e1="DDI-DrugBank.d179.s37.e0" e2="DDI-DrugBank.d179.s37.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s37.p2"
            e1="DDI-DrugBank.d179.s37.e0" e2="DDI-DrugBank.d179.s37.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s37.p3"
            e1="DDI-DrugBank.d179.s37.e1" e2="DDI-DrugBank.d179.s37.e2"
            ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d179.s37.p4"
            e1="DDI-DrugBank.d179.s37.e1" e2="DDI-DrugBank.d179.s37.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s37.p5"
            e1="DDI-DrugBank.d179.s37.e2" e2="DDI-DrugBank.d179.s37.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s38" text="- Methotrexate (e.g., Mexate) Use of methotrexate with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of methotrexate">
        <entity id="DDI-DrugBank.d179.s38.e0" charOffset="2-13"
            type="drug" text="Methotrexate"/>
        <entity id="DDI-DrugBank.d179.s38.e1" charOffset="22-27"
            type="brand" text="Mexate"/>
        <entity id="DDI-DrugBank.d179.s38.e2" charOffset="37-48"
            type="drug" text="methotrexate"/>
        <entity id="DDI-DrugBank.d179.s38.e3" charOffset="55-67"
            type="drug" text="sulfapyridine"/>
        <entity id="DDI-DrugBank.d179.s38.e4" charOffset="156-167"
            type="drug" text="methotrexate"/>
        <pair id="DDI-DrugBank.d179.s38.p0"
            e1="DDI-DrugBank.d179.s38.e0" e2="DDI-DrugBank.d179.s38.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s38.p1"
            e1="DDI-DrugBank.d179.s38.e0" e2="DDI-DrugBank.d179.s38.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s38.p2"
            e1="DDI-DrugBank.d179.s38.e0" e2="DDI-DrugBank.d179.s38.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s38.p3"
            e1="DDI-DrugBank.d179.s38.e0" e2="DDI-DrugBank.d179.s38.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s38.p4"
            e1="DDI-DrugBank.d179.s38.e1" e2="DDI-DrugBank.d179.s38.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s38.p5"
            e1="DDI-DrugBank.d179.s38.e1" e2="DDI-DrugBank.d179.s38.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s38.p6"
            e1="DDI-DrugBank.d179.s38.e1" e2="DDI-DrugBank.d179.s38.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s38.p7"
            e1="DDI-DrugBank.d179.s38.e2" e2="DDI-DrugBank.d179.s38.e3"
            ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d179.s38.p8"
            e1="DDI-DrugBank.d179.s38.e2" e2="DDI-DrugBank.d179.s38.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s38.p9"
            e1="DDI-DrugBank.d179.s38.e3" e2="DDI-DrugBank.d179.s38.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s39" text="- Methyldopa (e.g., Aldomet) Use of methyldopa with sulfapyridine may increase the chance of side effects affecting the liver and/or the blood">
        <entity id="DDI-DrugBank.d179.s39.e0" charOffset="2-11"
            type="drug" text="Methyldopa"/>
        <entity id="DDI-DrugBank.d179.s39.e1" charOffset="20-26"
            type="brand" text="Aldomet"/>
        <entity id="DDI-DrugBank.d179.s39.e2" charOffset="36-45"
            type="drug" text="methyldopa"/>
        <entity id="DDI-DrugBank.d179.s39.e3" charOffset="52-64"
            type="drug" text="sulfapyridine"/>
        <pair id="DDI-DrugBank.d179.s39.p0"
            e1="DDI-DrugBank.d179.s39.e0" e2="DDI-DrugBank.d179.s39.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s39.p1"
            e1="DDI-DrugBank.d179.s39.e0" e2="DDI-DrugBank.d179.s39.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s39.p2"
            e1="DDI-DrugBank.d179.s39.e0" e2="DDI-DrugBank.d179.s39.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s39.p3"
            e1="DDI-DrugBank.d179.s39.e1" e2="DDI-DrugBank.d179.s39.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s39.p4"
            e1="DDI-DrugBank.d179.s39.e1" e2="DDI-DrugBank.d179.s39.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s39.p5"
            e1="DDI-DrugBank.d179.s39.e2" e2="DDI-DrugBank.d179.s39.e3"
            ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d179.s40" text="- Phenytoin (e.g., Dilantin) Use of phenytoin with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of phenytoin">
        <entity id="DDI-DrugBank.d179.s40.e0" charOffset="2-10"
            type="drug" text="Phenytoin"/>
        <entity id="DDI-DrugBank.d179.s40.e1" charOffset="19-26"
            type="brand" text="Dilantin"/>
        <entity id="DDI-DrugBank.d179.s40.e2" charOffset="36-44"
            type="drug" text="phenytoin"/>
        <entity id="DDI-DrugBank.d179.s40.e3" charOffset="51-63"
            type="drug" text="sulfapyridine"/>
        <entity id="DDI-DrugBank.d179.s40.e4" charOffset="152-160"
            type="drug" text="phenytoin"/>
        <pair id="DDI-DrugBank.d179.s40.p0"
            e1="DDI-DrugBank.d179.s40.e0" e2="DDI-DrugBank.d179.s40.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s40.p1"
            e1="DDI-DrugBank.d179.s40.e0" e2="DDI-DrugBank.d179.s40.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s40.p2"
            e1="DDI-DrugBank.d179.s40.e0" e2="DDI-DrugBank.d179.s40.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s40.p3"
            e1="DDI-DrugBank.d179.s40.e0" e2="DDI-DrugBank.d179.s40.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s40.p4"
            e1="DDI-DrugBank.d179.s40.e1" e2="DDI-DrugBank.d179.s40.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s40.p5"
            e1="DDI-DrugBank.d179.s40.e1" e2="DDI-DrugBank.d179.s40.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s40.p6"
            e1="DDI-DrugBank.d179.s40.e1" e2="DDI-DrugBank.d179.s40.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s40.p7"
            e1="DDI-DrugBank.d179.s40.e2" e2="DDI-DrugBank.d179.s40.e3"
            ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d179.s40.p8"
            e1="DDI-DrugBank.d179.s40.e2" e2="DDI-DrugBank.d179.s40.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d179.s40.p9"
            e1="DDI-DrugBank.d179.s40.e3" e2="DDI-DrugBank.d179.s40.e4" ddi="false"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d639">
    <sentence id="DDI-DrugBank.d639.s0" text="Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. ">
        <entity id="DDI-DrugBank.d639.s0.e0" charOffset="21-26"
            type="brand" text="SUTENT"/>
        <entity id="DDI-DrugBank.d639.s0.e1" charOffset="79-90"
            type="drug" text="ketoconazole"/>
        <entity id="DDI-DrugBank.d639.s0.e2" charOffset="93-104"
            type="drug" text="itraconazole"/>
        <entity id="DDI-DrugBank.d639.s0.e3" charOffset="107-120"
            type="drug" text="clarithromycin"/>
        <entity id="DDI-DrugBank.d639.s0.e4" charOffset="123-132"
            type="drug" text="atazanavir"/>
        <entity id="DDI-DrugBank.d639.s0.e5" charOffset="135-143"
            type="drug" text="indinavir"/>
        <entity id="DDI-DrugBank.d639.s0.e6" charOffset="146-155"
            type="drug" text="nefazodone"/>
        <entity id="DDI-DrugBank.d639.s0.e7" charOffset="158-167"
            type="drug" text="nelfinavir"/>
        <entity id="DDI-DrugBank.d639.s0.e8" charOffset="170-178"
            type="drug" text="ritonavir"/>
        <entity id="DDI-DrugBank.d639.s0.e9" charOffset="181-190"
            type="drug" text="saquinavir"/>
        <entity id="DDI-DrugBank.d639.s0.e10" charOffset="193-205"
            type="drug" text="telithromycin"/>
        <entity id="DDI-DrugBank.d639.s0.e11" charOffset="208-219"
            type="drug" text="voriconizole"/>
        <entity id="DDI-DrugBank.d639.s0.e12" charOffset="236-244"
            type="drug" text="sunitinib"/>
        <pair id="DDI-DrugBank.d639.s0.p0" e1="DDI-DrugBank.d639.s0.e0"
            e2="DDI-DrugBank.d639.s0.e1" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d639.s0.p1" e1="DDI-DrugBank.d639.s0.e0"
            e2="DDI-DrugBank.d639.s0.e2" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d639.s0.p2" e1="DDI-DrugBank.d639.s0.e0"
            e2="DDI-DrugBank.d639.s0.e3" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d639.s0.p3" e1="DDI-DrugBank.d639.s0.e0"
            e2="DDI-DrugBank.d639.s0.e4" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d639.s0.p4" e1="DDI-DrugBank.d639.s0.e0"
            e2="DDI-DrugBank.d639.s0.e5" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d639.s0.p5" e1="DDI-DrugBank.d639.s0.e0"
            e2="DDI-DrugBank.d639.s0.e6" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d639.s0.p6" e1="DDI-DrugBank.d639.s0.e0"
            e2="DDI-DrugBank.d639.s0.e7" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d639.s0.p7" e1="DDI-DrugBank.d639.s0.e0"
            e2="DDI-DrugBank.d639.s0.e8" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d639.s0.p8" e1="DDI-DrugBank.d639.s0.e0"
            e2="DDI-DrugBank.d639.s0.e9" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d639.s0.p9" e1="DDI-DrugBank.d639.s0.e0"
            e2="DDI-DrugBank.d639.s0.e10" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d639.s0.p10" e1="DDI-DrugBank.d639.s0.e0"
            e2="DDI-DrugBank.d639.s0.e11" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d639.s0.p11" e1="DDI-DrugBank.d639.s0.e0"
            e2="DDI-DrugBank.d639.s0.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p12" e1="DDI-DrugBank.d639.s0.e1"
            e2="DDI-DrugBank.d639.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p13" e1="DDI-DrugBank.d639.s0.e1"
            e2="DDI-DrugBank.d639.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p14" e1="DDI-DrugBank.d639.s0.e1"
            e2="DDI-DrugBank.d639.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p15" e1="DDI-DrugBank.d639.s0.e1"
            e2="DDI-DrugBank.d639.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p16" e1="DDI-DrugBank.d639.s0.e1"
            e2="DDI-DrugBank.d639.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p17" e1="DDI-DrugBank.d639.s0.e1"
            e2="DDI-DrugBank.d639.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p18" e1="DDI-DrugBank.d639.s0.e1"
            e2="DDI-DrugBank.d639.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p19" e1="DDI-DrugBank.d639.s0.e1"
            e2="DDI-DrugBank.d639.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p20" e1="DDI-DrugBank.d639.s0.e1"
            e2="DDI-DrugBank.d639.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p21" e1="DDI-DrugBank.d639.s0.e1"
            e2="DDI-DrugBank.d639.s0.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p22" e1="DDI-DrugBank.d639.s0.e1"
            e2="DDI-DrugBank.d639.s0.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p23" e1="DDI-DrugBank.d639.s0.e2"
            e2="DDI-DrugBank.d639.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p24" e1="DDI-DrugBank.d639.s0.e2"
            e2="DDI-DrugBank.d639.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p25" e1="DDI-DrugBank.d639.s0.e2"
            e2="DDI-DrugBank.d639.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p26" e1="DDI-DrugBank.d639.s0.e2"
            e2="DDI-DrugBank.d639.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p27" e1="DDI-DrugBank.d639.s0.e2"
            e2="DDI-DrugBank.d639.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p28" e1="DDI-DrugBank.d639.s0.e2"
            e2="DDI-DrugBank.d639.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p29" e1="DDI-DrugBank.d639.s0.e2"
            e2="DDI-DrugBank.d639.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p30" e1="DDI-DrugBank.d639.s0.e2"
            e2="DDI-DrugBank.d639.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p31" e1="DDI-DrugBank.d639.s0.e2"
            e2="DDI-DrugBank.d639.s0.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p32" e1="DDI-DrugBank.d639.s0.e2"
            e2="DDI-DrugBank.d639.s0.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p33" e1="DDI-DrugBank.d639.s0.e3"
            e2="DDI-DrugBank.d639.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p34" e1="DDI-DrugBank.d639.s0.e3"
            e2="DDI-DrugBank.d639.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p35" e1="DDI-DrugBank.d639.s0.e3"
            e2="DDI-DrugBank.d639.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p36" e1="DDI-DrugBank.d639.s0.e3"
            e2="DDI-DrugBank.d639.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p37" e1="DDI-DrugBank.d639.s0.e3"
            e2="DDI-DrugBank.d639.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p38" e1="DDI-DrugBank.d639.s0.e3"
            e2="DDI-DrugBank.d639.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p39" e1="DDI-DrugBank.d639.s0.e3"
            e2="DDI-DrugBank.d639.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p40" e1="DDI-DrugBank.d639.s0.e3"
            e2="DDI-DrugBank.d639.s0.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p41" e1="DDI-DrugBank.d639.s0.e3"
            e2="DDI-DrugBank.d639.s0.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p42" e1="DDI-DrugBank.d639.s0.e4"
            e2="DDI-DrugBank.d639.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p43" e1="DDI-DrugBank.d639.s0.e4"
            e2="DDI-DrugBank.d639.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p44" e1="DDI-DrugBank.d639.s0.e4"
            e2="DDI-DrugBank.d639.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p45" e1="DDI-DrugBank.d639.s0.e4"
            e2="DDI-DrugBank.d639.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p46" e1="DDI-DrugBank.d639.s0.e4"
            e2="DDI-DrugBank.d639.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p47" e1="DDI-DrugBank.d639.s0.e4"
            e2="DDI-DrugBank.d639.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p48" e1="DDI-DrugBank.d639.s0.e4"
            e2="DDI-DrugBank.d639.s0.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p49" e1="DDI-DrugBank.d639.s0.e4"
            e2="DDI-DrugBank.d639.s0.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p50" e1="DDI-DrugBank.d639.s0.e5"
            e2="DDI-DrugBank.d639.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p51" e1="DDI-DrugBank.d639.s0.e5"
            e2="DDI-DrugBank.d639.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p52" e1="DDI-DrugBank.d639.s0.e5"
            e2="DDI-DrugBank.d639.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p53" e1="DDI-DrugBank.d639.s0.e5"
            e2="DDI-DrugBank.d639.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p54" e1="DDI-DrugBank.d639.s0.e5"
            e2="DDI-DrugBank.d639.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p55" e1="DDI-DrugBank.d639.s0.e5"
            e2="DDI-DrugBank.d639.s0.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p56" e1="DDI-DrugBank.d639.s0.e5"
            e2="DDI-DrugBank.d639.s0.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p57" e1="DDI-DrugBank.d639.s0.e6"
            e2="DDI-DrugBank.d639.s0.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p58" e1="DDI-DrugBank.d639.s0.e6"
            e2="DDI-DrugBank.d639.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p59" e1="DDI-DrugBank.d639.s0.e6"
            e2="DDI-DrugBank.d639.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p60" e1="DDI-DrugBank.d639.s0.e6"
            e2="DDI-DrugBank.d639.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p61" e1="DDI-DrugBank.d639.s0.e6"
            e2="DDI-DrugBank.d639.s0.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p62" e1="DDI-DrugBank.d639.s0.e6"
            e2="DDI-DrugBank.d639.s0.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p63" e1="DDI-DrugBank.d639.s0.e7"
            e2="DDI-DrugBank.d639.s0.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p64" e1="DDI-DrugBank.d639.s0.e7"
            e2="DDI-DrugBank.d639.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p65" e1="DDI-DrugBank.d639.s0.e7"
            e2="DDI-DrugBank.d639.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p66" e1="DDI-DrugBank.d639.s0.e7"
            e2="DDI-DrugBank.d639.s0.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p67" e1="DDI-DrugBank.d639.s0.e7"
            e2="DDI-DrugBank.d639.s0.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p68" e1="DDI-DrugBank.d639.s0.e8"
            e2="DDI-DrugBank.d639.s0.e9" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p69" e1="DDI-DrugBank.d639.s0.e8"
            e2="DDI-DrugBank.d639.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p70" e1="DDI-DrugBank.d639.s0.e8"
            e2="DDI-DrugBank.d639.s0.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p71" e1="DDI-DrugBank.d639.s0.e8"
            e2="DDI-DrugBank.d639.s0.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p72" e1="DDI-DrugBank.d639.s0.e9"
            e2="DDI-DrugBank.d639.s0.e10" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p73" e1="DDI-DrugBank.d639.s0.e9"
            e2="DDI-DrugBank.d639.s0.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p74" e1="DDI-DrugBank.d639.s0.e9"
            e2="DDI-DrugBank.d639.s0.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p75"
            e1="DDI-DrugBank.d639.s0.e10" e2="DDI-DrugBank.d639.s0.e11" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p76"
            e1="DDI-DrugBank.d639.s0.e10" e2="DDI-DrugBank.d639.s0.e12" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s0.p77"
            e1="DDI-DrugBank.d639.s0.e11" e2="DDI-DrugBank.d639.s0.e12" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d639.s1" text="Grapefruit may also increase plasma concentrations of SUTENT. ">
        <entity id="DDI-DrugBank.d639.s1.e0" charOffset="54-59"
            type="brand" text="SUTENT"/>
    </sentence>
    <sentence id="DDI-DrugBank.d639.s2" text="Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, carbamazepine, rifampin, rifabutin, rifapentin, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations. ">
        <entity id="DDI-DrugBank.d639.s2.e0" charOffset="21-26"
            type="brand" text="SUTENT"/>
        <entity id="DDI-DrugBank.d639.s2.e1" charOffset="70-82"
            type="drug" text="dexamethasone"/>
        <entity id="DDI-DrugBank.d639.s2.e2" charOffset="85-93"
            type="drug" text="phenytoin"/>
        <entity id="DDI-DrugBank.d639.s2.e3" charOffset="96-108"
            type="drug" text="carbamazepine"/>
        <entity id="DDI-DrugBank.d639.s2.e4" charOffset="111-118"
            type="drug" text="rifampin"/>
        <entity id="DDI-DrugBank.d639.s2.e5" charOffset="121-129"
            type="drug" text="rifabutin"/>
        <entity id="DDI-DrugBank.d639.s2.e6" charOffset="132-141"
            type="drug" text="rifapentin"/>
        <entity id="DDI-DrugBank.d639.s2.e7" charOffset="144-156"
            type="drug" text="phenobarbital"/>
        <entity id="DDI-DrugBank.d639.s2.e8" charOffset="188-196"
            type="drug" text="sunitinib"/>
        <pair id="DDI-DrugBank.d639.s2.p0" e1="DDI-DrugBank.d639.s2.e0"
            e2="DDI-DrugBank.d639.s2.e1" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d639.s2.p1" e1="DDI-DrugBank.d639.s2.e0"
            e2="DDI-DrugBank.d639.s2.e2" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d639.s2.p2" e1="DDI-DrugBank.d639.s2.e0"
            e2="DDI-DrugBank.d639.s2.e3" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d639.s2.p3" e1="DDI-DrugBank.d639.s2.e0"
            e2="DDI-DrugBank.d639.s2.e4" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d639.s2.p4" e1="DDI-DrugBank.d639.s2.e0"
            e2="DDI-DrugBank.d639.s2.e5" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d639.s2.p5" e1="DDI-DrugBank.d639.s2.e0"
            e2="DDI-DrugBank.d639.s2.e6" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d639.s2.p6" e1="DDI-DrugBank.d639.s2.e0"
            e2="DDI-DrugBank.d639.s2.e7" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d639.s2.p7" e1="DDI-DrugBank.d639.s2.e0"
            e2="DDI-DrugBank.d639.s2.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s2.p8" e1="DDI-DrugBank.d639.s2.e1"
            e2="DDI-DrugBank.d639.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s2.p9" e1="DDI-DrugBank.d639.s2.e1"
            e2="DDI-DrugBank.d639.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s2.p10" e1="DDI-DrugBank.d639.s2.e1"
            e2="DDI-DrugBank.d639.s2.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s2.p11" e1="DDI-DrugBank.d639.s2.e1"
            e2="DDI-DrugBank.d639.s2.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s2.p12" e1="DDI-DrugBank.d639.s2.e1"
            e2="DDI-DrugBank.d639.s2.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s2.p13" e1="DDI-DrugBank.d639.s2.e1"
            e2="DDI-DrugBank.d639.s2.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s2.p14" e1="DDI-DrugBank.d639.s2.e1"
            e2="DDI-DrugBank.d639.s2.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s2.p15" e1="DDI-DrugBank.d639.s2.e2"
            e2="DDI-DrugBank.d639.s2.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s2.p16" e1="DDI-DrugBank.d639.s2.e2"
            e2="DDI-DrugBank.d639.s2.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s2.p17" e1="DDI-DrugBank.d639.s2.e2"
            e2="DDI-DrugBank.d639.s2.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s2.p18" e1="DDI-DrugBank.d639.s2.e2"
            e2="DDI-DrugBank.d639.s2.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s2.p19" e1="DDI-DrugBank.d639.s2.e2"
            e2="DDI-DrugBank.d639.s2.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s2.p20" e1="DDI-DrugBank.d639.s2.e2"
            e2="DDI-DrugBank.d639.s2.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s2.p21" e1="DDI-DrugBank.d639.s2.e3"
            e2="DDI-DrugBank.d639.s2.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s2.p22" e1="DDI-DrugBank.d639.s2.e3"
            e2="DDI-DrugBank.d639.s2.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s2.p23" e1="DDI-DrugBank.d639.s2.e3"
            e2="DDI-DrugBank.d639.s2.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s2.p24" e1="DDI-DrugBank.d639.s2.e3"
            e2="DDI-DrugBank.d639.s2.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s2.p25" e1="DDI-DrugBank.d639.s2.e3"
            e2="DDI-DrugBank.d639.s2.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s2.p26" e1="DDI-DrugBank.d639.s2.e4"
            e2="DDI-DrugBank.d639.s2.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s2.p27" e1="DDI-DrugBank.d639.s2.e4"
            e2="DDI-DrugBank.d639.s2.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s2.p28" e1="DDI-DrugBank.d639.s2.e4"
            e2="DDI-DrugBank.d639.s2.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s2.p29" e1="DDI-DrugBank.d639.s2.e4"
            e2="DDI-DrugBank.d639.s2.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s2.p30" e1="DDI-DrugBank.d639.s2.e5"
            e2="DDI-DrugBank.d639.s2.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s2.p31" e1="DDI-DrugBank.d639.s2.e5"
            e2="DDI-DrugBank.d639.s2.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s2.p32" e1="DDI-DrugBank.d639.s2.e5"
            e2="DDI-DrugBank.d639.s2.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s2.p33" e1="DDI-DrugBank.d639.s2.e6"
            e2="DDI-DrugBank.d639.s2.e7" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s2.p34" e1="DDI-DrugBank.d639.s2.e6"
            e2="DDI-DrugBank.d639.s2.e8" ddi="false"/>
        <pair id="DDI-DrugBank.d639.s2.p35" e1="DDI-DrugBank.d639.s2.e7"
            e2="DDI-DrugBank.d639.s2.e8" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d639.s3" text="St. "/>
    <sentence id="DDI-DrugBank.d639.s4" text="Johns Wort may decrease SUTENT plasma concentrations unpredictably. ">
        <entity id="DDI-DrugBank.d639.s4.e0" charOffset="24-29"
            type="brand" text="SUTENT"/>
    </sentence>
    <sentence id="DDI-DrugBank.d639.s5" text="Patients receiving SUTENT should not take St. ">
        <entity id="DDI-DrugBank.d639.s5.e0" charOffset="19-24"
            type="brand" text="SUTENT"/>
    </sentence>
    <sentence id="DDI-DrugBank.d639.s6" text="Johns Wort concomitantly. "/>
    <sentence id="DDI-DrugBank.d639.s7" text="SUTENT dose modification is recommended in patients using concomitant CYP3A4 inhibitors or inducers.">
        <entity id="DDI-DrugBank.d639.s7.e0" charOffset="0-5"
            type="brand" text="SUTENT"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d723">
    <sentence id="DDI-DrugBank.d723.s0" text="Other eye drops or medications such as acetylcholine chloride (Miochol) and carbachol (Carboptic, Isopto Carbachol) may decrease the effects of suprofen ophthalmic.">
        <entity id="DDI-DrugBank.d723.s0.e0" charOffset="39-60"
            type="drug" text="acetylcholine chloride"/>
        <entity id="DDI-DrugBank.d723.s0.e1" charOffset="63-69"
            type="brand" text="Miochol"/>
        <entity id="DDI-DrugBank.d723.s0.e2" charOffset="76-84"
            type="drug" text="carbachol"/>
        <entity id="DDI-DrugBank.d723.s0.e3" charOffset="87-95"
            type="brand" text="Carboptic"/>
        <entity id="DDI-DrugBank.d723.s0.e4" charOffset="98-113"
            type="brand" text="Isopto Carbachol"/>
        <entity id="DDI-DrugBank.d723.s0.e5" charOffset="144-151"
            type="drug" text="suprofen"/>
        <pair id="DDI-DrugBank.d723.s0.p0" e1="DDI-DrugBank.d723.s0.e0"
            e2="DDI-DrugBank.d723.s0.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d723.s0.p1" e1="DDI-DrugBank.d723.s0.e0"
            e2="DDI-DrugBank.d723.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d723.s0.p2" e1="DDI-DrugBank.d723.s0.e0"
            e2="DDI-DrugBank.d723.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d723.s0.p3" e1="DDI-DrugBank.d723.s0.e0"
            e2="DDI-DrugBank.d723.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d723.s0.p4" e1="DDI-DrugBank.d723.s0.e0"
            e2="DDI-DrugBank.d723.s0.e5" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d723.s0.p5" e1="DDI-DrugBank.d723.s0.e1"
            e2="DDI-DrugBank.d723.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d723.s0.p6" e1="DDI-DrugBank.d723.s0.e1"
            e2="DDI-DrugBank.d723.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d723.s0.p7" e1="DDI-DrugBank.d723.s0.e1"
            e2="DDI-DrugBank.d723.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d723.s0.p8" e1="DDI-DrugBank.d723.s0.e1"
            e2="DDI-DrugBank.d723.s0.e5" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d723.s0.p9" e1="DDI-DrugBank.d723.s0.e2"
            e2="DDI-DrugBank.d723.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d723.s0.p10" e1="DDI-DrugBank.d723.s0.e2"
            e2="DDI-DrugBank.d723.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d723.s0.p11" e1="DDI-DrugBank.d723.s0.e2"
            e2="DDI-DrugBank.d723.s0.e5" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d723.s0.p12" e1="DDI-DrugBank.d723.s0.e3"
            e2="DDI-DrugBank.d723.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d723.s0.p13" e1="DDI-DrugBank.d723.s0.e3"
            e2="DDI-DrugBank.d723.s0.e5" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d723.s0.p14" e1="DDI-DrugBank.d723.s0.e4"
            e2="DDI-DrugBank.d723.s0.e5" ddi="true" type="effect"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d704">
    <sentence id="DDI-DrugBank.d704.s0" text="Drug-Drug Interactions: The pharmacokinetic and pharmacodynamic interactions between FLOMAX capsules and other alpha-adrenergic blocking agents have not been determined. ">
        <entity id="DDI-DrugBank.d704.s0.e0" charOffset="85-90"
            type="brand" text="FLOMAX"/>
        <entity id="DDI-DrugBank.d704.s0.e1" charOffset="111-142"
            type="group" text="alpha-adrenergic blocking agents"/>
        <pair id="DDI-DrugBank.d704.s0.p0" e1="DDI-DrugBank.d704.s0.e0"
            e2="DDI-DrugBank.d704.s0.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d704.s1" text="However, interactions may be expected and FLOMAX capsules should NOT be used in combination with other alpha-adrenergic blocking agents. ">
        <entity id="DDI-DrugBank.d704.s1.e0" charOffset="42-47"
            type="brand" text="FLOMAX"/>
        <entity id="DDI-DrugBank.d704.s1.e1" charOffset="103-134"
            type="group" text="alpha-adrenergic blocking agents"/>
        <pair id="DDI-DrugBank.d704.s1.p0" e1="DDI-DrugBank.d704.s1.e0"
            e2="DDI-DrugBank.d704.s1.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d704.s2" text="The pharmacokinetic interaction between cimetidine and FLOMAX capsules was investigated. ">
        <entity id="DDI-DrugBank.d704.s2.e0" charOffset="40-49"
            type="drug" text="cimetidine"/>
        <entity id="DDI-DrugBank.d704.s2.e1" charOffset="55-60"
            type="brand" text="FLOMAX"/>
        <pair id="DDI-DrugBank.d704.s2.p0" e1="DDI-DrugBank.d704.s2.e0"
            e2="DDI-DrugBank.d704.s2.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d704.s3" text="The results indicate significant changes in tamsulosin HCI clearance (26% decrease) and AUC (44% increase). ">
        <entity id="DDI-DrugBank.d704.s3.e0" charOffset="44-57"
            type="drug" text="tamsulosin HCI"/>
    </sentence>
    <sentence id="DDI-DrugBank.d704.s4" text="Therefore, FLOMAX capsules should be used with caution in combination with cimetidine, particularly at doses higher than 0.4 mg. ">
        <entity id="DDI-DrugBank.d704.s4.e0" charOffset="11-16"
            type="brand" text="FLOMAX"/>
        <entity id="DDI-DrugBank.d704.s4.e1" charOffset="75-84"
            type="drug" text="cimetidine"/>
        <pair id="DDI-DrugBank.d704.s4.p0" e1="DDI-DrugBank.d704.s4.e0"
            e2="DDI-DrugBank.d704.s4.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d704.s5" text="Results from limited in vitro and in vivo drug-drug interaction studies between tamsulosin HCI and warfarin are inconclusive. ">
        <entity id="DDI-DrugBank.d704.s5.e0" charOffset="80-93"
            type="drug" text="tamsulosin HCI"/>
        <entity id="DDI-DrugBank.d704.s5.e1" charOffset="99-106"
            type="drug" text="warfarin"/>
        <pair id="DDI-DrugBank.d704.s5.p0" e1="DDI-DrugBank.d704.s5.e0"
            e2="DDI-DrugBank.d704.s5.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d704.s6" text="Therefore, caution should be exercised with concomitant administration of warfarin and FLOMAX capsules.        ">
        <entity id="DDI-DrugBank.d704.s6.e0" charOffset="74-81"
            type="drug" text="warfarin"/>
        <entity id="DDI-DrugBank.d704.s6.e1" charOffset="87-92"
            type="brand" text="FLOMAX"/>
        <pair id="DDI-DrugBank.d704.s6.p0" e1="DDI-DrugBank.d704.s6.e0"
            e2="DDI-DrugBank.d704.s6.e1" ddi="true" type="advise"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d658">
    <sentence id="DDI-DrugBank.d658.s0" text="When administered concurrently, testolactone may increase the effects of oral anticoagulants; ">
        <entity id="DDI-DrugBank.d658.s0.e0" charOffset="32-43"
            type="drug" text="testolactone"/>
        <entity id="DDI-DrugBank.d658.s0.e1" charOffset="78-91"
            type="group" text="anticoagulants"/>
        <pair id="DDI-DrugBank.d658.s0.p0" e1="DDI-DrugBank.d658.s0.e0"
            e2="DDI-DrugBank.d658.s0.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d658.s1" text="monitor and adjust anticoagulant dosage accordingly. ">
        <entity id="DDI-DrugBank.d658.s1.e0" charOffset="19-31"
            type="group" text="anticoagulant"/>
    </sentence>
    <sentence id="DDI-DrugBank.d658.s2" text="Drug/Laboratory Test Interactions: Physiologic effects of testolactone may result in decreased estradiol concentrations with radioimmunoassays for estradiol, increased plasma calcium concentrations, and increased 24-hour urinary excretion of creatine and 17-ketosteroids.">
        <entity id="DDI-DrugBank.d658.s2.e0" charOffset="58-69"
            type="drug" text="testolactone"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d766">
    <sentence id="DDI-DrugBank.d766.s0" text="Since trimetrexate is metabolized by a P450 enzyme system, drugs that induce or inhibit this drug metabolizing enzyme system may elicit important drug-drug interactions that may alter trimetrexate plasma concentrations. ">
        <entity id="DDI-DrugBank.d766.s0.e0" charOffset="6-17"
            type="drug" text="trimetrexate"/>
        <entity id="DDI-DrugBank.d766.s0.e1" charOffset="184-195"
            type="drug" text="trimetrexate"/>
        <pair id="DDI-DrugBank.d766.s0.p0" e1="DDI-DrugBank.d766.s0.e0"
            e2="DDI-DrugBank.d766.s0.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d766.s1" text="Agents that might be coadministered with trimetrexate in AIDS patients for other indications that could elicit this activity include erythromycin, rifampin, rifabutin, ketoconazole, and fluconazole. ">
        <entity id="DDI-DrugBank.d766.s1.e0" charOffset="41-52"
            type="drug" text="trimetrexate"/>
        <entity id="DDI-DrugBank.d766.s1.e1" charOffset="133-144"
            type="drug" text="erythromycin"/>
        <entity id="DDI-DrugBank.d766.s1.e2" charOffset="147-154"
            type="drug" text="rifampin"/>
        <entity id="DDI-DrugBank.d766.s1.e3" charOffset="157-165"
            type="drug" text="rifabutin"/>
        <entity id="DDI-DrugBank.d766.s1.e4" charOffset="168-179"
            type="drug" text="ketoconazole"/>
        <entity id="DDI-DrugBank.d766.s1.e5" charOffset="186-196"
            type="drug" text="fluconazole"/>
        <pair id="DDI-DrugBank.d766.s1.p0" e1="DDI-DrugBank.d766.s1.e0"
            e2="DDI-DrugBank.d766.s1.e1" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d766.s1.p1" e1="DDI-DrugBank.d766.s1.e0"
            e2="DDI-DrugBank.d766.s1.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d766.s1.p2" e1="DDI-DrugBank.d766.s1.e0"
            e2="DDI-DrugBank.d766.s1.e3" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d766.s1.p3" e1="DDI-DrugBank.d766.s1.e0"
            e2="DDI-DrugBank.d766.s1.e4" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d766.s1.p4" e1="DDI-DrugBank.d766.s1.e0"
            e2="DDI-DrugBank.d766.s1.e5" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d766.s1.p5" e1="DDI-DrugBank.d766.s1.e1"
            e2="DDI-DrugBank.d766.s1.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d766.s1.p6" e1="DDI-DrugBank.d766.s1.e1"
            e2="DDI-DrugBank.d766.s1.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d766.s1.p7" e1="DDI-DrugBank.d766.s1.e1"
            e2="DDI-DrugBank.d766.s1.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d766.s1.p8" e1="DDI-DrugBank.d766.s1.e1"
            e2="DDI-DrugBank.d766.s1.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d766.s1.p9" e1="DDI-DrugBank.d766.s1.e2"
            e2="DDI-DrugBank.d766.s1.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d766.s1.p10" e1="DDI-DrugBank.d766.s1.e2"
            e2="DDI-DrugBank.d766.s1.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d766.s1.p11" e1="DDI-DrugBank.d766.s1.e2"
            e2="DDI-DrugBank.d766.s1.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d766.s1.p12" e1="DDI-DrugBank.d766.s1.e3"
            e2="DDI-DrugBank.d766.s1.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d766.s1.p13" e1="DDI-DrugBank.d766.s1.e3"
            e2="DDI-DrugBank.d766.s1.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d766.s1.p14" e1="DDI-DrugBank.d766.s1.e4"
            e2="DDI-DrugBank.d766.s1.e5" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d766.s2" text="In vitro perfusion of isolated rat liver has shown that cimetidine caused a significant reduction in trimetrexate metabolism and that acetaminophen altered the relative concentration of trimetrexate metabolites possibly by competing for sulfate metabolites. ">
        <entity id="DDI-DrugBank.d766.s2.e0" charOffset="56-65"
            type="drug" text="cimetidine"/>
        <entity id="DDI-DrugBank.d766.s2.e1" charOffset="101-112"
            type="drug" text="trimetrexate"/>
        <entity id="DDI-DrugBank.d766.s2.e2" charOffset="134-146"
            type="drug" text="acetaminophen"/>
        <pair id="DDI-DrugBank.d766.s2.p0" e1="DDI-DrugBank.d766.s2.e0"
            e2="DDI-DrugBank.d766.s2.e1" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d766.s2.p1" e1="DDI-DrugBank.d766.s2.e0"
            e2="DDI-DrugBank.d766.s2.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d766.s2.p2" e1="DDI-DrugBank.d766.s2.e1"
            e2="DDI-DrugBank.d766.s2.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d766.s3" text="Based on an in vitro rat liver model, nitrogen substituted imidazole drugs (clotrimazole, ketoconazole, miconazole) were potent, non-competitive inhibitors of trimetrexate metabolism. ">
        <entity id="DDI-DrugBank.d766.s3.e0" charOffset="59-73"
            type="group" text="imidazole drugs"/>
        <entity id="DDI-DrugBank.d766.s3.e1" charOffset="76-87"
            type="drug" text="clotrimazole"/>
        <entity id="DDI-DrugBank.d766.s3.e2" charOffset="90-101"
            type="drug" text="ketoconazole"/>
        <entity id="DDI-DrugBank.d766.s3.e3" charOffset="104-113"
            type="drug" text="miconazole"/>
        <entity id="DDI-DrugBank.d766.s3.e4" charOffset="159-170"
            type="drug" text="trimetrexate"/>
        <pair id="DDI-DrugBank.d766.s3.p0" e1="DDI-DrugBank.d766.s3.e0"
            e2="DDI-DrugBank.d766.s3.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d766.s3.p1" e1="DDI-DrugBank.d766.s3.e0"
            e2="DDI-DrugBank.d766.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d766.s3.p2" e1="DDI-DrugBank.d766.s3.e0"
            e2="DDI-DrugBank.d766.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d766.s3.p3" e1="DDI-DrugBank.d766.s3.e0"
            e2="DDI-DrugBank.d766.s3.e4" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d766.s3.p4" e1="DDI-DrugBank.d766.s3.e1"
            e2="DDI-DrugBank.d766.s3.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d766.s3.p5" e1="DDI-DrugBank.d766.s3.e1"
            e2="DDI-DrugBank.d766.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d766.s3.p6" e1="DDI-DrugBank.d766.s3.e1"
            e2="DDI-DrugBank.d766.s3.e4" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d766.s3.p7" e1="DDI-DrugBank.d766.s3.e2"
            e2="DDI-DrugBank.d766.s3.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d766.s3.p8" e1="DDI-DrugBank.d766.s3.e2"
            e2="DDI-DrugBank.d766.s3.e4" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d766.s3.p9" e1="DDI-DrugBank.d766.s3.e3"
            e2="DDI-DrugBank.d766.s3.e4" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d766.s4" text="Patients medicated with these drugs and trimetrexate should be carefully monitored.">
        <entity id="DDI-DrugBank.d766.s4.e0" charOffset="40-51"
            type="drug" text="trimetrexate"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d328">
    <sentence id="DDI-DrugBank.d328.s0" text="The drug interaction studies with valdecoxib were performed both with valdecoxib and a rapidly hydrolyzed intravenous prodrug form.">
        <entity id="DDI-DrugBank.d328.s0.e0" charOffset="34-43"
            type="drug" text="valdecoxib"/>
        <entity id="DDI-DrugBank.d328.s0.e1" charOffset="70-79"
            type="drug" text="valdecoxib"/>
        <pair id="DDI-DrugBank.d328.s0.p0" e1="DDI-DrugBank.d328.s0.e0"
            e2="DDI-DrugBank.d328.s0.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s1" text="The results from trials using the intravenous prodrug are reported in this section as they relate to the role of valdecoxib in drug interactions.">
        <entity id="DDI-DrugBank.d328.s1.e0" charOffset="113-122"
            type="drug" text="valdecoxib"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s2" text="General: In humans, valdecoxib metabolism is predominantly mediated via CYP 3A4 and 2C9 with glucuronidation being a further (20%) route of metabolism.">
        <entity id="DDI-DrugBank.d328.s2.e0" charOffset="20-29"
            type="drug" text="valdecoxib"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s3" text="In vitro studies indicate that valdecoxib is a moderate inhibitor of CYP 2C19 (IC50 = 6  g/mL or 19  M) and 2C9 (IC50 = 13  g/mL or 41  M), and a weak inhibitor of CYP 2D6 (IC50 = 31  g/mL or 100  M) and 3A4 (IC50 = 44  g/mL or 141  M )..">
        <entity id="DDI-DrugBank.d328.s3.e0" charOffset="31-40"
            type="drug" text="valdecoxib"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s4" text="Aspirin: Concomitant administration of aspirin with valdecoxib may result in an increased risk of GI ulceration and complications compared to valdecoxib alone.">
        <entity id="DDI-DrugBank.d328.s4.e0" charOffset="0-6"
            type="brand" text="Aspirin"/>
        <entity id="DDI-DrugBank.d328.s4.e1" charOffset="39-45"
            type="brand" text="aspirin"/>
        <entity id="DDI-DrugBank.d328.s4.e2" charOffset="52-61"
            type="drug" text="valdecoxib"/>
        <entity id="DDI-DrugBank.d328.s4.e3" charOffset="142-151"
            type="drug" text="valdecoxib"/>
        <pair id="DDI-DrugBank.d328.s4.p0" e1="DDI-DrugBank.d328.s4.e0"
            e2="DDI-DrugBank.d328.s4.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s4.p1" e1="DDI-DrugBank.d328.s4.e0"
            e2="DDI-DrugBank.d328.s4.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s4.p2" e1="DDI-DrugBank.d328.s4.e0"
            e2="DDI-DrugBank.d328.s4.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s4.p3" e1="DDI-DrugBank.d328.s4.e1"
            e2="DDI-DrugBank.d328.s4.e2" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d328.s4.p4" e1="DDI-DrugBank.d328.s4.e1"
            e2="DDI-DrugBank.d328.s4.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s4.p5" e1="DDI-DrugBank.d328.s4.e2"
            e2="DDI-DrugBank.d328.s4.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s5" text="Because of its lack of anti-platelet effect valdecoxib is not a substitute for aspirin for cardiovascular prophylaxis.">
        <entity id="DDI-DrugBank.d328.s5.e0" charOffset="44-53"
            type="drug" text="valdecoxib"/>
        <entity id="DDI-DrugBank.d328.s5.e1" charOffset="79-85"
            type="brand" text="aspirin"/>
        <pair id="DDI-DrugBank.d328.s5.p0" e1="DDI-DrugBank.d328.s5.e0"
            e2="DDI-DrugBank.d328.s5.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s6" text="In a parallel group drug interaction study comparing the intravenous prodrug form of valdecoxib at 40 mg BID (n=10) vs placebo (n=9), valdecoxib had no effect on in vitro aspirin-mediated inhibition of arachidonate- or collagen-stimulated platelet aggregation.">
        <entity id="DDI-DrugBank.d328.s6.e0" charOffset="85-94"
            type="drug" text="valdecoxib"/>
        <entity id="DDI-DrugBank.d328.s6.e1" charOffset="134-143"
            type="drug" text="valdecoxib"/>
        <entity id="DDI-DrugBank.d328.s6.e2" charOffset="171-177"
            type="brand" text="aspirin"/>
        <pair id="DDI-DrugBank.d328.s6.p0" e1="DDI-DrugBank.d328.s6.e0"
            e2="DDI-DrugBank.d328.s6.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s6.p1" e1="DDI-DrugBank.d328.s6.e0"
            e2="DDI-DrugBank.d328.s6.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s6.p2" e1="DDI-DrugBank.d328.s6.e1"
            e2="DDI-DrugBank.d328.s6.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s7" text="Methotrexate: Valdecoxib 10 mg BID did not show a significant effect on the plasma exposure or renal clearance of methotrexate.">
        <entity id="DDI-DrugBank.d328.s7.e0" charOffset="0-11"
            type="drug" text="Methotrexate"/>
        <entity id="DDI-DrugBank.d328.s7.e1" charOffset="14-29"
            type="drug" text="Valdecoxib 10 mg"/>
        <entity id="DDI-DrugBank.d328.s7.e2" charOffset="114-125"
            type="drug" text="methotrexate"/>
        <pair id="DDI-DrugBank.d328.s7.p0" e1="DDI-DrugBank.d328.s7.e0"
            e2="DDI-DrugBank.d328.s7.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s7.p1" e1="DDI-DrugBank.d328.s7.e0"
            e2="DDI-DrugBank.d328.s7.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s7.p2" e1="DDI-DrugBank.d328.s7.e1"
            e2="DDI-DrugBank.d328.s7.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s8" text="ACE-inhibitors:Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors.">
        <entity id="DDI-DrugBank.d328.s8.e0" charOffset="0-13"
            type="group" text="ACE-inhibitors"/>
        <entity id="DDI-DrugBank.d328.s8.e1" charOffset="36-41"
            type="group" text="NSAIDs"/>
        <entity id="DDI-DrugBank.d328.s8.e2" charOffset="87-100"
            type="group" text="ACE-inhibitors"/>
        <pair id="DDI-DrugBank.d328.s8.p0" e1="DDI-DrugBank.d328.s8.e0"
            e2="DDI-DrugBank.d328.s8.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s8.p1" e1="DDI-DrugBank.d328.s8.e0"
            e2="DDI-DrugBank.d328.s8.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s8.p2" e1="DDI-DrugBank.d328.s8.e1"
            e2="DDI-DrugBank.d328.s8.e2" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s9" text="This interaction should be given consideration in patients taking BEXTRA concomitantly with ACE-inhibitors.">
        <entity id="DDI-DrugBank.d328.s9.e0" charOffset="66-71"
            type="brand" text="BEXTRA"/>
        <entity id="DDI-DrugBank.d328.s9.e1" charOffset="92-105"
            type="group" text="ACE-inhibitors"/>
        <pair id="DDI-DrugBank.d328.s9.p0" e1="DDI-DrugBank.d328.s9.e0"
            e2="DDI-DrugBank.d328.s9.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s10" text="Furosemide: Clinical studies, as well as post-marketing observations, have shown that NSAIDs can reduce the natriuretic effect of furosemide and thiazides in some patients.">
        <entity id="DDI-DrugBank.d328.s10.e0" charOffset="0-9"
            type="drug" text="Furosemide"/>
        <entity id="DDI-DrugBank.d328.s10.e1" charOffset="86-91"
            type="group" text="NSAIDs"/>
        <entity id="DDI-DrugBank.d328.s10.e2" charOffset="130-139"
            type="drug" text="furosemide"/>
        <entity id="DDI-DrugBank.d328.s10.e3" charOffset="145-153"
            type="group" text="thiazides"/>
        <pair id="DDI-DrugBank.d328.s10.p0"
            e1="DDI-DrugBank.d328.s10.e0" e2="DDI-DrugBank.d328.s10.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s10.p1"
            e1="DDI-DrugBank.d328.s10.e0" e2="DDI-DrugBank.d328.s10.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s10.p2"
            e1="DDI-DrugBank.d328.s10.e0" e2="DDI-DrugBank.d328.s10.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s10.p3"
            e1="DDI-DrugBank.d328.s10.e1" e2="DDI-DrugBank.d328.s10.e2"
            ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d328.s10.p4"
            e1="DDI-DrugBank.d328.s10.e1" e2="DDI-DrugBank.d328.s10.e3"
            ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d328.s10.p5"
            e1="DDI-DrugBank.d328.s10.e2" e2="DDI-DrugBank.d328.s10.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s11" text="This response has been attributed to inhibition of renal prostaglandin synthesis."/>
    <sentence id="DDI-DrugBank.d328.s12" text="Anticonvulsants (Phenytoin): Steady state plasma exposure (AUC) of valdecoxib (40 mg BID for 12 days) was decreased by 27% when co-administered with multiple doses (300 mg QD for 12 days) of phenytoin (a CYP 3A4 inducer).">
        <entity id="DDI-DrugBank.d328.s12.e0" charOffset="0-14"
            type="group" text="Anticonvulsants"/>
        <entity id="DDI-DrugBank.d328.s12.e1" charOffset="17-25"
            type="drug" text="Phenytoin"/>
        <entity id="DDI-DrugBank.d328.s12.e2" charOffset="67-76"
            type="drug" text="valdecoxib"/>
        <entity id="DDI-DrugBank.d328.s12.e3" charOffset="191-199"
            type="drug" text="phenytoin"/>
        <pair id="DDI-DrugBank.d328.s12.p0"
            e1="DDI-DrugBank.d328.s12.e0" e2="DDI-DrugBank.d328.s12.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s12.p1"
            e1="DDI-DrugBank.d328.s12.e0" e2="DDI-DrugBank.d328.s12.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s12.p2"
            e1="DDI-DrugBank.d328.s12.e0" e2="DDI-DrugBank.d328.s12.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s12.p3"
            e1="DDI-DrugBank.d328.s12.e1" e2="DDI-DrugBank.d328.s12.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s12.p4"
            e1="DDI-DrugBank.d328.s12.e1" e2="DDI-DrugBank.d328.s12.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s12.p5"
            e1="DDI-DrugBank.d328.s12.e2" e2="DDI-DrugBank.d328.s12.e3"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s13" text="Patients already stabilized on valdecoxib should be closely monitored for loss of symptom control with phenytoin coadministration.">
        <entity id="DDI-DrugBank.d328.s13.e0" charOffset="31-40"
            type="drug" text="valdecoxib"/>
        <entity id="DDI-DrugBank.d328.s13.e1" charOffset="103-111"
            type="drug" text="phenytoin"/>
        <pair id="DDI-DrugBank.d328.s13.p0"
            e1="DDI-DrugBank.d328.s13.e0" e2="DDI-DrugBank.d328.s13.e1"
            ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s14" text="Valdecoxib did not have a statistically significant effect on the pharmacokinetics of phenytoin (a CYP 2C9 and CYP 2C19 substrate).">
        <entity id="DDI-DrugBank.d328.s14.e0" charOffset="0-9"
            type="drug" text="Valdecoxib"/>
        <entity id="DDI-DrugBank.d328.s14.e1" charOffset="86-94"
            type="drug" text="phenytoin"/>
        <pair id="DDI-DrugBank.d328.s14.p0"
            e1="DDI-DrugBank.d328.s14.e0" e2="DDI-DrugBank.d328.s14.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s15" text="Drug interaction studies with other anticonvulsants have not been conducted.">
        <entity id="DDI-DrugBank.d328.s15.e0" charOffset="36-50"
            type="group" text="anticonvulsants"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s16" text="Routine monitoring should be performed when therapy with BEXTRA is either initiated or discontinued in patients on anticonvulsant therapy.">
        <entity id="DDI-DrugBank.d328.s16.e0" charOffset="57-62"
            type="brand" text="BEXTRA"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s17" text="Dextromethorphan: Dextromethorphan is primarily metabolized by CYP 2D6 and to a lesser extent by 3A4.">
        <entity id="DDI-DrugBank.d328.s17.e0" charOffset="0-15"
            type="drug" text="Dextromethorphan"/>
        <entity id="DDI-DrugBank.d328.s17.e1" charOffset="18-33"
            type="drug" text="Dextromethorphan"/>
        <pair id="DDI-DrugBank.d328.s17.p0"
            e1="DDI-DrugBank.d328.s17.e0" e2="DDI-DrugBank.d328.s17.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s18" text="Coadministration with valdecoxib (40 mg BID for 7 days) resulted in a significant increase in dextromethorphan plasma levels suggesting that, at these doses, valdecoxib is a weak inhibitor of 2D6.">
        <entity id="DDI-DrugBank.d328.s18.e0" charOffset="22-31"
            type="drug" text="valdecoxib"/>
        <entity id="DDI-DrugBank.d328.s18.e1" charOffset="94-109"
            type="drug" text="dextromethorphan"/>
        <entity id="DDI-DrugBank.d328.s18.e2" charOffset="158-167"
            type="drug" text="valdecoxib"/>
        <pair id="DDI-DrugBank.d328.s18.p0"
            e1="DDI-DrugBank.d328.s18.e0" e2="DDI-DrugBank.d328.s18.e1"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d328.s18.p1"
            e1="DDI-DrugBank.d328.s18.e0" e2="DDI-DrugBank.d328.s18.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s18.p2"
            e1="DDI-DrugBank.d328.s18.e1" e2="DDI-DrugBank.d328.s18.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s19" text="Even so dextromethorphan plasma concentrations in the presence of high doses of valdecoxib were almost 5-fold lower than those seen in CYP 2D6 poor metabolizers suggesting that dose adjustment is not necessary.">
        <entity id="DDI-DrugBank.d328.s19.e0" charOffset="8-23"
            type="drug" text="dextromethorphan"/>
        <entity id="DDI-DrugBank.d328.s19.e1" charOffset="80-89"
            type="drug" text="valdecoxib"/>
        <pair id="DDI-DrugBank.d328.s19.p0"
            e1="DDI-DrugBank.d328.s19.e0" e2="DDI-DrugBank.d328.s19.e1"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s20" text="Lithium: Valdecoxib 40 mg BID for 7 days produced significant decreases in lithium serum clearance (25%) and renal clearance (30%) with a 34% higher serum exposure compared to lithium alone.">
        <entity id="DDI-DrugBank.d328.s20.e0" charOffset="0-6"
            type="drug" text="Lithium"/>
        <entity id="DDI-DrugBank.d328.s20.e1" charOffset="9-18"
            type="drug" text="Valdecoxib"/>
        <entity id="DDI-DrugBank.d328.s20.e2" charOffset="75-81"
            type="drug" text="lithium"/>
        <entity id="DDI-DrugBank.d328.s20.e3" charOffset="176-182"
            type="drug" text="lithium"/>
        <pair id="DDI-DrugBank.d328.s20.p0"
            e1="DDI-DrugBank.d328.s20.e0" e2="DDI-DrugBank.d328.s20.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s20.p1"
            e1="DDI-DrugBank.d328.s20.e0" e2="DDI-DrugBank.d328.s20.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s20.p2"
            e1="DDI-DrugBank.d328.s20.e0" e2="DDI-DrugBank.d328.s20.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s20.p3"
            e1="DDI-DrugBank.d328.s20.e1" e2="DDI-DrugBank.d328.s20.e2"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d328.s20.p4"
            e1="DDI-DrugBank.d328.s20.e1" e2="DDI-DrugBank.d328.s20.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s20.p5"
            e1="DDI-DrugBank.d328.s20.e2" e2="DDI-DrugBank.d328.s20.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s21" text="Lithium serum concentrations should be monitored closely when initiating or changing therapy with BEXTRA in patients receiving lithium.">
        <entity id="DDI-DrugBank.d328.s21.e0" charOffset="0-6"
            type="drug" text="Lithium"/>
        <entity id="DDI-DrugBank.d328.s21.e1" charOffset="98-103"
            type="brand" text="BEXTRA"/>
        <entity id="DDI-DrugBank.d328.s21.e2" charOffset="127-133"
            type="drug" text="lithium"/>
        <pair id="DDI-DrugBank.d328.s21.p0"
            e1="DDI-DrugBank.d328.s21.e0" e2="DDI-DrugBank.d328.s21.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s21.p1"
            e1="DDI-DrugBank.d328.s21.e0" e2="DDI-DrugBank.d328.s21.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s21.p2"
            e1="DDI-DrugBank.d328.s21.e1" e2="DDI-DrugBank.d328.s21.e2"
            ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s22" text="Lithium carbonate (450 mg BID for 7 days) had no effect on valdecoxib pharmacokinetics.">
        <entity id="DDI-DrugBank.d328.s22.e0" charOffset="0-16"
            type="drug" text="Lithium carbonate"/>
        <entity id="DDI-DrugBank.d328.s22.e1" charOffset="59-68"
            type="drug" text="valdecoxib"/>
        <pair id="DDI-DrugBank.d328.s22.p0"
            e1="DDI-DrugBank.d328.s22.e0" e2="DDI-DrugBank.d328.s22.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s23" text="Warfarin: The effect of valdecoxib on the anticoagulant effect of warfarin (1 - 8 mg/day) was studied in healthy subjects by coadministration of BEXTRA 40 mg BID for 7 days.">
        <entity id="DDI-DrugBank.d328.s23.e0" charOffset="0-7"
            type="drug" text="Warfarin"/>
        <entity id="DDI-DrugBank.d328.s23.e1" charOffset="24-33"
            type="drug" text="valdecoxib"/>
        <entity id="DDI-DrugBank.d328.s23.e2" charOffset="66-73"
            type="drug" text="warfarin"/>
        <entity id="DDI-DrugBank.d328.s23.e3" charOffset="145-150"
            type="brand" text="BEXTRA"/>
        <pair id="DDI-DrugBank.d328.s23.p0"
            e1="DDI-DrugBank.d328.s23.e0" e2="DDI-DrugBank.d328.s23.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s23.p1"
            e1="DDI-DrugBank.d328.s23.e0" e2="DDI-DrugBank.d328.s23.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s23.p2"
            e1="DDI-DrugBank.d328.s23.e0" e2="DDI-DrugBank.d328.s23.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s23.p3"
            e1="DDI-DrugBank.d328.s23.e1" e2="DDI-DrugBank.d328.s23.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s23.p4"
            e1="DDI-DrugBank.d328.s23.e1" e2="DDI-DrugBank.d328.s23.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s23.p5"
            e1="DDI-DrugBank.d328.s23.e2" e2="DDI-DrugBank.d328.s23.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s24" text="Valdecoxib caused a statistically significant increase in plasma exposures of R-warfarin and S-warfarin (12% and 15%, respectively), and in the pharmacodynamic effects (prothrombin time, measured as INR) of warfarin.">
        <entity id="DDI-DrugBank.d328.s24.e0" charOffset="0-9"
            type="drug" text="Valdecoxib"/>
        <entity id="DDI-DrugBank.d328.s24.e1" charOffset="78-87"
            type="drug" text="R-warfarin"/>
        <entity id="DDI-DrugBank.d328.s24.e2" charOffset="93-102"
            type="drug" text="S-warfarin"/>
        <entity id="DDI-DrugBank.d328.s24.e3" charOffset="207-214"
            type="drug" text="warfarin"/>
        <pair id="DDI-DrugBank.d328.s24.p0"
            e1="DDI-DrugBank.d328.s24.e0" e2="DDI-DrugBank.d328.s24.e1"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d328.s24.p1"
            e1="DDI-DrugBank.d328.s24.e0" e2="DDI-DrugBank.d328.s24.e2"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d328.s24.p2"
            e1="DDI-DrugBank.d328.s24.e0" e2="DDI-DrugBank.d328.s24.e3"
            ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d328.s24.p3"
            e1="DDI-DrugBank.d328.s24.e1" e2="DDI-DrugBank.d328.s24.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s24.p4"
            e1="DDI-DrugBank.d328.s24.e1" e2="DDI-DrugBank.d328.s24.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s24.p5"
            e1="DDI-DrugBank.d328.s24.e2" e2="DDI-DrugBank.d328.s24.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s25" text="While mean INR values were only slightly increased with coadministration of valdecoxib, the day-to-day variability in individual INR values was increased.">
        <entity id="DDI-DrugBank.d328.s25.e0" charOffset="76-85"
            type="drug" text="valdecoxib"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s26" text="Anticoagulant therapy should be monitored, particularly during the first few weeks, after initiating therapy with BEXTRA in patients receiving warfarin or similar agents.">
        <entity id="DDI-DrugBank.d328.s26.e0" charOffset="0-12"
            type="brand" text="Anticoagulant"/>
        <entity id="DDI-DrugBank.d328.s26.e1" charOffset="114-119"
            type="brand" text="BEXTRA"/>
        <entity id="DDI-DrugBank.d328.s26.e2" charOffset="143-150"
            type="drug" text="warfarin"/>
        <pair id="DDI-DrugBank.d328.s26.p0"
            e1="DDI-DrugBank.d328.s26.e0" e2="DDI-DrugBank.d328.s26.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s26.p1"
            e1="DDI-DrugBank.d328.s26.e0" e2="DDI-DrugBank.d328.s26.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s26.p2"
            e1="DDI-DrugBank.d328.s26.e1" e2="DDI-DrugBank.d328.s26.e2"
            ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s27" text="Fluconazole and Ketoconazole: Ketoconazole and fluconazole are predominantly CYP 3A4 and 2C9 inhibitors, respectively.">
        <entity id="DDI-DrugBank.d328.s27.e0" charOffset="0-10"
            type="drug" text="Fluconazole"/>
        <entity id="DDI-DrugBank.d328.s27.e1" charOffset="16-27"
            type="drug" text="Ketoconazole"/>
        <entity id="DDI-DrugBank.d328.s27.e2" charOffset="30-41"
            type="drug" text="Ketoconazole"/>
        <entity id="DDI-DrugBank.d328.s27.e3" charOffset="47-57"
            type="drug" text="fluconazole"/>
        <pair id="DDI-DrugBank.d328.s27.p0"
            e1="DDI-DrugBank.d328.s27.e0" e2="DDI-DrugBank.d328.s27.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s27.p1"
            e1="DDI-DrugBank.d328.s27.e0" e2="DDI-DrugBank.d328.s27.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s27.p2"
            e1="DDI-DrugBank.d328.s27.e0" e2="DDI-DrugBank.d328.s27.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s27.p3"
            e1="DDI-DrugBank.d328.s27.e1" e2="DDI-DrugBank.d328.s27.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s27.p4"
            e1="DDI-DrugBank.d328.s27.e1" e2="DDI-DrugBank.d328.s27.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s27.p5"
            e1="DDI-DrugBank.d328.s27.e2" e2="DDI-DrugBank.d328.s27.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s28" text="Concomitant single dose administration of valdecoxib 20 mg with multiple doses of ketoconazole and fluconazole produced a significant increase in exposure of valdecoxib.">
        <entity id="DDI-DrugBank.d328.s28.e0" charOffset="42-51"
            type="drug" text="valdecoxib"/>
        <entity id="DDI-DrugBank.d328.s28.e1" charOffset="82-93"
            type="drug" text="ketoconazole"/>
        <entity id="DDI-DrugBank.d328.s28.e2" charOffset="99-109"
            type="drug" text="fluconazole"/>
        <entity id="DDI-DrugBank.d328.s28.e3" charOffset="158-167"
            type="drug" text="valdecoxib"/>
        <pair id="DDI-DrugBank.d328.s28.p0"
            e1="DDI-DrugBank.d328.s28.e0" e2="DDI-DrugBank.d328.s28.e1"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d328.s28.p1"
            e1="DDI-DrugBank.d328.s28.e0" e2="DDI-DrugBank.d328.s28.e2"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d328.s28.p2"
            e1="DDI-DrugBank.d328.s28.e0" e2="DDI-DrugBank.d328.s28.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s28.p3"
            e1="DDI-DrugBank.d328.s28.e1" e2="DDI-DrugBank.d328.s28.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s28.p4"
            e1="DDI-DrugBank.d328.s28.e1" e2="DDI-DrugBank.d328.s28.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s28.p5"
            e1="DDI-DrugBank.d328.s28.e2" e2="DDI-DrugBank.d328.s28.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s29" text="Plasma exposure (AUC) to valdecoxib was increased 62% when coadministered with fluconazole and 38% when coadministered with ketoconazole.">
        <entity id="DDI-DrugBank.d328.s29.e0" charOffset="25-34"
            type="drug" text="valdecoxib"/>
        <entity id="DDI-DrugBank.d328.s29.e1" charOffset="79-89"
            type="drug" text="fluconazole"/>
        <entity id="DDI-DrugBank.d328.s29.e2" charOffset="124-135"
            type="drug" text="ketoconazole"/>
        <pair id="DDI-DrugBank.d328.s29.p0"
            e1="DDI-DrugBank.d328.s29.e0" e2="DDI-DrugBank.d328.s29.e1"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d328.s29.p1"
            e1="DDI-DrugBank.d328.s29.e0" e2="DDI-DrugBank.d328.s29.e2"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d328.s29.p2"
            e1="DDI-DrugBank.d328.s29.e1" e2="DDI-DrugBank.d328.s29.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s30" text="Glyburide: Glyburide is a CYP 2C9 substrate.">
        <entity id="DDI-DrugBank.d328.s30.e0" charOffset="0-8"
            type="drug" text="Glyburide"/>
        <entity id="DDI-DrugBank.d328.s30.e1" charOffset="11-19"
            type="drug" text="Glyburide"/>
        <pair id="DDI-DrugBank.d328.s30.p0"
            e1="DDI-DrugBank.d328.s30.e0" e2="DDI-DrugBank.d328.s30.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s31" text="Coadministration of valdecoxib (10 mg BID for 7 days) with glyburide (5 mg QD or 10 mg BID) did not affect the pharmacokinetics (exposure) of glyburide.">
        <entity id="DDI-DrugBank.d328.s31.e0" charOffset="20-29"
            type="drug" text="valdecoxib"/>
        <entity id="DDI-DrugBank.d328.s31.e1" charOffset="59-67"
            type="drug" text="glyburide"/>
        <entity id="DDI-DrugBank.d328.s31.e2" charOffset="142-150"
            type="drug" text="glyburide"/>
        <pair id="DDI-DrugBank.d328.s31.p0"
            e1="DDI-DrugBank.d328.s31.e0" e2="DDI-DrugBank.d328.s31.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s31.p1"
            e1="DDI-DrugBank.d328.s31.e0" e2="DDI-DrugBank.d328.s31.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s31.p2"
            e1="DDI-DrugBank.d328.s31.e1" e2="DDI-DrugBank.d328.s31.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s32" text="Coadministration of valdecoxib (40 mg BID (day 1) and 40 mg QD (days 2-7)) with glyburide (5 mg QD) did not affect either the pharmacokinetics (exposure) or the pharmacodynamics (blood glucose and insulin levels) of glyburide.">
        <entity id="DDI-DrugBank.d328.s32.e0" charOffset="20-29"
            type="drug" text="valdecoxib"/>
        <entity id="DDI-DrugBank.d328.s32.e1" charOffset="80-88"
            type="drug" text="glyburide"/>
        <entity id="DDI-DrugBank.d328.s32.e2" charOffset="216-224"
            type="drug" text="glyburide"/>
        <pair id="DDI-DrugBank.d328.s32.p0"
            e1="DDI-DrugBank.d328.s32.e0" e2="DDI-DrugBank.d328.s32.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s32.p1"
            e1="DDI-DrugBank.d328.s32.e0" e2="DDI-DrugBank.d328.s32.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s32.p2"
            e1="DDI-DrugBank.d328.s32.e1" e2="DDI-DrugBank.d328.s32.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s33" text="Coadministration of valdecoxib (40 mg BID (day 1) and 40 mg QD (days 2-7)) with glyburide (10 mg glyburide BID) resulted in 21% increase in glyburide AUC0-12 and a 16% increase in glyburide Cmax leading to a 16% decrease in glucose AUC0-24.">
        <entity id="DDI-DrugBank.d328.s33.e0" charOffset="20-29"
            type="drug" text="valdecoxib"/>
        <entity id="DDI-DrugBank.d328.s33.e1" charOffset="80-88"
            type="drug" text="glyburide"/>
        <entity id="DDI-DrugBank.d328.s33.e2" charOffset="97-105"
            type="drug" text="glyburide"/>
        <entity id="DDI-DrugBank.d328.s33.e3" charOffset="140-148"
            type="drug" text="glyburide"/>
        <entity id="DDI-DrugBank.d328.s33.e4" charOffset="180-188"
            type="drug" text="glyburide"/>
        <pair id="DDI-DrugBank.d328.s33.p0"
            e1="DDI-DrugBank.d328.s33.e0" e2="DDI-DrugBank.d328.s33.e1"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d328.s33.p1"
            e1="DDI-DrugBank.d328.s33.e0" e2="DDI-DrugBank.d328.s33.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s33.p2"
            e1="DDI-DrugBank.d328.s33.e0" e2="DDI-DrugBank.d328.s33.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s33.p3"
            e1="DDI-DrugBank.d328.s33.e0" e2="DDI-DrugBank.d328.s33.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s33.p4"
            e1="DDI-DrugBank.d328.s33.e1" e2="DDI-DrugBank.d328.s33.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s33.p5"
            e1="DDI-DrugBank.d328.s33.e1" e2="DDI-DrugBank.d328.s33.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s33.p6"
            e1="DDI-DrugBank.d328.s33.e1" e2="DDI-DrugBank.d328.s33.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s33.p7"
            e1="DDI-DrugBank.d328.s33.e2" e2="DDI-DrugBank.d328.s33.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s33.p8"
            e1="DDI-DrugBank.d328.s33.e2" e2="DDI-DrugBank.d328.s33.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s33.p9"
            e1="DDI-DrugBank.d328.s33.e3" e2="DDI-DrugBank.d328.s33.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s34" text="Insulin parameters were not affected."/>
    <sentence id="DDI-DrugBank.d328.s35" text="Because changes in glucose concentrations with valdecoxib coadministration were within the normal variability and individual glucose concentrations were above or near 70 mg/dL, dose adjustment for glyburide (5 mg QD and 10 mg BID) with valdecoxib coadministration (up to 40 mg QD) is not indicated.">
        <entity id="DDI-DrugBank.d328.s35.e0" charOffset="47-56"
            type="drug" text="valdecoxib"/>
        <entity id="DDI-DrugBank.d328.s35.e1" charOffset="197-205"
            type="drug" text="glyburide"/>
        <entity id="DDI-DrugBank.d328.s35.e2" charOffset="236-245"
            type="drug" text="valdecoxib"/>
        <pair id="DDI-DrugBank.d328.s35.p0"
            e1="DDI-DrugBank.d328.s35.e0" e2="DDI-DrugBank.d328.s35.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s35.p1"
            e1="DDI-DrugBank.d328.s35.e0" e2="DDI-DrugBank.d328.s35.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s35.p2"
            e1="DDI-DrugBank.d328.s35.e1" e2="DDI-DrugBank.d328.s35.e2"
            ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s36" text="Coadministration of glyburide with doses higher than 40 mg valdecoxib (e.g., 40 mg BID) have not been studied.">
        <entity id="DDI-DrugBank.d328.s36.e0" charOffset="20-28"
            type="drug" text="glyburide"/>
        <entity id="DDI-DrugBank.d328.s36.e1" charOffset="59-68"
            type="drug" text="valdecoxib"/>
        <pair id="DDI-DrugBank.d328.s36.p0"
            e1="DDI-DrugBank.d328.s36.e0" e2="DDI-DrugBank.d328.s36.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s37" text="Omeprazole: Omeprazole is a CYP 3A4 substrate and CYP 2C19 substrate and inhibitor.">
        <entity id="DDI-DrugBank.d328.s37.e0" charOffset="0-9"
            type="drug" text="Omeprazole"/>
        <entity id="DDI-DrugBank.d328.s37.e1" charOffset="12-21"
            type="drug" text="Omeprazole"/>
        <pair id="DDI-DrugBank.d328.s37.p0"
            e1="DDI-DrugBank.d328.s37.e0" e2="DDI-DrugBank.d328.s37.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s38" text="Valdecoxib steady state plasma concentrations (40 mg BID) were not affected significantly with multiple doses of omeprazole (40 mg QD).">
        <entity id="DDI-DrugBank.d328.s38.e0" charOffset="0-9"
            type="drug" text="Valdecoxib"/>
        <entity id="DDI-DrugBank.d328.s38.e1" charOffset="113-122"
            type="drug" text="omeprazole"/>
        <pair id="DDI-DrugBank.d328.s38.p0"
            e1="DDI-DrugBank.d328.s38.e0" e2="DDI-DrugBank.d328.s38.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s39" text="Coadministration with valdecoxib increased exposure of omeprazole (AUC) by 46%.">
        <entity id="DDI-DrugBank.d328.s39.e0" charOffset="22-31"
            type="drug" text="valdecoxib"/>
        <entity id="DDI-DrugBank.d328.s39.e1" charOffset="55-64"
            type="drug" text="omeprazole"/>
        <pair id="DDI-DrugBank.d328.s39.p0"
            e1="DDI-DrugBank.d328.s39.e0" e2="DDI-DrugBank.d328.s39.e1"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s40" text="Drugs whose absorption is sensitive to pH may be negatively impacted by concomitant administration of omeprazole and valdecoxib.">
        <entity id="DDI-DrugBank.d328.s40.e0" charOffset="102-111"
            type="drug" text="omeprazole"/>
        <entity id="DDI-DrugBank.d328.s40.e1" charOffset="117-126"
            type="drug" text="valdecoxib"/>
        <pair id="DDI-DrugBank.d328.s40.p0"
            e1="DDI-DrugBank.d328.s40.e0" e2="DDI-DrugBank.d328.s40.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s41" text="However, because higher doses (up to 360 mg QD) of omeprazole are tolerated in Zollinger-Ellison (ZE) patients, no dose adjustment for omeprazole is recommended at current doses.">
        <entity id="DDI-DrugBank.d328.s41.e0" charOffset="51-60"
            type="drug" text="omeprazole"/>
        <entity id="DDI-DrugBank.d328.s41.e1" charOffset="135-144"
            type="drug" text="omeprazole"/>
        <pair id="DDI-DrugBank.d328.s41.p0"
            e1="DDI-DrugBank.d328.s41.e0" e2="DDI-DrugBank.d328.s41.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s42" text="Coadministration of valdecoxib with doses higher than 40 mg QD omeprazole has not been studied.">
        <entity id="DDI-DrugBank.d328.s42.e0" charOffset="20-29"
            type="drug" text="valdecoxib"/>
        <entity id="DDI-DrugBank.d328.s42.e1" charOffset="63-72"
            type="drug" text="omeprazole"/>
        <pair id="DDI-DrugBank.d328.s42.p0"
            e1="DDI-DrugBank.d328.s42.e0" e2="DDI-DrugBank.d328.s42.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s43" text="Oral Contraceptives: Valdecoxib (40 mg BID) did not induce the metabolism of the combination oral contraceptive norethindrone/ethinyl estradiol (1 mg /35 mcg combination, Ortho-Novum 1/35 ).">
        <entity id="DDI-DrugBank.d328.s43.e0" charOffset="5-18"
            type="group" text="Contraceptives"/>
        <entity id="DDI-DrugBank.d328.s43.e1" charOffset="21-30"
            type="drug" text="Valdecoxib"/>
        <entity id="DDI-DrugBank.d328.s43.e2" charOffset="98-110"
            type="group" text="contraceptive"/>
        <entity id="DDI-DrugBank.d328.s43.e3" charOffset="112-124"
            type="drug" text="norethindrone"/>
        <entity id="DDI-DrugBank.d328.s43.e4" charOffset="126-142"
            type="drug" text="ethinyl estradiol"/>
        <entity id="DDI-DrugBank.d328.s43.e5" charOffset="171-181"
            type="brand" text="Ortho-Novum"/>
        <pair id="DDI-DrugBank.d328.s43.p0"
            e1="DDI-DrugBank.d328.s43.e0" e2="DDI-DrugBank.d328.s43.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s43.p1"
            e1="DDI-DrugBank.d328.s43.e0" e2="DDI-DrugBank.d328.s43.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s43.p2"
            e1="DDI-DrugBank.d328.s43.e0" e2="DDI-DrugBank.d328.s43.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s43.p3"
            e1="DDI-DrugBank.d328.s43.e0" e2="DDI-DrugBank.d328.s43.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s43.p4"
            e1="DDI-DrugBank.d328.s43.e0" e2="DDI-DrugBank.d328.s43.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s43.p5"
            e1="DDI-DrugBank.d328.s43.e1" e2="DDI-DrugBank.d328.s43.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s43.p6"
            e1="DDI-DrugBank.d328.s43.e1" e2="DDI-DrugBank.d328.s43.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s43.p7"
            e1="DDI-DrugBank.d328.s43.e1" e2="DDI-DrugBank.d328.s43.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s43.p8"
            e1="DDI-DrugBank.d328.s43.e1" e2="DDI-DrugBank.d328.s43.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s43.p9"
            e1="DDI-DrugBank.d328.s43.e2" e2="DDI-DrugBank.d328.s43.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s43.p10"
            e1="DDI-DrugBank.d328.s43.e2" e2="DDI-DrugBank.d328.s43.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s43.p11"
            e1="DDI-DrugBank.d328.s43.e2" e2="DDI-DrugBank.d328.s43.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s43.p12"
            e1="DDI-DrugBank.d328.s43.e3" e2="DDI-DrugBank.d328.s43.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s43.p13"
            e1="DDI-DrugBank.d328.s43.e3" e2="DDI-DrugBank.d328.s43.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s43.p14"
            e1="DDI-DrugBank.d328.s43.e4" e2="DDI-DrugBank.d328.s43.e5" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s44" text="Coadministration of valdecoxib and Ortho-Novum 1/35  increased the exposure of norethindrone and ethinyl estradiol by 20% and 34%, respectively.">
        <entity id="DDI-DrugBank.d328.s44.e0" charOffset="20-29"
            type="drug" text="valdecoxib"/>
        <entity id="DDI-DrugBank.d328.s44.e1" charOffset="35-45"
            type="brand" text="Ortho-Novum"/>
        <entity id="DDI-DrugBank.d328.s44.e2" charOffset="79-91"
            type="drug" text="norethindrone"/>
        <entity id="DDI-DrugBank.d328.s44.e3" charOffset="97-113"
            type="drug" text="ethinyl estradiol"/>
        <pair id="DDI-DrugBank.d328.s44.p0"
            e1="DDI-DrugBank.d328.s44.e0" e2="DDI-DrugBank.d328.s44.e1"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d328.s44.p1"
            e1="DDI-DrugBank.d328.s44.e0" e2="DDI-DrugBank.d328.s44.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s44.p2"
            e1="DDI-DrugBank.d328.s44.e0" e2="DDI-DrugBank.d328.s44.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s44.p3"
            e1="DDI-DrugBank.d328.s44.e1" e2="DDI-DrugBank.d328.s44.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s44.p4"
            e1="DDI-DrugBank.d328.s44.e1" e2="DDI-DrugBank.d328.s44.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s44.p5"
            e1="DDI-DrugBank.d328.s44.e2" e2="DDI-DrugBank.d328.s44.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s45" text="Although there is little risk for loss of contraceptive efficacy, the clinical significance of these increased exposures in terms of safety is not known."/>
    <sentence id="DDI-DrugBank.d328.s46" text="These increased exposures of norethindrone and ethinyl estradiol should be taken into consideration when selecting an oral contraceptive for women taking valdecoxib.">
        <entity id="DDI-DrugBank.d328.s46.e0" charOffset="29-41"
            type="drug" text="norethindrone"/>
        <entity id="DDI-DrugBank.d328.s46.e1" charOffset="47-63"
            type="drug" text="ethinyl estradiol"/>
        <entity id="DDI-DrugBank.d328.s46.e2" charOffset="123-135"
            type="group" text="contraceptive"/>
        <entity id="DDI-DrugBank.d328.s46.e3" charOffset="154-163"
            type="drug" text="valdecoxib"/>
        <pair id="DDI-DrugBank.d328.s46.p0"
            e1="DDI-DrugBank.d328.s46.e0" e2="DDI-DrugBank.d328.s46.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s46.p1"
            e1="DDI-DrugBank.d328.s46.e0" e2="DDI-DrugBank.d328.s46.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s46.p2"
            e1="DDI-DrugBank.d328.s46.e0" e2="DDI-DrugBank.d328.s46.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s46.p3"
            e1="DDI-DrugBank.d328.s46.e1" e2="DDI-DrugBank.d328.s46.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s46.p4"
            e1="DDI-DrugBank.d328.s46.e1" e2="DDI-DrugBank.d328.s46.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s46.p5"
            e1="DDI-DrugBank.d328.s46.e2" e2="DDI-DrugBank.d328.s46.e3"
            ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s47" text="Diazepam: Diazepam (Valium) is a CYP 3A4 and CYP 2C19 substrate.">
        <entity id="DDI-DrugBank.d328.s47.e0" charOffset="0-7"
            type="drug" text="Diazepam"/>
        <entity id="DDI-DrugBank.d328.s47.e1" charOffset="10-17"
            type="drug" text="Diazepam"/>
        <entity id="DDI-DrugBank.d328.s47.e2" charOffset="20-25"
            type="brand" text="Valium"/>
        <pair id="DDI-DrugBank.d328.s47.p0"
            e1="DDI-DrugBank.d328.s47.e0" e2="DDI-DrugBank.d328.s47.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s47.p1"
            e1="DDI-DrugBank.d328.s47.e0" e2="DDI-DrugBank.d328.s47.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s47.p2"
            e1="DDI-DrugBank.d328.s47.e1" e2="DDI-DrugBank.d328.s47.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s48" text="Plasma exposure of diazepam (10 mg BID) was increased by 28% following administration of valdecoxib (40 mg BID) for 12 days, while plasma exposure of valdecoxib (40 mg BID) was not substantially increased following administration of diazepam (10 mg BID) for 12 days.">
        <entity id="DDI-DrugBank.d328.s48.e0" charOffset="19-26"
            type="drug" text="diazepam"/>
        <entity id="DDI-DrugBank.d328.s48.e1" charOffset="89-98"
            type="drug" text="valdecoxib"/>
        <entity id="DDI-DrugBank.d328.s48.e2" charOffset="150-159"
            type="drug" text="valdecoxib"/>
        <entity id="DDI-DrugBank.d328.s48.e3" charOffset="233-240"
            type="drug" text="diazepam"/>
        <pair id="DDI-DrugBank.d328.s48.p0"
            e1="DDI-DrugBank.d328.s48.e0" e2="DDI-DrugBank.d328.s48.e1"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d328.s48.p1"
            e1="DDI-DrugBank.d328.s48.e0" e2="DDI-DrugBank.d328.s48.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s48.p2"
            e1="DDI-DrugBank.d328.s48.e0" e2="DDI-DrugBank.d328.s48.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s48.p3"
            e1="DDI-DrugBank.d328.s48.e1" e2="DDI-DrugBank.d328.s48.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s48.p4"
            e1="DDI-DrugBank.d328.s48.e1" e2="DDI-DrugBank.d328.s48.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s48.p5"
            e1="DDI-DrugBank.d328.s48.e2" e2="DDI-DrugBank.d328.s48.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s49" text="Although the magnitude of changes in diazepam plasma exposure when coadministered with valdecoxib were not sufficient to warrant dosage adjustments, patients may experience enhanced sedative side effects caused by increased exposure of diazepam under this circumstance.">
        <entity id="DDI-DrugBank.d328.s49.e0" charOffset="37-44"
            type="drug" text="diazepam"/>
        <entity id="DDI-DrugBank.d328.s49.e1" charOffset="87-96"
            type="drug" text="valdecoxib"/>
        <entity id="DDI-DrugBank.d328.s49.e2" charOffset="236-243"
            type="drug" text="diazepam"/>
        <pair id="DDI-DrugBank.d328.s49.p0"
            e1="DDI-DrugBank.d328.s49.e0" e2="DDI-DrugBank.d328.s49.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s49.p1"
            e1="DDI-DrugBank.d328.s49.e0" e2="DDI-DrugBank.d328.s49.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d328.s49.p2"
            e1="DDI-DrugBank.d328.s49.e1" e2="DDI-DrugBank.d328.s49.e2"
            ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d328.s50" text="Patients should be cautioned against engaging in hazardous activities requiring complete mental alertness such as operating machinery or driving a motor vehicle."/>
</document>
<document id="DDI-DrugBank.d782">
    <sentence id="DDI-DrugBank.d782.s0" text="Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine">
        <entity id="DDI-DrugBank.d782.s0.e0" charOffset="0-8"
            type="drug" text="Vindesine"/>
        <entity id="DDI-DrugBank.d782.s0.e1" charOffset="310-318"
            type="drug" text="Phenytoin"/>
        <entity id="DDI-DrugBank.d782.s0.e2" charOffset="353-371"
            type="group" text="Live virus vaccines"/>
        <entity id="DDI-DrugBank.d782.s0.e3" charOffset="412-418"
            type="drug" text="vaccine"/>
        <entity id="DDI-DrugBank.d782.s0.e4" charOffset="526-536"
            type="drug" text="Mitomycin-C"/>
        <entity id="DDI-DrugBank.d782.s0.e5" charOffset="588-608"
            type="group" text="Killed virus vaccines"/>
        <entity id="DDI-DrugBank.d782.s0.e6" charOffset="650-656"
            type="group" text="vaccine"/>
        <pair id="DDI-DrugBank.d782.s0.p0" e1="DDI-DrugBank.d782.s0.e0"
            e2="DDI-DrugBank.d782.s0.e1" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d782.s0.p1" e1="DDI-DrugBank.d782.s0.e0"
            e2="DDI-DrugBank.d782.s0.e2" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d782.s0.p2" e1="DDI-DrugBank.d782.s0.e0"
            e2="DDI-DrugBank.d782.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d782.s0.p3" e1="DDI-DrugBank.d782.s0.e0"
            e2="DDI-DrugBank.d782.s0.e4" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d782.s0.p4" e1="DDI-DrugBank.d782.s0.e0"
            e2="DDI-DrugBank.d782.s0.e5" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d782.s0.p5" e1="DDI-DrugBank.d782.s0.e0"
            e2="DDI-DrugBank.d782.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d782.s0.p6" e1="DDI-DrugBank.d782.s0.e1"
            e2="DDI-DrugBank.d782.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d782.s0.p7" e1="DDI-DrugBank.d782.s0.e1"
            e2="DDI-DrugBank.d782.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d782.s0.p8" e1="DDI-DrugBank.d782.s0.e1"
            e2="DDI-DrugBank.d782.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d782.s0.p9" e1="DDI-DrugBank.d782.s0.e1"
            e2="DDI-DrugBank.d782.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d782.s0.p10" e1="DDI-DrugBank.d782.s0.e1"
            e2="DDI-DrugBank.d782.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d782.s0.p11" e1="DDI-DrugBank.d782.s0.e2"
            e2="DDI-DrugBank.d782.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d782.s0.p12" e1="DDI-DrugBank.d782.s0.e2"
            e2="DDI-DrugBank.d782.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d782.s0.p13" e1="DDI-DrugBank.d782.s0.e2"
            e2="DDI-DrugBank.d782.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d782.s0.p14" e1="DDI-DrugBank.d782.s0.e2"
            e2="DDI-DrugBank.d782.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d782.s0.p15" e1="DDI-DrugBank.d782.s0.e3"
            e2="DDI-DrugBank.d782.s0.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d782.s0.p16" e1="DDI-DrugBank.d782.s0.e3"
            e2="DDI-DrugBank.d782.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d782.s0.p17" e1="DDI-DrugBank.d782.s0.e3"
            e2="DDI-DrugBank.d782.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d782.s0.p18" e1="DDI-DrugBank.d782.s0.e4"
            e2="DDI-DrugBank.d782.s0.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d782.s0.p19" e1="DDI-DrugBank.d782.s0.e4"
            e2="DDI-DrugBank.d782.s0.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d782.s0.p20" e1="DDI-DrugBank.d782.s0.e5"
            e2="DDI-DrugBank.d782.s0.e6" ddi="false"/>
    </sentence>
</document>
<document id="DDI-DrugBank.d759">
    <sentence id="DDI-DrugBank.d759.s0" text="Limited evidence suggests that ascorbic acid may influence the intensity and duration of action of bishydroxycoumarin.">
        <entity id="DDI-DrugBank.d759.s0.e0" charOffset="31-43"
            type="drug" text="ascorbic acid"/>
        <entity id="DDI-DrugBank.d759.s0.e1" charOffset="99-116"
            type="drug" text="bishydroxycoumarin"/>
        <pair id="DDI-DrugBank.d759.s0.p0" e1="DDI-DrugBank.d759.s0.e0"
            e2="DDI-DrugBank.d759.s0.e1" ddi="true" type="mechanism"/>
    </sentence>
</document>
</dataset>
